Final Programme - iuphar

of basic and clinical pharmacology 

WorldPharma2010 

16th World Congress on Basic and Clinical Pharmacology 

17-23 July, 2010, Copenhagen, Denmark 

Final 

Programme 

www.worldpharma2010.org 

Bridging Basic and Clinical 

Pharmacology

WorldPharma2010 

Welcome 3 

Organization 4 – 5 

General information 6 –10 

Registration 6 

Social programme 6 

Visiting Copenhagen 8 

Transportation 9 

Commercial exhibition 9 

Information to presenters 10 

Guidelines 10 

Information on the Internet 10 

Grants and sponsorships 11 

Map of congress venue 12 –13 

Programme at a glance 14 –15 

General events 16 

Day-to-day programme 17– 22 

Oral sessions 24 –157 

Sunday 18 July 24 – 29 

Monday 19 July 30 – 60 

Tuesday 20 July 61 –89 

Wednesday 21 July 90 –119 

Thursday 22 July 120 –147 

Friday 23 July 148 –157 

Poster sessions 159 – 312 

Monday 19 July 160 –198 

Tuesday 20 July 199 – 244 

Wednesday 21 July 245 – 279 

Thursday 22 July 280 – 312 

Index 313 – 381 

Notes 382 – 383 

The WorldPharma2010 scientific programme is the most 

comprehensive and interdisciplinary in the history of IUPHAR congresses 

Professor Sam Enna (USA) 

Secretary General of IUPHAR

Congress patron 

2 HRH Crown Princess Mary

Welcome to Copenhagen 

On behalf of the Danish Pharmacological 

Society and the British Pharmacological 

Society it is our great pleasure 

to welcome you to Copenhagen and 

the 16th World Congress on Basic and 

Clinical Pharmacology, or just World- 

Pharma2010. WorldPharma2010 is 

organized under the auspices of the 

International Union of Basic and Clinical 

Pharmacology, IUPHAR. 

The mission of WorldPharma2010 is to 

discuss how we can work together to 

meet the need for safe and effective 

medicines at affordable prices, and 

how to support the rational and wise 

use of drugs. 

WorldPharma2010 is the first joint 

world congress for both basic and clinical 

pharmacology, and our slogan is: 

“WorldPharma2010 – Bridging Basic 

and Clinical Pharmacology”. The highlevel 

bridge across the Oresound 

between Denmark and Sweden was a 

natural choice as logo. 

We will be approximately 3000 people 

in what most certainly is going to be 

one of the most spectacular events in 

the nearly 50-year history of IUPHAR 

world congresses. 

As you can see from the book that you 

are holding in your hand, the scientific 

programme is a cornucopia of about 

700 oral presentations and nearly 

2000 poster presentations organized 

in the opening lecture, the 50 years 

IUPHAR lecture, 24 plenary lectures, 

18 focused conferences, 36 workshops 

and symposia and one sponsored 

symposium. 

We will take this opportunity to thank 

the members of the local organizing 

and scientific committees, the British 

Pharmacological Society, the international 

scientific committee as well as 

numerous national societies for their 

efforts in what seems to be the most 

comprehensive and interdisciplinary 

scientific programme in IUPHAR’s 

history. We also want to thank all the 

international focused conference 

leaders and invited speakers and all 

the congress delegates for making 

WorldPharma2010 such an outstanding 

event. A special thanks to Rebecca 

Grove-Stephensen for her enthusiasm 

and enormous work in handling over 

3000 abstracts. 

Once again: Welcome to Copenhagen! 

Kim Brøsen Michael J Mulvany 

President Secretary General 

Welcome to Copenhagen 3

Congress President 

Kim Brøsen 

Secretary General 

Michael J Mulvany 

4 Organization 

Organization 

Local Organizing Committee 

Kim Brøsen (chairman) 

Kevin Kearns (for BPS) 

Michael J Mulvany (vice-chairman) 

Hans Bräuner-Osborne 

Ian Ahnfelt-Rønne 

Jørgen Matz 

Jørgen Søberg Petersen 

Host Organizations* 

Jointly with 

Under the auspices of 

of basic and clinical pharmacology 

Local Scientific Committee 

Kim Brøsen (chairman) 

Michael J Mulvany (vice-chairman) 

Ingolf Cascorbi 

Ulrik Gether 

Jesper Hallas 

Edward Högestatt 

Susanne Mandrup 

Helle Birgitte Mengel 

Anders Rane 

Ulf Simonsen 

Donald Singer (for BPS) 

Steffen Thirstrup 

* 

The Danish Society for Pharmacology comprises 

the five Danish pharmacological societies: 

■ Danish Society of Pharmacology, Toxicology 

and Medicinal Chemistry 

■ Danish Society of Clinical Pharmacology 

■ Danish Society of Pharmaco-epidemiology 

■ Danish Society of Clinical Chemical 

Pharmacology 

■ Pharmaceutical Society of Denmark

British Pharmacological Society 

Art Weston 

Chris Garland 

Ian McFadzean 

Jon Peters 

Kevin Park 

Munir Pirmohamed 

International Scientific Committee 

Sue P Duckles, USA 

Patrik du Souich, Canada 

Sam Enna, USA 

Masa Mishina, Japan 

Paul M Vanhoutte, Hong Kong 

Congress Secretariat 

ICS - International Conference Services 

P.O. Box 41 

Strandvejen 169–171 

DK-2900 Hellerup, Copenhagen 

Denmark 

Phone +45 7023 7823 

Fax +45 7023 7888 

E-mail: WorldPharma2010@ics.dk 

Website: www.ics.dk 

Venue 

Bella Center 

Center Boulevard 5 

DK-2300 Copenhagen S 

Phone +45 3252 8811 

E-mail: bc@bellacenter.dk 

Website: www.bellacenter.dk 

Organization 5

General information 

Registration & information desk 

Opening hours: 

Sunday 18 July: 09:00 - 18:30 

Monday 19 July: 07:30 - 18:30 

Tuesday 20 July: 08:00 - 18:30 

Wednesday 21 July: 08:00 - 18:30 

Thursday 22 July: 08:00 - 18:30 

Friday 23 July: 08:00 - 13:00 

Registration fees on-site: 

Regular participants: € 800 

PhD and research students: € 400 

Accompanying persons: € 150 

Hotel accomodation 

The Registration desk will handle all 

enquiries related to hotel accommodation. 

Entitlements participants 

Delegates’ registration includes: 

■ Participation in the scientific 

programme 

■ One copy of final programme 

■ One copy of abstracts 

(on USB-stick) 

■ Refreshment breaks according to 

the programme 

■ Opening reception at the congress 

venue 

■ Reception at City Hall – on 

availability basis 

6 General information 

Entitlements accompanying 

persons 

Accompanying persons’ 

registration includes: 

■ Opening reception at the congress 

venue 

■ Reception at City Hall 

– on availability basis 

■ Sightseeing tour of Copenhagen 

Registration cancellation & 

refund policy 

Credit cannot be given for unattended 

events, late arrivals or early departure. 

All reimbursements will only be processed 

after the congress. 

Social programme 

Sunday 18 July 17:30 - 20:00 

Opening ceremony, lecture and 

reception at the congress venue 

Attendance is free of charge, but 

enrolment is required, which you can 

do when you register. 

Monday 19 July 19:30 - 21:00 

Reception at Copenhagen City Hall 

The Municipality of the City of Copenhagen 

has invited the congress participants 

and their accompanying persons 

to a reception at the City Hall. The 

guests will be welcomed by one of the 

mayors of Copenhagen and a buffet 

will be served.

Fully booked – but returned invitations 

may be available at the registration 

desk. 

Wednesday 21 July 19:00 - 23:30 

Congress Dinner at the Tivoli 

Gardens 

Choose between a casual dinner or a 

gourmet dinner. 

A memorable highlight of the congress 

will be the congress dinner that provides 

an ideal opportunity to mingle and 

meet other colleagues at restaurants in 

the Tivoli Gardens. There will be two 

choices of menus at restaurants next 

to each other: Casual or gourmet. 

Tickets must be purchased at the registration 

desk in advance. 

Price: Casual dinner: € 60 includes a 

welcome drink, three-course dinner and 

2 glasses of wine. 

Gourmet dinner: € 90 includes a glass 

of Crement, a three-course dinner and 

wine ad libitum, coffee and avec. 

Excursions 

Tickets for tourist excursions will be 

sold from the Registration & information 

desk. 

Congress language 

The official language of the congress is 

English. No translation services will be 

provided. 

Name badges 

Entrance to the congress area and to 

the various social events will be limited 

to badge holders only. If the badge is 

lost, please contact the registration 

desk. A fee of DKK 50 (€ 7) will be 

charged for each new badge. 

Voltage and plugs 

Electricity in Denmark is 220-volt 

current. Plugs are European standard 

with two round pins. 

Insurance 

You are requested to arrange your own 

health and travel insurance. Neither the 

congress nor the congress organizers 

are able to take responsibility for any 

injuries or damages that may occur 

during the congress. 

General information 7

Banks, currency & credit cards 

The currency in Denmark is Danish 

Kroner (DKK). Most hotels and shops 

accept all major credit cards. Larger 

shops do also accept Euro. Automated 

cash machines, which you can use with 

your credit card, are available all over 

the city. Banks are open Monday to 

Friday from 10:00 to 16:00, Thursday 

to 18:00. 

Tipping 

Service charges are always included in 

the bill and extra gratuities are not 

necessary. 

Weather and dress 

Denmark has a maritime climate, which 

means that the weather is temperate, 

no extreme heat or cold. In July the 

weather is usually dry and pleasant 

with daytime temperatures around 


18 –22°C. However, rain may occur, 

so please bring a light raincoat or an 

umbrella. 

Visiting Copenhagen 

Copenhagen is at the cross-roads between 

continental Europe and Scandinavia 

and the Baltic area. The sea and 

waterfront dominates the city that has 

kept an old-world charm. The city’s old 

streets and architecture blends in with 

modern design symbolising its rapid 

growth. The modest size of the city is 

a great advantage for visitors. The best 

sights are within the centre which has a 

bustling pedestrian shopping area 

called “Strøget”. Most roads have a 

bike lane, and compared with other 

European cities the traffic is not too 

bad. Visitors may enjoy a leisurely stroll 

in a relaxed and safe environment – or 

a bicycle ride using the ubiquitous “free 

of charge” city bikes.

Transportation 

Copenhagen has an extensive and reliable 

network of public transportation. 

It includes buses, sailing harbour 

buses, trains and metro. 

Kastrup airport – Bella Center 

(congress venue) 

The Bella Center is situated between 

the airport and the city centre. By combining 

the train and the metro the Bella 

Center can be reached within 15 

minutes. Take the Øresundstog (leaving 

every 10 minutes) direction Helsingør/ 

Nivå to Ørestad station (5 minutes). 

Change to the metro (leaving every 4 

minutes) direction Vanløse and get off 

at Bella Center station (2 minutes). The 

fare is DKK 23.00 (€ 3.09). 

Kastrup airport – City centre 

Trains run every 10 minutes between 

the airport and the Copenhagen Central 

Station (Hovedbanegården). The train 

fare is DKK 34.50 (€ 4.65). The metro 

operates at 3–6 minute intervals from 

05:00 until midnight and every 15–20 

minutes during the night. The travel 

time from the airport to central Copenhagen 

is approximately 15 minutes. A 

typical taxi fare between the airport 

and the city centre is approximately 

DKK 200 (€ 26). 

City centre – congress venue 

The taxi fare from central Copenhagen 

to the congress venue comes to about 

DKK 200 (€ 26). Taxis accept credit 

cards. A metro service is available between 

the city centre and the Bella 

Center every 3–6 minutes (duration 

10 minutes). The fare is DKK 23.00 

(€ 3.09). Bus 30 runs between Vesterport 

Station (via Central Station) and the 

airport and stops at the Bella Center. 

Congress venue – Kastrup airport 

The Bella Center is situated between 

the airport and the city centre. By combining 

the metro and the train the airport 

can be reached within 15 minutes. 

The fare is DKK 23.00 (€ 3.09). 

Commercial exhibition 

Exhibition opening hours: 

Sunday 18 July: 18:30 – 21:00 

Monday 19 July: 08:00 – 18:30 

Tuesday 20 July: 08:00 – 18:30 

Wednesday 21 July: 08:00 – 18:30 

Thursday 22 July: 08:00 – 18:30 

Friday 23 July: 08:00 – 13:00 

General information 9

Information to presenters 

■ The auditoria will be equipped with 

PCs with Windows 7 and PowerPoint 

2010 software and data projectors. 

If your presentation is in another 

format (e.g. Mac) we cannot ensure 

compatibility 

■ Please bring your slides in Power- 

Point format on a USB-stick, and 

deliver it to the Speakers Preview 

Room (Room 16) at the congress at 

least 3 hours prior to the session 

start. For morning sessions leave 

them the day before, please 

■ Prepare your oral presentation so 

you have 5 minutes for discussion 

■ If your presentation includes video 

clips, remember to load them separately 

onto your USB-stik, please 

■ Speakers are requested to present 

themselves to the chair in the 

lecture room 15 minutes before 

session start 

Guidelines for posters 

■ The size at your disposal on the 

poster board is: 90 cm width x 120 

cm height. Only pins can be used to 

mount your poster. Pins will be supplied 

at the poster exhibition area 

■ The poster exhibition will take place 

in the Poster Area 


■ Posters should be mounted before 

10:00 on the day of your presentation 

and taken down by 18:00 hours 

the same day. You have been assigned 

a poster board number and date 

and you are expected to be at your 

assigned space 13:00 - 14:00 on 

the day of your presentation. 

Information on the internet 

About the congress: 

www.worldpharma2010.org 

What to see and do in 

Copenhagen: 

www.aok.dk 

Copenhagen Airport: 

www.cph.dk 

The weather in Denmark: 

www.dmi.dk 

The metro: 

www.m.dk 

Information about buses, harbour 

buses and trains: 

www.movia.dk 

www.dsb.dk/s-tog 

To find the easiest way to get 

around: 

www.rejseplanen.dk

Grants and sponsorships 

Major grant for bursaries: 

Diamond sponsors: 

Bronze sponsors 

Sponsors 

ADIS A Wolthers Kluwer Business 

American Society of Pharmacology and Experimental Therapeutics (ASPET) 

AstraZeneca (Italy) 

Danish Cardiovascular Research Academy 

European Association for Clinical Pharmacology and Therapeutics (EACPT) 

The Federation of European Pharmacological Societies (EPHAR) 

Hoffmann La Roche Switzerland 

Novo Nordisk Foundation 

Servier 

Grants and sponsorships 11

Hotel 

Bella Center Copenhagen 

Ground floor 

Hall A2 Hall A3 

Poster Area 

Hall A1 

Registration 

� 

Stairs 

to 1st 

floor 

Mart B-halls 

Cloak room 

Internet 

Bag out 

Aud. 

15 

Stairs to 

1st floor 

Stairs to 

1st floor 

Center hall 

� 

Bus 

Congress 

stop entrance 

West entrance 

12 Bella Center Copenhagen 

Taxi 

Stairs to 

1st floor

Meeting rooms 

1st floor 

10 

Auditorium 

11 12 

BV1 BV2 BV3 

Restaurant 

Bella Vista BV5 

BV4 

� 

Office 

congress dept. 

7 

6 

5 

Congress lobby 

(Ground floor) 

Congress 

entrance 

14 

16 17 

Aud. 15 

16 Speaker prep. room 

18 A 

18 B 

18 19 20 

Balcony 

� 

� 

23 24 25 

21 22 

Bella Center Copenhagen 13 

Scandinavian Trade Mart 

West entrance 

26

Programme at a glance 

Time Hall A2 Hall A3 Aud. 15 Aud. 10 Aud. 11 

Sunday 18 July 

09:45 - 12:45 

12:45 - 14:15 

14:15 - 16:15 

17:30 - 18:45 Opening ceremony – Hall A2 

18:45 - 20:00 Welcome reception – Hall A1 

Monday 19 July 

08:30 - 09:15 PL01 PL02 PL03 

09:30 - 12:15 FC09 FC02 FC05 FC01 FC04 

12:45 - 14:15 SS01 W05 W06 W07 W08 

14:30 - 17:15 FC09 FC02 FC05 FC01 FC04 

17:30 - 18:15 PL04 

Tuesday 20 July 

PL05 PL06 

08:30 - 09:15 PL07 PL08 PL09 

09:30 - 12:15 FC09 FC02 FC05 FC01 FC04 

12:45 - 14:15 W12 W13 W14 W15 W16 

14:30 - 17:15 FC09 FC02 FC05 FC01 FC04 

17:30 - 18:15 IUPHAR Plenary lecture – Hall A2 

18:30 IUPHAR general assembly – Auditorium 15 

Wednesday 21 July 

08:30 - 09:15 PL10 PL11 PL12 

09:30 - 12:15 FC13 FC09 FC16 FC11 FC17 

12:45 - 14:15 W20 W21 W22 W23 W24 

14:30 - 17:15 FC13 FC15 FC16 FC11 FC17 

17:30 - 18:15 PL13 PL14 PL15 

Thursday 22 July 

08:30 - 09:15 PL16 PL17 PL18 

09:30 - 12:15 FC13 FC15 FC16 FC11 FC17 

12:45 - 14:15 W28 W29 W30 W31 W32 

14:30 - 17:15 FC13 FC15 FC16 FC11 FC17 

17:30 - 18:15 PL19 

Friday 23 July 

PL20 PL21 

08:30 - 09:15 PL22 PL23 PL24 

09:30 - 12:15 FC13 FC15 FC16 FC11 FC17 

12:30 - 13:00 Closing ceremony & prize awards – Hall A2 

14 Programme at a glance

Aud. 12 Room 18/19 Room 20 Room BV 1/2/3 Room BV 5 Room 17 

W01 

W04 W02 W03 

W36 

FC06 FC07 FC03 W02 

W09 W10 W11 W02 

FC06 FC07 FC03 FC08 


W17 W04 W19 W18 


FC14 FC10 FC12 YI 

W25 W04 W27 W26 



W33 W34 W35 EPHAR CM 



Programme at a glance 15

16 General events 

General events 

Opening ceremony & opening lecture 

Sunday 18 July 17:30 - 18:45 ■ Hall A2 

Chair: Michael J Mulvany, (Denmark) 

17:30 - 17:45 Opening address 

Kim Brøsen, (Congress President) 

17:45 - 17:50 IUPHAR welcome 

Sue P Duckles, (President of IUPHAR) 

17:55 - 18:15 The Hans Christian Andersen Parade 

18:15 - 18:45 OL Opening lecture 

Found in translation: Human pharmacology and applied pharmacology come of age 

Jeffrey K Aronson, (UK) 

Welcome reception 

Sunday 18 July 18:45 - 20:00 ■ Hall A1 

IUPHAR general assembly 

Tuesday 20 July 18:30 ■ Auditorium 15 

Supported by the ASPET Division for Drug Discovery, Drug Development, and Regulatory Affairs 

Young Investigator Award competition 

Wednesday 21 July 09:15 - 12:15 ■ Room BV 1/2/3 

EPHAR council meeting 

Thursday 22 July 12:45 - 14:15 ■ Room BV 1/2/3 

Closing ceremony & prize awards 

Friday 23 July 12:30 - 13.00 ■ Hall A2 

Presentations to the winners of the Young Investigator Award 

Sue P Duckles and Sam J Ennea 

Information about coming meetings (EACPT2011, WorldPharma 2014) 

Remarks from the new president of IUPHAR 

Closing remarks 

Kim Brøsen

Day-to-day programme 

■ Plenary lectures 

■ Focused conference sessions 

■ Sponsored symposium 

■ Workshop sessions 

Listed in the order in which they are held and are indexed on pages 18 –22 

■ Posters for each day are listed after the oral programme 

Poster sections are indexed on page 159 

Focused Conferences represent a new and important concept. 

Professor Sue P Duckles (USA) 

President of IUPHAR and president of the 14th World Congress on 

Pharmacology (San Francisco, 2002) 

Day-to-day programme 17

Programme outline 

Plenary lectures 

Tue 17:30 IUL Paul M Vanhoutte The 50-Years IUPHAR Anniversary Lecture: Regenerate to be old. 

Sun 17:30 OL Jeffrey K Aronson Found in translation: Human pharmacology and applied 

pharmacology come of age. 

Mon 08:30 PL01 Salvador Moncada Vascular endothelium: Physiology, pharmacology and vascular 

disease. 

Mon 08:30 PL02 Klaus Cichutek Regulatory aspects of biomedicines. 

Mon 08:30 PL03 Trevor Sharp Pharmacological control of central serotonin neurons. 

Mon 17:30 PL04 Emmanuel Canet The challenges of the pharmaceutical industry in the 21st centure. 

Mon 17:30 PL05 Stefanie Dimmeler Cell therapy. 

Mon 17:30 PL06 Carlos Villalon The complex effects of 5-hydroxytryptamine in the cardiovascular 

system. 

Tue 08:30 PL07 Matthias Schwab Personalized medicine beyond pharmacogenetics. 

Tue 08:30 PL08 Thomas Pogge The Health Impact Fund: Making new medicines more accessible 

also for the poor 

Tue 08:30 PL09 Barry Halliwell Antioxidants & free radicals, good or bad? 

Wed 08:30 PL10 Brian K Kobilka Structural insights into GPCR activation. 

Wed 08:30 PL11 Masamitsu Iino Calcium and cell functions. 

Wed 08:30 PL12 Otto Cars Meeting the challenge of antibiotic resistance. 

Wed 17:30 PL13 Jes Olesen New drug targets for headache. 

Wed 17:30 PL14 Shizuo Akira Toll-like receptor and innate immunity. 

Wed 17:30 PL15 Sue P Duckles Understanding the neuroprotective effect of estrogen; inflammation, 

age and mitochondria. 

Thu 08:30 PL16 Olavi Pelkonen Drug metabolism – past, present and future. 

Thu 08:30 PL17 Morris J Brown Therapeutic potential of vaccines in the management of 

hypertension. 

Thu 08:30 PL18 Ian E Hughes Teaching pharmacology in 2020. 

Thu 17:30 PL19 Peter J Barnes Reversal of corticosteroid resistance in severe inflammatory 

diseases: A novel therapeutic strategy. 

Thu 17:30 PL20 Ernesto Schiffrin Renin-angiotensin system and vascular inflammation. 

Thu 17:30 PL21 Thomas Lönngren Successes and challenges in drug development – a regulatory 

perspective. 

Fri 08:30 PL22 Ding-Feng Su New strategies for stroke prevention. 

Fri 08:30 PL23 Elisabeth Bock New molecular targets in Alzheimer’s disease. 

Fri 08:30 PL24 Bernd Mayer Pharmacology of organic nitrates: From 19th century homeopathy 

to genetic mouse models. 

Focused conferences 

FC01 Clinical pharmacology in the emerging countries 

Mon 09:30 FC01.1 Clinical pharmacology and promotion of rational use of medicines in emerging and 

developing countries 

Mon 14:30 FC01.2 Clinical pharmacology and drug regulation in resource limited settings 

Tue 09:30 FC01.3 Clinical trials in countries with developing and emerging economies 

Tue 14:30 FC01.4 Pharmacovigilance in emerging and developing countries: A luxury or a must? 

18 Programme outline

FC02 Transmembrane transport: Perspectives for disease and drug discovery 

Mon 09:30 FC02.1 Molecular structure and pharmacology of membrane transporters 

Mon 14:30 FC02.2 Membrane transporters and disease 

Tue 09:30 FC02.3 Intestinal and hepatic transporters 

Tue 14:30 FC02.4 Membrane transporters: Molecular genetics and pharmacogenetics 

FC03 Ion channels in analgesia and anaesthesia 

Mon 09:30 FC03.1 Ion channel drug targets in the sensory nerve 

Mon 14:30 FC03.2 Voltage-operated calcium channels as targets for analgesic action 

Tue 09:30 FC03.3 Synaptic plasticity in analgesia-related pathways 

Tue 14:30 FC03.4 Ion channels as molecular targets for general anaesthetics 

FC04 Pharmacoepidemiology, current controversies and opportunities 

Mon 09:30 FC04.1 Methodological issues in pharmacoepidemiology 

Mon 14:30 FC04.2 Approaches to screening electronic medical records and claims data 

Tue 09:30 FC04.3 Regulatory challenges in managing risk of medicinal products 

Tue 14:30 FC04.4 In utero exposure to drugs 

FC05 Translational science in the metabolic syndrome: 

Basic and clinical pharmacology 

Mon 09:30 FC05.1 New molecular targets in metabolic syndrome 

Mon 14:30 FC05.2 Translational science in the metabolic syndrome: Basic and clinical pharmacology 

Tue 09:30 FC05.3 Normalizing blood glucose in metabolic syndrome I: GLP-1 analogues and DPP IV 

inhibitors 

Tue 14:30 FC05.4 Normalizing blood glucose in metabolic syndrome II: Glitazones and metformin 

FC06 The heart gone wrong; stabilization of cardiac function 

Mon 09:30 FC06.1 Molecular mechanisms of arrhythmia 

Mon 14:30 FC06.2 Novel anti-arrhythmics 

Tue 09:30 FC06.3 Novel treatments for systolic heart failure 

Tue 14:30 FC06.4 Treatment options for diastolic heart failure 

FC07 Simulation and data modelling in drug development. Better drugs faster? 

Mon 09:30 FC07.1 Modelling and simulation – how and why 

Mon 14:30 FC07.2 Disease models – using virtual organs and patient populations 

Tue 09:30 FC07.3 Modelling and simulation in clinical drug development 

Tue 14:30 FC07.4 Modelling and simulation – A regulator’s view 

FC08 Developments in the treatment of sexual dysfunction and diseases of the lower 

urinary tract 

Mon 14:30 FC08.1 Treatment of sexual dysfunction associated with cardiovascular disease 

Tue 09:30 FC08.2 Pharmacological treatment of lower urinary tract syndrome/benign prostatic hyperplasia 

Tue 14:30 FC08.3 Pharmacological treatment of bladder dysfunction 

FC09 Inflammation and immunopharmacology: New tools for old diseases 

Mon 09:30 FC09.1 Steroids and beyond: Novel treatments for asthma and allergy 

Mon 14:30 FC09.2 Biologicals in inflammatory diseases – successes, promises and problems 

Tue 09:30 FC09.3 iNOS – nitric oxide pathway in inflammation and as a target of anti-inflammatory 

treatment 

Tue 14:30 FC09.4 NSAIDs and COX-2 inhibitors. Current strategies and future directions 

Wed 09:30 FC09.5 Novel anti-inflammatory targets and mechanism 

Programme outline 19

FC10 Drugs for half the world: Paediatric clinical pharmacology 

Wed 09:30 FC10.1 Innovative methodological approaches in drug development in children 

Wed 14:30 FC10.2 WHO and medicines in developing countries 

Thu 09:30 FC10.3 Formulation issues 

Thu 14:30 FC10.4 Pain in children 

Fri 09:30 FC10.5 Recent advance in paediatric clinical pharmacology 

FC11 G protein-coupled 7TM receptors: From molecular to physiological function 

Wed 09:30 FC11.1 7TM receptor structure 

Wed 14:30 FC11.2 7TM receptors: Activation, inactivation and allosteric modulation 

Thu 09:30 FC11.3 7TM receptors: Scaffolding and signalling mechanisms 

Thu 14:30 FC11.4 7TM receptors: Genetic mouse models and disease 

Fri 09:30 FC11.5 7TM receptors: Drug discovery and new physiological functions 

FC12 Ion channelopathies: New windows on complex disease and therapy 

Wed 09:30 FC12.1 Ion channelopathies in the brain: Inherited epilepsy and migraine 

Wed 14:30 FC12.2 Ion channelopathies of peripheral nerve and muscle: Inherited pain and periodic paralysis 

Thu 09.30 FC12.3 Ion channelopathies in the cardiovascular system: Inherited arrhythmia and hypertension 

Thu 14:30 FC12.4 Ion channelopathies in endocrine systems 

Fri 09:30 FC12.5 Ion channelopathies in lymphocytes: Severe combined immunodeficiency and 

store-operated calcium channels 

FC13 Maximising benefits and minimizing harms from drugs 

Wed 09:30 FC13.1 Drug safety: The epidemiology 

Wed 14:30 FC13.2 Drug metabolism and drug toxicity 

Thu 09:30 FC13.3 Pharmacogenomics and adverse drug reactions 

Thu 14:30 FC13.4 New technologies – will they help in developing safer drugs 

Fri 09:30 FC13.5 New insights in the genetics of drug metabolism and action 

FC14 Addiction and doping: Neurobiological and clinical basis of emerging 

treatments 

Wed 09:30 FC14.1 Pharmacological treatment of opiate dependence – much achieved, much left to do 

Wed 14:30 FC14.2 Pharmacological treatments of alcohol dependence – illusion or opportunity? 

Thu 09:30 FC14.3 Craving and relapse to drug seeking: Lessons from animal models and human brain 

imaging 

Thu 14:30 FC14.4 The role of stress in the addictive process 

Fri 09:30 FC14.5 Doping – an underestimated problem with many unknowns 

FC15 Endothelium in health and disease 

Wed 14:30 FC15.1 Nitric oxide and oxidative stress 

Thu 09:30 FC15.2 Endothelium-dependent hyperpolarization 

Thu 14:30 FC15.3 Endothelium-mediated control of vascular tone 

Fri 09:30 FC15.4 Drug development and novet therapeutic targets and approaches 

FC16 Natural products: Past and future? 

Wed 09:30 FC16.1 Cardioprotection by natural products 

Wed 14:30 FC16.2 Products derived from one single plant with convincing pharmacological data in 

explaining their mechanism of action 

Thu 09:30 FC16.3 Multiple plant products: A matter of synergy 

Thu 14:30 FC16.4 East meets west: From prevention to therapy 

Fri 09:30 FC16.5 Globalization of natural/traditional products 


FC17 New approaches and targets in psychiatry 

Wed 09:30 FC17.1 The pathophysiological basis for psychosis 

Wed 14:30 FC17.2 Exploring new targets in schizophrenia using translation science 

Thu 09:30 FC17.3 Clinical aspects of treatment with antipsychotics 

Thu 14:30 FC17.4 Exploring new targets in affective disorders using translational science 

Fri 09:30 FC17.5 New pharmacological approaches for treatment of stress induced mood disorders 

FC18 Nuclear receptor targets for treatment of diseases 

Wed 14:30 FC18.1 Nuclear receptors and metabolic control 

Thu 09:30 FC18.2 Nuclear receptors, vascular function and Inflammation 

Thu 14:30 FC18.3 Nuclear receptors in the CNS 

Fri 09:30 FC18.4 The molecular basis of NR pharmacology 

Sponsored symposium 

Mon 12:45 SS01 Benefit/risk ratio for antipsychotics: Pharmacovigilance evidence and regulatory 

commitments 

Sponsored by AstraZeneca Italy 

Workshops 

W01 Symposium: Pharmacology of adrenoceptors: Eighth satellite meeting 

Sun 09:45 W01.1 Part I – Molecular structure 

Sun 12:45 W01.2 Part II – Pharmacology 

Sun 15:00 W01.3 Part III – Therapeutics 

W02 Symposium: Advances in GI pharmacology 

Sun 12:45 W02.1 Part I – Gastrointestinal nutrient chemosensing and the gut-brain axis 

Mon 9:30 W02.2 Part II – From functional to structural disease targets 

Mon 12:45 W02.3 Part III – From functional to structural disease targets, continued 

Sun 12:45 W03 Workshop: Targeting TRP channels for pain relief (and more) 

W04 Symposium: Antioxidants as therapeutic targets 

Sun 12:45 W04.1 Part I – Systems biology 

Tue 12:45 W04.2 Part II – Cardiovascular health 

Wed 12:45 W04.3 Part III – Antioxidants as therapeutic targets 

Mon 12:45 W05 Workshop: Clinical trials across Europe and the role of pharmacologists 

Mon 12:45 W06 Workshop: Effect of disease on cytochrome p450 and membrane transporters 

Mon 12:45 W07 Workshop: Circadian clocks for drug development and therapeutics 

Mon 12:45 W08 Workshop: Identifying targets for treating vascular diseases associated to metabolic 

disorders 

Mon 12:45 W09 Workshop: Blood cells and cytokines as emerging targets for cardiovascular 

pharmacology 

Mon 12:45 W10 Workshop: Innovative Medicines Initiative: A new approach to education & training in 

medicines research in Europe 

Mon 12:45 W11 Workshop: New opportunities in the pharmacology of neuro-immune interactions 

Tue 12:45 W12 Workshop: Experimental pain methods in development and validation of analgesics 

Programme outline 21

Tue 12:45 W13 Workshop: Novel peripheral mechanisms modulating the cardiovascular system: 

Pathophysiological, pharmacological and therapeutic relevance 

Tue 12:45 W14 Workshop: Translating the human genome: From orphan G-protein coupled 

receptors to novel therapeutic targets 

Tue 12:45 W15 Workshop: The IUPHAR initiative in integrative and organ systems pharmacology 

Tue 12:45 W16 Workshop: Implementation and obstacles of pharmacogenetics in clinical practice 

Tue 12:45 W17 Workshop: Standards for PhD education in pharmacology 

Tue 12:45 W18 Workshop: Low-dose aspirin, COXIBs and other NSAIDs: A clinical mosaic emerges 

Tue 12:45 W19 Workshop: Influence of degeneration and repair in the CNS and periphery 

Wed 12:45 W20 Workshop: Pharmacology education for a sustainable future 

Wed 12:45 W21 Workshop: Inflammation – here, there and everywhere 

Wed 12:45 W22 Workshop: The Pfizer senior investigator award in pharmacology 

Wed 12:45 W23 Workshop: Applying pharmacogenomics (PGX) from research into clinical practice: 

Present and future 

Wed 12:45 W24 Workshop: EU Innovative Medicines Initiative: Better and safer drugs faster for the 

public 

Wed 12:45 W25 Workshop: High science in the lowlands 

Wed 12:45 W26 Workshop: Translational human bio-markers for pain and disease severity in drug 

development 

Wed 12:45 W27 Workshop: Approaches to medicinal plant research in africa: Strategy towards 

2014 and beyond 

Thu 12:45 W28 Workshop: The Boehringer-Ingelheim post-doctoral award 

Thu 12:45 W29 Workshop: New horizons in therapeutic drug management (TDM) 

Thu 12:45 W30 Workshop: Is eNOS Still a valid therapeutic target? – The era after the discovery of 

eNOS uncoupling 

Thu 12:45 W31 Workshop: Developing new drugs for neglected infections 

Thu 12:45 W32 Workshop: The good, the bad and the ugly: When medicines cure most, harm some 

and confuse many 

Thu 12:45 W33 Workshop: Synaptic events in brain function 

Thu 12:45 W34 Workshop: State-of-the-art of basic and clinical pharmacology in Serbia 

Thu 12:45 W35 Workshop: Bridging pharmacovigilance and patient safety – experiences from 

regional pharmacovigilance units 

Sun 14:15 W36 Workshop: Challenges in the conduct of clinical trials in low and middle income 

settings 

Posters will be held on the following days 

Monday, 19 July Mon 001 – 500 

Tuesday, 20 July Tue 001 – 500 

Wednesday, 21 July Wed 001 – 500 

Thursday, 22 July Thu 001 – 500 

Posters will be displayed each day from 10:00 to 17:30. Presenters are asked to be by their poster 

from 13:00 to 14:00. For “on-site” abstracts please refer to material given out at registration. 


YOU’VE ONLY JUST 

ARRIVED & ALREADY 

WE’RE THINKING OF 

YOUR NEXT TRIP 

As the official airline network for the World Pharma 2010, we’d like 

to thank you for choosing the Star Alliance network and hope 

that all goes really well for you here today. 

Whilst you concentrate on the day’s events, we hope you’ll 

consider us the next time you need to attend a conference. 

With over 21,050 flights a day to 1,167 airports across 181 countries, 

our 27 member airlines will extend a wide choice of flights to any 

future conference you’re planning to attend. And no matter which 

of those airline’s frequent flyer programmes you belong to, you 

can earn and redeem miles across all of them. 

So the next time you want to concentrate all your energies 

on your conference, we hope you’ll decide to leave the travel 

arrangements to us. 

www.staralliance.com 

Information correct as at 05/2010

W01 Pharmacology of adrenoceptors: 

Eighth satellite meeting 

Leaders: John Ian McGrath, (UK) & Mika Scheinin, (Finland) 

Part I – Molecular Structure 

Chair: Roger Summers (Australia) 

09:45 - 10:00 W01.1.1 Pharmacology of adrenoceptors – convergence of molecular and integrative and 

systems pharmacology 

Roger J Summers, (Australia) 

10:00 - 11:00 W01.1.2 Crystal structure of β2-adrenoceptors – how we got there and what we learned 

Brian K Kobilka, (USA) 

11:00 - 11:30 W01.1.3 Molecular mechanisms of ligand-regulated receptor activation and oligomerization 

Leonardo Pardo, (Spain) 

11:30 - 12:00 W01.1.4 Agonist-specific conformational changes in α2a-adrenoceptors revealed by 

fluorescence resonance energy transfer 

Carsten Hoffmann, (Germany) 

12:00 - 12:45 LUNCH BREAK 

Part II – Pharmacology 

Chair: John Ian McGrath, (UK) 

12:45 - 13:15 W01.2.1 Pre- versus postsynaptic α2-adrenoceptors 

Ralf Gilsbach, (Germany), J Schneider, J Albarran-Juarez, L Hein 

13:15 - 13:45 W01.2.2 Localisation of adrenoceptors in live native tissue 

John Ian McGrath, (UK) 

13:45 - 14:15 W01.2.3 α1-adrenoceptors in the lower urinary tract 

Ikunobu Muramatsu, (Japan), A Nishimune 

14:15 - 14:40 W01.2.4 α2-adrenoceptors blockade accelerates the neurogenic, neurotrophic, and behavioural 

effects of chronic antidepressant treatment 

Vidita A Vaidya(India), S Yanpallewar, K Fernandes, S Marathe, K Vadodaria, D Jhaveri, 

K Rommelfanger, S Jha, V Muthig, L Hein, P Bartlett, D Weinshenker 

24 Sunday 18 July ■ 09:45 - 14:40 ■ Meeting Room 20

W01 Pharmacology of adrenoceptors: 

Eighth satellite meeting 

Leaders: John Ian McGrath, (UK) & Mika Scheinin, (Finland) 

Part III – Therapeutics 

Chair: Mika Scheinin, (Finland) 

15:00 - 15:20 W01.3.1 Possible therapeutic uses of release-modifying drugs acting on autoreceptors and 

neuronal transporters 

Salomon Z Langer, (Israel) 

15:20 - 15:40 W01.3.2 β3-adrenoceptor agonists in control of overactive bladder function – translational aspects 

Cees Korstanje, (The Netherlands) 

15:40 - 16:00 W01.3.3 The α2C-adrenoceptor as a neuropsychiatric target 

Jukka Sallinen, (Finland) 

16:00 - 16:15 W01.3.4 Concluding remarks: adrenoceptors – what's next? 

Mika Scheinin, (Finland) 

Sunday 18 July ■ 15:00 - 16:15 ■ Meeting Room 20 25

W02 Symposium on advances in GI pharmacology 

Organized by: IUPHAR Gastrointestinal Pharmacology Section 

Leader: Chi Hin Cho, (PR China) 

Part I – Gastrointestinal nutrient chemosensing and the gut-brain axis 

Chairs: Gary K Beauchamp (USA) & Koji Takeuchi (Japan) 

12:45 - 12:50 Opening remarks 

12:50 - 13:15 W02.1.1 Development of taste perception and food preference in human infants 

Gary K Beauchamp, (USA) 

13:15 - 13:40 W02.1.2 Dietary glutamate signal evokes gastric juice excretion in dogs 

Vasiliy Zolotarev, (Russian Federation) 

13:40 - 14:05 W02.1.3 Gastric endocrine cell functions by amino acids 

Eiji Nakamura, (Japan) 

14:05 - 14:30 W02.1.4 Probiotics and gastrointestinal disorders 

Chi Hin Cho, (PR China), CCM Wong 

14:30 - 14:55 COFFEE BREAK 

14:55 - 15:20 W02.1.5 Luminal chemosensing and upper gastrointestinal mucosal defenses 

Yasutada Akiba, (USA), JD Kaunitz 

15:20 - 15:45 W02.1.6 Assessment of MSG-promoted weight gain attenuation and fat oxidation in obese mice 

Ivan de Araujo, (USA), X Ren 

15:45 - 16:10 W02.1.7 Biological significance of glutamate signaling during digestion of food through the 

gut-brain axis 

Kunio Torii, (Japan) 

16:10 - 16:15 Closing remarks 

26 Sunday 18 July ■ 12:45 - 16:15 ■ Meeting Room BV 1/2/3

W03 Targeting TRP channels for pain relief (and more) 

Leaders: Arpad Szallasi (USA) & Kevin S Thorneloe (USA) 

Targeting TRP channels for pain relief (and more) 

Chairs: Pierangelo Geppetti, (Italy) & Riccardo Patacchin, (Italy) 

12:45 - 13:15 W03.1 TRPV1 antagonists for pain relief, cough, and incontinence 

Marcello Trevisani, (Italy) 

13:15 - 13:45 W03.2 TRPV3 receptor as a pain target: a therapeutic promise or just some more new biology? 

Neelima Khairatkar Joshi, (India), A Thomas, S Choudhary, PRVS Lingam, V Kattige, 

S Gullapalli, G Gudi 

13:45 - 14:15 W03.3 Identification of novel TRPV4 modulators 

Fabien Vincent, (USA) 


14:45 - 15:15 W03.4 The rising role of TRPA1 in asthma 

Riccardo Patacchini, (Italy) 

15:15 - 15:45 W03.5 Genetic polymorphisms in TRP channels are associated with the somatosensory function 

in neuropathic pain patients 

Denisa May, (Germany), A Binder, R Baron, C Maier, TR Tölle, R-D Treede, G Wasner, 

H Flor, S Haenisch, C Maihöfner, A Scherens, I Cascorbi 

15:45 - 16:00 W03.6 TRPV4 mutations produce familial digital arthropathy brachydactyly (FDAB) 

Peter McIntyre, (Australia), Y Yuan, I Gresshoff, C Little, D Armor, R Savarirayan, 

E Botzenhart, W Cole, J Bateman, S Lamandé 

Sunday 18 July ■ 12:45 - 16:15 ■ Meeting Room 17 27


Organized by: Canadian Society of Pharmacology and Therapeutics 

Leader: Issy Laher, (Canada) 

Part I – Systems biology 

Chairs: Issy Laher, (Canada) & Christopher M Rembold, (USA) 

12:45 - 13:25 W04.1.1 Free radical biology: what is new? 

Barry Halliwell, (Singapore) 

13:25 - 14:00 W04.1.2 Anti-oxidants and stroke 

Ding-Feng Su, (PR China) 

14:00 - 14:35 W04.1.3 Effect of an extract of Mangifera indica L. in patients with spinocerebellar ataxia type 2 

Mariela Guevara-García, (Cuba), L Velázquez, R Aguilera, R Rodríguez, O Ramírez, 

D Almaguer, G Sánchez, JC Rodríguez 

15:05 - 15:40 W04.1.4 Antioxidant therapy in sepsis 

John X Wilson, (USA) 

15:40 - 16:15 W04.1.5 Different facets of microparticles in the metabolic syndrome 

Ramaroson Andriantsitohaina, (France) 

28 Sunday 18 July ■ 12:45 - 16:15 ■ Meeting Room 18/19

W36 Workshop. Challenges in the conduct of clinical 

trials in low and middle income settings 

Organized by: Centre for International Child Health, University of 

British Columbia, Vancouver, Canada 

Leader: Stuart MacLeod, (Canada) 

Challenges in the conduct of clinical trials in low and middle income 

settings 

Chair: Stuart MacLeod, (Canada) 

14:15 - 14:35 W36.1 Current context for international pediatric clinical trials 

Stuart MacLeod, (Canada) 

14:35 - 14:55 W36.2 WHO Better Medicines for Children Program: objectives 

Suzanne R Hill, (Switzerland) 

14:55 - 15:15 W36.3 Design challenges and methodological innovation 

Martin Offringa, (The Netherlands) 

15:15 - 15:35 W36.4 EMEA perspective on international pediatric clinical trials 

Agnes Saint-Raymond, (UK) 

15:35 - 15:55 W36.5 A viewpoint from Africa 

David Ofori-Adjei, (Ghana) 

15:55 - 16:15 W36.6 A viewpoint from Southeast Asia 

Krisantha Weerasuriya, (India) 

Opening ceremony and opening lecture in Hall A2 

Sunday 18 July 17:30 - 18:45 

Welcome reception in Hall A1 

Sunday 18 July 18·45 - 20:00 

Sunday 18 July ■ 14:15 - 16:15 ■ Meeting Room BV5 29


PL01 Plenary lecture, Hall A2 

Chair: Paul M Vanhoutte, (PR China) 

08:30 - 09:15 PL01 Vascular endothelium: physiology, pharmacology and vascular disease 

Salvador Moncada, (UK) 


Chair: Steffen Thirstrup, (Denmark) 

08:30 - 09:15 PL02 Regulatory aspects of biomedicines 

Klaus Cichutek, (Germany) 

PL03 Plenary lecture, Auditorium 15 

Chair: Sam Enna, (USA) 

08:30 - 09:15 PL03 Pharmacological control of central serotonin neurons 

Trevor Sharp, (UK) 

30 Monday 19 July ■ 08:30 - 9:15


Leader: Lembit Rägo, (Switzerland) 

FC01.1 Clinical pharmacology and promotion of rational use of medicines in 

emerging and developing countries 

Chair: Suzanne R Hill, (Switzerland) 

09:30 - 09:55 FC01.1.1 Clinical pharmacology in developing countries: overview of current status and future 

trends. 

Andrew Walubo, (South Africa) 

09:55 - 10:20 FC01.1.2 Promoting clinical pharmacology in developing countries through education and research 

training 

Folke Sjöqvist, (Sweden) 

10:20 - 10:45 FC01.1.3 Update of the WHO publication on clinical pharmacology 1970: 

what we learned from the process and main outcomes 

Simon RJ Maxwell, (UK) 


11:15 - 11:40 FC01.1.4 Is WHO’s Essential Medicines List contributing to rational medicines use in developing 

countries? 

Andrew L Gray, (South Africa), K Holloway 

11:40 - 11:55 FC01.1.5 Free Communication Presentation: 

Lamivudine trial in hepatitis B surface antigen carriers with persistence hepatitis B core 

IgM antibody 

Husham Ali Alsinde, (Iraq) 


Comparison of efficacy of ORS + Zn verses ORS + Zn + Saccharomyces Boulardii strain 

in treatment of acute non infective diarrhea in Indian children 

Meeta Burande, (India) 

Monday 19 July ■ 09:30 - 12:15 ■ Auditorium 10 31

FC02 Transmembrane transport: 

Perspectives for disease and drug discovery 

Supported by an unrestricted grant from Novo Nordisk Foundation 

Leaders: Randy Blakely, (USA) & Richard Kim, (Canada) 

FC02.1 Molecular structure and pharmacology of membrane transporters 

Chairs: Jonathan A Javitch, (USA) & Ulrik Gether, (Denmark) 

09:30 - 09:55 FC02.1.1 The dopamine transporter: new insights into the molecular actions of cocaine and 

amphetamine 

Ulrik Gether, (Denmark) 

09:55 - 10:20 FC02.1.2 Mechanisms of sodium-coupled transport 

Jonathan A Javitch, (USA), Y Zhao, D Terry, L Shi, M Quick, H Weinstein, SC Blanchard 

10:20 - 10:45 FC02.1.3 Molecular pharmacology of the breast cancer resistance protein (ABCG2) 

Hendrik W van Veen, (UK) 


11:15 - 11:40 FC02.1.4 Structure and function of ABC transporters in health and disease 

Michael M Gottesman, (USA) 


A comparative genomics approach identifies the xenobiotic responsive enhancer as a 

crucial MDR1 upstream regulatory element 

Oliver Burk, (Germany), H Qiu, L Wojnowski, M Schwab 


The influence of drug transporter polymorphisms on atorvastatin and rousvastatin 

plasma concentrations in a patient population 

Marianne DeGorter, (Canada), R Hegele, U Schwarz, R Tirona, R Kim 

32 Monday 19 July ■ 09:30 - 12:15 ■ Hall A3


Organized by the British Pharmacological Society 

Leaders: Clifford J Wolf, (USA) & Nicholas Franks, (UK) 

FC03.1 Ion channel drug targets in the sensory nerve 

Chairs: Peter McNaughton, (UK) & Sulayman D Dib-Hajj, (USA) 

09:30 - 09:55 FC03.1.1 Acid sensing ion channels in sensory perception 

Eric Lingueglia, (France) 

09:55 - 10:20 FC03.1.2 The role of TRP ion channels in pain and temperature sensation 

Ardem Patapoutian, (USA) 

10:20 - 10:45 FC03.1.3 Modulation of TRP channels: impact on pain sensation 

Peter A McNaughton, (UK) 


11:15 - 11:40 FC03.1.4 Voltage sensitive sodium channels in chronic pain states 

Sulayman D Dib-Hajj, (USA) 


Molecular basis of peripheral blockade of inflammatory pain by opioids. 

Thiago Cunha, (Brazil), D Roman-Campos, C Lotufo, H Duarte, G Souza, W Verri Jr, 

S Chiavegatto, J Cruz, M Teixeira, J Hotershall, F Cunha, S Ferreira 


Analgesic actions of a potent sodium channel blocker, HFI-1, in a rat model of 

neuropathic pain due to spinal cord injury 

Bevyn Jarrott, (Australia), R Weston 

Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room 20 33

FC04 Pharmacoepidemiology, current controversies and 

opportunities 

Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark) 

FC04.1 Methodological issues in pharmacoepidemiology 

Chairs: Til Stürmer, (USA) & Jesper Hallas, (Denmark) 

09:30 - 09:55 FC04.1.1 Immortal and immeasurable time biases in pharmacoepidemiology 

Samy Suissa, (Canada) 

09:55 - 10:20 FC04.1.2 Natural experiments in pharmacoepidemiology 

Olaf H Klungel, (The Netherlands) 

10:20 - 10:45 FC04.1.3 Treatment decisions and propensity scores 

Til Stürmer, (USA) 


11:15 - 11:40 FC04.1.4 Healthy starters, sick stoppers, and the value of new user designs with active referents 

in pharmacoepidemiology 

Robert J Glynn, (USA), S Schneeweiss, T Sturmer 


Improved measure of patient's adherence based of prescription claims data 

Lucie Blais, (Canada), M-F Beauchesne, C Lemière, A Forget 


EU-ADR: Opportunities for large-scale drug safety monitoring using multiple healthcare 

databases 

Preciosa Coloma, (The Netherlands), M Schuemie, G Trifirò, R Gini, R Herings, 

J Hippisley-Cox, G Mazzaglia, C Giaquinto, G Corrao, L Pedersen, J van der Lei, 

M Sturkenboom 

34 Monday 19 July ■ 09:30 - 12:15 ■ Auditorium 11



Supported by an unrestricted grant from Novo Nordisk A/S, Denmark 

Leaders: Leif Groop, (Sweden), Henning Beck-Nielsen, (Denmark) & 

Jan-Erik Henriksen, (Denmark) 

FC05.1 New molecular targets in metabolic syndrome 

Chairs: Anna Krook, (Sweden) & Jørgen Rungby, (Denmark) 

09:30 - 09:55 FC05.1.1 Adipose tissue, reducing inflammation as a means of targeting the metabolic syndrome 

Bjørn Richelsen, (Denmark), J Bruun, S Pedersen 

09:55 - 10:20 FC05.1.2 The muscle as a target for treatment of the metabolic syndrome 

Anna Krook, (Sweden) 

10:20 - 10:45 FC05.1.3 Sodium glucose co-transporter 2 inhibitors in the treatment of hyperglycaemia 

John PH Wilding, (UK) 


11:15 - 11:40 FC05.1.4 Solute carrier family 30 proteins as targets for beta-cell stimulation 

Fabrice Chimienti, (France) 


Effect of tempol on insulin sensitivity and renal responses to angiotensin II and 

adrenergic agonists in fructose-fed rats 

Nor A Abdullah, (Malaysia), MH Abdulla, MZ Abdul Sattar, MAH Khan, EJ Johns 


Mitochondria mediated vasodilation and insulin resistance 

David Busija, (USA), P Katakam, A Institoris 


FC06 The heart gone wrong: 

Stabilization of cardiac function 

Leaders: Michael C Sanguinetti, (USA) & Lionel H Opie, (South Africa) 

FC06.1 Molecular mechanisms of arrhythmia 

Chairs: Michael Sanguinetti, (USA) & Søren-Peter Olesen, (Denmark) 

09:30 - 09:55 FC06.1.1 The cardiac hERG channel and arrhythmogenesis 

Michael Sanguinetti, (USA), M Perry, V Garg 

09:55 - 10:20 FC06.1.2 Would modulating intracellular Ca be antiarrhythmic? 

Penelope A Boyden, (USA) 

10:20 - 10:45 FC06.1.3 Cardiac electrical remodeling in health and disease 

David S Rosenbaum, (USA) 


11:15 - 11:40 FC06.1.4 Pharmacological modulation of cardiac potassium channels 

Søren-Peter Olesen, (Denmark), BH Bentzen, K Calloe, J Diness, M Grunnet, RS Hansen 


The B1-kinin receptor antagonism reduces the hypertrophic effects of angiotensin II in 

the cardiovascular system of rats 

Graziela S Ceravolo, (Brazil), TJ Costa, EH Akamine, R Tostes, ZB Fortes, MHC Carvalho 


Quercetin ameliorated isoproterenol-induced and post-infarction remodeling of rat heart: 

haemodynamic, genetic and morphological aspects 

Victor Dosenko, (Ukraine), M Kuzmenko, L Tumanovskaya, V Pavlyuchenko, S Kaplinskiy, 

V Gurianova, A Shalamai, A Moibenko 


FC07 Simulation and data modelling in drug development. 

Better drugs faster? 

Leaders: Hartmut Derendorf, (USA) 

FC07.1 Modelling and simulation – how and why 

Chairs: Hans V Westerhoff, (The Netherlands) & Erik Mosekilde, (Denmark) 

09:30 - 09:55 FC07.1.1 Multiscale modelling of living systems: towards drugs and therapy 

Erik Mosekilde, (Denmark) 

09:55 - 10:20 FC07.1.2 Hitting robustness 

Hiroaki Kitano, (Japan) 

10:20 - 10:45 FC07.1.3 Identifying mechanisms of chronotolerance and chronoefficacy for anticancer drugs 

Albert Goldbeter, (Belgium), A Altinok, F Lévi 


11:15 - 11:40 FC07.1.4 Using systems biology to develop better oncology drugs 

Birgit Schoeberl, (USA) 


Modelling and simulation of data from allostery at a simple pharmaco-dynamic level 

Niels Bindslev, (Denmark) 

Adis Journals are proud to be a 

Bronze Sponsor of WorldPharma 2010 

�� 

� �� 

� �� 

� �� 

�� 

�� 

�� 

Visit us 

at Stand A-006 

Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room 18/19 37

FC09 Inflammation and immunopharmacology: 

New tools for old diseases 

Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland), 

Ian Adcock,(UK) & Frans Nijkamp, (The Netherlands) 

FC09.1 Steroids and beyond: novel treatments for asthma and allergy 

Chairs: Ian Adcock, (UK) & Hiromasa Inoue, (Japan) 

09:30 - 09:55 FC09.1.1 Improving current steroids 

Ian M Adcock, (UK) 

09:55 - 10:20 FC09.1.2 The mast cell as a target for anti-asthma drugs 

Christian Taube, (Germany) 

10:20 - 10:45 FC09.1.3 Effector and regulatory T cells in asthma 

Cezmi A Akdis, (Switzerland) 


11:15 - 11:40 FC09.1.4 Suppressor of cytokine signaling in asthma 

Hiromasa Inoue, (Japan) 


MAP kinase phosphatase-1 as a novel anti-inflammatory target 

Riku Korhonen, (Finland), R Nieminen, T Turpeinen, V Taimi, AR Clark, E Moilanen 


Pitavastatin improves lung inflammation and survival in septic mice: prevention of 

reduced lung glucocorticoid receptors. 

Ken-ichi Takano, (Japan), S Yamamoto, K Tomita, H Yamazaki, H Yokoo, Y Takano, 

Y Hattori 


IN PHARMACOLOGY 

�� 

ACADEMIC PUBLISHING IN THE 21 ST CENTURY 

�� 

�� 

�� 

�� 

�� 

�� 

FRONTIERS IN ANALYTICAL 

AND EXPERIMENTAL 

PHARMACOLOGY 

Martin Michel and 

Salvatore Salomone 

FRONTIERS IN BIOPHARMACY 

AND DRUG DELIVERY SYSTEMS 

Véronique Préat 

FRONTIERS IN CLINICAL TRIALS 

AND PHARMACOTHERAPY 

Filippo Drago 

FRONTIERS IN DRUG DISCOVERY 

Markus Follmann 

FRONTIERS IN DRUG 

METABOLISM AND TRANSPORT 

Jaime Kapitulnik 

FRONTIERS IN 

ETHNOPHARMACOLOGY 

Michael Heinrich 

FRONTIERS IN 

G PROTEIN-COUPLED 

RECEPTOR PHARMACOLOGY 

R A John Challiss 

FRONTIERS IN 

GASTROINTESTINAL 

PHARMACOLOGY 

Gareth J Sanger 

FRONTIERS IN INTEGRATIVE 

PHARMACOLOGY 

Jerry Buccafusco † 

FRONTIERS IN 

NEUROPHARMACOLOGY 

Nicholas M Barnes 

FRONTIERS IN 

PAIN PHARMACOLOGY 

Giustino Varrassi 

FRONTIERS IN PEDIATRIC 

CLINICAL PHARMACOLOGY 

Gérard Pons 

FRONTIERS IN 

PHARMACOECONOMICS 

AND HEALTH OUTCOMES 

Dominique Dubois 

FRONTIERS IN 

PHARMACOGENETICS 

Ulrich Zanger 

FRONTIERS IN PHARMACOLOGY 

OF ION CHANNEL AND 

CHANNELOPATHIES 

Philippe Lory and Diana Conte 

FRONTIERS IN PHARMACOLOGY 

OF NATURAL PRODUCTS 

Ding-Feng Su 

www.frontiersin.org 

FRONTIERS IN 

PHARMACOLOGY OF 

THROMBOSIS 

Bianca Rocca 

FRONTIERS IN 

PHARMACOTHERAPY 

OF CARDIOVASCULAR 

DISORDERS 

Eliot Ohlstein 

FRONTIERS IN 

PHARMACOTHERAPY OF 

INFLAMMATION 

Paola Patrignani 

FRONTIERS IN 

PHARMACOTHERAPY OF 

NEOPLASTIC DISEASES 

Olivier Feron 

FRONTIERS IN 

PREDICTIVE TOXICITY 

Olavi Pelkonen 

FRONTIERS IN 

SIGNAL TRANSDUCTION 

PHARMACOLOGY 

Vincent Laudet



Leader: Sando Szabo, (USA) 

Part II – Advances in GI pharmacology: From functional to structural 

disease targets 

Chairs: Sandor Szabo, (USA) & Koji Takeuchi, (Japan) 

09:30 - 09:35 W02.2.1 GI pharmacology: the importance of bench-to-bedside-and-back concept 

Duan Chen, (Norway) 

09:35 - 10:00 W02.2.2 The changing organ/disease targets & new molecular mechanisms in GI pharmacology 

Sandor Szabo, (USA) 

10:00 - 10:25 W02.2.3 The evolution of proton pump inhibitors: lansoprazole protects the gastrointestinal 

mucosa by a mechanism unrelated to antisecretory action 

Hiroshi Satoh, (Japan), K Amagase, K Takeuchi 


10:50 - 11:15 W02.2.4 Prostaglandin EP receptors and their roles in mucosal protection and ulcer healing in 

gastrointestinal tract 

Koji Takeuchi, (Japan) 

11:15 - 11:40 W02.2.5 Glucocorticoids ARE gastroprotective – in physiologic conditions 

Ludmila Filaretova, (Russian Federation) 

11:40 - 11:55 W02.2.6 CYP2C9*3 is a potent risk factor for NSAID induced gastrointestinal bleeding 

Laurent Becquemont, (France), N Carbonell, C Verstuyft, J Massard, A Letierce, 

C Cellier, L Deforges, F Saliba, JC Delchier 

11:55 - 12:10 W02.2.7 New pharmacologic approach to ulcerative colitis (UC): novel use of D2 dopamine 

receptor (D2R) agonists 

Ganna Tolstanova, (Ukraine), X Deng, T Kaplan, B Paunovic, S Szabo, Z Sandor 

12:15 - 12:45 LUNCH BREAK 

40 Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3



Leader: Sando Szabo, (USA) 

Part III – Advances in GI pharmacology: from functional to structural 

disease targets 

Chairs: Sandor Szabo, (USA) & Koji Takeuchi, (Japan) 

12:45 - 13:10 W02.3.1 The pentadecapeptide BPC 157 is the new drug effective both in the upper & lower GI 

tract 

Predrag Sikiric, (Croatia), S Seiwerth, R Rucman, B Turkovic 

13:10 - 13:35 W02.3.2 Modern pharmacologic approaches to IBS 

Yvett Taché, (USA) 

13:35 - 14:00 W02.3.3 Recent developments in IBD therapy 

Gaetano Iaquinto, (Italy) 

Monday 19 July ■ 12:45 - 14:15 ■ Meeting Room BV 1/2/3 41

SS01 Sponsored symposium 

Sponsored by AstraZeneca Italy 

Benefit/risk ratio for antipsychotics: 

Pharmacovigilance evidence and regulatory commitments 

Chairs: Charles Marsden, (UK) & Filippo Drago, (Italy 

12:45 - 13:10 SS01.1 Risk/benefit assessment of antipsychotic drugs in clinical practice 

Michael Davidson, (Israel) 

13:10 - 13:20 SS01.2 Safety of antipsychotics:pharmacovigilance and regulatory commitments 

Christina Sampaio, (Portugal) 

13:20 - 13:40 SS01.3 Receptor occupancy as a criterion for the assessmentof antipsychotics benefit/risk ratio 

Marco A Riva, (Italy) 

13:40 - 14:00 SS01.4 New drug delivery models: how do they improve antipsychotics benefit/risk ratio? 

Luca Pani, (Italy) 


W05 Workshop. Clinical trials across Europe and the role 

of pharmacologists 

Organized by: Turkish Pharmacological Society 

Leader: Hakki Zafer Güney, (Turkey) 

Clinical trials across Europe and the role of pharmacologists 

Chair: H Zafer Güney, (Turkey) 

12:45 - 13:05 W05.1 Clinical trials across Europe and the role of pharmacologists 

Hakki Zafer Güney, (Turkey) 

13:05 - 13:25 W05.2 Role of pharmacologists in pharmaceutical companies in drug development and 

utilisation 

Ugur Özkutlu, (Switzerland) 

13:25 - 13:45 W05.3 Alternative strategies and trial design for early drug development in oncology – do we 

know what we are doing? 

Volker Wacheck, (Austria) 

13:45 - 14:05 W05.4 The role of clinical pharmacologists in expertorganizations recommending drugs for the 

greater Stockholm area 

Carl-Olav Stiller, (Sweden) 

Monday 19 July ■ 12:45 - 14:15 ■ Hall A3 43

W06 Workshop. Effect of disease on cytochrome p450 

and membrane transporters 


Leader: Patrick du Souich, (Canada) 

Effect of disease on cytochrome p450 and membrane transporters 

Chairs: Patrick du Souich, (Canada) & Micheline Piquette-Miller, (Canada) 

12:45 - 13:00 W06.1 Regulation of cytochrome P450s in inflammation 

Edward T Morgan, (USA) 

13:00 - 13:15 W06.2 Inflammation-mediated alterations on drug transporters; implications on therapeutic drug 

response 

Micheline Piquette-Miller, (Canada) 

13:15 - 13:30 W06.3 Altered drug metabolism and transport in cancer and cachexia 

Graham R Robertson, (Australia), A Painter, L Jankova, J Chick, M Kacevska, M Tsoli, 

R Taylor, M Baker, C Liddle, M Molloy, S Clarke 

13:30 - 13:45 W06.4 Evidence of the impact of kidney disease on drug metabolism and transport 

Vincent Pichette, (Canada) 

13:45 - 14:00 W06.5 Clinical and therapeutic repercussions of disease-induced down-regulation of the 

cytochrome P450 and of membrane transporters 

Patrick du Souich, (Canada) 


W07 Workshop. Circadian clocks for drug development 

and therapeutics 

Organized by: Institut National de la Santé et de la Recherche 

Médicale (INSERM), (France) 

Leader: Francis Lévi, (France) 

Circadian clocks for drug development and therapeutics 

Chairs: Francis Lévi, (France) & Francesco Scaglione, (Italy) 

12:45 - 13:00 W07.1 Chronopharmacology of cardiovascular agents 

Bjoern Lemmer, (Germany) 

13:00 - 13:15 W07.2 The circadian timing system: implications for the personalization of anticancer drug 

delivery 

Francis Lévi, (France) 

13:15 - 13:30 W07.3 Relevance of circadian timing for the development of cyclin dependent kinase inhibitors 

Moustapha Hassan, (Sweden) 

13:30 - 13:45 W07.4 Mathematical modelling of cell proliferation, circadian rhythm and pharmacokineticspharmacodynamics 

to optimise cancer treatments 

Jean Clairambault, (France) 

13:45 - 14:15 W07.5 Mathematical chronoPK-PD models for tailoring chronotherapeutics – 

Round Table Discussion 

Francesco Scaglione, (Italy) 


W08 Workshop. Identifying targets for treating vascular 

diseases associated to metabolic disorders 

Organized under the auspices of Universidad Autónoma de Madrid 

Leader: Concepción Peiró, (Spain) 

Identifying targets for treating vascular diseases associated to metabolic 

disorders 

Chairs: Carlos F Sánchez-Ferrer, (Spain) & Ramaronson Andriantsitahoina, (France) 

12:45 - 13:00 W08.1 Adipokines as regulators of vascular function 

Concepción Peiró, (Spain) 

13:00 - 13:15 W08.2 Different facets of microparticles in the metabolic syndrome 

Ramaronson Andriantsitahoina, (France) 

13:15 - 13:30 W08.3 Which role for high glucose in vascular inflammation? 

Carlos F Sánchez-Ferrer, (Spain) 

13:30 - 13:45 W08.4 Vascular actions of insulin 

Monica Montagnani, (Italy) 

13:45 - 14:00 W08.5 Statins as vascular anti-inflammatory drugs 

Maria-Jesus Sanz, (Spain) 


W09 Workshop. Blood cells and cytokines as emerging 

targets for cardiovascular pharmacology 

Organized by: Spanish Pharmacology Society (SPS) 

Leader: Teresa Tejerina, (Spain) 

Blood cells and cytokines as emerging targets for cardiovascular 

pharmacology 

Chairs: Maria José Alcaraz, (Spain) & Santiago Redondo, (Spain) 

12:45 - 13:00 W09.1 Cytokines and inflammatory disease 

Maria José Alcaraz, (Spain) 

13:00 - 13:15 W09.2 Chemokines as therapeutic targets in atherosclerosis 

Christian Weber, (Germany) 

13:15 - 13:30 W09.3 Cell response of TGF-beta takes central stage in therapeutical design 

Santiago Redondo, (Spain) 

13:30 - 13:45 W09.4 Tumour suppressor genes and cardiovascular diseases 

Vincente Andrés, (Spain), H González-Navarro, JJ Fuster, Y Naim Abu Nabah, A Vinué, 

KI Nakayama, K Nakayama, A Díez-Juan, C Rodríguez, J Martínez-González, M Collado, 

M Serrano 

13:45 - 14:00 W09.5 Stem cell therapy for myocardial repair 

Francisco Fernandez-Aviles, (Spain) 


W10 Workshop. Innovative Medicines Initiative: 

A new approach to education & training in 


Organized by: Austrian Pharmacological Society (APHAR) 

Leader: Michael Wolzt, (Austria) 

Innovative Medicines Initiative: a new approach to education & training in 


Chairs: Michael Wolzt, (Austria) & Michel Goldman, (Belgium) 

12:45 - 13:05 W10.1 EMTRAIN – European Medicines Research Training Network 

Michael Hardman, (UK), J Demotes, I Steneker, M Wolzt on behalf of the EMTRAIN 

Consortium 

13:05 - 13:25 W10.2 SafeSciMET – European modular education and training programme in Safety Sciences 

for Medicine 

Theodor Guentert, (Switzerland), N Vermeulen, L Cornes, L Dencker, P Detilleux, 

D Dietrich, J Dierach, A Hartmann, H Linden, DR Newal, S Price, C Vos on behalf of the 

SafeSciMET Consortium 

13:25 - 13:45 W10.3 PharmaTrain – pharmaceutical medicines training programme 

Fritz R Bühler, (Switzerland), M Hardman, R Bass, J-M Boeynaems, A Chan, S Daniel, 

K Donaldson, M Gottwald, R Hargreaves, J-M Husson, S Kerpel-Fronius, I Klingmann, 

J Lahuerta, A Mollet, G Nell on behalf of the PharmaTrain Consortium 

13:45 - 14:05 W10.4 EU2P – European programme for pharmacovigilance & pharmacoepidemiology 

Deborah Szafir, (France), A Fourrier-Réglat on behalf of the Eu2P Consortium 

48 Monday 19 July ■ 12:45 - 14:15 ■ Meeting Room 18/19

W11 Workshop. New opportunities in the pharmacology 

of neuro-immune interactions 

Organized by: The Federation of European Pharmacological Societies 

(EPHAR) 

Leaders: Ulrich Förstermann, (Germany) & Aletta D Kraneveld, 

(The Netherlands) 

New opportunities in the pharmacology of neuro-immune interactions 

Chairs: Aletta D. Kraneveld, (The Netherlands) & Thomas Griesbacher, (Austria) 

12:45 - 13:10 W11.1 Cytokine-induced sickness behaviour: mechanisms and implications 

Jan-Pieter Konsman, (France) 

13:10 - 13:35 W11.2 Neuropeptide receptors in the control of pain and inflammation: focus on migraine 

Pierangelo Geppetti, (Italy) 

13:35 - 14:00 W11.3 Gut-brain and brain-gut axis revisited: possible implications in IBD and food allergy 

Aletta D Kraneveld, (The Netherlands) 

Monday 19 July ■ 12:45 - 14:15 ■ Meeting Room 20 49



FC01.2 Clinical pharmacology and drug regulation in resource limited settings 

Chair: Alar Irs, (Estonia) 

14:30 - 14:55 FC01.2.1 Regulatory clinical pharmacologist – an ambassador of sanity 

Alar Irs, (Estonia) 

14:55 - 15:20 FC01.2.2 Objective drug information versus advertising 

Krisantha Weerasuriya, (India) 

15:20 - 15:45 FC01.2.3 Drug utilisation monitoring: Planning interventions and guiding selection 

Vera Vlahovic-Palèevski, (Croatia) 


16:15 - 16:40 FC01.2.4 Advise on drug reimbursement issues: A developing country perspective 

Victor Zarate, (UK) 


Pharmacokinetics of isoniazid in Ethiopian Children with tuberculosis in relation to the 

N-acetyltransferase genotype 

Ephrem Engidawork, (Ethiopia), M Ibrahim, G Yimer, K Babosha, A Assefa 


Beneficial effects of ispaghula husk in newly diagnosed patients of type 2 diabetes 

mellitus 

Jaspal Singh Gill, (India), J Rai, PK Gill, S Singh 


FC02 Transmembrane Transport: 




FC02.2 Membrane transporters and disease 

Chairs: Heidrun Potschka, (Germany) & Søren Nielsen, (Denmark) 

14:30 - 14:55 FC02.2.1 ABC transporters in adaptive immunity 

Robert Tampé, (Germany) 

14:55 - 15:20 FC02.2.2 Aquaporines and disease 

Søren Nielsen, (Denmark) 

15:20 - 15:45 FC02.2.3 Multidrug resistance in human epilepsy 

Heidrun Potschka, (Germany) 


16:15 - 16:40 FC02.2.4 The regulation and dysregulation of neurotransmitter transport into synaptic vesicles 

Robert H Edwards, (USA), T Hnasko, G Goh 


Gemfibrozil inhibits epithelial cAMP transport 

Gerda Majgaard Jensen, (Denmark), J Meyer, K Kleberg, N Bindslev 


Transport of mycophenolic acid (MPA) and its glucuronides by OATP1B1*1a and its 

variant OATP1B1*5 

Joerg Koenig, (Germany), H Michelon, L Becquemont, MF Fromm 





FC03.2 Voltage-operated calcium channels as targets for analgesic action 

Chairs: Annette Dolphin, (UK) & Terrance P Snutch, (Canada) 

14:30 - 14:55 FC03.2.1 The slow-inactivation modulation of selective sodium and calcium channel isoforms 

attenuates neuropathic and acute pain signalling by reducing excitability of both 

peripheral nociceptors and dorsal horn spinal cord neurons 

Terrance P Snutch, (Canada) 

14:55 - 15:20 FC03.2.2 Pharmacological regulation of T-type calcium channels in peripheral pain pathways 

Slobodan M Todorovic, (USA) 

15:20 - 15:45 FC03.2.3 Identification of T-type calcium channel blockers 

Emmanuel Bourinet, (France) 


16:15 - 16:40 FC03.2.4 Calcium channel α2δ subunits, dysregulation in disease and therapeutic target 

Annette Dolphin, (UK), C Bauer, A Tran-Van-Minh, J Hendrich, I Kadurin, A Alvarez-Laviada 


Peripheral hyperalgesia via the cyclic AMP/protein kinase A pathway involves activation 

of T-type calcium channels in rats 

Atsufumi Kawabata, (Japan), Y Aoki, F Sekiguchi, M Nakagawa, D Kanaoka, S Yoshida 


Innovative approaches for screening TRPV1 antagonists using noxious heat as a stimulus 

for opening the channel 

Marianthi Papakosta, (UK), J De Cock, R Lane, A Alderton, A Dunlop, A Haythornthwaite, 

R Ward, R Russell 

52 Monday 19 July ■ 14:30 - 17:15 ■ Meeting Room 20


opportunities 


FC04.2 Approaches to screening electronic medical records and claims data 

Chair: Andrew Bate, (USA) 

14:30 - 14:55 FC04.2.1 Approaches to screening electronic medical records and claims data 

Andrew Bate, (USA), RF Reynolds 

14:55 - 15:20 FC04.2.2 The Observational Medical Outcome Partnership (OMOP) initiative. What it is, its 

importance and results so far 

Abraham G Hartzema, (USA) 

15:20 - 15:45 FC04.2.3 An international perspective on screening for adverse effects of drugs and vaccines – 

how far can and should active surveillance go? 

Stephen JW Evans, (UK) 



Ethnic disparities in initiation and persistence to statin treatment in patients with 

diabetes: A nationwide 10-year follow-up study 

Helena Dominguez, (Denmark), TK Schramm, GH Gislason, ML Nørgaard, J Raunsø, 

SZ Abildstrøm, L Køber, HE Poulsen, C Torp-Pedersen 


First trimester exposure to tramadol: a prospective comparative study 

Aurore Gouraud, (France), MN Beyens, M Boyer, P Carlier, MA Thompson, C Garayt, 

N Bernard, T Vial 


SALT-I (Study of Acute Liver Transplant): A study of NSAID-exposed acute liver failure in 

European transplant centres 

Sinem Ezgi Gulmez, (France), S Lignot-Maleyran, C de Vries, MCJM Sturkenboom, 

S Perez-Gutthann, J Bénichou, F Bissoli, D Larrey, GP Pageaux, Y Horsmans, J Bernuau, 

B Stricker, D Thorburn, P Blin, N Moore, on behalf of SALT-I team 


Preadmission antidiabetic treatments and mortality after ischemic stroke in patients with 

diabetes mellitus: a nationwide population-based follow-up study 

Henriette Thisted Horsdal, (Denmark), F Mehnert, J Rungby, SP Johnsen 







FC05.2 Translational science in the metabolic syndrome: Basic and clinical 

pharmacology 

Chairs: Patricia Iozzo, (Finland) & Hans Erik Bøtker, (Denmark) 

14:30 - 14:55 FC05.2.1 Insulin resistance: Marker or mediator of increased cardiovascular risk? 

Heinrich Taegtmeyer, (USA) 

14:55 - 15:20 FC05.2.2 Pathophysiology and treatment of heart failure in patients with type 2 DM 

Paolo G Camici, (UK) 

15:20 - 15:45 FC05.2.3 Antithrombotic treatment in patients with type 2 DM 

Steen Dalby Kristensen, (Denmark) 


16:15 - 16:40 FC05.2.4 Polypharmacy in type 2 diabetes: significance of drug interactions 

Janne T Backman, (Finland) 


Effect of GLP-1 agonist exendin-4 on pharmacological effects of morphine 

Anil Gulati, (USA), M Lavhale, S Briyal, G Matwyshyn, S Sharma 


Muscle specific ablation of LKB1 impairs cardiac function 

Niels Jessen, (Denmark), Ho-Jin Koh, CD Folmes, C Wagg, N Fujii, MF Hirshman, 

GD Lopaschuk, LJ Goodyear 


R&D at a glance 

engineering 

proteins into 

superior therapies 

World-class competence within 

recombinant protein technology 

�� Leader within insulin therapies for 

diabetes 

�� Discoverer of recombinant human 

factor VIIa used as haemostatic 

agent, NovoSeven ® 

�� 

pre-mixed human growth hormone 

delivered in a dedicated pen system, 

Norditropin SimpleXx ® 

1,003 

active patent 

families 

DKK 8 

billion is our 

R&D spend 

15% 

of revenues are 

invested in R&D 

Novo Nordisk is a healthcare company and a world leader in diabetes care. In 

addition, Novo Nordisk has a leading position within areas such as haemostasis 

management, growth hormone therapy and hormone replacement therapy. 

Novo Nordisk manufactures and markets pharmaceutical products and 

services that make a significant difference to patients, the medical profession 

and society. With headquarters in Denmark, Novo Nordisk employs more than 

29,300 employees in 76 countries, and markets its products in 179 countries. 

Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and 

London. Its ADRs are listed on the New York Stock Exchange under the symbol 

‘NVO’. For more information, visit: 

www.novonordisk.com/rd 

5,200 

4,600 people 

work with R&D 

160,000 L 

is the scale up to which 

we express proteins




FC06.2 Novel anti-arrhythmics 

Chairs: Leif Carlsson, (Sweden) & Søren Peter Olesen (Denmark) 

14:30 - 15:15 FC06.2.1 Novel principles for pharmacological treatment of atrial fibrillation 

Leif Carlsson, (Sweden) 

15:15 - 15:45 FC06.2.2 Effect of dronedarone at rest and on exercise in patients with permanent atrial fibrillation 

Jean-Marc Davy, (France) 


16:15 - 16:40 FC06.2.4 Kv1.5 blockers for atrial fibrillation 

Eva Delpón, (Spain) 


Hypertension induced microRNA changes in the rat heart 

Tilde Eskildsen, (Denmark), AY Nossent, M Schneider, D Andersen, M Sandberg, 

H Jensen, P Jeppesen, B Jensen, P Bie, S Sheikh 


Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian 

patients 

Mohamed Gad, (Egypt), S Hassanein, S Abdel-Maksoud, G Shaban, H Elgabarty 





FC07.2 Disease models – using virtual organs and patient populations 

Chairs: Hartmut Derendorf, (USA) & Amin Rostami-Hodjegan, (UK) 

14:30 - 14:55 FC07.2.1 Can we predict pharmacokinetics (PK) in disease populations? 

Amin Rostami-Hodjegan, (UK) 

14:55 - 15:20 FC07.2.2 Integrated models for the glucose – insulin system 

Mats O Karlsson, (Sweden) 

15:20 - 15:45 FC07.2.3 Heart modelling in drug development 

Blanca Rodriguez, (UK) 


16:15 - 16:40 FC07.2.4 From circadian control of PK/PD to personalized cancer chemotherapy and 

chronotherapeutics 

Francis Lévi, (France) 


Target mediated disposition – the central clearance mechanism for anti-IL13R huMAb 

clinical pharmacokinetics 

Yue Huang, (USA), P Lu, J-E Charoin 

Monday 19 July ■ 14:30 - 17:15 ■ Meeting Room 18/19 57

FC08 Development in the treatment of sexual dysfunction 

and diseases of the lower urinary tract 

Leaders: Karl-Erik Andersson, (USA) & Francois Giuliano, (France) 

FC08.1 Treatment of sexual dysfunction associated with cardiovascular disease 

Chairs: Graham Jackson, (UK) & Ulf Simonsen, (Denmark) 

14:30 - 14:55 FC08.1.1 Animal models for sexual dysfunction and cardiovascular disease 

Delphine Behr-Roussel, (France) 

14:55 - 15:20 FC08.1.2 The promise of Rho kinase inhibitors in the treatment of cardiovascular and sexual 

dysfunction 

Kanchan Chitaley, (USA) 

15:20 - 15:45 FC08.1.3 Treatment of sexual dysfunction associated with cardiovascular disease 

Graham Jackson, (UK) 


16:15 - 16:40 FC08.1.4 Effects of cardiovascular drugs on sexual function 

Javier Angulo, (Spain) 

16:40 - 17:00 FC08.1.5 Phosphodiesterase type 5 and inhibitors – an update 

Jackie D Corbin, (USA) 


Expression of connexins and neurochemical receptors in human detrusor: differences in 

gender and in multiple sclerosis 

Elizabeth Burcher, (Australia), F Shang, L Liu, K Vaux, R Millard 

58 Monday 19 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3




Ian Adcock, (UK) & Frans Nijkamp, (The Netherlands) 

FC09.2 Biologicals in inflammatory diseases – successes, promises and problems 

Chair: Marc Feldmann, (UK) & Ian Ahnfelt-Rønne, (Denmark) 

14:30 - 14:55 FC09.2.1 TNF-α antagonists – translating molecular insights in autoimmunity into effective therapy 

Marc Feldmann, (UK) 

14:55 - 15:20 FC09.2.2 Immunomodulatory drugs in multiple sclerosis – from interferon β to specific monoclonal 

antibodies 

Roland Martin, (Germany) 

15:20 - 15:45 FC09.2.3 Immunogenicity and other problems in the use of biologicals 

Michael G Tovey, (France), C Lallemand 



Similar effects of disease modifying anti rheumatic drugs, glucocorticoids and biologics 

on radiographic progression in rheumatoid arthritis. Meta-analysis of 70 randomised 

placebo or drug controlled studies including 112 comparisons 

Niels Graudal, (Denmark), G Jürgens 


Predictive value of pretreatment adipocytokine levels for remission rates in early RA 

treated with DMARDs and infliximab 

Katriina Vuolteenaho (Finland), P Hannonen, M Kauppi, M Korpela, T Möttönen, 

O Kaipiainen-Seppänen, H Kautiainen, R Nieminen, T Levälampi, M Leirisalo-Repo 

16:45 - 17:00 FC09.2.6 Test for neutralising antibodies in hemophilia 

Matthias Germer, (Germany) 


Adverse effects of rituximab in non oncological patients 

Aurore Gouraud, (France), L Moachon, G Miremont, MJ Pastor, C Villier, J Descotes, 

T Vial 




Chair: Jørgen Matz, (Denmark) 

17:30 - 18:15 PL04 The challenges of the pharmaceutical industry in the 21st centure 

Emmanuel Canet, (France) 


Chair: Jørgen Søberg Petersen, (Denmark) 

17:30 - 18:15 PL05 Cell therapy 

Stefanie Dimmeler, (Germany 


Chair: Ulf Simonsen, (Denmark 

17:30 - 18:15 PL06 The complex effects of 5-hydroxytryptamine in the cardiovascular system 

Carlos Villalon, (Mexico) 

Reception at Copenhagen City Hall 

Monday 19 July 19:30 - 21:00 

60 Monday 19 July ■ 17:30 - 18:15

FC01 Clinical Plenary pharmacology lectures in the emerging countries 

Leader: Lembit Rägo (Switzerland) 

PL07 EACPT plenary lecture, Hall A2 

Chair: Ingolf Cascorbi, (Germany) 

08:30 - 09:15 PL07 Personalized medicine beyond pharmacogenetics 

Matthias Schwab, (Germany 


Chair: Mohammed T Khayyal, (Egypt) 

08:30 - 09:15 PL08 The Health Impact Fund: Making new medicines more accessible also for the poor 

Thomas Pogge, (USA) 


Chair: Gabriella Hawksworth, (UK) 

08:30 - 09:15 PL09 Antioxidants & free radicals, good or bad? 

Barry Halliwell, (Singapore) 

Tuesday 20 July ■ 08:30 - 09:15 61



FC01.3 Clinical trials in countries with developing and emerging economies 

Chair: Lembit Rägo, (Switzerland) 

09:30 - 09:55 FC01.3.1 Global drug development in Singapore: regulatory perspective 

Yang-Tong Foo, (Singapore) 

09:55 - 10:20 FC01.3.2 Ethical issues related to the clinical trials outside ICH regions. 

Juntra Karbwang-Laothavorn, (Switzerland) 

10:20 - 10:45 FC01.3.3 Clinical trials registries in countries with emerging and developing economies 

Davina Ghersi, (Switzerland) 



The role of CYP2B6 genetic polymorphisms in predicting toxicity from cyclophosphamide 

based therapy in Lebanese patients with breast cancer or Non-Hodgkin’s Lymphoma 

F Haroun, H Hatoum, A Bazarbachi, A Shamseddin, Z Salem, A Taher, N El Saghir, 

A Tfayli, Nathalie Zgheib, (Lebanon) 


Evaluation of the effect of intramuscular dexamethasone injection on the duration of 

labor and its adverse effects 

Maryam Kashanian, (Iran), F Dadkhah, F Mokhtari 


Randomized, double blind, placebo controlled, evaluation of albendazole in patients with 

single enhancing lesions (SELs) 

Sandeep Kaushal, (India), S Kaur, S Tandon, SC Chopra, G Singh 


Zagreb medical students’ attitudes towards online learning resources on medical 

therapeutics 

Robert Likic, (Croatia), L Bielen, V Erdeljic, KM Ausperger, MR Aumiler, D Juricic, 

I Francetic, S Maxwell 

62 Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 10





FC02.3 Intestinal and hepatic transporters 

Chairs: Richard B Kim, (Canada) & Martin F Fromm, (Germany) 

09:30 - 09:55 FC02.3.1 Organic anion transporting polypeptide (OATP) transporters 

Richard B Kim, (Canada) 

09:55 - 10:20 FC02.3.2 Transporter-mediated drug-interactions 

Martin F Fromm, (Germany) 

10:20 - 10:45 FC02.3.3 Peptide transporters 

Hannelore Daniel, (Germany) 


11:15 - 11:40 FC02.3.4 SLC6 amino acid transporters 

Stefan Broer, (Australia) 


Mapping of the allosteric binding site in the serotonin transporter 

Claus J Loland, (Denmark), P Plenge, L Shi, P Zhang, JA Javitch, AH Newman, 

H Weinstein, U Gether 


A subtle C-terminus mutation of the dopamine transporter results in impaired synaptic 

targeting and an attenuated psychostimulant response, possibly attributable to disrupted 

PDZ-mediated protein-protein interactions 

Mattias Rickhag, (Denmark), G Sørensen, K Nørgaard-Strandfelt, P Weikop, B Andresen, 

EM Füchtbauer, J Gomeza, G Wörtwein, D Woldbye, U Gether 

Tuesday 20 July ■ 09:30 - 12:15 ■ Hall A3 63




FC03.3 Synaptic plasticity in analgesia-related pathways 

Chairs: Clifford J Woolf, (USA) & MacDonald J Christie, (Australia) 

09:30 - 09:55 FC03.3.1 Cellular neuroadaptations to chronic opioids 

MacDonald J Christie, (Australia), E Bagley, J Hacker, G McNally, V Chefer, 

T Shippenberg 

09:55 - 10:20 FC03.3.2 NMDA receptors and chronic pain hypersensitivity 

Mike Salter, (Canada) 

10:20 - 10:45 FC03.3.3 Synaptic dis-inhibition in chronic pain states 

Hans Ulrich Zeilhofer, (Switzerland), A Di Lio, R Witschi, Z-J Wang, RV Edwankar, 

JM Cook 


11:15 - 11:40 FC03.3.4 Selectively targeting ion channels for analgesia 

Clifford J Woolf, (USA) 


D113 of the human 5-HT3A receptor is a major determinant of ion permeation 

John A Peters, (UK), MR Livesey, M Cooper, JJ Lambert 


Stimulation of heteromeric TASK channel trafficking by 14-3-3 protein 

Kathryn Rees, (UK), E Veale, A Mathie 

64 Sunday 20 July ■ 09:30 - 12:15 ■ Meeting Room 20


opportunities 


FC04.3 Regulatory challenges in managing risk of medicinal products 


09:30 - 09:55 FC04.3.1 What are the issues driving the regulatory agenda on drug safety and risk management? 

June M Raine, (UK) 

09:55 - 10:20 FC04.3.2 Are the available research methods sufficiently valid to address current benefit-risk 

issues on medicinal products? 

Stephen JW Evans, (UK) 

10:20 - 10:45 FC04.3.3 New approaches to fill the methods gap in pharmacovigilance 

Marieke de Bruin, (The Netherlands) 



Prescription drug use during pregnancy in Estonia 

Alar Irs, (Estonia), J Iljuhhina, O Laius, J Lass 


Cannabis-related adverse events: A hospitalization-based pharmacoepidemiological study 

Émilie Jouanjus, (France), F Leymarie, M Tubéry, M Lapeyre-Mestre 


Bisphosphonates Effectiveness Safety Tradeoff (BEST) 

Francesco Lapi, (Italy), G Corrao, N Montanaro, M Sturkenboom, P Geppetti, D Gregori, 

F Carle, A Menna, A Caputi, A Vestri, M Valenti, G Mazzaglia 


A model for prediction of adverse drug reactions in hospitalized patients 

Thiyagu Rajakannan, (India), V Guddattu, SR Mallayasamy, R Vilakkthala, S Kamath, 

LK Bairy, PGM Rao 

Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 11 65






FC05.3 Normalizing blood glucose in metabolic syndrome I: GLP-1 analogues and 

DPP IV inhibitors 

Chairs: Michael A Nauck, (Germany) & Jens Juul-Holst, (Denmark) 

09:30 - 09:55 FC05.3.1 Incretin mimetics 2010: the safety experience 

Wolfgang E Schmidt, (Germany) 

09:55 - 10:20 FC05.3.2 GLP-1 secretion as a prerequisite for the antidiabetic activity of DPP-4 inhibitors: 

Can it be modified? 

Fiona M Gribble, (UK) 

10:20 - 10:45 FC05.3.3 Incretin-based medication and cardiovascular disease 

Baptist Gallwitz, (Germany) 


11:15 - 11:40 FC05.3.4 The GlP-1 receptor as a target for treatment of diabetes 

Lotte Bjerre Knudsen, (Denmark) 


Metformin and WIN55212 increases FGF21 expression in primary rat and 

humanhepatocytes 

Eva Byskov Nygaard, (Denmark), S Vienberg, C Ørskov, H Hansen, B Andersen 


Metabolic syndrome associates with resistance to aspirin in patients with coronary artery 

disease 

John Oates, (USA), J Smith, E Haddad, O Boutaud, D Oram, D Blakemore, C Chen, 

M Taylor 




Supported by an unrestricted grant from Danish Cardiovascular 

Research Academy 


FC06.3 Novel treatments for systolic heart failure 

Chair: Juan Tamargo, (Spain) 

09:30 - 09:55 FC06.3.1 Metabolic therapy for heart failure 

Lionel Opie, (South Africa) 

09:55 - 10:20 FC06.3.2 New therapeutic targets in heart failure 

Juan Tamargo, (Spain) 

10:20 - 10:45 FC06.3.3 Effects of serotonin in the failing cardiac ventricle: potential therapeutic implications 

Finn Olav Levy, (Norway) 


11:15 - 11:40 FC06.3.4 Metabolic perturbations, modulators and cardiac function 

Kieran Clarke, (UK) 


Pharmacologic inhibition of SK channels terminates and prevents atrial fibrillation in rat 

and guinea pig ex vivo and in vivo models 

Rie Hansen, (Denmark), J Diness, M Grunnet, T Jespersen, U Sørensen 


Effect of Rho kinase inhibitor Y-27632 on the cardiac proteome in ischemia/reperfusion 

injury 

J Sawicka, V Cadete, D Polewicz, A Doroszko, Grzegorz Sawicki, (Canada) 





FC07.3 Modelling and simulation in clinical drug development 

Chairs: Hans-Günter Schäfer, (Germany) & Hartmut Derendorf, (USA) 

09:30 - 09:55 FC07.3.1 Modelling and simulation in clinical drug development at Boehringer Ingelheim 

Hans-Günter Schäfer, (Germany), A Staab 

09:55 - 10:20 FC07.3.2 Modeling and simulation in clinical drug development at Bristol-Myers Squibb 

Amit Roy, (USA), M Pfister 

10:20 - 10:45 FC07.3.3 Modelling and simulation in clinical drug development at Pfizer 

Sriram Krishnaswami, (USA) 


11:15 - 11:40 FC07.3.4 Modelling and simulation in clinical drug development at Eli Lilly 

Sandra RB Allerheiligen, (USA) 


Therapeutic drug monitoring and population pharmacokinetic modelling of topiramate in 

patients with epilepsy 

Mihajlo Jakovljevic, (Republic of Serbia), T Vovk, M Keres Kos, S Jankovic, A Mrhar, 

I Grabnar 


A population pharmacokinetic study of methotrexate in children with acute lymphoblastic 

leukemia 

N Jebabli, E Gaïes, I Salouage, S Trabelsi, H El jebari, M Lakhal, Anis Klouz, (Tunisia) 

68 Tuesday 20 July ■ 09:30 - 12:15 ■ Meeting Room 18/19




FC08.2 Pharmacological treatment of lower urinary tract syndrome/benign 

prostatic hyperplasia 

Chairs: Karl-Erik Andersson, (USA) & Francois Giuliano, (France) 

09:30 - 09:55 FC08.2.1 Central pharmacological targets for the treatment of ejaculatory disorders 

Francois Giuliano, (France) 

09:55 - 10:20 FC08.2.2 Sensory functions as a basis for symptoms and therapy in the overactive bladder 

Karl-Erik Andersson, (USA) 

10:20 - 10:45 FC08.2.3 GnRH antagonists – from basic science to the clinic in BPH and lower urinary tract 

symptoms (LUTS) 

Enrico Colli, (Denmark) 


11:15 - 11:40 FC08.2.4 BPH – beyond alpha-adrenoceptors and 5a-reductase 

Christian Gratzke, (Germany) 


Hypoxic vasodilatation of penile arteries: involvement of nitric oxide (NO) and modulation 

by reactive oxygen species (ROS) 

Dolores Prieto, (Spain), P Kaminski, M Ahmad, MS Wolin 


Loss of balance between excitatory P2X3 and inhibitory A1 receptors contribute to 

cholinergic hyperactivity in the obstructed human bladder 

Miguel Silva-Ramos, (Portugal), I Silva, M Duarte-Araújo, T Magalhães-Cardoso, 

J Lafuente-de-carvalho, P Correia-de-Sá 

Tuesday 20 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 69





FC09.3 iNOS – nitric oxide pathway in inflammation and as a target of 

anti-inflammatory treatment 

Chairs: Salvador Moncada, (UK) & Eeva Moilanen, (Finland) 

09:30 - 09:55 FC09.3.1 NO as a factor in inflammation 

Eeva Moilanan, (Finland) 

09:55 - 10:20 FC09.3.2 Exhaled NO in the diagnosis and therapy monitoring of inflammatory airway disease 

Kjell Alving, (Sweden) 

10:20 - 10:45 FC09.3.3 Nitric oxide and nitrosative stress in inflammation 

David A Wink, (USA), C Switzer, W Flores-Santana, S Glynn, R Cheng 


11:15 - 11:40 FC09.3.4 iNOS inhibitors in inflammatory diseases: Lessons from animal and human studies 

Richard G Knowles, (UK) 

11:40 - 12:20 FC09.3.5 NO, mitochondrial function and tissue injury in inflammation and septic shock 

Salvador Moncada, (UK) 

70 Tuesday 20 July ■ 09:30 - 12:20 ■ Hall A2




Part II – Cardiovascular health 


12:45 - 13:05 W04.2.1 Anti-oxidants and cardiovascular health 

Ernesto Schiffrin, (Canada) 

13:05 - 13:25 W04.2.2 Anti-oxidants and endothelial progenitor cells 

Alex F Chen, (USA) 

13:25 - 13:45 W04.2.3 Anti-oxidant potential of polyphenols 

Valerie Schini-Kerth, (France) 

13:45 - 14:05 W04.2.4 Future strategies for therapeutic use of antioxidants 

Andreas Daiber, (Germany) 

Tuesday 20 July ■ 12:45 - 14:15 ■ Meeting Room 18/19 71

W12 Workshop. Experimental pain methods in 

development and validation of analgesics 

Organized by: Mech-Sense, Aalborg Hospital & Center for 

Sensory-Motor Interaction (SMI), Aalborg University 

Leader: Asbjørn Mohr Drewes, (Denmark) 

Experimental pain methods in development and validation of analgesics 

Chair: Lona Christrup, (Denmark) 

12:45 - 13:00 W12.1 Experimental pain and analgesics – introduction 

Asbjørn Mohr Drewes, (Denmark) 

13:00 - 13:15 W12.2 Translational human pain biomarkers in drug development 

Lars Arendt-Nielsen, (Denmark) 

13:15 - 13:30 W12.3 Back-translating human pain biomarkers to animals 

Parisa Gazerani, (Denmark), BE Cairns, L Arendt-Nielsen 

13:30 - 13:45 W12.4 Ketamine: Acute and chronic pain relief and its influence on diffuse noxious inhibitory 

control 

Marieke Niesters, (The Netherlands), A Dahan 

13:45 - 14:00 W12.5 Tissue differentiated effects of transdermal buprenorphine and fentanyl 

Trine Andresen, (Denmark), C Staahl, L Arendt-Nielsen, A Mohr Drewes 

14:00 - 14:15 W12.6 Experimental pain: The role of descending inhibition and implications for drug research 

Christina Brock, (Denmark) 


W13 Workshop. Novel peripheral mechanisms 

modulating the cardiovascular system: 

Pathophysiological, pharmacological and 

therapeutic relevance 

Organized by: Mexican Pharmacological Society 

Leader: Carlos Villalón, (Mexico) 

Novel peripheral mechanisms modulating the cardiovascular system: 

pathophysiological, pharmacological and therapeutic relevance 

Chair: Carlos M. Villalón, (Mexico) 

12:45 - 13:05 W13.1 Female sex hormones mediating neurovascular mechanisms involved in the 

pathophysiology of migraine 

Antoinette Maassen van den Brink, (The Netherlands) 

13:05 - 13:25 W13.2 Role of proteinase receptor-2 (PAR2), a novel class of GPCR, in the cranial vasculature 

Saurabh Gupta, (Denmark) 

13:25 - 13:45 W13.3 Comparative pharmacological analysis of the moxonidine-induced cardiac sympathoinhibition 

in rats suffering from spontaneous hypertension 

David Centurión, (Mexico), LE Cobos-Puc, A Sánchez-López, MB Ramírez-Rosas, 

CM Villalón 

13:45 - 14:05 W13.4 The role of α2C-adrenoceptors in UK14304-induced vasoconstrictor responses in rat tail 

arteries: potential relevance in Raynaud’s phenomenon 

Heinz H Pertz, (Germany), F Jantschak 


W14 Workshop. Translating the human genome: 

From orphan G-protein coupled receptors to novel 

therapeutic targets 

Organized by: International Union of Basic and Clinical Pharmacology 

Committee on Receptor Nomenclature and Drug Classification 

(NC-IUPHAR) 

Leader: Anthony Davenport, (UK) 

Translating the human genome: From orphan G-protein coupled receptors 

to novel therapeutic targets 

Chairs: Anthony Davenport, (UK) & Tony Harmar, (UK) 

12:45 - 13:05 W14.1 Apelins and the APJ receptor 

Anthony P Davenport, (UK) 

13:05 - 13:25 W14.2 Relaxin family peptides and their receptors: Realising the therapeutic potential 

Roger J Summers, (Australia), M Halls, E van der Westhuizen, M Kocan, R Bathgate 

13:25 - 13:45 W14.3 Trace amines and TA1 receptors 

Janet J Maguire, (UK) 

13:45 - 14:05 W14.4 Discovery of GPCR ligands for GPR3, a GPCR modulating amyloid secretion in 

Alzheimer’s disease 

David F Fischer, (The Netherlands) 


-DB 

The IUPHAR Database of Receptors and Channels 

The official database of the IUPHAR committee on 

receptor nomenclature and drug classification 

Features include: 

• Comprehensive ligand lists 

• Links to genomic and structural data 

• Tissue distribution 

• Functional and pathophysiological data 

Fully curated data, submitted by world experts 

www.iuphar-db.org

W15 Workshop. The IUPHAR initiative in integrative and 

organ systems pharmacology 

Organized by: IUPHAR Integrative and Organ Systems Pharmacology 

Committee 

Leader: David B Bylund, (USA) 

The IUPHAR initiative in integrative and organ systems pharmacology 

Chair: Sam J Enna, (USA) 

12:45 - 13:10 W15.1 Integrative and organ systems pharmacology 

David B Bylund, (USA) 

13:10 - 13:35 W15.2 Initiatives to support integrative (in vivo) pharmacology and physiology research and 

training in the UK 

Michael Collis, (UK) 

13:35 - 14:00 W15.3 IOSP in Africa 

Christiaan B Brink, (South Africa) 


W16 Workshop. Implementation and obstacles of 

pharmacogenetics in clinical practice 

Organized by: IUPHAR Subcommittee of Pharmacogenetics 

Leader: Ingolf Cascorbi, (Germany) 

Implementation and obstacles of pharmacogenetics in clinical practice 

Chairs: Ingolf Cascorbi, (Germany) & Magnus Ingelmann-Sundberg, (Sweden) 

12:45 - 13:00 W16.1 Challenges in bringing pharmacogenetics into practice: the US perspective 

Deanna Kroetz, (USA) 

13:00 - 13:15 W16.2 Challenges of global implementation of pharmacogenetics into clinical practice 

Guilherme Suarez-Kurtz, (Brazil) 

13:15 - 13:30 W16.3 Present use and limitations of pharmacogenetics in clinical psychiatry 

Adrián Llerana, (Spain) 

13:30 - 13:45 W16.4 Obstacles to the implementation of pharmacogenetic testing in Australia 

Andrew Somogyi, (Australia) 

13:45 - 14:00 W16.5 Imaging pharmacogenetics – brain fMRI for visualizing intermediate phenotypes of drug 

response 

Angela Seeringer, (Germany) 

14:00 - 14:15 W16.6 Postgenomics medicine, empiricism and ethics of bioethics: Preventing both 

underprotection of subjects and misdirected precaution 

Vural Özdemir, (Canada), S Samper 


W17 Workshop. Standards for PhD Education in 

Pharmacology 

Organized by: Danish Society of Pharmacology, Toxicology and 

Medicinal Chemistry 

Leader: Michael J Mulvany, (Denmark) 

Standards for PhD Education in Pharmacology 

Chair: Zdravko Lackovic, (Croatia) 

12:45 - 13:05 W17.1 ORPHEUS: Towards standards for PHd education in biomedicine and health sciences in 

Europe 

Michael J Mulvany, (Denmark), Z Lackovic 

13:05 - 13:25 W17.2 Working towards PhD standardization in the UK 

Nicolas Goulding, (UK) 

13:25 - 13:45 W17.3 Standards for PhD education in the United States 

Joey W Barnett, (USA) 

13:45 - 14:05 W17.4 Setting the standards for PhD education in Turkey, keeping up with dynamisim, giving up 

the nonsense 

Hakan S Orer, (Turkey) 


W18 Workshop. Low-dose aspirin, coxibs and other 

NSAIDs: A clinical mosaic emerges 

Organized by: Italian Society of Pharmacology (SIF) 

Leader: Carlo Riccardi, (Italy) 

Low-dose aspirin, coxibs and other NSAIDs: a clinical mosaic emerges 

Chairs: Carlo Riccardi, (Italy) & Filippo Drago, (Italy) 

12:45 - 13:05 W18.1 Aspirin as an antiplatelet agent: From COX-1 acetylation to randomized clinical trials and 

back 

Carlo Patrono, (Italy) 

13:05 - 13:25 W18.2 Recommendations on aspirin in the primary prevention in diabetic patients: how the same 

data can generate divergent conclusions 

Antonio Nicolucci, (Italy) 

13:25 - 13:45 W18.3 Insights into the efficacy and risk management of COX-2 inhibitors: an example of 

translational medicine 

Paola Patrignani, (Italy) 

13:45 - 14:05 W18.4 Selective COX-2 inhibitors: Where do we go from here? 

Colin N Baigent, (UK), N Bhala, C Patrono 

Tuesday 20 July ■ 12:45 - 14:15 ■ Meeting Room BV 1/2/3 79

W19 Workshop. Influence of degeneration and repair in 

the CNS and periphery 

Organized by: Hungarian Society for Experimental and Clinical 

Pharmacology 

Leader: Beáta Sperlágh, (Hungary) 

Influence of degeneration and repair in the CNS and periphery 

Chair: Zsuzsanna Fürst, (Hungary) 

12:45 - 13:05 W19.1 Analysis of central regulation of gastric mucosal defence in rat 

Klara Gyires, (Hungary), N Shujaa, Z Zádori 

13:05 - 13:25 W19.2 P2X and P2Y receptors in neurodegenerative diseases and neuropathic pain: An update 

Beáta Sperlágh, (Hungary), A Heinrich, R Andó, Z Hracskó, M Baranyi 

13:25 - 13:45 W19.3 Role of the transient receptor potential vanilloid 1 (TRPV1) receptor and sensory 

neuropeptides in airway inflammation and hyperresponsiveness 

Zsuzsanna Helyes, (Hungary), K Elekes, K Sándor, A Kemény, A Markovics, 

E Szöke, E Pintér, M Mester, L Kereskai, JP Quinn, PC Emson, J Szolcsányi 

13:45 - 14:05 W19.4 Cardiac ion channels as therapeutic targets 

András Varró, (Hungary) 

80 Tuesday 20 July ■ 12:45 - 14:15 ■ Meeting Room 20



FC01.4 Pharmacovigilance in emerging and developing countries: 

A luxury or a must? 

Chairs: Ambrose O Isah, (Nigeria) & Lembit Rägo, (Switzerland) 

14:30 - 14:55 FC01.4.1 Specific features of medicines safety and pharmacovigilance in Africa 

Ambrose O Isah, (Nigeria) 

14:55 - 15:20 FC01.4.2 Pharmacovigilance as part of regulatory framework: Brazilan experience 

Murilo Freitas Dias, (Brazil) 

15:20 - 15:45 FC01.4.3 WHO Programme for International Drug Monitoring as an effective framework for 

strengthening national pharmacovigilance systems 

Lembit Rägo, (Switzerland) 



Pilot study examining the frequency of several gene polymorphisms involved in morphine 

pharmacodynamics and pharmacokinetics in a morbidly obese population 

C Lloret Linares, A Hajj, C Poitou, JL Laplanche, JP Lepine, JF Bergmann, 

Stephane Mouly, (France), K Peoc’h 


Self self-reported adherence may be a factor for emergence of drug resistance to 

antiretroviral therapy in resource limited settings 

Celestino Obua, (Uganda), R Balikuddembe, M Ntale, J Kayiwa, S Baveewo, P Waako 


Obesity, diabetes and hypertension associated with antipsychotic use in schizophrenia 

Sahoo Saddichha, (India), N Manjunatha, S Akhtar 


Risk factors for efavirenz-based ART associated hepatotoxicity in treatment naïve HIV 

patients from Ethiopia 

Getnet Yimer, (Ethiopia), W Amogne, A Habtewold, E Makonnen, A Worku, G Aderaye, 

L Lindquist, E Aklillu 






FC02.4 Membrane transporters: Molecular genetics and pharmacogenetics 

Chairs: Randy Blakely, (USA) & Ingolf Cascorbi, (Germany) 

14:30 - 14:55 FC02.4.1 SLC6 Neurotransmitter transporters 

Randy Blakely, (USA) 

14:55 - 15:20 FC02.4.2 Clinical significance of ABCC4 

Heyo K Kroemer, (Germany), G Jedlitschky 

15:20 - 15:45 FC02.4.3 Clinical consequences of transporter variants 

Ingolf Cascorbi, (Germany) 


16:15 - 16:40 FC02.4.4 Regulation of drug transporters 

Gerd A Kullak-Ublick, (Switzerland)) 


Functional expression of ATP-binding cassette (ABC) transporters in a mouse Sertoli cell 

line system (TM4): Relevance to antiretroviral drug (ARV) permeability 

Kevin Robillard, (Canada), R Bendayan 


Polymorphisms in drug transporters rather than drug metabolizing enzymes influence the 

pharmacokinetics but not adverse effects with clonazepam 

Brian Tomlinson, (PR China), BSP Fok, OQP Yin, TTW Chu, M Hu, VHL Lee 





FC03.4 Ion channels as molecular targets for general anaesthetics 

Chairs: Nicholas Franks, (UK) & Michel Lazdunski, (France) 

14:30 - 14:55 FC03.4.1 Ion channels as targets for general anaesthetics 

Nicholas Franks, (UK) 

14:55 - 15:20 FC03.4.2 Two pore domain potassium channels as targets for general anaesthetics 

Michel Lazdunski, (France) 

15:20 - 15:45 FC03.4.3 GABAA receptors as targets for general anaesthetics 

Neil L Harrison, (USA) 


16:15 - 16:40 FC03.4.4 HCN channel subunit specific effects of general anaesthetics 

Douglas A Bayliss, (USA) 


Searching for downstream molecules of N-type voltage-dependent calcium channels 

(Cav2.2) contributing to the neuropathic pain 

Tsutomu Tanabe, (Japan), E Sakurai, T Kurihara, K Kouchi, H Saegusa, S Zong 

Tuesday 20 July ■ 14:30 - 17:15 ■ Meeting Room 20 83


opportunities 


FC04.4 In utero exposure to drugs 

Chairs: Lolkje TW de Jong-van den Berg, (The Netherlands) & 

Corinne de Vries, (The Netherlands) 

14:30 - 14:55 FC04.4.1 The impact of thalidomide and its revival as a vital medicine. 

Lessons learned from history 

Trent D Stephens, (USA) 

14:55 - 15:20 FC04.4.2 Pharmacological considerations of drug teratogenicity – why animal studies are not 

sufficient 

Per Damkier, (Denmark) 

15:20 - 15:45 FC04.4.3 Unique methodological features in the pharmacoepidemiology of birth defects 

Corinne de Vries, (UK) 


16:15 - 16:40 FC04.4.4 Determining drug effects – clinical considerations when establishing birth outcomes 

Lolkje TW de Jong-van den Berg, (UK) 


Risk of ischemic stroke associated with antidepressant drug use in elderly persons 

Gianluca Trifiro, (Italy), J Dieleman, A Caputi, G Gambassi, M Sturkenboom 


Drug safety signal detection and substantiation by integrative mining of electronic healthcare 

records and biomedical knowledge: preliminary results from the EU-ADR project 

Gianluca Trifiro, (Italy), M Sturkenboom, C Diaz Acedo, A Fourrie Reglat, F Sanz, 

JL Oliveira, E Molero, J van der Lei, on behalf of the EU-ADR Consortium 







FC05.4 Normalizing blood glucose in metabolic syndrome II: Glitazones and 

metformin 

Chairs: Philip Home, (UK) & Henning Beck-Nielsen, (Denmark) 

14:30 - 14:55 FC05.4.1 The role of metformin and glitazones in the regulation on hepatic glucose metabolism 

Michael Roden, (Germany) 

14:55 - 15:20 FC05.4.2 Rosiglitazone: Lessons from the RECORD study 

Philip Home, (UK) 

15:20 - 15:45 FC05.4.3 Metformin: Lessons from UKPDS 

Amanda Adler, (UK) 


16:15 - 16:40 FC05.4.4 Translational science in metabolic syndrome – future directions 

Henning Beck-Nielsen, (Denmark) 


PPAR γ agonist pioglitazone provides comparable renoprotection to an ACE inhibitor 

against normotensive nondiabetic nephropathy in rat 

Peter Ochodnicky, (Slovak Republic), J Klimas, L Mesarosova, P Krenek, J Kyselovic 


Zinc Transporter 3, a pharmacological target for the treatment of beta-cell failure? 

Kamille Smidt, (Denmark), A Pedersen, B Brock, J Rungby 





FC06.4 Treatment options for diastolic heart failure 

Chairs: Douglas L Mann, (USA) & Ulf Simonsen, (Denmark) 

14:30 - 15:00 FC06.4.1 Clinical applications of microRNAs in cardiac remodeling and heart failure 

Douglas L Mann, (USA) 

15:00 - 15:30 FC06.4.3 Autophagy and apoptosis in heart failure 

Kinya Otsu, (Japan) 


16:00 - 16:30 FC06.4.4 Rescuing a failing heart 

Mark E Anderson, (USA) 


Hypoxic preconditioning improves survival of human adipose-derived stem cells for 

cardiac tissue engineering 

Samantha Stubbs, (Australia), R Dilley, H Peshavariya, G Dusting 


The interaction of 14-3-3eta and PKCepsilon in cardiocyte protection induced by IPC 

Lei Tang, (PR China), Z Liao, D Yin, Y Luo, Y Liu, M He 

17:00 - 17:15 General discussion 





FC07.4 Modelling and simulation – a regulator’s view 

Jogarao VS Gobburu, (USA) & Hartmut Derendorf, (USA) 

14:30 - 14:55 FC07.4.1 Role of modelling and simulation at the FDA 

Jogarao VS Gobburu, (USA) 

14:55 - 15:20 FC07.4.2 Role of modelling and simulation at the European Medicines Agency 

Franz König, (UK) 

15:20 - 15:45 FC07.4.3 Role of modelling and simulation for drug approval in Asia 

Yuki Ando, (Japan) 


16:15 - 16:40 FC07.4.4 Exposure-response and disease modelling from a regulatory view 

Siv Jönsson, (Sweden), A Henningsson 


Bridging preclinical and clinical data using a population-based simulation software 

Frank Larsen, (Denmark), KG Jensen, KB Petersen 


Tuesday 20 July ■ 14:30 - 17:15 ■ Meeting Room 18/19 87




FC08.3 Pharmacological treatment of bladder dysfunction 

Chairs: Karl Erik Andersson, (USA) & Mark T Nelson, (USA) 

14:30 - 14:55 FC08.3.1 Molecular mechanisms of bladder dysfunction 

George J Christ, (USA) 

14:55 - 15:20 FC08.3.2 Modulation of electromechanical coupling in the bladder 

Christopher H Fry, (UK) 

15:20 - 15:45 FC08.3.3 K channel modulation of bladder contractility 

Mark T Nelson, (USA) 


16:15 - 16:40 FC08.3.4 Botulinum toxin treatment for overactive bladder 

Marcus John Drake, (UK) 


Is there a functional significance of the cyclic AMP-mediated signalling pathway in the 

control of the human prostate? 

Eginhard Waldkirch, (Germany), S Uckert, CG Stief, MA Kuczyk, P Hedlund 


88 Tuesday 20 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3





FC09.4 NSAIDs and COX-2 inhibitors. Current strategies and future directions 

Chairs: Jane A Mitchell, (UK) & Per-Johan Jakobsson, (Sweden) 

14:30 - 14:55 FC09.4.1 Pharmacology of COX-1 and COX-2: Is there still a place for COX-2 selective NSAIDs? 

Jane A Mitchell, (UK) 

14:55 - 15:20 FC09.4.2 Anti-inflammatory benefits and cardiovascular toxicity of NSAIDs and COX-2 inhibitors 

Paola Patrignani, (Italy) 

15:20 - 15:45 FC09.4.3 COX-2 and gastric carcinogenesis 

Ari Ristimäki, (Finland) 


16:15 - 16:40 FC09.4.4 Inhibitors of microsomal PGE synthase-1 

Per-Johan Jakobsson, (Sweden) 

16:40 - 17:05 FC09.4.5 Endocannabinoids and beyond. Paracetamol, NSAIDs and novel mechanisms to treat 

inflammatory pain 

Peter Zygmunt, (Sweden), E Högestätt 


The role of formyl peptide receptor 2 (Fpr2) in leukocytes trafficking 

Vincenzo Brancaleone, (UK), N Dufton, J Dalli, RJ Flower, M Perretti 

IUL IUPHAR Plenary Lecture 

Chair: Sue P Duckles, (USA) 

17:30 - 18:15 IUL The 50-Years IUPHAR Anniversary Lecture: Regenerate to be old 

Paul M Vanhoutte, (PR China) 

IUPHAR general assembly in Auditorium 15 

Tuesday 20 July 18:30 

Supported by the ASPET Division for Drug Discovery, Drug Development, and Regulatory Affairs 


PL10 ASPET Plenary Lecture 

Chair: Thue W Schwartz, (Denmark) 

PL10 Structural insights into GPCR activation 

Brian Kobilka, (USA) 

Wednesday 21 July ■ 08:30 - 09:15 ■ Hall A2 

PL11 Plenary Lecture 

Chair: Urs T Ruegg, (Switzerland) 

PL11 Calcium and cell functions 

Masamitsu Iino, (Japan) 


P12 Plenary Lecture 

Chair: Petra Thürmann, (Germany) 

PL12 PL12 Meeting the challenge of antibiotic resistance 

Otto Cars, (Sweden) 

Wednesday 21 July ■ 08:30 - 09:15 ■ Auditorium 15 

90 Wednesday 21 July ■ 08:30 - 09:15





FC09.5 Novel anti-inflammatory targets and mechanisms 

Chairs: Frans P Nijkamp, (The Netherlands) & J Edwin Blalock, (USA) 

09:30 - 09:55 FC09.5.1 Dendritic cells as targets for immunomodulation in asthma and COPD 

Guy G Brusselle, (Belgium) 

09:55 - 10:20 FC09.5.2 CXC chemokines and antagonists in chronic airway inflammation 

Gert Folkerts, (The Netherlands), E Blalock, S Braber, A Kraneveld, F Nijkamp 

10:20 - 10:45 FC09.5.3 Neuro-immune interactions in health and disease 

J Edwin Blalock, (USA) 



Inhibition of protein kinase C down-regulates the expression of tristetraprolin in activated 

macrophages in an isoenzyme-specific manner 

Tiina Leppänen, (Finland), R Korhonen, RK Tuominen, E Moilanen 


Role of AGEs inhibitors in inflammation and rheumatoid arthritis 

Prem Chand Goel, (India), R Jindal, TG Singh, S Sharma, P Sharma, H Kaur, K Vohra 


Endogenous glucocorticoids inhibit myocardial inflammation induced by 

lipopolysaccharide in rats 

Jian-Dong Luo, (PR China)), H-N Zhang, M-S Chen 


Calcitonin and glucocorticoids – a novel approach to anti-inflammatory co-therapy 

Adam Al-Kashi, (UK), N Moradi, J Dalli, J Gilligan, N Mehta, M Perretti 

Wednesday 21 July ■ 09:30 - 12:15 ■ Hall A3 91

FC10 Drugs for half the world: 

Paediatric clinical pharmacology 

Leader: John N van den Anker, (USA) 

FC10.1 Innovative methodological approaches in drug development in children 

Chair: Gérard Pons, (France) 

09:30 - 09:55 FC10.1.1 Place of the innovative methodological approaches in the development of medicinal 

products in children 

Gérard Pons, (France) 

09:55 - 10:20 FC10.1.2 Increasing role of the observational approaches in the assessment of safety and efficacy 

of medicinal products in children 

Emilio J Sanz, (Spain) 

10:20 - 10:45 FC10.1.3 A collaborative approach to improving the treatment of malaria: 

The Worldwide Antimalarial Resistance Network 

Karen I Barnes, (South Africa) 


11:15 - 11:40 FC10.1.4 Specificities of clinical trials in adolescent girls: contraception and abortion 

Viveca Odlind, (Sweden) 


Determinants of 6-mercaptopurine metabolites concentrations variability during 

maintenance therapy for children with acute lymphoblastic leukemia and occurrence of 

hepatotoxicity 

Tiphaine Adam de Beaumais, (France), M Fakhoury, Y Medard, S Azougagh, D Zhang, 

K Yakouben, E Jacqz-Aigrain 


Large differences in the availability of oral formulations labeled for use in young children 

in Serbia, Germany and the USA 

Milca Bajcetic, (Republic of Serbia), I Jovanovic, M Brajovic, J van den Anker 

92 Wednesday 21 July ■ 09:30 - 12:15 ■ Meeting Room 18/19

FC11 G protein-coupled 7TM receptors: 

From molecular to physiological function 


Leaders: Brian K Kobilka, (USA) & Jean-Philippe Pin, (France) 

FC11.1 7TM receptor structure 

Chair: Gebhard FX Schertler, (UK) 

09:30 - 09:55 FC11.1.1 New G-protein-coupled receptor crystal structures: Insights and limitations. 

Gebhard FX Schertler, (UK) 

09:55 - 10:20 FC11.1.2 Ligand binding and micro-swicthes in 7TM receptor structures 

Thue W Schwartz, (Denmark) 

10:20 - 10:45 FC11.1.3 Signalling state of a G protein coupled 7TM receptor: Insights from spectroscopic and 

structural studies on rhodopsin 

Klaus Peter Hofmann, (Germany) 


11:15 - 11:40 FC11.1.4 Structural views of the extracellular domains of class C GPCRs 

Hisato Jingami, (Japan) 


The selectivity of β-adrenoceptor agonists at the human β1, β2 and β3 adrenoceptors 

Jillian Baker, (UK) 


GPR55; signaling pathways and functions 

Maria Waldhoer, (Austria), NAB Balenga, R Schröder, J Kargl, W Platzer, S Blättermann, 

A Heinemann, E Kostenis 

Wednesday 21 July ■ 09:30 - 12:15 ■ Auditorium 10 93

FC12 Ion channelopathies: 

New windows on complex disease and therapy 

Leader: William A Catterall, (USA) 

FC12.1 Ion channelopathies in the brain: inherited epilepsy and migraine 

Chairs: William A Catterall, (USA) & Daniela Pietrobon, (Italy) 

09:30 - 09:55 FC12.1.1 Sodium channelopathies and epilepsy 

Ingrid Scheffer, (Australia) 

09:55 - 10:20 FC12.1.2 Mechanisms of hyperexcitability, febrile seizure, and ataxia in a mouse model of severe 

myoclonic epilepsy of infancy 

William A Catterall, (USA) 

10:20 - 10:45 FC12.1.3 Functional effects of sodium channel mutations in inherited epilepsy and migraine 

Massimo Mantegazza, (Italy) 


11:15 - 11:40 FC12.1.4 Gain-of-function mutations of calcium channels in familial hemiplegic migraine 

Daniela Pietrobon, (Italy) 


Tyrosine nitration of voltage-dependent calcium channels in experimental colitis. 

Hamid Akbarali, (USA), G Ross, M Kang 


L-type calcium channels dominate the quantal catecholamine release in rat embryo 

cromafín cells stimulated with potassium or hypoxia 

Antonio MG de Diego, (Spain), JC Fernandez-Morales, AG Garcia 

94 Wednesday 21 July ■ 09:30 - 12:15 ■ Meeting Room 20

FC13 Maximising benefits and minimising harms from 

drugs 


Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK) 

FC13.1 Drug safety: The epidemiology 

Chairs: Kees van Grootheest, (The Netherlands) & Alasdair Breckenridge, (UK) 

09:30 - 09:55 FC13.1.1 Adverse drug reactions in hospitals 

Kees van Grootheest, (The Netherlands) 

09:55 - 10:20 FC13.1.2 An industry perspective of drug safety 

Michael A Ibara, (USA) 

10:20 - 10:45 FC13.1.3 Drug regulation and drug safety 

Alasdair Breckenridge, (UK) 


11:15 - 11:40 FC13.1.4 Clinical toxicology perspective of drug safety 

Simon Thomas, (UK) 


Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the 

treatment of respiratory tract infection (HAPPY AUDIT) 

Lars Bjerrum, (Denmark), MP Hansen, JM Cots, C Llor, A Munck, B Gahrn-Hansen 


A drug burden index (DBI) to improve quality use of medicines in Australian war veterans 

and widows 

Danijela Gnjidic, (Australia), S Hilmer, E Roughead, A Gilbert, D Le Couteur, D Abernethy 


FC14 Addiction and doping: Neurobiological and clinical 

basis of emerging treatments 

Leaders: Markus Heilig, (USA) & Yavin Shaham, (USA) 

FC14.1 Pharmacological treatment of opiate dependence – much achieved, 

much left to do 

Chairs: Sharon Walsh, (USA) & Yasmin L Hurd, (USA) 

09:30 - 09:55 FC14.1.1 Efficacy of current pharmacotherapies for opioid dependence: What challenges remain? 

Sharon Walsh, (USA) 

09:55 - 10:20 FC14.1.2 Neurobiological consequences of opioid exposure: Implications for pharmacotherapy 

development 

Yasmin L Hurd, (USA) 

10:20 - 10:45 FC14.1.3 Implication of agonist-selective receptor complexes for opioid dependence 

Christopher Evans, (USA) 


11:15 - 11:40 FC14.1.4 Global impact of opioid pharmacotherapy: Beyond heroin dependence 

Nicolas C Clark, (Switzerland) 


Different Alcohol exposures induce selective alterations on the expression of the 

endogenous opioid system genes: possible epigenetic mechanisms 

Claudio D'Addario, (Italy), F Caputi, R Rimondini, S Candeletti, P Romualdi 


NSAIDs may confound results of urinary testosterone doping tests 

Jonas Lundmark, (Sweden), L Ekström, J-O Thörngren, M Garle, A Rane 

96 Wednesday 21 July ■ 09:30 - 12:15 ■ Auditorium 12


Organized by the IUPHAR Section on the Pharmacology of Natural 

Products 

Leaders: Ricky Ying-Keung Man, (PR China), Tai-Ping Fan, (UK) & 

Zhi-bin Lin, (PR China) 

FC16.1 Cardioprotection by natural products 

Chairs: Roberto Soares de Moura, (Brazil) & David D Ku, (USA) 

09:30 - 09:55 FC16.1.1 Red wine polyphenols 


09:55 - 10:20 FC16.1.2 Cardioprotection by natural products: Dark chocolate 

Thomas F Lüscher, (Switzerland), I Sudano, A Flammer, FT Ruschitzka, G Noll 

10:20 - 10:45 FC16.1.3 Garlic, allicin and NO protection against pulmonary hypertension and right ventricular 

hypertrophy 

David D Ku, (USA) 


11:15 - 11:40 FC16.1.4 Fish oil and ω3-unsaturated omega fatty acids 

Hiroaki Shimokawa, (Japan) 


The Crataegus extract WS® 1442 protects against endothelial hyperpermeability – 

insights into the underlying dual mechanism 

Robert Fürst, (Germany), MF Bubik, P Bihari, G Jürgenliemk, H Ammer, F Krombach, 

S Zahler, AM Vollmar 


Modulation of nuclear transcription factor (NF)-κB as a potential mechanism of Punica 

granatum in inflammatory bowel disease 

Tejal Gandhi, (India), T Shah, K Patel, C Joshi 



Supported by an unrestricted grant from H Lundbeck A/S, Denmark 

Leaders: David J Nutt, (UK) & Birte Glenthøj, (Denmark) 

FC17.1 The pathophysiological basis for psychosis 

Chairs: Anthony A Grace, (USA) & Albert Gjedde, (Denmark) 

09:30 - 09:55 FC17.1.1 Hippocampal hyperactivity drives dopamine hyper-responsivity in an animal model of 

schizophrenia 

Anthony A Grace, (USA) 

09:55 - 10:20 FC17.1.2 Cortical and subcortical dopamine receptor interactions in sensation-seeking 

Albert Gjedde, (Denmark) 

10:20 - 10:45 FC17.1.3 Imaging the dopamine system in schizophrenia: Imbalance between cortical and 

subcortical dopamine regulation 

Anissa Abi-Dargham, (USA) 


11:15 - 11:40 FC17.1.4 Glutamate dysfunction in schizophrenia: From prefrontal cortex to disrupted networks 

Judith Pratt, (UK), N Dawson, B Morris 


Contribution of glycogen synthase kinase-3 to the psychotomimetic effects of ketamine 

Hwei-Hsien Chen, (Taiwan), P-H Chiu, M-H Chan, C-Y Lin 


Molecular imaging in Alzheimer’s disease: From basic to clinical. 

Kazuhiko Yanai, (Japan), S Furumoto, T Yoshikawa, R Iwata, M Tashiro, N Okamura 


YI Young investigators’ session 

Chairs: Sue Piper Duckles, (USA) and SJ Enna, (USA) 

09:30 - 09:45 YI.01 Free Communication Presentation: Reversible allosteric inhibition of RGS GAP activity by 

small molecules reveals a general mechanism for inhibition of protein-protein interactions 

Levi Blazer, (USA), B Greedy, S Husbands, R Neubig 

09:45 - 10:00 YI.02 Free Communication Presentation: Intranasal delivery of mesenchymal stem cells to the 

brain 

Lusine Danielyan, (Germany), R Schäfer, A von Ameln-Mayerhofer, F Bernhard, 

S Verleysdonk, M Buadze, B Proksch, GH Buniatian, M Schwab, WH Frey II, CH Gleiter 

10:00 - 10:15 YI.03 Free Communication Presentation: Functional and structural analysis of NO production by 

equine and naturally occurring estrogens 

Ana Paula Dantas, (Spain), L Novensa, J Selent, M Pastor, K Sandberg, M Heras 

10:15 - 10:30 YI.04 Free Communication Presentation: The impact of TCF7L2 variants on antidiabetic 

treatment regime selection: a Malaysian perspective 

Muhammad H Haron, (Malaysia), R Pendek, Z Mohamed, VL Raj, NA Abdullah 

10:30 - 10:45 YI.05 Free Communication Presentation: The ryanodine receptor – BKCa channel signaling in 

erectile function 

Shreena Joshi, (UK), M Werner, M Nelson 


11:15 - 11:30 YI.06 Free Communication Presentation: Lipocalin-2, an inflammatory adipokine, uncouples 

endothelial nitric-oxide synthase and enhances endothelial dysfunction caused by dietary 

obesity 

Jacky TC Liu, (PR China), A Xu, TW Mak, CF Liang, IKM Law, RYK Man, PM Vanhoutte, 

Y Wang 

11:30 - 11:45 YI.07 Free Communication Presentation: Association between Pro12Ala polymorphism of the 

PPAR-gamma2 gene and insulin sensitivity in Iranian patients with type II diabetes mellitus 

Azadeh Motavallian Naeini, (Iran), H Mirmohammad Sadeghi, M Amini, F Moazen 

11:45 - 12:00 YI.08 Free Communication Presentation: Co-administration of ondansetron reduces the 

analgesic efficacy of tramadol in postoperative pain in humans 

Ana Carolina Pereira do Vale, (Portugal), MFSC Oliveira, JPFC Assunção, CF Ribeiro, 

FC Pereira 

12:00 - 12:15 YI.09 Free Communication Presentation: Molecular predictors in dhfr and dhps genes and in 

vivo response to antifolate in Plasmodium falciparum malaria in Nigerian children 

Ernest Tambo, (Benin), CT Happi, GO Gbotosho, OA Folarin, A Sowunmi, MJ Oduola 

12:15 - 12:30 YI.10 Free Communication Presentation: Identification of a small molecule inhibitor of the 

PICK1 PDZ domain that inhibits hippocampal LTP and LTD 

Thor S Thorsen, (Denmark), KL Madsen, N Rebola, MA Rathje, V Anggono, A Bach, 

IS Moreira, N Stuhr-Hansen, T Dyhring, D Peters, T Beuming 

Wednesday 21 July ■ 09:30 - 12:30 ■ Meeting Room BV 1/2/3 99




Part III – Antioxidants as therapeutic targets 


12:45 - 13:05 W04.3.1 Molecular aspects of ROS generation by Noxes – (patho)physiological implications 

Rhian Touyz, (Canada) 

13:05 - 13:25 W04.3.2 Investigations of green tea polyphenols using the mouse model of Duchenne muscular 

dystrophy 

Urs T Ruegg, (Switzerland), C Gallo, J Patte-Reutenauer, E Gayi, O Dorchies 

13:25 - 13:45 W04.3.3 Sirtuin1 is a molecular switch for cardiovascular oxidative stress 

Huige Li, (Germany) 

13:45 - 14:05 W04.3.4 Success and failures in the use of anti-oxidants 

Christopher M Rembold, (USA) 

100 Wednesday 21 July ■ 12:45 - 14:15 ■ Meeting Room 18/19

W20 Workshop. Pharmacology education for a 

sustainable future 

Organized by: IUPHAR Teaching Section 

Leaders: Christiaan B Brink, (South Africa) & Patangi K Rangachari, 

(Canada) 

Pharmacology education for a sustainable future 

Chair: Joan M Lakoski, (USA) 

12:45 - 13:05 W20.1 E-learning and e-assessment in pharmacology 

Paul White, D Dewhurst 

13:05 - 13:25 W20.2 Teaching pharmacology in a global arena 

Christiaan B Brink, (South Africa) 

13:25 - 13:45 W20.3 Active teachers/ engaged students: A status report 

Patangi K Rangachari, (Canada) 

13:45 - 14:05 W20.4 Pharmacology education for clinical students 

Simon Maxwell, (UK) 


W21 Workshop. Inflammation – here, there and 

everywhere 

Organized by: Finnish Pharmacological Society 

Leaders: Heikki Vapaatalo, (Finland) & Eeva Moilanen, (Finland) 

Inflammation – here, there and everywhere 

Award Winners’ Symposium – Young Investigators from Finland 

Chairs: Heikki Vapaatalo, (Finland) & Eeva Moilanan, (Finland) 

12:45 - 13:00 W21.1 Inflammation in vasculature – could it be affected by nutrition? 

Pauliina Jäkälä, (Finland) 

13:00 - 13:15 W21.2 Novel immunomodulatory factors in cardiac hypertrophy and heart failure 

Jaana Rysä, (Finland) 

13:15 - 13:30 W21.3 Neuroinflammation – Stem-cell derived neural progenitors and inflammatory response in 

a mouse model of cerebral stroke 

Katja A Puttonen, (Finland), K Savolainen, M Ruponen, T Malm, J Koponen, 

S Ylä-Herttuala, J Koistinaho, O Hovatta, A Muona 

13:30 - 13:45 W21.4 Inflammation and obesity – neuropeptide Y in pathogenesis of metabolic syndrome 

Suvi Ruohonen, (Finland), L Toukola, S Ruohonen, M Röyttä, E Savontaus 

13:45 - 14:00 W21.5 Novel treatments of arthritis – MAP kinase pathways in the focus 

Riina Nieminen, (Finland), R Korhonen, T Moilanen, AR Clark, E Moilanen 

102 Wednesday 21 July ■ 12:45 - 14:15 ■ Hall A3

W22 Workshop. The Pfizer senior investigator award in 

pharmacology 


Leader: Kathryn Gaebel, (Canada) 

The Pfizer senior investigator award in pharmacology 

Chair: Richard Kim, (Canada) 

13:00 - 14:00 W22 From Peroxynitrite to Tetracyclines: Targeting intracellular matrix metalloproteinase-2 in 

heart disease 

Richard Schulz, (Canada) 


W23 Workshop. Applying pharmacogenomics (PGX) from 

research into clinical practice: Present and future 

Organized by: The Japanese Society of Clinical Pharmacology and 

Therapeutics 

Leader: Hiroshi Watanabe, (Japan) 

Applying pharmacogenomics (PGX) from research into clinical practice: 

Present and future 

Chairs: Shinichi Kawai, (Japan) & Kyoichi Ohashi, (Japan) 

12:45 - 13:00 W23.1 PGx from research into clinical practice (overview) 

Hiroshi Watanabe, (Japan), K Takeuchi, N Inui 

13:00 - 13:15 W23.2 GWAS and PGx in rheumatological treatment 

Naoyuki Kamatani, (Japan) 

13:15 - 13:30 W23.3 Pharmacogenetics and cardiovascular treatment 

Dan M Roden, (USA) 

13:30 - 13:45 W23.4 PGx and treatment of upper GI disorders 

Takahisa Furuta, (Japan), M Sugimoto, C Kodaira, M Nishino, M Yamade, T Uotani, 

K Umemura, H Watanabe 

13:45 - 14:00 W23.5 PGx and cancer treatment 

Magnus Ingelman-Sundberg, (Sweden) 


W24 Workshop. EU Innovative Medicines Initiative: 

Better and safer drugs faster for the public 

Organized by: EU IMI 

Leader: Adam Vas, (Hungary) 

EU Innovative Medicines Initiative: Better and safer drugs faster for the 

public 

Chairs: Adam Vas, (Hungary) & Michel Goldman, (Belgium) 

12:45 - 13:05 W24.1 Innovative Medicines Initiative: The EU at the forefront of novel R&D partnerships 

Michel Goldman, (Belgium) 

13:05 - 13:25 W24.2 Challenges and opportunities in drug research 

Christian Noe, (Austria) 

13:25 - 13:45 W24.3 IMI and the Hungarian answer: National platform on drug research 

Adam Vas, (Hungary) 

13:45 - 14:05 W24.5 Stem cells and microRNA in drug discovery 

Jozef Dulak, (Poland) 


W25 Workshop. High science in the lowlands 

Organized by: NVF – Dutch Pharmacological Society 

Leaders: AE Alewijnse, (The Netherlands) & Aletta K Kraneveld, 


High science in the lowlands 

Chairs: Astrid E Alewijnse, (The Netherlands) & Martina Schmidt, 


12:45 - 13:10 W25.1 GPCR crystal structures: She is beautiful 

Adriaan P IJzerman, (The Netherlands) 

13:10 - 13:35 W25.2 Love for opium and beyond 

Jan Marius van Ree, (The Netherlands) 

13:35 - 14:00 W25.3 Endothelial pharmacology in the Dutch Top Institute Pharma 

Jo GR de Mey, (The Netherlands) 


W26 Workshop. Translational human bio-markers for 

pain and disease severity in drug development 

Organized by: Center for Sensory-Motor Interaction (SMI) Aalborg 

University and Nordic Bioscience a/s, Denmark 

Leader: Lars Arendt-Nielsen, (Denmark) 

Translational human bio-markers for pain and disease severity in drug 

development 

Chair: Lars Arendt-Nielsen, (Denmark) 

12:45 - 13:00 W26.1 Translational human pain bio-markers in early drug development 

Lars Arendt-Nielsen, (Denmark) 

13:00 - 13:15 W26.2 Biochemical markers of tissue remodelling: translational science and the FDA critical 

path – marker of prognosis and drug efficacy in arthritis 

Morten A Karsdal, (Denmark), A-C Bay-Jensen, K Henriksen, C Christiansen 

13:15 - 13:30 W26.3 Inflammatory pain-biomarkers assessed by microdialysis: A new method for target 

validation of new compounds 

Lars J Petersen, (Denmark) 

13:30 - 13:45 W26.4 Bio-markers related to cartilage degradation and pain in arthritic diseases: Combining 

MRI and biochemical marker based techniques 

Anne Christine Bay-Jensen, (Denmark), K Henriksen, C Christiansen, E Dam, M Karsdal 

13:45 - 14:00 W26.5 The impact of combining different biochemical markers in the evaluation of drugs within 

pain in early clinical development 

Hans Christian Hoeck, (Denmark) 

Wednesday 21 July ■ 12:45 - 14:15 ■ Meeting Room BV 1/2/3 107

W27 Workshop. Approaches to medicinal plant research 

in Africa: Strategy towards 2014 and beyond 

Organized by: Pharmacology for Africa (PharfA) Initiative 

Leader: Christiaan B Brink, (South Africa) 

Approaches to medicinal plant research in Africa: Strategy towards 2014 

and beyond 

Chair: Douglas W Oliver, (South Africa) 

12:45 - 13:00 W27.1 Purified plant extracts as lead compounds in pharmacology research 

Anis Klouz, (Tunisia) 

13:00 - 13:15 W27.2 The utilization of crude plant extracts to investigate pharmacological effects: Potential 

and pitfalls 

Badiaa Lyoussi, (Morocco) 

13:15 - 13:30 W27.3 The utilization of crude plant extracts to investigate toxicity: Potential and pitfalls 

Anastasia Guantai, (Kenya) 

13:30 - 13:45 W27.4 Clinical testing and pharmacovigilance data for scientific evaluation of medicinal plants 

used in traditional medicine 

Alexander Dodoo, (Ghana) 

13:45 - 14:00 W27.5 Cultural-ethical dilemmas in medicinal plant research 

Guata Yoro Sy, (Senegal) 

14:00 - 14:15 Approaches to medicinal plant research – What works best in Africa? Opportunities in 

Africa, pitfalls, capacity building strategies, way forward towards 2014 and beyond 

Panel Discussion led by Douglas W Oliver, (South Africa) 

108 Wednesday 21 July ■ 12:45 - 14:15 ■ Meeting Room 20




FC10.2 WHO and medicines in developing countries 

Chair: Kalle Hoppu, (Finland) 

14:30 - 14:55 FC10.2.1 Introduction & background : Why and how was the resolution WHA 60.20 better 

medicines for children born 

Kalle Hoppu, (Finland) 

14:55 - 15:20 FC10.2.2 Essential Medicines List for children and other activities related to paediatric medicines 

by the WHO 

Suzanne R Hill, (Switzerland) 

15:20 - 1545 FC10.2.3 Essential medicines list for children, what it means for the developing countries 

Shalini Sri Ranganathan, (Sri Lanka) 


16:15 - 16:40 FC10.2.4 Case: Use of old data and modern scientific methods to provide more rational dosing 

and FDC formulations of TB medicines for children 

Gregory L Kearns, (USA), SM Abdel-Rahman 


Homocysteine as a biomarker for vascular disease in children and adolescents with 

epilepsy 

Laura S Cheng, (Canada), DJ Freeman, FH Mahmud, AN Prasad, MJ Rieder 


Antibiotic resistance of E.coli urinary tract isolates in pediatric patients hospitalized in a 

University Pediatric Hospital in Novi Sad, Serbia 

Emil Jakovljevic, (Republic of Serbia), K Ilic, G Kostantinidis 

Wednesday 21 July ■ 14:30 - 17:15 ■ Meeting Room 18/19 109





FC11.2 7TM receptors: Activation, inactivation and allosteric modulation 

Chairs: Jean Philippe R Pin, (France) & Thue W Schwartz, (Denmark) 

14:30 - 14:55 FC11.2.1 Molecular dynamics of metabotropic glutamate and GABA receptors 

Jean Philippe R Pin, (France), L Comps-Agrar, C Monnier, E Trinquet, J Kniazeff, 

P Rondard, L Prezeau 

14:55 - 15:20 FC11.2.2 Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology 

Arthur Christopoulos, (Australia) 

15:20 - 15:45 FC11.2.3 Allosteric modulation of adenosine receptors 

Adriaan P IJzerman, (The Netherlands) 


16:15 - 16:40 FC11.2.4 Activation and inactivation of chemokine 7TM receptors 

Mette M Rosenkilde, (Denmark) 


Towards pharmacological tissue selectivity: screening for novel nicotinic acid receptor 

ligands that avoid on-target adverse effects 

Clara C Blad, (The Netherlands), JP van Veldhoven, MR van Winsen, J Brussee, JR Lane, 

AP Ijzerman 


Serotonin 2A receptor interaction with the microtubule-associated protein 1A: 

Implications for Alzheimer’s disease 

Christoffer Clemmensen, (Denmark), AB Klein, GM Knudsen, S Aznar 





FC12.2 Ion channelopathies of peripheral nerve and muscle: Inherited pain and 

periodic paralysis 

Chairs: Sulayman D Dib-Hajj, (USA) & Karin Jurkat-Rott, (Germany) 

14:30 - 14:55 FC12.2.1 Functional effects of sodium channel mutations in inherited chronic pain syndromes 

Sulayman D Dib-Hajj, (USA), SG Waxman 

14:55 - 15:20 FC12.2.2 Selective inhibition of voltage-gated sodium channels by gating modifier toxins 

Theodore R Cummins, (USA), Y Xiao 

15:20 - 15:45 FC12.2.3 Leak-induced pathogenesis and treatment of periodic paralysis 

Karin Jurkat-Rott, (Germany), M-A Weber, M Fauler, F Lehmann-Horn 


16:15 - 16:40 FC12.2.4 Gating pore cation currents in hypokalemic and normokalemic periodic paralysis 

Todd Scheuer, (USA) 


Ca 2+ release-activated Ca 2+ channel is a promising target for vascular proliferative 

diseases 

Jing Li, (PR China), Y Yu, T Wang, Y Wang, G He, X Zheng, J Soboloff, D Gill, X Tang 

Wednesday 21 July ■ 14:30 - 17:15 ■ Meeting Room 20 111


drugs 



FC13.2 Drug metabolism and drug toxicity 

Chairs: Frank J Gonzalez, (USA) & B Kevin Park, (UK) 

14:30 - 14:55 FC13.2.1 Use of human pregnane X receptor and CYP3A4 double-humanized mice in the study of 

drug toxicity and efficacy 

Frank J Gonzalez, (USA), X Ma, J Cheng 

14:55 - 15:20 FC13.2.2 Chemically reactive metabolites: Separating fiction from facts 

Brian Kevin Park, (UK) 

15:20 - 15:45 FC13.2.3 The importance of studying mechanisms of cell death in toxicology 

Sten Orrenius, (Sweden) 


16:15 - 16:40 FC13.2.4 Pharmacogenetics of drug metabolism – TPMT as a paradigm 

William E Evans, (USA) 


In vitro preclinical cardiac safety pharmacology: Development of drug proarrhythmic 

measurement with human embryonic stem cell derived cardiomyocyts network 

Tetsuo Kitamura, (Japan), F Nomura, T Kaneko, P Sartipy, K Fukuda, A Sugiyama, 

M Sekijima, K Yasuda 


The hepatic extraction of paracetamol is reduced in old age following a single pass 

through the isolated perfused rat liver 

Sarah Mitchell, (Australia), A Huizer-Pajkos, D Le Couteur, A McLachlan, S Hilmer 





FC14.2 Pharmacological treatments of alcohol dependence – illusion or 

opportunity? 

Chairs: Rainer Spanagel, (Germany) & Barbara J Mason, (USA) 

14:30 - 14:55 FC14.2.1 Targeting glutamate receptors – preclinical and clinical studies 

Rainer Spanagel, (Germany) 

14:55 - 15:20 FC14.2.2 Targeting GABA system: Role of GABABergic drugs 

Giovanni Addolorato, (Italy) 

15:20 - 15:45 FC14.2.3 The α3β4* neuronal nicotinic acetylcholine receptor plays an important role in ethanol 

consumption and seeking 

Selena E Bartlett, (USA), S Chatterjee, P Steensland, J Simms, J Holgate, JW Coe, 

RS Hurst, C Schaffer, H Rollema 


16:15 - 16:40 FC14.2.4 Gabapentin in alcoholism: from laboratory study to clinical trial 

Barbara J Mason, (USA) 


The effects of the opiate neutral antagonist 6beta-naltrexol in opiate dependent subjects 

John Mendelson, (USA), K Flower, CW Harris, W Sadee, W Snape, GP Galloway 


The influence of a cysteinyl leukotriene receptor (CysLT-R) antagonist on experimental 

morphine-induced physical dependence 

Mihai Nechifor, (Romania), M Cuciureanu, D Chelarescu 


FC15 Endothelium in Health and disease 


Leaders: Christopher J Garland, (UK) & Arthur Weston, (UK) 

FC15.1 Nitric oxide and oxidative stress 

Chairs: Alex F Chen, (USA) & Christopher G Sobey, (Australia) 

14:30 - 15:00 FC15.1.1 Interaction of NOS and ROS in vascular disease 

Ralph P Brandes, (Germany) 

15:00 - 15:30 FC15.1.2 eNOS uncoupling and vascular disease 

Alex F Chen, (USA) 


Exercise in type 2 diabetes: some mechanistic insights 

Ismail Laher, (Canada) 


16:15 - 16:45 FC15.1.4 NADPH oxidase and therapeutic targeting 

Christopher G Sobey, (Australia), S Selemidis, G Drummond 


Role of Annexin A1 at the blood brain barrier level in mediating the brain response to 

inflammation 

Enrico Cristante, (UK), S McArthur, G Gillies, E Solito 


Xanthine oxidase inhibition for the treatment of cardiovascular disease: A systematic 

review and meta-analysis 

Peter Higgins, (UK), J Dawson, KR Lees, K McArthur, TJ Quinn, MR Walters 




Products 



FC16.2 Products derived from one single plant with convincing pharmacological 

data in explaining their mechanism of action 

Chairs: Yong-Xiang Zhang, (PR China) & Rudolf Bauer, (Austria) 

14:30 - 14:55 FC16.2.1 Pharmacological and clinical research on Ganoderma lucidum (Lingzhi) in China 

Zhi-Bin Lin, (PR China) 

14:55 - 15:20 FC16.2.2 Molecular actions of alkamides from Echinacea explaining their immunomodulatory 

activity 

Rudolf Bauer, (Austria) 

15:20 - 15:45 FC16.2.3 Memory retrieval improvement by Ptychopetalum olacoides, a traditional Amazonian 

medicine 

Elaine Elisabetsky, (Brazil), AL da Silva, M Figueiró 


16:15 - 16:40 FC16.2.4 Novel synergistic and/or side-effects neutralizing combinations of activities in natural 

products 

Anwar-ul-Hassan Gilani, (Pakistan) 


Blockade by nanomolar resveratrol of exocytosis, but not fusion pore formation in 

chromaffin cells 

Antonio G Garcia, (Spain), JC Fernandez-Morales, AMG De Diego, JC Gonzalez, L Cortes, 

M Yañez, F Orallo, J Hernández-Guijo 


Lutein inhibits the function of transient receptor potential A1 in different in vitro and in 

vivo models 

Zsuzsanna Helyes, (Hungary), E Szoke, A Kemeny, P Molnar, J Deli, L Szente, T Bozo, 

A Pal, A Devay, M Simonyi, J Szolcsanyi, G Horvath 





FC17.2 Exploring new targets in schizophrenia using translation science 

Chairs: P Jeffrey Conn, (USA) & Torgny H Svensson, (Sweden) 

14:30 - 14:55 FC17.2.1 Mutants in translation: Can new models of schizophrenia provide new insight & targets? 

John L Waddington, (Ireland), C O'Tuathaigh 

14:55 - 15:20 FC17.2.2 Neural synchrony as a pathophysiological mechanism in schizophrenia 

Peter J Uhlhaas, (Germany), C Gruetzner, M Wibral, M Leweke, W Singer 

15:20 - 15:45 FC17.2.3 Allosteric modulators of GPCRs for treatment of schizophrenia 

P Jeffrey Conn, (USA) 


16:15 - 16:40 FC17.2.4 What can we learn from the existing drugs with atypical profiles? 

Torgny H Svensson, (Sweden) 


Spadin: A new concept in the antidepressant drug design 

Catherine Heurteaux, (France), J Mazella, O Petrrault, G Lucas, E Deval, 

S Beraud-Dufour, M El-Yacoubi, A Guyon, C Widmann, E Chevet, J-L Nahon, M Borsotto 


Antidepressant-like effects of Commiphora Mukul resin and involvement of serotonergic 

system in forced swimming test in mice 

Mahsa Hadipour Jahromy, (Iran), SH Khakpour, M Faal, MH Jahromy 


Got world-class professional skills? That’s a good start 

At 

Lundbec Lundbeck, k, we 

are 

connected in inn 

a 

very 

special way. 

Something beyond beyoond 

words, words, 

formulas, 

aand 

nd 

procedures 

b bbinds 

inds 

us 

ttogether. 

ogether. 

In everything 

we wedo– 

do – 

from from 

our everyday 

interaction 

to our 

greatest 

scientific discoveries 

– we w we 

are 

united by 

a passion and responsibility 

responsibbility 

for 

helping the people who 

rely 

on oon 

our CNS solutions. 

Creating 

successful medicine depends deppends 

on uniting uniting many 

different 

processes 

and and specialist skills. We Wee 

cover 

the thee 

BRAINMATES 

entir entire e value 

chain 

from 

discovering disco v vering 

an 

inter interesting esting molecule through 

testing, 

rregulatory 

egulatory approval 

and marketing, markeeting, 

to distr distributing ibuting and selling the tab- 

lets worldwide. 

This 

takes 

a highly higghl 

y 

de developed veloped 

and inno innovative vative 

culture cultture 

of 

cooper cooperation. ation. Our solution is an 

inter- 

national netw network ork of talented people ppeople 

eexchanging 

xchanging 

knowledge 

and developing dee 

veloping 

ideas. 

We 

call them Brainmates. Brainmatees. 

Our researchers, 

for 

instance, are 

not 

onl only y highl highly y specialized. 

They 

also aalso 

mas- 

ter the the art 

of cross-functional 

com- 

mmunication 

unication and collabor collaboration. atiion. 

That 

is ho how ww we e turn a linear step-by-step 

R&D pr process ocess into a flow flowof 

of f knowledge 

that achieves 

better results. resultss. 

So if you 

ha have ve 

high-le high-level vel 

skills in your youur 

field and 

vvalue 

alue cooper cooperation, ation, you 

could couuld 

be one 

of our ne new wBr Brainmates. ainmates. 

Pursue Brainmate opportunities at www.lundbeck.com/careers



Leaders: Bart Staels, (France) & Vincent Laudet, (France) 

Local coordinator: Susanne Mandrup, (Denmark) 

FC18.1 Nuclear receptors and metabolic control 

Chairs: David J Mangelsdorf, (USA) & Susanne Mandrup, (Denmark) 

14:30 - 14:55 FC18.1.1 Control of cholesterol homeostasis by LXRs 

Peter Tontonoz, (USA) 

14:55 - 15:20 FC18.1.2 From metabolism to development via nuclear receptors 

Béatrice Desvergne, (Switzerland) 

15:20 - 15:45 FC18.1.3 Nuclear Receptor Regulation of Feeding and Fasting 

David J Mangelsdorf, (USA), SA Kliewer 


16:15 - 16:40 FC18.1.4 PPAR γ in adipocyte differentiation and metabolic control 

Susanne Mandrup, (Denmark) 


Activation of peroxisome proliferator-activated receptor-beta/delta reduced splanchnic 

ischemia and reperfusion injury 

Salvatore Cuzzocrea, (Italy), R Di Paola, E Esposito, E Mazzon, I Paterniti, M Galuppo, 

T Genovese, P Bramanti 


Central PPAR-α activation reduces pain and hyperalgia in mice via NF-kB inhibition 

Giuseppe D'Agostino, (Italy), G La Rana, R Russo, O Sasso, A Iacono, R Meli, 

A Calignano 

118 Wednesday 21 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3


Chair: Sergio H Ferreira, (Brazil) 

PL13 New drug targets for headache 

Jes Olesen, (Denmark) 



Chair: Patrick du Souich, (Canada) 

PL14 Toll-like receptor and innate immunity 

Shizuo Akira, (Japan), K Matsushita, O Takeuchi 



Chair: Kim Brøsen, (Denmark) 

PL15 Understanding the neuroprotective effect of estrogen; inflammation, age 

and mitochondria 

Sue P Duckles, (USA) 

Wednesday 21 July ■ 17:30 - 18:15 ■ Auditorium 15 

Congress dinner in the Tivoli Gardens 

Wednesday 21 July 19:30 

Wednesday 21 July ■ 17:30 - 18:15 119


Supported by an unrestricted grant from ADIS 

Chair: Munir Pirmohamed, (UK) 

PL16 Drug metabolism – past, present and future 

Olavi Pelkonen, (Finland) 

Thursday 22 July ■ 08:30 - 09:15 ■ Hall A2 


Chair: Edward Högestätt, (Sweden) 

PL17 Therapeutic potential of vaccines in the management of hypertension 

Morris J Brown, (UK) 



Chair: Christiaan B Brink, (South Africa) 

PL18 Teaching pharmacology in 2020 

Ian E Hughes, (UK) 

Thursday 22 July ■ 08:30 - 09:15 ■ Auditorium 15 

120 Thursday 22 July ■ 08:30 - 09:15



Supported by an unrestricted grant from Hoffmann La Roche, 

Switzerland 


FC10.3 Formulation issues 

Chairs: Jörg Breitkreutz, (Germany) & Klaus Rose, (Switzerland) 

09:30 - 09:55 FC10.3.1 End-user specifications for optimal paediatric formulations 

Atieno Ojoo, (Denmark), K Hoppu 

09:55 - 10:20 FC10.3.2 Novel drug formulations for children 

Jörg Breitkreutz, (Germany) 

10:20 - 10:45 FC10.3.3 Adapting formulations for children 

Anthony J Nunn, (UK) 


11:15 - 11:40 FC10.3.4 Taste assessment and taste masking 

Catherine Tuleu, (UK) 


Drug interactions in the paediatric population 

Trevor Johnson, (UK), A Rostami-Hodjegan 


According to Summaries of Product Characteristics (SPC) most medicines in neonates 

are used off-label 

Jana Lass, (Estonia), K Jõgi, R Käär, T Metsvaht, H Varendi, I Lutsar 

Thursday 22 July ■ 09:30 - 12:15 ■ Meeting Room 18/19 121





FC11.3 7TM receptors: Scaffolding and signalling mechanisms 

Chairs: Michel Bouvier, (Canada) & Heidi E Hamm, (USA) 

09:30 - 09:55 FC11.3.1 G-Protein-Coupled Receptors as Oligomeric Signaling Machines 

Michel Bouvier, (Canada) 

09:55 - 10:20 FC11.3.2 New insights into mechanisms of receptor-mediated G protein activation 

Heidi E Hamm, (USA), A Preininger, N Van Eps, A Kaya, T Thacker, SM Meier, 

N Alexander, J Meiler, JL Vey, AI Kaya, LS Busenlehner, RN Armstrong, TM Iverson, 

WL Hubbell 

10:20 - 10:45 FC11.3.3 Scaffolding of G protein coupled receptors 

Laurant Fagni, (France), J Perroy, F Raynaud, E Moutin 


11:15 - 11:40 FC11.3.4 Recent methodological advances in the discovery of GPCR-associated protein complexes 

Ralf Jockers, (France) 


The GABAB dimer of heterodimers: A physiological reality 

Laëtitia Comps-Agrar, (France), J Kniazeff, M Gassmann, M Laget, T Durroux, B Bettler, 

E Trinquet, J-P Pin 


A new family of mGluRs agonists identified by virtual screening binds in an extended 

glutamate binding pocket opening perspectives to develop potent and selective ligands 

Cyril Goudet, (France), B Vilar, C Selvam, I Lemasson, I Brabet, N Oueslati, 

H-O Bertrand, F Acher, J-P Pin 

122 Thursday 22 July ■ 09:30 - 12:15 ■ Auditorium 10




FC12.3 Ion channelopathies in the cardiovascular system: Inherited arrhythmia 

and hypertension 

Chairs: Michael C Sanguinetti, (USA) & Bernard C Rossier, (Switzerland) 

09:30 - 09:55 FC12.3.1 Molecular mechanisms of potassium channel dysfunction in long- and short-QT 

syndromes 

Michael C Sanguinetti, (USA) 

09:55 - 10:20 FC12.3.2 Sodium channelopathies in cardiac arrhythmia 

Alfred L George, (USA) 

10:20 - 10:45 FC12.3.3 Molecular mechanism of ryanodine receptor dysfunction in cardiac arrhythmia 

Andrew R Marks, (USA) 


11:15 - 11:40 FC12.3.4 Liddle’s disease and salt-dependent hypertension 

Bernard C Rossier, (Switzerland) 


Different sodium channel currents and responses to class I antiarrhythmic drugs in rat 

atrial and ventricular myocytes 

Xiao-Hui Xu, (PR China), K-H Chen, G-R Li, M-W Jin 


Thursday 22 July ■ 09:30 - 12:15 ■ Meeting Room 20 123


drugs 



FC13.3 Pharmacogenomics and adverse drug reactions 

Chairs: Steven J Leeder, (USA) & Munir Pirmohamed, (UK) 

09:30 - 09:55 FC13.3.1 The pharmacogenetics of drug hypersensitivity 

Simon Mallal, (Australia) 

09:55 - 10:20 FC13.3.2 Genetic predisposition to drug-induced liver toxicity 

Ann K Daly, (UK) 

10:20 - 10:45 FC13.3.3 Developmental considerations for severe adverse drug reactions in children 

Steven J Leeder, (USA) 


11:15 - 11:40 FC13.3.4 Variability in response to anticoagulants 

Munir Pirmohamed, (UK) 


Pharmacokinetic (PK) modeling of factor V activity accurately predicts factor V levels 

after treatment with fresh frozen plasma 

Kathleen Neville, (USA), G Kearns, J Daniel, W Andrews, B Wicklund 


Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated 

chronic heart failure patients 

Morten Petersen, (Denmark), J Andersen, K Broedbaek, B Hjelvang, S Afzal, 

M Nyegaard, A Børglum, S Stender, L Køber, C Torp-Pedersen, H Poulsen 

124 Thursday 22 July ■ 09:30 - 12:15 ■ Hall A2




FC14.3 Craving and relapse to drug seeking: Lessons from animal models and 

human brain imaging 

Chair: Yavin Shaham, (USA) 

09:30 - 09:55 FC14.3.1 Synaptic plasticity in the mesolimbic system: therapeutic implications for substance 

abuse 

Antonello Bonci, (USA) 

09:55 - 10:20 FC14.3.2 The role of the drug environment in relapse to drug seeking: Lessons from rat studies 

Yavin Shaham, (USA), J Bossert 

10:20 - 10:45 FC14.3.3 Imaging craving in human addicts: Does it predict drug relapse? 

Rajita Sinha, (USA), D Seo, C Lacadie, T Constable, K Bergquist 


11:15 - 11:40 FC14.3.4 Incubation of craving in cigarette smokers 

Harriet de Wit, (USA) 


Targeting the delta opioid receptor effectively modulates ethanol consumption and 

seeking and represents a novel target for new therapies for alcohol use disorders 

Carsten Nielsen, (USA), J Simms, R Li, J Holgate, J Richards, S Ananthan, S Bartlett 


Histamine H3 receptor in the modulation of alcohol-related behaviors 

Saara Nuutinen, (Finland), Y Ojala, J Vanhanen, P Panula 

Thursday 22 July ■ 09:30 - 12:15 ■ Auditorium 12 125

FC15 Endothelium in Health and disease 



FC15.2 Endothelium-dependent hyperpolarization 

Chairs: Chris J Garland, (UK) & Arthur Weston, (UK) 

09:30 - 09:55 FC15.2.1 SKCa and IKCa channels in myoendothelial signalling 

Arthur Weston, (UK), G Edwards 

09:55 - 10:20 FC15.2.2 Endothelial microdomains and integration of arterial dilatation 

Christopher J Garland, (UK), KA Dora 

10:20 - 10:45 FC15.2.3 The calcium-sensing receptor in blood pressure modula 

Jacob Tfelt-Hansen, (Denmark) 


11:15 - 11:40 FC15.2.4 The function of calcium pulsars in endothelial cells 

Mark T Nelson, (USA) 


Nox4 NADPH oxidase is a transforming growth factor target gene in human vascular 

endothelial cells 

Jaing Fan, (PR China), H Peshavariya, C Chang, G Dusting 


Female apolipoprotein E-deficient mice are protected against the development of 

endothelial dysfunction with ageing 

Wing CB Kong, (PR China), RYK Man, PMV Vanhoutte, SWS Leung 




Products 



FC16.3 Multiple plant products: A matter of synergy 

Chairs: Zhi-Bin Lin, (PR China) & Tai-Ping Fan, (UK) 

09:30 - 09:55 FC16.3.1 Defining the mechanism of action of Liuwei Dihuang decoction with nuclear-magneticresonance-spectroscopy-based 

metabonomic analysis 

Yong-Xiang Zhang, (PR China), N Jiang, W-X Zhou, X-Z Yan, Q Zhang 

09:55 - 10:20 FC16.3.2 Danshen diwan 

Henry Sun, (PR China) 

10:20 - 10:45 FC16.3.3 Choto-san and recognition behaviour 

Kinzo Matsumoto, (Japan) 



Anti-inflammatory activity of extracts from Orthosiphon stamineus leaves 

Mirka Laavola, (Finland), R Nieminen, J Welling, H Vapaatalo, MF Yam, A Sadikun, 

Z Asmawi, R Basir, E Moilanen 


Development of an in vitro model for the assessment of pyrrolizidine alkaloids-induced 

hepatotoxicity 

Yanhong Li, (PR China), N Li, G Lin 


Composite anti-melanoma action of dry olive leaf extract 

Sanja Mijatovic, (Serbia), G Timotijevic, D Miljkovic, J Radovic, M Mojic, 

D Maksimovic-Ivanic, D Dekanski, S Stosic-Grujicic 


The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits beta-amyloid-evoked fibril 

formation and neuronal toxicity in vitro 

Scott Smid, (Australia), B Harvey, U Musgrave 





FC17.3 Clinical aspects of treatment with antipsychotics 

Chairs: Shitij Kapur, (UK) & Birte Glenthøj, (Denmark) 

09:30 - 10:00 FC17.3.1 The speed and onset of antipsychotic response – implications for theory and practise 

Shitij Kapur, (UK) 

10:00 - 10:30 FC17.3.2 Changes in cortical and subcortical dopamine D2 receptor binding in schizophrenia: 

Relation to psychopathology and treatment repsonse 

Birte Glenthøj, (Denmark) 

10:30 - 11:00 FC17.3.3 Personalized procognitive pharmacotherapy in schizophrenia 

Andreas Meyer-Lindenberg, (Germany) 


11:30 - 12:00 FC17.3.4 Prospects for boosting cognition and treating cognitive decline 

Verity Brown, (UK) 


The inhibitory effect of olanzapine on psychotomimetic symptoms of 

tetrahydrocannabinol 

Hendrik Daniel Kleinloog, (The Netherlands), M Liem-Moolenaar, GE Jacobs, M de Kam, 

JMA van Gerven 






FC18.2 Nuclear receptors, vascular function and inflammation 

Chairs: Christopher K Glass, (USA) & Bart Staels, (France) 

09:30 - 09:55 FC18.2.1 Nuclear receptor-dependent repression mechanisms that regulate inflammation 

Christopher K Glass, (USA) 

09:55 - 10:20 FC18.2.2 PPARa and residual cardiovascular risk 

Bart Staels, (France) 

10:20 - 10:45 FC18.2.3 Mineralocorticoid receptor and vascular function 

Peter Fuller, (Australia) 


11:15 - 11:40 FC18.2.4 NR4A nuclear receptors and vascular function 

Carlie JM DeVries, (The Netherlands), C van Tiel, P Bonta, T Pols 


Induction of cardiac Angptl4 by dietary fatty acids is mediated by PPARδ and protects 

against oxidative stress 

Anastasia Georgiadi, (The Netherlands), L Lichtenstein, T Degenhardt, M Boekschoten, 

M Bilsen, B Desvergne, M Möller, S Kersten 


FXR agonists as novel medication for metabolic syndrome and NASH 

Claus Kremoser, (Germany), E Hambruch, U Abel, A Schulz, T Schlueter, B Birk, 

M Burnet, U Deuschle 

EPHAR council meeting 

in Meeting Room BV 1/2/3 

Thursday 22 July 12:45 - 14:15 

Thursday 22 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 129

W28 Workshop. The Boehringer-Ingelheim post-doctoral 

award 


Leader: James Hammond, (Canada) 

The Boehringer-Ingelheim post-doctoral award 

Chair: James Hammond, (Canada) 

13:00 - 14:00 W28.1 The role of ion channels in neuroprotection against cerebral ischemia 

Hong-Shuo Sun, (Canada) 


W29 Workshop. New horizons in therapeutic drug 

management (TDM) 

Organized by: DSK2F, Danish Society of Clinical Chemical 

Pharmacology 

Leader: Helle R Angelo, (Denmark) 

New horizons in therapeutic drug management (TDM) 

Chairs: Per Hartvig Honore, (Denmark) & Helle Riis Angelo, (Denmark) 

12:45 - 13:05 W29.1 Improved psychotropic therapy using TDM 

Finn Bengtsson, (Sweden) 

13:05 - 13:25 W29.2 Prediction of individual antibiotic dose in the clinic 

Inga Odenholt, (Sweden) 

13:25 - 13:45 W29.3 Antibiotic dose prediction from in vitro and in vivo population data 

Elisabet Nielsen, (Sweden), A Mohamed, L Friberg 

13:45 - 14:05 W29.4 Therapeutic drug monitoring, a practical application 

C Kees Neef, (The Netherlands), DJ Touw 

Thursday 22 July ■ 12:45 - 14:15 ■ Hall A3 131

W30 Workshop. Is eNOS still a valid therapeutic target? 

– the era after the discovery of eNOS uncoupling 

Supported by unrestricted grants from 

Sanofi-Aventis Deutschland GmbH and Actavis Deutschland GmbH 

Leader: Huige Li, (Germany) 

Is eNOS still a valid therapeutic target? – the era after the discovery of 

eNOS uncoupling 

Chair: Huige Li, (Germany) 

12:45 - 13:00 Introduction: All roads lead to eNOS 


13:00 - 13:15 W30.1 Molecular mechanisms of eNOS uncoupling 

Yong Xia, (USA) 

13:15 - 13:30 W30.2 Pharmacological approaches to recouple eNOS 

Andreas Daiber, (Germany) 

13:30 - 13:45 W30.3 Posttranslational regulation of eNOS activity 


13:45 - 14:00 W30.4 Multiple ways to target eNOS: Killing n birds with one stone 



W31 Workshop. Developing new drugs for neglected 

infections 

Organized by: Brazilian Society of Pharmacology and Experimental 

Therapeutics (SBFTE) 

Leader: Mauro M Teixeira, (Brazil) 

Developing new drugs for neglected infections 

Chair: Mauro M Teixeira, (Brazil) 

12:45 - 13:05 W31.1 New medicines to improve control and contribute to the eradication of malaria 

Timothy NC Wells, (Switzerland) 

13:05 - 13:25 W31.2 Development of antiviral compounds against Flavivirus 

Wouter Schul, (Singapore) 

13:25 - 13:45 W31.3 New perspectives to treat Trypanosome infection using NO donors 

Joao Santana da Silva, (Brazil), PMM Guedes, R Sesti-Costa, JJN Silva, JCM Pereira, 

DW Franco 

13:45 - 14:05 W31.4 Anti-inflammatory strategies to treat severe infections 

Mauro M Teixeira, (Brazil), D Souza, F Amaral, C Fagundes, V Vasconcelos 


W32 Workshop. The good, the bad and the ugly: 

When medicines cure most, harm some and 

confuse many 

Organized by: International Society of Pharmacovigilance (ISoP) 

Leader: Giampaolo Velo, (Italy) 

The good, the bad and the ugly: When medicines cure most, harm some 

and confuse many 

Chairs: Alex Dodoo, (Ghana) & Giampaolo Velo, (Italy) 

12:45 - 13:05 W32.1 The H1N1 story: The black and the white 

Pia Caduff-Janosa, (Switzerland) 

13:00 - 13:15 W32.2 From signals to therapy 

Nicholas Moore, (France) 

13:15 - 13:30 W32.3 New safety approaches towards advanced therapies 

Brian Edwards, (UK) 

13:30 - 13:45 W32.4 Between the rock and a hard place – safety monitoring of medicines for neglected 

diseases 

Alex Dodoo, (Ghana) 

13:45 - 14:00 W32.5 Drug information? Drug promotion? 

Giampaolo Velo, (Italy) 


W33 Workshop: Synaptic events in brain function 

Organized by: Hellenic Society of Pharmacology 

Leaders: Athineos Philippu, (Austria) & Charis Liapi, (Greece) 

Synaptic events in brain function 

Chairs: Athineos Philippu, (Austria) & Charis Liapi, (Greece) 

12:45 - 12:50 W33.1 Approaches to synaptic events in vivo under physiological and pathological conditions: 

State of the art 

Athineos Philippu, (Austria) 

12:50 - 13:10 W33.2 Synaptic events in the living brain, new approaches: Pharmaco magnetic resonance 

imaging in parallel with high performance neurochemical monitoring 

Alexander Rauch, (Germany), X Zhang, N Logothetis 

13:10 - 13:30 W33.3 Synaptic events in sleep and waking 

Helmut L Haas, (Germany), O Selbach, O Sergeeva 

13:30 - 13:50 W33.4 Sex differences in animal models of depression: focus on behavioural and neurochemical 

manifestation 

Christina Dalla, (Greece), P Pitychoutis, Z Papadopoulou-Daifoti 

13:50 - 14:10 W33.5 Synaptic events in stress and depression 

Karl Ebner, (Austria), N Singewald 


W34 Workshop. State-of-the-art of basic and clinical 

pharmacology in Serbia 

Leader: Milos P Stojiljkovic, (Republic of Serbia) 

State-of-the-art of basic and clinical pharmacology in Serbia 

Chairs: Milos P Stojiljkovic, (Republic of Serbia), Milica Prostran-Veselinovic, 

(Republic of Serbia) & Violeta Stanimirovic, (Republic of Serbia) 

12:45 - 13:00 W34.1 Bioethical principles in pharmacology: teaching of animal bioethics at the School of 

Medicine, University of Belgrade 

Zoran Todorovic, (Republic of Serbia), M Prostran-Veselinovic 

13:00 - 13:15 W34.2 Undergraduate and postgraduate education in basic and clinical pharmacology in Serbia 

Milica Prostran-Veselinovic, (Republic of Serbia) 

13:15 - 13:30 W34.3 Importance of pharmaco-toxicological evaluation of increased drug impurities and 

preserving drug quality and patient’s safety 

Violeta Stanimirovic, (Republic of Serbia), T Sipetic, D Nikolic, M Stojiljkovic, 

B Stanimirovic, V Dragojevic-Simic 

13:30 - 13:45 W34.4 Clinical pharmacologist in the healthcare system of Serbia: Where we are and where to 

go? 

Momir M Mikov, (Republic of Serbia), S Golocorbin-Kon, Z Tomic, A Sabo 

13:45 - 14:00 W34.5 Ethical committees of healthcare institutions in Serbia: Who guards patient safety? 

Viktorija Dragojevic-Simic, (Republic of Serbia), MP Stojiljkovic, V Stanimirovic 

136 Thursday 22 July ■ 12:45 - 14:15 ■ Meeting Room 18/19

W35 Workshop. Bridging pharmacovigilance and 

patient safety – experiences from regional 

pharmacovigilance units 

Leader: Ulf Bergman, (Sweden) 

Bridging pharmacovigilance and patient safety – experiences from 

regional pharmacovigilance units 

Chair: Ulf Bergman, (Sweden) 

12:45 - 13:05 W35.1 From pharmacovigilance to patient safety: Prevention of adverse drug events 

Petra A Thürmann, (Germany) 

13:05 - 13:25 W35.2 Is case-based pharmacovigilance still needed in an era of computerized data bank based 

drug risk assessment? 

Jörg Hasford, (Germany) 

13:25 - 13:45 W35.3 Pharmacovigilance in Africa – necessary, frivolous or essential? 

Alex Dodoo, (Ghana) 

13:45 - 14:05 W35.4 Pharmacovigilance and patient safety – experiences from a regional pharmacovigilance 

centre in Sweden 

Ulf Bergman, (Sweden) 



Pediatric clinical pharmacology 


FC10.4 Pain in children 

Chair: Dick Tibboel, (The Netherlands) 

14:30 - 14:55 FC10.4.1 Postoperative pain in children; do we really need morphine? 

Dick Tibboel, (The Netherlands) 

14:55 - 15:20 FC10.4.2 Developmental pharmacology of immature organs 

John N van den Anker, (USA) 

15:20 - 15:45 FC10.4.3 Neonatal analgesia: Still in search of a balanced approach? 

Karel Allegaert, (Belgium) 


16:15 - 16:40 FC10.4.4 Pain assessment methods in the newborn 

Lena Hellström-Westas, (Sweden) 


Therapeutic drug monitoring within the ALL-BFM trials 

Dominik Schrey, (Germany), C Lanvers-Kaminsky, G Hempel, J Boos 


Effects of caffeine on central and autonomous nervous system parameters in 

adolescents 

L Schrier, (The Netherlands), JK Burggraaf, W van Es, M Bosch, M de Kam, 

JMA van Gerven, AF Cohen 

138 Thursday 22 July ■ 14:30 - 17:15 ■ Meeting Room 18/19





FC11.4 7TM receptors: Genetic mouse models and disease 

Chairs: Marc G Caron, (USA) & Brigitte L Kieffer, (France) 

14:30 - 14:55 FC11.4.1 Akt/GSK3 Signaling in the Action of Psychotropic Drugs. 

Marc G Caron, (USA) 

14:55 - 15:20 FC11.4.2 Pharmacology of pre- versus postsynaptic alpha2-adrenoceptors 

Lutz Hein, (Germany), R Gilsbach, M Haubold, J Albarran-Juarez, J Schneider 

15:20 - 15:45 FC11.4.3 Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to 

obesity 

Sadaf Farooqi, (UK) 


16:15 - 16:40 FC11.4.4 Opioid receptors: Genetic approaches to study G protein coupled receptor function in 

vivo 

Brigitte L Kieffer, (France) 


The protein interactome of GPCRs: molecular sites for novel drugs? 

Christian Gruber, (Austria), M Freissmuth 


An essential role for the first extracelullar loop in activating the adenosine A2B receptor 

Miriam Peeters, (The Netherlands), GJP van Westen, D Guo, MW Beukers, AP Ijzerman 





FC12.4 Ion channelopathies in endocrine systems 

Chairs: Louis J Ptacek, (USA) & Per-Olof Berggren, (Sweden) 

14:30 - 14:55 FC12.4.1 Physiological and pathophysiological Ca2+ signalling in the pancreatic β-Cell 

Per-Olof Berggren, (Sweden), S-N Yang 

14:55 - 15:20 FC12.4.2 Channelopathies of ATP-gated potassium channels and insulin release 

Frances Ashcroft, (UK) 

15:20 - 15:45 FC12.4.3 ATP-sensitive potassium channels in different tissues: recent insights and surprises 

Colin G Nichols, (USA) 


16:15 - 16:40 FC12.4.4 Channels in muscle disease 

Louis J Ptacek, (USA) 


Functional role of volume-Regulated chloride channel complex in cardioprotection against 

heart failure 

Linda Ye, (USA), M Zhang, G Wang, L Liu, K Schegg, DJ Burkin, JR Hume, DD Duan 


140 Thursday 22 July ■ 14:30 - 17:15 ■ Meeting Room 20


drugs 



FC13.4 New technologies – will they help in developing safer drugs 

Chairs: David B Goldstein, (USA) & Roy Goodacre, (UK) 

14:30 - 14:55 FC13.4.1 Safety pharmacogenomics 

David B Goldstein, (USA) 

14:55 - 15:20 FC13.4.2 Metabolomics and its role in predicting ADRs 

Roy Goodacre, (UK) 

15:20 - 15:45 FC13.4.3 Use of Omics in understanding mechanisms of ADRs 

Richard S Paules, (USA), Y Cui 


16:15 - 16:40 FC13.4.4 Systems biology approaches to drug metabolism and personalized medicine 

Urich M Zanger, (Germany) 


Noscapine is a potent CYP2C inhibitor 

Staffan Rosenborg, (Sweden), S Otto, J Östervall, Q-Y Yue, E Eliasson 


Safety of long-term treatment by piribedil in patients with chronic heart failure and 

cognitive disorders. 

Zhanna Sizova, (Russian Federation), N Lapidus 





FC14.4 The role of stress in the addictive process 

Chairs: George F Koob, (USA) & Markus Heilig, (USA) 

14:30 - 14:55 FC14.4.1 The role of stress systems and the amygdale in addictive disorders 

George F Koob, (USA) 

14:55 - 15:20 FC14.4.2 Stress related neuropeptides: Candidate treatment targets in alcoholism 

Markus Heilig, (USA) 

15:20 - 15:45 FC14.4.3 Alcohol induced aggression: The role of CRH systems 

Klaus A Miczek, (USA) 


16:15 - 16:40 FC14.4.4 The role of kappa-opioid transmission in dysphoric states related to stress and addiction 

Charles Chavkin, (USA) 


Safety of indirect dopamine agonists (IDA) for psychostimulant dependence. A systematic 

review and meta-analysis of randomized controlled trials 

Clara Pérez-Mañá, (Spain), X Castells, X Vidal, M Casas, D Capellà 


Inhibitory effects of Dendrobium alkaloids on memory impairment induced by 

lipopolysaccharide in rats 

Jing-Shan Shi, (PR China), Y-F Li, F Li, Q-H Gong, Q Wu 





FC15.3 Endothelium-mediated control of vascular tone 

Chairs: William B Campbell, (USA) & David J Webb, (UK) 

14:30 - 14:55 FC15.3.1 Endothelium-mediated control of vascular tone: COX-1 products 

Michel Félétou, (France) 

14:55 - 15:20 FC15.3.2 COX-2 products 

Yu Huang, (PR China) 

15:20 - 15:45 FC15.3.3 Dinucleoside polyphosphates and the purinergic system 

Joachim Jankowski, (Germany) 


16:10 - 16:35 FC15.3.4 Endothelial 15-lipoxygenase eicosanoids 

William B Campbell, (USA) 

16:35 - 17:00 FC15.3.5 Endothelins 

David J Webb, (UK) 


Hydrogen sulfide stimulates angiogenesis 

Andreas Papapetropoulos, (Greece), A Pyriochou, Z Altaany, A Marazioti, G Yang, 

R Wang, C Szabo 




Products 



FC16.4 East meets West: From prevention to therapy 

Chairs: Paul M Vanhoutte, (PR China) & Arnold G Herman, (Belgium) 

14:30 - 14:55 FC16.4.1 Holistic treatment by traditional Chinese medicine 

Tai-Ping Fan, (UK) 

14:55 - 15:20 FC16.4.2 The philosophy of Ayurvedic medicine and beyond 

Arunabha Ray, (India), K Gulati 

15:20 - 15:45 FC16.4.3 Contributions of plant-derived products to Western medicine 

Arnold G Herman, (Belgium) 


16:15 - 16:40 FC16.4.4 Systems biology and the future of traditional medicine 

Guoan Luo, (PR China) 


Marine compound Xyloketal B regulates nitric oxide signaling in endothelial cells 

Hong-Mei Tan, (PR China), G-L Wang, W-L Chen, T-T Yan, Q Li, J Liu 


Dietary intake of sulforaphane glucosinolate suppresses Japanese cedar pollen-induced 

allergic responses via modulating Th1/Th2 balance in mice 

Akinori Yanaka, (Japan), M Irie, A Fukumoto, S Ishikawa, H Mori, T Inakuma 





FC17.4 Exploring new targets in affective disorders using translational science 

Chairs: Christopher A Lowry, (USA) & David J Nutt, (UK) 

14:30 - 14:55 FC17.4.1 Can we target specific neuronal populations to improve the efficacy and safety of 

antidepressants? 

Christopher A Lowry, (USA) 

14:55 - 15:20 FC17.4.2 In vivo approaches in preclinical models 

Arne Mørk, (Denmark), M Kreilgaard, LT Brennum, N Plath 

15:20 - 15:45 FC17.4.3 Using imaging as a translational tool for studying depression in humans 

Susannah E Murphy, (UK), C Harmer 


16:15 - 16:40 FC17.4.4 Understanding current antidepressants’ action as a way to develop improved therapies 

David J Nutt, (UK) 


Acute vagal nerve stimulation promotes noradrenaline release in minipig brain 

Anne M Landau, (Denmark), S Dyve, AKO Alstrup, S Jakobsen, A Gjedde, DJ Doudet 


Glutamate receptors mediate striatal Nur77 expression induced by antipsychotic drugs 

Daniel Levesque, (Canada), J Maheux, E Tirotta, E Borrelli, C Rouillard, P-P Rompré 






FC18.3 Nuclear receptors in the CNS 

Chairs: Michael T Heneka, (Germany) & Gary E Landreth, (USA) 

14:30 - 14:55 FC18.3.1 Glucocorticoid actions in the brain 

Osborne F Almeida, (Germany) 

14:55 - 15:20 FC18.3.2 Roles of PPAR in stroke 

Jaroslaw Aronowski, (USA) 

15:20 - 15:45 FC18.3.3 PPAR γ modulation in neurodegenerative disease 

Michael T Heneka, (Germany) 


16:15 - 16:40 FC18.3.4 Liver X receptors as therapeutic targets in Alzheimer’s Disease 

Gary E Landreth, (USA) 


Structural basis for ligand-dependent and -independent gene repression by nuclear 

receptors 

A le Maire, C Teyssier, C Erb, M Grimaldi, S Alvarez, A de Lera, P Balaguer, 

H Gronemeyer, C Royer, P Germain, William Bourguet, (France) 


Evidence for the role of PPAR-beta/delta in the development of spinal cord injury 

Irene Paterniti, (Italy), E Mazzon, E Esposito, T Genovese, M Galuppo, R Di Paola, 

P Bramanti, A Kapoor, C Thiemermann, S Cuzzocrea 

146 Thursday 22 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3


Chair: Ian Ahnfelt-Rønne, (Denmark) 

PL19 Reversal of corticosteroid resistance in severe inflammatory diseases: 

A novel therapeutic strategy 

Peter J Barnes, (UK) 



Chair: Donald R Singer, (UK) 

PL20 Renin-angiotensin system and vascular inflammation 

Ernesto Schiffrin, (Canada) 


PL21 EPHAR Plenary Lecture 

Chair: Eeva Moilanen, (Finland) 

PL21 Successes and challenges in drug development – a regulatory 

perspective 

Thomas Lönngren, (UK) 

Thursday 22 July ■ 17:30 - 18:15 ■ Auditorium 15 

Thursday 22 July ■ 17:30 - 18:15 147


Chair: Zhi-Bin Lin, (PR China) 

PL22 New strategies for stroke prevention 

Ding-Feng Su, (PR China), A-J Liu 

Friday 23 July ■ 08:30 - 09:15 ■ Hall A2 


Chair: Masayashi Mishina, (Japan) 

PL23 New molecular targets in Alzheimer’s disease 

Elisabeth Bock, (Denmark) 

Friday 23 July ■ 08:30 - 09:15 ■ Hall A3 


Chair: David J Webb, (UK) 

PL24 Pharmacology of organic nitrates: From 19th century homeopathy to 

genetic mouse models 

Bernd Mayer, (Austria) 

Friday 23 July ■ 08:30 - 09:15 ■ Auditorium 15 

148 Friday 23 July ■ 08:30 - 09:15




FC10.5 Recent advance in paediatric clinical pharmacology 

Chair: Shinya Ito, (Canada) 

09:30 - 09:55 FC10.5.1 Post-genomics pharmacogenetics in children 

Evelyne Jacqz-Aigrain, (France) 

09:55 - 10:20 FC10.5.2 National active surveillance network for serious adverse drug reactions in children: 

Past and current pharmacogenomic targets 

Bruce Carleton, (Canada) 

10:20 - 10:45 FC10.5.3 Population PK-guided simulation study in children exposed to drugs in human milk 

Shinya Ito, (Canada), F Garcia-Bournissen, A Panchaud, C Csajka, J Kristensen, 

A Taddio, K Ilett, E Begg, G Tomlinson 


11:15 - 11:40 FC10.5.4 Use of biopharmaceuticals in pediatric field: Tocilizumab, an anti-IL-6 receptor 

monoclonal antibody, for children with systemic juvenile idiopathic arthritis 

Shumpei Yokota, (Japan) 


Population pharmacokinetics and bayesian estimator of mycophenolic acid in children 

with idiopathic nephrotic syndrome 

Wei Zhao, (France), V Elie, V Baudouin, A Bensman, JL Andre, K Brochard, F Broux, 

M Cailliez, C Loirat, E Jacqz-Aigrain 

Friday 23 July ■ 09:30 - 12:15 ■ Meeting Room 18/19 149





FC11.5 7TM receptors: drug discovery and new physiological functions 

Chairs: Hans Bräuner-Osborne, (Denmark) & P Jeffrey Conn, (USA) 

09:30 - 09:55 FC11.5.1 Characterization of GPRC6A – a promiscuous 7TM receptor activated by basic L-amino 

acids 

Hans Bräuner-Osborne, (Denmark), BK Hansen, B Christiansen, C Clemmensen, 

LD Johansen, DS Pedersen, DE Gloriam, S Smajilovic, P Wellendorph 

09:55 - 10:20 FC11.5.2 Allosteric modulators of GPCRs as a novel approach to treatment of CNS disorders 

P Jeffrey Conn, (USA) 

10:20 - 10:45 FC11.5.3 GPCRs as metabolite receptors 

Stefan Offermanns, (Germany) 


11:15 - 11:40 FC11.5.4 The ghrelin and the GPR39 receptors as regulators of metabolic functions. 

Birgitte Holst, (Denmark) 


Allosteric and orthosteric sites for ligands in the chemokine receptor CCR5 

Stefanie Thiele, (Denmark), M Rosenkilde 


Studies on the specific gamma-hydroxybutyric acid (GHB) binding site in the mammalian 

brain using novel radioiodinated ligands 

Petrine Wellendorph, (Denmark), S Høg, P Sabbatini, MFH Pedersen, L Martiny, 

GM Knudsen, B Frølund, RP Clausen, H Bräuner-Osborne 

150 Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 10




FC12.5 Ion channelopathies in lymphocytes: Severe combined immunodeficiency 

and store-operated calcium channels 

Chair: Michael D Cahalan, (USA) 

09:30 - 09:55 FC12.5.1 Orai and stim in store-operated calcium release 

Michael D Cahalan, (USA) 

09:55 - 10:20 FC12.5.2 Diverse functions of STIM in store- operated calcium entry 

Richard S Lewis, (USA) 

10:20 - 10:45 FC12.5.3 Roles of store-operated Ca2+ entry mediated by STIM1 and ORAI1 in immunity 

Stefan Feske, (USA) 


11:15 - 11:40 FC12.5.4 Store-operated calcium entry: Pore architecture of the ORAI1 calcium channel and 

evidence that STIM1 gates ORAI1 channels in vitro 

Patrick G Hogan, (USA), Y Zhou, P Meraner, A Rao 


Computational structural pharmacology of L-type calcium channel 

Boris S Zhorov, (Canada) 


Friday 23 July ■ 09:30 - 12:15 ■ Meeting Room 20 151


drugs 



FC13.5 New insights in the genetics of drug metabolism and action 

Chairs: Magnus Ingelman-Sundberg, (Sweden) & Richard M Weinshilboum, (USA) 

09:30 - 09:55 FC13.5.1 Molecular mechanisms of altered drug response 

Magnus Ingelman-Sundberg, (Sweden) 

09:55 - 10:20 FC13.5.2 Genetic variability of adrenergic receptors 

Ian P Hall, (UK) 

10:20 - 10:45 FC13.5.3 Genetic variability of pain perception and treatment 

Jörn Lötsch, (Germany) 


11:15 - 11:40 FC13.5.4 Pharmacogenetics to pharmacogenomics 

Richard M Weinshilboum, (USA) 


The analgesic effect of oxycodone in relation to genetic variations in the OPRM1 and 

ABCB1 genes 

Stine T Zwisler, (Denmark), TP Enggaard, L Noehr-Jensen, S Mikkelsen, C Verstuyft, 

L Becquemont, S Sindrup, K Brøsen 


152 Friday 23 July ■ 09:30 - 12:15 ■ Hall A2




FC14.5 Doping – an underestimated problem with many unknowns 

Chairs: Harrison G Pope, (USA) & Anders Rane, (Sweden) 

09:30 - 09:55 FC14.5.1 Societal aspects of doping 

Harrison G Pope, (USA) 

09:55 - 10:20 FC14.5.2 Morbidity and mortality in users of anabolic androgenic steroids 

Ingmar Thiblin, (Sweden), G Ågren, H Mobini 

10:20 - 10:45 FC14.5.3 Anabolic-androgenic steroid addiction? Insights from animal 

Ruth I Wood, (USA) 



Discovery of new drugs for anti-relapse based on dopamine D3 receptors 

Rui-Bin Su, (PR China), R Song, H-Y Gou, Y Liu, N Wu, X-Q Lu, R-F Yang, S-Q Zhang, 

Z-Q Zhang, J Li 


A framework for the integration of pharmacotherapy in the treatment of alcohol 

dependence in the Free State province, South Africa 

Paulina van Zyl, (South Africa), C Gagiano, W Mollentze, J Snyman 


Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 12 153




FC15.4 Drug development and novel therapeutic targets and approaches 

Chairs: Johannes-Peter Stasch, (Germany) & Harald Schmidt, (The Netherlands) 

09:30 - 09:55 FC15.4.1 Stimulators and activators of soluble guanylate cyclase: From bench to bedside 

Johannes-Peter Stasch, (Germany) 

09:55 - 10:20 FC15.4.2 Gaseous signalling molecules: the biological effects of hydrogen sulfide – comparison 

with nitric oxide 

Csaba Szabó, (USA) 

10:20 - 10:45 FC15.4.3 Therapeutic effects of enhancing endothelial nitric-oxide synthase (eNOS) expression and 

preventing eNOS uncoupling 

Ulrich Förstermann, (Germany), H Li 


11:15 - 11:40 FC15.4.4 NOX 1, 2, 3 and counting: targeting oxidative stress 

Harald Schmidt, (The Netherlands), K Wingler, C Kleinschnitz 


Effects of K + channel blockers on the relaxation induced by nitric oxide (NO) donors in 

basilar artery from renal hypertensive 2K-1C rats 

Michele Paulo, (Brazil), J Vercesi, J Biazzotto, R da Silva, L Bendhack 


MicroRNA-27b rescues impaired endothelial progenitor cell-induced angiogenesis and 

wound healing via suppressing thrombospondin-1 in type 2 diabetes 

Alex Chen, (USA), J Wang, 


Co-activation of PKCdelta/ERK1/2 and p38 MAPK mediates angiotensin II-induced 

cyclooxygenase-2 up-regulation in endothelial cells and the clinical implications 

Siu Ling Wong, (PR China), CW Lau, WT Wong, A Xu, CL Au, X Yao, Y Huang 

154 Friday 23 July ■ 09:30 - 12:30 ■ Hall A3



Products 



FC16.5 Globalization of natural/traditional products 

Chairs: Ricky Ying-Keung Man, (PR China) & Monique Simmonds, (UK) 

09:30 - 09:55 FC16.5.1 Geographical sustainability of natural products: As modelled by the Araliaceae family 

Yuri N Zhuravlev, (Russian Federation) 

09:55 - 10:20 FC16.5.2 Authentication of natural products 

Monique Simmonds, (UK) 

10:20 - 10:45 FC16.5.3 Standardization of natural products (chemical and biological finger printing) 

Y-C Cheng, Robert Tilton, (USA) 


11:15 - 11:40 FC16.5.4 Challenges in research on natural products and dietary supplements 

Josephine P Briggs, (USA) 


Studies on the ADME/Tox characteristics of Xiao Chai Hu Tang in Caco-2 cell model 

Jun-Ning Zhao, (PR China), L-C Yan, Q-C Liu, Y-Q Bi, J-H Yi 


Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 15 155




FC17.5 New pharmacological approaches for treatment of stress induced mood 

disorders 

Chairs: Elisabeth B Binder, (Germany) & Rosanio Leopardi, (Switzerland) 

09:30 - 09:55 FC17.5.1 Using gene x environment interactions to target personalised treatment in mood 

disorder. 

Elisabeth B Binder, (Germany) 

09:55 - 10:20 FC17.5.2 Epigenomic effects of stress: Novel targets for treatment of mood disorders? 

Johannes MHM Reul, (UK) 

10:20 - 10:45 FC17.5.3 Can brain mechanism in PTSD help direct treatment advances? 

Eric Vermetten, (The Netherlands) 


11:15 - 11:40 FC17.5.4 Treatment needs in psychosocial stress, exhaustion and depression 

Rosanio Leopardi, (Sweden) 


Cannabinoid CB1 and vanilloid TRPV1 receptors: Contrary functions in an animal model 

of panic attack 

Fabricio Moreira, (Brazil), P Casarotto, D Aguiar, A Terzian, H Zangrossi, F Guimaraes, 

C Wotjak 

11:55 - 12:10 FC17.5.6 General discussion 

156 Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 11





FC18.4 The molecular basis of NR pharmacology 

Chairs: Shigeaki Kato, (Japan) & Vincent Laudet, (France) 

09:30 - 09:55 FC18.4.1 Structural studies of intact nuclear receptor complexes in their functionally revealing 

complexes 

Fraydoon Rastinejad, (USA) 

09:55 - 10:20 FC18.4.2 The global organization of nuclear receptor regulatory elements 

Gordon Hager, (USA), TC Voss, RL Schiltz, M-H Sung, S Baek, M Wiench, SC Biddie, 

TA Johnson, D Stavreva, S John 

10:20 - 10:45 FC18.4.3 The role of co-regulators/co-regulator complexes in NR function 

Shigeaki Kato, (Japan) 


11:15 - 11:40 FC18.4.4 Nuclear hormone receptor superfamily: From comparative genomics to evolution 

Vincent Laudet, (France) 


Functional characterization of the semi-synthetic bile acid derivative INT-767, a dual FXR 

and TGR5 agonist 

Giovanni Rizzo, (Italy), D Passeri, F De Franco, G Ciaccioli, L Donadio, G Rizzo, 

S Orlandi, B Sadeghpour, XX Wang, T Jiang, M Lev, M Pruzanski, L Adorini 


Anti-inflammatory/neuroprotective properties of palmitoylethanolamide in a model of beta 

amyloid neurotoxicity 

Caterina Scuderi, (Italy), G Esposito, A Blasio, M Valenza, P Arietti, D De Filippis, 

T Iuvone, L Steardo 

Closing ceremony & prize awards in Hall A2 

Friday 23 July 12:30 - 13.00 

Friday 23 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 157

158

Poster sessions 

Focused Conferences Workshops General section 

FC01 

Mon 001 - 039 

Tue 001 - 036 

FC02 

Mon 040 - 080 

Tue 037 - 076 

FC03 

Mon 081 - 089 

Tue 077 - 085 

FC04 

Mon 116 - 146 

Tue 086 - 115 

FC05 

Mon 147 - 187 

Tue 116 - 156 

FC06 

Mon 188 - 221 

Tue 157 - 189 

FC07 

Mon 222 - 230 

Tue 190 - 198 

FC08 

Mon 231 - 251 

Tue 199 - 218 

FC09 

Mon 252 - 332 

Tue 219 - 300 

FC10 

Wed 001 - 019 

Thu 001 - 020 

FC11 

Wed 020 - 095 

Thu 021 - 096 

FC12 

Wed 096 - 108 

Thu 097 - 109 

FC13 

Mon 333 - 392 

Tue 301 - 359 

Wed 109 - 167 

Thu 110 - 168 

FC14 

Wed 168 - 193 

Thu 171 - 196 

FC15 

Wed 194 - 292 

Thu 197 - 294 

FC16 

Wed 294 - 392 

Thu 295 - 393 

FC17 

Wed 393 - 433 

Thu 394 - 432 

FC18 

Wed 437 - 449 

Thu 433 - 445 

W01 

Mon 393 - 397 

W02 

Tue 460 - 476 

W03 

Mon 398 - 402 

W04 

Mon 403 - 416 

W11 

Tue 477 - 478 

W12 

Mon 090 - 115 

W14 

Tue 479 

W18 

Tue 360 

W19 

Mon 417 - 470 

W20 

Mon 471 - 481 

W23 

Tue 480 - 494 

W29 

Thu 169 - 170 

W30 

Wed 293 

W33 

Wed 434 

W34 

Wed 435 - 436 

WorldPharma2010 combines and integrates basic 

and clinical pharmacology exactly the way I had hoped 

Professor Paul M Vanhoutte (Hong Kong) 

Past President of IUPHAR (2002–6) 

Miscellaneous 

Tue 361 - 371 

Airway 

Tue 372 - 373 

Biologics 

Tue 374 - 378 

Cell Biology 

Tue 379 - 380 

Haematology 

Tue 381 - 382 

Hepatology 

Tue 383 - 393 

Oncology 

Tue 394 - 442 

Toxicology 

Tue 443 - 459 

Poster sessions 159


Mon 001 Patterns of influenza infection in Sylhet division of Bangladesh 

Salim Ahmed, (Bangladesh), ATMA Jalil, SS Ahmed, MM Siddika 

Mon 002 Comparative study of initial and aquired drug resistance in pulmonary tuberculosis 

Seyed Yousef Agha Alaie, (Iran), SD Mansoori, S Khazali, AA Hashtroodi, S Arami 

Mon 003 Adverse events of benznidazole in children with Chagas disease – a cohort study 

Jaime Altcheh, (Canada), G Moscatelli, S Moroni, F Garcia-Bournissen, H Freilij 

Mon 004 Antioxidant activity of phenolic extracts of Tunisian plants and their effect on mitochondrial respiration 

in vitro 

S Bacha, H Ferchichi, I Salouage, L Ouanes, M Boussaïd, M Lakhal, Anis Klouz, (Tunisia) 

Mon 005 Efficacy and safety of add-on mirtazapine in depression 

Dinesh K Badyal, (India), P Matreja, R Deswal 

Mon 006 Glutathione S-transferase M1 and Glutathione S-transferase T1 polymorphisms and lung cancer risk in 

Tunisian men 

Majda-Noura Belkhiria, (Tunisia), MA Jebali, I Harrabi, J Knani 

Mon 007 Piroxicam provides adequate analgesia after impacted lower third molar removal regardless of the 

surgeon’s experience 

Adriana Calvo, (Brazil), T Dionísio, F Giglio, P Gonçalves, C Santos 

Mon 008 Investigation of the relationship between plasma L-carnitine concentration and its antioxidant activity 

after single oral administration of L-carnitine in healthy volunteers 

Yu Cao, (PR China), Z-W Han, HJ Qu, C-B Wang 

Mon 009 Oral pharmacokinetics of three fluoroquinolones in Mexicans: Evidence for interethnic differences 

Miriam Carrasco-Portugal, (Mexico), G Lozoya-Moreno, S Patiño-Camacho, F Flores-Murrieta 

Mon 010 Patient’s access to antiretroviral medicines: how do they view themselves? 

DM Carvalho, MH Magalhães, AMR Felix, ECA Costa, WA Souza, Marcia HMC Podestá, (Brazil) 

Mon 011 Inequivalence of doxorubicin liposomal formulations commercialized in Latin America 

Gilberto Castañeda-Hernández, (Mexico), L Villafaña-Godínez, MA Valdés, L González-Flores 

Mon 012 In vitro antiplasmodial activity of 8-hydroxyquinoline derivatives 

Chien-Teng Chen, (South Africa), R van Zyl 

Mon 013 Association of the ABCB1 3435C>T polymorphism and adverse events of cilostazole in healthy 

subjects 

Sung Kweon Cho, (South Korea), LA Lim, SB Jang, YJ Lee, DH Lee, HK Son, JY Chung, K Park 

Mon 014 Pharmapoly, game as a teaching strategy in pharmacology classes 

Luis Cifuentes, (Colombia) 

Mon 015 Summary of PK and PD in a practical way 

Luis Cifuentes, (Colombia), 

Mon 016 Pharmacokinetics of florfenicol (water soluble formulation) in health and Pasteurella infected broiler 

chickens 

Hesham Elzorba, (Egypt), H El-Banna 

Mon 017 Antibiotic activity against urinary pathogens in hospitalized medical patients in eastern Nigeria 

Oguamanam Enwere, (Nigeria), K Duruewuru, V Okwara 

160 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area


Mon 018 Can steady state plasma concentration of efavirenz predict virologic outcomes in treatment naïve HIV 

Ethiopian patients? 

Abiy H Eyakem, (Ethiopia), W Amogne, G Yimer, E Makonnen, G Aderaye, A Worku, L Lindquist, 

L Bertilsson, J Burhenne, E Aklillu 

Mon 019 Population pharmacokinetics of oseltamivir carboxylate in Mexican patients with influenza A(H1N1) 

Francisco Flores-Murrieta, (Mexico), M Barranco-Garduño, M Carrasco-Portugal, H León-Molina, 

A Cervantes-Nevárez, G Castañeda-Hernández 

Mon 020 Analysis of n-acetyltransferase 2 phenotype and genotype in a Tunisian population 

E Gaïes, Anis Klouz, (Tunisia), I Salouage, S Trabelsi, I Hamza, N Jebabli, M Aouichri, M Lakhal 

Mon 021 Tunisian clinical pharmacology experience 

E Gaïes, R Sahnoun, D Bensaid, N Jebabli, I Salouage, S Trabelsi, I Hamza, M Aouichri, 

Anis Klouz,(Tunisia), M Lakhal 

Mon 022 Estimation of transfer of nifurtimox, for Chagas disease, into breastmilk. Population pharmacokinetics 

and simulation analysis 

Facundo Garcia-Bournissen, (Canada), J Altcheh, A Panchaud, S Ito 

Mon 023 Evaluation of the effect of an extract of Mangifera indica L. in patients with spinocerebellar ataxia 

type 2 

Mariela Guevara-García, (Cuba), L Velázquez, R Aguilera, R Rodríguez, O Ramírez, D Almaguer, 

JC Rodríguez 

Mon 024 Cost analysis of antibacterial drugs in a developing country, India 

Devi D Gupta, (India), M Gupta 

Mon 025 Characterization of resistance to cytosine arabinoside (ARA-C) IN NALM-6 human B leukemia cells 

Masaaki Ishikawa, (Japan), S-I Kanno 

Mon 026 Potential drug-drug interactions of lopinavir/ritonavir in antiretroviral prescriptions with prescribed daily 

doses not according to the recommended antiretroviral doses in South Africa 

Norah Lucky Katende-Kyenda, (South Africa), M Lubbe, J Serfontein, I Truter 

Mon 027 Complete overhaul of the authorization and single-central ethical committee approval procedure of 

clinical trials in Hungary 

Peter Kovacs, (Hungary), A Vas 

Mon 028 Effect of mastitis on disposition kinetics of levofloxacin following single dose i.v. administration in goats 

Birendra Kumar, (India), M Ram, V Singh, R Prasad, K Singh 

Mon 029 A phase I clincical study of CKD-732 in combination with capecitabine and oxaliplatin in patients with 

metastatic colorectal cancer 

Yoon Jung Lee, (South Korea), S Shin, HC Chung, K Park 

Mon 030 Latin America a successful emerging market for clinical research 

Federico Lerner, (Argentina) 

Mon 031 Effect on the expression of CYP450 enzyme in rat liver induced by total panax notoginsenoside and the 

potential drug-drug interaction study 

Xiao-yu Li, (PR China), G-L Liu, J-C Zhou, G Qian, B Sun, Y-K Guo, J-W Gao 

Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 161


Mon 032 Pharmacokinetic study of recombinant humanized anti-VEGF monoclonal antibody (Bevacizumab) in 

Chinese subjects with advanced malignancies 

Yang Li, (PR China), X Hu, G Cheng, YL Nie, YB Zhao, JY Wu, KX Li, C Qi 

Mon 033 Pharmacokinetics and pharmacodynamics of pegylated interferon-α2a in healthy male volunteers 

Lay Ahyoung Lim, (South Korea), H Son, S Jang, Y Lee, JY Chung, K Park 

Mon 034 Discovery of novel influenza neuraminidase inhibitors from natural products 

Ailin Liu, (PR China), S Lee, Y Wang, G Du 

Mon 035 Disruption of BBB in rat MCAO and a protective effect of anti-HMGB1 antibody 

Keyue Liu, (Japan), J Zhang, HK Takahashi, Y Tomono, H Wake, T Maruo, A Otsuka, S Mori, 

M Nishibori 

Mon 036 Evaluation of the effect of increasing hydration to premedication treatments of chemotherapy with 

cisplatin in decreasing renal side effects of it in patients of Air force and Buali hospitals in Tehran from 

2007 to 2009 

Artin Mardirosian, (Iran), MH Lashkari, F Nejad Dadgar, H Molana, M Fotouhi 

Mon 037 The attitude of medical students towards traditional medicine 

Ortrun Meissner-Kirch, (South Africa), EN Kwizera 

Mon 038 Safety and efficacy of granulocyte colony-stimulating factor (ior-LeukoCIM) in oncohematology patients. 

Phase IV 

Ivis Cristina Mendoza Hernandez, (Cuba), EG Lopez, MW de Leon, AM Veitia, JDF Aguila, EV Olazabal, 

MR Garcia, PP Sierra, GS Martinez, Y Barrese Pérez 

Mon 039 Clinical pharmacology service rationalized use of costly drug in academic hospital of a country in 

socio-economic transition 

Dragan Milovanovic, (Republic of Serbia), S Jankovic, D Ruzic Zecevic 


FC02 Transmembrane transport: Perspectives for disease 

and drug discovery 

Mon 040 Consequences of chronic postnatal stress on glutamatergic transporter and on behavioural test in the 

rat 

Gabriela Acosta, (Argentina), MM Odeon, ML Orta, A Salatino 

Mon 041 Cyclosporine A, but not tacrolimus, show relevant inhibition of OATP1B1 mediated transport of 

atorvastatin 

Rune Amundsen, (Norway), H Christensen, B Zabihyan, A Åsberg 

Mon 042 Uptake of folic acid and methyltetrafolic acid by rat and human blood-brain barrier endothelial cell lines 

João R Araújo, (Portugal), P Goncalves, F Martel 

Mon 043 Interactions between verapamil and digoxin in Langendorff - perfused rat hearts: the role of inhibition of 

P-glycoprotein in heart 

M Aylin Arýcý, (Turkey), E Kilinc, O Demir, M Ates, A Yesilyurt, A Gelal 

Mon 044 Impacts of EGFR-antisense and carbenoxolone on cancer cell lines 

Masoud Asadi, (Iran), H Hamzeiy, J Barar, Y Omidi, S Mohammadi 

Mon 045 Rho kinase inhibitor Fasudil modifies the actin cytoskeleton of astrocytes up-regulating glutamate 

transport and anti-inflammatory mechanisms 

Philip Beart, (Australia), C Lau, V Perreau, N Cheung, M Chen, L Bischof, R O'Shea 

Mon 046 New naphthalene derivatives of citalopram discriminate between the primary and the allosteric binding 

sites at the human serotonin transporter 

Klaus Bøgesø, (Denmark), P Bregnedal, K Juhl, H Zhong, O Wiborg 

Mon 047 A fast and sensitive LC-MS/MS assay for quantification of nortriptyline and its active metabolites E- and 

Z-10-hydroxynortriptyline in human plasma 

Gitte Bonke, (Denmark), BP Jensen 

Mon 048 SLCO1B1 variants as pharmacogenetic predisposition for hepatotoxicity induced by HMGCoA 

reductase inhibitors 

Nada Božina, (Croatia), I Mercep, V Miroševic, T Božina, J Sertic, Z Reiner 

Mon 049 Pharmacokinetic interactions of cimetidine and pramipexole in relation to OCT2 

Chang-Ik Choi, (South Korea), S-M, Moon, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Mon 050 Pharmacogenetics of metformin 

Mette Marie Hougaard Christensen, (Denmark), CB Andersen, P Damkier, HB Nielsen, K Brøsen 

Mon 051 The role of p-glycoprotein in bacterial attachment to intestinal cells 

Andrew Crowe, (Australia) 

Mon 052 Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonyl-glycine inhibition of glycine 

transport 

Amelia Edington, (Australia), R Ryan, R Vandenberg 

Mon 053 The effect of loperamide and fentanyl on the distribution kinetics of verapamil in the lung and brain in 

Sprague Dawley rats 

Iman El-Kiweri, (Saudi Arabia), MT van Patot, YL Zhang, U Christians, T Henthorn 

Mon 054 Cannabidiol inhibits BCRP and P-gp in human placental trophoblast cell lines BeWo and Jar 

Valeria Feinshtein, (Israel), G Holcberg, Z Ben-Zvi 




Mon 055 Gene expression and comparative genomic hybridization profiles of 6-mercaptopurine- and 

6-thioguanine-resistant human leukaemia cells 

Alan Fotoohi, (Sweden), J Hashemi, A Moshfegh, C Larsson, F Albertioni 

Mon 056 Pharmacokinetic interaction between puerarin and edaravone and effect of borneol on the brain 

distribution kinetics of puerarin in rats 

C Gao, X Li, T Li, L Wang, Ming Xue, (PR China) 

Mon 057 Influence of polyphenols in a colon tumoral cell line: effect on butyrate uptake and on proliferation, 

differentiation, viability and apoptosis 

Pedro Gonçalves, (Portugal), JR Araújo, MJ Pinho, F Martel 

Mon 058 Characterization of LeuT, a bacterial member of the neurotransmitter:sodium symporter family, in an 

inward-facing conformation 

Kamil Gotfryd, (Denmark), D Kruger, J Kniazeff, J Javitch, C Loland, U Gether 

Mon 059 IL1β-mediates time and concentration dependent induction of ABCC2 gene expression via p38 MAPK 

and Akt pathway in Sk-Hep1 cells 

Sierk Haenisch, (Germany), S Lächelt, A Schmall, I Cascorbi 

Mon 060 Confounding factors in quantifying the concentration dependent P-glycoprotein mediated transport in in 

vitro cell permeation experiments 

Aki T Heikkinen, (Finland), T Korjamo, V Lepikkö, J Mönkkönen 

Mon 061 Modulating the dopamine transporter expression through changes in the proteostasis environment 

Freja Henriksen, (Denmark), I Ammendrup-Johnsen, U Gether 

Mon 062 Regulation of microglial immune fuction by store-operated calcium channels(SOCs) 

Dae Keon Heo, (South Korea), MG Lee, JY Kim 

Mon 063 Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic 

metabolism 

Elina Immonen, (Finland), M Kummu, A Petsalo, T Pihlaja, K Vàhàkangas, P Myllynen 

Mon 064 Influence of P-glycoprotein polymorphism on nortriptyline-induced postural hypotension 

Berit P Jensen, (New Zealand), R Vyas, G Bonke, RR Roberts, D Jardine, EJ Begg 

Mon 065 Significant pharmacokinetic interaction between pitavastatin and clarithromycin in healthy subjects 

Kyeong-Joo Jeon, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Mon 066 Evaluation of the pharmacokinetic profile of ezetimibe in healthy Koreans with different SLCO1B1 

genotype 


Mon 067 Identification of kinases regulating monoamine transporter function by kinome-wide siRNA screening 

Trine Nygaard Jørgensen, (Denmark), I Ammendrup-Johnsen, U Gether 

Mon 068 Characterization of TMEM16 family and its functional implications in human pancreatic acinar cells 

Jinsei Jung, (South Korea), JH Nam, JS Yoon, MG Lee 

Mon 069 Influence of MRP2 C-24T polymorphism on the disposition of orally administered ezetimibe in healthy 

subjects 

Seul-Ki Keum, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 




Mon 070 Interactions of atazanavir (ATV) with solute carrier (SLC) transporters in Caco-2 cells, an in vitro model 

of human intestinal epithelium 

O Kis, J Zastre, M Ramaswamy, Kevin Robillard, (Canada), R Bendayan 

Mon 071 Transport of cyclic nucleotides in human colonic epithelium 

Karen Kleberg, (Denmark), GM Jensen, JG Meyer, S Knuhtsen, MB Hansen, N Bindslev 

Mon 072 Tissue expression and function of organic anion transporting polypeptide 2B1 splice variants 

Michael Knauer, (Canada), R Kim, R Tirona 

Mon 073 Application of fluorescence spectroscopy to study conformational dynamics of LeuT, a bacterial 

homologue of mammalian neurotransmitter transporters 

Dinna B Krüger, (Denmark), J Kniazeff, L Shi, K Gotfryd, CC Billesbølle, CJ Loland, JA Javitch, 

H Weinstein, U Gether 

Mon 074 Histamine transport into neonatal rat astrocytes: an experimental and computational study 

Mojca Krzan, (Slovenia), K Perdan-Pirkmajer, J Mavri 

Mon 075 Acetylcholinesterase reactivators – in vitro prediction of passive drug transport through the blood-brain 

barrier 

Kamil Kuca, (Czech Republic), J Zdarova-Karasova, P Stodulka, K Musilek, M Pohanka 

Mon 076 ABC transporters and heavy metals in BeWo human choriocarcinoma cells 

Maria Kummu, (Finland), A Rautio, K Vähäkangas, P Myllynen 

Mon 077 Quantification, pharmacokinetics and brian distribution kinetics of thiencynonate and its optical isomers 

in rat 

Y Liu, Y Xu, Ming Xue, (PR China), J Ruan, K Liu 

Mon 078 Structural elucidation of in vivo metabolites of phencynonate and its analogue thiencynonate in rats by 

liquid chromatography-tandem mass spectrometry 

Y Liu, Ming Xue, (PR China), Y Ku, Y Xu, J Ruan, K Liu 

Mon 079 ITH12233, a new multifunctional compound, reduces infarct volume after focal cerebral ischemia in 

mice 

Silvia Lorrio, (Spain), P Negredo, MI Rodríguez-Franco, S Conde, MP Arce, M Villarroya, JM Roda, 

MG López, AG García 

Mon 080 In vitro evaluation of drug interaction with P-glycoprotein and permeability of F-80002-RR in early stages 

of development 

Maria Luisa Lucero, (Spain), A Gonzalo, I Soengas, M Rodriguez 



Mon 081 Rocuronium interferes with cytochrome P450 in vitro 

Pavel Anzenbacher, (Czech Republic), E Anzenbacherova, A Tunkova, M Adamus 

Mon 082 Potentiating effect of diltiazem on pentobarbital hypnosis may be related to the 5-HT1A and 5-HT2A/2C 

receptors: the DRN, TMN and VLPO as key elements in the pathway 

Su-Ying Cui, (PR China), Y-H Zhang, X Zhao, X-Q Zhang 

Mon 083 Effects of ketamine on nociception, learning and memory in rats 

Damianka Getova, (Bulgaria), N Doncheva 

Mon 084 N-methyl-D-aspartate channel blocking properties of dual reuptake inhibitors 

Peter Heusler, (France), A Tourette, C Cathala, D Cussac 

Mon 085 The effect of tramadol on concentration of noradrenaline in the locus coeruleus of rats during the 

formalin test 

Akram Jamshidzadeh, (Iran), MA Mobasher, J Sajedianfard 

Mon 086 Time course of changes in TRPV1 channel function in rat urinary bladder following streptozotocin 

induced diabetes 

Teeraporn Katisart, (UK), M Parsons, C Benham 

Mon 087 Features of Meloxicam antinociceptive potential under experimental equivalent of Parkinson’s disease 

on a background of Amantadine therapy 

Olga Makarenko, (Ukraine) 

Mon 088 The effects of gabapentin on norepinephrine, serotonin and their metabolites in Raphe magnus in 

formalin test by the method of microdialysis in male rats 

Mohammad M Namvaran, (Iran), A Jamshidzadeh, J Sajedianfard, MA Mobasher 

Mon 089 The GTP-cyclohydrolase deficient mouse shows reduced acute pain perception 

Arafat Nasser, (Denmark), OJ Bjerrum, A-M Heedaard, LB Møller 


W12 Experimental pain methods in development and 

validation of analgesics 

Mon 090 The pharmacogenomics of escitalopram in the treatment of neuropathic pain 

Charlotte Brasch-Andersen, (Denmark), MU Møller, SH Sindrup, K Brøsen, M Otto 

Mon 091 Single dose of tramadol on neurotransmitter systems in target and non-target areas of rat brain without 

nociception 

Pandanaboina Chetan, (USA), S Rajbanshi, R Wudayagiri 

Mon 092 Comparison of the PD/PK of Rotundine crystal form A and C in mice 

Lida Du, (PR China), X Li, J Ying, X Bai, S Yang, H Zhang, G Wang, Y Lu 

Mon 093 Neurotropin relieves the oxaliplatin-induced peripheral neuropathy by inhibiting neurodegeneration 

Nobuaki Egashira, (Japan), T Kawashiri, H Watanabe, Y Ikegami, T Yano, H Ikesue, R Oishi 

Mon 094 Characterization of the antinociceptive and anti-inflammatory activities of nicotinamide and its isomers 

in different experimental models 

Wallace Ferreira, (Brazil), A Godin, L Rocha, R Vieira, E Nascimento, J Seniuk, M Coelho 

Mon 095 Characterization of the antinociceptive and anti-inflammatory activities of nicotinic acid and its isomers 

in different experimental models 

Wallace Ferreira, (Brazil), A Godin, L Rocha, R Vieira, E Nascimento, J Seniuk, M Coelho 

Mon 096 Botulinum toxin type A reduces migraine symptoms in rats: bilateral allodynia and dural extravasation 

after infraorbital nerve constriction injury 

B Filipovic, I Matak, L Bach-Rojecky, Zdravko Lackovic, (Croatia) 

Mon 097 Evatuation of the effects induced by nicorandil and its immediate precursor in the models of 

formaldehyde-induced nociceptive response and carrageenan-induced edema in mice 

Adriana Godin, (Brazil), W Ferreira, F Oliveira, L Rocha, R Vieira, E Nascimento Jr, J Seniuk, 

A de Fátima, M Coelho 

Mon 098 Lack of correlation between plasma asymmetric dimethylarginine (ADMA) levels and pain-related 

behaviors in neuropathic rats 

E Hafizoglu, (Turkey), Ahmet Ulugol 

Mon 099 Evidence for CGRP uptake in rat dura mater encephali: Relevance to migraine 

Inger Jansen-Olesen, (Denmark), D Amrutkar, A Mataji, H Salmasi, M Sheykhzade, K Messlinger, 

J Olesen, S Gupta 

Mon 100 Effects of Diclofenac on the repolarization in dog ventricular muscle 

Norbert Jost, (Hungary), A Kristof, I Koncz, T Szell, P Biliczki, J Papp, A Varro, L Virag 

Mon 101 Inhibitory effects of dopamine on spinal reflex potentials of rat 

K Kawamoto, Ken-ichi Otsuguro, (Japan), S Ito 

Mon 102 Local anaesthetic infused at the incision site for post-operative pain management following abdominal 

surgery 

Sumithra Krishnan, (Australia), R Morris, P Hewett, A Karatassas, J Tonkin, J Field 

Mon 103 Investigation of antinociceptive activity of mirtazepine and its mechanism 

Fatma Sultan Kýlýç, (Turkey), AE Doan, K Erol 

Mon 104 Does pheny-N-tert-butylnitrone (ROS scavenger) has the antinociceptive effect through spinal 

mechanism in formalin rat? 

Won Hyung Lee, (South Korea), YK Ko 


W12 Experimental pain methods in development and 

validation of analgesics 

Mon 105 Antinociceptive effects of biphalin and its analog AM 94 

Sheila Leone, (Italy), L Brunetti, G Orlando, A Mollica, L Recinella, C Ferrante, A Chiavaroli, C Di Nisio, 

P Di Michele, R Shohreh, M Vacca 

Mon 106 Role of pituitary adenylate cyclase activating polypeptide in the nitroglycerin-induced migraine model of 

the mouse 

Adrienn Markovics, (Hungary), K Sándor, E Szõke, V Kormos, B Botz, A Imreh, B Gaszner, D Reglõdi, 

A Baba, J Tajti, J Szolcsányi, Z Helyes 

Mon 107 The influence of intravenous promethazine on intravenous morphine for the treatment of acute severe 

pain: a randomised clinical trial 

Nasir Mohamad, (Malaysia), AH Saim, NH Abu Bakar, KA Baharuddin, R Ismail 

Mon 108 Antinociceptive effect of Endomorphin 1 administered using polybutylcyanoacrylate nanoparticulate 

delivery systems 

Ostin Mungiu, (Romania), D Geta, I Jaba, B Tamba, C Bohotin, X Patras 

Mon 109 Systematic review and meta-analysis of tryptans in the acute treatment of cluster headache 

C Mustata, Ricardo Pardo, (Spain), E Papaseit, M Farre 

Mon 110 Role of pituitary adenylate cyclase activating polypeptide in nocifensive behaviours, inflammatory and 

neuropathic hyperalgesia 

Katalin Sándor, (Hungary), V Kormos, B Botz, A Imreh, K Bölcskei, B Gaszner, D Reglõdi, J Szolcsányi, 

N Shintani, H Hashimoto, A Baba, Z Helyes 

Mon 111 Experimental research on the interactions of diethylamine with opioid and non-opioid analgesics 

Ana Segarceanu, (Romania), I Ghita, O Coman, I Fulga 

Mon 112 SA14867 ((+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-ethoxyethyl)-N-isopropylamino)propoxy)-5-me 

thoxyphenyl]benzothiazoline O,Oκ f-diacetyl-L-tartarate), a newly synthesized κ-opioid agonist, shows 

anti-nociceptive and anti-pruritic effects 

Fumio Tsuji, (Japan), Y Tsukahara, M Niwa, M Nakamura, M Sasano, H Aono 

Mon 113 Acetyl-L-Carnitine increases artemin level and prevents neurotrophic factor alterations in neuropathic 

pain state 

Elisa Vivoli, (Italy), L Di Cesare Mannelli, A Salvicchi, A Bartolini, C Ghelardini 

Mon 114 Structure-activity relationship study of novel fentanyl analogues 

S Vuckovic, Z Nesic, K Savic Vujovic, M Milovanovic, Milica Prostran-Veselinovic, (Republic of Serbia) 

Mon 115 Influence of bile acid derivates on morphine analgesic effect in mice 

Sasa Vukmirovic, (Republic of Serbia), V Vasovic, D Lendak, M Mikov, M Vukmirovic Papuga, 

N Stilinovic 



opportunities 

Mon 116 The effect of adverse drug reactions (adr) on drug prescriptions during acute hospital admissions 

Paul Acheampong, (UK), M Doshi, C Doig 

Mon 117 Prescription patterns of controlled medicines in Istanbul 

Ahmet Akici, (Turkey), D Demircan, I Topcu, H Yilmaz, B Donertas, K Berkman 

Mon 118 Drug use during pregnancy: a register-based nationwide cohort study of FDA's drug classification of 

fetal risks 

Jon T Andersen, (Denmark), M Petersen, N Andersen, S Afzal, K Broedbaek, B Hjelvang, 

C Torp-Pedersen, HE Poulsen 

Mon 119 Association between FDA drug classification of fetal risks and the risk of major congenital 

malformations: a register-based nationwide cohort study 

Jon T Andersen, (Denmark), M Petersen, NL Andersen, S Afzal, K Broedbaek, B Hjelvang, 

C Torp-Pedersen, HE Poulsen 

Mon 120 Adherence to antihypertensive medications and all-cause mortality and cardiovascular events: 

A population-based study based on administrative data 

Silvia Benemei, (Italy), S Saragoni, P Batacchi, P Geppetti, M Di Bari, N Marchionni, S Buda, 

ED Esposti, LD Esposti 

Mon 121 Consumption of drugs against ADHD in Denmark more than ten doubled in ten years 

Bine Kjøller Bjerregaard, (Denmark) 

Mon 122 Statin treatment reduces mortality in severe infections – a systematic review and meta-analysis 

Linda Björkhem-Bergman, (Sweden), P Bergman, J Andersson, J Lindh 

Mon 123 Off-label vs compassionate drug use: Level of evidence for applications 

Encarnación Blanco, (Spain), A Muñoz, I Bellido, M Salazar, EI Márquez 

Mon 124 Gender difference in the impact of long-term psychoactive drug use on cognitive functioning: 

The VISAT cohort 

O Boeuf-Cazou, B Bongue, D Ansiau, J-C Marquié, Maryse Lapeyre-Mestre, (France) 

Mon 125 Monitoring of adverse reaction by classical antipsychotics in older patient, Cuba 2003–2008 

Ashley Lázaro Chao Cardeso, (Cuba), GJ López, IA Orta, JA Pérez, ID Mato 

Mon 126 Management of cardiovascular medication in surgical patients: Indications in summary of product 

characteristics and substitution for intravenous forms 

Liliana Castanheira, (Portugal), P Fresco, AF Macedo 

Mon 127 Adherence to treatment: feasibility of a specific self-reported questionnaire to assess medication taking 

behaviour 

Josip Culig, (Croatia), M Leppee, J Boskovic 

Mon 128 Emergence of H274Y mutation and oseltamivir resistance during treatment in two patients in the 2009 

epidemics of swine flu in Argentina 

Roberto Diez, (Argentina), ML Valinotto, P Barrero, M Viegas, MC Alvarez López, E López, 

AS Mistchenko 

Mon 129 A community pharmacy multinational project to investigate the prescription drug abuse 

Paola D’Incau, (Italy), M Lapeyre-Mestre, A Carvajal, U Bergman, ER Heerdink, RV Stichele, D Macias, 

L Pourcel, A Conforti 



opportunities 

Mon 130 Gender differences of ADRs related to psychotropic drug use: A survey from France, Italy and Spain 

Paola D'Incau, (Italy), M Lapeyre-Mestre, M Sáinz, M Donati, A Carvajal 

Mon 131 Aluminium phosphide poisoning – a retrospective study 

Nandlal Disania, (India), L Sharma, S Janani, BM Gupta 

Mon 132 Management of acute myocardial infarction in France: Results from inclusion of a national cohort 

Cécile Droz-Perroteau, (France), C Dureau-Pournin, D Thomas, N Danchin, J Tricoire, J Bénichou, 

F Paillard, P Ducimetière, S Hercberg, H Maïzi, E Guiard, M-A Bernard, P Blin, N Moore 

Mon 133 Analysis of pharmacotherapy for pregnant women in Primorye Region 

Ekaterina Eliseeva, (Russian Federation), Y Feoktistova, L Lozinskaya 

Mon 134 Medical prognosis of perioperative prophylaxis efficiency in cholecystectomy 

Ekaterina Eliseeva, (Russian Federation), V Shevtsov 

Mon 135 Clinical pharmacology outpatient clinic: outcomes and maternal characteristics associated with pregnancy 

exposure to FDA category X drugs 

Viktorija Erdeljic, (Croatia), I Francetic, K Makar-Ausperger, R Likic, M Radacic-Aumiler, D Juricic, 

L Bielen 

Mon 136 Prescription of potentially inappropriate medications: Comparison between internal medicine service 

and geriatric unit 

Leslie Escobar, (Chile), P Jara, M Jirón, M Rain, G Martinez, C Dechent 

Mon 137 Mini-cases as a method to dynamize lectures of autonomic nervous system pharmacology in a medical 

school 

Magi Farre, (Spain), J-E Baños 

Mon 138 Macro-study on-line of searching in internet for health and drug products: A social pharmacology 

approach 

Juan Antonio Formigos, (Spain), M Palmero, JL Alloza, 

Mon 139 Quality of antibiotic prescribing in infant in ambulatory care 

Kristina Garuoliene, (Lithuania), J Gulbinovic 

Mon 140 Administrative complexities for a European observational study 

Sinem Ezgi Gulmez, (France), S Lignot-Maleyran, S Micon, F Hamoud, C De Vries, M Sturkenboom, 

P Blin, N Moore 

Mon 141 SALOME: A pilot study to test causality assessment of drug-exposed acute liver failure cases using different 

scales 

Sinem Ezgi Gulmez, (France), GP Pageaux, D Larrey, S Lignot-Maleyran, F Hamoud, S Micon, 

R Lassalle, J Jové, F Bissoli, Y Horsmans, J Bernuau, B Stricker, D Thorburn, P Blin, N Moore on 

behalf of SALT-I team 

Mon 142 Methods for improving compliance with medicine intake(MICMI): Pilot project to evaluate the ’Personal 

Electronic Medicine profile’[PEM] 

Philipp Harbig, (Denmark), I Barat, P Lund Nielsen, EM Damsgaard 

Mon 143 Do vasodilating properties of amiodarone contribute to its antiarrthythmic action in clinical practice? 

Apostolos Hatzitolios, (Greece), N Katsiki, G Ntaios, C Savopoulos, A Spiliopoulos, C Papadopoulos, 

V Mirtsou-Fidani 



opportunities 

Mon 144 The effect of co-administration of CYP1A2 and P-glycoprotein inducers or inhibitors on serum 

theophylline concentration 

Milka Hauta-aho, (Finland), T Laurikainen, T Katiskalahti, T Tirkkonen, K Laine 

Mon 145 Factors associated with short-term adherence to dietary and lifestyle guidelines in secondary 

prevention of acute myocardial infarction in real life practice in France 

S Hercberg, D Thomas, Cécile Droz-Perroteau, (France), C Dureau-Pournin, P Ducimetière, F Paillard, 

J Tricoire, M-A Bernard, J Bénichou, N Danchin, L Guize, P Blin, N Moore 

Mon 146 Influence of nurses’ attitudes on adverse drug reaction reporting: a pilot study in Portugal 

Maria T Herdeiro, (Portugal), S Pernas, O da Cruz e Silva, A Figueiras 




Mon 147 The blood glucose levels in healthy volunteers administered with repaglinide and genetic 

polymorphisms of CYP3A4 and CYP2C8 

Ruzilawati Abu Bakar, (Malaysia), MS Ab Wahab, G Siew Hua 

Mon 148 Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas- 

Ligand pathway in mice 

A Agouni, P-H Ducluzeau, T Benameur, M Sladkova, G Leftheriotis, O Pechanova, 

Carmen Martinez, (France), R Andriantsitohaina 

Mon 149 A lineal mathematical model based on HbA1c levels follow up may predict the years of evolution of 

type 2 diabetes mellitus starting from a single HbA1c level quantification 

Inmaculada Bellido, (Spain), AE Santos, L García-Carrascal, JJ Sanchez-Luque, E-I Marquez, E Blanco, 

A Gomez-Luque 

Mon 150 Toxicity of cytostatic agents to granulocyte-macrophage progenitors (CFU-GM) increased in Zucker 

obese rats 

I Benkõ, Krisztina Géresi, (Hungary), K Benkõ, B Szabó, A Megyeri, E Ungvári, B Peitl, Z Szilvássy 

Mon 151 Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities 

Ibrahim Benter, (Kuwait), G Dhaunsi, M Yousif, S Akhtar, M Chappell, D Diz 

Mon 152 PKCβ/HuR/VEGF a new pathway in diabetic retinopathy 

Claudio Bucolo, (Italy), A Pascale, M Amadio, S Govoni, F Drago 

Mon 153 Evaluation of guideline-conformity of initiation of oral hypoglycemic treatment for incident diabetes 

mellitus type 2 in Austria 

Anna Bucsics, (Austria), M Asslaber, R Bauer, T Burkhardt, M Pogantsch, A Schautzer, PR Wieninger, 

WC Winkelmayer 

Mon 154 TNFα does not inhibit insulin-stimulated 2-deoxy-glucose uptake in in situ skeletal muscle, but does 

increase lipolysis and lower total glucose utilization 

Christian Selmer Buhl, (Denmark), CN Petersen, N Jessen, O Schmitz, S Lund, ES Buhl 

Mon 155 Alterations in aromatase enzyme levels of ovary, testis, uterus and vas deferens tissues of diabetic rats 

Nihan Burul-Bozkurt, (Turkey), C Pekiner, P Kelicen 

Mon 156 Central injection of CDP-Choline suppresses serum ghrelin levels while it increases serum leptin levels 

in rats 

Sinan Cavun, (Turkey), S Kýyýcý, NF Basaran, V Savci, S Imamoglu 

Mon 157 α-linolenic acid protects renal cells against palmitic acid lipotoxicity via reduction of endoplasmic 

reticulum stress 

Prabal Chatterjee, (UK), E Katsoulieris, J Mabley, M Samai, I Green 

Mon 158 Discovery of a novel dipeptidyl peptidase-IV inhibitor BPR1G462 

Chiung-Tong Chen, (Taiwan), K-C Yeh, C-Y Huang, W-T Jiaang, C-B Hu, Y-W Huang,T Hsu, J-S Song, 

T-K Yeh, C-H Chien, S Chen, Y-S Chao 

Mon 159 A genetic variant in the gene encoding adrenomedullin predicts the development of dysglycaemia over 

6.4 years in Chinese 

Bernard MY Cheung, (PR China), AWK Tso, KL Ong, RYH Leung, SS Cherny, PC Sham, TH Lam, 

KSL Lam 




Mon 160 Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood 

stabilizers 

Eva Choong, (Switzerland), M Etter, B Oneda, H Tayebi, G Bondolfi, CB Eap 

Mon 161 Type 2 diabetes-associated non-synonymous mutations in the gene coding for the melatonin MT2 

receptor impair melatonin signalling 

Nathalie Clement, (France), A Bonnefond, K Fawcett, E Vaillant, J-L Guillaume, B Balkau (the MAGIC 

consortium), M Marre, G Charpentier, M Vaxillaire, I Barroso, R Jockers, P Froguel 

Mon 162 Results about the influence of Metformin on the concentrations of magnesium,zinc and cooper in 

NIDDM patients. 

Monica Daniela Dosa, (Romania), LC Petcu, C Gales, M Nechifor 

Mon 163 Interaction between cicletanine and preconditioning in concious rabbits with insulin resistance 

László Drimba, (Hungary), B Peitl, T Patonay, Z Szilvássy 

Mon 164 Tumor necrosis factor α inhibition by pentoxifylline protects from the impairment in vascular reactivity 

associated with insulin resistance 

Hany El-Bassossy, (Egypt), M El-Moselhy, M Fouad 

Mon 165 Protein kinase C inhibition protects from the impairment in vascular responsiveness associated with 

insulin deficiency but not insulin resistance 

Hany El-Bassossy, (Egypt), A Fahmy, W Barakat, N Dsokey 

Mon 166 Effect of taurine, pyridoxine and α lipoic acid on cafeteria diet fed rats 

Priya Ganpathy, (India), R Ghosh, S Pitre, V Kadam 

Mon 167 Carboplatin-induced toxicity increased to granulocyte-macrophage progenitors (CFU-GM) in 

Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats 

Krisztina Géresi, (Hungary), K Benkõ, B Szabó, A Megyeri, B Peitl, Z Szilvássy, I Benkõ 

Mon 168 Effect of bis-1-4-dihydropyridine in kidneys of diabetic rats 

Raquel Gómez-Pliego, (Mexico), R Villalobos-Molina, M Ibarra-Barajas, B Velasco-Bejarano, 

J Gómez-Zamudio 

Mon 169 Effect of atorvastatin on pancreatic β-cell function and insulin resistance in type 2 diabetes mellitus 

patients 

Aman Goyal, (India), S Singh, N Tandon, N Gupta, YK Gupta 

Mon 170 Does HGF/c-Met signalling exert its effects on vascular dysfunction by small GTPases in diabetic rats? 

Mukaddes Gumustekin, (Turkey), A Arici, F Arslan, M Karaman, M Ates, E Guneli 

Mon 171 Transcriptome profiling reveals involvement of PKC in the development of insulin resistance in liver of 

HFD+STZ fed rats via Rho kinase pathway 

Jeena Gupta, (India), K Tikoo 

Mon 172 The interaction of human urotensin II and vasodilator agents in human internal thoracic artery: Clinical 

implications 

Guo-Wei He, (PR China), X-Y Bai, X-C Liu, W-B Jing, Q Yang 

Mon 173 Fish oil affects clock gene and clock-controlled metabolism-related gene expression in the mouse liver 

Akiko Hirao, (Japan), H Nagahama, M Itokawa, M Shimoda, Y Tahara, S Shibata 




Mon 174 Angiotensin II type 2 receptor activation modulates insulin receptor signalling pathways in adult sensory 

neurons 

Narumi Hobara, (Japan), N Hashikawa, Y Zamami, H Kawasaki, C Yutani 

Mon 175 Early indications for clinical efficacy of diabetes drugs in development in phase 1 studies: How? 

Marcus Hompesch, (USA), L Morrow 

Mon 176 Modification of perivascular adipose tissue (PVAT) by diabetes mellitus 

Enrique Hong, (Mexico), O Echeverría 

Mon 177 Anti-obesity and anti-diabetic effects of acacia polyphenol 

Nobutomo Ikarashi, (Japan), T Toda, T Okaniwa, K Ito, W Ochiai 

Mon 178 Effects of polyphenolic compounds on glutathione level and endothelial NO production in 

hypercholesterolemic rats 

Akira Ishihata, (Japan), Y Igarashi, Y Shimizu, Y Kobayashi, A Yamada, S Hishinuma, T Hosoda, 

Y Katano 

Mon 179 Dysfunction of presynaptic regulation of norepinephrine release from adrenergic nerves of caudal artery 

in type 2 diabetic Goto-Kakizaki rats 

Reiko Ishii-Nozawa, (Japan), M Mita, M Shoji, K Takeuchi 

Mon 180 Basic fibroblast growth factor upregulates hypoxia inducible factor 1α and glucose transporter 1 in 

adipose cells 

Yoshitaka Kihira, (Japan), S Tomita, Y Ikeda, K Ishizawa, K Tsuchiya, T Tamaki 

Mon 181 Antiplatelet action of statins in diabetic rabbits: Interaction with leptin 

Ivan Kocic, (Poland), B Racek-Król, I Rusiecka, I Pawlowska, R Wasilewski, M Bitel 

Mon 182 Differences in the pharmacokinetics of Cyp3a substrates in TSOD mice and streptozotocin-induced 

diabetic mice 

T Kudo, T Toda, T Ushiki, K Ohi, N Ikarashi, W Ochiai, Kiyoshi Sugiyama (Japan) 

Mon 183 Suppression of NF- κB signalling pathway by epigallocatechin gallate can prevent diabetes associated 

cognitive deficits 

Anurag Kuhad, (India), M Bishnoi, V Tiwari, K Chopra 

Mon 184 Cardiovascular dysfunction and the role of COX-2 in two rat models of diabetes 

Joanne YT Leung, (Canada), SL Lim, CCY Pang 

Mon 185 Effect of bicyclol on high fat diet (HFD)-induced fatty liver in rats 

Yan Li, (PR China), H Yu, H Chen 

Mon 186 Leptin induces hypertrophy via activating PPARα pathway in cultured neonatal rat cardiomyocytes 

Jian-Dong Luo, (PR China), N Hou, M-S Chen 

Mon 187 Association of VKORC1 -1639 G>A polymorphism with intima-media thickness of common carotid 

artery in subjects with type 2 diabetes mellitus 

Vangelis G Manolopoulos, (Greece), I Petridis, G Ragia, M Vassileiadis, I Heliopoulos, D Christakidis, 

A Tavridou 


FC06 The heart gone wrong; stabilization of cardiac 

function 

Mon 188 Effect of vitamin E on renal ischemic preconditioning in male and female rats 

Nahid Abotaleb, (Iran), S Aryamanesh, SM Ebrahimi, M Nobakht 

Mon 189 Modulatory effects of zinc supplementation on cardiovascular complications in streptozotocin-induced 

diabetes in rats 

Nouf MI AL-Rasheed, (Saudi Arabia), NMI AL-Rasheed, HA Attia, LM Faddah 

Mon 190 Cardioprotective mechanism of telmisartan through the PPAR-γ pathway against isoproterenol-induced 

myocardial infarction in experimental diabetes 

Dharamvir S Arya, (India), S Goyal 

Mon 191 Mechanical and structural characteristics of carotid plaques: Analysis by multi-array echotracking 

system and MRI. 

Hélène Beaussier, (France), O Naggara, D Calvet, R Joannides, B Laloux, E Bozec, 

E Guegan-Massardier, E Gerardin, I Masson, C Oppenheim, P Boutouyrie, S Laurent 

Mon 192 Rational drug correction of the systemic inflammatory response syndrome in patients with congestive 

heart failure 

Tamar Bochorishvili, (Georgia), MA Rogava, ET Tsiwtsiwadze 

Mon 193 Relevance of free MPA monitoring in early period following heart transplantation 

Roselyne Boulieu, (France), X Cussonneau, M Larger, O Bastien 

Mon 194 Prostacyclin IP receptor activation, transforming growth factor signalling and cardiac fibrosis in 

hyperlipidemic mice 

Elsa Chan, (Australia), G Dusting, N Guo, H Peshavariya, R Dilley, S Narumiya, F Jiang 

Mon 195 Effect of pre-ischaemic conditioning on anoxic dopamine efflux in the mouse caudate. 

Nikky Kanti Chauhan, (UK), AMJ Young, CL Gibson, C Davidson 

Mon 196 Cardioprotective effects of exogenous and endogenous hydrocortisone in the rabbit model of 

ischemia-reperfusion 

Ali Davarian, (Iran), V Khori, O Shirinbeik Mohajer 

Mon 197 Engagement of imidazoline receptors in effects of imidazoline drugs on isolated rat heart atria 

Justyna Dlugokecka, (Poland), A Radwanska, R Kaliszan, A Nasal 

Mon 198 Effects of ultra-low doses of peroral antibodies to angiotensin II receptor in non-invasive and invasive rat 

models of heart failure 

Julia Dugina, (Russian Federation), IA Kheyfets, SA Sergeeva, OI Epstein 

Mon 199 Effect of atorvastatin addition to cardioplegic solution on myocardial protection in isolated rat heart 

Deniz Kaleli Durman, (Turkey), M Agirgol, M Kucur, F Basinoglu, O Ozdemir, BS Uydes-Dogan 

Mon 200 Disproportionally impaired microvascular structure in patients with very mild essential hypertension 

Ashkan Eftekhari, (Denmark), ON Mathiassen, NH Buus, O Gotzsche, MJ Mulvany, KL Christensen 

Mon 201 Effect of grapefruit juice on dronedarone pharmacokinetics in healthy subjects 

Christine Gaud, (France), A Brunet, E Sultan, J Galleyrand, T Duvauchelle 

Mon 202 Effects of dronedarone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects 

Christine Gaud, (France), J-P Duret, A Brunet, E Sultan, R Ebrahimi 

Mon 203 Effects of dronedarone on the pharmacokinetics of digoxin in healthy subjects 

Christine Gaud, (France), F Hurbin, A Brunet, E Sultan, J Galleyrand, E Guénolé 



function 

Mon 204 Pharmacokinetic and pharmacodynamic interaction of dronedarone and verapamil in healthy subjects 

Christine Gaud, (France), S Doroumian, A Brunet, E Sultan, J Galleyrand 

Mon 205 Pharmacokinetics and tolerability of dronedarone in patients with moderate hepatic impairment 

Christine Gaud, (France), A Brunet, E Sultan, J Galleyrand, K Lasseter, T Marbury 

Mon 206 The oxidative stress predicts a higher coronary risk 

Jose Antonio González Correa, (Spain), M Carnero, J Muñoz-Marin, F Reguillo, M Ramajo, J Navarro- 

Dorado, S Redondo, JP De la Cruz, T Tejerina 

Mon 207 Ambulatory control of arterial pressure in patients with isolated systolic hypertension and associated 

ischemic heart disease 

Jose Ernesto Groning, (Cuba), R Garcia, D Garcia-Barreto, A Hernandez-Cañero 

Mon 208 Potentiation of uterus-relaxing effects of nifedipine with β-adrenergic agonists: Studies on rats and 

human myometrium 

Judit Hajagos-Tóth, (Hungary), Z Kormányos, G Falkay, R Gáspár 

Mon 209 Ginsenoside Rg-1 and salvianolic acid B mediated autophagy and apoptosis in nutrient starvation 

cardiac myocytes 

Xiao Han, (PR China), J-X Liu, X-Z Li 

Mon 210 The role of voltage-dependent anion channel in ischemia/reperfusion injury mediated by chloride 

Ming He, (PR China), Z Liao, L Tang, D Yin, F Zou, S Yin 

Mon 211 The effects of cannabidiol and the CB1 antagonist AM251 on the depressor responses to ACEA in vivo 

Claire Hepburn, (UK), O Keown, S Watt, I Megson, S Leslie, K Kane, C Wainwright 

Mon 212 Continuous infusion of a tiny dose of corticosterone improves ageing and hypertension related heart 

function impairment and reduces cardiac fibrosis 

JJ Rob Hermans, (The Netherlands), M Minnaard-Huiban, IPE Beugels, H van Essen, JJ Debets, 

H AJ Struijker-Boudier, JFM Smits 

Mon 213 Effects of calcitonin gene-related peptide(CGRP) on the underperfusion with norepinephrine injuries in 

diabetic rat hearts 

Makie Higuchi, (Japan), T Akamine 

Mon 214 Targeting antioxidants to sites of oxidative stress using dual action drugs 

Nitya Jani, (Australia), J Ziogas, C Schiesser, C Wright 

Mon 215 Fetal de novo cholesterol synthesis is required for neuroectodermal survival and cardiovascular 

differentiation in early mouse embryos 

Heli Jokela, (Finland), P Rantakari, T Lamminen, L Strauss, R Ola, A-L Mutka, H Gylling, T Miettinen, 

P Pakarinen, K Sainio, M Poutanen 

Mon 216 Phapmacotherapy of patients with ischemic heart disease and left ventricle dysfunction targeting to 

restore inotropic action and bionergetic reserve of myocardium 

Ketevan T Kapanadze, (Georgia), GV Sukoyan, MA Rogava 

Mon 217 Strategies to induce cardiac electrophysiological properties in C2C12 skeletal myoblasts 

X Koenig, E Zebedin-Brandl, M Mille, M Schnuerch, M Koley, MD Mihovilovic, R Cervenka, P Lukacs, 

H Todt, Karlheinz Hilber (Austria) 

Mon 218 Disrupted ion channel function in dystrophic cardiomyocytes 

Xaver Koenig, (Austria), M Mille, S Kimbacher, R Cervenka, P Lukacs, H Todt, RE Bittner, K Hilber 



function 

Mon 219 Cardiotrophin-1 is upregulated, but left ventricular function is not affected after acute daunorubicin 

treatment in the spontaneously hypertensive rats 

Peter Krenek, (Slovak Republic), K Turcekova, H Cernecka, L Mesarosova, M Snopkova, 

P Ochodnicky, P Musil, J Kyselovic, J Klimas 

Mon 220 DPP IV deficiency preserves cardiac function of endotoxemic rats via GLP signaling 

Hui Chun Ku, (Taiwan), MJ Su 

Mon 221 Fast aorta reModelling following the administration and withdrawal of calcium antagonists in 

spontaneously hypertensive rats 

Jan Kyselovic, (Slovak Republic), V Vaja, P Krenek, J Klimas, P Ochodnicky 




Mon 222 Protective effect of aqueous saffron extract (Crocus sativus L.) on carbon tetrachloride-induced 

hepatotoxicity in rats 

Amir Ashna, (Iran), H Najafzadeh 

Mon 223 Modelling outcomes of antibiotic therapy by discrete event simulation (DES) or multi-agent-based 

simulation (MABS) of nosocomial pneumonia 

Mario Eandi, (Italy), P De Luca, L Pradelli, S Iannazzo 

Mon 224 Molecular dynamics simulations of serotonin and S-citalopram in serotonin transporter 

Mari Gabrielsen, (Norway), AW Ravna, K Kristiansen, I Sylte 

Mon 225 A new dimeric linear dipeptide mimetic of NGF active on animal models of Parkinson’s disease 

Tatiana Gudasheva, (Russian Federation), P Povarnina, T Antipova, S Seredenin 

Mon 226 The use of truncated area under the curve as a measure of relative extent in bioequivalence studies 

Seong Bok Jang, (South Korea), YJ Lee, LA Lim, K Park 

Mon 227 PK/PD model for pegylated, long-acting human growth hormone in adults with growth hormone 

deficiency 

Thomas Klitgaard, (Denmark), J Madsen, BS Hansen, MH Rasmussen 

Mon 228 Mechanistic Modelling of antigen-sink effect for therapeutic monoclonal antibodies: a case study 

YY Lau, L Roskos, M Liang, H Lu, M Zusmanovich, Bing Wang, (USA) 

Mon 229 Modelling and literature analysis to evaluate the pharmacokinetics of new fast release Ibuprofen based 

on a comparison of studies performed in India and Europe 

John C Lukas, (Spain), M Rodriguez, A Knapp, P Kraahs 

Mon 230 Preparation of artificial receptors for clozapine and study of their binding properties 

Seyed Ahmad Mohajeri, (Iran), G Karimi, M Rajabnia 


FC08 Developments in the treatment of sexual 

dysfunction and diseases of the lower urinary tract 

Mon 231 Finasteride and Prazosin mixed therapy in patient with bening prostatic hyperplasia 

Seyed Yousef Agha Alaie, (Iran), SS Kashaf, B Najafian, P Musavi 

Mon 232 Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats 

Delphine Behr-Roussel, (France), D Broquères-You, S Oger, S Compagnie, A Caisey, P Denys, 

E Chartier-Kastler, F Giuliano 

Mon 233 Rho-kinase inhibition relaxes detrusor from neurogenic patients 

Delphine Behr-Roussel, (France), S Oger, D Gorny, J Bernabé, E Chartier-Kastler, P Denys, F Giuliano 

Mon 234 Prevention of urinary tract infections in Norwegian nursing homes 

Jenny Bergman, (Norway), H Salvesen Blix, J Schjøtt 

Mon 235 Innervated myofibroblasts in the urinary bladder? Functional and ultrastructural evidence 

Elizabeth Burcher, (Australia), P Sadananda, S Sandow 

Mon 236 Comparison of central nervous system penetration of antimuscarinic drugs for overactive bladder 

E Callegari, R Webster, K Fenner, J LaPerle, B Malhotra, Peter Bungay (USA) 

Mon 237 Role of rasayan herbs on reproductive parameters of male rats 

Nagendra Chauhan, (India), VK Dixit 

Mon 238 Fractionation of saw palmetto extracts and bioassay fractions in isolated rat prostate 

Thiam Chua, (Australia), J Simpson, S Ventura 

Mon 239 Vascular insulin resistance in penile arteries from a rat model of metabolic syndrome 

C Contreras, A Sánchez, B Climent, A García-Sacristán, S Benedito, Dolores Prieto, (Spain) 

Mon 240 Role of CX43 in the maintenance of spontaneous activity in the guinea pig prostate 

Anupa Dey, (Australia), S Kusljic, RJ Lang, B Exintaris 

Mon 241 Developments in the treatment of sexual dysfunction and diseases of the lower urinary tract 

Saintmoses Eromosele, (Nigeria), V Eruanga, PA Francis 

Mon 242 Pacemaker cells and contractility in the prostate gland 

Betty Exintaris, (Australia), A Dey, S Kusljic, M Lam, D-T Nguyen, R Lang 

Mon 243 Hydrogen sulfide promotes function of T-type calcium channels and secretion of prostatic acid 

phosphatase in neuroendocrine-like prostate cancer cells from the androgen-sensitive LNCaP cell line 

Kazuki Fukami, (Japan), R Kasamatsu, S Yoshida, F Sekiguchi, A Kawabata 

Mon 244 Effects of duloxetine on bladder and external urethral sphincter in anesthetized female guinea-pigs with 

intravesical acetic acid 

Véronique Guilloteau, (France), S Palea, M Guerard, T Westfall, P Lluel 

Mon 245 On pharmaco-toxicological approaches to vesical dysfunction 

Ulrich Härlin, (Germany), E Neu, A Hofstetter, G Staehler, S Magour, G Ernst, W Seidenbusch, 

MC Michailov, D Hüting, U Welscher, J Foltinova 

Mon 246 To investigate the effects of 5-HT and electrical field stimulation (EFS) in the bladder of Suncus murinus 

Farideh A Javid, (UK) 

Mon 247 Effects of potassium channel openers on parameters of ureteral function – an in vivo animal study 

Carsten Krahtz, (Germany), AJ Becker, ME Mayer, MA Kuczyk, CG Stief 




Mon 248 The effect of imatinib mesylate on spontaneous activity in the guinea-pig prostate 

Michelle Lam, (Australia), A Dey, B Exintaris 

Mon 249 Golgi activation of cdc2 kinase in paclitaxel-inuced apoptosis in human androgen-independent prostate 

cancers 

Pin Hsuan Lu, (Taiwan), JH Guh 

Mon 250 Analysis of cellular signalling for epidermal growth factor-mediated suppression of androgen-induced 

expression of prostate-specific antigen gene in human prostate cancer LNCaP cells 

Yuma Maeda, (Japan), R Yamanaka, F Sekiguchi, A Kawabata 

Mon 251 Effects of fesoterodine 8 mg once daily on the pharmacokinetics and pharmacodynamics of a single 

supratherapeutic dose of warfarin in healthy subjects 

Bimal Malhotra, (USA), G Duczynski, C Alvey, J Gong, X Li, K Gandelman 




Mon 252 Effect of chronic mild stress ‘CMS’ on CYP1A2 enzyme activity and inducibility in Wistar rats 

Ahmed M-D Abdel-tawab, (Egypt), AM Hassan, AN-E Hassan 

Mon 253 Inhibitory effect of carbon monoxide-releasing molecule CORM-2 on TNF-α release from activated-RBL- 

2H3 cells 

Masaaki Akagi, (Japan), Y Yasui, M Watanabe, A Maruyama, N Matsui, R Akagi 

Mon 254 5-(4-Methanesulphonyl-phenyl)-thyazole derivatives: new tools for chronic inflammatory disease 

biotherapy 

Melchor Alvarez de Mon, (Spain)F Ledo, E SanAntonio, E Sanz, R Corcostegui, A Berisa, V Rubio, 

ML Lucero, A Muñoz, A de-la-Hera 

Mon 255 Roles of COX/PGE/EP4 receptors in healing of indomethacin- induced small intestinal lesions in rats: 

Relation to VEGF expression 

Kikuko Amagase, (Japan), A Kojo, N Abe, R Hatazawa, M Tanigami, K Takeuchi 

Mon 256 Whole-body distribution and pharmacokinetics of radioiodinated fully humanized anti-VAP-1 antibody – 

a PET imaging study of rabbits 

Anu Autio, (Finland), PJ Vainio, A Mali, J Vainio, S Suilamo, V Oikonen, P Luoto, M Teräs, T Karhi, 

A Roivainen 

Mon 257 Analbuminemia: Cardiovascular function of endotoxemic rats 

Hermes Vieira Barbeiro, (Brazil), CB Lorigados, DF Barbeiro, S Catanozi, E Nakarandake, IT Velasco, 

FB Fusco, A dos Santos Filho, FG Soriano 

Mon 258 The effect of acute and chronic administration of Nevirapine on interleukin-2 in a rat model 

Zanelle Bekker, (South Africa), A Walubo, JB Du Plessis 

Mon 259 Apparent differences in pharmacokinetic performance between generic mycophenolate mofetil tablet 

formulations 

Darren Bentley, (UK), L Banken, R Robson 

Mon 260 Anti-inflammatory and antioxidant activities of an Indian medicinal plant, Emblica officinalis, in rodent 

models of inflammation 

Jagriti Bhatia, (India), M Golechha, DS Arya, F Tabassum 

Mon 261 Age-dependent effects of dexamethasone on hypoxic-ischemic brain edema 

Gábor Blazsó, (Hungary), M Pásztor, A Balogh, A Márki, G Dombi, G Falkay 

Mon 262 The differences of antiulcer activity of proton pump inhibitor (PPI) and H2-antagonist in diabetic rats 

Teresa Bobkiewicz-Kozlowska, (Poland), R Forjasz, M Nowaczyk 

Mon 263 Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis 

Roselyne Boulieu, (France), TMH Nguyen, C Le Gall, A Lachaux 

Mon 264 Searching for novel analgesic and anti-inflammatory analogs of anandamide 

Sumner Burstein, (USA), G Li, R Salmonsen, C McQuain, T Al, V Kattamuri 

Mon 265 Mitigation effect of esculentic acid on radiation-induced pneumonia and pulmonary fibrosis 

Yong-Bing Cao, (PR China), S-M Yang, Y-P Tian, M Zhang, L Zhang, K-Z Zhang, L-J Yin, B-R Zhang, 

R Howell, Y-Y Jiang, P Okunieff, L Zhang 

Mon 266 Remicade alleviates airway inflammation and hyperreactivity in asthmatic E3 rats 

Yong-Xiao Cao, (PR China), Y Cai, SM Lu, CB Xu, LO Cardell 




Mon 267 Dosage regimen of vancomycin in NICU/PICU patients 

Oleg Cerná, (Czech Republic), Pavla Pokorná, J Sedivý 

Mon 268 The adjuvant effects of specific phytocompounds on tumor cell lysate-pulsed dendritic cell-based 

vaccine via induction of immunogenic tumor cell death 

Hui-Ming Chen, (Taiwan), S-S Chen, N-S Yang 

Mon 269 Theophylline-substituted KMUP-1 inhibits allergen-induced pulmonary vascular and bronchial 

inflammation: eNOS-enhancement and MMP-9-suppression 

Ing-Jun Chen, (Taiwan) 

Mon 270 Oxytocin injected on ovariectomized female rats can ameliorate heatstroke via increasing circulating 

endothelial progenitor cells 

Sheng-Hsien Chen, (Taiwan), W-T Huang, CY Kang 

Mon 271 Relationship of plasma interleukin-6 and its genetic variants with hypertension in Hong Kong Chinese 

Bernard MY Cheung, (PR China), AWK Tso, KL Ong, RYH Leung, SS Cherny, PC Sham, GN Thomas, 

TH Lam, KSL Lam 

Mon 272 Inhibitory effect of AS1517499, a novel STAT6 inhibitor, on antigen-induced airway 

hyperresponsiveness in mice 

Yoshihiko Chiba, (Japan), M Todoroki, Y Nishida, M Tanabe, M Misawa 

Mon 273 Effect of crotoxin, the main toxin of the rattlesnake C.d.terrificus venom, on secretory activity of 

peritoneal macrophages during tumor progression 

ES Costa, AMSC Francisco, OJ Faiad, Y Cury, Sandra Sampaio, (Brazil) 

Mon 274 Possible role of the endocannabinoid system in the analgesic effect of paracetamol-ibuprofen 

association – an experimental study 

Mihnea Costescu, (Romania), H Paunescu, OA Coman, I Fulga 

Mon 275 Hydrogen sulfide improves neutrophil migration and surival in sepsis via K+ATP channel activation 

Fernando Cunha, (Brazil), F Spiller, M Orrico, F Souto, J Alves-Filho, S Ferreira, J Hothersall, A Freitas 

Mon 276 Opioid receptor activation and expression is regulated by peripheral injury in both dorsal root ganglia 

(DRG) and nerve paw (NP) of rats 

Yara Cury, (Brazil), V Zambelli, AC Fernandes, V Gutierrez, C Parada 

Mon 277 PD98059, a specific mitogen-activated protein kinase inhibitor, attenuates the development of 

bleomycin-induced lung injury 

Salvatore Cuzzocrea, (Italy), M Galuppo, E Mazzon, E Esposito, R Di Paola, T Genovese, P Bramanti 

Mon 278 Influence of prolonged-release aspirin on platelet function in patients with chronic coronary disease 

Jose P de la Cortes, (Spain), A Guerrero, E Rueda, J Muñoz-Marín, JA Lopez-Villodres, 

JA Gonzalez-Correa 

Mon 279 The anti-inflammatory and anti-hypernociceptive activities of LASSBio-1141: The role of adenosine 

receptors 

Cleverton KF de Lima, (Brazil), RB Lacerda, LL da Silva, CAM Fraga, E de Jesus Barreiro, 

ALP de Miranda 

Mon 280 Analysis of the immunogenicity of an interferon β1a biosimilar 

Roberto Diez, (Argentina), M Kauffman, A Sterin-Prync, M Papouchado, E Gonzalez, A Grossberg, 

S Chuppa, B Odoriz, C Vrech, H Ferro 




Mon 281 NCX4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of IκB-α 

degradation in human monocytes 

Melania Dovizio, (Italy), E Ricciotti, L Di Francesco, P Anzellotti, T Salvatore, A Di Francesco, 

MG Sciulli, G Pistritto, A Monopoli, P Patrignani 

Mon 282 Cannabinoids and calcium mobilisation in microglia cells 

Khalil El Deeb, (UK), SPH Alexander, D Pritchard, DA Kendall 

Mon 283 Peripheral effects of the marijuana smoke in the lung of mice 

Krisztian Elekes, (Hungary), K Sandor, E Szoke, D Toth, A Markovics, I Szitter, L Jakab, B Szakacs, 

L Kereskai, J Szolcsanyi, T Molnar, Z Helyes 

Mon 284 Antiviral activity of anaferon for children in pandemic A/H1N1 in mice 

Oleg Epstein, (Russian Federation), JL Dugina, SA Tarasov, SA Sergeeva 

Mon 285 Substance P interacting proteins: Potential mechanisms for non-receptor mediated effects 

Nuray Erin, (Turkey), V Bui, G Clawson 

Mon 286 The absence of a functional peroxisome proliferator-activated receptor-α gene in mice enhances 

dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 

Emanuela Esposito, (Italy), E Mazzon, I Paterniti, T Genovese, S Cuzzocrea 

Mon 287 TRPA1 plays an important role in TNFα-induced mechanical hyperalgesia 

Elizabeth S Fernandes, (UK), FA Russell, D Spina, R Graepel, C Gentry, J Keeble, S Bevan, SD Brain 

Mon 288 Meropenem controlled-release system 

Gonzalo Fernández Govantes, (Spain), JJT Durán, ST Durán 

Mon 289 Modulation of Th2-cytokines production and adhesion molecule expression on bone marrow and 

peripheral blood eosinophils in allergic mice by inducible nitric oxide synthase 

Heloisa HA Ferreira, (Brazil), EH Pellaquini, LR Benetti, LGR Fernandes, WMSC Tamashiro 

Mon 290 The sweet syndrome: two cases induced by amoxicillin- clavulanic acid 

Houda Filali, (Morocco), I Rahmoun, A Elgharbi, F Hakkou 

Mon 291 Inhibition of NF-κB activation by Cymbopogon citratus leaves and their polyphenols in human 

macrophages: a potential natural source of anti-inflammatory drugs 

Vera Francisco, (Portugal), A Figueirinha, BM Neves, C Garcia-Rodriguez, MC Lopes, MT Cruz, 

MT Batista 

Mon 292 Estrogen minimizes cell death caused by H2O2 in cells of rat glioma 

Lucas AM Franco, (Brazil), L Yshii, E Kawamoto, L Lima, C Scavone, C Munhoz 

Mon 293 Effect of red-wine polyphenolic compounds on allergen induced hyperreactivity of the airways 

Sona Franova, (Slovak Republic), M Joskova, E Novakova, K Adamicova, G Nosalova, O Pechanova 

Mon 294 The protective effect of atorvastatin against proliferative alterations produced by croton oil on mouse 

epidermis 

Alireza Garjani, (Iran), Y Doustar, H Rezazadeh, S Andalib, N Maleki-Dizaji 

Mon 295 Effect of AT1 receptor blockade on the antioxidants enzymes activities in an experimental model of 

periodontal disease induced by lipopolysaccharide in the rat 

Maria del Rosario Garrido, (Venezuela), MG Matos, JA Silva, Y Mathison, A Israel 




Mon 296 Novel small molecular weight CCL2 inhibitors reduce inflammatory response in mice 

Beatrice Garrone, (Italy), A di Matteo, G Mangano, C Bartella, C Apicella, N Cazzolla, G Furlotti, 

A Guglielmotti 

Mon 297 Diclofenac sodium suppresses rat calvarial bone defect regeneration 

T Georgopoulou-Karanikola, Stergios Tsartsalis, (Greece), H Kalekou, AA Veis, B Kokkas, AT Tsirlis 

M Mironidou-Tzouveleki 

Mon 298 Biomembrane with laticifers proteins from Calotropis procera induces tissue neoformation in mice 

Danilo Gonçalves, (Brazil), I Figueiredo, I Calou, R Oliveira, L Freitas, R Pinheiro, T Andrade, M Frade, 

GA Brito, R Leitão, M Ramos, N Alencar 

Mon 299 Comparative study of the effects of lovastatin and sinvastatin in models of acute inflammation in 

rodents and human neutrophils 

Danilo Gonçalves, (Brazil), I Calou, A Araújo, I Figueiredo, T Olinda, LK Leal, G Viana 

Mon 300 Effect of rupatadine on histamine-induced rat paw oedema formation and the concomitant upregulation 

of H1R and PAFR gene expression 

Antonis Goulas, (Greece), K Kalokasidis, D Molyva, E Varsamidou, B Kokkas, K Varsamidis 

Mon 301 CANCELLED 

Mon 302 Inhibition of iNOS, COX-2 and mPGES-1 expression, and NO and PGE2 production by flavonoids in 

activated macrophages 

Mari Hämäläinen, (Finland), R Nieminen, MZ Asmawi, P Vuorela, H Vapaatalo, E Moilanen 

Mon 303 Rho-kinase inhibitors augment anesthetics-induced relaxation in rat airway smooth muscle 

Motohiko Hanazaki, (Japan), A Kohjitani, S Mizobuchi, K Morita, H Sakai, Y Chiba, M Misawa 

Mon 304 Elevation of the venodilatatory responsiveness to nitric oxide in nasal mucosae of rats with allergic 

rhinitis 

Tatsuya Hara, (Japan), J Enzaka, M Sakai-Oshita, H Sakai, Y Chiba, M Misawa 

Mon 305 Expression of a novel truncated variant of Nox2 in macrophages 

Craig Harrison, (Australia), GR Drummond, CG Sobey, S Selemidis 

Mon 306 Relation of HSPs expression and formation of atherosclerotic lesions in the aorta of ApoE-deficient 

mice 

Naoya Hashikawa, (Japan), N Hobara, C Yutani 

Mon 307 Comparison of positive reaction of Tuberculin skin test and QuantiFERON among Healthy adult males in 

Japan 

Tomoko Hasunuma, (Japan), M Kuwamata, M Takatsuki, N Kobayashi, A Aoki, Y Monuki, M Morikawa, 

T Fukushima, M Nishiwaki, H Iijima, Y Kumagai 

Mon 308 Endogenous heparin levels in the controlled asthmatic patients 

Ivan Havlik, (South Africa), A Ahmed, M Mer, H Davids 

Mon 309 Role of nitric oxide in methotrexate-induced abnormal 5-hydroxytryptamine metabolism and damage in 

the rat small intestine 

Masahiko Hirafuji, (Japan), Y Takano, M Hirano, A Kamiya, T Machida, N Hamaue, K Iizuka 

Mon 310 Inhibition of ovalbumin-induced asthma-like reactions in BALB/c mice by the anti-inflammatory 

compound amurensin H 

Qi Hou, (PR China), L Yang, S Yuan, Z Wu, M Wen, J Bai, C Yao, Y Li, M Lin, G Cheng 




Mon 311 ROS-dependent c-Fos/AP-1 induction up-regulates heme oxygenase-1 expression by bradykinin in brain 

astrocytes 

Hsi-Lung Hsieh, (Taiwan), C-M Yang 


Mon 313 Microsomal prostaglandin E synthase-1 and COX-2 are coordinately contribute to ischemic excitotoxicity 

through EP3 receptors 

Yuri Ikeda-Matsuo, (Japan), H Tanji, Y Hirayama, S Uematsu, S Akira, Y Sasaki 

Mon 314 Comparative mechanisms underlying the healing effects of captopril and ranitidine on aspirin-induced 

gastric lesions 

Nafeeza Ismail, (Malaysia), N Basri 

Mon 315 Therapeutic targeting of CCL17 via the systemic administration of a monoclonal antibody ameliorates 

experimental fungal asthma 

Ugur Ismailoglu, (USA), A-P Moreira, M Ryan, A Das, AL Coelho, CM Hogaboam 

Mon 316 Are there differences in the activities of CYP3A, CYP2D6 and P-glycoprotein between therapy-naïve HIVinfected 

patients and healthy volunteers? 

Alexander Jetter, (Switzerland), G Fätkenheuer, D Frank, T Klaassen, A Seeringer, O Doroshyenko, 

J Kirchheiner, W Hein, E Schömig, U Fuhr, C Wyen 

Mon 317 Whole blood challenge tests as translational tools for early assessment of anti-inflammatory/ immunosuppressive 

effects of drugs 

Andrea J Kales, (The Netherlands), J Burggraaf, C Kluft, M Moerland 

Mon 318 Influence of STW 11, a fixed combination medicinal product, on cytokine production of human 

macrophages 

Careen Katryniok, (Germany), G Bonaterra, D Weiser, O Kelber, R Kinscherf 

Mon 319 PACAP deficiency enhances oxazolone-induced allergic contact dermatitis in mice 

A Kemeny, R Cseharovszky, D Reglodi, N Shintani, H Hashimoto, A Baba, Erika Pintér, (Hungary), 

J Szolcsányi, Z Helyes 

Mon 320 The role of adhesive molecules in experimental sabacachnoid hemorrhage 

Aij-Lie Kwan, (Taiwan), C-Z Chang, C-L Lin, S-L Howng 

Mon 321 Effects of bio-liberated gold ions on human mononuclear cells. An in vitro study of dissolucytotic gold 

liberation from metallic gold implants 

Agnete Larsen, (Denmark), T Christensen, C Høst, M Stoltenberg, G Danscher, AM Larsen 

Mon 322 Adenosine A2B receptor mediated inhibition of anti-IgE induced human mast cell activation 

Hang Yung Alaster Lau, (PR China), KH Yip, H Wise 

Mon 323 Dysfunction of cholinergic anti-inflammatory pathways mediates organ damage in hypertension 

DJ Li, Fu-ming Shen, (PR China) 

Mon 324 The expression of five cytokines(IFN-α ,IFN-γ,IL-18,IL-10,IL-12) in PAM212 cell line and L929 cell line 

influenced by rHu IFN-α 2b cream 

Jin Li, (PR China), Q Zhu, J Liu, J Hu 

Mon 325 Toll-like Receptor 4 mediates the vasoconstrictor response initiated by adipose tissue in mice arteries 

Chao Fan Liang, (PR China), A Xu, PM Vanhoutte 




Mon 326 Neuroprotective effect of pioglitazone on iron-induced neurodegeneration: α-synuclein aggregation 

Anya Maan-Yuh Lin, (Taiwan), HJ Yu, SF Fang, PL Chao 

Mon 327 Thrombin-induced connective tissue growth factor expression requires c-Src/JAK2/STAT3 signalling 

pathway in human lung fibroblasts 

Chien-Huang Lin, (Taiwan), H-C Pai, B-C Chen 

Mon 328 Molecular mechanisms for ER stress mediated anti-inflammatory actions in macrophages 

Wan-Wan Lin, (Taiwan), HR Ho 

Mon 329 Inhaled glucocorticoids decrease rapidly bronchial NO flux in childhood asthma 

Laura Linkosalo, (Finland), L Lehtimäki, K Holm, M Kaila, J Laitinen, E Moilanen 

Mon 330 Establishment of in vitro binding assay of HMGB1 and S100A12 to RAGE: Effects of heparin and 

domain peptides on the binding 

Rui Liu, (Japan), S Mori, H Wake, J Zhang, K Liu, Y Izushi, M Okamura, HK Takahashi, M Nishibori 

Mon 331 Anisodamine augments its cholinergic anti-inflammatory role through potentializing stimulation effect of 

IL10 on α7nAChR in sepsis 

X Liu, Q Li, A-J Liu, Ding-Feng Su, (PR China) 

Mon 332 Effects of anti-TCR antibody on collagen-induced arthritis in DBA/1 mice 

Yongxue Liu, (PR China), C Han, Q Wang, Z Gao, M Peng, J Cheng 


FC13 Maximising benefits and minimizing harms from 

drugs 

Mon 333 Population pharmacokinetics of repaglinide in healthy Malaysian subjects and genetic polymorphisms of 

CYP3A4 and CYP2C8 

Ruzilawati Abu Bakar, (Malaysia), G Siew Hua, MS Ab Wahab 

Mon 334 Bioequivalence study of 1500 mg glucosamine sulfate in Thai healthy volunteers 

Pravit Akarasereenont, (Thailand), S Chatsiricharoenkul, P Pongnarin, K Sathirakul, A Wongkajornsilp, 

S Kongpatanakul 

Mon 335 Protective effect of lafutidine against loxoprofen-induced small intestinal lesions in rats 

Kikuko Amagase, (Japan), R Kawahara, S Takayama, T Sugihara, A Ochi, S Kato, K Takeuchi 

Mon 336 Cynodon dactylon – a potent, economic, natural anti-diarrhoeal herb in developing countries 

Manoj Amrutkar, (India), V Undale, D Bharti, A Bhosale 

Mon 337 In vitro characterisation of the clopidogrel bioactivation pathways by cytochromes P450 and potential 

drug-drug interactions 

Virginie Ancrenaz, (Switzerland), Y Daali, C Samer, M Besson, P Fontana, P Dayer, J Desmeules 

Mon 338 Hepatoprotective effect of pistacia lentiscus against isoniazide induced liver toxicity in rats 

M Aouichri, M Haouari, L Sfaxi, R Zermani, M Ben-Attia, M Lakhal, Anis Klouz, (Tunisia) 

Mon 339 Publication trends of the cytochromes p450 research: 1977–2008 

Charles-Daniel Arreto, (France), C Wilson, C Robert 

Mon 340 Single-dose pharmacokinetics of cefepime in healthy Egyptian buffalo calves 

Taha A Attia, (Egypt), MA Tohamy, AAM El-Gendy 

Mon 341 Striatal delivery of CDNF by AAV2 vector is neuroprotective in a rat partial lesion model of Parkinson’s 

disease 

Susanne Bäck, (Finland), J Peränen, L Lonka, T Tamminen, MH Voutilainen, A Raasmaja, M Saarma, 

PT Männistö, RK Tuominen 

Mon 342 Cutaneous adverse drug reactions: Analysis of spontaneous reports from healthcare professionals in 

Croatia 

Ana Balazin, (Croatia), V Macolic-Sarinic, S Arapovic, D Krnic, M Banovac, S Tomic 

Mon 343 Serious psychiatric adverse drug reactions spontaneously reported in Croatia from 2006 till 2009 

Ana Balazin, (Croatia), V Macolic-Sarinic, S Arapovic, D Krnic, M Banovac, S Tomic 

Mon 344 The study of response to bronchodilators according to polymorphism B2-adrenergic receptors 

Nadyia Berdnikova, (Russian Federation) 

Mon 345 Publication rate among investigator-initiated clinical drug trials in Denmark 

Louise Berendt, (Denmark), KF Bach, T Callreus, LG Petersen, HE Poulsen, K Dalhoff 

Mon 346 Both heavy and light smoking reduces serum estradiol and estrone in postmenopausal women during 

estrogen-progestogen therapy 

Nina Hannover Bjarnason, H Jorgensen, C Christiansen 

Mon 347 Simvastatin decreases malondialdehyde level in plasma and tissues of rats 

Vlasta Bradamante, (Croatia), M Marija, L Jasna, K Marijan, K Pasko 

Mon 348 Inhibitory effects of Origanum onites essential oil against contractions of isolated rat vas deferens 

induced by Androctonus crassicauda venom 

A Cakmak, F Caliskan, Suleyman Aydin, (Turkey) 



drugs 

Mon 349 An overview on attenuation of drug-induced nephrotoxicity 

Guoying Cao, (PR China), X Hu 

Mon 350 Pharmacological treatment of poststroke depression 

Margarida Caramona, (Portugal), E Silva, B Oliveiros, E Ponciano 

Mon 351 Thiopurine methyltransferase phenotype-genotype concordance in children with acute lymphoblastic 

leukaemia 

Cher Cartwright, (UK), C Mitchell, N Goulden, A Vora, L Lennard 

Mon 352 A chemical genomics approach to cardiovascular therapeutics 

Katherine Casey-Green, (UK), A Marsh, P Taylor, S Ladwa, W Dimitri, J Zhang, D Singer 

Mon 353 Personalised therapies using a chemical genomics approach 

Katherine Casey-Green, (UK), A Marsh, P Taylor, S Ladwa, W Dimitri, D Singer 

Mon 354 Calcium channel is involved in neomycin-induced hair cell toxicity in the zebrafish lateral line 

Ming-Huan Chan, (Taiwan), C-F Liu, H-H Chen 

Mon 355 Bioequivalence study of two formulations of 35mg trimetazidine modified release tablets in Thai healthy 

volunteers under fasting and fed conditions 

Weerawadee Chandranipapongse, (Thailand), T Ruangnapa, S Ngokpol, K Sathirakul, P Pongnarin, 


Mon 356 The effect of C825T polymorphism of the GNB3 gene on valproate-induced metabolic abnormalities in 

bipolar disorder patients 

Hui Hua Chang, (Taiwan), W Gean, YK Yang, HC Huang, HC Wang, RB Lu, PS Chen 

Mon 357 Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers 

Somruedee Chatsiricharoenkul, (Thailand), W Thangboonjit, K Sathirakul, P Pongnarin, K Konhan, 

S Kongpattanakul 

Mon 358 Effects of CYP2D6*10 allele on the pharmacokinetics of atomoxetine in healthy Koreans 

Chang-Ik Choi, (South Korea), J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Mon 359 Dose adjustment of omeprazole based on CYP2C19 genotype 

Chang-Ik Choi, (South Korea), S-M Moon, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Mon 360 Changing doctors prescription behaviour. A Drug Committee perspective: TNF inhibitors 

Hanne R Christensen, (Denmark), H Thomsen 

Mon 361 HPLC method development & validation for the determination of Warfarin in human plasma 

Yung An Chua, (Malaysia), WZW Abdullah, SH Gan 

Mon 362 High level of blood zolpidem concentrations in the morning and in the early afternoon after a single 

dose of a hypnotic drug followed by a night of sleep in healthy elderly subjects: potential link with 

impaired driving 

Antoine Coquerel, (France), M Loilier, S Marie, F Bertran, V Lelong-Boulouard, P Denise, M-L Bocca 

Mon 363 An enzyme-linked immunosorbent assay for therapeutic drug monitoring of trastuzumab 

François Darrouzain, (France), I Teulon, T Ternant, D David, D Degenne, H Watier, P Gilles 

Mon 364 Menatetrone and Nigella Sativa: a prophylactic role in corticosteroid induced osteoporosis in the rat 

Suzan A Darwish, (Egypt), HM Khalifa, IE Darwish, EI Anwar 



drugs 

Mon 365 Vancomycin dosing and monitoring in children: compliance with guidelines in a Belgian teaching hospital 

Pieter De Cock, (Belgium), E Haegeman, N Goerlandt, P Vanhaesebrouck, V Stove, A Verstraete, 

P Schelstraete, H Robays 

Mon 366 The relaxant effect of hydrogen sulfide is potentiated while that of acetylcholine is not altered in 

pulmonary and mesenteric arteries isolated from streptozotocin-induced diabetic rats 

Merve Denizalti, (Turkey), TE Bozkurt, I Sahin-Erdemli, N Abacioglu 

Mon 367 Bisphosphonate-related osteonecrosis of the jaw (BONJ) 

G Dimosiari, Konstantinos Imprialos, (Greece), M Mironidou-Tzouveleki 

Mon 368 CYP2D6 and CYP2C19: a comparison of direct versus predicted phenotyping in a South African 

population 

Tyren Dodgen, (South Africa), D Cromarty, H Fickl, M Pepper 

Mon 369 Thyroxine medication and CYP 3A4 activity as measured by the urinary 6β-hydroxycortisol/cortisol 

ratio: a pilot study 

Josef Donnerer, (Austria), J-P Siest, E Beubler 

Mon 370 Statins consumption in the Republic of Croatia in 2005, 2006, 2007 and 2008 

Pero Draganic, (Croatia), S Zezelic, V Macolic-Sairinic, S Tomic 

Mon 371 Usage of and attitudes towards the drug-drug interaction database SFINX – a questionnaire study within 

Sweden 

Birgit Eiermann, (Sweden), M Andersson, M-L Ovesjö, P Bastholm, A Veg, M Edlert, Y Böttiger 

Mon 372 Comparative efficacy and bioavailability of different praziquantel brands 

Naglaa El-Lakkany, (Egypt), S Seif el-Din, AN Sabra, M Ibrahim, S Botros 

Mon 373 Resistance of Escherichia coli and Klebsiella pneumoniae isolates in three tertiary intensive care units: 

A result of insufficient employment of infection control measures or inadequate antibiotic consumption? 

Viktorija Erdeljic, (Croatia), I Francetic, Z Bosnjak, A Budimir, S Kalenic, L Bielen, R Likic, 

K Makar-Ausperger 

Mon 374 Does missense mutation in the SMPD3 gene increase the risk of pulmonary hypertension? 

Lucía Escolano, (Spain), MA Nieto, L Moreno, A Cogolludo, A Roman, JL Alvarez-Sala, F Perez-Vizcaino 

Mon 375 Distribution of methylphenidate and ritalinic acid in oral fluid 

Magi Farre, (Spain), R Pardo, E Marchei, O Garcia-Algar, M Pellegrini, R Pacifici, S Pichini 

Mon 376 Central nervous system pathology during pregnancy. Study of 25 clinical cases using an 

evidence-based approach 

Isabel Vitória Figueiredo, (Portugal), AC Rama, O Isabel, F Tavares, T Santos, F Fernández-Llimós, 

MM Castel-Branco, A Cabral, M Caramona, 

Mon 377 Adverse drug reactions in infants and children 

Houda Filali, (Morocco), A Elgharbi, F Hakkou 

Mon 378 Causes of therapeutic errors in older adults 

Houda Filali, (Morocco), H Elkarimi, D Mzah, A Miftah, F Hakkou 


Mon 380 Contribution of CYP2C8 to the metabolism of montelukast in vitro 

Anne Filppula, (Finland), J Laitila, PJ Neuvonen, JT Backman 



drugs 

Mon 381 Multi-target drugs for cognitive impairment therapy: In vitro inhibition of histamine H3 receptors and 

cholinesterase by original Donepezil hybrids 

L Flammini, S Bertoni, C Giorgio, M Tognolini, Vigilio Ballabeni, (Italy), G Morini, M Incerti, E Barocelli 

Mon 382 Montelukast reverses albuterol-induced β2-adrenoceptor tolerance in airway smooth muscle 

Stefano Fogli, (Italy), F Stefanelli, L Picchianti, MC Breschi 

Mon 383 Lack of interference of carbamazepine and its metabolites in the enantioselective therapeutic drug 

monitoring of eslicarbazepine acetate 

Ana Fortuna, (Portugal), G Alves, J Sousa, R Direito, M Rocha, A Falcão, P Soares-da-Silva 

Mon 384 Activity assessment of individual CYP2D6 variants using population pharmacokinetics of 

dextromethorphan 

Uwe Fuhr, (Germany), D Frank, A Gaedigk, T Klaassen, D Tomalik-Scharte, A Jetter, U Jaehde, 

R Süverkrüp, J Kirchheiner, K Abduljalil 

Mon 385 Pharmacovigilance between science and craft 

Giovanni Furlan, (Italy) 

Mon 386 Bioequivalence study of two formulations of desmopressin nasal spray: a comparison between the 

novel KW-8008RTS to be stored at room temperature and the conventional KW-8008 to be stored in 

refrigeration 

Hidetoshi Furuie, (Japan), M Yagi, T Yajima, N Sakoda, K Matsumoto, H Ando, Y Amano, T Sakurai 

Mon 387 The effect of resveratrol on ileal smooth muscle: functional investigation in a rat sepsis model 

N Gacar, SS Gocmez, G Gacar, IK Celikyurt, Oguz Mutlu, (Turkey), T Utkan 

Mon 388 A simple, novel method for assessing medication adherence: Capsule photographs taken with cellular 

telephones 

GP Galloway, JE Guillén, JR Coyle, K Flower, John Mendelson, (USA) 

Mon 389 Correlation of cytochrome P450 3A4*18 genetic polymorphisms with postoperative fentanyl 

requirements 

Siew Hua Gan, (Malaysia), PCS Tan, SK Hassan, N Abdullah 

Mon 390 Potentially inappropriate medications in elderly attended at primary care 

Jose Luis Garcia Fuentes, (Chile), M Jiron, I Ruiz, M Santibañez 

Mon 391 Oxaliplatin-induced neuropathy: glial activation in spinal cord and brain 

Carla Ghelardini, (Italy), L Di Cesare Mannelli, L Bonaccini, A Pacini, A Bartolini 

Mon 392 A randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and 

sedative medications in older people 

Danijela Gnjidic, (Australia), S Hilmer, D Le Couteur, D Abernethy 


W01 Pharmacology of adrenoceptors: Eighth satellite 

meeting 

Mon 393 In vivo and Ex vivoreceptor occupancy assays for the rat α2A/D receptor 

Sarah Able, (UK), R Fish, C Powell, S Katugampola 

Mon 394 Virtual screening using α1–adrenergic receptor pharmacophores identifies a novel structural framework 

for α1A/D-adrenergic receptor selective ligands 

Angela M Finch, (Australia), ES Stoddart, IJA MacDougall, R Griffith 

Mon 395 Ligand-directed signalling by β-adrenoceptor antagonists at the human β1- and β3-adrenoceptors 

Dana Hutchinson, (Australia), M Sarwar, E Stancic, M Sato, B Evans, R Summers 


Mon 397 What is the functional role of the hydrophobic domain in the N-terminal tail of the α2C-adrenoceptor? 

Staffan Uhlen, (Norway), JA Jahnsen 


W03 Targeting TRP channels for pain relief (and more) 

Mon 398 LASSBio-881: An n-acylhydrazone TRPV1 antagonist orally effective against capsaicin- and partial 

sciatic ligation-induced hypernociception 

Marilia Guimaraes, (Brazil), J Tributino, M Santos, C Mesquita, C Lima, L Silva, C Duarte, E Barreiro, 

C Fraga, N Castro, AL Miranda 

Mon 399 Molecular mechanism of ETAR-operated Ca2+ entry via TRPC channels and visualization of homo- and 

heteromeric TRPC3/6 interaction in living cells using BiFC 

Takahiro Horinouchi, (Japan), T Higa, H Aoyagi, H Asano, T Nishiya, A Nishimoto, S Miwa 

Mon 400 Pharmacological resting state-fmri study using THC 

Linda E Klumpers, (The Netherlands), RP Soeter, N Khalili-Mahani, SARB Rombouts, MA van Buchem, 

JMA van Gerven 

Mon 401 Creating TRPV1 knock down mice by tentiviral transgenesis 

Éva Szõke, (Hungary), DM Tóth, K Kvell, B Bender, Z Bõsze, Z Sándor, J Szolcsányi 

Mon 402 SA13353, a transient receptor potential vanilloid 1 agonist, attenuates leukocyte infiltration in 

LPS-induced acute lung injury and ovalbumin-induced allergic airway inflammation 

Fumio Tsuji, (Japan), M Murai, K Oki, H Inoue, M Sasano, H Aono 


W04 Antioxidants as therapeutic targets 

Mon 403 Effect of β2-glucans on photodynamic therapy of Lewis lung carcinoma 

Dalia Akramiene, (Denmark), C Aleksandraviciene, K Suziedelis, U Simonsen, E Stankevicius 

Mon 404 Hydrogen sulphide generation in porcine tissues 

Stephen Alexander, (UK), M Doe, M Garle 

Mon 405 Aggravation by selective serotonin re-uptake inhibitor of antral ulcers induced by indomethacin in rats: 

Pathogenic importance of impaired anti-oxidative system 

Kikuko Amagase, (Japan), A Kojo, C Izuhara, K Nukui, A Tanaka, K Takeuchi 

Mon 406 Nucleic acid oxidation is predominantly determined by non-genetic factors in elderly Danish twins 

Kasper Brødbæk, (Denmark), R Ribel-Madsen, T Henriksen, A Weimann, M Petersen, J T Andersen, 

S Afzal, B Hjelvang, A Vaag, P Poulsen, H E Poulsen, 

Mon 407 Melatonin modulates oxidative stress and prevents cell death in human leukocytes. Effect of 

intracellular calcium overload and age 

Javier Espino, (Spain), I Bejarano, SD Paredes, D González, RJ Reiter, JA Pariente, AB Rodríguez 

Mon 408 Involvement of EGFR/AKT / Cyclin D1 / CDK4 signalling pathway in inhibiting UVA-induced apoptosis of 

HaCaT cells by polypeptide from Chlamys farreri 

Zhiwu Han, (PR China), L Zhu, J Tong, P Li, L Yan, C Wang 

Mon 409 The effect of captopril on the activity of selenoenzymes thioredoxin reductase and glutathione 

peroxidase, redox homeostasis and trace element level in rat liver 

Anna Hodková, (Czech Republic), D Kotyzová, V Eybl 

Mon 410 Drugs with known pharmacological profiles, such as monensin, disulfiram and salinomycin, show 

cancer-selective inhibition of prostate cancer cell growth by increasing oxidative stress 

Kirsi Ketola, (Finland), P Vainio, P Halonen, P Kohonen, V Fey, RC Grafström, M Perälä, O Kallioniemi, 

K Iljin 

Mon 411 Role of Na+-K+ ATP-ase in the nitric oxide independent relaxation in pig urinary bladder neck 

Ana Martínez-Saénz, (Spain), LM Orensanz, P Recio, S Bustamante, S Benedito, A García-Sacristán, 

D Prieto, M Hernández 

Mon 412 Ozone attenuates imipramine-induced anti-immobility effects in the rat, while imipramine protects 

against ozone-induced oxidative damage in the rat hippocampus 

Mmalebuso Mokoena, (South Africa), CB Brink, BH Harvey, DW Oliver 

Mon 413 Upregulation of endogenous antioxidant and phase 2 enzymes by dietary supplementation of 

scopoletin, a plant derived coumarin, in rat liver: Possible role in protection against chronic diseases 

with an underlying oxidative stress 

Sudhakar Raja Subramaniam, (UK), EM Ellis 

Mon 414 Protective effect of L-carnitine against H2O2-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells 

Chunbo Wang, (PR China), Z Han, L Zhu, J Yu, J Ye, J Tong 


Mon 416 Noradrenaline attenuates hydrogen peroxide-induced cell death of astrocyte through the increase in the 

level of intracellular glutathione 

Yasuhiro Yoshioka, (Japan), H Kadoi, A Yamamuro, A Kasai, A Maeda 


W19 Influence of degeneration and repair in the CNS 

and periphery 

Mon 417 The study of ABCB1 polymorphisms in Romanian epileptic patients 

Ioana Corina Bocsan, (Romania), AD Buzoianu, FC Militaru, R Popp, A Trifa, LP Dumbrava, 

E Brusturean 

Mon 418 The effect of chemical absence model on the progression of kindling in wistar rats 

Nihan Carcak, (Turkey), M Sahiner, E Sakallý, K Tezcan, R Gülhan, F Onat 

Mon 419 Calcium antagonistic effects of some antimigraine drugs in rat isolated basilar artery 

Edip Guvenc Cekic, (Turkey), M Tuncer 

Mon 420 Comparison of GABA-A in vivo occupancy in rat brain and spinal cord 

Rebecca Fish, (UK), S Able, C Powell, L Booth 

Mon 421 Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 

ratio 

Mei Gao, (PR China), W-C Zhang, J-J Hu, G-H Du 

Mon 422 Neuroprotective effect of dimebon in rats with intracerebral post-traumatic hematoma (hemorrhagic 

stroke) 

TL Garibova, TA Voronina, SA Litvinova, VV Grigoriev, SO Bachurin, Tatiana S Kalinina, (Russian 

Federation) 

Mon 423 P53 in amyloid-β peptide-induced apoptosis in cerebral endothelial cell 

Ming-Jen Hsu, (Taiwan), Y-F Chuang, P-T Chiu, C-Y Wang, J-R Sheu 

Mon 424 Paraquat activates Nrf2-ARE pathway: implication of decrease in proteasome activity in dopaminemediated 

cytotoxicity 

Yasuhiko Izumi, (Japan), S Matsushima, N Yamamoto, T Kume, H Sawada, A Akaike 

Mon 425 The effect of KYP-2047, a prolyl oligopeptidase inhibitor, on extracellular neurotensin- and substance 

P-like-immunoreactivity in the rat brain 

Aaro Jalkanen, (Finland), K Savolainen, M Forsberg 

Mon 426 Nephroprotective activity of the low-esterified pectins 

Maxim Khotimchenko, (Russian Federation), A Kropotov, Y Khotimchenko 

Mon 427 Association study of single nucleotide polymorphisms in the COMT gene and Korean autism spectrum 

disorders 

Soon Ae Kim, (South Korea), HJ Yoo, IH Cho, M Park 

Mon 428 Genome-wide association scan of Korean autism spectrum disorders with language delay 

Soon Ae Kim, (South Korea), SY Yang 

Mon 429 Neuroprotective effect of mildronate, a mitochondria-targeted drug, in Parkinson’s disease model in 

rats 

Vija Klusa, (Latvia), J Pupure, S Isajevs, D Svirina, U Beitnere, B Jansone, J Rumaks, S Svirskis, 

R Vilskersts, I Kalvinsh 

Mon 430 Acute Allopregnanolone administration may exacerbate, rather than attenuate, striatal damage during 

ischaemia in vitro 

Steve Knight, (UK), C Davidson, A Young, C Gibson 

Mon 431 Study of time dependence of afobazol and mexidol protective activity in itracerebral posttraumatic 

hematoma model 

Valentina Krayneva, (Russian Federation), A Fedorenko, S Seredenin 



and periphery 

Mon 432 Neuroprotective effect of serofendic acid on in vitro and in vivo neuronal injury 

Toshiaki Kume, (Japan), Y Izumi, A Akaike 

Mon 433 Quercetin protects cortical neurovascular unit against amyloid β25-35 peptide-induced amnesia in mice 

Rui Liu, (PR China), GF Qiang, Y Jian, X Lan, HG Yang, GH Du 

Mon 434 Efficacy of Panax notoginseng saponins on patients with intracerebral hemorrhage 

Yumin Luo, (PR China), Q Liu, J Song, P Liu, L Gao 

Mon 435 Dopamine inhibits NO production by LPS-activated microglia through the formation of quinoprotein 

Sadaaki Maeda, (Japan), A Tozawa, T Kitamoto, A Yamamuro, A Kasai, Y Yoshioka 

Mon 436 The seizures and status epilepticus in emergency department of pediatrics.The clinical and 

pharmacological implications of some benzodiazepines 

Ioan Magyar, (Romania) 

Mon 437 Ventral tegmental area NMDA receptors play a role in the effect of scopolamine on inhibitory avoidance 

memory in rats 

Gelavizh Mahmoudi, (Iran), M-R Zarrindast, A Pourmotabbed 

Mon 438 Distribution of the CYP2C9*2, CYP2C9*3 gene variants in a Romanian epileptic patients group 

Florentina Claudia Militaru, (Romania), A Buzoianu, C Bocsan, A Trifa, R Popp, LP Dumbrava, 

E Brusturean 

Mon 439 Angiotensin II type 1 (AT1) receptor blocker, telmisartan, protects brain damage induced by ischemia 

and amyloid-β injection partly due to PPAR-γ activation 

Masaki Mogi, (Japan), J Iwanami, K Tsukuda, M Horiuchi 

Mon 440 Noradrenaline protects neurons against hydrogen peroxide toxicity by increasing the release of 

glutathione from astrocytes 

Toshiki Motegi, (Japan), Y Yoshioka, A Yamamuro, A Kasai, S Maeda 

Mon 441 Functional analysis of Transferrin receptor-1 expressed in brain 

Yukary Nakamura, (Japan), T Takarada, Y Yoneda 

Mon 442 Pentacycloundecane conjugates of aminoguanidine and tryptamine: Nitric oxide synthase inhibition 

Douglas W Oliver, (South Africa), SF Malan, DK Wilkes, A de Vries 

Mon 443 Modulation of cognition and neuronal function in the age-accelerated mouse (SAMP8) by pterostilbene 

and resveratrol 

Merce Pallas, (Spain), J Chang, K Bryan, J Reeves, MA Smith, A Camins, A Rimando, B Shukitt-Hale, 

J Joseph, G Casadesus 

Mon 444 Prolyl oligopeptidase is not located in the long projection neurons of the rat brain 

Iida Peltonen, (Finland), TT Myöhänen, PT Männistö 

Mon 445 L-3-n-butylphthalide suppressed Lipopolysaccharide-induced inflammation through Nrf2 dependent 

pathway 

Ying Peng, (PR China), Y Hu, L Lu, S Xu, L Wang, X Wang 

Mon 446 Silvergold-cyankali methods for staned glial cells 

Bojana Petrovic, (Republic of Serbia), Z Zoric, D Drekic 

Mon 447 Spontaneous and amphetamine –induced locomotor activity in A30P -transgenic mice 

Marjo Piltonen, (Finland), S Patrikainen, PT Männistö 



and periphery 

Mon 448 Elderly patients with migraine: An open-label study on prophylaxis therapy with Levetiracetam 

V Pizza, V Busillo, A Agresta, A Bisogno, Anna Capasso, (Italy) 

Mon 449 Factor XIII Val 34 Leu polymorphism in migraine and cardiovascular disease 

V Pizza, F Infante, G Schiavo, E Lamaida, C Colucci d'Amato, A Bisogno, Anna Capasso, (Italy) 

Mon 450 MEK1/2 inhibition improves neurological outcome and abolishes cerebrovascular ETB and 5-HT1B 

receptor upregulation after subarachnoid hemorrhage in the rat 

Gro Klitgaard Povlsen, (Denmark), C Larsen, M Rasmussen, L Edvinsson 

Mon 451 Incidence of severe hyponatremia drug-induced and other causes in a terciary care hospital 

Elena Ramirez, (Spain), AM Borobia, SL Lei, R Muñoz, A Campos, C Zegarra, AJ Carcas, J Frias 

Mon 452 Interaction of phenytoin with melatonin and α-lipoic acid in experimental seizures in rats 

KH Reeta, (India), J Mehla, YK Gupta 

Mon 453 Disruptive effects of systemically administered angiotensin II on cerebral perfusion and learning in the 

rat 

Michael Rowan, (Ireland), W Cullen, B Ryan 

Mon 454 The protective effect of low dose of SNP on L-DOPA induced apoptosis 

Mousa Sahebgharani, (Iran), Z Sepehrizadeh, M Talebi, Saboori, J Esmaeili, E Jaberi 

Mon 455 Changes in hippocampal connexin 36 mRNA and protein levels during acquisition of seizures in the 

kindling model of epileptogenesis 

Mohammad Sayyah, (Iran), S Beheshti, S Majzoob Zanjani, M Golkar, H Sepehri, J Babaie, B Vaziri 

Mon 456 Lateral somatosensory cortex in spontaneous and PTZ-induced spike-wave discharges of the rat 

evaluated by ethosuximide 

Fu-Zen Shaw, (Taiwan), K-H Yeh 

Mon 457 ER stress is involved in hyperphosphorylated tau-induced cytotoxicity 

Yuxian Shen, (PR China), L Feng, A Sun, Y Shen, S Fang, J Li 

Mon 458 Hrd1 expression is associated with neuronal survival and tau degradation in Alzheimer's disease 

Yuxian Shen, (PR China), L Feng, A Sun, Q Li, H Hou, H Wang, H Fang, S Fang 

Mon 459 Contribution of CYP3A5 isozyme to the in vivo metabolism of cortisol to 6β-hydroxycortisol in humans 

Hiromi Shibasaki-Hirano, (Japan), S Okamoto, T Furuta 

Mon 460 The effect of anti-Parkinsonian drugs on oxidative stress induced pathological [3H]dopamine efflux after 

in vitro rotenone exposure in rat striatal slices 

Beata Sperlagh, (Hungary), E Milusheva, M Baranyi, Z Hracsko, S Vizi 

Mon 461 Activation of JNK signal by NO in cochlear spiral ligament fibrocytes following intense noise exposure 

Hajime Tanaka, (Japan), R Nagashima, T Yamaguchi, A Matsushita, K Ogita 

Mon 462 Effects of mexidol and hemantane in animal models of parkinsonism 

Elena Valdman, (Russian Federation), L Nerobkova, I Kapitsa, T Voronina, O Popova, N Zolotov 

Mon 463 Anti-Parkinsonian effects of MDMA in the rat: Contributions of 5-HT1A-receptors and serotonin 

transporters and role of chirality 

Andreas von Ameln-Mayerhofer, (Germany), M Hüpkes, C Riegel, S Seeger-Armbruster, NY Lettfuss 



and periphery 

Mon 464 Reconstruction of the nigrostriatal projections in dissociated primary cultures: A role of striatal cells in 

dopaminergic neurite outgrowth 

Seiko Wakita, (Japan), Y Izumi, T Kume, H Sawada, A Akaike 

Mon 465 Microenvironment improving effect of octacosanol in 6-hydroxydopamine-induced parkinsonian models 

in rats 

Tao Wang, (China), P Zuo, P Chan 

Mon 466 Development of 2-(1-Hydroxypentyl)-benzoate, a pro-drug for treatment of cerebral ischemia and 

dementia 

Xiaoliang Wang, (PR China), J Li, S Xu, N Feng, L Wang, Y Hu, Y Peng 

Mon 467 Protective effect of rolipram on memory impairments in rats injected with amyloid-(25¨C35) 

Jiangping Xu, (PR China), C Wang, Y Cheng, H Zhang 

Mon 468 Polypeptide from Chlamys farreri protect neuroblastoma (SH-SY5Y) cells from oxidative stress by 

endoplasmic reticulum stress and JNK activation 

Junli Ye, (PR China), X Liu, J Yu, J Tong, C Wang 

Mon 469 Glycosaminoglycans mimetics regulation of lysosomal disturbances and tau hyperphosphorylation 

induced by oxidative stress 

Ganlin Zhang, (PR China), S Lehri, XX Zhu, MB Huynh, L Sissoeff, YJ Li, X Liu, R Raisman, C Morin, 

P Li, D Papy-Garcia 

Mon 470 Preliminary studies on the relationship between STUB1 and the key pathological proteins in AD animal 

model SAMP8 

Gui-Rong Zhang, (PR China), X-R Cheng, W-X Zhou, Y-X Zhang, D-L Gao, X-D Xia, X-P Jiang, L-Y Nie, Y Ji, 

S-P Zhou 


W20 Pharmacology education for a sustainable future 

Mon 471 The use of e-learning improved the pharmacology learning in chiropodist’s pharmacology training 

Inmaculada Bellido, (Spain), E-I Marquez, JA Garcia-Arnes, E Blanco, A Gomez-Luque 

Mon 472 Self-assessment with Moodle from activities proposed by students. 

Juan Formigós, (Spain), MM Palmero, V Maneu, NC García-Cabanes 

Mon 473 Favorable student attitudes towards hospital training in pharmacology in nursing degree 

Cristina García-Cabanes, (Spain), V Maneu, MM Palmero, J Formigós 

Mon 474 Short term impacts of rational pharmacotherapy course on the rational prescribing skils of fourth-year 

medical students 

Nil Hocaoglu, (Turkey), H Guven, S Gidener, Y Tuncok, S Kalkan, M Guneli, A Gelal 

Mon 475 Pharmacotherapeutics skills training design: a case study of Medical Faculty – Andalas University 

Laila Isrona, (Indonesia) 

Mon 476 Six years’ experience of using an interactive voting device in teaching basic pharmacology to students 

of pharmacy and medicine 

Ewen MacDonald, (Finland) 

Mon 477 Building themes together: Student's involvement in pharmacology subjects 

Victoria Maneu, (Spain), J Formigós, MC García-Cabanes, MM Palmero 

Mon 478 Developing rational prescribing competence in medical school: The relation between student 

perceptions and examination performance 

Shirra Moch, (South Africa), D Naidoo, L Green-Thompson, 

Mon 479 Pharmacology in UNO-agenda 21 

Eva Neu, (Germany), U Welscher, B Schubert, MC Michailov, M Holler, M Schratz, W Seidenbusch, 

G Weber, I Ivanova, V Foltin, U Härlin, Y Zebuhr 

Mon 480 Interactive 3D encyclopedia for the teaching of pharmacology to medical students 

Evelyn P Obando, (Colombia), MP Usta, T Escobar, R Escobar, J Estupiñan, DA Ospina 

Mon 481 Problem-based–learning in pharmacology subjects: Prons and some cons 

Mercedes Palmero, (Spain), MC García-Cabanes, J Formigós, V Maneu 



Tue 001 Amitriptyline in the management of distal sensory neuropathy in South African patients with HIV 

Shirra Moch, (South Africa), N Dinat, P Kamerman, E Marinda, N Hatta, N Zwane 

Tue 002 The antimalarial properties of metronidazole thiosemicarbazone analogues 

Emma Moseley, (South Africa), R van Zyl, M Abid, I Havlik, A Azam 

Tue 003 The chemotherapeutic action of synthetic dyes against Plasmodium falciparum 

Harold Motau, (South Africa), R Van Zyl, L Harmse 

Tue 004 Clinical toxicities of first-line antiretroviral therapy in a resource limited setting 

Tinashe Mudzviti, (Zimbabwe), C Maponga, S Khoza, Q Ma, D Tagwireyi 

Tue 005 Genetic variations in ABCB1 and CYP3A5 as well as sex influence quinine disposition among Ugandans 

Jackson K Mukonzo, (Uganda), P Waako, J Ogwal-Okeng, L Gustafsson, E Aklillu 

Tue 006 Determination of trimetazidine in human plasma for assessing bioequivalence study 

Suthatip Ngokpol, (Thailand) 

Tue 007 Development and validation of a sensitive liquid chromatography/tandem mass spectrometry 

(LC-MS/MS) method for quantification of olanzapine in human plasma 

Suthatip Ngokpol, (Thailand), P Pongnarin, A Kongsiang, J Jantaka, U Panich, S Chatsiricharoenkul, 


Tue 008 Quality of life of colorectal cancer patients in post-surgery recovery period after being supplemented 

with Agaricus Sylvaticus fungus: a randomized, double-blind, placebo-controlled clinical study 

Maria Rita Novaes, (Brazil), R Fortes 

Tue 009 Influence of rifampicin on nevirapine level in HIV patient with TB 

Agus W Nugroho, (Indonesia), Nafrialdi, A Simatupang 

Tue 010 Adverse reactions to medicines experienced in a Nigerian hypertension clinic 

Abimbola Olowofela, (Nigeria), AO Isah 

Tue 011 Artemether may affect the analgesic activity of piroxicam in malaria 

Temidayo Olurishe, (Nigeria), S Ado, I Adamu 

Tue 012 Excretion of the antiparasitic moxidectin into the breast milk of lactating non-breastfeeding women 

Virginia Parks, (France), J Korth-Bradley, S Chalon, I Gourley, K Matschke, L Fleckenstein, P Bryson, 

S Gossart 

Tue 013 Teaching clinical pharmacology and pharmaceutical medicine in Serbia: Postgraduate studies 

Milica Prostran-Veselinovic, (Republic of Serbia), Z Todorovic, R Stojanovic 

Tue 014 Effect of Citrullus colocynthis on serum glucose, lipidemic profile and c-peptide changes in patients 

with type II diabetes mellitus 

Alireza Rahbar, (Iran), I Nabipoor 

Tue 015 Treatment of sheep by hypertonic dextrose after experimental salinomycin poisoning 

Hamid Rajaian, (Iran), S Nazifi, R Hosseini, A Hajmohammadi, J Jalaei, K Nayeri 

Tue 016 Anti-inflammatory effect of an extract of Mangifera indica L. (Vimang®) in patients with chronic 

dermatitis 

Lorena Safonts, (Cuba), M Guevara, T Pérez, C Morales 

Tue 017 Enzymatic analysis of the venom of Hemiscorpius lepturus, an Iranian scorpion 

Ramin Seyedian, (Iran), K Euikyung, A Zare 

Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 199


Tue 018 Evaluation of bioequivalency/bioavailability trials in our clinic 

Zafer Sezer, (Turkey), A Inal, N Küçük, Ö Soydan, A Erenmemisoglu 

Tue 019 Gatifloxacin induced hypoglycemia in Type 2 DM patient with UTI.-A case report 

K Sharma, Lokendra K Sharma, (India), K Sharma 

Tue 020 Cost effective drug distribution system in Rajasthan (India) 

Lokendra K Sharma, (India), K Sharma, M Mathur, J Chaudhary, R Mandia 

Tue 021 Lypodystrophy due to antiretrovirals. Case presentation from resource-poor health care country 

Abraham Simatupang, (Indonesia), F Suling 

Tue 022 Combined treatment with sertindole and clozapine – reports of cases of patients with drug-resistant 

schizophrenia 

Bozena Spila, (Poland), A Grzywa-Celiñska, A Urbañska 

Tue 023 Development and validation of bioanalytical method of amlodipine besylate in human plasma 

Ganesh P Subedi, (Nepal), GM Khan 

Tue 024 Drugs with both anxiolytic and psychostimulating action: New opportunities for anxiety disorders 

treatment 

Sergey Syunyakov, (Russian Federation), D Chumakov, E Teleshova, G Neznamov 

Tue 025 Environmental risk factors and occurrence of gastritis and colitis in a mestizo population of 

Chabeklumil, state of Chiapas, México 

Diana C Tapia-Pancardo, (Mexico), R Jesus-Sandoval, L Aburto-Cortes, M Angeles-Gamiño, 

XE Nolasco-Velazquez, MM Valera-Mota, R Villalobos-Molina 

Tue 026 Clinical pharmacology for undergraduate medical students in Serbia 

Zoran Todorovic, (Republic of Serbia), M Prostran-Veselinovic 

Tue 027 Developing a model checklist for the evaluation of the dispensing scores in the pharmacy 

HZ Toklu, GA Dulger, Bulent Gumsel, (Turkey), E Yaris, NI Klayoncu, A Akici 

Tue 028 The bidirectional regulation of vitamin D3 on calcification in human joints and ligaments 

Xinglong Tong, (PR China), Y Xu, Y Xu 

Tue 029 Prescription audit as an important tool in the analysis of the prescriptions for the children 

Canan Uluoglu, (Turkey), Z Güney, T Ercanlý 

Tue 030 The impact of a ‘Groningen Model’ of pharmacotherapy training for general practitioners in Kayseri, 

Turkey 

Hasan Basri Ulusoy, (Turkey), T Sumak, S Þahin, H Gültekin 

Tue 031 Evaluation of the rational pharmacotherapy clerkship at Erciyes University Faculty of Medicine, Kayseri, 

Turkey 

Hasan Basri Ulusoy, (Turkey), T Sumak, E Eroglu, H Gultekin 

Tue 032 New times, new trends for ethionamide 

Nuno Vale, (Portugal), HA Santos, E Mäkilä, J Salonen, J Hirvonen, P Gomes 

Tue 033 Effect of CTOL on the Proliferation of AF by BrdU 

Chunxia Wang, (PR China), L Hou 

Tue 034 Analysis on quality control of drug clinical trials 

Shaohua Wang, (PR China) 

200 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area


Tue 035 Study on protection effect of erythropoietin on newborn rats with hypoxic-ischemic brain damage 

Yunxiao Wang, (PR China), W Liu, Y Cao, Y Meng 

Tue 036 Differences in efficacy among FOLFOX for advanced gastric cancer involve 14-3-3 δ 

Bo Yi, (PR China), QY Li, OP Huang, D Liu, D Yin, M He 




Tue 037 Ivermectin activates Cys-loop ligand-gated chloride channels by interacting with the third 

transmembrane domain 

Timothy Lynagh, (Australia), T Webb, J Lynch 

Tue 038 A role of α2 isoform of the Na,K-pump in mesenteric small arteries wall 

Vladimir Matchkov, (Denmark), NM Nielsen, C Aalkjær 

Tue 039 Expression and function of the organic cation transporter 3 (OCT3) in the human placenta 

Karen May, (Germany), V Rozehnal, M Grube, M Zygmunt, HK Kroemer, W Siegmund 

Tue 040 Effect of the P-glycoprotein on the intestinal absorption of herbal products associated with 

antiretrovirals in mice 

Joe Miantezila Basilua, (France), G Mamadou, N Limas Nzouzi, G Peytavin, B Eto 

Tue 041 Impact of OATP1B1, OATP1B3 and ABCC2 on the hepatic uptake and pharmacokinetics of the 

MRI-contrast agent Gd-EOB-DTPA in healthy volunteers 

A Nassif, S Oswald, J-P Kühn, C Modess, N Hosten, Werner Siegmund (Germany) 

Tue 042 Mitochondrial sodium/calcium exchanger as a new target to develop neuroprotective drugs 

Santos Nicolau, (Spain), J Egea, M López, A García 

Tue 043 Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of ezetimibe and its glucuronide in 

healthy subjects 

Da-Hee Oh, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Tue 044 The role of OATP1B1 genetic variants in the disposition of pitavastatin in healthy Koreans 


Tue 045 Influence of efavirenz on the disposition and lipid-lowering effects of ezetimibe in healthy subjects 

Stefan Oswald, (Germany), H Meyer zu Schwabedissen, A Nassif, C Modess, D Lütjohann, Z Desta, 

H Kroemer, W Siegmund 

Tue 046 SLC26 transporters are regulated via the [Cl-]i-sensitive Ste20p kinases 

Hyun Woo Park, (South Korea), JH Nam, MG Lee 

Tue 047 Modification of equilibrative nucleoside transporter 1 (ENT1) function by sulfhydryl reagents involves 

cysteine residues in transmembrane regions 6 and 7 

Jamie Park, (Canada), J Hammond 

Tue 048 The expression of organic cation transporter mrna in cultured adult and neonatal rat astrocytes and 

their possible functional role 

Katja Perdan-Pirkmajer, (Slovenia), S Pirkmajer, Z Grubiè, M Krzan 

Tue 049 Influence of rifampicin on pulmonary expression of ABCB1 and ABCC2 and on distribution of 

clarithromycin into epithelial lining fluid and broncho-alveolar cells of foals 

Jette Peters, (Germany), J Freyer, W Block, S Oswald, M Venner, W Siegmund 

Tue 050 Effect of viral infection on hepatic and placental drug transporters and endogenous substrates in 

pregnant rats 

Vanja Petrovic, (Canada), M Piquette-Miller 

Tue 051 Block of the IKr current by the HMG-CoA reductase inhibitor rosuvastatin is modulated by BCRP, MDR1 

and OATP2B1 membrane drug-transporter activites 

I Plante, M Frappier, F Belanger, Jacques Turgeon (Canada) 




Tue 052 A liposomal formulation of Azithromycin for treatment of cutaneous leishmania 

Omid Rajabi, (Iran), P Layegh, M Khoddami, R Salari 

Tue 053 Small-molecule drug design targeting PICK1 using a C-terminal dopamine transporter peptide 

Mette Rathje, (Denmark), MV Andersen, SE Andersen, PO Heidarsson, S Erlendsson, A Bach, 

FM Poulsen, K Strømgaard, U Gether 

Tue 054 The organic solute transporter OSTα-OSTβ – a potential determinant of drug absorption 

Ute Schwarz, (Canada), H Meyer zu Schwabedissen, B Urquhart, R Tirona, R Kim 

Tue 055 TRPC3 mediates thrombin-induced astrocyte activation and upregulates its own expression in rat 

cortical astrocytes 

H Shirakawa, T Nakagawa, Shuji Kaneko, (Japan) 

Tue 056 Transport characteristics of caffeine in human intestinal Caco-2 cell monolayer 

Libuse Smetanova, (Czech Republic), V Stetinova, D Kholova, J Kvetina, J Smetana, Z Svoboda 

Tue 057 MDR1 gene C3435T polymorphism is associated with the risk of threatened pregnancy interruption 

E Sokova, I Ignatiev, A Prilutsky, Dmitry A Sychev, (Russian Federation), V Kukes 

Tue 058 Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin 

induced diabetic rats 

Nepton Soltani, (Iran), F Kharazmi, M Keshavarz 

Tue 059 Discovery of a monoamine transporter inhibitor via high throughput molecular model docking and 

pharmacophore modeling 

Christopher Surratt, (USA), M Indarte, Y Liu, J Madura 

Tue 060 Na + /Ca 2+ exchanger is involved in nitric oxide-mediated apoptosis in cultured astrocytes 

Kazuhiro Takuma, (Japan), T Kitao, T Kawasaki, Y Inoue, A Ikehara, T Nashida, Y Ago, T Matsuda 

Tue 061 Evidence for a key contribution of TMEM16A protein to the calcium-activated chloride current in rat 

pulmonary artery smooth muscle cells 

Paolo Tammaro, (UK), B Manoury, A Tamuleviciute 

Tue 062 Grapefruit juice markedly reduces the plasma concentrations of the OATP2B1 substrate aliskiren 

Tuija Tapaninen, (Finland), PJ Neuvonen, M Niemi 

Tue 063 Drug transporters in human mammary epithelial cells 

Lisa Bee-Gek Tee, (Australia), TF Sim, D Williams, A Crowe, K Ilett 

Tue 064 Pharmacokinetic analysis of irinotecan in Oatp1b2 knockout mice 

Wendy Teft, (Canada), S Mansell, S Welch, R Kim 

Tue 065 Molecular determinants for selective recognition of antidepressants in the human serotonin and 

norepinephrine transporters 

Mette Thomsen, (Denmark), L Sørensen, J Andersen, K Strømgaard, AK Kristensen 

Tue 066 Effect of garlic, ginkgo and St. John’s wort on the pharmacokinetics of fexofenadine in rats 

Jasmina Turkanovic, (Australia), MB Ward, RW Milne 

Tue 067 Highly sensitive and rapid assessment of P-glycoprotein activity in Caco-2 cells 

Hirkazu Wakuda, (Japan), Y Tada, N Nejime, S Kagota, K Nakamura, K Umegaki, S Yamada, 

K Shinozuka 




Tue 068 Activation of M3 muscarinic acetylcholine receptors and α1-adrenoceptors induces AQP5 trafficking in 

rat parotid acinar cells 

Di Wang, (Japan), G Cho, M Shono, Y Ishikawa 

Tue 069 Interaction between troxerutin and bovine serum albumin 

L Wang, X Li, Y Li, Y Chen, Y Fan, Ming Xue (PR China) 

Tue 070 Structural elucidation of the metabolites of tanshinone I and its analogue dihydrotanshinone I in rats by 

HPLC-ESI-MSn 

M Wang, H Dai, X Li, Y Li, L Wang, Ming Xue (PR China) 

Tue 071 Electrophysiological properties of YM-244769, a novel and potent Na+/Ca2+ exchange inhibitor, in 

cardiac ventricular myocytes of guinea pig 

Yasuhide Watanabe, (Japan), J Kimura, K Yamashita, T Yamakawa, T Iwamoto 

Tue 072 Stimulation of noradrenalin transporter and serotonin transporter activity by soy phytoestrogen 

genistein 

Nobuyuki Yanagihara, (Japan), Y Toyohira, S Ueno, M Tsutsui, K Takahashi 

Tue 073 UDCA-induced HNF-1γα inhibition and pharmacokinetic changes of pitavastatin in relation to OATP1B1 

transport activity 

So-Jung Youn, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Tue 074 In vivo study of penetration of acetylcholinesterase reactivators through blood-brain barrier 

Jana Zdarova Karasova, (Czech Republic), K Kuca, M Pohanka, L Novotny 

Tue 075 Calcium signal passway-based on to research the neuroprotection of effective components of 

traditional Chinese medicine 

Yi Zhang, (PR China), X Lai, J Zhang 

Tue 076 Molecular mechanisms of hERG K+ channel blockade by fluoroquinolone antibiotic agent chinfloxacin 

hydrochloride 

Zhao Zhang, (PR China), X Zhang, J Guo, J Liu, Z Zhu, Z Hu, Z Zhao 



Tue 077 Topical application of disodium isostearyl 2-O-l-ascorbyl phosphate, a skin-permeable amphiphilic 

ascorbic derivative, attenuates chemotherapy-induced neuropathic hyperalgesia in rats 

Kazumasa Okubo, (Japan), T Takahashi, M Matsunami, H Shibayama, A Kawabata 

Tue 078 Models for screening in rats the effects of TRPV1 receptor antagonists on thermal hyperalgesia and 

thermoregulation 

G Pethö, K Bölcskei, V Tékus, A Kis-Varga, L Dézsi, É Szentirmay, A Visegrády, C Horváth, 

Janos Szolcsányi, (Hungary) 

Tue 079 Local anaesthetic activity of new piperidine’s derivatives and their immobilized forms 

Guram Pichkhadze, (Kazakhstan), K Praliev, D Kadyrova, S Nasyrova, S Imashova, M Amyrkulova, 

G Muhamedzhanova, D Assylbekova 

Tue 080 Characterization of Philantotoxin analogues as subtype-selective AMPA receptor antagonists 

Mette Poulsen, (Denmark), S Lucas, K Strømgaard, AS Kristensen 

Tue 081 Effect of diclofenac on compound action potential 

Jelena Scekic, (Montenegro), M Drecun, M Bajagic 

Tue 082 Discovery and characteristics of inducible spinal D-amino acid oxidase as a novel target for the 

treatment of chronic pain 

Yong Xiang Wang, (PR China), N Gong, Z-Y Gao, J-L Huang 

Tue 083 Antinociception of synthetic ω-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium 

channel blocker, and its effects on morphine analgesia in chemical stimulus tests after acute or chronic 

intrathecal administration in rodent 

Ling-Di Yan, (PR China), Y-L Liu, L Zhang, H-J Dong, P-L Zhou, R-B Su, Z-H Gong, P-T Huang 

Tue 084 Involvement of glutamate receptors existing in peripheral ending of primary afferent fibers in 

nociception 

Norifumi Yonehara, (Japan), Y Koike 

Tue 085 Regulation of NMDA receptors by copper ions 

Haitao You, (Canada), S Tsutsui, PK Stys, GW Zamponi 



opportunities 

Tue 086 Portuguese pharmacist attitudes towards the use of herbal complementary and alternative medicines in 

oncology 

Maria T Herdeiro, (Portugal), E Mendes, A Figueiras, F Pimentel 

Tue 087 Hepatotoxicity associated with antituberculosis drugs: a cohort of incident patients receiving treatment 

or on chemoprophylaxis 

Luisa Ibáñez, (Spain), M Sabaté, E Pérez, X Vidal, Hepatox-TBC Group 

Tue 088 Analysis of suspected adverse reactions to antidiabetic drugs in Spain,2006–2008 

María-Isabel Jiménez-Serranía, (Spain), R Mateos-Campos 

Tue 089 Utilization study of antidiabetic drugs in Spain, 2006–2008 

María-Isabel Jiménez-Serranía, (Spain), R Mateos-Campos 

Tue 090 Emergence of Artemisinin resistant malaria in Western Cambodia 

Phisit Khemawoot, (Thailand), L Chanthap, Y Se, D Bethell, D Saunders, S Sriwichai, 

P Teja-isavadharm, S Tyner, D Walsh, H Noedl, D Socheat, M Fukuda 

Tue 091 Surgical site infections incidence as a quality indicator for proper antibiotic prophylactic use in tertiary 

health care hospital inpatients 

Aleksandra Kovacevic, (Republic of Serbia), V Dragojevic-Simic, V Suljagic, M Jevtic, J Vukovic, 

D Jandric 

Tue 092 Identification of drug-induced anaphylaxis using the French hospital administrative database 

L Lacoin, C Lecomte, A Kostrzewa, V Gilleron, N Moore, G Miremont-Salamé, Françoise Haramburu 

(France) 

Tue 093 Use of serotoninergic medications and cardiac valvulopathy: A nested case-control study in The Health 

Improvement Network (THIN) database 

Francesco Lapi, (Italy), F Nicotra, A Rubino, L Scotti, M Thomson, A Vannacci, A Zambon, G Corrao, 

A Mugelli 

Tue 094 Expression of adeA gene is associated with multidrug-resistance in Acinetobacter baumannii clinical 

isolates 

Baodong Ling, (PR China), G Liu, X Zhu, L Lin, Y Zeng, Y Xie 

Tue 095 Drug consumption in Croatia: The effects of pricing policy changes 

Tomislav Madjarevic, (Croatia), T Buble, M Gantumur, M Vitezic, B Sestan, J Mrsic Pelcic, D Vitezic 

Tue 096 Correlates of (inadequate) benzodiazepine use: The Netherlands Study of Depression and Anxiety 

(NESDA) 

Leonie Manthey, (The Netherlands), T van Veen, EJ Giltay, JE Stoop, A Knuistingh-Neven, 

BWJH Penninx, FG Zitman 

Tue 097 A comparative study of medicinal plants used against gastrointestinal disorders in two districts of 

Bangladesh 

Ariful Haque Mollik, (Bangladesh), R Faruque, R McField, A Chowdhury, KK Thapa, T Islam 

Tue 098 Most frequent adverse drug reactions in cardiology patients registered with intensive monitoring 

system 

Snezana Mugosa, (Montenegro), Z Todorovic 

Tue 099 Future approaches to pharmacology in context of philosophy and economics 

Renate Neu, (Germany), MC Michailov, M Holler, E Neu, T Senn, RK Stappen, R Schinabek, G Schulz, 

D Martin, S Molnar, M Schratz, G Weber 



opportunities 

Tue 100 Determinants of antibiotics prescription among doctors in a Nigerian teaching hospital 

Olayinka O Ogunleye, (Nigeria), SO Ogundele, AF Yinka-Ogunleye 

Tue 101 Quality of life of arthritis rheumatology patients evaluation 

PCR Palmiere, WA Souza, OMGC Vilas-Boas, EB Ferreira, Marcia HMC Podestá, (Brazil) 

Tue 102 A study of the longitudinal utilization of traditional non-steroidal anti-inflammatory drugs and COX-2 

selection inhibitors using a pharmacy based approach 

Emilian Damian Popovici, (Romania), MG Popovici, C Trandafirescu, M Kolliali, IM Malita, LM Baditoiu 

Tue 103 Pharmacological patterns of treatment in acute manic episode: A Spanish epidemiological multicentric 

study 

Esther Prieto, (Spain), J Galán 

Tue 104 Pharmacoepidemiology as an opportunity for prognostic studies in rare diseases: The example of giant 

cell arteritis and the French APOGEE cohort (Artérite en POpulation GEnérale) 

Gregory Pugnet, (France), L Sailler, R Bourrel, A Sommet, JL Montastruc, M Lapeyre-Mestre 

Tue 105 Effects of genetic polymorphisms of angiotensin converting enzyme in Iranian children with idiopathic 

nephrotic syndrome 

Parvaneh Rahimi-Moghaddam, (Iran) 

Tue 106 Communication of toxic effects of drugs with polymorphism genes GST and CYP450 

Natalya Shipovskaya, (Russian Federation), E Zaklyazminskaya, D Litvinov, L Shelihova 

Tue 107 Clinical importance of the evidentiary level basis for drug approval in oncology 

Gerald Sokol, (USA), L Loftus, B Djulbegovic, L Cantilena 

Tue 108 Patients’ preferences for written information about effects and undesirable side effects of drugs 

Petra A Thürmann, (Germany), V Mülders, D Simic, O Herber, D Schwappach, S Wilm 

Tue 109 The feasibility of monitoring paediatric adverse drug reactions via specialist clinics 

Mansour Tobaiqy, (UK), D Stewart, PJ Helms, CM Bond, AJ Lee, JHG Williams, JS McLay 

Tue 110 Compounding of extemporaneous items in pharmacies in South Africa 

Ilse Truter, (South Africa), M Lubbe, N Butler, D Nazer, A Gous, D Bayever, M Naidoo, P Naidoo, 

V Tlala, S Putter 

Tue 111 Antipsychotic prescribing to adults: A community pharmacy database analysis 

Ilse Truter, (South Africa) 

Tue 112 Prescribing for Parkinson’s disease in the private sector in South Africa 

Ilse Truter, (South Africa), 

Tue 113 The evaluation of quality of pharmacological treatment in elderly patients 

Martin Wawruch, (Slovak Republic), L Kostkova, A Macugova, K Strateny, M Kuzelova, D Jezova, 

A Dukat, V Kristova 

Tue 114 Psychotropic drug utilization in old-adult community 

N Yodu, C Peña, René Delgardo-Hernandez,(Cuba) 

Tue 115 Proton pump inhibitor (PPI) or statin associated risk for Clostridium difficile associated disease (CDAD)? 

Anita Zachow, (Germany), S Sonnenberg, G Haase, S Koenig, B Drewelow, SC Mueller 



basic and clinical pharmacology 

Tue 116 Level of response to antiplatelet therapy in patients with type 2 diabetes 

E Martin-Aurioles, F Padin, MM Arrebola, JA López-Villodres, Nuria Jebrouni, (Spain), JP de la Cruz, 

JA Gonzalez-Correa 

Tue 117 Five kinds of alkaloids from Rhizoma Coptis improve glucose uptake of 3T3-L1 cells without 

adipogenesis activity 

Xianli Meng, (PR China), J Li, X Fan, Y Zhang 

Tue 118 Propionyl-l-carnitine prevent metabolic and cardiovascular alterations in a model of diet-induced obesity 

Carmen Mingorance Gutiérrez, (Spain), M Chalopin, G Simard, PH Ducluzeau, Y Malthery, MD Herrera, 

M Álvarez de Sotomayor, R Andriantsitohaina 

Tue 119 Effect of genetic polymorphism on hypolipidemic response to rosuvastatin in metabolic syndrome 

Misbah Misbahuddin, (India), F Ahmad, S Ziaurrahman, A Khan, S Siddiqui 

Tue 120 Ethnomedicinal uses of some plant species by the traditional healers in Gaibandha district of 

Bangladesh 

Ariful Haque Mollik, (Bangladesh), R Faruque, R McField, D Sen, KK Thapa, AI Hassan 

Tue 121 Insulin resistance in the obese Zucker rat is not associated with pulmonary arterial hypertension 

Javier Moral-Sanz, (Spain), C Menendez, L Escolano, L Moreno, A Cogolludo, F Perez-Vizcaino 

Tue 122 Effect of Kampo, Chinese traditional medicine on clock- and metabolism-related gene expression in 

mice 

Takeshi Morishima, (Japan), G Koiwa, Y Tahara, A Hirao, S Shibata 

Tue 123 Effects of rosiglitazone on the prejunctional facilitatory actions of angiotensin II and α-2-antagonists 

Daniel Moura, (Portugal), H Pinheiro, F Silva, L Pereira, R Bastos 

Tue 124 Pre-emptive treatment with hemin suppresses hyperglycemia and improves glucose metabolism and 

diabetic nephropathy in the first generation offspring of Goto-kakizaki rats 

Joseph F Ndisang, (Canada), N Lane, A Jadhav 

Tue 125 Description and application of the Thrittene radioimmunoassay 

József Németh, (Hungary), G Fürjes, A Tóth, B Peitl, R Sári, R Pórszász, Z Szilvássy 

Tue 126 Aliskiren reduces albuminuria and affects renal TNF-α and Bcl-2 expression in a model of diabetic 

nephropathy in rats 

P Panagopoulos, Stergios Tsartsalis, (Greece), T Georgopoulou-Karanikola, C Tomos, T Mavrakanas, 

M Mironidou-Tzouveleki 

Tue 127 Role of AT1 receptor on the CNS insulin signalling in animal model of type 2 diabetes 

Mariella Pastorello, (Venezuela), A Israel 

Tue 128 The cyclic GMP-independent selective insulin sensitizing effect of oral isosorbide mononitrate in 

conscious rabbits 

Barna Peitl, (Hungary), R Sári, Z Szilvássy 

Tue 129 Protein kinase G regulates mitochondrial biogenesis and differentiation of brown adipocytes via 

inhibition of the RhoA/ROCK pathway 

Alexander Pfeifer, (Germany), B Haas, K Jennissen, P Mayer 

Tue 130 Analyzing the key enzymes of tricarboxylic acid circulation and researching metabonomics in diabetes 

and diabetic susceptible groups 

Jing Ping, (PR China), X Guan, L Wu, Y Zhao, K Bi 




Tue 131 Antidiabetic activity of biotin, sodium selenate and folic acid in diabetic rats 

Shweta Pitre, (India), R Ghosh, P Ganpathy, V Kadam 

Tue 132 Psammomys Obesus a promising animal model for type 2 diabetes 

Rasmus Pold, (Denmark), C Godfredsen, S Lund, T Bodvarsdottir 

Tue 133 Liquid fructose modifies insulin signalling pathway independently of AMPK activation in female 

Sprague-Dawley rats 

Núria Roglans, (Spain), A Rebollo, A Padrosa, L Vilà, M Alegret, JC Laguna 

Tue 134 Visfatin/PBEF/Nampt: a new therapeutical target in vascular inflammation 

Tanya Romacho, (Spain), V Azcutia, N Matesanz, E Cercas, R Carraro, L Rodriguez-Mañas, 

CF Sanchez-Ferrer, C Peiro 

Tue 135 Attenuated coronary vasodilator responses to adenosine receptor agonists in hearts from Zucker 

diabetic rats 

Roselyn Rose'Meyer, (Australia), D Wang 

Tue 136 Ca 2+ -dependent mechanism for hydrogen peroxide-induced apoptosis in pancreatic β-cells 

Yurie Sayama, (Japan), A Noguchi, M Takada, Y Kaneko, T Ishikawa 

Tue 137 Effect of α-lipoic acid on lipid peroxidation and microscopic structures of liver, pancreas and heart in 

STZ diabetic rats 

Manju Sharma, (India), KK Pillai, T Anwer, D Ahmad, WA Anjum, MW Siddique 

Tue 138 Ubiquitin ligase Hrd1 facilitates degradation of the Z variant α-1-antitrypsin 

Yuxian Shen, (PR China), H Wang, Q Li, A Sun, Y Shen, F Wang, H Fang, L Feng, X Zhu, X He, S Fang 

Tue 139 Upregulated pancreatic NF-κB/iNOS expression and impaired glucose stimulated insulin secretion in 

monosodium glutamate (MSG) induced obese rats after long-term fenofibrate treatment 

Zhufang Shen, (PR China), S Liu 

Tue 140 Fasting-induced increase in galanin mRNA expression in several hypothalamic nuclei 

Tomohiro Shiiya, (Japan), T Niki, H Higuchi 

Tue 141 Cardioprotective drug mildronate enhances the anti-diabetic activity of metformin in obese Zucker rats 

Elina Skapare, (Latvia), E Liepinsh, B Svalbe, M Dambrova 

Tue 142 Impaired neurogenic relaxation of the sphincter of Oddi of rabbits with insulin resistance 

Zoltán Szilvássy, (Hungary), J Németh, R Sári, B Peitl 

Tue 143 Atrial enlargement and decreased heart rate in SHRSP.Z-Leprfa/IzmDmcr rats, a model of metabolic 

syndrome 

Yukari Tada, (Japan), S Kagota, N Nejime, H Wakuda, K Nakamura, M Kunitomo, K Shinozuka 

Tue 144 Coronary artery bypass grafting surgery worsens oxidative stress among patients with coronary 

disease 

Teresa Tejerina, (Spain), MC M. Carnero, J Muñoz-Marin, JA González-Correa, E Gallardo, J Navarro- 

Dorado, M Ramajo, S Redondo 

Tue 145 Development and application of a quantitative LC-MS/MS method for endocannabinoids 

Brian Thomas, (USA), S Warren, Q Zhan, J Sasay, D Russell, A Howlett 

Tue 146 Neuronal insulin resistance in the nucleus Tractus solitarii induces hypertension in the fructose fed rats 

Ching-Jiunn Tseng, (Taiwan), B-R Chen, W-Y Ho, W-H Cheng, P-W Cheng 




Tue 147 Body temperature regulation after dietary intervention of three kinds of high-fat diets 

Hiromi Tsushima, (Japan), M Mori, K Yamada, H Okuyama, Y Hashimoto, T Ohkubo, H Hibino 

Tue 148 Evaluation of a glucagon challenge test as a tool in diabetes research 

Marloes GJ Van Dongen, (The Netherlands), BF Geerts, S Bhanot, ML de Kam, AF Cohen, JA Romijn, 

J Burggraaf 

Tue 149 CB1 cannabinoid receptor expression is regulated by glucose and feeding state in murine pancreatic 

islets 

Rafael Villalobos-Molina, (Mexico), A Vilches-Flores, NL Delgado-Buenrostro, G Navarrete-Vazquez 

Tue 150 Metabolic syndrome prevalence in university students of México City 

Rafael Villalobos-Molina, (Mexico), JR Jimenez-Flores, AR Mendez-Cruz, NY Rodríguez-Soriano, 

MI Mendoza-Ramos, M Murguia-Romero, SC Sigrist-Flores, M Rodriguez-Salazar, L Anguiano, 

E Gonzalez-Dalhaus 

Tue 151 Cell membrane crossing oligomers – a novel antisense therapy for reduction of apolipoprotein 

B-containing lipoproteins 

Georg Wietzorrek, (Austria), Y Nakada, B Werner, H Bock, T Lindhorst, H Dieplinger 

Tue 152 The role for L-carnitine in STZ-induced diabetic mice peripheral nerve injury 

Yunqiu Xia, (PR China), W Zhong, S Tao, C Wang, J Dong 

Tue 153 Role of heparan sulfate in glucose-induced insulin secretion in mouse pancreatic β-cell line MIN6 cells 

Takeo Yoshikawa, (Japan), S Takayanagi, N Noguchi, D Zhang, Y Ariyama, A Uruno, H Okamoto, 

A Sugawara, K Yanai 

Tue 154 Chronic hyperinsulinemia induces hypertension resulted from abnormal innervation of perivascular 

nerves in rat mesenteric resistance arteries 

Yoshito Zamami, (Japan), S Takatori, N Yabumae, M Hosoda, T Koyama, N Hobara, K Sasaki, 

H Kawasaki 

Tue 155 Bimodality of plasma glucose distributions in cynomolgus macaques 

Guodong Zhang, (PR China), D Yi, C Zhou, C Zhu, P Chan 

Tue 156 Treating diabetic complications? Multitargeting effects of Scutellarein 

Banghao Zhu, (PR China) 



function 

Tue 157 Possible role of endocannabinoids in the cardioprotective effects of a polyunsaturated fatty acid-rich 

diet in rats 

Istvan Lepran, (Hungary), N Morvay 

Tue 158 Effects of Lenalidomide on Ob/ob mice cardiac function: The role of TNF- αinhibitors 

Linlin Li, (PR China), R Jun, Y Hua 

Tue 159 Role of acetylcholine in protecting H9c2 cells against oxidative stress induced by angiotensin II 

J-J Liu, D-L Li, L Sun, M Zhao, X-J Yu, Wei-Jin Zang (PR China) 

Tue 160 Cardiac safety assessment: Beyond QT 

S Lynagh, David Bunton, (UK) 

Tue 161 Cystamine and sildenafil treatment of right ventricular hypertrophy in rats with pulmonary hypertension 

Lars Høj Markvardsen, (Denmark), CU Andersen, M Aalling, JH Rønn, U Simonsen 

Tue 162 Neonatal hyperleptinaemia possibly modulates cardiac function 

E Marques, F Toste, S Marques, J Raimundo, G Sudo, R Sudo, A Vieyra, 

Christianne Scaramello, (Brazil) 

Tue 163 Changes in the expression of enos and nnos in human peripheral blood lymphocytes and heart failure 

Diana Vicente Miralles, (Spain), F Monto, E Oliver, D Barettino, J Rueda, J Aguero, L Almenar, 

P D'Ocon 

Tue 164 Methylsufonylmethane (MSM) treatment improves hemodynamics in monocrotaline-induced pulmonary 

hypertension 

Sadollah Mohammadi, (Iran), A Garjani, M Najafi, H Hamzeiy, N Maleki-Dizaji, M Darabi, K Hassanzadeh, 

M Asadi 

Tue 165 Changes in the expression of α1 and β-adrenoceptors or of GRKs in human and rat hearts induced by 

chronic carvedilol treatment 

Fermí Josep Montó Guillot, (Spain), D Vicente, E Oliver, D Barettino, J Rueda, J Agüero, L Almenar, 

P D´Ocon 

Tue 166 Decreased matricellular protein thrombospondin (TSP) -4 expression in human calcified aortic valves 

Erja Mustonen, (Finland), V Pohjolainen, P Taskinen, J Näpänkangas, T Peltonen, H Leskinen, 

T Juvonen, J Satta, H Ruskoaho, J Rysä 

Tue 167 Effects of administration of statins for a certain term before undergoing coronary artery bypass 

grafting on platelet activation and inflammatory responses 

Kazuo Nakamura, (Japan), H Iwase, H Kariyazono, S Oiso, R Ikeda, J Arima, K Takahama, R Sakata 

Tue 168 Effects of SERCA activators, ellagic acid and gingerol, on diabetes mellitus-induced diastolic 

dysfunction in isolated murine ventricular myocardia 

Iyuki Namekata, (Japan), M Ohhara, Y Hirota, T Kawanishi, A Takahara, H Tanaka 

Tue 169 Phenotyping of heterozygous calsequestrin targeted mice 

Joachim Neumann, (Germany), P Bock, M Fischer, S Hauptmann, U Gergs 

Tue 170 Acute block of Kv1.5 channels by DHA increases rabbit atrial refractory period 

Christophe Pignier, (France), R Letienne, N Cabriol, Y Calmettes, B Le Grand 

Tue 171 Cardioprotection against ischemia afforded by F 16916, a blocker of persistent sodium current 

Christophe Pignier, (France), R Letienne, P Pajeau, L Bel, A-M Bessac, B Vacher, B Le Grand 



function 

Tue 172 Selective inhibition of persistent sodium current by F 15845 prevents ischemia-induced arrhythmias 

Christophe Pignier, (France), R Letienne, B Vie, C Culie, B Vacher, B Le Grand 

Tue 173 The myocardial protective and antioxidative effects of L-carnitine on patients with CHD after PCI 

Haijun Qu, (PR China), F Jing, Z Sui, Y Cao, Z Han, L Zhu, C Wang 

Tue 174 Targeting therapy of the systemic inflammatory response syndrome in patients with congestive heart 

failure 

Mamanti Rogava, (Georgia), T Bochorishvili, N Dolidze, M Mirziashvili 

Tue 175 State of endothelial and humoral regulation in heart failure of the aged patients on essential 

hypertension with combined IHD during the treatment 

Olesya Romashenko, (Russian Federation) 

Tue 176 Phenothiazine derivatives effects on experimental tachyarrithmias 

Kristina Sarkisyan, (Russian Federation), M Ivashev 

Tue 177 Elucidation of the mechanism that sulfaphenazole suppresses cardiac ischemia-reperfusion injury. 

Analysis using sulfaphenazole derivatives 

Masaya Sekine, (Japan), A Hamaguchi, Y Kobayashi, Y Ishihara, M Nakazawa, N Shimamoto 

Tue 178 Tetramethylpyrazine inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: 

Involvement of calcineurin 

Jing-Shan Shi, (PR China), J Deng, Q Wu, Y Gao, X-N Huang 

Tue 179 Investigation of anilocain and lidocain antiarrhythmic action on the barium chloride arrhythmia model 

Tatjana A Skorobogatova, (Russian Federation), VI Pantsurkin, MN Ivashev, 

Tue 180 Mechanism of the anti-hypertrophic action of RGS2 in cardiomyocytes 

Alina J Sobiesiak, (Canada), CH Nguyen, P Chidiac 

Tue 181 Effects of reduction of sympathetic nervous tone on ventrical myocytes contraction and the response 

of β1 and β2 adrenoceptor to isoprenaline in the aged rats 

Hong Sun, (PR China), Z Zhao, L Gao, Q Wu, Y Hao, C Xu, Y Sun, C Yan 

Tue 182 The pharmacokinetics and pharmacodynamics of biomarkers in patients with left ventricular systolic 

dysfunction (LVSD) and CHF treated with eplerenone 

John Vincent, (USA), J Cumps, F Zannad, J Ketelslegers 

Tue 183 Attenuation of ischemia-induced Ca2+ overload and LV mechanical dysfunction by inhibitors of late INa 

Lianguo Wang, (Canada), B Vacher, B Le Grand, A Clanachan 

Tue 184 Protective effect of rutaecarpine against myocardial hypertrophy in rats 

Qin Wu, (PR China), L Deng, X-N Huang, J-S Shi 

Tue 185 LDL increases vascular ETB2 receptor expression via activation of ERK1/2 and p38 MAPK pathways 

Cang-Bao Xu, (Sweden), J-P Zheng, Y Zhang, W Zhang, L Edvinsson 

Tue 186 Mechanism of improvement in vagal activity against myocardial ischemic injury 

Wei-Jin Zang, (PR China), L Sun, D-L Li, S-S Kong, H-K Jiang, Y-H Wang, X-J Yu 

Tue 187 Mechanism of improvement in vagal activity against myocardial ischemic injury 

Wei-Jin Zang, (PR China), L Sun, D-L Li, S-S Kong, H-K Jiang, Y-H Wang, X-J Yu 



function 

Tue 188 Dose-dependent drug-drug interaction between paracetamol and warfarin in adults receiving long-term 

oral anticoagulants 

Q Zhang, G Simoneau, L Drouet, C Bal-dit-Sollier, J-C Alvarez, I Mahé, J-F Bergmann, 

Stephane Mouly, (France) 

Tue 189 Amoxicillin/clavulanic acid did not increase INR in patients treated with warfarin 

Q Zhang, G Simoneau, C Verstuyft, L Drouet, C Bal-dit-Sollier, J-C Alvarez, J-F Bergmann, 

L Becquemont, Stephane Mouly, (France) 




Tue 190 Infliximab pharmacokinetics in rheumatoid arthritis is influenced by body surface area, erythrocyte 

sedimentation rate, methotrexate and antibodies towards infliximab 

Gilles Paintaud, (France), E Ducourau, T David, C Anca, LG Benoît, P Aleth, D Valérie, S-G Elisabeth, 

G Philippe, M Denis 

Tue 191 Pharmacokinetics of florfenicol following a single SC injection in calves 

Ali Rassouli, (Iran), P Lees, P Sidhu 

Tue 192 New approach for fitting of data of fluorescence anisotropy and intensity for characterization of ligand 

binding to melanocortin 4 receptors 

Ago Rinken, (Estonia), S Veiksina, S Kopanchuk 

Tue 193 α2 adrenoceptor distribution in pig brain, mapped with radiolabeled yohimbine by means of positron 

emission tomography 

A Rodell, S Jakobsen, Albert Gjedde, (Denmark) 

Tue 194 Design of novel and selective HDAC8-inhibitors as anticancer agents 

Barij Nayan Sinha, (India), V Jayaprakash 

Tue 195 7TM-homology modelling of long form of human and rat D2 dopamine receptor and validation for 

evaluating ligands recognition 

Marvin A Soriano-Ursúa, (Mexico), JO Ocampo-López, JG Trujillo-Ferrara, J Correa-Basurto 

Tue 196 The RAAS hypertension PhysioLab platform: A systems modelling approach to hypertension 

Antoine Soubret, (Switzerland), A Sarkar, M Hallow, B Bieth, A Georgieva, A Lo, J Beh, S Ermakov, 

S Ramanujan, M Rodrigo, D Keefe, A Charney 

Tue 197 Influence of non-compliance on antimicrobial therapy with levofloxacin based on pharmacokinetic/ 

pharmacodynamic simulation 

Maria Elena Suarez Gonzalez, (Spain), N Carral, R Calvo Duo, J Lukas 

Tue 198 Methotrexate influences neither pharmacokinetics nor concentration-effect relationship of infliximab in 

ankylosing spondylitis 

David Ternant, (France), F Lauferon, D Mulleman, D Wendling, E Ducourau, J-P Valat, P Goupille, 

G Paintaud 




Tue 199 Regulation of urothelial spontaneous contractile activity 

Christian Moro, (Australia), R Chess-Williams 

Tue 200 The relationship between hyperlipidemia-induced erectile dysfunction and serum ADMA levels in a time 

dependent manner 

N Murat, A Toylu, Atiye Sinem Evcim, (Turkey), BC Soner, O Demir, B Irer, T Demir, N Atabey, 

S Gidener, AA Esen 

Tue 201 Alteration of carbachol-induced prostate contraction in adiponectin transgenic mice 

Koji Nobe, (Japan), A Fujii, T Negoro, K Saito, Y Nakano, T Hashimoto, K Honda 

Tue 202 The effect of testosterone on intracellular calcium and cAMP in human cultured prostatic stromal cells 

Victoria Oliver, (Australia), C Anderson, J Haynes 

Tue 203 Comparison of the effects of AdTx1 and tamsulosin on the increase in intra-urethral and arterial 

pressures induced by phenylephrine in anesthetized male rats 

Stefano Palea, (France), N Gilles, V Guilloteau, M Guérard, P Lluel 

Tue 204 Stimulation of β3-adrenoceptors inhibits EFS-induced contractions of human isolated urinary bladder 

M Rekik, C Rouget, P Camparo, H Botto, P Lluel, T Westfall, Stefano Palea, (France) 

Tue 205 Involvement of both β2- and β3-adrenoceptors in the inhibition of neurogenic contractions of mouse 

isolated urinary bladder 

C Rouget, T Westfall, M Rekik, P Lluel, Stefano Palea (France) 

Tue 206 Stimulation of both both β2- and β3-adrenoceptors produces relaxation of KCl-induced contractions of 

mouse isolated urinary bladder 

C Rouget, T Westfall, M Rekik, P Lluel, Stefano Palea, (France) 

Tue 207 Effect of psychotropic drugs (Fluoxetine and Mirtazapine) on Phenylephrine-induced rat vas deferens 

contractility 

Cristina Sampayo, (Portugal), I Silva, R Pinto, B Silva-Lima 

Tue 208 Interaction between nitric oxide and dopaminergic transmission in the peripheral control of penile 

erection 

Amira Senbel, (Egypt) 

Tue 209 Acute toxicity studies and phytochemical screening of an erectile dysfunction herbal treatment; 

Kosteletzskya begoniifolia (Ulbr) 

Julius Kihdzee Tanayen, (Uganda), J Oloro, AA Ganafa 

Tue 210 Expression of phosphodiesterase (PDE) isoenzymes PDE4, PDE5 and PDE11 in the human seminal 

vesicles – an immunohistochemical study 

Stefan Ückert, (Germany), J Sonnenberg, V Steffenhagen, M Kuczyk, P Hedlund 

Tue 211 Is there a significance of the cyclic AMP specific phosphodiesterase 4 (PDE4) in the control of prostate 

smooth muscle? A functional and biochemical approach 

Stefan Ückert, (Germany), D Schönfeld, G Kedia, M Kuczyk 

Tue 212 Rho-kinase related proteins in human vaginal arteries – functional and immunohistochemical studies 

Stefan Ückert, (Germany), E Waldkirch, M Kuczyk, P Hedlund 

Tue 213 Impaired Ca 2+ handling in penile arteries from prediabetic Zucker rats: Involvement of Rho-kinase 

N Villalba, A García-Sacristán, M Hernández, Dolores Prieto, (Spain) 




Tue 214 On human relevancy of pharmco-toxicological experiments on example of genito-urology 

Ursula Welscher, (Germany), J Stiglmayr, J Milbradt, E Neu, HW Bauer, R Wilkowski, N Moro, 

MC Michailov, R Schätzle, L Zebuhr, W Seidenbusch, J Foltinova 

Tue 215 Characterisation of the muscarinic receptor subtype mediating contraction in the mouse prostate gland 

Carl White, (Australia), J Short, S Ventura 

Tue 216 Is phytotherapy effective for the urinary dysfunction in patients with benign prostatic hypertrophy? 

Shizuo Yamada, (Japan), M Abe, Y Ito, S Onoue 

Tue 217 Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and 

imidafenacin in rats by positron emission tomography 

Shizuo Yamada, (Japan), A Yoshida, Y Ito, H Tsukada 

Tue 218 Prostatoprotective activity of bee pollen lipophilic extract 

Ganna V Zaychenko, (Ukraine), S Gevoyan 




Tue 219 Lipopolysaccharide induced changes of liver function in μ-opioid-receptor-wildtype and -knockout mice 

Amelie Lupp, (Germany), S Schulz 

Tue 220 Cerebral ischemia induces micro vascular pro-inflammatory cytokine expression via the MEK/ERK 

pathway 

Aida Maddahi, (Sweden), L Edvinsson 

Tue 221 Pharmacological evaluation of clinically active compounds in a model of cystic fibrosis related 

inflammation 

Rangan Maitra, (USA), A Giddings, J Tajuba 

Tue 222 Malnutrition and biomarkers of inflamation in elderly patients 

Eva Mala, (Czech Republic), E Buresova, J Novosad, I Krcmova, J Krejsek, M Pliskova, L Sobotka, 

I Urbanova 

Tue 223 Clavulanic acid reduces neutrophil infiltration and oedema response in carrageenan-induced acute 

inflammation 

Nasrin Maleki-Dizaji, (Iran), A Banani, A Garjani, H Hamishehkar, A Fakhrjou 

Tue 224 Association of genetic polymorphisms of eNOS and iNOS with immune sensitization in asthmatic 

children 

Vangelis G Manolopoulos, (Greece), M Iordanidou, A Tavridou, E Paraskakis, A Chatzimichael 

Tue 225 Paradoxical influences of mTOR inhibitor everolimus on progressive renal failure 

Satohiro Masuda, (Japan), S Nakagawa, K Nishihara, K Inui 

Tue 226 Effect of valsartan on bone loss in periodontal disease induced by lipopolysaccharides in the rat 

Maria Gabriela Matos, (Venezuela), L Perdomo, M Alvarez, M Varela, A Stern, M del Rosario Garrido 

Tue 227 Inhibitor of apoptosis proteins (IAPs) as novel targets in inflammatory processes of endothelial cells 

Bettina Mayer, (Germany), C Reichel, F Krombach, S Zahler, A Vollmar, R Fürst 

Tue 228 Administration of edoxaban, an oral factor Xa inhibitor, is safe in healthy subjects post warfarin 

treatment- encore abstract 

Jeanne Mendell, (USA), R Noveck, I Rubets, M Shi 

Tue 229 A novel mechanism for neutrophil trapping in endotoxemic hepatic microvasculature: Downregulation of 

β-2 integrin via IL-10 

Gustavo Menezes, (Brazil), W-Y Lee, H Zhou, C Waterhouse, D Cara, P Kubes 

Tue 230 Agonist-mediated changes in intracellular calcium in human bronchial epithelial cells 

P Menon, K Varanou, Ian McFadzean, (UK) 

Tue 231 The enhancement of pentylenetetrazole-induced seizure threshold in mice via cyclooxygenase-2 

inhibition by nimesulide 

Azam Mesdaghinia, (Iran), A Heydari, P Khazaee, H Yazdanpanah 

Tue 232 Cannabinoid receptor activation inhibits smooth muscle cell proliferation and endothelial cytokine 

production 

Lisa Michel, (UK), K Skene, S Teixeira, E Hector, H Vosper, C Wainwright 

Tue 233 Expression of 5-HT receptors by human immune cells: Impact of physiological activation 

Sarah Milton, (UK), A Butler, J Curnow, J Gordon, N Barnes 

Tue 234 Aqueous cigarette tar extract causes marked bronchial smooth muscle hyperresponsiveness in rats 

Miwa Misawa, (Japan), A Watanabe, A Fujita, H Sakai, J Kamei, Y Chiba 




Tue 235 TRPA1 agonists iodoacetate and allyl isothiocyanate induce COX-2 expression in chondrocyte and 

macrophage cell lines 

Lauri Moilanen, (Finland), R Nieminen, E Moilanen 

Tue 236 Effect of Helicobacter pylori infection on the adherens junctions of gastric parietal cells in Mongolian 

gerbils 

Motonobu Murakami, (Japan), Y Tamura, Y Kuroda, A Sugiyama, A Nakagiri, K Tsuchida, K Amagase, 

K Takeuchi 

Tue 237 Up-regulation of survivin expression in simvastatin treated rats in endotoxic shock 

Lana Nezic, (Bosnia and Herzegovina), L Amidzic, R Skrbic, SS Satara, N Stojakovic 

Tue 238 Adenosine A2α agonist and A2β antagonist mediate an inhibition of inflammation-induced contractile 

disturbance of a rat gastrointestinal preparation 

Karen Nieber, (Germany), C Warstat, S Michael, L Yan, CE Müller 

Tue 239 Gold-containing DMARDs inhibit COX-2, MMP-3 and IL-6 expression in chondrocytes by increasing MKP-1 

expression and decreasing p38 phosphorylation 

Riina Nieminen, (Finland), R Korhonen, T Moilanen, AR Clark, E Moilanen 

Tue 240 Stimulation of macrophages by INFα in combination with LPS leads to effective elimination of 

F. tularensis experimental infection 

J Novosad, Eva Mala, (Czech Republic), M Holicka, M Novosadova, I Krcmova, J Krejsek 

Tue 241 Evaluation of antioxidant and anti-inflammatory effects of flavonoids and metal-flavonoids complexes 

Cristina Okuyama, (Brazil), D de Oliveira, C Miyashiro, R Pereira 

Tue 242 Epac and PKA inhibit cigarette smoke-induced production of IL-8 in airway smooth muscle cells 

Anouk Oldenburger, (The Netherlands), SS Roscioni, E Jansen, MH Menzen, AJ Halayko, H Meurs, 

M Schmidt 

Tue 243 Lipopolysaccharide stimulates diabetic gingival fibroblast to express TGF-β via MIP-2. Role of PI3K 

Sandra HP Oliveira, (Brazil), A Tamae, MA Machado 

Tue 244 COX imaging by PET with 11C-labeled nonsteroidal anti-inflammatory drugs (NSAIDs) 

Hirotaka Onoe, (Japan), M Shukuri, M Takashima-Hirano, M Goto, T Takashima, T Keiko, Y Watanabe, 

H Doi, M Suzuki 

Tue 245 The effect of terpenes on skin absorption of tiaprofenic acid gel Ex vivoand in vivo in rats 

Zeliha Pala Kara, (Turkey), A Okyar, M Nuriyev, A Yýldýz, N Öztürk 

Tue 246 Histological study of bone healing in rats after treatment with parecoxib 

Paraskevi Papaioannidou, (Greece), P Akritopoulos, M Dermentzopoulou, H Hatzokos, E Iosifidou, 

M Kotoula, V Mirtsou 

Tue 247 Anti-inflammatory properties of a dual PPAR γ/α agonist muraglitazar in in vitro and in vivo models 

Erja-Leena Paukkeri, (Finland), M Lindholm, T Leppänen, PH Aulaskari, MF Yam, MZ Asmawi, 

E Moilanen 

Tue 248 Metallic gold improves clinical outcome, induces neuroprotective astrocytosis and evokes stem cell 

response in an EAE rat model of multiple sclerosis 

Dan Sonne Pedersen, (Denmark), A Larsen, PM Fredericia, MØ Pedersen, M Stoltenberg, J Rungby, 

M Penkowa 




Tue 249 In vitro and in vivo effects of WIN55,212 on exocrine pancreas in physiological condition and during 

acute pancreatitis 

Carla Petrella, (Italy), S Alemà, S Agostini, M Broccardo, P Casolini, C Giuli, F Carpino, G Improta 

Tue 250 Investigation of anti-inflammatory and anti-nociceptive effects of a non-peptide somatostatin 4 receptor 

agonist TEZ-321 

Erika Pinter, (Hungary), Z Helyes, T Szuts, G Keri, A Kemeny, K Sandor, K Elekes, E Szoke, T Bagoly, 

Z Hegedus, J Szolcsanyi 

Tue 251 Is severity of clinical manifestations following H lepturus envenomation relates to serum TNF-α level? 

Mohammad Hassan Pipelzadeh, (Iran), A Jalali, A Ahmadzadehd, A Khodadadi, M Makvandi, M Taraz 

Tue 252 Dual effect of antagonist K-14585 on PAR-2 pro-inflammatory signalling 

Robin Plevin, (UK), F Goon Goh, PY Ng 

Tue 253 Mildronate regulates iNOS and myelin expression in the rat model of experimental autoimmune 

encephalomyelitis 

Jolanta Pupure, (Latvia), J Rumaks, N Karajeva, S Isajevs, B Jansone, S Svirskis, V Klusa 

Tue 254 Association between polymorphisms of IL-4 receptor α chain gene and plasma IgE levels in Malaysian 

asthmatics 

Vijaya Lechimi Raj, (Malaysia), R Nai, AK Radhakrishnan, CK Liam, MR Mustafa 

Tue 255 Irinotecan-induced intestinal mucositis: Role of cytokines on inducible nitric oxide synthase activation 

Ronaldo A Ribeiro, (Brazil), MHLP Souza, GAC Brito, RB Oriá, FQ Cunha, DVT Wong, RCP Lima-Júnior 

Tue 256 Angiotensin II promotes cytokine production in human podocytes 

Arianna Carolina Rosa, (Italy), L Rattazzi, G Miglio, R Fantozzi 

Tue 257 α-pinene inhibits interleukin-1-induced nitric oxide production by NF-κB-dependent and independent 

mechanisms in human chondrocytes 

Susana Rosa, (Portugal), J Goncalves, F Judas, L Salgueiro, C Cavaleiro, C Lopes, AF Mendes 

Tue 258 Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced 

inflammatory injuries in mice 

F Saccani, L Flammini, T Gobbetti, G Vegezzi, P Ghizzardi, S Bertoni, M Tognolini, V Ballabeni, 

Elisabetta Barocelli, (Italy) 

Tue 259 Angiotensin II induces hyperresponsiveness of bronchial smooth muscle via an activation of p42/44 

ERK in rats 

Hiroyasu Sakai, (Japan), Y Chiba, M Hanazaki, M Misawa 

Tue 260 Dual roles of the PGE2-EP4 signalling in mouse experimental autoimmune encephalomyelitis 

Daiji Sakata, (Japan), Y Esaki, Y Li, C Yao, E Segi-Nishida, T Matsuoka, K Fukuda, S Narumiya 

Tue 261 Drug prescription after third molar removal: A retrospective study in the Faculty of Dental Medicine of 

the University of Porto/Portugal 

Carlos Santos, (Brazil), A Calvo, T Dionísio, JR Lauris, MH Fernandes, A Felino 

Tue 262 Induction of duodenal ulcers by selective cyclooxygenase (COX)-1 and COX-2 inhibitors in cats 

Hiroshi Satoh, (Japan), K Amagase, K Takeuchi 

Tue 263 Analysis of various biological responses induced by Helicobacter pylori extract: Independent of 

proteinase-activated receptors? 

Fumiko Sekiguchi, (Japan), Y Maeda, Y Matsumoto, M Matsunami, H Nishikawa, A Kawabata 




Tue 264 Novel selective COX-2 inhibitor pyrazole derivative proven effective as anti-inflammatory and analgesic 

drug 

Amira Senbel, (Egypt), MM Mohy El-Din, AA Bistawros, A El-Mallah, NA Nour El-Din, AA Bekhit, 

H Abdel Razek 

Tue 265 Involvements of RhoA geranylgeranylation in the pathogenesis of allergic bronchial asthma 

Aya Shibuya, (Japan), S Sato, Y Chiba, M Misawa 

Tue 266 Changes of inflammatory cytokines in rats with naturally occurring gingivitis 

Mitsuko Shinohara, (Japan), A Hidaka, K Iwamoto, K Ohura 

Tue 267 The influence of ramipril on the inflammation markers and the immediate prognosis of myocardial 

infarction 

Anton Skotnikov, (Russian Federation), A Vertkin 

Tue 268 Sustained improvement of glycemic control reduces urinary leukotriene E4 excretion in patients with 

type 1 diabetes 

Françoise Stanke, (France), R Boizel, G Bruttmann, PY Benhamou, S Halimi 

Tue 269 Novel Pan-JAK inhibitor shows efficacy in both steroid sensitive and steroid insensitive inflammatory 

pathway 

Laurie Stevens, (UK), P Fenwick, W Liu, I Kilty, M Yeadon, L Donnelly 

Tue 270 Development of an in vitro model to investigate changes in kidney-derived exosomes with disease 

Jonathan M Street, (UK), M Bailey, F Frame, TS Walsh, DJ Webb, JW Dear 

Tue 271 Investigation of the role of TRPV1 capsaicin receptors and tachykinins in dextrane-sulphate induced 

mouse colitis model 

Istvan Szitter, (Hungary), E Pinter, G Pozsgai, K Sandor, A Kemeny, A Perkecz, K Elekes, Z Helyes, 

J Szolcsanyi, J Quinn 

Tue 272 Prostaglandin E2 inhibits advanced glycation end products-induced activation of human monocytes 

Hideo Takahashi, (Japan), K Liu, H Wake, S Mori, M Nishibori 

Tue 273 IL-16 accelerates cell proliferation mediated by ERK- cyclin D1 pathway in hepatocellular carcinoma 

Yuko Takeba, (Japan), N Matsumoto, T Kumai, M Watanabe, Y Kinoshita, S Kobayashi 

Tue 274 Roles of prostaglandins, nitric oxide and enterobacteria in pathogenesis of ischemic enteritis in rats 

Koji Takeuchi, (Japan), S Kojima, A Kuki, Y Nakamori, Y Komatsu, T Kotani 

Tue 275 New roles for kinin B1 receptor in the control of core temperature 

Sébastien Talbot, (Canada), H de Brito Gariépy, R Couture 

Tue 276 The study of effects of psychotropic drug Ladasten on LPS-induced changes cytokines profile and 

behavior in mice C57Bl/6 

Anna Tallerova, (Russian Federation), L Kovalenko, E Shipaeva, M Yarkova, A Durnev, S Seredenin 

Tue 277 Inhibitory effects of (3S)-7-(3,4-dihydroxyphenyl)-1-phenyl-(1E)-1-hepten-3-ol, a novel compound isolated 

from Curcuma comosa on nitric oxide and prostaglandin E2 production in lipopolysaccharide-induced 

microglial activation 

Anusorn Thampithak, (Thailand), Y Jaisin, B Meesarapee, N Poopyruchpong, Y Sanvarinda 

Tue 278 MKP-1 negatively regulates the expression of IL-8, IL-6 and COX-2 in human A549 epithelial cells 

Tuija Turpeinen, (Finland), R Nieminen, E Moilanen, R Korhonen 




Tue 279 The antimicrobial properties of 8-hydroxyquinoline derivatives and interaction with vitamin B12 

Robyn L van Zyl, (South Africa), M McLaverty, SF van Vuuren 

Tue 280 GLPG0259, a small molecule kinase inhibitor being developed for rheumatoid arthritis, shows good 

safety, tolerability and pharmacokinetics in healthy volunteers 

Frédéric Vanhoutte, (Belgium), J Beetens, L Gheyle, E Vets, W Haazen, F Namour, N Vandeghinste, 

S Blockhuys, P Wigerinck 

Tue 281 Minocycline reverses behavior and neurochemical changes in the model of global brain ischemia in rats 

Glauce SB Viana, (Brazil), AGG de Carvalho, AVB Peixoto, CCB Bezerra 

Tue 282 Minocycline reverts neurochemical and behavior alterations in the PD model of 6-OHDA-induced striatal 

lesions in rats 

Glauce SB Viana, (Brazil), PLF Tavares, IPP Xavier, IR Holanda, GM de Andrade 

Tue 283 Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis 

Katriina Vuolteenaho, (Finland), A Koskinen, S Juslin, R Nieminen, T Moilanen, E Moilanen 

Tue 284 Identification of a selective antagonist for prostaglandin (PG) E2-glyceryl ester: AGN-217673 

J Wang, David Woodward, (USA), L Ford, R Ross, M Rogers 

Tue 285 Tumor necrosis factor-related apoptosis inducing ligand promotes early atherogenesis in 

apolipoprotein(E)-deficient mice 

Yan Wang, (PR China), F Jiang, Y Zhang, C Zhang, Y Zhao 

Tue 286 R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by 

p75NTR induction 

Zhipeng Wang, (PR China), H Jin, Q Mei, D Fan 

Tue 287 Possible involvement of Src family kinases in the rat bronchial smooth muscle contraction 

Yu Watanabe, (Japan), H Sakai, Y Chiba, M Misawa 

Tue 288 B lymphocyte stimulator receptors and autoimmune diseases 

Wei Wei, (PR China) 

Tue 289 Expression and functionality of leptin receptor (Ob-R) in the human near-term myometrium 

Maeva Wendremaire, (France), F Lirussi, M Sediki, F Goirand, C Peyronel, S Lionnais-Couvreur, 

M Dumas, P Sagot, M Bardou 

Tue 290 Leptin prevents LPS-induced apoptosis in an in vitro human model of myometrial inflammation 

Maeva Wendremaire, (France), F Lirussi, M Sediki, F Goirand, S Lionnais-Couvreur, C Peyronel, 

M Dumas, P Sagot, M Bardou 

Tue 291 Carnosol modulates NF-κB activity by dual mechanisms in endothelial cells 

Being-Sun Wung, (Taiwan) 

Tue 292 Phosphodiesterase 4 inhibition attenuates nicotine-induced airway hyperresponsiveness to kinin 

receptor agonists 

Yuan Xu, (Sweden), Y Zhang, L-O Cardell 

Tue 293 TLR4-dependent induction of VCAM-1 in rheumatoid arthritis synovial fibroblasts: roles of cPLA2/COX-2 

Chuen-Mao Yang, (Taiwan), H-L Hsieh 




Tue 294 Prostaglandin E2-EP4 signalling promotes immune inflammation through Th1 cell differentiation and 

Th17 cell expansion 

Chengcan Yao, (Japan), D Sakata, Y Esaki, Y Li, T Matsuoka, K Kuroiwa, Y Sugimoto, S Narumiya 

Tue 295 Carboxyamidotriazole inhibited the secretion of pro-inflammation cytokines and the expression of iNOS 

in macrophages of adjuvant arthritis rats 

Caiying Ye, (PR China), D Zhang, R Zheng, L Guo 

Tue 296 The effect of carboxyamidotriazole on dextran sulphate sodium induced mouse experimental ulcerative 

colitis 

Dechang Zhang, (PR China), C Ye, X Hao, R Zheng 

Tue 297 Anti-inflammatory activity of a novel natural salicylate derivative from Gaultheria yunnanensis (FRANCH.) 

REHDER 

Tiantai Zhang, (PR China), L Sun, R Liu, X Lan, JH Sun, GH Du 

Tue 298 Up-regulation of kinin receptors in rat bronchi via IκB kinase-mediated inflammatory signalling pathway 

Yaping Zhang, (Sweden), Y Lei, Y-X Cao, L Edvinsson, C-B Xu 

Tue 299 Artesunate potentiates antibacterial effects of antibiotics in vitro and in vivo by increased accumulation 

of antibiotics via an inhibition on drug efflux pumps, AcrAB-TolC and MdtABC 

Hong Zhou, (PR China), BL Li, Q Yao, R Zhang, X Pan, J Li, G Ding, X Liu, C Wu, J Zheng 

Tue 300 Interference of newly developed antivirals with activity of immune system 

Zdenek Zídek, (Czech Republic), E Kmonícková, A Holý 



drugs 

Tue 301 Molecular determinants of warfarin pharmacokinetics and response 

Inna Gong, (Canada), R Tirona, U Schwarz, N Crown, G Dresser, S LaRue, N Langlois, A Lazo-Langner, 

P Wells, R Kim 

Tue 302 Determination of the rate of release of ibuprofen and dexibuprofen via topical route 

AVM González, G Ccalleja, Liliana Bautista Chávez, (Spain), JJT Durán, PB Papantonakis, ST Durán 

Tue 303 Covariate analysis of T-wave morphology and QTc prolongation: new insights into drug-induced ECG 

changes 

Claus Graff, (Denmark), E Toft, J Matz, JK Kanters, MP Andersen, J Nielsen, JJ Struijk 

Tue 304 Imatinib determination in human serum by high-performance liquid chromatography 

Paula Granic, (Croatia), D Sertic, M Lovric, Z Lalic, N Bozina, B Labar, J Sertic 

Tue 305 Impact of CYP2C9, CYP2C19 and VKORC1 polymorphisms on acenocoumarol time-to-achieve stability 

Liliane Gschwind, (Switzerland), V Rollason Gumprecht, M Rebsamen, V Nepote, P Bonnabry, 

F Boehlen, C Combescure, P Francis, P Chopard, P Dayer, J Desmeules 

Tue 306 Quality-analysis of aminoglycoside therapy in children at a Belgian university hospital 

Evelien Haegeman, (Belgium), P De Cock, N Goerlandt, P Vanhaesebrouck, V Stove, A Verstraete, 

P Schelstraete, H Robays 

Tue 307 Neuroprotective and antitremor effect of Baicalein against 6-OHDA-induced experimental Parkinsonism 

Guorong He, (PR China), X Mu, X Li, X Yu, K Wang, G Du 

Tue 308 Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9 

Anders Helldén, (Sweden), U Bergman, K Engström Hellgren, I Nilsson Remahl, I Odar-Cederlöf, 

M Ramsjö, L Bertilsson 

Tue 309 Gentamicin pharmacokinetics and dosing in older people: Is frailty a factor? 

Sarah Hilmer, (Australia), K Tran, P Rubie, J Wright, S Matthews, D Gnjidic, P Carroll 

Tue 310 Can drug removals involving cyclooxygenase inhibitors be avoided? Results from volunteer studies 

using ex vivo whole blood analyses 

Burkhard Hinz, (Germany), K Brune 

Tue 311 Association of genetic variants of UGT1A1 gene with serum bilirubin level in the Japanese 

Akira Hirasawa, (Japan), T Akahane, T Tsuruta, K Saito, T Zama, Y Tanigawara, N Susumu, D Aoki 

Tue 312 Pharmacokinetics, tolerability, and safety of almorexant in Japanese and Caucasian healthy male 

subjects 

Matthias Hoch, (Switzerland), P Hoever, F Alessi, J Marjason, J Dingemanse 

Tue 313 Potentially inappropriate medication in a German stroke cohort 

S Holt, Jacek Szymanski, (Germany), C Diederichs, PA Thürmann, K Berger 

Tue 314 A German list of potentially inappropriate medication in the elderly 

S Holt, Petra A Thürmann, (Germany), S Schmiedl 

Tue 315 Pharmacokinetic drug interaction of enoxacin and tizanidine via CYP1A2 inhibition 

Masato Homma, (Japan), K Momo, T Kobayashi, Y Kohda 

Tue 316 Strong inhibition of CYP2C8 within 1 hour after gemfibrozil dosing: Estimation of the onset of CYP2C8 

inactivation using repaglinide as an in vivo probe 

Johanna Honkalammi, (Finland), M Niemi, PJ Neuvonen, JT Backman 



drugs 

Tue 317 The expression of 14-3-3 subtypes in uterine leiomyoma 

Ouping Huang, (PR China), SF Fang, L Wang, D Yin, B Yi, L Tang, M He 

Tue 318 Effect of losartan on metabolism of arachidonic acid in human liver microsomes 

Nobuo Inotsume, (Japan), T Toda, K Sakamoto, S Takeuchi, T Hayakawa, B Ask, E Eliasson, A Rane 

Tue 319 Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in 

Sahiwal cattle 

Zahid Iqbal, (Pakistan), A Basit, I Javed, IU Jan, UA Khan 

Tue 320 Inhibitory effects of OTC-drugs on cytochrome P450 in human liver microsome 

Mariko Iwase, (Japan), Y Nishimura, N Kurata, Y Saito, N Uchida, H Yasuhara 

Tue 321 Amoxicillin pharmacokinetics in patients with aspiration pneumonia as a complication of overdosage 

with psychotropic drugs: a pilot study 

Dusan Jandric, (Republic of Serbia), V Dragojevic-Simic, B Ciric, D Jovanovic, V Kilibarda, S Vucinic, 

S Dobric 

Tue 322 Total and free clearance of R- and S-warfarin in elderly people 

Berit P Jensen, (New Zealand), P Chin, RR Roberts, J Maddison, EJ Begg 

Tue 323 CYP2C9*3 and *13 alleles significantly affected the pharmacokinetics of meloxicam in healthy subjects 


Tue 324 The role of CYP2C9 genetic variants in the disposition of glipizide in healthy subjects 


Tue 325 Pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after multiple-dose oral 

administration of L-carnitine solution in healthy subjects 

Fanbo Jing, (PR China), H Qu, Z Sui, Y Cao, Z Han, L Zhu, C Wang 

Tue 326 Potentially inappropriate drug prescription in hospitalized geriatric patients 

Marcela Jirón, (Chile), P Jara, L Escobar, S Orellana, I Huala, L Arriagada, MD Castillo, VH Carrasco 

Tue 327 Cockcroft-Gault and MDRD in estimating renal function in older heart failure patients – implications for 

prescribing of predominantly renally cleared medications 

Sally Johns, (Australia), J Maddison, S Shakib 

Tue 328 Erythropoietin use in cancer-related anemia in Croatia 

Danica Juricic, (Croatia), S Badzek, L Bielen, V Erdeljic, K Makar-Ausperger, M Radacic-Aumiler, 

R Likic, I Francetic 

Tue 329 Prediction of non-compliance with antibiotic therapy in ambulatory patients 

Kristina Kandrotaite, (Lithuania), V Neverauskas, M Jievaltas, V Saferis, V Briedis, R Maciulaitis 

Tue 330 Gemfibrozil markedly increases the plasma concentrations of montelukast: A previously unrecognized 

role for CYP2C8 in the metabolism of montelukast 

Tiina Karonen, (Finland), J Laitila, M Niemi, P Neuvonen, J Backman 

Tue 331 CYP2D6 genetic polymorphism has an impact on the pharmacokinetics of carvedilol in Korean subjects 

Seul-Ki Keum, (South Korea), J-W Bae, C-G Jang, S-Y Lee 

Tue 332 Gliclazide pharmacokinetics in relation to CYP2C19 genotype in healthy Koreans 

Seul-Ki Keum, (South Korea), C-I Choi, J-W Bae, C-G Jang, S-Y Lee 



drugs 

Tue 333 Pharmacokintic and pharmacodynamic alterations of omeprazole in relation to CYP2C19 genotype 

Seul-Ki Keum, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Tue 334 Knowledge, Attitude and Perception (KAP) Study on Clinical Trial of Pharmaceuticals and Informed 

Consent in Korea 

Kyung-Soo Kim, (South Korea), SH Lee, BI Choe, CM Kim 

Tue 335 Comprehensive genotyping of drug metabolizing enzymes and transporters for the assessment of 

pharmacokinetics and pharmacodynamics of atorvastatin 

Suk-Ran Kim, (South Korea), H-H Won, J-W Kim, J-W Ko, W Huh, O-Y Bang, S-C Lee, H-G Kim, S-Y Lee 

Tue 336 Individual differences of CYP2C19 mRNA expression in the small intestine of Japanese subjects 

Yuichi Kinoshita, (Japan), M Hayashi, N Matsuomoto, Y Tkeba, T Kumai, S Kobayashi 

Tue 337 CYP2D6 mRNA expression and genetic polymorphism in the small intestine of Japanese 

Shinichi Kobayasi, (Japan), S Takenosihta-Nakaya, Y Kinoshita, N Matsumoto, Y Takeba, T Kumai 

Tue 338 Pharmacokinetic and pharmacodynamic Modelling of denopamine in patients with congestive heart 

failure 

Yuichi Koike, (Japan), N Yonehara 

Tue 339 Racemic ketoprofen induces more injection pain than dexketoprofen 

Hannu Kokki, (Finland), T Saarelainen, M Kokki 

Tue 340 In vitro evaluation of linezolid and novel oxazolidinone actions on central nervous system neurones 

Samuel Kombian, (Kuwait), O Phillips 

Tue 341 Bioequivalence study of two oral preparations, thyrosit (100 μg levothyroxine sodium) vs eltroxin (100 

μg anhydrous thyroxine sodium) in patients who have hypothyroidism with euthyroid in steady state 

Supornchai Kongpattanakul, (Thailand), S Vannasaeng, K Sathirakul, S Chatsiricharoenkul 

Tue 342 Pharmacokinetic study of immediate and prolonged generic molsidomine formulations 

Jiri Kopecky, (Czech Republic), D Kholova, A Polaskova, J Zoulova, I Zubata, L Vyslouzil, K Macek, 

J Chladek, J Kvetina 

Tue 343 Novel candidates for replacement of standard acetylcholinesterase reactivators – antidotes in case of 

nerve agent and pesticide poisonings 

Kamil Kuca, (Czech Republic), K Musilek, D Jun, J Kassa, M Pohanka, L Novotny, J Cabal, 

J Zdarova-Karasova 

Tue 344 Preparation, characterization & evaluation of solvatomorphs of atorvastatin 

Astha Kuhad, (India), R Chadha 

Tue 345 Type and prevalence of serious adverse events in phase I trials performed in Japan 

Yuji Kumagai, (Japan), T Momma, I Fukazawa, H Iijima 

Tue 346 How to view JUPITER 

Cyrus Kumana, (PR China), HF Tse, CP Lau 

Tue 347 CYP2D6 genotype: Effect on serum levels, response and side effects of venlafaxine 

A Lalla, Lazara Montane Jaime, (Trinidad & Tobago) 

Tue 348 Influence of gender on clopidogrel disposition in healthy volunteers 

O Laosa, Alberto M Borobia, (Spain), B Mosquera, SH Lei, JL Lopez-Durán, B Duque-Bascuñana, 

P Guerra-López, AJ Carcas-Sansuán, J Frías-Iniesta 



drugs 

Tue 349 Pharmacokinetic comparisons of sustained- and immediate-release oral formulations of cilostazol in 

healthy Koreans 

Donghwan Lee, (South Korea), LA Lim, SB Jang, YJ Lee, H Son, S Cho, J Chung, K Park 

Tue 350 CYP2C9*3 and *13 alleles significantly affected the pharmacokinetics of celecoxib in healthy Korean 

subjects 

Seok-Yong Lee, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang 

Tue 351 Genetic polymorphisms of CYP2C9 and their influences on warfarin sensitivity in mechanical heart valve 

replacement patients 

Su-Jun Lee, (South Korea), YJ Jang, E-Y Cha, H-S Kim, M-S Hwang, SS Lee, J-G Shin 

Tue 352 Identification of CYFC19A1 single nucleotide polymorphisms in Koreans and comparative analysis of 

functionally important CYFC19A1 variants with different ethnic groups 

Su-Jun Lee, (South Korea), W-Y Kim, I-S Jung, J-Y Choi, SS Lee, J-G Shin 

Tue 353 The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment 

outcome for children with acute lymphoblastic leukaemia 

Lynne Lennard, (UK), C Cartwright, R Wade, S Richards, C Mitchell, S Kinsey, T Eden, J Lilleyman, 

A Vora 

Tue 354 Maximising benefits and minimizing side effects of acetylsalicylic acid by using antioxidant drug 

thiotriazolin 

Anton Levykh, (Ukraine), V Mamchur 

Tue 355 The test dose – how to be a more valuable and reliable predictor? 

Nianzhi Li, (UK), J Aronson 

Tue 356 Does definition of medication errors have any impact at prevalence? A systematic review of definitions 

Marianne Lisby, (Denmark), LP Nielsen, B Brock, J Mainz 

Tue 357 How should medication errors be defined: A systematic approach to terminology, concepts and 

definitions – applied in a clinical setting 

Marianne Lisby, (Denmark), J Mainz, B Brock, LP Nielsen 

Tue 358 The effect of systematic medication review in patients admitted to an acute medical department 

Marianne Lisby, (Denmark), A Thomsen, LP Nielsen, NM Lyhne, C Breum-Leer, U Fredberg, 

H Jørgensen, B Brock 

Tue 359 Metallic silver ignites inflammation and causes toxic cavity formation in the brain 

LJ Locht, Agnete Larsen, (Denmark), MØ Pedersen, S Markholt, BM Bibby, J Rungby, M Penkowa, 

M Stoltenberg 


W18 Synaptic events in brain function 

Tue 360 Effects of acute and chronic treatment with attention-deficit/hyperactivity disorder drugs on 

monoaminergic transmission in mice 

Ken Koda, (Japan), Y Ago, Y Cong, K Takuma, T Matsuda 


FC19 General session 

Tue 361 Analgesic activity of the aqueous seed extract of Hunteria umbellata (K. Schum.) Hallier f. 

(Apocynaceae) in rodents 

Olufunmilayo Adeyemi, (Nigeria), A Adeneye, T Alabi 

Tue 362 Effect of environmental temperature on norepinephrine-induced contraction in isolated chicken cubital 

vein: gender variation 

Simon Comerma-Steffensen, (Venezuela), J Rojas, A Risso, M Rossini, V De Basilio, I Oliveros, H Zerpa 

Tue 363 Drugs used for the treatment of type 2 diabetes mellitus in Finland during the years 2004-2009 

Annikka Kalliokoski, (Finland), LK Saastamoinen, JE Martikainen 

Tue 364 Detecting stimulant and sedative properties of drugs using home cage tracking in rats 

John Kelly, (Ireland), F Dunne, A O'Halloran, K Lane, J Simpson, S O'Brien 

Tue 365 Two glutathione S-transferase inhibitors from Radix Angelicae Sinensis 

Shaojing Li, (PR China), F Huang, X Lu, A Liu, G Du 

Tue 366 The role of endogenous adenosine on mechanism of citalopram-induced cardiovascular toxic effects 

K Oransay, N Hocaoglu, Mujgan Buyukdeligoz, (Turkey), Y Tuncok, S Kalkan 

Tue 367 Safety of herbal products: Data from the Serbian pharmacovigilance database 

Marija Petronijevic, (Republic of Serbia), K Ilic, I Kovacevic 

Tue 368 Provocation-based learning (PBL) in large classes: Promising? 

Patangi Rangachari, (Canada), S Nastos 

Tue 369 Experimental study of effects of triphasic oral contraceptive pills on fluctuations tear 

Khatereh Safavi Naeini, (Iran) 

Tue 370 The study of effect of iohexol on Schirmer tear test values in clinically normal cattle 

Aboutorab Tabatabaei Naeini, (Iran), J Ceverie 

Tue 371 Phytoestrogenic effects of catalpol in T47D and MDA-MB231 cells in culture 

Jifeng Wang, (PR China), J Niu, Q Hao, P Zhao 


FC19 General session – Airway 

Tue 372 In vivo [11C]PK11195 PET imaging as a biomarker to assess lipopolysaccharide-induced lung 

inflammation in rat 

Sidath Katugampola, (UK), A Zhu, K Zasadny, M Callahan, C Proctor-Brown, M Skaddan, K Kuszpit, 

T Bocan 

Tue 373 The effect of inhaled KP-496, a novelantagonist for cystenyl leukotriene receptor and thromboxane A2 

receptor, on experimental allergic asthma in guinea pigs 

Hiroichi Nagai, (Japan), M Suda, T Okuda, M Ishimura, S Kurokawa, S Tokuoka, T Nakamura, 

Y Takahasi, H Tanaka 


FC19 General session – Biologics 

Tue 374 Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion 

Chi-Feng Hung, (Taiwan), C-M Chan, H-H Lin 

Tue 375 Involvement of 5’-AMP-activated protein kinase in proliferation and survival of neural stem/progenitor 

cells 

Nobuyuki Kuramoto, (Japan), S Sano, N Tanaka, M Yoneyama, R Nagashima, K Ogita 

Tue 376 Edaravone promotes the proliferation/survival of neural progenitor cells after granule cell loss in the 

hippocampal dentate gyrus of mice 

Tatsuo Shiba, (Japan), K Kawada, M Yoneyama, K Ogita 

Tue 377 Nicotinic acetylcholine receptor stimulation enhances the DNA synthesis and proliferation of mouse 

induced pluripotent stem cells 

Yasuhiro Watanabe, (Japan), T Ishizuka, T Hiramoto 

Tue 378 Structural alterations of PKC gene promoter by cytosine methylation decreases SP1 binding affinity 

Shumei Yang, (USA), J Tenayuca, L Zhang 


FC19 General session – Cell biology 

Tue 379 Dual regulation of hepatocyte apoptosis by reactive oxygen species: Increased BimEL expression 

downstream of ERK and suppressive BimEL degradation by proteasome inhibition 

Yasuhiro Ishihara, (Japan), M Sekine, K Takeuchi, F Ito, N Shimamoto 

Tue 380 Analysis of gene expression in the spontaneously cartilage calcification insufficient (CCI) rat 

Masami Tanaka, (Japan), I Yokomi, M Watanabe, K Sudo, H Satoh, T Igarashi, A Seki, S Kobayashi 


FC19 General session – Haematology 

Tue 381 Modulated human maternal and premature neonatal erythrocyte membrane enzyme activities: In vitro 

restoration by L-carnitine 

K Schulpis, G Vlachos, A Antsaklis, Charis Liapi, (Greece), V Stolakis, A Zarros, S Tsakiris 

Tue 382 Effect of Rhynchophylline on platelet aggregation and cytoplasmic free calcium level in rabbit platelets 

Jing-Shan Shi, (PR China), Z-L Xie, M Wu, Q Wu, Z-N Huang, Q-H Gong 


FC19 General session – Hepatology 

Tue 383 Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone 

supplementation. 

Linda Björkhem-Bergman, (Sweden), J Acimovic, U-B Torndal, P Parini, L Eriksson 

Tue 384 A study on the protective mechanism of tiβn medicine potentilla anserina on experimental liver injury 

Guangming Cai, (PR China), Z Zhu, X Fu 

Tue 385 Effect of siRNA-mediated knockdown of ALDH2 on GTN-induced cGMP formation in PK1 cells 

Yohan D'Souza, (Canada), BM Bennett 

Tue 386 Potential antifibrotic effects of losartan or silymarin coadministration with praziquantel against 

experimental Schistosoma mansoni-induced liver fibrosis 

Naglaa El-Lakkany, (Egypt), W El-Maadawy, A Ain-Shoka, A Badawy, F Ebeid 

Tue 387 Congenital-neonatal hypothyroidism impacts hepatic lipid metabolism in adulthood 

Leandro Fernández-Pérez, (Spain), R Santana-Farré, L Henríquez-Hernández, C Bocos, N Kahlon, 

E Herrera, N Gunnar, P Parini, A Flores-Morales 

Tue 388 Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism 

of aconitine 

Yue Gao, (China) 

Tue 389 Roles of DNA damage and inflammation in the gender-selective liver carcinogenicity of 4-aminobiphenyl 

in mice 

Denis Grant, (Canada), K Sugamori, A Emami, S Wang, D Brenneman 

Tue 390 An acyclic retinoid, NIK-333, accelerates liver regeneration and lowers serum transaminase activities in 

70% partially hepatectomized rats in vivo 

Mitsutoshi Kimura, (Japan), N Ishibashi, S Yanagida, M Ogihara 

Tue 391 Estradiol interacts with growth hormone and thyroid hormones to regulate the expression of 

suppressors of cytokine signalling (SOCS) in liver 

Ruymán Santana-Farré, (Spain), A Flores-Morales, G Norstedt, L Fernández-Pérez 

Tue 392 Influence of estradiol on growth hormone-regulated liver transcriptome in male rats 

Ruymán Santana-Farré, (Spain), A Flores-Morales, M Mirecki-Garrido, G Norstedt, L Fernández-Pérez 

Tue 393 Inhibitory effects of schisandrin A and schisandrin B on CYP3A activity 

Hua-Wen Xin, (PR China), W-L Li, M-W Su 


FC19 General session – oncology 

Tue 394 An increased precryopreservation time reduces the feasibility and the recount of the CD34(+) cells of 

the umbilical cord blood. 

Inmaculada Bellido, (Spain), L Ponce, MC Hernández, M Barrios, I Prat, AI Heiniger 

Tue 395 Impact of ABCB1 variants on neutrophil depression: A prospective study 

Troels K Bergmann, (Denmark), C Brasch-Andersen, H Gréen, M Mirza, K Skougaard, J Wihl, 

N Keldsen, P Damkier, C Peterson, W Vach, K Brøsen 

Tue 396 Ionizing radiation alters the bone marrow microenvironment by inducing senescence of mesenchymal 

stromal cells 

Cynthia Carbonneau, (Canada), G Despars, A Fortin, O Le, T Hoang, CM Beausejour 

Tue 397 Temozolomide induces apoptosis and autophagy in glioma cells 

A Carmo, H Carvalheiro, Maria Celeste Lopes, (Portugal) 

Tue 398 Indole-3-carbinol attenuates migration and invasion of breast cancer cells by blocking the ERK/ 

Sp1-mediated MMP-2 gene transcription 

Hui-Chiu Chang, (Taiwan) 

Tue 399 Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor 

neovasculature 

Hong-Zhuan Chen, (PR China), D-H Yu, Q Lu, J Xie, C Fang 

Tue 400 Cryptotanshinone has opposite cell cycle-arresting effects on melanoma cells of different metastatic 

capacity 

L Chen, S-Z Zheng, A-Y Wang, Lu Yin, (PR China) 

Tue 401 Pulmonary toxicity of bleomycin involved in upregulation of lysyl oxidase activity in cultured human fetal 

lung fibroblasts 

Lijun Chen, (PR China), S Li, X Su, G Lin 

Tue 402 The mechanism of MNNG-induced-apoptosis: AMPK could be a transmitter from PARP activation to 

mitochondrial dysfunction 

Yi-Cheng Chen, (Taiwan), J-H Guh 

Tue 403 The relationship between MEKK1 and carcinogenesis & development of pancreatic cancer 

Xiaoguang Cheng, (China), F Su, K Li, Y Zhang, C Yan 

Tue 404 Novel imidazo[1,2-a]pyridines in the induction of colonic cell differentiation and apoptosis 

Nurit Dahan-Farkas, (South Africa), C De Koning, L Harmse, H Davids 

Tue 405 New HPLC-mass spectrometry method for the simultaneous quantification in human plasma of the 

antileukemia drugs Imatinib, Dasatinib, and Nilotinib 

Silvia De Francia, (Italy), A D'Avolio, F De Martino, E Pirro, F Piccione, S Racca, F Di Carlo 

Tue 406 Beer polyphenols against human glioblastoma: Effects of xanthohumol on T98G cell apoptosis 

Michela Festa, (Italy), A Capasso, L Parente, CW D'Acunto, C Pizza, S Piacente 

Tue 407 Morphological evaluation of rat liver tissue after the subcutaneous injection of 1,2-dimethylhydrazine 

Ana Fortuna, (Portugal), R Direito, G Alves, J Sousa, A Falcão, A Cabrita 

Tue 408 HPLC method developement for the simultaneous determination of Arabinoside-C and Doxorubicin 

concentrations in human serum 

Suew Hua Gan, (Malaysia), AF Mistiran, AD Abdullah 



Tue 409 Cytotoxic activity of bioactive fractions of bioactive fractions of Asparagus officinalis L. 

Mª Dolores García-Gimenez, (Spain), R De la Puerta, MA Fernández-Arche, MT Saenz-Rodríguez 

Tue 410 Characterization of a lipid kinase involved in the synthesis of alkyl lysophosphatidic acid 

Amanda Gellett, (USA), Y Kharel, K Lynch 

Tue 411 HGF/c-Met overexpressions, but not Met mutation, correlates with progression of non-small cell 

carcinomas 

Mukaddes Gumustekin, (Turkey), A Kargi, G Bulut, A Gozukizil, C Ulukus, I Oztop, N Atabey 

Tue 412 Haishengsu extracted from Tegillarca granosa inhibits cell growth of human hepatic cancer in nude 

mice 

Yantao Han, (PR China), X Chen, Z Han, P Li, J Tong, C Wang 

Tue 413 Arachidonic acid promotes glutamate-induced cell death associated with necrosis through 

12-lipoxygenase activation in glioma cells 

Yoshihiro Higuchi, (Japan), M Hashii, H Tanii, Y Koriyama 

Tue 414 The effects of azole-based heme oxygenase inhibitors on breast cancer growth and metastasis in vivo 

Maaike Hum, (Canada), RA Dercho, S Nagy, JZ Vlahakis, WA Szarek, K Nakatsu 

Tue 415 Nerve growth factor (NGF) prevents tumor growth 

Hiromu Kawasaki, (Japan), M Goda, S Takatori, Y Zamami, N Hobara, Y Kitamura 

Tue 416 The effect of estrogen supplementation on cell proliferation and distribution of prostatic interstitial cells 

in the rat prostate 

Snezana Kusljic, (Australia), B Exintaris 

Tue 417 Role of cortistatin in modulating the growth of colon cancer cells 

Francis FY Lam, (PR China), ESK Ng, CH Cho 

Tue 418 XJ-6-A inhibits tumor invasion and metastasis and its potential molecular mechanisms 

Xuejun Li, (PR China), Y Cao 

Tue 419 Preparation of monoclonal antibodies by in vivo electroporation-assisted HE4 gene immunization in 

mice 

H Luan, X Gao, J Fu, Z Ma, L Dong, L Fan, Haifeng Song, (PR China) 

Tue 420 Chemoenzymatic synthesis of new diazabicyclic amides of 12-phenylacetylricinoleic acid and in vitro 

antineoplastic activity in mouse and human leukemic cells 

Axel Luviano, (Mexico), R Tiburcio, I Aguiñiga, P Demare, M López, J Cardoso, I Monsalvo, I Castillo, 

E Santiago, I Regla 

Tue 421 Undernutrished patients with head-neck cancer and PEG in adjuvant radioterapy 

Eva Mala, (Czech Republic), E Buresova, I Krcmova, J Novosad, J Krejsek, M Vosmik, R Cap, 

L Sobotka 

Tue 422 Candida albicans induces proliferation and neurosphere formation from mouse retinal progenitor cells 

Victoria Maneu, (Spain), C Murciano, ML Gil, A Yáñez, D Gozalbo 

Tue 423 Anticancer effect of horse chestnut extract 

Gabriela Mojzisova, (Slovak Republic), J Mojzis, L Varinska, M Pilatova, A Bomba 

Tue 424 Study of noscapine-induced cell death in hepatocellular carcinoma cell line 

Seyed Hadi Mousavi, (Iran), H Parsaee, Z Tayarani-Najaran 



Tue 425 Study on the phytoestrogenic effects of ferulic acid 

Jianzhao Niu, (PR China), J Wang, Q Hao, P Zhao 

Tue 426 Effect of topiramate on tumor angiogenesis and serum proteome of mice bearing Lewis lung 

carcinoma 

Yan Pan, (PR China), B Ma, X Yang, H-M Yu, X-J Li 

Tue 427 Acetylation of p53 by histone deacetylase inhibitors sensitizes lung cancer cells to ionizing radiation 

induced cell death 

In-Chul Park, (South Korea), S-K Seo, H-O Jin, T-B Choe 

Tue 428 Antitumoral and antimetastatic activities of a proteolytic fraction from Carica candamarcensis latex 

Miriam Teresa Paz Lopes, (Brazil), D Dittz, C Figueiredo, CTR Viana, CE Salas 

Tue 429 Novel Pim kinase inhibitor impairs Pim-dependent stimulation of cancer cell motility 

Niina Santio, (Finland), R Vahakoski, E Rainio, S Virtanen, J Sandholm, M Prudhomme, F Anizon, 

P Moreau, P Koskinen 

Tue 430 Role of cardiac mitochondrial nitric oxide-cGMP pathway on rat cardiomyocyte apoptosis 

Kazuhiko Seya, (Japan), K Ono, S Fujisawa, S Motomura, K-I Furukawa 

Tue 431 Study in vitro of the mechanism of action by which coumarin and 7-hydroxycoumarin promotes 

apoptosis in two human lung adenocarcinoma cell lines 

Maribel Soto-Núñez, (Mexico), P Cuautle-Rodríguez, JA Molina-Guarneros 

Tue 432 The mechanism of gingival overgrowth as a side effect of nifedipine 

Reiri Takeuchi, (Japan), H Matsumoto, Y Akimoto, A Fujii 

Tue 433 Isophthalic acid derivatives targeted to the C1 domain of PKC induce cell cycle arrest in HeLa cells 

Virpi Talman, (Finland), E Ekokoski, A Olli, G Boije af Gennäs, J Yli-Kauhaluoma, RK Tuominen 

Tue 434 HPLC method development & validation for the determination of Imatinib Mesylate in human serum 

Ka Liong Tan, (Malaysia), R Hassan, SH Gan 

Tue 435 Gene expression profiling of human mesenchymal stem cells for identification of surrogate markers for 

in vitro culture stage 

Shihori Tanabe, (Japan), Y Sato, T Suzuki, T Yamaguchi, K Suzuki 

Tue 436 High-throughput screening for novel prostate cancer drug targets 

Paula Vainio, (Finland), K Ketola, J-P Mpindi, S Kilpinen, P Kohonen, V Fey, S Gupta, M Perälä, 

O Kallioniemi, K Iljin 

Tue 437 Oncology clinical trials in Croatia 

Dinko Vitezic, (Croatia), M Lovrek, S Omic 

Tue 438 Development of an in vitro assay to evaluate sunscreen efficacy 

Nicole Walter, (Switzerland), C Surber, G Kunze 

Tue 439 Investigations on the antitumor effects and mechanisms of 13 compounds 

Juan Wang, (PR China), XH Chen 

Tue 440 Apoptosis of U937 cells induced by Brucea javanica oil emulsion 

Chunfu Wu, (PR China), H Zhang, J Yang, L Wang, F Zhou, W Zhang 



Tue 441 AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits 

antitumor activity both in vitro and in vivo 

Hua Xie, (PR China), L Lin, Y Jiang, J Guo, J Ding 

Tue 442 Direct antiproliferative effect of novel nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors 

István Zupkó, (Hungary), A Berényi, S Marchais-Oberwinkler, M Frotscher 


FC19 General session – Toxicology 

Tue 443 Ultraviolet action spectrum and effect of EPC-K1 on ultraviolet-radiation-induced injury in cultured NHEK 

Kayo Aoki, (Japan), T Nakanishi-Ueda, M Tsuji, T Okuno, K Oguchi, H Yasuhara 

Tue 444 Melamine migration from melamine food contact articles available on the Malaysian market 

Zamri Chik, (Malaysia), DEM Haron, MA Mohamad, ED Ahmad, H Taha 

Tue 445 Topotecan vitreous levels after periocular or intravitreal delivery in healthy albino rabbits: An alternative 

for advanced retinoblastoma chemotherapy 

Denisa Darsova, (Czech Republic), P Pochop, E Klapkova, D Kodetova, H Tesfaye, J Uhlik, L Vajner 

Tue 446 Oxaliplatin-dependent neuropathy in the rat: Pain behaviour and peripheral nervous system alterations 

Lorenzo Di Cesare Mannelli, (Italy), L Bonaccini, A Pacini, C Ghelardini, A Bartolini 

Tue 447 Role of sister chromatid exchange analysis in assessment of proguanil genotoxicity in cultured human 

lymphocytes 

Domagoj Dinter, (Croatia), G Gajski, V Garaj-Vrhovac 

Tue 448 Synthesis of new detergents derived from quaternary ammonium salts as a part of disinfection and 

decontamination means 

Daniel Jun, (Czech Republic), J Marek, K Musilek, J Cabal, O Soukup, M Hrabinova, M Pohanka, 

P Stodulka, K Kuca 

Tue 449 Adenosine mediated – cardiovascular toxicity in amitriptyline poisoning rats 

S Kalkan, Nil Hocaoglu, (Turkey), K Oransay, M Buyukdeligoz, Y Tuncok 

Tue 450 Does amitriptyline, a tricyclic antidepressant, bind to adenosine A1 or A2a receptors? 

S Kalkan, (Turkey), H Gurdal, Nil Hocaoglu, M Buyukdeligoz 

Tue 451 Potentiating α-lipoic acid hepatoprotective effect by l-Carnitine and Methylsulfonylmethane in 

Bromobenzene-induced hepatotoxicity in rats 

Dina Mansour, (Egypt), SA Nada, ES El-denshary, AK Bahgat, EA Omara 

Tue 452 Thymoquinone from Nigella sativa induces apoptosis in SiHa cells via p53-dependent pathway 

Wei Keat Ng, (Malaysia), L Saiful Yazan, M Ismail 

Tue 453 Lead poisoning after gunshot injuries in lower part of body: a case report 

Lokendra K Sharma, (India), S Kochar, K Sharma, M Mathur, S Dutta 

Tue 454 Interaction of silymarin and doxorubicin in rat 

Nebojsa Stilinovic, (Republic of Serbia), R Sederino, A Raskovic, M Mikov, V Jakovljevic, S Vukmirovic 

Tue 455 Gas chromatography mass spectrometry (GC/MS) method optimization & validation for detection of 

Paraquat 

Suk Peng Tang, (Malaysia), SA Sulaiman, SH Gan 

Tue 456 The anticancer and metal chelating properties of 8-hydroxyquinoline derivatives 

Robyn Van Zyl, (South Africa), A Hibbins, M McLaverty 

Tue 457 Determination of pseudocholinesterase serum activity among Agrinion pesticide applicators pre- and 

post-exposed to organophosphates (Fenthion and Dimethoate) 

G Vrioni, H Souki, K Kasiotis, M Katramadou, Haris Carageorgiou, (Greece) 

Tue 458 Chemical form of metals underlying potential cytoxicity of metal-containing traditional medicines in 

various cell lines 

Qin Wu, (PR China), Y-F Lu, J-Z Shi, J Liu 


FC19 General session – Toxicology 

Tue 459 Nasal instillation of nanoparticle-rich diesel exhaust particle affects emotional behavior and learning 

capability in rats 

Syunji Yokota, (Japan), H Takashima, T Miyahara, Y Yoshida, T Negura, Y Saito, N Hirabayashi, 

T Watanabe, R Ohta, S Horiuchi, Y Fujitani, S Hirano, H Fujimaki 



Tue 460 Mechanisms underlying the modulation of gut permeability by cannabinoids 

Abdussalam Alhamoruni, (UK), K Wright, A Lee, M Larvin, S O'Sullivan 

Tue 461 Evaluation of the proulcerogenic effect of Atorvastatin on Indomethacin induced gastric injury in rats 

Ilkay Alp, (Turkey), O Uyanik, H Ozyogurtcu, A Gurel, P Atukeren, K Gumustas, A Kapucu, C Demirci, 

O Ozdemir, BSU Dogan 

Tue 462 Pro-apoptotic and anti-proliferative mechanisms of STW 5 

G Bonaterra, S Zügel, W Hildebrandt, Olaf Kelber, (Germany), D Weiser, J Metz, R Kinscherf 

Tue 463 αL-Tryptophan rich diet improves ulcer healing via endogenous melatonin, prostaglandins and 

downregulation of hypoxia inducible factor 1α (HIF-1) 

Tomasz Brzozowski, (Poland), A Ptak-Belowska, R Pajdo, S Kwiecien, M Pawlik, I Brzozowska, 

PC Konturek, WW Pawlik, SJ Konturek 

Tue 464 Could vitamin K2 guard against experimentally induced gastric stress ulcers in rats 

Inas Darwish, (Egypt), A Mohamed, H Abdel Aziz 

Tue 465 Cannabidiol controls intestinal inflammation throught the modulation of enteric glial cell activation 

Daniele De Filippis, (Italy), G Esposito, M Cipriano, C Scuderi, J De Man, L Steardo, T Iuvone 

Tue 466 Protective effect of VEGF on ethanol-induced hemorrhagic gastric erosions in rats 

Xiaoming Deng, (USA), X Xiong, Z Sandor, S Szabo 

Tue 467 Enhancement of aspirin-induced gastric bleeding by pretreatment of clopidogrel, an anti-platelet drug, in 

rats: prophylactic effects of antiulcer drugs 

Chitose Izuhara, (Japan), K Yamazaki, H Nishio, K Amagase, K Takeuchi 

Tue 468 Tetrodotoxin induces mouse colonic contraction in vitro through blockade of enteric inhibitory 

innervation 

Takio Kitazawa, (Japan), Y Okuno 

Tue 469 Evaluation of calcium channel antagonist activity of some new 9,10 dihydro-7H,8H-chromeno [4,3-b] 

chromene-6,11-dione 

Mohammad Miri, (Iran), M Sharifi, A Bagheri, R Motamedi, A Shafiee 

Tue 470 Generation of gut-like tissue from induced pluripotent stem cells that can be applied for functional 

characterization 

Kazuhiko Oishi, (Japan), Y Ogawa 

Tue 471 The cannabinoid, WIN55,212, reduces pacemaker frequency in the gastric antrum of conscious ferrets; 

a potential mechanism for cannabinoid-induced gastroparesis 

N Percie du Sert, Wing Sze Vanessa Ho, (UK), JA Rudd, PLR Andrews 

Tue 472 Cogitum effects at the experimental gastropathy 

Ivan Savenko, (Russian Federation), A Sergienko 

Tue 473 Importance of acid inhibition for gastroesophageal reflux disease with low-dose aspirin 

Mitsushige Sugimoto, (Japan), M Nishino, C Kodaira, M Yamade, T Uotani, M Ikuma, K Umemura, 

H Watanabe, T Furuta 

Tue 474 Multiple effects of L-ascorbic acid on conjugation reactions in colon carcinoma cells 

Hiroomi Tamura, (Japan), H Tsuruta, M Shimizu 



Tue 475 Incidence, severity and aetiology of drug-induced acute pancreatitis 

Karel Urbánek, (Czech Republic), I Vinklerová, D Hajdu, V Procházka 

Tue 476 Protection of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis 

Clover Ching Man Wong, (Hong Kong), CH Cho 


W11 New opportunities in the pharmacology of 

neuro-immune interactions 

Tue 477 Expression change in nicotinic receptor according to cellular maturity of antigen presenting cell line 

Yukiko Kondo, (Japan), E Tachikawa, S Ohtake, K Kudo, K Mizuma, T Kashimoto, Y Irie, E Taira 

Tue 478 Candida albicans increases TLR2 mRNA expression in mouse retinal progenitor cells 

Victoria Maneu, (Spain), C Murciano, ML Gil, A Yáñez, D Gozalbo 


W14 Translating the human genome: 

From orphan G-protein coupled receptors to novel 

therapeutic targets 

Tue 479 The IUPHAR Database: Tools to navigate pharmacological space 

JL Sharman, CP Mpamhanga, WA Catterall, Anthony P Davenport, (UK), RR Neubig, E Ohlstein, 

JA Peters, M Spedding, A Harmar 


W23 Applying pharmacogenomics (PGX) from research 

into clinical practice: Present and future 

Tue 480 DPYD polymorphisms and adjuvant 5-FU/LV treatment outcome in colorectal cancer patients 

Shoaib Afzal, (Denmark), SA Jensen, B Vainer, U Vogel, JB Sørensen, HE Poulsen 

Tue 481 The study of CYP2C19 polymorphisms in Romanian epileptic patients 

Anca Dana Buzoianu, (Romania), IC Bocsan, FC Militaru, R Popp, A Trifa, L Perju-Dumbrava 

Tue 482 Genetic variation in the hTAS2R38 taste receptor and Brassica vegetables intake 

Nela Gorovic, (Denmark), S Afzal, A Tjønneland, K Overvad, U Vogel, C Albrechtsen, HE Poulsen 

Tue 483 CYP2D6 mRNA expression and genetic polymorphism in the small intestine of Japanese 

Shinichi Kobayashi, (Japan), S Takenoshita-Nakaya, Y Kinoshita, N Matsumoto, Y Takeba, T Kumai 

Tue 484 Impact of CYP2D6 and CYP3A5 gene polymorphisms on pharmacokinetics of oxycodone and its 

demethylates and dose escalation rate in cancer patients 

Takafumi Naito, (Japan), K Yamamoto, Y Takashina, M Tashiro, Y Kagawa, K Ohnishi, J Kawakami 

Tue 485 Distribution and genotype frequency of the SNP 45T/G polymorphism in Iranian population: progression 

to diabetes and response to pioglitazone 

Fatemeh Namvaran, (Iran), P Rahimi-Moghaddam, N Azarpira 

Tue 486 Renal secretion clearance of N1-methylnicotinamide as an endogenous biomarker for tubular organic 

cation transporter type 2 activity in man 

Ryuichi Ogawa, (Japan), Y Nobuoka, H Echizen 

Tue 487 Role of ace and MTHFR genes polymorphisms in migraine 

V Pizza, A Bisogno, E Lamaida, A Agresta, G Bandieramonte, A Volpe, R Galasso, L Galasso, 

Anna Capasso, (Italy) 

Tue 488 Polymorphism gene apolipoprotein E in migraine and cardiovascular disease 

V Pizza, F Infante, G Schiavo, A Agresta, C Colucci d'Amato, A Bisogno, Anna Capasso, (Italy) 

Tue 489 Interethnic and gender dependent differences in CYP2C19 activity. A comparison between Swedes and 

Koreans 

Margareta Ramsjö, (Sweden), E Aklillu, L Bohman, M Ingelman-Sundberg, H-K Roh, L Bertilsson 

Tue 490 Impact of CYP2D6 genetics on serum concentration of escitalopram in relation to CYP2C19 genotype 

Ida Rudberg, (Norway), M Hermann, H Refsum, E Molden 

Tue 491 Impact of CYP3A5 and ABCB1 gene polymorphisms on plasma disposition of fentanyl and its clinical 

responses in cancer patients with opioid switching to fentanyl transdermal system 

Yoshiaki Takashina, (Japan), T Naito, Y Mino, K Ohnishi, J Kawakami 

Tue 492 VKORC1 and CYP2C9 genotyping using a rapid single nucleotide polymorphism (SNP) detection system 

named smart amplification process (SmartAmp) method 

Minoru Watanabe, (Japan), N Matsumoto, T Kumai, M Tanaka, Y Mitani, Y Hayashizaki, S Kobayashi 

Tue 493 A multiplexed primer extension denaturing high performance liquid chromatography method for the 

identification of 3 ABCC2 (MRP2) genetic polymorphisms 

Ian Westley, (Australia), J Coller, M Ward, A Evans, R Morris, B Sallustio 

Tue 494 Lack of drug-drug interaction between ketoconazole and brivanib 

Daphne Williams, (USA), S Syed, D Lathers, G Kollia, A Gupta, J Pursley, Y-Q Xia, E Masson 


FC10 Drugs for half the world: Paediatric clinical 

pharmacology 

Wed 001 Risk factors for abnormal newborn hearing in the era of extended dose interval amikacin administration 

Karel Allegaert, (Belgium), K Kneepkens, K Vandendriessche, F Debruyne, M Rayyan, G Naulaers, 

C Desloovere 

Wed 002 Does the need for domperidone administration shortly after delivery affect the duration breastfeeding 

after preterm delivery? 

Karel Allegaert, (Belgium), G Bosmans, M Vanhaver, V Cossey, A Debeer, C Vaanhole, K Janssens 

Wed 003 Population pharmacokinetics study of benznidazole in children with Chagas disease 

Jaime Altcheh, (Argentina), G Moscatelli, G Mastrantonio, S Moroni, N Giglio, G Koren, H Freilij, 

F Garcia-Bournissen 

Wed 004 Bioavailability and bioequivalence of three different sirup formulations cefeleksine at children in therapy 

of severe tonsillitis 

Adnan Bajraktarevic, (Bosnia Herzegovina), J Musabegovic, T Frankic, H Sladic, D Abduzaimovic 

Wed 005 Graphic and pictorial tables explaining drug’s routes administration reduce the anxiety of the 

hospitalized children in the intensive care unit. 

MV Bellido, Inmaculada Bellido, (Spain), A Gomez-Luque 

Wed 006 EUROPain – European pain audit in neonates – NeoOpioid Consortium 

Lena Bergqvist, (Sweden), M Eriksson, KJS Anand, EM Boyle, H Lagercrantz, S Andersson, G Menon, 

B van Overmeire, M Keller, L Hellström-Westas, V Fellman, RHN van Schaik, J-P Osselaere, A Rane, 

J Schollin, R Carbajal 

Wed 007 Drugs use in paediatric population. Evaluation in two areas: Neonatology and intensive care units 

Encarnación Blanco, (Spain), I Bellido, EI Márquez, A Medina, JA González-Correa 

Wed 008 Documentation of recent drug history in children visiting a pediatric emergency clinic 

Ylva Böttiger, (Sweden), E Kimland, S Lindemalm 

Wed 009 Diagnosis and treatment of seizures in the neonatal intensive care unit 

N Cosic-Cerovac, Milca Prostran-Veselinovic, (Republic of Serbia), N Jovic, R Stojanovic, Z Stojanovic 

Wed 010 Therapeutic drug monitoring: hydroquinidine administration in a newborn infant with short QT syndrome. 

A case report 

Silvia De Francia, (Italy), E Pirro, E Banaudi, C Riggi, F De Martino, F Piccione, F Di Carlo 

Wed 011 Nephrotic syndrome in children: Genetic variability of the clinical presentation and therapeutic response 

Valery Elie, (France), M Fakhoury, Y Medard, A Rousseau, G Deschenes, E Jacqz-Aigrain 

Wed 012 CANCELLED 

Wed 013 N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children; 

translational pharmacokinetics 

Lauren Hanly, (Canada), N Chen, B Baw, B Malkin, M Culter, D Freeman, M Rieder, G Koren 

Wed 014 Expression of cytochrome P450 metabolizing enzymes depends on gestational age in critically ill 

preterm infants 

Betty Kalikstad, (Norway), H Göransson, T Kristoffersen, A Isaksson 

Wed 015 Modulation of gene expression in critically ill preterm infants following stress 

Betty Kalikstad, (Norway), H Göransson, T Kristoffersen, A Isaksson 

Wed 016 Genotype-specific pharmacodynamics in BH4 responsive phenylketonuria 

Florian B Lagler, (Austria), C Zsifkovits, SW Gersting, R Fingerhut, H Glossmann, C Muntau 

Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 245


pharmacology 

Wed 017 Pharmacokinetics and outcomes of gentamicin therapy in neonates critically ill during the first week of 

life: Volumes of fluid infused or retained as possible covariates 

Jirina Martinkova, (Czech Republic), P Pokorná, J Záhora, J Chladek, V Vobruba, I Selke-Krulichova, 

J Chladkova 

Wed 018 Does budesonide applied in prevention of child asthma affect variations in body weight in asthmatic 

children? 

Milica Martinovic, (Republic of Serbia) 

Wed 019 Does budesonide applied in prevention of child asthma decrease height velocity of asthmatic children? 

Milica Martinovic, (Republic of Serbia), S Pantovic 

246 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area



Wed 020 Development of a P2X7 binding and Ex vivooccupancy assay in rat brain 

Sarah Able, (UK), R Fish, L Booth, S Katugampola 

Wed 021 Cerebrovascular contractile receptors up-regulate via a Raf sensitive signalling pathway 

Hilda Ahnstedt, (Sweden), L Edvinsson 

Wed 022 Pre-versus postsynaptic α2A-adrenoceptors functions mediated via Gαi-isoforms 

Julian Albarran-Juarez, (Germany), R Gilsbach, R Piekorz, K Pexa, B Nürnberg, L Hein 

Wed 023 Palmitoyl CoA antagonism of ADP-induced relaxation of rat thoracic aorta 

Eman Alefishat, (UK), S Alexander, V Ralevic 

Wed 024 Muscarinic m3AchR is regulated by cGMP, via a PKG-II dependent phosphorylation in plasma 

membranes from tracheal smooth muscle 

Marcelo J Alfonzo, (Venezuela), M Alfonzo-Gonzalez, RG Alfonzo, A Misle, IL Becemberg 

Wed 025 Role of receptor recycling in the recovery of Ca 2+ signalling by recombinantly expressed neuromedin U 

2 receptors (NMU2) 

Khaled Al-Hosaini, (UK), RAJ Challiss, GB Willars 

Wed 026 FRET-based evidence for ligand-independent preassociation of 5-HT7 serotonin receptors with Gs 

Kjetil W Andressen, (Norway), L Hommers, AH Ulsund, MJ Lohse, KA Krobert, M Bünemann, FO Levy 

Wed 027 Antimitogenic and apoptotic effects of selective 5HT3 receptor antagonist on HT29 colorectal cancer 

cell line. 

Ramin Ataee, (Iran), M Zarrindast, S Ajdary, S Sharyari 

Wed 028 REEP family members modulate α2C-adrenoceptor expression by an ER interaction 

Susann Björk, (Finland), C Hurt, B Kobilka, T Angelotti 

Wed 029 CRIP1a regulates CB1 cannabinoid receptor internalization and signal transduction 

Lawrence C Blume, (USA), CC Bass, GD Dalton, DE Selley, A Howlett 

Wed 030 Protein kinase C (PKC) regulation of type 5 metabotropic glutamate (mGlu5) receptor-stimulated Ca2+ 

oscillations in rat cerebrocortical astroglia 

Sophie J Bradley, (UK), JM Watson, RAJ Challiss 

Wed 031 The inverse agonist effect of rimonabant in brain membranes is not mediated by the CB1 receptor 

Luis F Callado, (Spain), AM Erdozain, R Diez-Alarcia, JJ Meana 

Wed 032 Modulation of ligand binding to the α1B adrenergic receptor: a potential role for the second extracellular 

loop 

Adrian Campbell, (Australia), I McDougal, R Griffith, A Finch 

Wed 033 Long-term cigarette smoke exposure induces bronchial hyperresponsiveness to G-protein coupled 

receptor agonists 

Lei Cao, (Sweden), Y Zhang, Y-X Cao, L Edvinsson, C-B Xu 

Wed 034 mmLDL upregulates endothelin type A and type B receptors in rat basilar artery 

Yong-Xiao Cao, (PR China), J Li, ZY Yuan, L Cao, CB Xu 

Wed 035 Activation of OX1, but not OX2, receptors in the periaqueductal gray produces antinociception via 

retrograde endocannabinoid-induced disinhibition 

Lih-Chu Chiou, (Taiwan), Y-C Ho, H-J Lee, Y-Y Liao, S-Y Fu, S-F Teng, H-T Liao 




Wed 036 Quantitative phosphoproteomics dissection of 7TM receptor signalling using full and biased agonists 

Gitte Lund Christensen, (Denmark), CD Kelstrup, C Lyngsøe, U Sarwar, R Bøgebo, SP Sheikh, 

S Gammeltoft, JV Olsen, JL Hansen 

Wed 037 Receptor mechanisms of the long-lasting and persistent arterial contractile effects of Endothelin-1 

Matthijs Compeer, (The Netherlands), M Meens, C Höltke, W Neugebauer, J De Mey 

Wed 038 Behavioral effects of 5'-GNTI and 6'-GNTI in mice 

Alan Cowan, (USA), S Inan 

Wed 039 Selective modulation by singlet oxygen of CCK1R and other G protein-coupled receptors in live cells 

Zong Jie Cui, (PR China), Y Wang, TT Li, SF Zhang, B Nashun, HY Liang, ZQ Han 

Wed 040 Serotonin is involved in airway hyperreactivity at bovine tracheal smooth muscle 

Darwin J Da Costa-Guevara, (Venezuela), E Trejo, M Alfonzo 

Wed 041 Lack of kinin receptors affected ACE expression in mice abdominal aorta 

Eliete da Silva Rodrigues, (Brazil), RP Martin, JB Pesquero, SI Shimuta 

Wed 042 Role of β2-adrenoceptor on vascular inflammatory mediators and oxidative stress induced by 

isoproterenol treatment 

Ana Paula Davel, (Brazil), C Wenceslau, G Ceravolo, MH Carvalho, P Brum, L Rossoni 

Wed 043 Impact of ambient extracellular calcium on analysis and interpretation of agonism and allosteric 

modulation of the extracellular calcium sensing receptor (CaSR) 

Anna E Davey, (Australia), K Leach, AD Conigrave, PM Sexton, A Christopoulos 

Wed 044 Crosstalk between GABAB and Group III mGlu receptors following intranigral drug administration in the 

reserpine-treated rat 

Susan Duty, (UK), M Broadstock 

Wed 045 Taurine and its analogue tauropyrone: Comparative pharmacological activities 

Zane Dzirkale, (Latvia), J Pupure, J Rumaks, M Vanina, S Svirskis, R Mezhapuke, MA Fernandes, 

G Duburs, R Muceniece, V Klusa 

Wed 046 Functional expression of CB1 receptors in rat brain nuclear fractions 

Leire Echeazarrra, (Spain), S Barrondo, GG del Caño, M Montaña, ML de Jesús, J Sallés 

Wed 047 The scaffold protein NHERF2 determines neuronal ion channel coupling of glutamate mGluR5 and 

nucleotide P2Y1 receptors 

Alexander K Filippov, (UK), J Simon, EA Barnard, DA Brown 

Wed 048 The conserved proline of helix 6 plays a role in the folding and expression of α1B and α2 – adrenergic 

receptors 

Angela M Finch, (Australia), SJ Humphrey, AP Campbell 

Wed 049 Angiotensin II modulates α1D-adrenoceptors expression in vascular smooth muscle cells 

Itzell Gallardo-Ortiz, (Mexico), P López-Sánchez, JJ López-Guerrero, M Ibarra, R Villalobos-Molina 

Wed 050 The effect of nociceptin on uterine contractions in term-pregnant rats in vitro 

Robert Gaspar, (Hungary), A Klukovits, K Tekes, O Gunduz, S Benyhe, A Borsodi, BH Deak, 

J Hajagos-Tóth, J Verli, G Falkay 

Wed 051 Stereoselectivity of the recombinant and native histamine H3 receptor isoforms: The H3-autoreceptor is 

a short isoform 

Florence Gbahou, (France), A Rouleau, S Morisset, J-M Arrang 




Wed 052 Interactions of SDF-1 and ADP in platelet activation 

Olof Gidlöf, (Sweden), C Högberg, B Olde, D Erlinge 

Wed 053 From phylogeny to pharmacology; chemogenomic pharmacological GPCR clustering and 

ligand-inference 

David Gloriam, (Denmark), S Garland 

Wed 054 Autocrine effects of extracellular cyclic AMP in skeletal muscle 

Rosely Godinho, (Brazil), E Aparecida-Santos, AL Andrade-Lopes, T Chiavegatti 

Wed 055 Pseudo-irreversible allosteric modulators – mathematical models predicting their behaviour and a 

putative practical example 

David Hall, (UK) 

Wed 056 Role of keratinocytes GPR109A and COX-2 in nicotinic acid and mono-methyl fumarate induced flushing 

Julien Hanson, (Belgium), A Gille, S Zwykiel, M Lukasova, BE Clausen, K Ahmed, S Tunaru, A Wirth, 

S Offermanns 

Wed 057 Understanding adrenomedullin binding to its receptors 

Debbie Hay, (New Zealand), T Qi, K Ly, D Rathbone, J Simms, D Poyner 

Wed 058 Allosteric modulation of ‘reproductive’ GPCRs – a case for the luteinizing hormone receptor 

Laura Heitman, (The Netherlands) 

Wed 059 The role of nitric oxide in the local antinociceptive effects and expression of cannabinoid-2 receptors 

during neuropathic pain in mice 

A Hervera, R Negrete, S Leánez, J Martín-Campos, Olga Pol, (Spain) 

Wed 060 Change in feeding behavior by siRNAs for a NPY receptor into paraventricular nuclei 

Hiroshi Higuchi, (Japan), T Shiiya, S-I Murase 

Wed 061 Ubiquitin/proteasome-dependent down-regulation following clathrin-mediated internalization of histamine 

H1-receptors in Chinese hamster ovary cells 

Shigeru Hishinuma, (Japan), H Komazaki, H Fukui, M Shoji 

Wed 062 The platelet activator succinate – a possibly drug candidate for the future? 

Carl Högberg, (Sweden), O Gidlöf, B Olde, D Erlinge 

Wed 063 M3-muscarinic acetylcholine receptor stimulation of glucose uptake in L6 skeletal muscle cells: 

evidence for a CaMKKβ-AMPK-dependent mechanism 

Dana Hutchinson, (Australia), J Merlin, R Csikasz, B Evans, T Bengtsson, R Summers 

Wed 064 GPR120 mediates high-fat diet-induced adipocyte hypertrophy and obesity 

Atsuhiko Ichimura, (Japan), A Hirasawa, S Miyauchi, G Tsujimoto 

Wed 065 Possible involvement of β-endorphin in tolerance to fentanyl-induced anti-hyperalgesia under a pain-like 

state 

Satoshi Imai, (Japan), M Narita, N Kuzumaki, LA Devi, Y Uezono, T Suzuki 

Wed 066 5-HT2A receptor Modelling and agonist design 

Vignir Isberg, (Denmark), D Gloriam, T Balle, T Sander, FS Jørgensen 

Wed 067 Apelin is mainly regulated by HIF-1α in astrocytes 

Yuki Ishimaru, (Japan), A Kasai, Y Yoshioka, A Yamamuro, S Maeda 




Wed 068 Role of nitric oxide/cyclic GMP and cyclic AMP in the β-adrenoceptor vasorelaxant response 

Maria Dolores Ivorra, (Spain), N Flacco, S Estrada, M Perez-Aso, P D'Ocon 

Wed 069 5-HT2C receptor signal peptide 

Jan Anker Jahnsen, (Norway), S Uhlen 

Wed 070 The angiotensin II type 1 receptor regulates microRNA expression by Gq and Erk1/2 dependent 

mechanisms 

Pia Jeppesen, (Denmark), GL Christensen, M Schneider, Y Nossent, HB Jensen, DC Andersen, 

S Gammeltoft, JL Hansen, SP Sheikh 

Wed 071 Inhibition of dopamine and noradrenaline transporters (DAT & NET) and monoamine oxidase (MAO) in 

the prefrontal cortex of COMT knock-out mice 

Mikko Käenmäki, (Finland), C Amberg, PT Männistö 

Wed 072 Evidence for functional heteromerization between melatonin MT1 and MT2 receptors and serotonin 

5-HT2C receptors 

Maud Kamal, (France), J-L Guillaume, A Daulat, P Chen, C Mannoury La Cour, MJ Millan, L Vincent, O 

Nosjean, JA Boutin, M Spedding, P Delagrange, R Jockers 

Wed 073 Regulation of GPR55 by the G protein coupled receptor associated sorting proteins 

Julia Kargl, (Austria), N Balenga, L Martini, J Whistler, M Waldhoer 

Wed 074 Two distinct pathways, PKA and TrkA, mediate activation of CREB during α2-AR induced neuronal 

differentiation 

G Karkoulias, P Papathanasopoulos, Christodoulos Flordellis, (Greece) 

Wed 075 Apelin is a crucial factor for hypoxia-induced retinal angiogenesis 

Atsushi Kasai, (Japan), Y Ishimaru, T Kinjo, Y Yoshioka, A Yamamuro, N Shintani, A Baba, S Maeda 

Wed 076 Characterization of a sphingosine 1-phosphate receptor antagonist prodrug 

Perry Kennedy, (USA), R Zhu, J Tomsig, T Huang, T Mathews, T Macdonald, K Lynch 

Wed 077 The GABAB dimers of heterodimers: a way to increase the functional complexity? 

Julie Kniazeff, (France), L Comps-Agrar, D Maurel, E Trinquet, J-P Pin 

Wed 078 Physiological significance of extracellular ATP in HaCaT keratinocytes 

Daisaku Kobayashi, (Japan), S Ohkubo, N Nakahata 

Wed 079 Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions 

between GPCRs and β-arrestins 

Martina Kocan, (Australia), HB See, NG Sampaio, BJ Feldman, KA Eidne, KDG Pfleger 

Wed 080 Ligand-directed signalling at the relaxin family peptide receptor 3 (RXFP3) 

Martina Kocan, (Australia), ET van der Westhuizen, MA Hossain, JD Wade, RJ Summers 

Wed 081 MTα is a selective α2B-adrenoceptor antagonist 

Katja Koivula, (Finland), S Rondinelli, J Näsman 

Wed 082 The effects of naturally occurring single nucleotide polymorphisms (SNPs) at the glucagon-like peptide 

1 receptor (GLP-1R) 

Cassandra Koole, (Australia), J Simms, D Wootten, A Christopoulos, PM Sexton 

Wed 083 Possible regulation of GABAB receptors expression by phosphatases 

Akira Koutani, (Japan), H Niihara, N Kuramoto, K Ogita 




Wed 084 Identification and electrophysiological characterization of new NR3-containing NMDA receptor 

modulators 

Trine Kvist, (Denmark), JR Greenwood, KB Hansen, RP Clausen, SF Traynelis, H Bräuner-Osborne 

Wed 085 Characterization of the binding site of low molecular weight frizzled-1/2 antagonists 

Hilde Laeremans, (The Netherlands), HCJ Ottenheijm, JFM Smits, MW Blankesteijn 

Wed 086 Viral chemokine receptor US28 activates β-catenin signalling pathway 

Ellen Langemeijer, (The Netherlands), E Slinger, D Maussang, M Siderius, R Leurs, M Smit 

Wed 087 Lack of BAMBI (BMP and Activin membrane-bound inhibitor) in mutant mice increases the analgesic 

effect of morphine, without favouring tolerance development or worsening withdrawal severity 

Aquilino Lantero, (Spain), D Merino, ML Laorden, A Díaz, MA Hurlé 

Wed 088 Involvement of the first transmembrane segment of the human 2α-adrenoceptor in the subtype 

selectivity of bulky antagonists 

Jonne M Laurila, (Finland), H Xhaard, G Wissel, JO Ruuskanen, MS Johnson, M Scheinin 

Wed 089 Probing the binding and function of orthosteric, allosteric and bitopic agonists at the M4 muscarinic 

acetylcholine receptor 

Katie Leach, (Australia), AE Davey, PM Sexton, A Christopoulos 

Wed 090 Activation of group II metabotropic glutamate receptors inhibits neuronal excitability and epilepsy in the 

entorhinal cortex via down-regulation of protein kinase A pathway 

Saobo Lei, (USA), C Yang, Z Xiao, J Pribula 

Wed 091 The ligand binding properties of human membrane estrogen receptors 

Amanda HY Lin, (PR China), GPH Leung, SWS Leung, RYK Man 

Wed 092 Octopamine receptors from the barnacle Balanus improvisus exhibit cAMP-mediated signalling by the 

antifouling substance medetomidine 

Ulrika Lind, (Sweden), M Rosenblad, L Frank, S Falkbring, L Brive, J Laurila, K Pohjanoksa, 

L Gunnarsson, M Scheinin, L Mårtensson-Lindblad, A Blomberg 

Wed 093 Lactate is the endogenous ligand for GPR81 and suppresses lipolysis in adipocytes 

Timothy Lovenberg, (USA), C Liu, C Kuei, T Mirzadegan, J Shelton, J Yu, J Zhu 

Wed 094 Molecular determinants of the interaction of selective negative allosteric modulators with metabotropic 

glutamate receptor 2 

Linda Lundström, (Switzerland), C Bissantz, J Beck, T Woltering, J Wichmann, JG Wettstein, S Gatti 

Wed 095 Epac induces airway smooth muscle relaxation by shifting the RhoA/Rac1 balance towards Rac1 

Harm Maarsingh, (The Netherlands), SS Roscioni, CRS Elzinga, LJ Schuur, MH Menzen, AJ Halayko, 

H Meurs, M Schmidt 


FC12 Ion channelopathies: New windows on complex 

disease and therapy 

Wed 096 Non-genomic effects of oestrogen derivatives on BK channels 

M Allen, Jacqueline Maher, (UK), A Hunter, J Mabley 

Wed 097 The role of potassium channels in experimental sepsis 

Jamil Assreuy, (Brazil), R Sordi, D Fernandes 

Wed 098 Diabetogenic ABCC8/KCNJ11: Mechanisms to personalized treatment 

Andrey Babenko, (USA) 

Wed 099 The Kv11.1 channel opener NS1643 shortens the QT in transgenic rabbits with long QT-syndrome 1 in 

vivo and shortens the APD90 ex vivo, but is associated with increased risk of arrhythmias 

Bo Bentzen, (Denmark), S Bahrke, K Wu, AP Larsen, J Biermann, X Peng, G Koren, M Zehender, 

C Bode, M Grunnet, M Brunner 

Wed 100 GRP-78 is a possible target in GABAA-channelopathies 

Ksenia Chekina, (Russian Federation) 

Wed 101 Variable expression of ABCC8 and ABCC9 transporters in pregnant rat myometrium: influence of 

gestation age 

George Falkay, (Hungary), N Lovasz, E Ducza, R Gaspar 

Wed 102 Contribution of Trpc1 to the pathogenesis of dystrophic mice: analysis of double knock-out Trpc1 -/dystrophin 

Chiara Gallo, (Switzerland), OM Dorchies, G Shapovalov, N Zanou, P Gailly, E Roulet, UT Ruegg 

Wed 103 The antivasoconstrictor effect of potassium channel opener FC1075 in the human vascular grafts 

Ljiljana Gojkovic-Bukarica, (Republic of Serbia), A Novakovic, B Beleslin-Cokic, M Peric, 

J Markovic-Lipkovski, S Cirovic, V Kanjuh 

Wed 104 Volume-regulated chloride channel mediates foam cell formation in atheroscerosis 

Yong-Yuan Guan, (PR China) 

Wed 105 Simulation of the effect of the phasphorylation on the gap junction channel closure by computatinal 

chemistry 

Nobuo Homma, (Japan) 

Wed 106 Minocycline inhibits d-amphetamine-elicited action potential bursts in a central snail neuron 

Hui-Yu Hsu, (Taiwan), Y-H Chen 

Wed 107 The regulation of melatonin release by BK channel activity in pinealocytes 

Yuji Imaizumi, (Japan), H Mizutani, H Yamamura, M Muramatsu, S Ohya 

Wed 108 Does iPLA2β play a role in store-operated calcium entry in Edl-mdx-2 myotubes? 

Karin Jacobson, (Switzerland), O Petermann, E Roulet, U Rüegg 



drugs 

Wed 109 Relevance of manganese superoxide dismutase (SOD2 Val16Ala) and glutathione peroxidase1 (GPX1 

Pro200Leu) functional polymorphisms in patients with idiosyncratic drug-induced liver injury (DILI) 

Maribel Isabel Lucena, (Spain), E Garcia-Martin, RJ Andrade, C Martinez, C Stephens, JD Ruiz, 

E Ulzurrun, MC Fernandez, JA Duran, A Melcon de Dios, Y Borraz, JAG Agundez 

Wed 110 Introducing clinical events classification for improving antibiotic prescribing 

Tatyana Lugovkina, (Russian Federation), B Richards 

Wed 111 Usefulness of Bayes TDM for monitoring in immunosuppression using the Dynapred® platform: 

An example with tacrolimus 

John C Lukas, (Spain), I Oteo, R Calvo, A Valdivieso, N Leal, E Suarez 

Wed 112 Impaired function of CYP2C9 metabolic enzyme and OATP1B1 transporter as a predisposition for 

HMGCoA reductase inhibitors induced rhabdomyolysis:case reports 

V Macolic-Sarinic, N Mirosevic-Skvrce, Nada Božina, (Croatia), S Marusic, S Tomic 

Wed 113 The pharmacodynamics of single dose R- and S-warfarin when administered alone and in combination 

as a function of VKORC1 genotype in healthy volunteers 

John Maddison, (Australia), A Somogyi, B Jensen, M Gentgall, P Rolan 

Wed 114 Inhibition of basal and ultraviolet B induced melanogenesis by cannabinoid receptors CB1 

Sofia Magina, (Portugal), C Esteves Pinto, E Moura, MP Serrão, I Correia-de-Sá, D Moura, 

M-A Vieira-Coelho 

Wed 115 Protective effects of glutathione and the related thiols against hepatotoxicity of acetaminophen and 

furosemide in mice 

Yasuhiro Masubuchi, (Japan), J Nakayama, Y Sadakata 

Wed 116 On expressing drug dosage 

Mukul Mathur, (India), L Sharma, KK Sharma 

Wed 117 Influence of VKORC1 polymorphism on PT-INR adherence to the target therapeutic range in long-term 

warfarin therapy 

Naoki Matsumoto, (Japan), M Watanabe, T Kumai, M Tanaka, Y Takeba, Y Harimoto, S Takenoshita, 

Y Kinoshita, M Yamauchi, F Miyake, H Musha, S Kobayashi 

Wed 118 Influence of Escherichia coli Nissle 1917 on cytochrome P450 protein expression in the intestine of 

male rats 

Zuzana Matuskova, (Czech Republic), A Tunkova, E Anzenbacherova, R Vecera, 

H Tlaskalova-Hogenova, Z Zidek, P Anzenbacher 

Wed 119 Incidence, genetic and non-genetic risk factors for severe phenprocoumon associated gastrointestinal 

bleeding leading to hospitalisation 

Karen May, (Germany), K Wergin, S Müller, M Hippius, K Farker, B Drewelow, J Szymanski, 

D Rosskopf, PA Thürmann, W Siegmund 

Wed 120 Effect of low-dose and high-dose aspirin on the pharmacokinetics and pharmacodynamics of edoxaban 

Jeanne Mendell, (USA), S Chen, R Noveck, F Lee, V Petrushun, M Shi 

Wed 121 Effect of naproxen on the pharmacokinetics and pharmacodynamics of edoxaban- encore abstract 

Jeanne Mendell, (USA), S Chen, R Noveck, F Lee, V Petrushun, M Shi 

Wed 122 The effect of quinidine and verapamil, P glycoprotein/CYP3A4/5 inhibitors, on edoxaban 

pharmacokinetics and pharmacodynamics 

Jeanne Mendell, (USA), R Noveck, H Zahir, F Lee, V Petrushun, I Rubets, G Zhang, M Shi, S Chen 



drugs 

Wed 123 Effects of CYP4F2 genetic polymorphisms on warfarin dose requirements in Caucasian patients 

initiating therapy 

Veronique Michaud, (Canada), M Frappier, M Champagne, D Brouillette, D Roy, I Taillon, G O'Hara, 

D Gossard, M Phillips, A Ajami, J Turgeon 

Wed 124 Inhibition of human liver microsomal opioid glucuronidation by ketamine – A potential pharmacokinetic 

drug-drug interaction 

John Miners, (Australia), V Uchipichat, P Ruangrut, D Elliot, B Janchawee, A Evans 

Wed 125 Estimation of creatinine clearance and gentamicin dose using lean body weight prediction 

Sarah Mitchell, (Australia), S Hilmer, C Kirkpatrick, R Hansen, MF Singh 

Wed 126 Estimation of lean body weight in older black and white men and women: the Health, Aging and Body 

Composition Study 

Sarah Mitchell, (Australia), C Kirkpatrick, A Newman, S Satterfield, A Schwartz, A Simonsick, S Hilmer 

Wed 127 Influence of the VKORC1 genetic polymorphism and patient characteristics upon warfarin dose in 

Japanese elderly patients 

Jun Miura, (Japan), H Nakashima, T Tateishi 

Wed 128 Relation between ethanol-induced oxidative stress and apoptosis in human hepatoma (SK-Hep-1) cells 

Yoshiya Mochizuki, (Japan), M Tsuji, H Oyamada, M Ota, C Kurahashi, K Oguchi 

Wed 129 Genotypic determinants of CYP2D6 activity and its clinical implications in Indo-Trinidadians 

Lazara Montane Jaime, (Trinidad & Tobago), A Lalla 

Wed 130 Making therapeutic drug monitoring of efavirenz work: what is a subtherapeutic concentration? 

Emilia C Monteiro, (Portugal), U Caixas, I Germano, S Gouveia, A Carlos, TF Lampreia, T Branco, 

SA Pereira 

Wed 131 Effects of the Crotalus durissus cascavella venom on renal tubular cells 

Janaina Monteiro, (Brazil), A Torres, R Menezes, F Monteiro, R Dantas, A Martins, H Monteiro 

Wed 132 The development of a novel system for the investigation of microvascular dysfunction 

E Moss, L Rankin, S Lynagh, David Bunton, (UK) 

Wed 133 Variability of tamoxifen metabolism in vivo is influenced by genotypes of drug metabolizing enzymes 

Thomas Mürdter, (Germany), W Schroth, H Brauch, M Eichelbaum, M Schwab 

Wed 134 Frequency of adverse drug reactions type A and type B registered with intensive monitoring system 

Snezana Mugosa, (Montenegro), Z Todorovic, N Duborija-Kovacevic 

Wed 135 Spontaneous reporting of adverse drug reactions and level of intervention 

Snezana Mugosa, (Montenegro), Z Todorovic, A Boskovic, N Duborija-Kovacevic 

Wed 136 A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single dose efavirenz population 

pharmacokinetics in Ugandans 

Jackson K Mukonzo, (Uganda), D Röshammar, P Waako, M Andersson, T Fukasawa, L Milani, 

J Ogwal-Okeng, L Gustafsson, E Aklillu 

Wed 137 Using prescribing data to determine drug persistence for the purpose of pharmacovigilance 

Isa Naina Mohamed, (UK), P Helms, C Simpson, J McLay 

Wed 138 Metformin and lactic acidosis: Do we pay attention to the renal function in the elderly? 

Makiko Nakagawa, (Sweden), U Bergman 



drugs 

Wed 139 Outcome among head trauma patients on anticoagulants or platelet inhibitors prior to trauma 

Sigrid Narum, (Norway), M Kringen, O Brørs, O Stokland 

Wed 140 Gender differences in the disposition of drugs 

C Neta, J Silva, F Martins, A Pedroso, T Macedo, Carlso Fontes Ribeiro, (Portugal) 

Wed 141 Gas mediator hydrogen as a tool for protection of Parkinson's disease 

Mami Noda, (Japan), K Fujita, M Kido, T Katafuchi, Y Nakabeppu 

Wed 142 Flurbiprofen pharmacokinetics in relation to CYP2C9 genotype 

Da-Hee Oh, (Republic Of South Korea), J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Wed 143 Contribution of CYP2D6*10 allele to the inter-individual variability in the pharmacokinetic of metoprolol 

and its β-hydroxy metabolite in Koreans 


Wed 144 Use of confidence intervals in the fractional analysis of the interaction between non-depolarizing 

neuromuscular blockers 

Antonio Carlos Oliveira, (Brazil), CR Souza, WL Silva, CSM Serra 

Wed 145 Effect of lamivudine-artesunate co-administration on some hematological, hepatic and renal biomarkers 

in rats 

Temidayo Olurishe, (Nigeria), H Kwanashie, J Anuka, H Muktar 

Wed 146 Comparative study of adverse drug reactions between a public and a private specialist hospital in 

Lagos, South West Nigeria 

Ibrahim Oreagba, (Nigeria), I Ishola, A Akinyandenu 

Wed 147 The metabolism of the novel dopamine stabiliser ACR16 (Pridopidine)is mainly mediated by CYP2D6 

Georgios Panagiotidis, (Sweden), A Hellden, J Tedroff, N Waters, S Waters, L Bertilsson 

Wed 148 Role of genetic factors on between-subject variability in cytarabine cytotoxicity 

Sumit Parmar, (Germany), A Seeringer, K Pitterle, D Denich, F Gärtner, E Lebedeva, J Kirchheiner 

Wed 149 Nephrotoxic medications in acute kidney injury: Opportunities for learning 

Peysh Patel, (UK), A Sengupta, O Martin, F Razik, O Johnson 

Wed 150 Early postnatal ketamine anesthesia causes persistent deficits in rhesus monkey cognition 

Merle G Paule, (USA), M Li, X Zou, C Hotchkiss, JP Hanig, TA Patterson, W Slikker, C Wang 

Wed 151 Linkage disequilibrium between the rapid CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 

alleles: identification of CYP2C haplotypes in healthy Nordic populations 

Rasmus S Pedersen, (Denmark), C Brasch-Andersen, SC Sim, TK Bergmann, J Halling, MS Petersen, 

P Weihe, A-L Börresen-Dale, VN Kristensen, K Brøsen, M Ingelman-Sundberg 

Wed 152 Effects of verapamil, over materno-fetal pharmacokinetics and transplacental exchange of ivermectin, 

in pregnant sheep 

Ruben Perez, (Chile), C Palma, MJ Nuñez, P Urrutia, L Morales, D Vera, J Cox 

Wed 153 Determining toxicological parameters of atropine/scopolamine mixture as food contaminant 

L Perhariè, M Zidariè, Lovro Stanovnik, (Slovenia) 

Wed 154 Parenteral alanyl-glutammine in critically ill patients: a Bayesian meta-analysis of published trials 

Lorenzo Pradelli, (Italy), O Zaniolo, S Iannazzo, M Eandi 



drugs 

Wed 155 Provocative potassium handling to predict changes in ambulatory serum potassium with dual 

renin-angiotensin-aldosterone (RAAS) blockade 

Richard Preston, (USA), D Afshartous 

Wed 156 Emotional state dependence of the pressor response in normal dogs 

Joseph Prinsen, (USA), NS Archambault, AJ Lange, NB Olivier 

Wed 157 Carbamazepine induced leucopenia in 20-year-old male patient 

Vesna Radovic, (Republic of Republic of Serbia) 

Wed 158 Fexofenadine is not a substrate for OATP2B1 

Gregory Reed, (USA), C Flynn, B Hagenbuch 

Wed 159 From pharmacogenetics to personalized medicine: A Cuban regulatory perspective 

Diadelis Remirez-Figueredo, (Cuba) 

Wed 160 Hypertension in general practice – an APO-audit 

Lene Reuther, (Denmark), P Schultz-Larsen, J Damsgaard, D Gilså Hansen, A Munck, J Søndergaard, 

M Skov Paulsen, M Andersen 

Wed 161 Rational drug use at hospitals and in the primary-secondary care interface 

Lene Reuther, (Denmark), H Thomsen, HR Christensen, B Kirkeby 

Wed 162 Influence of aldehyde dehydrogenase-2 gene polymorphism on vasodilatation induced by organic 

nitrates in healthy human subjects 

S Sakata, K Ichishima, H Oniki, T Miwa, H Arima, K Matsumura, T Yoshihara, 

F Takahashi-Yanaga, F Shiraishi, Toshiyuki Sasaguri, (Japan) 

Wed 163 Changes in drug-metabolizing enzyme activities in the multiple histamine receptor gene knockout mice 

Eiichi Sakurai, (Japan), E Sakurai, Y Ueda, Y Sakurai, K Yanai 

Wed 164 Medication errors in critical care unit 

Nicole Salazar, (Chile), L Escobar, M Jirón 

Wed 165 The effect of paraxon organophosphate insecticide on antioxidant system in rat brain tissue 

Maryam Salehi, (Iran), M Jafari, M Saleh Moqadam, A Asghari, M Kazemi, M Abasnejad, 

M Haggholamali 

Wed 166 Genetic polymorphism and drug interactions modulating CYP2D6 and CYP3A activities have a major 

impact on oxycodone analgesic efficacy, safety and pharmacokinetics 

Caroline Samer, (Switzerland), Y Daali, M Wagner, G Hopfgartner, CB Eap, MC Rebsamen, MF Rossier, 

D Hochstrasser, P Dayer, JA Desmeules 

Wed 167 Awareness of the risk of venous thromboembolism among users of oral contraceptives 

Isidora Samojlik, (Republic of Serbia), M Panduriv, B Bogdanov 




Wed 168 Neuroprotective effect of adenosine A1 and A2A receptors in chronic alcohol withdrawal syndrome in 

mice 

Kiran Kumar Akula, (India), K Chopra, SK Kulkarni 

Wed 169 Comparison of the neurochemical changes induced by acute and repeated administration of morphine, 

cocaine and amphetamine in the rat lateral septum 

Katherine A Araya, (Chile), MR Ibañez, V Noches, R Sotomayor-Zarate, K Gysling 

Wed 170 Pharmacodynamic effects of 3,4-methylenedioxyamphetamine (MDA) 

MJ Baggott, J Siegrist, JR Coyle, K Flower, GP Galloway, John Mendelson, (USA) 

Wed 171 Vitamins as antioxidants have important role of asthmatic additional therapy in children and protection 

of passive smoking 

Adnan Bajraktarevic, (Bosnia Herzegovina), M Miokovic, D Abduzaimovic, J Ceman Saric, T Frankic, 

J Musabegovic, I Tahmiscija, A Selimovic, JA Maglajlic, B Begovic 

Wed 172 Areca nut dependence among chewers in a South Indian community who do not also use tobacco 

Robert L Balster, (USA), SJS Bhat, MD Blank, M Nichter, M Nichter 

Wed 173 Interaction of protein kinase C and allosteric modulation at extrasynaptic GABA-A receptors following 

chronic ethanol treatment 

I Barrett, Stephen Kelley, (UK) 

Wed 174 Memantine prevents the cognitive deficits induced by methamphetamine in rats 

Jorge Camarasa, (Spain), T Rodrigo, D Pubill, E Escubedo 

Wed 175 Russian biosimilar epoetins and their possible use in sport 

Yuliya I Dykhal, (Russian Federation), GI Krotov, PV Postnikov, GM Rodchenkov 

Wed 176 Testosterone inhibits endothelial nitric oxide synthase mRNA expression and nitric oxide production 

Lena Ekström, (Sweden), C Skogastierna, A Rane 

Wed 177 In vitro neurochemical profile of MDMA and its metabolite α-methyldopamine 

Elena Escubedo, (Spain), S Abad, I Torres, J Camarasa, D Pubill 

Wed 178 Acetaldehyde stimulates IL-6 mRNA expression and IL-6 protein secretion in cultured rat astrocytes 

Polonca Ferk, (Slovenia), L Sarc, B Wraber, M Lipnik-Stangelj 

Wed 179 The effect of centrally injected Gly-L-Gln (Glycyl-Glutamine) on nucleus accumbens GABA output after 

acute morphine administration 

Nesrin Filiz Basaran, (Turkey), S Cavun, RL Buyukuysal, WR Millington 

Wed 180 Exercise influence on the amphetamine-dependent behaviour and dopamine in striatum, frontal cortex 

and hippocampus 

Carlos Alberto Fontes-Ribeiro, (Portugal), E Marques, F Pereira, AP Silva, T Macedo 

Wed 181 Effect of methylenedioxymethamphetamine (MDMA) on cytosolic calcium levels in PC 12 cells. Role of 

nicotinic receptors 

Sara Garcia-Rates, (Spain), E Escubedo, J Camarasa, D Pubill 

Wed 182 Intranasal administration of the dopamine D3 receptor antagonist SB-277011A inhibits cocaine 

self-administration and cocaine-enhanced brain-stimulation reward in rats 

Eliot Gardner, (USA), X-Q Peng, X Li, C Ashby, Z-X Xi 

Wed 183 Testosterone enanthate induces the expression of HMGCR and cholesterol levels 

Nina Gårevik, (Sweden), C Skogastierna, A Rane, L Ekström 




Wed 184 Enhancement of clonidine-induced analgesia by sulfisoxazole in mice 

Anil Gulati, (USA), G Matwyshyn, M Boxwalla, B Puppala, S Andurkar 

Wed 185 The role of D1/D2 dopamine receptors in the development and expression of nigrostratal DA 

sensitisation in rats 

Susanna Gyarmati, (Hungary), J Timar, A Horvath, A Fendt, S Fürst 

Wed 186 Toxic dose of methamphetamine induces endoplasmic reticulum stress related gene 

CHOP/Gadd153/ddit3 in dopaminergic neural cells 

Yasuyuki Irie, (Japan), M Saeki, H Tanaka, S Otake, Y Kondo, K Kudo, K Mizuma, Y Kamisaki, N Miki, 

E Taira 

Wed 187 Intereceptive effects of atypical anxiolytics with neuroprotective properties 

Tatiana S Kalinina, (Russian Federation), AV Volkova, TA Voronina, SB Seredenin 

Wed 188 Experimental study of the antinociceptive effects of GB-115, a dipeptide analogue of cholecystokinin 

Larisa Kolik, (Russian Federation), V Zhukov, T Gudasheva, S Seredenin 

Wed 189 Inhibition of heat shock protein 90 attenuates adenylate cyclase sensitization after chronic morphine 

treatment 

Takaaki Koshimizu, (Japan), H Tsuchiya, S Fujimura, Y Fujiwara, A Fujimura 

Wed 190 Activation of cAMP-response-binding-element protein (CREB) in the nucleus accumbens reduces relapse 

to methamphetamine-seeking behaviour in rats 

Niree Kraushaar, (Australia), L Hunt, J Cornish 

Wed 191 Predicting steady state oral methadone dosage with CYP3A4 activity? Preliminary results 

Kamilia Ksouda, (France), F Vorspan, S Mouly, V Bloch, A Hajj, K Peoch, J-L Laplanche, P Houze, 

J-P Lepine 

Wed 192 Role of metabotropic glutamate receptor 5 in ethanol regulation of NMDA receptor function and in 

ethanol-induced change in blood pressure in rats 

Chih-Chia Lai, (Taiwan), W-K Hsieh 

Wed 193 Assessing potential for drug abuse in humans: Defining clinical important differences in subjective 

pharmacodynamic measures 

Naama Levy-Cooperman, (Canada), K Schoedel, N Chen, D Feltner, CB Billing Jr., E Sellers, D Milovan 



Wed 194 Anatomical regional differences in aortic tissue reactivity: The role of perivascular adipose tissue in 

normal and diabetic rats 

Francis I Achike, (Malaysia), CB Chua, CY Kwan 

Wed 195 Potassium channel modulation of acidosis-induced vasodilatation of normal and diabetic rat aorta. 

Francis I Achike, (Malaysia), JL Yeo 

Wed 196 Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in 

zucker fatty rats (Fa/Fa) 

A Agouni, A-H Lagrue-Lak-Hal, HA Mostefai, A Tesse, P Mulder, P Rouet, F Desmoulins, C Heymes, 

MC Martinez, Ramaroson Andriantsitohaina, (France) 

Wed 197 Species difference in calcium dependency of cromakalim induced relaxation in porcine and human 

coronary arteries 

Nora Ambrus, (Hungary), J Pataricza, I Krassoi, Z Marton, M Bitay, A Varro, GJ Papp 

Wed 198 Various types of potassium channels are activated by the new nitric oxide (NO) donor 

[Ru(terpy)(bdq)NO+]3+ (Terpy) in mesenteric resistance arteries of renal hypertensive rats 

Alice Araújo, (Brazil), J Vercesi, J Biazzotto, R da Silva, L Bendhack 

Wed 199 The variations in measurements of blood pressurec values obtained by the conventional method and 

the ambulatory blood pressure monitoring 

Mensura Asceric, (Bosnia Herzegovina), N Mulabegovic, E Kapic, F Becic, S Loga-Zec, J Kusturica 

Wed 200 Functional distribution of nitrergic nerve derived from pterygoparatine ganglion in monkey cerebral 

artery 

Kazuhide Ayajiki, (Japan), S Kobuchi, N Toda, M Hanamitsu, T Okamura 

Wed 201 Mast cell activation alters neuronal nitric oxide release in rat mesenteric artery 

Gloria Balfagón, (Spain), J Blanco-Rivero 

Wed 202 Temporal effects of ATP/ADP in a murine sepsis model 

Hermes Vieira Barbeiro, (Brazil), DF Barbeiro, FR Laurindo, HP Souza, IT Velasco, FG Soriano 

Wed 203 Vascular reactivity on Nagase analbuminemic rats challenged by LPS 

Hermes Vieira Barbeiro, (Brazil), CB Lorigados, DF Barbeiro, S Catanozi, E Nakarandake, IT Velasco, 

FB Fusco, A dos Santos Filho, FG Soriano 

Wed 204 Volemic reposition on vascular reactivity of endotoxemic rats. 

Hermes Vieira Barbeiro, (Brazil), RC Petroni, TSL Garcia, DF Barbeiro, CB Lorigados, FG Soriano, 

IT Velasco 

Wed 205 The peculiarities of action of pentoxifylline on rat isolated aorta in experimental hypokinesia 

Aram Baykov, (Armenia), A Manukyan 

Wed 206 The endothelial pathway for current spread is modulated by smooth muscle K+-channels 

Timea Z Beleznai, (UK), KA Dora 

Wed 207 Endothelium-derived hyperpolarizing factor and nitric oxide regulate arterial wall viscosity in vivo in 

humans 

Jeremy Bellien, (France), M Iacob, C Thuillez, R Joannides 

Wed 208 Oral sildenafil increases sodium nitroprusside iontophoresis induced skin hyperaemia in healthy 

volunteers 

S Blaise, M Hellmann, M Roustit, S Isnard, Jean-Luc Cracowski, (France) 




Wed 210 Analysis of nitric oxide sensitive guanylyl cyclase activation by ciguates based on MANT-GTP 

fluorescence 

Mareike Busker, (Germany), JR Kraehling, M Seeanner, S Behrends 

Wed 211 PKG mediates the testosterone vasorelaxant effect in human umbilical artery without endothelium 

Elisa Cairrão, (Portugal), AJ Santos-Silva, I Verde 

Wed 212 Rat kidney antioxidant enzymes in an experimental model of preeclampsia 

Elsa Camacho, (Venezuela), J Silva, MG Matos, M Varela, MR Garrido, A Israel 

Wed 213 Increased sensitivity of cerebral and coronary arteries to GPCR agonists in spontaneously hypertensive 

rats 

Lei Cao, (Sweden), Y Zhang, Y-X Cao, L Edvinsson, C-B Xu 

Wed 214 Correlation between amine oxidases kinetic parameters and nitric oxide production in human 

mesenteric arteries 

Margarida Caramona, (Portugal), S Nunes, J Pereira, C Lopes, I Figueiredo 

Wed 215 Coronary artery bypass grafting surgery worsens oxidative stress among patients with coronary 

disease 

Manuel Carnero, (Spain), J Muñoz-Marin, JA González Correa, F Reguillo, J Navarro-Dorado, M Ramajo, 

JP de la Cruz, T Tejerina 

Wed 216 Estrogen receptor α as a key target of red wine polyphenols action on the endothelium 

M Chalopin, A Tesse, MC Martinez, D Rognan, JF Arnal, Ramaroson Andriantsitohaina, (France) 

Wed 217 The hypocholesterolemic effect of a novel series of compounds with structural properties of α-asarone 

and fibrates in tyloxapol treated mice. 

Germán Chamorro, (Mexico), C Zúñiga, L Garduño, MdC Cruz, R Pérez, F Labarrios, J Tamariz 

Wed 218 Secretoneurin induces endothelium-dependent relaxation of the porcine coronary artery 

Calvin KY Chan, (PR China), JCW Mak, PM Vanhoutte 

Wed 219 NADPH oxidase and TGF-β signalling in extracellular matrix production in cardiac fibroblasts 

Elsa Chan, (Australia), H Peshavariya, G Nancy, F Jiang, G Dusting 

Wed 220 Characterization of VIP and PACAP receptors in the human coronary and meningeal artery 

Kayi Chan, (The Netherlands), M Baun, J Danser, I Jansen-Olesen, AM van den Brink, S Gupta 

Wed 221 Acute effect of sulfaphenazole on isolated mesenteric small arteries from db/db mice 

Hua Chen, (Denmark), U Simonsen, C Aalkjaer 

Wed 222 Role of RhoA/ROK in vascular hyporeactivity induced by endotoxin in early and late sepsis 

Shiu-Jen Chen, (Taiwan), M-H Liao, C-C Wu 

Wed 223 High-sodium loaded in rats impairs central baroreflex and ACh-induced vasodilation 

Akiko Chisyaki, (Japan), M Tsuruhisa, M Miyakawa, T Masuda, Y Hirabara, K Honda, R Saito, Y Takano 

Wed 224 Increased outward currents recorded in situ from endothelial cells of rabbit coronary arteries after 

ischemia reperfusion 

Belén Climent, (Spain), AL García-Villalón, N Fernández, L Monge, G Diéguez, A García Sacristán, 

L Rivera 



Wed 225 Contribution of smooth muscle BKCa currents to outward currents recorded from endothelial cells in 

situ 

Belén Climent, (Spain), P de la Villa, U Simonsen, A García-Sacristán, L Rivera 

Wed 226 Ceramide is involved in the hypoxic vasoconstriction of chicken pulmonary and choriallantoic arteries 

Angel Cogolludo, (Spain), E Villamor, J Moral-Sanz, R Scheepers, B Barreira, C Menendez, L Escolano, 

L Moreno, F Perez-Vizcaino 

Wed 227 Epac proteins as a determinant for forskolin-induced vasorelaxant effect and cAMP-inhibition of store 

operated Ca 2+ entry in vascular myocytes 

Andrea Cuíñas, (Spain), J Elies, M Campos-Toimil 

Wed 228 A comparative study of α-adrenergic receptor mediated Ca 2+ signals and contraction in intact human 

and mouse vascular smooth muscle 

Jiazhen Minnie Dai, (Canada), H Syyong, C van Breemen, J Navarro-Dorado, S Redondo, M Alonso, 

T Tejerina 

Wed 229 Activators of small conductance calcium-activated potassium channels selectively enhance bradykinin 

NO-mediated vasodilatation in porcine retinal arterioles 

Thomas Dalsgaard, (Denmark), C Kroigaard, M Misfeldt, T Bek, U Simonsen 

Wed 230 Nitrite and nitroglycerin preferentially dilate large systemic arteries during hypoxia 

Thomas Dalsgaard, (Denmark), C Kroigaard, A Fago, U Simonsen 

Wed 231 Exposure to concentrated ambient fine particles (PM2.5) of urban Sao Paulo air pollution induces 

endothelial dysfunction and structural changes in rat pulmonary arteries 

Ana Paula Davel, (Brazil), M Lemos, L Pastro, L Rossoni, P Saldiva 

Wed 232 Changes in rats vascular reactivity in response to neonatal induced hyperleptinaemia 

Fernanda Carla Ferreira de Brito, (Brazil), NAV da Motta, EB Marques, CBV Scaramello, LL da Silva 

Wed 233 Role of protein disulfide Isomerase in angiotensin II induced contraction in vascular smooth muscle 

cells from spontaneously hypertensive rats 

Livia de Lucca Camargo, (Brazil), ACD Androwiki, GS Ceravolo, AZ Chignalia, Alexandre Denadai- 

Souza, MN Muscará, MHC de Carvalho, ZB Fortes, M Janizewski, LR Lopes 

Wed 234 Signalling via IRAG regulates NO- and ANP-mediated smooth muscle relaxation 

Matthias Desch, (Germany), B Hieke, D Bernhard, K Hoecherl, F Hofmann, J Schlossmann 


Wed 236 Thalidomide produces smooth muscle relaxation 

James R Docherty, (Ireland), SW Seto 

Wed 237 Protein disulfide isomerase regulates reactive oxygen species generation and angiotensin II induced 

contraction in aorta from wistar rats 

Ana Alice Dos Santos Dias, (Brazil), LL Camargo, GS Ceravold, ACD Androwiki, MHC Carvsalho, 

FRM Laurindo, M Janiszewski, LR Lopes 

Wed 238 Evidence for functional two-pore domain potassium channels (K2P) in rat mesenteric arteries 

Gillian Edwards, (UK), E Porter, N Ashton, A Gurney, A Weston, I Johnson 

Wed 239 Rho kinase-dependent calcium sensitization in the interplay between pressure- and agonist-induced 

constriction of cerebral artery 

Ahmed El-Yazbi, (Canada), RP Johnson, K Takeya, EJ Wlash, MP Walsh, WC Cole 



Wed 240 Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in 

pulmonary hypertensive rats 

Yvonne Eskildsen-Helmond, (Denmark), L Østergaard, B Honore, L Bech Thorsen, J Baandrup, 

B Elmedal Laursen, H Vorum, M Mulvany, U Simonsen 

Wed 241 Unfolded protein response involved in oxidized LDL-evoked endothelial dysfunction 

Yvonne Eskildsen-Helmond, (Denmark), M Jørgensen, E Stankevicius, N Christophersen, E Falk, 

U Simonsen 

Wed 242 Tanshinone IIA inhibits ER-α activity in MCF-7 breast cancer cell 

Guanwei W Fan, (China), XM Gao, H Wang, Y Zhu, J Zhang, L Hu 

Wed 243 Prostaglandin E2 promotes angiogenesis by synergizing with fibroblast growth factor receptor-1/ 

fibroblast growth factor-2 system 

Federica Finetti, (Italy), S Donnini, L Morbidelli, A Giachetti, M Ziche 

Wed 244 High salt intake abolishes AT2-mediated vasodilation of pial arterioles in rats 

Sebastien Foulquier, (France), C Perrin-Sarrado, F Dupuis, F Soussi, P Liminana, Y-W Kwan, 

C Capdeville-Atkinson, I Lartaud, J Atkinson 

Wed 245 Impact of window L-type Ca 2+ influx on activity of Ca 2+ channel blockers in aortic smooth muscle cells 

of C57Bl6 mice 

Paul Fransen, (Belgium), CE Van Hove, C Michiels, J van Langen, H Bult 

Wed 246 Significance of window L-type calcium influx for contraction of C57Bl6 mouse aortic segments 

Paul Fransen, (Belgium), CE Van Hove, J van Langen, H Bult 

Wed 247 Role of HIF-1 β in endothelial cells in monocrotaline-induced pulmonary hypertension in mice 

Yayoi Fukuhara, (Japan), S Tomita, Y Imamura, Y Horinouchi, M Imanishi, T Sakurada, T Kitagawa, 

T Tamaki 

Wed 248 The difference in cerebrovascular effects of Afobazol and Nimodipin under the conditions of combined 

cardiac and cerebral vascular pathology 

Tamara Ganshina, (Russian Federation), R Mirzoyan, N Khaylov, S Seredenin 

Wed 249 ABCB1 C3435T genetic polymorphism alters clinical response to losartan in patients with hypertension 

MT Goktas, F Pepedil, G Sain-Guven, B Cakir, Melih O Babaoglu, (Turkey), U Yasar, A Bozkurt 

Wed 250 Pharmacodynamic/pharmacokinetic study of two formulation of acetylsalicylic acid in patients with 

chronic coronary disease 

Jose Antonio Gonzalez-Correa, (Spain), A Guerrero, E Rueda, MM Arrebola, JA Lopez-Villodres, 

JP de la Cruz 

Wed 251 Effect of sulodexide on vascular permeability in the kidney of diabetic rats 

Caroline González-Serryn, (Venezuela), D Fernandes, Y Mathison 

Wed 252 Alteration of the effects of growth factors by simulated microgravity 

Daniela Grimm, (Denmark), C Ulbrich, J Pietsch, M Infanger, G Aleshcheva, J Bauer 

Wed 253 Endothelial dysfunction of uterine artery in suramin-induced preeclampsia-like syndrome in rats 

Sebile Guler, (Turkey), EG Cekic, G Soydan, D Ertoy Baydar, M Tuncer 

Wed 254 Sexual dimorphism in aortic endothelial function of streptozotocin-induced diabetic rats 

X Han, R Zhang, L Anderson, Roshanak Rahimian, (USA) 



Wed 255 Is hydrogen sulfide an endothelium-derived relaxing factor? 

Joanne Hart, (Australia), M Al-magableh 

Wed 256 Change in intracellular Ca 2+ response of middle cerebral artery of stroke-prone spontaneously 

hypertensive rats 

Terumasa Hashimoto, (Japan), H Ohata, T Miyazaki, K Shibata, K Nobe, K Honda 

Wed 257 Maternal high fat diet programmed endothelial dysfunction on juvenile offspring born to high fat diet on 

nonhuman primate model 

Guo-Wei He, (PR China), L Fan, P Sinnayah, KL Grove 

Wed 258 Synergistic effect of iron and glucose on endothelial cells is mediated by DDAH/ADMA/ROS signalling 

pathway 

Ming He, (PR China), D Liu, D Yin, Z Liao, L Tang, Q Huang 

Wed 259 Protective effect of sodium nitroprusside against in vitro ischemia-reperfusion injury of rat mesenteric 

artery 

X He, M Zhao, H-L Zhang, X-L Xu, L-Y Xie, L Sun, X-J Yu, Wei-Jin Zang, (PR China) 

Wed 260 Vascular actions of the calcimimetic, cinacalcet 

Vanessa W-S Ho, (UK), P Thakore 

Wed 261 Ischemic suppression of cerebral endothelial eNOS: Effects of estrogen 

James Horne, (USA), S Duckles, D Krause 

Wed 262 Orexins depolarize rostral ventrolateral medulla neurons and regulate cardiovascular functions in the rat 

mainly via orexin 2 receptor 

Shang-Cheng Huang, (Taiwan), Y-W Dai, Y-H Li, C-T Chen, L-L Hwang 

Wed 263 Effect of fluvastatin on cerebral salt wasting after subarachnoid hemorrhage in rats 

Takahiro Igarashi, (Japan), M Yoneko, J Kojima, N Moro, Y Kondo, Y Katayama 

Wed 264 NO dilates rat retinal blood vessels through the COX-1-dependent prostanoids-cAMP signalling pathway 

in vivo 

Kunio Ishii, (Japan), A Mori, K Sakamoto, T Nakahara 

Wed 265 Role of AT1 receptor and NAD(P)H oxidase in the pressor resonse and hypothalamic antioxidant 

enzymes activity induce by forced immobilization in rats 

Anita Israel, (Venezuela), J Silva, S DeJesus, I Medina, MR Garrido 

Wed 266 Involvement of early release of HMGB1 in aggravation of neuronal damage after transient focal 

ischemia in diabetic rat brain 

Naohiro Iwata, (Japan), M Okazaki, S Kamiuchi, Y Hibino 

Wed 267 The effect of connexin 43 remolding in vascular restenosis 

Liping Jiang, (China), L Zhu, T Hong, J Feng 

Wed 268 Evidence for a novel signalling mechanism involving NAADP in endothelium-dependent hyperpolarization 

of resistance arteries 

Francesc Jimenez-Altayo, (UK), KA Dora, P Galindo, GC Churchill, A Galione, CJ Garland 

Wed 269 Reduced two-pore domain potassium channel (K2P) function may contribute to hypertension in 

spontaneously-hypertensive rats 

Ian Johnson, (UK), E Porter, N Ashton, A Gurney, A Weston 



Wed 270 Roles of binding affinity and lipophilicity in the kinetics of prostanoid receptor ligands 

Robert Jones, (UK), D Woodward, J Wang, R Clark 

Wed 271 Arterial vasodilation mediated by proteinase-activated receptor-2 in obese diabetic mice 

Satomi Kagota, (Japan), JJ McGuire 

Wed 272 Cessation of the metabolic disturbances progressing and endothelial dysfunction in patients with 

ischemic heart disease 

Tamara Kezeli, (Georgia), N Gongadze, M Chipashvili, M Mirziashvili, K Bakuridze 

Wed 273 Chronic intake of RWPs improves EDHF-mediated relaxation in the mesenteric artery of old rats: Role of 

angiotensin II and AT1 receptors 

N Khodja, T Chataigneau, C Auger, Valerie B Schini-Kerth (France) 

Wed 274 3',4'-Dihydroxyflavonol decreases vascular contraction through inhibition of the RhoA/Rho-kinase 

pathway in endothelium-denuded rat aorta 

InKyeom Kim, (South Korea) 

Wed 275 Calcium sensitization induced by sodium fluoride in permeabilized rat mesenteric arteries 


Wed 276 Protective effect of Ilex latifolia on glutamate-induced neurotoxicity in vitro and focal cerebral ischemia 

in vivo 

Joo Youn Kim, (South Korea), YH Seong 

Wed 277 Functional analysis of single nucleotide polymorphsims in NOS2A 

Soon Ae Kim, (South Korea), SY Yang 

Wed 278 Expression of soluble VEGF receptor-1 in human monocyte-derived mature dendritic cells 

Masatoshi Kishuku, (Japan), Y Nishioka, K Teraoka, K Kawazoe, H Hochi, S Sone, K Minakuchi 

Wed 279 Estrogen-induced relaxation of rat tail artery was attenuated in rats with pulmonary hypertension 

Ivan Kocic, (Poland), R Szczepazka, I Pawlowska 

Wed 280 Dimerization of nitric oxide sensitive guanylyl cyclase 

Jan Robert Kraehling, (Germany), M Busker, T Haase, M Seeanner, S Behrends 

Wed 281 Expression and functional studies of small- and intermediate conductance calcium-activated potassium 

channels in human small pulmonary arteries and bronchioles 

Christel Kroigaard, (Denmark), T Dalsgaard, B Elmedal Laursen, H Pilegaard, U Simonsen 

Wed 282 SKCa and BKCa expression is upregulated in pulmonary arteries from chronic hypoxic rats 

Christel Kroigaard, (Denmark), T Dalsgaard, S-P Olesen, U Simonsen 

Wed 283 Sex difference in experimental hypoxic pulmonary hypertension in rats 

Olga Kudryavtseva, (Denmark), N Medvedeva, V Koshelev 

Wed 284 Involvement of large-conductance Ca 2+ -activated K + channels in acetylcholine-evoked vasodilation of 

human penile small arteries 

Attila Kun, (Hungary), I Kiraly, A Varro, U Simonsen, J Pataricza, JG Papp, L Pajor 

Wed 285 Vasoconstriction in omental arteries from obese human subjects 

Hye Chung Kwak, (UK), M Larvin, P Leeder, J Ahmed, S O'Sullivan 

Wed 286 Methyl palmitate is the retina-derived relaxing factor 

Yuan-Chieh Lee, (Taiwan), H-H Chang, C-H Liu, M-F Chen, P-Y Chen, H-S Kuo, TJ-F Lee 



Wed 287 Dual ECE/NEP inhibition and ETA/B receptor antagonists: Two ways of inhibiting endogenous ET-1 

effects in resistance arteries 

Pieter Lemkens, (The Netherlands), J Nelissen, JGPJ Bost, BJA Janssen, PMA Schiffers, JGR De Mey 

Wed 288 Impairment of both nitric oxide and endothelium-derived hyperpolarizing factor in streptozotocin-induced 

diabetic small mesenteric artery 

Chen Huei Leo, (Australia), J Ziogas, JL Favaloro, OL Woodman 

Wed 289 7 day treatment with 3’,4’-dihydroxyflavonol prevents endothelial dysfunction in mesenteric arteries 

from streptozotocin-induced diabetic rats 

Chen Huei Leo, (Australia), J Ziogas, JL Favaloro, OL Woodman 

Wed 290 Inhibition of cyclooxygenase activity improves endothelium-dependent relaxation in mesenteric arteries 

of ovariectomized rats following chronic inhibition of nitric oxide synthase 

Susan WS Leung, (PR China), MLY Chan, GSK Man, RYK Man 

Wed 291 Inhibition of Ikα kinase a/b (IKKα/β) improved insulin resistance of endothelial cells induced by high 

glucose in vitro 

ZX Li, FH Chen, LL Liu, RX Zhan, Y Gao, SR Peng, CX Chen, Qi-Ren Huang, (PR China) 

Wed 292 Characterization of the CGRP receptor antagonist telcagepant (MK0974) in human isolated coronary 

arteries 

Kayi Chan, (The Netherlands), L Edvinsson, S Eftekhari, R de Vries, S Kane, R Hargreaves, J Danser, 

AM van den Brink 


W30 Is eNOS Still a valid therapeutic target? 

– The era after the discovery of eNOS uncoupling 

Wed 293 DHEA prevents pulmonary arterial hypertension in a rodent model of pulmonary hypertension in infants 

Jean-Pierre Savineau, (France), T Ducret, J-F Quignard, G Simon, R Marthan, E Dumas de la Roque 



Wed 294 Mechanism of antiproliferative action of Xylopia aethiopica (annonaceae) dried fruits extract on human 

cervical cancer cells 

Oluwatosin Adaramoye, (Nigeria), N Singh, S Meena, B Changkija, R Konwar, S Sinha, J Sarkar 

Wed 295 The analgesic and antiinflammatory activities of the aqueous leaf and stem extract of Asystasia 

gangetica 

Olufunmilayo O Adeyemi, (Nigeria), FR Aigbe, GN Uyaiabasi 

Wed 296 In vivo antioxidant activity of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) extract in 

carbon tetrachloride-induced hepatotoxicity in rats 

Olufunmilayo O Adeyemi, (Nigeria), A Akindele, K Ezenwanebe, C Anunobi 

Wed 297 Cardiac and renal effects of Tityus serrulatus venom and a new isolated peptide 

Renata S Alves, (Brazil), ARC Jorge, RM Ximenes, A Havt, NRF Nascimento, MGR Queiroz, 

AMC Martins, MH Toyama, HSA Monteiro 

Wed 298 Evaluation of the anticonvulsant activity of Zanthoxylum capense (Thunb.) Harv. (Rutaceae) leaf 

methanol extract in mice 

George Amabeoku, (South Africa), CG Kinyua 

Wed 299 Improving the antibacterial activity of lysozyme by conjugation with polysaccharides 

Mahmoud Aminlari, (Iran) 

Wed 300 Shikonin, a natural naphtoquinone, promotes wound healing in intestinal epithelial cells-18 

Isabel Andújar, (Spain), MC Recio, JL Ríos 

Wed 301 A new anticoccidial product developed from Artemisia sieberi plant 

Hossein Ali Arab, (Iran), A Rasouli, J Kaboutari, S Rahbari 

Wed 302 Evaluation of the gastric antiulcer activity of a proteolytic fraction from Carica candamarcensis latex 

Ana Cândida Araújo e Silva, (Brazil), FO Lemos, C Figueiredo, CTR Viana, CM Souza, GD Cassali, 

CE Salas, MTP Lopes 

Wed 303 Antinociceptive activity of fruits of methanolic extract of Capparis ovata in mice 

Rana Arslan, (Turkey), N Bektas 

Wed 304 Evaluation of hepatoprotective activity of Garcinia indica in rodents: Evidence of antioxidant activity 

Hardik D Ashar, (India), VS Panda 

Wed 305 Effects of free D-amino acids present in foods on human dermal fibroblasts 

Yutaka Ashida, (Japan), S Shimada, C Okamura, M Mita, K Hamase 

Wed 306 Several fruit and berry juices and purées are potent inducers of endothelium-dependent relaxations in 

the porcine coronary artery via activation of nitric oxide and endothelium-derived hyperpolarizing factor 

pathways 

C Auger, S Trinh, J-H Kim, T Chataigneau, Valerie B Schini-Kerth, (France) 

Wed 307 Effect of the anthraquinone compound rhein on human colon adenocarcinoma cell proliferation 

Gabriella Aviello, (Italy), I Rowland, C Gill, AM Acquaviva, R Capasso, AA Izzo, F Capasso, F Borrelli 

Wed 308 Inhibitory actions of carvacrol 1,4-cineole but not 1,8-cineole on field stimulation of isolated rat vas 

deferens: Role of isopropyl group as a pharmacophore 

Suleyman Aydin, (Turkey), Y Cakmakci 

Wed 309 The effects of carvacrol thymol and propofol on isolated rat atrium 

Yasemin Aydin, (Turkey), S Arkan, S Aydin 



Wed 310 Pharmacological screening of medicinal plants in Swaziland 

Peter Aziba, (Nigeria) 

Wed 311 Effects of surfacen in low and maintained dose in the treatment of ARDS. Preliminary results. 

Yinet Barrese Pérez, (Cuba), Y Avila Albuerne, E Díaz Casañas, O Fernández Lima, R Uranga Piña, 

CM Ballagas Flores 

Wed 312 Effects of the endemic plant, Eryngium kotschyi, on rat isolated ileum and detrussor muscle 

E Baydan, M Kartal, S Aslan, S Ýnce, Begum Yurdakok, (Turkey), H Ekici, H Alp 

Wed 313 Honey: the oldest modern remedies for mastitis 

Mokhtar El-Bachir Benhanifia, (Algeria), L Boukraâ 

Wed 314 Study of influency indol-3-carbinol, epigallocatechin-3-gallate and soy on proliferation diseases of the 

reproductive system in women 

Nadyia Berdnikova, (Russian Federation), L Zorina, S Serebrova 

Wed 315 Study of the antihypertensive potential of Indian medicinal plant, Emblica officinalis, in a rat model of 

hypertension 

Jagriti Bhatia, (India), F Tabassum, DS Arya, S Joshi, AK Shrivastava 

Wed 316 Anti-inflammatory and antiproliferative potential of extracts and purified fractions from Mediterranean 

marine algae 

Abderrahmene Bouraoui, (Tunisia), W Chaouch, L Mhadhebi, A Dellai, M Dridi, A Laroche, F Berrue, 

R Kerr, J Robert 

Wed 317 Today’s use of medicinal natural products by Italian women in Sicily 

Gioacchino Calapai, (Italy), A Pieratti, D Crupi, A De Sarro 

Wed 318 Anti-inflammatory effects of the pentacyclic triterpenes α,β-amiryns on animal models of irritative 

contact dermatitis induced by tetradecanoylphorbol 13-acetate 

Iana Calou, (Brazil), D Gonçalves, T Melo, T Olinda, GA Brito, V Rao, M Chaves, F Santos 

Wed 319 The anti-inflammatory effect of the pentacyclic triterpenes α and β amiryns on animal model of delayed 

hypersensitivity induced by repeated applications of oxazolone 

Iana Calou, (Brazil), D Gonçalves, T Olinda, T Melo, I Figueiredo, GA Brito, M Chaves, V Rao, F Santos 

Wed 320 Molecular mechanisms of Pistacia lentiscus essential oil antiproliferative activity 

Elisabetta Casarin, (Italy), B Barocco, A Buriani, M Carrara 

Wed 321 Effect of chromium enriched fermentation product of bareley and beer yeast and its combination with 

rosiglitazone on experimentally induced hyperglycemia in mice 

Vlada Cekic, (Republic of Serbia), V Vasovic, V Jakovljevic, D Lalosevic, M Mikov, A Sabo 

Wed 322 Inhibition of catecholamine secretion by a terpenoid extracted from Syneilesis aconitifolia (Bunge) 

maxim in cultured bovine adrenal chromaffin cells 

L Chai, H Mao, Y Su, Han Zhang, (PR China), H Guo, Y Jin, Z Zang 

Wed 323 Gastroprotective activity of Annona muricata L. on ethanol induced gastric lesions in rodents 

Pit Foong Chan, (Malaysia), R Abdul Hamid 

Wed 324 Pharmacological exploration of hypericum perforatum growing in India using rodent models 

Shyam Sunder Chatterjee, (Germany), V Kumar 

Wed 325 Structure activity relationship (SAR) of Hyperforin for its antidepressant-like activity profile 

Shyam Sunder Chatterjee, (Germany), O Kristhal 



Wed 326 A novel antitussive botanical drug PDC-1427 

Jui-Ching Chen, (Taiwan), C-Y Lin, Y-L Ku 

Wed 327 Modulatory effects of the extract of burdock tea on hyperlipidemia rat and rice models 

Xiangguo Chen, (PR China), Y Xu, Y Cao, Z Han, P Li, C Wang 

Wed 328 Approach of action mechanism of TCM-98 and its active component on neuro-inflammation in in vivo 

and in vitro models 

Yuh-Fung Chen, (Taiwan), Y-W Wang, H-Y Tsai 

Wed 329 Resveratrol inhibits 8-iso-prostaglandin F2α production in young and aged rat brain 

Annalisa Chiavaroli, (Italy), L Brunetti, G Orlando, L Menghini, L Recinella, S Leone, C Ferrante, 

C Di Nisio, R Shohreh, P Di Michele, M Vacca 

Wed 330 A novel protocol for the discovery of angiogenesis-modulators 

Chin-wen C Cho, (UK), J-C Yeh, T-P Fan 

Wed 331 Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's 

metabolites ginsenoside Rh1 and protopanaxatriol 

Shifeng Chu, (PR China), J Chen, Y Wang, N Chen, J Zhang 

Wed 332 Crotoxin: a toxin from rattlesnake venom that induces a long-lasting inhibitory effect on the phagocytic 

activity of neutrophils 

Maria Cristina Cirillo, (Brazil), TS Lima, SC Cataneo, SC Sampaio, MC Della-Casa 

Wed 333 Crotoxin: a toxin from rattlesnake venom with potential anti-inflammatory properties 

Maria Cristina Cirillo, (Brazil), FPB Nunes, BC Zychar, MS Della-Casa, SC Sampaio, LRC Gonçalves 

Wed 334 Involvement of formyl peptide receptors on the long-lasting anti-inflammatory effect of crotoxin, a toxin 

from rattlesnake venom 

Maria Cristina Cirillo, (Brazil), FPB Nunes, BC Zychar, MS Della-Casa, SC Sampaio, LRC Gonçalves 

Wed 335 Inhibition of the 26S proteasome complex by chemical constituents of Smilax Regelii and its possible 

chemotherapeutic capabilities on mammary tumours in Sprague Dawley rats 

Damian Cohall, (Barbados), PDA Singh 

Wed 336 JNK signalling pathway involves in Aβ1-40-induced neuronal death and protective effect of extracts of 

ginseng and Ginkgo biloba 

Weihong Cong, (PR China), J Liu, L Sheng, C Lin 

Wed 337 Oxalis pes-caprae L. inhibit NA concentration-response curves in human internal mammary artery 

Maria Cotrim, (Portugal), M Campos, M Gaspar, D Fonseca, C Frigerio, M Antunes 

Wed 338 Comparative studies on the antimutagenicity and antioxidant activities of the fruiting body and mycelium 

of Thai Ganoderma lucidum 

Theera Dalodom, (Thailand), A Aramphongphan 

Wed 339 Heparin prevent the cardiotoxic effect of bothropstoxin I & II 

Miguel de Lemos Neto, (Brazil), HD Ricardo, MM Machado, VV Martins, BL Cons, A Cintra, PA Melo 

Wed 340 Hydro-alcoholic extract of açaí (an Amazon plant) prevents endothelial dysfunction, oxidative stress and 

development of renovascular hypertension 

Miguel de Lemos Neto, (Brazil), CA Costa, RS de Moura, LCRM Carvalho, PRB Oliveira, PJC Sousa, 

AC Resende 



Wed 341 Protective action of hydro-alcoholic extract of açaí (an Amazon plant) on experimental metabolic 

syndrome in C57BL/6 mice 

Roberto Soares de Moura, (Brazil), PRB Oliveira, CA Costa, L Carvalho, M de Lemos Neto, PJC Sousa, 

AC Resende 

Wed 342 Preventive action of açai (an Amazon plant) hydroalcoholic extract on deleterious effect of cigarette 

smoke in mouse lungs 

Roberto Soares de Moura, (Brazil), AC Resende, M de Lemos Neto, MAS Silva, ETL Trajano, JN Alves, 

RT Nesi, PJC Sousa, LC Porto, SS Valença 

Wed 343 Gastroprotective effect of Olea europaea leaf extract in experimentaly induced gastric lesions in rats 

Dragana Dekanski, (Republic of Serbia), S Ristic, V Piperski, N Radonjic, N Petronijevic, D Mitrovic 

Wed 344 Pharmacological profile and therapeutic potentiality of natural product obtain from stem bark of 

mangifera indica l (VIMANG) and its glucosilxantona, mangiferin 

Rene Delgado-Hernandez, (Cuba), B Garrido Suarez, D Garcia-Rivera, GL Pardo-Andreu, P Hernandez 

Casaña, I Rodeiro-Guerra, I Hernandez-Balmaseda, N Merino-Garcia, MM Guevara-Garcia, 

A Alvarez-Leon, Y Maragiño, AJ Nuñez-Selles 

Wed 345 Mechanisms of the dilator action of a Danshen and Gegen formulation on rat basilar artery 

Shirlly Y Deng, (PR China), FFY Lam, ESK Ng, JHK Yeung, YW Kwan, CBS Lau, JCM Koon, PC Leung, 

KP Fung 

Wed 346 Vasorelaxant effects of coptisine in rat aortic rings 

Lian-Hua Fang, (PR China), L-L Gong, J-J Hu, H-L Qin, Y Lv, G-H Du 


Wed 348 Effect of Ulva lactuca in liver conservation in Wistar rat model 

H Ferchichi, I Salouage, S Bacha, L Ouanes, M Lakhal, Anis Klouz, (Tunisia) 

Wed 349 Asparagus officinalis regulates cholesterol metabolism and improves antioxidant status in 

hypercholesterolemic rats 

Aangeles Fernández-Arche, (Spain), D García -Gonzalez, R Saenz-Rodriguez, R Puerta-Vazquez 

Wed 350 Acute oral and acute dermal toxicity study of Dioscorea hispida (nami) aqueous plant extract in 

sprague-dawley rats 

Mona Liza Flores, (Philippines) 

Wed 351 Effects of resveratrol on learning and memory in rats 

Nejat Gacar, (Turkey), O Mutlu, T Utkan, I Komsuoglu Celikyurt, SS Gocmez, G Ulak 

Wed 352 A Jerte Valley cherry-based product acts as an enhancer of sleep, improves mood and possesses 

antioxidant properties 

Maria Garrido, (Spain), D Gonzalez-Gomez, M Lozano, MT Hernandez, MS Salcedo, C Barriga, 

SD Paredes, AB Rodriguez 

Wed 353 Pharmacological use of Borago officinalis 

Anwar-ul-Hassan Gilani, (Pakistan) 

Wed 354 Pharmacological basis for the medicinal use of Psyllium husk in constipation and diarrhea 

Anwar-ul-Hassan Gilani, (Pakistan), MH Mehmood 

Wed 355 Antidepressant activity of Orchis mascula 

Anwar-ul-Hassan Gilani, (Pakistan), S Khan, HS Siddiqi 



Wed 356 Pharmacological basis for the medicinal use of Origanum Vulgare Linn. in urolithiasis 

Anwar-ul-Hassan Gilani, (Pakistan), A Khan 

Wed 357 The effects of Lavandula stoechas extract on cholesterol levels and cardiac functions on 

ischemia-reperfusion model in isolated rat hearts 

Sule Gok, (Turkey), E Olmez, A Sonmez, K Vural, E Darýverenli, M Soylar 

Wed 358 Effect of hydroalcoholic extract of Emblica officinalis (HAEEO) against kainic acid induced seizures, 

oxidative stress and expression of heat shock proteins in rat brain 

Mahaveer Golechha, (India), J Bhatia, A Goyal 

Wed 359 Trans-resveratrol enhances eNOS expression and decreases its interaction with caveolin 1 in vascular 

smooth muscle and endothelial cells 

JE Gomez, A Cuíñas, J Leiro, F Orallo, Manuel Campos-Toimil, (Spain) 

Wed 360 Enzymatic inhibition, antioxidant and antibacterial activity of medicinal plant extracts: Potential 

application in the management of type 2 diabetes 

Vandana Gulati, (Australia), I Harding, E Palombo 

Wed 361 Effects of high-salt diet and bioactive peptides on mRNA expression of common markers of 

renin-angiotensin-aldosterone system in Goto-Kakizaki rat aorta 

Anne Hakala, (Finland), P Jäkälä, AM Turpeinen, R Korpela, H Vapaatalo 

Wed 362 Sasanquasaponin pretreatment protects cadiocytes from acute anoxia damage via a ERK1/2-HSP70 

pathway 

M He, Qingxian Zhu, (PR China), D Liu, L Tang, D Yin, Z Liao 

Wed 363 Ginkgolide B slows the cystogenesis and growth in MDCK and embryonic kidney models of polycystic 

kidney disease via PKA-dependent pathway 

Zhou Hong, (PR China), G Jinsheng, Y Baoxue 

Wed 364 Effect of Crocus sativus extract on seizure-induced extracellular changes of glutamate and aspartate in 

the rat hippocampus 

Hossein Hosseinzadeh, (Iran), H-R Sadeghnia, A Rahimi 

Wed 365 Preliminary investigation to the clinical application of phospholipase A2 inhibitor from snake serum 

Chunghong Huang, (PR China), X Deng, K Chen 

Wed 366 Snake venom C type lectin protein, agacutegrin, inhibits platelet aggregation and carcinoma cell 

migration 

Chunhong Huang, (PR China), S Tu, Z Liao, X Deng, K Chen 

Wed 367 Anti-hepatitis B virus activity in cultured cell line HepG2.2.15 cells of total phenolics extracted from 

Oenanthe javanica 

Zheng-Ming Huang, (PR China), X-J Wang, X-B Yang, J-G Song 

Wed 368 Mechanism of inhibition of transcription factor specificity protein 1 by betulinic acid 

Jan-Jong Hung, (Taiwan), W-C Chang 

Wed 369 Anti-inflammatory activity of aqueous fruit pulp extract of Hunteria umbellata K. Schum in acute and 

chronic inflammation 

Ighodaro Igbe, (Nigeria), P Ching, A Eromon 



Wed 370 Exploring gender differences in the relaxant effect of quercetin on phenylephrine-contracted normal and 

diabetic rat aorta 

Aloysius Iguegbe, (Malaysia), F Achike, R Mustafa 

Wed 371 Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the 

rat spinal excitatory and inhibitory synapses 

Yushi Ito, (Japan), O Akaike, MC Shin, K Nonaka, T Harakawa, A Ginnaga 

Wed 372 Tea polyphenols inhibit tube formation in cocultured endothelial cells with fibroblasts 

Shinichi Iwai, (Japan), A Tsuboi, C Kurahashi, A Yura, K Oguchi 

Wed 373 Inhibitory effect of piperlongumine on platelet aggregation via collagen receptor 

Masaya Iwashita, (Japan), Y Nasu, A Okuda, N Nakahata 

Wed 374 Effects of 3,5,7,3',4'-pentamethoxyflavone on isolated human cavernosum 

Chaweewan Jansakul, (Thailand), K Techanaparukse, P Sirirugsa 

Wed 375 Hypotensive constituents and their mechanisms responsible for the hypotensive activity of Phyllanthus 

acidus (L.) Skeels 

Chaweewan Jansakul, (Thailand), Y Leeya, M Mulvany, E Queiroz, A Marston, K Hostettmann 

Wed 376 Antispasmodic effect of Achillea fillipendula extract on the guinea pig ileum 

Katayou Javidnia, (Iran), R Miri, H Mirkhani, E Faghih mirzaei, M Sharifi 

Wed 377 Acute oral toxicity and acute dermal toxicity of the aqueous extract of Gmelina arborea Roxb. (Family 

Verbenaceae) leaves 

Maria Cesthrine Jane Javier, (Philippines) 

Wed 378 Gene expression profiling of cardioprotective effects of Qi-Shen-Yi-Qi on acute myocardial infarction 

M Jiang, G Wang, P Cui, Z Zhao, Xiaoying Wang, (PR China),G Luo 

Wed 379 Proteomic and metabonomic-based investigations on mechanisms of aging of senescence-accelerated 

mouse and actions of Liuwei and Bawei Dihuang decoctions 

Ning Jiang, (PR China), W-X Zhou, Y-X Zhang, X-Z Yan, Q Zhang 

Wed 380 Dyskinesia and plasma DOPA levels in hemi-Parkinsonian rats after chronic oral administration of 

Mucuna pruriens seed extract or L-DOPA methyl ester 

Monica Jørgensen, (Denmark), JB Gramsbergen, LP Christensen 

Wed 381 Evaluation of antihyperlipidemic & cardioprotective effect of methanolic extract of Lagenaria siceraria 

Amitesh Khare, (India), VV Khadke, AW Patil 

Wed 382 STW 5, an herbal preparation, is effective in experimental inflammatory bowel disease 

Mohamed T Khayyal, (Egypt), H Abdel-Aziz, W Wadie, DM Abdallah, O Kelber, B Vinson, D Weiser 

Wed 383 The protective effects by the extract from Platycodon Grandiflorum against myocardial ischemia in rats 

Eun-Joo Kim, (South Korea), M-H Lee, K-S Kim, B-Y Byun 

Wed 384 Effects of phytoalexin glyceollin isolated from soybean, on vascular contraction in rat aortas 


Wed 385 Aronia juice, a polyphenol-rich berry juice, induces redox-sensitive activation of endothelial nitric oxide 

synthase and relaxation in porcine coronary arteries 

J-H Kim, C Auger, T Chataigneau, Valerie B Schini-Kerth, (France) 



Wed 386 Inhibitors of Ca 2+ -ATPase thapsigargin and trilobolide possess immunostimulatory properties 

Eva Kmonícková, (Czech Republic), J Harmatha, K Vokác, Z Zídek 

Wed 387 Effects of antioxidant xanthones from Gentiana dinarica on Acantoscelides obtectus aging in vivo 

Dijana Krstic-Milosevic, (Republic of Serbia), I Spasojevic, A Nikolic-Kokic, M Spasic, D Blagojevic 

Wed 388 Modulation of vascular reactivity by kaempferol in porcine coronary arteries 

Yat Tin Lau, (PR China), SWS Leung, RYK Man 

Wed 389 The effect of Phela, a traditional medicine extract, on interleukin-2 in a rat model 

Makhotso R Lekhooa, (South Africa), A Walubo, J Du plessis, G Matsabisa 

Wed 390 A comprehensive method for identification of ‘Phela’, a traditional herbal medicine, using different 

chromatographic techniques 

Makhotso R Lekhooa, (South Africa), A Walubo, JB Du Plessis, MG Matsabis 

Wed 391 The use of metabolite peakokinetics to monitor ‘Phela’, a herbal medicine, in plasma after oral 

administration in a rat model 

Makhotso R Lekhooa, (South Africa), A Walubo, JB Du Plessis, MG Matsabisa 

Wed 392 Treatment of children’s asthma with a lipid extract of the New Zealand green lipped mussel (Perna 

canaliculus) (Lyprinol) – a double blind, randomised controlled trial in children with moderate to severe 

chronic obstructive asthma 

James Lello, (New Zealand), A Liang, E Robinson, D Leutenegger, A Wheat 



Wed 393 Effects of selected glutamatergic ligands on novelty-induced hyperactivity of GluA1-deficient mouse line 

Teemu Aitta-aho, (Finland), C Procaccini, ER Korpi, AM Linden 

Wed 394 The antipsychotic-like effect of myricitrin, a PKC inhibitor in mice 

Roberto Andreatini, (Brazil), M Pereira, L Pereira, MABF Vital, ARS dos Santos, MG Pizzolatti 

Wed 395 Magnesium sulphate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal 

model of manic state 

Roberto Andreatini, (Brazil), FJ Barbosa, B Hesse, RB de Almeida, IP Baretta, R Boerngen-Lacerda 

Wed 396 Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against Homocysteine-induced 

cognitive impairment and oxidative stress in the rat 

Amin Ataie, (Iran), M Sabetkasaei, A Haghparast 

Wed 397 The HPA axis, cardio-vascular system and behavior in rat CMS model of depression. 

Elena V Bouzinova, (Denmark), S Christiansen, K Henningsen, R Palme, O Wiborg 

Wed 398 The role of CYP2D6 and ABCB1 pharmacogenetics in the clinical efficacy of orally administered 

risperidone 

Nada Božina, (Croatia), N Jovanovic, M Lovric, V Medved, M Kudumija-Slijepèevic, J Grubišin 

Wed 399 Cholinergic and glutamate-nitric oxide signalling pathways in a genetic animal model of depression, the 

Flinders Sensitive Line (FSL) rat 

Linda Brand, (South Africa), EL Minnaar, J van Zyl, G Wegener, BH Harvey 

Wed 400 Rescue of TGF-β1 signalling as a new neuroprotective tool in Alzheimer's disease 

Filippo Caraci, (Italy), G Battaglia, ML Giuffrida, V Bruno, P Bosco, MA Sortino, F Drago, F Nicoletti, 

A Copani 

Wed 401 Neuroplastic changes precede chronic antidepressant responses of the 5-HT4 receptor agonist 

RS67333 

Elena Castro, (Spain), A Díaz, EM Valdizán, R Vidal, F Pilar-Cuellar, A Pazos 

Wed 402 Expression of VGLUTs in the process of degeneration and acquisition of learning and memory 

Xiaorui Cheng, (PR China), Y Zhao, W Zhou, Y Zhang 

Wed 403 Impairment of heme oxygenase-1 expression by the defect of Parkinson-related PINK1 protein 

Wei-Lin Chien, (Taiwan), J-R Li, M-J Li, W-M Fu 

Wed 404 Fluvoxamine pharmacokinetics in elderly subjects and patients with chronic heart failure 

Sara De Martin, (Italy), R Orlando, M Floreani, P Palatini 

Wed 405 Effect of GABAmimetics on the duration of immobility in behavioral despair swim test 

Abdalla Elhwuegi, (Libya), N Zahaf 

Wed 406 The effects of sertraline on behavioral alterations caused by environmental enrichment 

Kevser Erol, (Turkey), E Yildirim, E Ulupinar 



Wed 409 Oxytocin antagonist prevents pro-cognitive effect of angiotensin IV 

Paul Gard, (UK), C Naylor 

Wed 410 The involvement of ERK-dependent processes in antidepressant drugs effects on β-arrestins 

Moran Golan, (Israel), G Schreiber, S Avissar 



Wed 411 Involvement of 5-HT1A receptors in the effects of cannabidiol injected into the bed nucleus of the stria 

terminalis on behavioral and cardiovascular responses induced by contextual conditioned fear 

Felipe V Gomes, (Brazil), DG Reis, FHF Alves, FMA Côrrea, L Resstel, FS Guimarães 

Wed 412 Effect of combined oral contraceptives on the serum concentration of olanzapine 

Tore Haslemo, (Norway), H Refsum, E Molden 

Wed 413 Involvement of α7 nicotinic acetylcholine receptor on the conditioned place aversion induced by naloxone 

in single-dose morphine-treated rats 

Shigeru Ishida, (Japan), Y Ikuta, I Miyazaki, M Asanuma, H Matsunaga, T Sendo, H Araki, H Kawasaki, 

Y Kitamura 

Wed 414 Serotonergic gene polymorphisms and drug plasma concentration influence therapeutic response to 

paroxetine in patients with panic disorder 

Shin Ishiguro, (Japan), M Ueda, T Watanabe, Y Saeki, T Ayugase, A Saito, K Akiyama, Y Inoue, 

S Morita, G Hirokane, N Yamada, K Shimoda 

Wed 415 Association between autonomic nervous system activity in schizophrenia and antipsychotic medication: 

the comparison of typical and atypical antipsychotic drugs 

Yohko Iwamoto, (Japan), I Kisida, M Fujibayashi, S Tanaka, C Kawanishi, N Ishii, Y Hirayasu, T Moritani 

Wed 416 Ilex latifolia protects against amyloid β protein (25-35)-induced neurotoxicity in cultured neurons and 

has antidementia activities in mice 

Ha Yeon Jeong, (South Korea), YH Seong 

Wed 417 St. John´s wort extract or fluoxetine influence gene expression of hypothalamic and hippocampal tissues 

in a model of stress induced depression 

Peggy Jungke, (USA), G Ostrow, J Li, C Kolb, O Kelber, D Weiser, K Nieber, V Butterweck 

Wed 418 Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle 

Alireza Karimollah, (Iran), M Ghasemi, MH Ghahremani, AR Dehpour 

Wed 419 Effect of propranolol alone and in combination with alprazolam on elevated plus maze and forced 

swimming induced-stress in rats 

Razia Khanam, (India), F Ahmed, D Vohora, K Pillai 

Wed 420 Investigation of antidepressant and anxiolytic effects of Simvastatine in rats 

Fatma Sultan Kilic, (Turkey), Y Özatýk, B Kaygisiz, C Baydemýr, K Erol 

Wed 421 The atidepressant and anxiolytic activities of Gabapentine 

Fatma Sultan Kilic, (Turkey), S Ismailoglu, C Baydemir, K Erol 

Wed 422 Dysfunction of autonomic nervous system activity in schizophrenia and the influence of neuroleptics 

Ikuko Kishida, (Japan), M Fujibayashi, S Tanaka, C Kawanishi, Y Iwamoto, T Furuno, C Ishii, N Ishii, 

Y Hirayasu, T Moritani 

Wed 423 Effects of cariprazine on D2 and D3 dopamine receptor signalling mechanisms in vitro 

B Kiss, Zsolt Nemethy, (Hungary), S Peterson, K Fazekas, B Masri, M Caron 

Wed 424 Influence of the suppression of cell proliferation and neurogenesis in the ability of antidepressants in an 

ACTH-induced animal model of treatment-resistant 

Yoshihisa Kitamura, (Japan), M Doi, H Hayashi, I Miyazaki, M Asanuma, H Kawasaki 

Wed 425 Effect of temperature and glucose concentration on anoxic dopamine efflux in the mouse caudate 

Steve Knight, (UK), N Chauhan, A Young, C Gibson, C Davidson 



Wed 426 Cognitive enhancers: different targets – common objective 

Georgy Kovalev, (Russian Federation), J Firstova 

Wed 427 Neuroprotective effect of rice bran oil on amyloid β protein (25-35)-induced neurotixicity: In vitro and in 

vivo 

Hong-Kyu Lee, (South Korea), YH Seong 

Wed 428 Isolation rearing alters protein expression of synaptic markers, myelin markers and GABAB1 receptor in 

the rat brain 

Ann Li Lim, (Australia), DA Taylor, DT Malone 

Wed 429 Multiple therapeutical targets revealed by protein expression profiles analysis in the brains of Balb/c 

mice subjected to unpredictable chronic mild stress 

Yanyong Liu, (PR China), N Yang, C Ji, P Zuo 

Wed 430 Cytochrome P-450 enzyme genetic polymorphisms influence antidepressant escitalopram metabolism 

and treatment response 

Yu-Li Liu, (Taiwan), K-M Lin, M-H Tsai, M-C Hsiao, WW Shen, M-L Lu, H-S Tang, C-K Fang, C-S Wu, 

S-C Lu, SC Liu, C-Y Chen 

Wed 431 Tryptophan hydroxylase 2 (TPH2) gene is associated with major depressive disorder in the three main 

ethnic groups of the Malaysian population 

AC Loke, LH Lian, NZ Zainal, Zahurin Mohamed, (Malaysia) 

Wed 432 Antidepressant use and salivary cortisol: The Netherlands Study of Depression and Anxiety (NESDA) 

Leonie Manthey, (The Netherlands), C Leeds, EJ Giltay, T van Veen, SA Vreeburg, BWJH Penninx, 

FG Zitman 

Wed 433 Increased reuptake masks elevated sensitivity to monoamines in peripheral but not cerebral resistive 

arteries of rats depressed in response to the chronic mild stress (CMS) 

Vladimir Matchkov, (Denmark), E Bouzinova, T Brøgger, NM Nielsen, K Henningsen, O Wiborg, 

C Aalkjær 


W33 Synaptic events in brain function 

Wed 434 Endomorphin-1 stimulates norepinephrine release in rat hypothalamus 

Lucia Recinella, (Italy), L Brunetti, G Orlando, A Mollica, C Ferrante, A Chiavaroli, S Leone, C Di Nisio, 

R Shohreh, P Di Michele, F Pinnen, M Vacca 


W34 State-of-the-art of basic and clinical pharmacology 

in Serbia 

Wed 435 The new association in clinical pharmacology: Section of Clinical Pharmacology Serbian Medical 

Assotiation 

Dragana A Kastratovic, (Republic of Serbia), MM Mikov, VV Stanimirovic, AJ Sabo, SM Jankovic, 

N Japundzic-Zigon, DR Milovanovic, R Lilic, MH Vukovic, VM Jugovic 

Wed 436 Influence of ticlopidine alone and in combination with aspirin on liver function test in rats 

Zorica Stanojevic, (Republic of Serbia), R Mitic, S Stevic, M Dejanovic, Z Bukumiric 



Wed 437 Study of 5HT3 and HT4 receptors expression in HT29 Cell line and human colon adenocarcinoma 

tissues 

Ramin Ataee, (Iran), S Ajdary, M Zarrindast, M Rezayat, MA Shokrgozar 

Wed 438 Effects of gonadectomy on hippocampal aromatase expression in both genders 

Nihan Burul-Bozkurt, (Turkey), P Kelicen, C Pekiner 

Wed 439 Involvement of autophagy in the sex-different brain injury caused by iron overload 

Tzu-Yin Chen, (Taiwan), S-I Lue, C Hsu 

Wed 440 Activation of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) by gw501516 prevents fatty 

acid-induced NF-βB activation and insulin resistance in skeletal muscle cells 

T Coll, AM Gomez-Foix, Manuel Vazquez-Carrera, (Spain) 

Wed 441 Gastroprotective effect of peroxisome proliferator-activated receptor-γ (PPARγ) agonist, rosiglitazone 

against stress-induced gastric mucosal injury in rats 

Mohamed A.EL-Moselhy, (Egypt), W H. Nazmy, HM Ibrahim 

Wed 442 Synergistic interaction between PPAR agonists and albuterol on human bronchial smooth muscle cell 

proliferation 

Stefano Fogli, (Italy), L Picchianti, F Stefanelli, MC Breschi 

Wed 443 Distinct roles for the nuclear receptors Nur77 and Nor-1 in dopamine-mediated and psychostimulantinduced 

behaviors 

Céline Hodler, (Canada), B Paquet, J Baillargeon, P Seeman, D Lévesque, C Rouillard 

Wed 444 Single-label time-resolved fluorescence based estrogen receptor-ligand binding assay 

Roope Huttunen, (Finland), Shweta, E Martikkala, M Lahdenranta, P Hänninen, H Härmä 

Wed 445 Type II diabetes drug metformin induces transcriptional coactivator PGC-1α in liver possibly through 

AMPK independent mechanism 

Sanna-Mari Järvenpää, (Finland), J Hakkola 

Wed 446 Bi-transgenic mice expressing human hydroxysteroid (17β) dehydrogenase 1 (HSD17B1) and estrogen 

response element (ERE) -reporter gene provide a novel tool to monitor action of HSD17B1 inhibitors 

Päivi Järvensivu, (Finland), T Saloniemi, P Koskimies, P van der Saag, M Poutanen 

Wed 447 Downregulation of PPARα expression by glucose in pancreatic α-cells is mediated by ChREBP 

Lars La Cour Poulsen, (Denmark), M Børgesen, SF Schmidt, F Frigerio, P Maechler, S Mandrup 

Wed 448 Cytochrome P450 2A5 expression is dependent on redox-sensitive transcription factor Nrf2 in liver 

Virpi Lämsä, (Finland), A-L Levonen, H Hurttila, S Ylä-Herttuala, M Yamamoto, J Hakkola 

Wed 449 Progesterone receptor activation of extra-nuclear signalling pathways in regulating p53 expression in 

vascular endothelial cells 

Wen-Sen Lee, (Taiwan), S-P Hsu 



pharmacology 

Thu 001 Sy Cushing at the child with asthma, case report 

Milica Martinovic, (Republic of Serbia) 

Thu 002 Using Adapt® in paediatric patients: Pharmacokinetic modelling for lamotrigine 

Janet Mifsud, (Malta), D Soler, H Shabbi 

Thu 003 Effects of paracetamol during first days of life 

Petra Millfors, (Sweden), KJS Anand, LL Bergqvist 

Thu 004 Effect of soybean on male reproductive physiology 

Mehrdad Modaresi, (Iran), M Messripour, H Khorami 

Thu 005 Clinical efficacy of bovine colostrum in non-organic failure to thrive 

Yashar Moharamzad, (Iran), Y Panahi, G Falahi, M Falahpour 

Thu 006 Blood level of Cyclosporine-A in Iranian renal transplant patients 

Manijeh Motevalian, (Iran), H Otukesh, RH Shamsabadi, M Chalian 

Thu 007 Safety in paediatric drug trials – an update from randomised controlled trials published in 2007 

KNB Nor Aripin, Helen M Sammons, (UK), I Choonara 

Thu 008 The effect of premedication for intubation on amplitude-integrated electroencephalography in a 

randomized blinded intervention study of preterm infants 

Elisabeth Norman, (Sweden), S Wikström, I Rosén, V Fellman, L Hellstrom-Westas 

Thu 009 Pediatric outcomes following in utero exposure to psychotropic medications: An update 

Irena Nulman, (Canada) 

Thu 010 Pharmacokinetics, pharmacodynamics and bioequivalence of dexamethasone liquid and tablet 

formulations 

Christian Queckenberg, (Germany), B Wachall, P Di Gion, D Tomalik-Scharte, M Abdel-Tawab, U Fuhr 

Thu 011 Population pharmacokinetics of hydrocortisone in extremely premature infants 

Hesty Ramadaniati, (Indonesia), B Charles, H Liley 

Thu 012 Saliva efavirenz levels as a non-invasive alternative to determine adherence in children 

Malie Rheeders, (South Africa), M Viljoen, A Theron, T Meyers 

Thu 013 Clinical trial of epigallocatechin-3-gallate in Duchenne muscular dystrophy 

Urs T Ruegg, (Switzerland), A von Moers, F Paul, Y Nakae, O Dorchies 

Thu 014 Discovery of novel pharmacological chaperones for phenylketonuria 

S Santos Sierra, (Austria), A Perna, J Kirchmayer, K Kemter, DD Messing, SW Gersting, AC Muntau, 

H Glossmann, G Wolber, FB Lagler 

Thu 015 Oral antibodies to S100 protein in attention deficit and hyperactivity disorder: first clinical trial in 

children 

Svetlana Sergeeva, (Russian Federation), JL Dugina, IA Kheifets, OI Epstein 

Thu 016 Prevalence of CYP2B6-516G>T polymorphism in black South African HIV-infected children on efavirenz 

based antiretroviral therapy 

Michelle Viljoen, (South Africa), C Dandara, M Rheeders, KR Conradie, HS Kruger, H Gous, TM Meyers 

Thu 017 Population pharmacokinetics of carbamazepine and its metabolite in Chinese children with epilepsy 

Li Wang, (PR China), Y Liu 

280 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area


pharmacology 

Thu 018 Evaluation of a limited sampling strategy for determination of the mycophenolic acid-AUC in different 

renal pediatric patients 

Martin Wiesen, (Germany), M Feldkötter, H Stützer, C Müller 

Thu 019 Asthma drug regimens and health service utilization: What impact do changes in the optimal use of 

medication have on children with asthma? 

Tingting Zhang, (Canada), A Smith, R Prosser, B Carleton 

Thu 020 Pharmacoepidemiological studies in Chinese and Canadian children – lack of comprehensive 

prescription data a major limitation 

Tingting Zhang, (Canada), Z Li, A Smith, Y Wang, D Cao, B Carleton 

Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 281



Thu 021 Synthesis and characterization of peripherally selective CB1 receptor antagonists 

Rangan Maitra, (USA), Y Zhang, M Roche, J Tajuba, R Snyder, N Gaudette, T Fennell, B Thomas, 

H Seltzman 

Thu 022 The role of dopaminergic receptors in the inhibition of the vasopressor sympathetic outflow in pithed 

rats 

Guadalupe Manrique-Maldonado, (Mexico), A González-Hernández, BA Marichal-Cancino, 

A Sánchez-López, D Centurión, CM Villalón 

Thu 023 Association of β3-adrenergic receptor polymorphism with contractile responses in human atrium 

Alina Marandykina, (Lithuania), A Bogdelis, D Zablockaite, R Treinys, VA Skeberdis 

Thu 024 Brain region specificity of 5-HT1A receptor activation by selective agonists demonstrated by functional 

autoradiography 

Jean-Claude Martel, (France), N LeducC, A Newman-Tancredi 

Thu 025 Constitutive activation is responsible for the intracellular predominance of the C18S mutant AT1 

receptor of angiotensin II 

Renan Martin, (Brazil), E Rodrigues, L Oliveira, S Shimuta 

Thu 026 A novel nanoscale high throughput assay screening membrane based protein-protein interactions 

S Mathiasen, Vikram Kjøller Bhatia, (Denmark), S Pedersen, K Strømgaard, D Stamou 

Thu 027 Development and characterization of a β2 adrenergic receptor cAMP biosensor assay 

Jesper M Mathiesen, (Denmark), H Bräuner-Osborne 

Thu 028 Molecular organization and dynamics of the MT1 melatonin receptor/RGS20/Gαi protein complex 

reveal asymmetry of receptor dimers for RGS coupling 

P Maurice, AM Daulat, R Turecek, K Ivankova-Susankova, F Zamponi, JL Guillaume, B Bettler, 

P Delagrange, Ralf Jockers, (France) 

Thu 029 The pharmacology of GluN3 containing NMDA receptors 

David McClymont, (UK), I Mellor 

Thu 030 Synergy between α-1-adrenoceptor subtypes and P2X receptors in nerve induced vascular responses 

revealed by successive α-1-adrenoceptor knockouts and antagonists 

John McGrath, (UK), C Daly, P Simpson, E Wallace, L Methven 

Thu 031 Regulation of noradrenaline release by administration of stressin I into the locus coeruleus: A brain 

microdialysis study in awake rat 

J Javier Meana, (Spain), I Horrillo, JE Ortega 

Thu 032 GRK6 regulates the desensitization of 5-HT4 receptors in the rat oesophagus 

Teshome Nedi Megersa, (Australia), H Irving, I Coupar, P White 

Thu 033 The relationship between GRα and NFκB related proteins in children idiopathic nephrotic syndrome 

Ladislav Mirossay, (Slovak Republic), K Szilagyi, L Podracka, A Mirossay, J Mojzis 

Thu 034 Identification of a novel ligand for glutamate receptor β2 

Masayoshi Mishina, (Japan), T Uemura, S-J Lee, M Yasumura, T Yoshida 

Thu 035 New HTRF solutions for cell surface receptors study and screening. Application to GPCR dimerization 

and highly selective ligand binding assays 

Hamed Mokrane, (France), E Trinquet, T Roux, L Comps-Agrar, J-P Pin, J-L Tardieu 




Thu 036 The conserved Trp IV:10 (4.50) together with Ser/Asn II:05 (2.45) are crucial for 7TM receptors 

activation and might be a putative cholesterol binding site 

Jacek Mokrosinski, (Denmark), R Nygaard, MS Engelstoft, L Valentin-Hansen, B Holst, TW Schwartz 

Thu 037 Screening and characterization of GPCR C-terminal tail interactions with the PSD-95 PDZ domains 

Thor Møller, (Denmark), P Jacky, A Bach, K Strømgaard, T Schwartz, K Martinez 

Thu 038 Novel pathway of smooth muscle contraction by UTP in rat aortic myocyte 

Hiromitsu Morita, (Japan), M Sugihara, M Matsuda, S Kajioka, Y Ito, K Abe, M Hirata 

Thu 039 β3-adrenoceptors substitute the role M2 muscarinic receptors in the heart of stressed mice 

Jaromir Myslivecek, (Czech Republic), M Novakova, V Farar, R Kvetnansky 

Thu 040 Presynaptic BK channels activated by IP3-induced Ca 2+ release are involved in prostanoid TP 

receptor-mediated inhibition of noradrenaline release from the rat gastric sympathetic nerves 

Kumiko Nakamura, (Japan), K Yokotani 

Thu 041 Mutational analysis of an M4 muscarinic acetylcholine receptor allosteric site 

Vindhya Nawaratne, (Australia), K Leach, CC Felder, PM Sexton, A Christopoulos 

Thu 042 The involvement of nitric oxide in the local antinociceptive effects of JWH-015 and expression of 

cannabinoid-2, μ- and δ-opioid receptors during chronic inflammatory pain in mice 

R Negrete, J Martín-Campos, A Hervera, S Leánez, Olga Pol (Spain) 

Thu 043 Pharmacological evaluation of new bivalent ligands aimed to interact with orthosteric and allosteric 

sites of mAChRs 

Marta Nesi, (Italy) 

Thu 044 Conditional mutant mouse with enhanced Gα-i2 signalling due to loss of regulator of G protein signalling 

(RGS) regulation 

Richard Neubig, (USA), X Huang, S Wade, R Charbeneau 

Thu 045 Pertussis toxin inhibits EP4 and IP receptor-mediated cAMP production in adult rat dorsal root ganglion 

cells 

Kai-Yu Ng, (PR China), Y-H Wong, H Wise 

Thu 046 Identification of Adrenergic Receptor Interacting Protein (ARIP), as a novel receptor-interacting protein 

that modulates α1A- and α1L-adrenoceptor expression 

Atsushi Nishimune, (Japan), F Suzuki, H Yoshiki, S Morishima, I Muramatsu 

Thu 047 G protein-coupled estrogen receptor 1 function in vivo and in vitro 

B Olde, C Sandén, S Broselid, U Mårtensson, Fredrik Leeb-Lundberg, (Sweden) 

Thu 048 The expression of cardiac and lymphocytic GRKs in human cardiovascular diseases correlated to the 

expression levels of β-ARs 

Eduardo Oliver, (Spain), F Monto, D Vicente, J Agüero, EE Rovira, L Almenar, P D'Ocon 

Thu 049 Conditional functional selectivity of β2-adrenoceptor ligands in stimulating adenylyl cyclase and ERK 

phosphorylation in HEK 293 cells 

Gülnihal Özcan, (Turkey), A Kaya, O Onaran, Ö Ugur 

Thu 050 The three α1-AR subtypes show different spatio-temporal patterns of ERK1/2 phosphorylation and 

internalization 

Miguel Perez-Aso, (Spain), V Segura, M-A Noguera, P D'Ocon 




Thu 051 Chimaering orexin receptors reveal selectivity-conferring areas for orexins 

Jaana Putula, (Finland), P Turunen, L Johansson, R Ra, J Näsman, J Kukkonen 

Thu 052 Effects of route of administration on dexmedetomidine pharmacokinetics in C57Bl/6J and 

α2A-adrenoceptor knock-out mice 

Ville Ranta-Panula, (Finland), M Lahtinen, S Tikka, T Streng, M Scheinin 

Thu 053 Local enhanced contractile response of ETB, 5-HT1B and AT1 receptors following distal focal 

permanent occlusion 

Marianne NP Rasmussen, (Denmark), M Hornbak, L Edvinsson 

Thu 054 Functional and morphological characterization of presynaptic A1 and A3 adenosine receptors in the 

superior mesenteric artery of spontaneously hypertensive rats 

C Rocha-Pereira, P Fresco, S Arribas, MC González, MV Conde, J Gonçalves, Carmen Diniz, (Portugal) 

Thu 055 The orphan GPR50 receptor promotes transforming growth factor β (TGFβ) signalling by interacting 

with the TGFβ type I receptor 

A Saade, A Daulat, N Ferrand, P Delagrange, Nathalie Clement, (France), C Prunier, R Jockers 

Thu 056 DMSO-lipid soluble cigarette smoking particles upregulate contractile endothelin type B and 

thromboxane A2 receptors of rat middle cerebral arteries 

Hardip Sandhu, (Denmark), C-B Xu, L Edvinsson 

Thu 057 Involvement of H2O2 in adenosine-mediated regulation of coronary flow 

Maryam Sharifi Sanjani, (USA), B Teng, T Krahn, S Tilley, C Ledent, J Mustafa 

Thu 058 β-arrestin 1 and 2 stabilize the Angiotensin II type 1 receptor in distinct high-affinity conformations 

Samra Joke Sanni, (Denmark), JT Hansen, MM Bonde, T Speerschneider, GL Christensen, S Munk, 

S Gammeltoft, JL Hansen 

Thu 059 Receptor localization to caveolae regulates differential G protein coupling of mouse β3-adrenoceptor 

splice variants 

Masaaki Sato, (Australia), D Hutchinson, B Evans, R Summers 

Thu 060 Pharmacological characterisation of an allosteric small-molecule agonist for the chemokine receptor 

CXCR3 

Danny Scholten, (The Netherlands), M Canals, S de Munnik, M Wijtmans, I de Esch, M Smit, R Leurs 

Thu 061 Overexpression of kinin B1 receptor induces increased reactivity of DBK and BK in transgenic rat aorta 

Suma Imura Shimuta, (Brazil), RF da Silva, JB Pesquero, RP Martin, ES Rodrigues 

Thu 062 Role of the α-2 adrenoceptors subtypes in regulation of gastric motor activity in the rat and mouse 

Nashwan Shujaa, (Hungary), Z Zadori, M Al-khrasani, M Rossi, L Hein, K Gyires 

Thu 063 Sorting nexin-25 interacts with D1 and D2 dopamine receptors to regulate receptor expression and 

signaling 

David Sibley, (USA), R Free, Y Namkung, L Hazelwood, C Furman 

Thu 064 Crosstalk between excitatory A2A, NK1 and M3 receptors on a tripartite myenteric synapse 

Isabel Silva, (Portugal), D Fernandes, F Ferreirinha, C Vieira, M Duarte-Araújo, P Correia-de-Sá 

Thu 065 Cell-based screening for modulators of regulator of G protein signalling protein 9 (RGS9) – implications 

in Parkinson’s disease 

Benita Sjögren, (USA), RR Neubig 




Thu 066 Rapid functional upregulation of ETB receptors in rat coronary arteries during myograph studies 

Gry Freja Skovsted, (Denmark), AF Pedersen, M Sheykhzade, L Edvinsson 

Thu 067 Identification of G protein-coupled receptor (GPCR) targets using RT-PCR array: validation of PAR1 as 

the most highly expressed GPCR in regulation of cardiac fibroblasts 

Aaron Snead, (USA), P Insel 

Thu 068 Evidence for an anti-inflammatory role of the Ang(1-7)-Mas receptor axis in LPS-induced macrophages 

Laura Souza, (Brazil), C Costa-Neto 

Thu 069 Characterization of bimodal multivalent interactions for the bifunctional muscarinic receptor (mAChR) 

antagonist and β2-adrenoceptor agonist (MABA), THRX 198321 

Tod Steinfeld, (USA), AD Hughes, U Klein, JAM Smith, M Mammen 

Thu 070 Expression of NMDA receptor subunits NR1 and NR2A and metabotropic mGluR1 immunoreactivity in 

the intertrigeminal region of the lateral pons in rats 

Milan Stoiljkovic, (Republic of Serbia), S Pesic, N Stojiljkovic, V Nikolic 

Thu 071 Cardiovascular effects of dexmedetomidine in awake α2A-adrenoceptor knock-out mice 

Tomi Streng, (Finland), V Ranta-Panula, S Tikka, M Scheinin 

Thu 072 Muscarinic acetylcholine receptor subtypes involved in carbachol-induced HCO3- secretion in mouse 

duodenum in vitro 

Koji Takeuchi, (Japan), M Koyama, K Takahashi, E Aihara, N Kurata, S Hayashi 

Thu 073 Induction of kinin B1 receptor by stimulation of TRPV1 

S Talbot, J Pena Dias, Réjean Couture, (Canada) 

Thu 074 ADP receptor P2Y13 induce apoptosis in pancreatic β-cells 

Chanyuan Tan, (Sweden), A Salehi, S Svensson, B Olde, D Erlinge 

Thu 075 Structural analysis of two selective inhibitors of G protein-coupled receptor kinase 2 

David Thal, (USA), R Yeow, J Tesmer 

Thu 076 a2-adrenoceptor mediated increases phosphorylation of MAP-2c in rat pheochromocytoma cells (PC12 

cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism 

Lu Tie, (China), X-J Li 

Thu 077 Manganese enhances agonist binding to 5-HT1A receptors by inhibiting guanosine nucleotide binding to 

receptor-coupled G-proteins 

Lauri Tontson, (Estonia), S Parkel, A Rinken 

Thu 078 Heteromerization of HCMV encoded chemokine receptors 

Pia Tschische, (Austria), K Tadagaki, M Kamal, R Jockers, M Waldhoer 

Thu 079 TRPC2 channels modulate both calcium- and cAMP-mediated signalling in rat thyroid FRTL-5 cells 

Minna Vainio, (Finland), P Sukumaran, C Löf, K Törnquist 

Thu 080 Similar adenosine A1 receptor allosteric agonists require different orthosteric site conformations for 

stimulus transmission 

Celine Valant, (Australia), L Aurelio, P Scammells, P Sexton, A Christopoulos 

Thu 081 Proteinase activated receptor 2 (PAR-2) and toll like receptor 4 (TLR4) receptors cross-talk in rat 

vascular reactivity 

Valentina Vellecco, (Italy), M Bucci, V Brancaleone, F Roviezzo, R Meli, G Mattace Raso, G Cirino 




Thu 082 Mutation of the S1P1 receptor differentially affects signalling by agonists 

Dennis Verzijl, (The Netherlands), P Van Loenen, C De Graaf, R Didier, S Peters, A Alewijnse 

Thu 083 LSP4-2022 is a new selective and potent mGlu4 agonist with antihyperalgesic effect 

Bruno Vilar, (France), J Busserolles, I Brabet, B Ling, F Acher, J-P Pin, A Eschalier, C Goudet 

Thu 084 Ca 2+ -signalling of α2B-adrenoceptors in A7r5 vascular smooth muscle cells 

Anne Vuorenpää, (Finland), A Huhtinen, M Scheinin 

Thu 085 Oligomerization of chemokine receptors CXCR3 and CXCR4 

Anne Watts, (The Netherlands), M van Lipzig, S Jähnichen, R Alimahomed, G Zaman, M van der Lee, 

N Siderius, H Vischer, M Smit, R Leurs 

Thu 086 Supported cell-membrane sheets as a model system to analyze pathways ofintracellular GPCR signaling 

Volker F Wirth, (Denmark), TC Møller, KL Martinez 

Thu 087 The structural and functional landscape of the ADP receptor P2Y12 

Doreen Wittkopf, (Germany), M Cöster, A Kreuchwig, K-U Simon, G Kleinau, D Thor, G Krause, 

T Schöneberg 

Thu 088 Rapid characterization of bimatoprost pharmacology in human ocular cells by using cellular dielectric 

specroscopy 

David Woodward, (USA), J Wang, D Piwnica, R Carling, C Cornell, J Martos, D Stamer 

Thu 089 Characteristics of junctophilin 3 and 4 expressions in neurons derived from mouse embryonic stem 

cells 

Jiaying Wu, (PR China), Y Gao, H Wang, X Zhang, W Zhu, J Qian, Y Shen, H Yu, Q Wang, Y Lou 

Thu 090 T-type calcium channels mediate nicotine-induced cerebral neurogenic nitrergic vasodilation 

Yin-Chieh Wu, (Taiwan), HC Lee, PY Chen, MH Nam, MF Chen, TJF Lee 

Thu 091 Pharmacological characterization of the first potent and selective cysteinyl leukotriene 2 receptor 

antagonist 

Frank Wunder, (Germany), H Tinel, R Kast, A Geerts, E-M Becker, P Kolkhof, J Hütter, J Ergüden, 

M Härter 

Thu 092 Oestrogen confers cardioprotection by up-regulating β2-AR 

C Xu, A Liu, Hong Sun, (PR China) 

Thu 093 Serotonin 5-HT2C receptors alters gene expression of amyloid precursor protein 

Ming Yin, (PR China), LC Guo, J Zhang 

Thu 094 Endomorphins are potential endogenous regulators of the gastric mucosal integrity 

Zoltan Zadori, (Hungary), N Shujaa, A Rónai, K Gyires 

Thu 095 Biochemical analysis of the cleaved n-terminal of the PAR1 receptor 

Dimitrios Zampatis, (Germany), N Tsopanoglou, R Schuelein 

Thu 096 The presence of P2X receptors in CD34-positive cells of human umbilical cord blood 

Airat U Ziganshin, (Russian Federation), RR Kazakova, IG Moustafin, DV Nurullina, GZ Sagdieva, 

FF Kazakova, LE Ziganshina 


FC12 Ion channelopathies: New windows on complex 

disease and therapy 

Thu 097 Administration of clarithromycin and furosemid alters cardiac ion channel gene expression and induces 

β-adrenergically evoked Torsades de Pointes in rat 

Jan Klimas, (Slovak Republic), J Kmecova, K Mackovicova, P Vavrinec, P Krenek, J Kyselovic, 

P Ochodnicky 

Thu 098 Different mutations in the ABCC8 gene can either enhance or reduce sulfonylurea receptor 1 mediated 

apoptosis 

Martina Lösle, (Germany), S Ackermann, S Hiller, A Hambrock 

Thu 099 Decreased expression of connexin 26 in the cochlear spiral ligament fibrocyte following intense noise 

exposure 

Reiko Nagashima, (Japan), T Yamaguchi, H Tanaka, A Matsushita, K Ogita 

Thu 100 Effect of mebudipine and dibudipine two new calcium channel blockers in comparison to nifedipine on 

vascular flow of isolated kidney from diabetic rat 

Lili Sepehr-Ara, (Iran), M Mahmoudian 

Thu 101 Anticonvulsive evaluation of THIP in the murine pentylenetetrazole kindling model 

Charlotte Simonsen, (Denmark), A Kloppenburg, K Sonderskov, U Kristiansen, S Hansen 

Thu 102 Function of BK-VDCC complex in vascular smooth muscle cells 

Yoshiaki Suzuki, (Japan), H Yamamura, S Ohya, Y Imaizumi 

Thu 103 Assessment of salivary AQP5 as a biomarker for xerostomia 

Di Wang, (Japan), F Iwata, Y Pan, M Muraguchi, K Ooga, Y Ohmoto, M Takai, X-J Li, T Mori, Y Ishikawa 

Thu 104 Angiotensin II inhibites IKr /hERG channels through protein kinase C- 

Yuhong Wang, (PR China), J Xu, X Chen, Y Xu 

Thu 105 Protein kinases modulate store-operated channels in pulmonary artery myocytes 

Bin-Nan Wu, (Taiwan), I-S Chen, D Welsh, Z-K Dai, I-J Chen 

Thu 106 Localization of BKCa channels and effect of BKCa channels on CGRP release in the rat trigeminal 

nucleus caudalis 

Helle Wulf-Johansson, (Denmark), DV Amrutka, A Hay-Schmidt, A Poulsen, D Klaerke, J Olesen, 

I Jansen-Olesen 

Thu 107 Molecular assembly in fuctional Ca 2+ microdomain in vascular smooth muscle cells 

Hisao Yamamura, (Japan), S Ohya, Y Imaizumi 

Thu 108 Studies on epileptic animal model bearing a genetic abnormality identified in autosomal dominant 

nocturnal frontal lobe epilepsy (ADNFLE) and benign familial newborn baby convulsions (BFNC) of 

human 

Sayaka Yamashita, (Japan), M Nagano, Y Tanaka, M Deshimaru, M Okada, S Kaneko, S Hirose, 

R Saito, K Honda, Y Takano 

Thu 109 Mechanisms of amphotericin B-induced renal tubular cell injury 

Takahisa Yano, (Japan), Y Itoh, E Kawamura, A Maeda, Y Arimura, N Egashira, M Nishida, H Kurose, 

R Oishi 



drugs 

Thu 110 Lacritin, a novel secretagogue, increases tear flow in rabbits 

Sandeep Samudre, (USA), J Sheppard, F Lattanzio, G Laurie, R McKown, P Williams 

Thu 111 Crono-pharmacokinetic of irinotecan after hepatic intra arterial perfusion in patients with metastatic 

colon carcinoma 

Francesco Scaglione, (Italy), S Bareggi, A Nasisi, G Bondiolotti, M Pirovano 

Thu 112 Blunted reward system activation to erotic stimuli under paroxetine as compared to bupropion or 

placebo in healthy subjects 

Angela Seeringer, (Germany), B Abler, A Hartmann, G Groen, M Walter, J Kirchheiner 

Thu 113 Transient neurological disturbance in a patient with lamotrigine overdose 

Anshuman Sengupta, (UK), O Martin, G Lane, P Patel, S Abbasi 

Thu 114 Plasma serotonin levels and influence of granisetron on pharmacokinetics and pharmacodynamics of 

omeprazole in healthy subjects and patients with peptic ulcer disease 

Svetlana Serebrova, (Russian Federation), A Starodubtzev, S Kondratenko, G Belyakova, N Berdnikova 

Thu 115 Amphotericin B molecular organization and the particle size as essential factors to reduce its toxicity 

by hemolysis 

Dollores R Serrano Lopez, (Spain), HKR Saldaña, JJT Durán, MP Ballesteros, ST Durán 

Thu 116 Chemical forms of mercurials differentiate the potential of mercury for toxicity from that for medicinal 

remedy 

Jing Zhen Shi, (PR China), F Kang, Q Wu, YF Lu, J Liu, YJ Kang 

Thu 117 Effect of a novel fungal triprenyl phenol metabolite (Cpd-7) on acetic acid-induced embolic cerebral 

infarction model in mice 

Keita Shibata, (Japan), T Hashimoto, K Nobe, K Hasumi, K Honda 

Thu 118 Evaluation of clinical relevance of drug interactions based on metabolism: comparison of two CDK 

inhibitors 

Michal Siller, (Czech Republic), P Anzenbacher, E Anzenbacherova, K Dolezal, M Strnad 

Thu 119 Antihypertensive treatment and blood pressure control in primary health care 

D Silva, Isabel Vitórial Figueiredo, (Portugal), A Figueiras, MT Herdeiro, M Caramona, J Polónia 

Thu 120 Drug use pattern in hospital outpatients and private practice in Sylhet city of Bangladesh 

Sharadindu Kanti Sinha, (Bangladesh), WR Choudhury, MR Choudhury 

Thu 121 SLCO1B1 and CYP2C9 genetic variants could be associated with fluvastatin induced side effects in 

solid organ allotransplant recipients: case series 

NM Skvrce, L Zibar, Nada Božina, (Croatia), VM Sarinic, S Tomic 

Thu 122 Effects of fullerenol on rat uterus contraction and antioxidative enzymes activity 

Marija Slavic, (Republic of Serbia), Z Orescanin-Dusic, R Radojicic, S Milovanovic, A Djordjevic, 

M Spasic, D Blagojevic 

Thu 123 The HLA class I B*1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver 

damage and outcome in Spanish patients 

Camilla Stephens, (Spain), MA Lopez-Nevot, RJ Andrade, F Ruiz-Cabello, MC Fernandez, C Guarner, 

G Soriano, M Romero-Gomez, JM Navarro, JL Solís-Herruzo, J Costa, MI Lucena 

Thu 124 Antimicrobial consumption and polypharmacy in patients on immunosuppressive therapy 

Jan Strojil, (Czech Republic), P Langerová, K Urbánek 



drugs 

Thu 125 Gentamicin pharmacokinetics estimated using rat model of early sepsis with capillary leak syndrome 

Studena Studena, (Czech Republic), J Martinkova, J Chladek, D Slizova, O Krs, J Zahora 

Thu 126 Analysis of proarrhythmic effects of typical IKr blockers using human ES/iPS cell-derived 

cardiomyocytes 

Atsushi Sugiyama, (Japan), T Kitamura, F Nomura, T Kaneko, P Sartipy, K Fukuda, K Yasuda 

Thu 127 Routine use of pharmacogenetic tests for detection of CYP2C19 genetic polymorphisms in Clopidogrel 

non-responders in resource limited setting 

Chonlaphat Sukasem, (Thailand), R Tunthongb, V Pairoj, C Srichunrasamia, P Vathesatogkit, P Sritarab, 

W Chantratita 

Thu 128 Determination of Olanzapine in human plasma by a validated LC-MS/MS method 

Dobrin Svinarov, (Bulgaria), L Kasabova 

Thu 129 Reduced activity of CYP2C9 in the application of a complex pharmacotherapy at Russian patients with 

decompensation of chronic heart failure 

Dmitry A Sychev, (Russian Federation), A Levanov, A Savchenko, G Ramenckaya, V Dmitriev, 

S Bogoslovscaya, V Kukes 

Thu 130 Investigation of bioavailability of nanosized telmisartan in rat 

Anita Sztojkov-Ivanov, (Hungary), G Filipcsei, G Heltovics, F Darvas, I Zupkó 

Thu 131 Potentially inappropriate medication leading to adverse drug reactions and hospitalisation 

Jacek Szymanski, (Germany), S Schmiedl, S Holt, K Farker, B Drewelow, M Hippius, K May, 

PA Thürmann 

Thu 132 Cevimeline raises saliva volume and level of substance P in saliva 

Masaharu Takeyama, (Japan), K Amada, S Tsuda, Y Sato, H Itoh 

Thu 133 Lithium potentiates the effects of thiocolchicoside on neuronal excitability in rat dentate gyrus 

Giuseppe Talani, (Italy), N Obili, E Fadda, R Uras, G Cordeddu, C Fois, S Prinzis, A Frau, V Piras, 

L Siuni, P Niola, PL De Riu, GP Sechi, G Biggio, E Sanna 

Thu 134 Preliminary experimental data regarding the bioavailability and biodistribution of systemically 

administered 99MTC-coupled AA124 silica nanoparticle 

Bogdan I Tamba, (Romania), C Stefanescu, I Jaba, O Mungiu, A Wirth, U Pieles 

Thu 135 Transfection of a mutant mu-opioid receptor into mice periaqueductal gray resulted in naloxonemediated 

antinociception without tolerance and dependence 

Pao-Luh Tao, (Taiwan), SH Chou, HI Ma, PY Law, HH Loh 

Thu 136 Taste perceptions of salbutamol-containing inhalers: A randomised crossover trial 

Jolyn Tay, (New Zealand), TR Ingham, B Jones, N Pierse, C Burgess 

Thu 137 Delay of monitoring may add to pre-existing toxicity risk in elderly patients treated with potentially 

nephrotoxic antibiotics: case series study 

Hundie Tesfaye, (Czech Republic), R Prusa, B Jedlickova, J Lukaskova, M Palivoda, V Pavelkova 

Thu 138 Effect of losartan on metabolism of arachidonic acid using recombinant cytochrome P450 (CYP) 

enzymes 

Takaki Toda, (Japan), N Inotsume, K Sakamoto, S Takeuchi, T Hayakawa, B Ask, E Eliasson, A Rane 

Thu 139 Dose response for simvastatin in a rat model for the evaluation of myopathy 

Brian Tomlinson, (PR China), VWL Mak, TWC Lo, DK Rowlands, M Hu, B Chadwick, AE James 



drugs 

Thu 140 Pharmacogenetics of laβlol are influenced by CYP2C19 rather than CYP2D6 

Brian Tomlinson, (PR China), BSP Fok, OQP Yin, SSW Ko, CWY Tam, TTW Chu, M Hu, VHL Lee 

Thu 141 Colloids improve morphine excretion in elderly patients after single intravenous dose 

Stergios Tsartsalis, (Greece), M Vasileiadis, E Flioni, M Myronidou-Tzouveleki 

Thu 142 In vitro release and permeation characteristics of three nimesulide gel products (Sulidin, Nimes and 

Nimelid gels) in Turkey 

F Cankat Tulunay, (Turkey), L Kaytanlioglu, K Embil, A Okyar, G Baktir 

Thu 143 Clinical efficacy and adverse effects of the partial dopaminergic agonist aripiprazole compared with 

other antipsychotics 

Ingunn Fride Tvete, (Norway), M Klemp, J Gaasemyr, B Natvig, T Skomedal, I Aursnes 

Thu 144 In vivo phenotyping for CYP3A4 by determination of a single-point plasma concentration and urinary 

excretion of midazolam and its metabolites 

Shinya Uchida, (Japan), M Miura, S Misaka, Y Katoh, S Yamada, K Ohashi, H Watanabe, N Namiki 

Thu 145 Effect of 2-iminobiotin and N-ω-propyl-L-arginine on learning and memory in rats 

T Utkan, SS Gocmez, IK Celikyurt, Oguz Mutlu, (Turkey), N Gacar, F Aricioglu 

Thu 146 Development of new Catechol-O-methyltransferase inhibitors for treatment of Parkinson’s disease 

Nuno Vale, (Portugal), N Micaelo 

Thu 147 The effect of 5 artificial sweeteners on Caco-2 cells 

Armorel Van Eyk, (South Africa) 

Thu 148 Qunidine and aspirin kinetics in blood and central nervous system of rats after intraarterial application 

Velibor Vasovic, (Republic of Serbia), S Vukmirovic, V Jakovljevic, M Mikov, B Milijasevic, I Mikov 

Thu 149 Gender differences in pharmacokinetics of tacrolimus in renal transplant recipients 

Radmila Velickovic-Radovanovic, (Republic of Serbia), M Mikov, A Catic-Djordjevic, G Paunovic, 

V Djordjevic 

Thu 150 Biotransformation of a new anxiolytic aphobazole in rats 

Anastassia Viglinskaya, (Russian Federation), S Seredenin, V Zherdev, G Kolyvanov, A Litvin, 

T Mozhaeva, D Bastrigin 

Thu 151 Influence of clonidine within analgesic combinations administered epiduraly on postoperative analgesia 

quality 

Jelena Vukovic, (Republic of Serbia), L Grbovic, Z Milan, V Dragojevic-Simic, D Jandric, A Kovacevic 

Thu 152 Prescriptions analysis of analgesic medicines by primary care physician 

Nida'a Wadi, (Oman), M Bhupathyraaj, KAI Harthy 

Thu 153 A validated stereoselective assay for 3,4-methylenedioxymethamphetamine in human urine samples 

Wan Raihana Wan Aasim, (Malaysia), SH Gan, SC Tan 

Thu 154 Development of a novel therapeutic system of adenovirus gene therapy in combination with 

macromolecular drug therapy 

Yoshiteru Watanabe, (Japan), N Koizumi, Y Yamagishi, E Hagiwara, H Mizuguchi, M Fujii 

Thu 155 Oxidative DNA damage induced by ethanol is associated with its ADH1B/ALDH2 metabolic pathway in 

human peripheral lymphocytes 

Chunfu Wu, (PR China), Y Yan, J Yang, Y Mou, L Wang 



drugs 

Thu 156 Population pharmacokinetics and pharmacogenetics of clobazam and its active metabolite in Japanese 

adults with refractory epilepsy 

Ikuko Yano, (Japan), M Shibata, S Yasuda, A Yokomasu, K Hosohata, S Masuda, A Ikeda, R Takahashi, 

K Inui 

Thu 157 Vascular effects of protease inhibitors and non-nucleoside reverse transcriptase inhibitors, the major 

components of highly active antiretroviral therapy [HAART] 

Yuen Ting Yeung, (PR China), SS Lee, PM Vanhoutte, SWS Leung 

Thu 158 The role of the reactive oxygen species (ROS)-induced ROS release mediated by mitochondrial 

permeability transition pore in iron overload resulted in hepatic damage 

Dong Yin, (PR China), D Liu, A Que, Q Huang, M He 

Thu 159 Urinary cortisone/cortisol ratio corrected with the cortisol concentration serves as an index for the 

activity of human11 β-HSD2 in vivo 

Akitomo Yokokawa, (Japan), H Shibasaki, T Furuta 

Thu 160 CYP2C9*3 and *13 alleles were significantly associated with the decreased metabolism of lornoxicam 

So-Jung Youn, (South Korea), J-W Bae, C-G Jang, S-Y Lee 

Thu 161 Impact of genetic variations in CYP450 enzymes on the pharmacokinetics of cilostazol 

So-Jung Youn, (South Korea), C-I Choi, J-W Bae, C-G Jang, S-Y Lee 

Thu 162 Partial effects of UGT1A1*28 allele on the pharmacokinetics of ezetimibe and its glucuronide in healthy 

subjects 

So-Jung Youn, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee 

Thu 163 Polyprenols facilitate transporting of adriamycin across brain-blood barrier via anti-angiogenesis and 

P-gp inhibition 

Shenghua Yuan, (PR China), W Ge, H Li, H Zhu, C Wang 

Thu 164 The influence of CYP2A6 polymorphism on artesunate and amodiaquine tolerability 

Wardah Yusof, (Malaysia), SH Gan 

Thu 165 Influence of calcium antagonists on DNA-damage induced by cyclophosphamide and dioxidine 

Aliy K Zhanataev, (Russian Federation), AV Kulakova, EA Anisina, AD Durnev, SB Seredenin 

Thu 166 Hangover effects of orally, nocturnally administrated antihistamines: a double-blinded, placebocontrolled, 

crossover positron emission tomography (PET) study in healthy subjects 

Dongying Zhang, (Japan), M Tashiro, K Shibuya, Y Funaki, S Watanuki, M Kato, K Yanai 

Thu 167 Creation of a new class of medicinal agents on the basis of nanotechnologies 

Vadim Zhdanov, (Russian Federation), A Dygai, A Artamonov, A Bekarev, E Vereschagin, A Churin 

Thu 168 Gender factors in pharmacokinetics of ciprofloxacin in healthy volunteers 

Jana Zoulova, (Czech Republic), J Kopecky, Z Vybiralova, J Chladek, K Macek, J Kvetina 


W29 New horizons in therapeutic drug management 

(TDM) 

Thu 169 A rapid and sensitive high-performance liquid chromatographic method to quantify carbamazepine, 

oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma 

Ana Fortuna, (Portugal), G Alves, L Santos, A Falcão, P Soares-da-Silva 

Thu 170 Biodistribution of 18F-labeled thermally hydrocarbonized porous silicon nanoparticles for drug delivery 

Mirkka Sarparanta, (Finland), E Mäkilä, T Heikkilä, J Salonen, V-P Lehto, HA Santos, J Hirvonen, 

AJ Airaksinen 




Thu 171 Aquaporin 4 deficiency modulates glutamate transporters expression and glutamate uptake in chronic 

morphine-treated mice 

Jin Li, (PR China), H-T Yan, N Wu, R-B Su, J-Q Zheng 

Thu 172 Tramadol reverses reserpine-induced hypothermia via μ opioid receptor in mice 

Jian-Hui Liang, (PR China), H-L Sun, M Zhang, K Wang 

Thu 173 Benzodiazepines reveals the addictive properties of buprenorphine in a conditioned place preference in 

mice 

Lin Lin Ma, (France), V Lelong-Boulouard, A Coquerel 

Thu 174 Effect of subchronic Pueraria radix extract administration on mRNA expression of POMC, PENK, PDYN, 

MOR, DOR and KOR genes in brain of WHP and WLP alcohol drinking rats 

Przemyslaw L Mikolajczak, (Poland), A Bogacz, M Karasiewicz, I Okulicz-Kozaryn, E Kaminska, 

M Szulc, P Figura, T Bobkiewicz-Kozlowska, W Dyr, W Kostowski, PM Mrozikiewicz 

Thu 175 The influence of magnesium, zinc and copper in reward system in rats 

Mihai Nechifor, (Romania), D Chelarescu, D Ciubotariu 

Thu 176 CNS effects of CB2 cannabinoid receptors 

Emmanuel Onaivi, (USA), H Ishiguro, Q-R Liu, J-P Gong, P Tagliaferro, A Brusco, G Uhl 

Thu 177 3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) in humans: Gender differences in 

pharmacodynamics and pharmacokinetics 

Ricardo Pardo, (Spain), M Farre, S Yubero, B O'Mahony, M Torrens, C Mustata, C Perez-Maña, 

E Menoyo, M Perez, S Martin, R de la Torre 

Thu 178 Role of the dose of ethanol on the generation of endogenous hydroxytyrosol-DOPET 

Clara Perez-Maña, (Spain), M Farre, R Pardo, C Mustata, E Papaseit, A Pastor, E Orrtiz, E Menoyo, 

M Perez, S Martin, R de la Torre 

Thu 179 In vivo upregulation of central nicotinic receptors induced by methylenedioxymethamphetamine (MDMA) 

and its association with nicotine 

David Pubill, (Spain), S Garcia-Ratés, E Escubedo, J Camarasa 

Thu 180 Cannabinoid-induced tolerance reduction by lithium chloride in guinea-pig small intestine 

Fatemeh Rezania, (Iran), S Ejtemaei Mehr, AR Dehpour 

Thu 181 A laboratory package for personalised methadone therapy 

Ismail Rusli, (Malaysia), SC Tan, HL Sim, M Nurfadhlina, KC Sanjaya, MZ Iqbal, T Nazila, R Fazni, 

N Mohamad 

Thu 182 Icariin attenuates learning and memory deficits induced by D-galactose in rats 

Jing-Shan Shi, (PR China), F Li, Q-H Gong, Q Wu, Y-F Lu 

Thu 183 CANCELLED 

Thu 184 Pharmacokinetics of Dendrobine, an alkaloid from Dendrobium nobile, in rats 

Jing-Shan Shi, (PR China), C Liu, Q Wu, Y-F Lu, Q-H Gong 

Thu 185 Reflection of Dendrobium nobile lindl. alkaloids on lipopolysaccharide induced tau protein 

hyperphosphorylation in the hippocampus of rats 

Jing-Shan Shi, (PR China), S Yang, F Li, Q-H Gong, Q Wu, Y-F Lu 




Thu 186 Resveratrol prevents the inflammatory process and the dopaminergic degeneration induced by the 

intranigral injection of lipopolysaccharide 

Jing-Shan Shi, (PR China), F Jin, H Jin, Q Wu, F Zhang, Y-F Lu, Q-H Gong 

Thu 187 Activation of GABA B receptors abolishes dopamine release induced by systemic amphetamine in the 

rat lateral septum 

Ramón Sotomayor-Zárate, (Chile), K Araya, P Pereira, P Carreño, K Gysling, G Quiroz, E Blanco 

Thu 188 Molecular mechanisms underlying the lack of δ-opioids-induced rewarding effects associated with the 

downregulation of central dopaminergic transmission under the neuropathic pain-like state 

Tsutomu Suzuki, (Japan), S Imai, M Narita, K Niikura, N Kuzumaki, M Narita 

Thu 189 The antihypnotic and antihypoxic effects of mildronate 

Baiba Svalbe, (Latvia), R Muceniece, E Vavers, E Liepinsh, L Zvejniece 

Thu 190 Ethanol and the cannabinoid system interaction at GABAergic synapses within the basolateral amygdala 

Giuseppe Talani, (Italy), DM Lovinger 

Thu 191 Investigation of morphine preference in Swiss and C57BL/6J mice 

David Taylor, (Australia), B Bernard, D Malone 

Thu 192 Increased vulnerability of perinatally drug-exposed rats towards subsequent drug abuse 

Julia Timar, (Hungary), M Sobor, S Gyarmati, P Riba, M Al-Khrasani, S Fürst 

Thu 193 Negative impact of methamphetamine on glutamatergic neuron-astrocyte interaction 

Ana Sofia Travassos, (Portugal), T Morgadinho, J Gonçalves, AP Silva, CF Ribeiro, FC Pereira 

Thu 194 Effects of single in vivo doses of gaboxadol, a high-efficacy agonist of extrasynaptic GABA-A receptors, 

on glutamatergic transmission in VTA DA neurons 

Elena V Vashchinkina, (Finland), AE Panhelainen, OY Vekovischeva, ER Korpi 

Thu 195 The selective mGluR7 agonist AMN082 inhibits cocaine-triggered relapse by a glutamate mechanism in 

the nucleus accumbens in rats 

Zheng-Xiong Xi, (USA), X Li, J Li, E Gardner 

Thu 196 Cocaine induces nitric oxide production and apoptosis in fetal rat myocardial cells 

Shumei Yang, (USA), G Li, L Zhang 



Thu 197 Protective role of the adrenomedullin receptor in vascular hypertrophy 

Lihuan Liang, (UK), C Tam, G Pozgai, R Siow, K Husmann, W Born, J Fischer, R Poston, A Shah, 

S Brain 

Thu 198 Intermittent hypoxia alters the expression of NMDA receptor subunits and antioxidant enzymes in the 

rat rostral ventrolateral medulla 

Hsun-Hsun Lin, (Taiwan), C-C Lai 

Thu 199 Plasma fibrinogen mediates the binding of streptokinase to activated human platelets 

Chao-Zong Liu, (Taiwan), P-S Jiang, L-Y Chang 

Thu 200 COX-1 or COX-2 deletion is associated with increased nuclear NF-κB in the endothelium of the aortic 

arch 

Martina H Lundberg, (UK), LS Harrington, PDM Leadbeater, TD Warner, JA Mitchell 

Thu 201 5-Hydroxytryptamine induces cycolooxygenase-2 through mechanism involving Src, PKC and MAPK in 

rat vascular smooth muscle cells 

Takuji Machida, (Japan), K Iizuka, M Hirafuji 

Thu 202 Interactions between carbon monoxide releasing molecules and nitric oxide donors in vascular tissue 

Antonia Marazioti, (Greece), P Baskaran, M Bucci, C Szabo, G Cirino, C Romao, AR Marques, A Beuve, 

A Papapetropoulos 

Thu 203 Spinal dihydroergotamine inhibits capsaicin-induced canine external carotid vasodilatation via central 

5-HT1B/1D receptors and α2-adrenoceptors 

Bruno Marichal-Cancino, (Mexico), G Manrique-Maldonado, A González-Hernández, 

MT Villamil-Hernández, O Alcántara-Vázquez del Mercado, D Centurión, A Sánchez-López, C Villalón 

Thu 204 Plasma melatonin primes for a long-term endothelial cell cultures 

Regina Markus, (Brazil), E Tamura, P Fernandes, M Marçola, S Cruz-Machado 

Thu 205 Glycosaminoglycans and candesartan prevent renal alteration and oxidative stress in the kidney of 

diabetic rats 

Yaira Mathison, (Venezuela), C Ciangherotti, M Álvarez, H Fernández, A Israel 

Thu 206 Nitric oxide levels in the renal cortex of streptozocin-induced diabetic rats treated with ramipril and 

eplerenone 

T Mavrakanas, Constantinos Tomos, (Greece), M Mironidou-Tzouveleki 

Thu 207 Effects of cyclooxygenase inhibitors on protease-activated receptor 2 activating peptide-induced 

relaxations of aorta in chronic angiotensin II treated mice 

John J McGuire, (Canada), KH Hughes 

Thu 208 Calcitonin gene-related peptide terminates endothelin-1-induced vasoconstriction and vasopressor 

responses 

Merlijn JPMT Meens, (The Netherlands), NJA Mattheij, H van Essen, MG Compeer, BJA Janssen, 

JGR De Mey 

Thu 209 Aspirin may prevent preeclampsia and its complications in women with abnormal uterine artery doppler 

ultrasound 

Elaheh Mesdaghinia, (Iran), H Talari, A Zolfagharpour, M Abedzadeh, P Rezapourian 

Thu 210 Nampt/Visfatin as a novel therapeutic target for stroke 

Chao-Yu Miao, (PR China), P Wang, T-Y Xu, W-W Tian, Y-F Guan, D-F Su, Y-C Rui, B Viollet, Q-W Zhai 



Thu 211 On pharmaco-physiological problems of hypertonia idiopathica 

Michael C Michailov, (Germany), E Neu, U Welscher, S Ivanova, N Senn, J Foltinova, W Seidenbusch 

Thu 212 Vasodilatory activity of a new quinoxaline N-acylhydrazone derivative LASSBio-1120: The participation 

of NO/cGMP pathway 

Ana Luisa Miranda, (Brazil), L Louback, LM Lima, A Monge, EJ Barreiro 

Thu 213 Distinct effects of tissue-type plasminogen activator and Cpd-7 on cerebrovascular inflammation during 

thrombolysis 

Takuro Miyazaki, (Japan), O Hisayuki, K Hasumi, K Honda 

Thu 214 Evaluation of the EndoPAT as a tool to assess endothelial function 

Matthijs Moerland, (The Netherlands), A Kales, L Schrier, D Bradnock, J Burggraaf 

Thu 215 Modulation of vasoactivity and platelet aggregation by 5-HT antagonism 

Matthijs Moerland, (The Netherlands), M Kemme, L Bergougnan, A Cohen, J Burggraaf 

Thu 216 Antiangiogenic effect of 4-hydroxychalcone 

Jan Mojzis, (Slovak Republic), L Varinska, M van Wijhe, P Koolwijk, L Mirossay, G Mojzisova 

Thu 217 Neutral sphingomyelinase-NADPH oxidase as a redox amplification pathway for hypoxic pulmonary 

vasoconstriction 

Laura Moreno, (Spain), G Frazziano, C Menendez, J Moral-Sanz, E Moreno, L Escolano, C Gonzalez, 

E Villamor, A Cogolludo, F Perez-Vizcaino 

Thu 218 Antihypertensive efficacy of aliskiren/hydrochlorothiazide combination: a meta-analytical approach 

Manuel Morgado, (Portugal), S Morgado, L Castanheira, A Macedo, M Castelo-Branco 

Thu 219 Boldine protects vascular endothelial function in Spontaneously Hypertensive rats (SHR) by inhibiting 

free radicals 

Dharmani D Murugan, (Malaysia), YS Lau, MR Mustafa 

Thu 220 Kallidinogenase inhibits the retinal neovascularization via the cleavage of VEGF 

Shinsuke Nakamura, (Japan), H Isuta, K Tsuruma, M Shimazawa, H Hara 

Thu 221 Antihypertensive efficacy of dual ECE/NEP inhibition during the onset of spontaneous hypertension in 

rats 

Jelly Nelissen, (TheNetherlands), BFJ Heijnen, P Lemkens, H van Essen, JGR De Mey, 

HAJ Struijker-Boudier, BJA Janssen 

Thu 222 Endothelin receptor activation reverses hypoxic vasodilation in porcine large coronary arteries 

Elise Nielsen, (Denmark), E Stankevicius, U Simonsen, O Fröbert 

Thu 223 Dexamethasone-releasing biodegradable vascular stents – in vitro and in vivo results 

R Nieminen, A Kotsar, I Uurto, Mari Hämäläinen, (Finland), J Mikkonen, J Leppiniemi, T Isotalo, M Talja, 

J-P Salenius, M Kellomäki, T Tammela, E Moilanen 

Thu 224 Roles of vinculin and Rho kinase on fibroblast fiber contraction 

Hiromi Nobe, (Japan), K Nobe, R Paul, K Honda, Y Sakai 

Thu 225 Aging has a negative effect on estrogen modulation of nitric oxide (NO) production in mice aorta 

Laura Novensa, (Spain), S Novella, G Segarra, P Medina, N Castillo, C Hermenegildo, AP Dantas 

Thu 226 Inhibitory role of phosphorylation of myosin light chain at threonine-9 in the mechanical activity of 

canine basilar artery 

Kazuo Obara, (Japan), T Ishikawa, K Nakayama 



Thu 227 Intravenous administration of sodium nitrite alleviates ischemia/reperfusion-induced cerebral injury in 

nondiabetic rats but not in diabetic rats 

Mari Okazaki, (Japan), N Iwata, E Takamura, S Kamiuchi, Y Hibino 

Thu 228 UII plays a proatherogenic role in the hyperglycemic milieu characteristic of diabetes 

Murat Olukman, (Turkey), A Watson, TJ Allen, ME Cooper 

Thu 229 The mechanism of contractions induced by electrical field stimulation of rat mesenteric artery in 

calcium-free solution 

Melike Hacer Ozkan, (Turkey), S Uma 

Thu 230 Effects of atorvastatin and L-arginine pretreatments on electrical field stimulation-mediated relaxations 

in monocrotaline-induced pulmonary hypertensive rats 

Elif Inci Ozturk, (Turkey), S Uma 

Thu 231 Circulating molecules lipoprotein – HDL, LDL AND VLDL: possible risk factor with function of time in 

restenosis? 

Snezana Pantovic, (Republic of Serbia), M Martinovic 

Thu 232 The growth factor pleiotrophin induces migration of endothelial and tumour cells that express ανβ3 

integrin and nucleolin on their cell surface 

Evangelia Papadimitriou, (Greece), M Koutsioumpa, C Mikelis 

Thu 233 The effect of rapamycin on endothelial function 

Ayse Parlar, (Turkey), A Erol, C Can 

Thu 234 Cystamine reduces blood pressure in SHR and attenuates inward eutrophic remodelling in vitro 

Morten Engholm Pedersen, (Denmark), A Eftekhari, MJ Mulvany 

Thu 235 Dual changes in pulmonary vascular reactivity in rats with ventilator-induced lung injury 

Francisco Perez Vizcaino, (Spain), C Menedez, L Martinez-Caro, J Moral-Sanz, E Moreno, JA Lorente, 

N Nin, A Esteban 

Thu 236 Participation of endothelial superoxide anion on alteration of angiotensin II-induced contraction in 

contralateral carotid of diabetic rats after balloon catheter injury 

Larissa Pernomian, (Brazil), M Santos Gomes, AM de Oliveira 

Thu 237 Endothelial TREK-1 potassium channels mediate acetylcholine-induced longitudinal hyperpolarization 

transfer to synchronize the diameter changes along cerebral arteries 

Olivier Pétrault, (France), C Widmann, C Misioreck, M De Bock, V Bérézovski, L Leybaert, R Ceccelli, 

C Heurteaux, M Borsotto 

Thu 238 Effect of chronic shear stress on endothelial cell morphology in vitro and in vivo: relevance to areas at 

risk of atherosclerosis in the aorta 

Claire MF Potter, (UK), MH Lundberg, HH Gashaw, J Gorelik, AV Moshkov, LS Harrington, 

PD Weinberg, JA Mitchell 

Thu 239 Importance of cerebrovascular vasoconstrictor receptor upregulation for the long-term outcome of 

experimental subarachnoid hemorrhage in rats 

Gro Klitgaard Povlsen, (Denmark), S Johansson, C Larsen, L Edvinsson 

Thu 240 Endothelial progenitor cell depletion in atherosclerotic patients is not related to increased apoptosis by 

plasmatic TGF-β 

Santiago Redondo, (Spain), A Gonzalez-Rocafort, J Navarro-Dorado, M Ramajo, M Hristov, 

A Gordillo-Moscoso, F Reguillo, M Carnero, E Rodriguez, C Weber, T Tejerina 



Thu 241 TLR3 and TLR4 ligands induce intracellular IL-1β immunoreactivity in human aortic endothelial cells 

(HAEC) and lung microvascular endothelial cells (HLMVECs) 

Daniel M Reed, (UK), WR Wright, CMF Potter, HH Gashaw, LK Bailey, M Paul-Clark, JA Mitchell 

Thu 242 Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in renovascular 

hypertension 

Vincent Richard, (France), J Gao, E Gomez, B Dautreaux, F Bounoure, M Skiba, C Thuillez, J Bellien 

Thu 243 Improved vascular function and altered cardiac phenotype in mice overexpressing melanocytestimulating 

hormone 

Petteri Rinne, (Finland), I Heinonen, A Saraste, ST Ruohonen, S Ruohonen, E Savontaus 

Thu 244 Non-invasive laser speckle contrast imaging to assess skin microvascular reactivity in humans 

Matthieu Roustit, (France), C Millet, S Blaise, B Dufournet, J-L Cracowski 

Thu 245 Cathodal iontophoresis of treprostinil and iloprost induce a sustained increase in skin blood flow in rats 

Matthieu Roustit, (France), S Blaise, C Ribuot, C Millet, J-L Cracowski 

Thu 246 Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen and flurbiprofen in human blood 

Maria Isabel Ruiz-Moreno, (Spain), JJ Reyes-Vega, JA Lopez-Villodres, N Jebrouni, JA Gonzalez-Correa, 

JP de la Cruz 

Thu 247 Effect of cinnamaldehyde (C) on vascular function in diabetic rats 

Ramzi Sabra, (Lebanon), M Khalaf 

Thu 248 Involvement of secretory phospholipase A2 in stretch-induced aberrant contraction in pulmonary 

arteries isolated from pulmonary hypertensive rats 

Maki Saito, (Japan), Y Tanabe, A Kamataki, T Sawai, K Nakayama 

Thu 249 Differential COX-2-mediated arachidonic acid metabolism in coronary and penile arteries from 

prediabetic obese Zucker rats 

A Sánchez, C Contreras, N Villalba, P Martínez, A García-Sacristán, M Hernández, Dolores Prieto, 

(Spain) 

Thu 250 Thyroid hormone up-regulates elastin and lysyl oxidase genes in rat aorta 

Mitsutoshi Satoh, (Japan), S Yanagino, T Nishimaki-Mogami, K Suzuki, Y Sato 

Thu 251 NO synthase and Thrombospondin-1 in the initiation of flow-related reModelling of rat mesenteric 

resistance arteries 

Paul Schiffers, (The Netherlands), P Lemkens, G Boari, G Fazzi, G Janssen, J Murphy-Ullrich, J De Mey 

Thu 252 Distinct NADPH-cytochrome P450 reductase dependence of heme oxygenase-1 and heme oxygenase-2 

Monika Seeanner, (Germany), JR Kraehling, M Busker, S Behrends 

Thu 253 In vitro dissolution kinetics studies of amlodipine tablets marketed in Russia under biowaiver conditions 

IE Shohin, GV Ramenskaya, GF Vasilenko, EA Malashenko, KS Davydova, Dmitry A Sychev, (Russian 

Federation), VG Kukes 

Thu 254 Role of AT1 and AT2 receptor and NAD(P)H oxidase on angiotensin II-stimulated antioxidant enzymes 

activity in the rat hypothalamus 

Jose Silva, (Venezuela), M Pastorello, S De Jesus, MG Matos, MR Garrido, A Israel 

Thu 255 Potential beneficial effect of ergothioneine in protecting endothelial dysfunction 

Albert SM Sit, (PR China), EYW Ho, RWS Li, YW Kwan, M Hausman, PM Vanhoutte, GPH Leung 



Thu 256 Statin-dependent effects on vascular tone and gene expression in human endothelial cells 

Cristine Skogastierna, (Sweden), L Luksha, K Kublickiene, E Eliasson, A Rane, L Ekström 

Thu 257 Adding ezetimibe to statin halts progression of carotid plaque 

J David Spence, (Canada) 

Thu 258 Involvement of endothelial sphingolipid metabolism in release and action of endothelium-derived 

contracting factors 

Léon Spijkers, (The Netherlands), R van der Akker, A Alewijnse, S Peters 

Thu 259 Small and intermediate calcium-activated K channels are involved in release of NO and EDHF in small 

arteries 

Edgaras Stankevicius, (Denmark), C Krøjgaard, T Dalsgaard, L Beck, AD Hughes, U Simonsen 

Thu 260 Electropharmacological analysis of triggered activity in the pulmonary vein myocardium of the guinea 

pig 

Akira Takahara, (Japan), T Sugimoto, K Takeda, I Namekata, H Tanaka 

Thu 261 Proton mediates perivascular adrenergic and CGRPericg neurotransmission in the rat mesenteric artery 

Shingo Takatori, (Japan), K Hirai, H Fujiwara, X Jin, S Egutchi, Y Kitamura, H Kawasaki 

Thu 262 ω6-polyunsatulated fatty acids, but not other free fatty acids, evoke endothelial dysfunction by inhibiting 

store-operated Ca2+ entries 

Kazuhiko Takeuchi, (Japan), J Wei, N Inui, H Watanabe 

Thu 263 Different contributions of Rho-kinase to the vasoconstrictions caused by 5-HT and noradrenalin in the 

isolated human internal thoracic artery and saphenous vein 

Naoko Tanaka, (Japan), T Kanai, Y Matsuo, M Kuwabara, E Nakamura, K Nakamura, Y Asada, H Hisa, 

R Yamamoto 

Thu 264 Impaired arterial smooth muscle calcium signalling and ultrastructural deterioration appear linked in the 

elderly 

Teresa Tejerina, (Spain), J Navarro-Dorado, M Alonso, M Ramajo, S Redondo, C van Breemen, 

N Fameli 

Thu 265 Renovascular hypertension increases the hypothalamic content of serotonin in rats 

José A Terrón, (Mexico), B García-Iglesias, I López-Islas 

Thu 266 FP and TP receptors are responsible for increased vasoconstriction induced by Prostaglandin F2α in 

preeclamptic human umbilical vein 

Gokce Topal Tanyilmaz, (Turkey), SB Uydes Dogan, M Kucur, A Gezer, R Madazli, O Ozdemir, X Norel 

Thu 267 Endothelial cells during a parabolic flight – which changes appear? 

C Ulbrich, Jessica Pietsch, (Germany), J Bauer, D Grimm 

Thu 268 Protective effect of amlodipine against the decrease in bone density in rats 

Kentarou Ushijima, (Japan), Y Liu, E Ishikawa, T Maekawa, Y Motosugi, H Ando, A Fujimura 

Thu 269 Sensitivity to Rho kinase inhibitor Y-27632 is increased in the mesenteric arteries of L-NAME 

hypertensive rats 

B Sonmez Uydes-Dogan, (Turkey), F Gezerler, S Takir, FI Alp, O Ozdemir 

Thu 270 Genomic changes caused by chronic exposure to high cholesterol or fish oil in native and regenerated 

porcine coronary endothelial cells 

Paul M Vanhoutte, (PR China), MYK Lee, Y Wang, HF Tse 



Thu 271 Effect of sulodexide on aortic vasodilation capacity and associated morphological changes in rats with 

streptozotocin-induced diabetes 

José Vázquez, (Venezuela), Y Mathison, E Romero, C Suárez 

Thu 272 Peroxynitrite stimulates pulmonary artery endothelial cell proliferation and may be generated in 

pulmonary hypertension 

Roger Wadsworth, (UK), EO Agbani, P Milliken, AT Demiryurek, P Coats, A Mills, A McPhaden, T Hoehn 

Thu 273 EDHF-mediated responses in the renal circulation of double transgenic hypertensive mice developing 

renal failure 

Ludovic Waeckel, (France), F Bertin, N Clavreul, R Kohler, P Sansilvestri-Morel, S Simonet, 

C Vayssettes-Courchay, H Wulff, TJ Verbeuren, M Félétou 

Thu 274 Endothelial dysfunction in the isolated aorta of double transgenic hypertensive mice developing aortic 

aneurysm 

Ludovic Waeckel, (France), N Clavreul, P Sansilvestri-Morel, S Simonet, C Vayssettes-Courchay, 

TJ Verbeuren, M Félétou 

Thu 275 Histidine-rich glycoprotein inhibits the angiogenic response induced by the combination of high mobility 

group box 1 and heparin in matrigel plug assay 

Hidenori Wake, (Japan), S Mori, HK Takahashi, K Liu, M Nishibori 

Thu 276 AGEs breakers reverse endothelial cell dysfunction and enhance the antihypertensive effect of 

Nifedipine in diabetic-hypertensive rats 

LiLi Wang, (PR China), B Zhang, G Chen, S Li 

Thu 277 Exercise improves the dilatation function of mesenteric artery in post-infarction rats: involved the 

mechanism of PI3K/Akt mediated eNOS cascaded 

Y-H Wang, (PR China), S-P Wang, H-K Jiang, S-F Chen, M Zhao, J Yang, J Zhang, Y Cai, S-J Fan, 

Y-L Tian, X-J Yu, W-J Zang 

Thu 278 20-HETE activation of TRPV1 in small diameter primary sensory neurons 

Hairuo Wen, (UK), J Östman, C Panayiotou, J Priestley, M Baker, A Ahluwalia 

Thu 279 Reduced action of sildenafil in pulmonary arteries from mice lacking the PKGI or the BKCa channel 

Matthias Werner, (UK), S Lia, M Nelson, A Gurney 

Thu 280 Albumin-facilitated extravasation of siRNA across vascular endothelium in vivo 

Paul White, (Australia), S Lau, N Cao, B Graham, C Pouton, B Boyd 

Thu 281 Both D- and L-arginine increase contractions to dexmedetomidine in the presence of L-NAME in the rat 

aorta with endothelium 

Emily SW Wong, (PR China), RYK Man, PM Vanhoutte, KFJ Ng 

Thu 282 Chronic treatment of Vitamin D derivatives reduce endothelium-dependent contractions in the aorta of 

the spontaneously hypertensive rat 

Michael SK Wong, (PR China), RYK Man, PM Vanhoutte 

Thu 283 Role of hydrogen sulfide (H2S) in conduit and resistance arteries from septic rats 

Chin-Chen Wu, (Taiwan), S-J Chen, C-T Chiu, M-H Liao 

Thu 284 Effects of CYP7A1 polymorphisms on the fasting plasma concentrations of bile acids, bile acid 

synthesis marker, and total cholesterol in humans 

Xiaoqiang Xiang, (Finland), PJ Neuvonen, M Niemi 



Thu 285 Radiation of electromagnetic waves to a finger using Yubi-MR reduces oxidative stress in blood by 

electron-transfer via negatively charged water formation 

Naomasa Yamamoto, (Japan), Y Koike, K Kumano, N Yonehara 

Thu 286 CNS pericytes originate from the circulating hematopoietic progenitors 

Seiji Yamamoto, (Japan), M Muramatsu, E Azuma, M Dohmoto, S Kita, T Iwamoto, I Komuro, 

K Takano, S Niida, M Shibuya, N Matsuda, Y Hattori 

Thu 287 AVE3085 inhibits homocysteine-induced endothelial dysfunction: role of phosphatidylinositol 3-kinase / 

Protein kinase Akt 

Qin Yang, (PR China), H-M Xue, J-H Huang, G-W He 

Thu 288 Role of canonical transient receptor potential channels in endothelial function and the effect of 

hypoxia-reoxygenation 

Qin Yang, (PR China), J-H Huang, H-M Xue, X-Q Yao, G-W He 

Thu 289 Vasodilatation to NO- in rat small mesenteric arteries; a role for potassium channels 

Polina Yarova, (UK), C Garland, K Dora 

Thu 290 Mechanism for the differential regulation of iNOS expression in J774 macrophages and vascular 

smooth muscle cells by the c-Jun N-terminal kinase inhibitor SP600125 

Marzieh Zamani, (UK), S Thakur, A Baydoun 

Thu 291 The influence of moxonidine on plasma resistin levels in patients with essential hypertension 

Iwona Zaporowska-Stachowiak, (Poland), A Targonska, T Bobkiewicz-Kozowska 

Thu 292 Protective effect of celecoxib against acute myocardial ischemia on coronary artery of rabbits 

M Zhao, X He, H-L Zhang, X-J Yu, Wei-Jin Zang, (PR China) 

Thu 293 Generating novel hypothetical associations between statin therapy and endothelial adhesion molecules 

using computerized tool SemBT 

Lovro Ziberna, (Slovenia), M Lunder, G Drevensek, D Hristovski 

Thu 294 Vitamin D3 does not augment EDHF-mediated relaxations to bradykinin 

Qian Zou, (PR China), PM Vanhoutte 



Thu 295 Protective effects of Ganoderma lucidum polysaccharides on intestine damage in vivo and in vitro and 

mechanisms approach 

Wei Dong Li, (PR China), LH Chen, J Ma, Y Qin, JQ Zhang, J Yang, ZB Lin 

Thu 296 Proteomic study of hepatotoxicity induced by retrorsine, a representative pyrrolizidine alkaloid 

Yanhong Li, (PR China), WCS Tai, N Li, WLW Hsiao, G Lin 

Thu 297 In vivo and in vitro mechanistic studies of the wound-healing effects of Radix Rehmanniae towards 

diabetic foot ulcer using bioassay-guided fractionation 

Cheuk-Lun Liu, (PR China), L Cheng, HF Kwok, KM Lau, CM Koon, CP Lau, KP Fung, BS Lau 

Thu 298 Oxidative stress-induced stimulation of AMP-activated protein kinase involves in sodium ferulate-induced 

cardioprotection 

Dan Liu, (PR China), D Yin, L Tang, B Zhong, D Sun, M He 

Thu 299 Effects and mechanism of WNK on reperfusion-induced vascular injury to cerebral microvessels after 

global cerebral ischemia 

Jianxun Liu, (PR China), Y Zheng, X Li, L Xu 

Thu 300 Antioxidant activity of oligosaccharide ester extracted from Polygala tenuifolia roots in senescenceaccelerated 

mice 

Ping Liu, (PR China), Y Hu 

Thu 301 San-Huang- Xie-Xin-Tang protects against MPTP-induced dopaminergic neurotoxicity via inhibition of 

oxidative stress and apoptosis 

Yi-Ching Lo, (Taiwan), Y-T Shih 

Thu 302 Complementary and alternative drugs use among preoperative patients: A cross-sectional study in 

Tuscany (Italy) 

Ersilia Lucenteforte, (Italy), E Gallo, A Pugi, F Giommoni, P Lupi, M La Torre, G Diddi, F Firenzuoli, 

A Mugelli, A Vannacci, F Lapi 

Thu 303 Investigation of the phytochemistry, antioxidant activities and anticancer effects of total extract and 

some of the purified compounds of Ferula szowitsiana D.C. on several human cancer cell lines 

Omid Mashinchian, (Iran) 

Thu 304 Role of Terminalia arjuna an Indian medicinal plant in cardiovascular diseases 

Subir Kumar Maulik, (India) 

Thu 305 The neuroprotective effects of a purified compound extracted from curcuma longa against 6-OHDA - 

induced dopaminergic neurotoxicity in SH-SY5Y cells 

Benjawan Meesarapee, (Thailand), A Thampithak, Y Jaisin, Y Sanvarinda 

Thu 306 Simultaneous determination of gallic acid and protocatechuic acid in rabbit serum by HPLC after oral 

administration of Fructus choerospondiatis extract 

Xianli Meng, (PR China), P Wang, Y Zhang, H Liu 

Thu 307 Effects of a water-soluble Cinnamomum cassia extract on isolated rat platelets 

Zsofia Mezei, (Hungary), G Mester, Z Mécs, A Leprán, D Rédei, G Szabó 

Thu 308 Antiproliferative activity of some solanidine analogs on HL-60 cells 

Renata Minorics, (Hungary), T Szekeres, G Krupitza, P Saiko, B Giessrigl, J Wölfling, E Frank, I Zupkó 

Thu 309 Synthesis and cytotoxic activity of novel benzopyrano[3,2-c]chromene-6,8-dione derivatives 

Ramin Miri, (Iran), O Firuzi, S Meili, AR Mehdipour, R Motamedi, A Shafiee 



Thu 310 Effect of Polygonum bistorta and tannic acid against carbon tetrachloride induced hepatic damage in 

albino rats 

Deepak Kumar Mittal, (India) 

Thu 311 Clinical efficacy of a topical herbal cream (aloe vera, geranium robertianum and lavandula stoechas) in 

second-degree burn wounds 

Yashar Moharamzad, (Iran), Y Panahi, F Beiraghdar, I Feizi 

Thu 312 Evaluation of the reproductive and developmental toxicities of the aqueous extract of Labisia pumila 

var. alata in female rats 

Wan Ezumi Mohd Fuad, (Malaysia), SS Amrah, J Hasnan, SSJ Mohsin 

Thu 313 Analyzing cytotoxic and apoptogenic properties of Scutellaria litwinowii root extract on cancer cell lines 

Seyed Hadi Mousavi, (Iran), SA Emami, Z Tayarani-Najaran, J Asili, A Mirzaei 

Thu 314 Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice 

Xin Mu, (PR China), G He, X Li, G Du 

Thu 315 The effects of the aqueous extract of Asystasia gangetica on the blood pressure and heart rate in 

spontaneously hypertensive male wistar rats 

Pierre Mugabo, (South Africa), J-A Amunjela, D Hanse, G Hikumwah, F Hoedemaker, M Motsoaole, 

P Mwandingi, X Sambo 

Thu 316 Anti-inflammatory effects of bergamot essential oil in carrageenan-induced paw oedema in rat 

Michele Navarra, (Italy), C Mannucci, E Trapasso, S Pergolizzi, MR Ursino, S Micali, N Miceli, 

G Calapai 

Thu 317 The multi-herbal drug STW 5: potential mechanisms for the treatment of irritable bowel syndrome 

Karen Nieber, (Germany), M Michael, U Voss, D Weiser, O Kelber 

Thu 318 Ibogain in vitro effects on erythrocytes antioxidative enzymes activites 

Aleksandra Nikolic-Kokic, (Republic of Serbia), Z Orescanin-Dusic, M Slavic, P Jamnik, R Paskulin, 

M Spasic, D Blagojevic 

Thu 319 Possible drug interaction with Oren-gedoku-to by the inhibition of CYP2D metabolism 

Yuki Nishimura, (Japan), N Kurata, M Iwase, Y Saito, H Yasuhara 

Thu 320 Antitumor effect of Cordyceps sinensis via adenosine receptors 

Arisa Nishiuchi, (Japan), N Yoshikawa, Y Takahashi, Y Kimoto, A Sato, M Kunitomo, S Kagota, 

K Shinozuka, K Nakamura 

Thu 321 Biochemical and blood pressure alterations of elderly patients with colorectal cancer after of dietary 

supplementation with Agaricus Sylvaticus fungi 

Maria Rita Novaes, (Brazil), R Fortes, LC Novaes 

Thu 322 Effects of dietary supplementation with Agaricus Sylvaticus fungi on the metabolic and blood pressure 

evaluation of patients with colorectal cancer in the postsurgical phase 

Maria Rita Novaes, (Brazil), R Fortes 

Thu 323 Immunological and hematological effects of a dietary supplementation with Agaricus Sylvaticus in 

breast cancer patients undergoing chemotherapy 

Maria Rita Novaes, (Brazil), F Valadares 

Thu 324 Cardioprotective effect of resveratrol 

Aleksandra Novakovic, (Republic of Serbia), LG Bukarica, D Nezic, M Peric, V Kanjuh 



Thu 325 Inhibition of prostate cell growth and angiogenesis induced by different phytosterols of marine origin 

Silvia Novio, (Spain), M Freire-Garabal, G Amigo, MJ Nuñez-Iglesias 

Thu 326 Evaluating the anti-diabetic properties of Paspalum vaginatum 

Nkechi Veronica Offiah, (Trinidad & Tobago), CD Ezeokoli 

Thu 327 The study of antidiabetic effects of partially purified extract from the roots of Thottea grandiflora Rottb 

Patrick Okechukwu, (Malaysia), G Marimuthu, GA Akuwoah 

Thu 328 Antimalaria and anticancer properties of Labisia pumila 

Maizatul Hasyima Omar, (UK), A Crozier, NR Abdullah, Z Ismail 

Thu 329 Effects of ibogaine on rat uterus contraction and antioxidative enzymes activity 

Zorana Orescanin-Dusic, (Republic of Serbia), M Slavic, R Paskulin, P Jamnik, S Milovanovic, M Spasic, 

D Blagojevic 

Thu 330 In vivo evaluation of the antitumor activity of daphnetin in murine melanoma model 

Fausto AJ Orozco, (Mexico), MJ García Mondragón, A Maldonado Espinza, MA Herrera Henriquez, 

N Mendoza Patiño, JJ Mandoki Weitzner 

Thu 331 Chinese herbal medicine ‘Wu Ling San’ had anti-inflammatory activity in crystal induced nephritis in rats 

Yoko Oyama, (Japan), S Tancharoen, T Ito, T Hashiguchi, T Uchimura, K Kawahara, I Maruyama 

Thu 332 Antioxidant effect of a methanol extract of Garcinia kola biflavonoid agbilu 

Jones Chukwudi Ozokwere, (South Africa), F Udoh, B Lawal, E Olivier 

Thu 333 Study of antidepressant activity of portulaca oleracea linn in mice 

Vinod Pawar, (India), S Gujar, S Rayate, RN Patil, S Hugar 

Thu 334 Acute and subacute toxicity of virgin coconut oil in rodents 

Ryan Pekson, (The Philippines), I Sia 

Thu 335 Optimization of aristolochic acid I detection in Aristolochia tagala Cham and Thai traditional recipe using 

TLC 

Rattana Phadungrakwittaya, (Thailand), P Akarasereenont, A Lumlerdkij, S Chaisri, S Chotewuttakorn, 

T Laohapand 

Thu 336 Membrane with a vegetative extract based on the collagen for tissue regeneration 

Guram Pichkhadze, (Kazakhstan), G Ustenova, I Kaulambaeva, D Assylbekova 

Thu 337 Cannabidiol inhibits human cancer cell invasion via upregulation of tissue inhibitor of matrix 

metalloproteinases-1 

Robert Ramer, (Germany), J Merkord, B Hinz 

Thu 338 Intraperitoneal and oral LD50 of an active principle of Nigella sativa, thymoquinone, in mice and rats 

Muhammad Akram Randhawa, (Saudi Arabia), A Al-Ali, AA Alkhawajah, NA Shaikh 

Thu 339 Regulatory status of herbal medicines. Considerations about Cuba 

Diadelis Remirez-Figueredo, (Cuba) 

Thu 340 Analysing on compatibility principle of pharmacologic action of traditional Chinese medicine formula by 

network approach 

Junguo Ren, (PR China), X Ma, C Lin, H Li, M Wang, J Li, Y Wang, J Liu 



Thu 341 Bak foong pills, a traditional remedy for dysmenorrhoea, inhibits nociception via the somatostatin 

pathway 

Dewi K Rowlands, (PR China), YG Cui, SC So, LL Tsang, YW Chung, HC Chan 

Thu 342 Protective effect of Nigella sativa extract and thymoquinone on serum/glucose deprivation-induced 

PC12 cells death 

Hamid Reza Sadeghnia, (Iran), SH Mousavi, Z Tayarani-Najaran, M Asghari 

Thu 343 Effect of anchusan, Japanese traditional herbal medicine, on midazolam metabolism in rats 

Yusuke Saito, (Japan), Y Nishimura, N Kurata, M Iwase, H Yasuhara 

Thu 344 San'oshashinto prevents cardiac ischemia/reperfusion injury in ovariectomized rat via antioxidant 

properties 

Mayuko Sakanashi, (Japan), T Matsuzaki, K Noguchi, J Nakasone, M Sakanashi, K Chinen, 

M Sakanashi, M Tsutsui 

Thu 345 Effect of momordica charantia on blood glucose level in experimentally induced diabetic rats 

Mahmed Salahuddin, (Bangladesh) 

Thu 346 Effect of three plants: Hypericum humifusum, Crataegus L. Azarolus and Myrtus Communis L. on 

ischemia-reperfusion liver in Wistar male rats 

I Salouage, H Ferchichi, T Ayadi, S Bacha, I Ouanes, M Lakhal, Anis Klouz (Tunisia) 

Thu 347 Antioxidant activity of Rhizophora mangle (L.) bark and its effect on redox mechanisms involved in 

wound healing 

J Sánchez Calero, R Faure García, G Martínez Sánchez, O Fernández Limia, M Mitjavila Cors, 

E Marrero Faz, Yinet Barrese-Pérez, (Cuba) 

Thu 348 Selective detection of CYP3A4 inhibition by complementary products 

Danielle Sevior, (Finland), J Hokkanen, A Tolonen, K Abass, L Tursas, O Pelkonen, J Ahokas 

Thu 349 The “Zinaxin” clinical – pharmacological application aspects 

Evgeniya Shikh, (Russian Federation), O Shumkova 

Thu 350 Cinnamomi ramulus ethanol extract exerts vasorelaxation through inhibition of the rho-kinase signalling 

pathway 

Heung Shin, (South Korea), Y Kang 

Thu 351 Solavetivone reduces intracellular calcium in cultured myocytes isolated from guinea-pig ileum 

Joelmir LV Silva, (Brazil), F De Andrade Cavalcante, VLC Rigoni, TMS Silva, TL Nascimento, 

J Aboulafia, BA Silva, VLA Nouailhetas 

Thu 352 Trachylobane-360 decreases intracellular calcium in cultured myocytes isolated from guinea-pig ileum 

Joelmir LV Silva, (Brazil), RF Santos, VLS Rigoni, JJF Tavares, MS Silva, TL Nascimento, J Aboulafia, 

BA Silva, VLA Nouailhetas 

Thu 353 Crotalus durissus terrificus snake venom: a potential natural product in controlling inflammatory 

diseases 

Tatiane Soares de Lima, (Brazil), S Coccuzzo Sampaio, MC Cirillo 

Thu 354 On future phytopharmacology 

Jakob Stiglmayr, (Germany), J Milbradt, E Neu, SK Gupta, J Foltinova, M Schratz, W Seidenbusch, 

G Weber, N Senn, R Neu, U Welscher, M Michailov 



Thu 355 Mechanism of action of compounds isolated from Cecropia glazioui Sneth, a plant used to treat 

hypertension in Brazilian folk medicine 

Mirtes Tanae, (Brazil), MTR Lima-Landman, TMA Lima, KKY Isla, C Souccar, AJ Lapa 

Thu 356 Effects of a standardized extract of Centella asiatica ECa 233 on second degree burn wound in rats 

Boonyong Tantisira, (Thailand), M Tantisira, K Wannarat 

Thu 357 A randomized, single blind, placebo controlled trial on the effects of a standardized extract of Centella 

asiatica ECa 233 on minor aphthous ulcers 

Mayuree Tantisira, (Thailand), C Ruengprasertkit, B Tantisira, N Hongprasong 

Thu 358 Study of the effects of natural zeolite modified with zinc (ZZ) and its cellular signalling mechanisms in 

diabetes 

A Torres Domínguez, O León, G Rodríguez, LC de Menorval, M Casanova, L Rodriguez, 

René Delgardo-Hernandez, (Cuba) 

Thu 359 Non-ethanol fractions isolated from red wine have potent vasodilation activity in isolated rat aorta 

Milena Trandafilovic, (Republic of Serbia), M Janzek, L Ziberna, M Lunder, S Kreft, D Janes, 

G Drevensek 

Thu 360 Pro-apoptotic effect of ouabain in Jurkat and A549 cells 

Annalisa Trenti, (Italy), F Cusinato, S Luciani, L Trevisi 

Thu 361 The safety of Aristolochia tagala Cham. and Homnawakod recipe in Wistar rats: renal function study 

Pinpat Tripatara, (Thailand), S Booranasubkajorn, S Soukasem, W Onlamul, S Huabprasert, 

A Lumlerdkj 

Thu 362 Post-treatment with an active component of Scutellariae radix (TChi-2) reduces LPS-induced acute lung 

injuries and fatality 

Tzu-Ling Tseng, (Taiwan), M-F Chen, Y-H Hsu, TJF Lee 

Thu 363 Evaluation of haematinic activity of naga bhasma(NB) in phenylhydrazine induced haemolytic anaemia in 

rats 

Vaishali R Undale, (India), AV Yadav, PN Jagtap, CD Upasani, AV Bhosale 

Thu 364 Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell 

growth 

MR Ursino, E Trapasso, G Calapai, P Bramanti, Michele Navarra, (Italy) 

Thu 365 In vitro antimicrobial activity of some herbal extracts against oral pathogens 

Surena Vahabi, (Iran), E Najafi 

Thu 366 Sreening of Portuguese propolis and its plant sources for inhibitory activity against pathogenic 

protozoa 

Nuno Vale, (Portugal), S Falcão, V Batista, C Freire, L Maes, M Villas-Boas 

Thu 367 Effects of apple polyphenols on oxidative DNA damage induced by ethanol 

Fang Wang, (PR China), J Yang, J Du, C Wu 

Thu 368 The effectiveness and safety of arsenic trioxide with and without all-trans retinoic acid in the treatment 

of acute promyelocytic leukaemia: a meta-analysis 

Hao Wang, (PR China), Z-X Rong, H Qi, Y Zhang, B-S Wang, H-Z Chen 

Thu 369 Study on absorption kinetics of baicalin in extracted scutellaria affected by Rubarb anthraquinones 

Ping Wang, (PR China), X Meng, Y Zhang, H Liu 



Thu 370 Neuroprotective effects of morroniside against transient forebrain ischemia in the rat cortex 

Wen Wang, (PR China), L Li, J Xiang, H Ai, L Zhang, P Wang, L Li 

Thu 371 Liquorice, pharmacological and clinical experiments from the traditional Chinese medicine to the 

modern research 

Xiaoying Wang, (China), H Zhang, X Gao 

Thu 372 The action mechanism and metabolism characteristics of the effective components groups of 

Xiaoxuming decoction for anti-ischemia 

Yuehua Wang, (PR China), N Zhou, X He, J Hu, H Zhang, Y Ding, H Qin, J Zhang, Z Li, G Du 

Thu 373 Lutein, a natural carotenoid, inhibits PDGF-BB and oxidative stress-induced signalling in vascular smooth 

muscle cells 

Wen-Bin Wu, (Taiwan), Y-C Lin 

Thu 374 Ellucidation of Crotalus durissus cascavella natriuretic peptide mode of action in isolated rat kidney: 

Expression of GC-A and GC-C receptors 

Rafael Matos Ximenes, (Brazil), JSAM Evangelista, RS Alves, ARC Jorge, PCP Sousa, AMC Martins, 

MEA Moraes, MM Rabello, MZ Hernandes, MH Toyama, A Havt, HSA Monteiro 

Thu 375 Effect of three purine alkaloids in tea on learning and memory functions of ratss exposed to restraint 

stress 

Jie-Kun Xu, (PR China), W-K Zhang, Q-G Wang, K Hiroshi, X-S Yao 

Thu 376 WNK improves learning and memory by modulating the neurotransmitter levels in rats and mice with 

vascular demantia 

Li Xu, (PR China), J-X Liu, W-H Cong 

Thu 377 Curcumin inhibits renal cyst formation and enlargement through regulating intracellular signalling 

pathways 

Baoxue Yang, (PR China), J Gao, H Zhou, T Lei, W Li, X Li 

Thu 378 Cornel iridoid glycoside promotes cell survival via the activation of PI-3K/Akt signalling pathway after 

stroke in the rat 

Ruiqin Yao, (China), X Wang, X Liu, L Zhang, C Ye, W Wang, H Ai, L Li 

Thu 379 Morinda Citrifolia leave extract prolongs human blood coagulation in vitro 

Peng Nam Yeoh, (Malaysia), JK Kumar, JW Mak, SK Cheong 

Thu 380 Effect of Morinda citrifolia hot water extract on platelet aggregation 

Peng Nam Yeoh, (Malaysia), V Ramachandran, JW Mak, SK Cheong, CF Leong 

Thu 381 Mitochondria and dihydrotanshinone-induced apoptosis in HepG2 cells 

JHK Yeung, WYW Lee, Peter Xuelin Zhou, (PR China), YW Kwan, SK Kong, HP Ho 

Thu 382 Gravidoprotective activity of glucosamine 

Ganna V Zaychenko, (Ukraine) 

Thu 383 Connection between cognition and sexual function 

Juntian Zhang, (PR China) 

Thu 384 Effects of Salvianolic acid A on renal injury in type 2 diabetic KKAy mice 

Li Zhang, (PR China), G Qiang, L Shi, H Zhang, B Chen, G Du 

Thu 385 In vitro antioxidant and in vivo anti-inflammatory and antinociceptive activities of Ophioglossum thermale 

Xue-Qiong Zhang, (PR China), Y-H Zhang, J-H Kim, J-T Bae, J-Y Oh, G-S Lee, H-B Pyo 



Thu 386 Involvement of serotonergic system in Ganoderma Lucidum extraction-induced hypnosis 

Yong-He Zhang, (PR China), X-Y Cui 

Thu 387 Roles of antioxidants and heat shock proteins as an antifatigue effect induced by meirusenjyu on aged 

mice 

Jianrong Zhou, (Japan), K Yokomizo, T Miyata 

Thu 388 Study on anti-tumor activity and mechanism of methylacryloylshikonin in vitro and in vivo 

Liming Zhou, (PR China), Y Wu, X Zheng, Z Shao 

Thu 389 Protection of a water-soluble Danshen (Salvia miltiorrhiza) extract and its active ingredients on 

paracetamol-induced toxicity in rat hepatocytes 

Peter Xuelin Zhou, (PR China), WYW Lee, CM Cheung, PMY Or, JHK Yeung 

Thu 390 Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet 

aggregation 

Z Zhu, Q Zhang, L Chen, S Ren, Dali Luo, (PR China) 

Thu 391 In vitro antifungal activity of the essence of Thymus vulgaris and Myrtus communis L against candida 

albicans strains isolated from the patients with oral candidiasis in comparison with Nystatin 

Mohammadali Zia, (Iran), M Rouholamin, M Bayat, H Khalkhali 

Thu 392 Making cream from bee propolis for treatment of dermatophytic infections 

Mohammadali Zia, (Iran), M Rouholamin, R Mannani, S Gavanji 

Thu 393 Investigating potential immunomodulatory activity in native flora 

James Ziogas, (Australia), L Ng, L Bennett, R Williams, K Robinson, S Sudharmarajan, AG Stewart 



Thu 394 A collaborative capacity building project for developing human resources in the area of clinical trials in 

psychiatry: a Cuban –Canadian experience 

Yudexi Mendoza, (Cuba), M Fors, MA Pascual, B Horner, C Cash, S Kutcher, R Valle, Y Cachimaille 

Thu 395 Placebo response in depression. Results from two clinical trials in Cuba 

Yudexi Mendoza, (Cuba), R Valle, MA Pascual 

Thu 396 Extinction of avoidance behavior by safety learning depends on intrahippocampal endocannabinoid 

signaling 

Vincenzo Micale, (Germany), R Marsch, F Pamplona, F Drago, CT Wotjak 

Thu 397 Prenatal stress induces anxiety-like behavior together with structural and functional disruption of central 

serotonin neurons in mice 

Kazuya Miyagawa, (Japan), M Tsuji, T Takeuchi, H Takeda 

Thu 398 α2C-adrenoceptor blockage increases DOPA uptake and dopamine synthesis in the central nervous 

system of mice 

Eduardo Moura, (Portugal), C Esteves-Pinto, MP Serrão, MA Vieira-Coelho 

Thu 399 Pharmacological evaluation of the antidepressant effects of new 2-adrenoceptor antagonists 

Carolina Muguruza, (Spain), F Rodriguez, JE Ortega, L Urigüen, JJ Meana, I Rozas, LF Callado 

Thu 400 Chronic antidepressants dampen the increase of depolarization-evoked glutamate release induced by 

acute behavioural stress in prefrontal/frontal cortex 

Laura Musazzi, (Italy), M Milanese, F Pasqualina, Z Simona, B Tiziana, M Alessandra, B Pietro, 

R Giorgio, R Maurizio, B Fabio, B Giambattista, P Maurizio 

Thu 401 Effects of clozapine and olanzapine on acquisition, consolidation and retention of memory in elevated 

plus maze test in mice 

Oguz Mutlu, (Turkey), G Ulak, I Komsuoglu Celikyurt, F Erden, F Yýldýz Akar 

Thu 402 Knockdown of DISC1 by in utero gene transfer impaired postnatal dopaminergic maturation in the 

frontal cortex and adult behaviors 

Toshitaka Nabeshima, (Japan), M Niwa, A Kamiya, K Kubo, K Kohda, P O'Donnell, Y Noda, A Sawa, 

K Nakajima 

Thu 403 Effects of early intervention with fluoxetine on anxiety-related behaviors induced in prenatally 

glucocorticoid exposed rats 

Masatoshi Nagano, (Japan), M Liu, H Ozawa, H Suzuki 

Thu 404 Chronic L-DOPA treatment prevents increased binding of [11C] MDL100907 to 5-HT2A receptors in a 

rat model of Parkinson’s disease 

Adjmal Nahimi, (Denmark), A Landau, M Høltzermann, S Jakobsen, S Østergaard, A Møller, D Doudet, 

A Gjedde 

Thu 405 Dyskinesia inducing dopamine originates in serotoninergic neurons 

Adjmal Nahimi, (Denmark), M Høltzermann, A Landau, K Vang, S Jacobsen, A Møller, G Wegener, 

D Doudet, A Gjedde 

Thu 406 Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice 

Atsushi Oyagi, (Japan), Y Oida, K Kakefuda, M Shimazawa, N Shioda, S Moriguchi, K Kitaichi, D Nanba, 

Y Furuta, K Fukunaga, S Higashiyama, H Hara 

Thu 407 Description of a new method of primary culture of bovine retinal ganglion cells 

Mercedes Palmero, (Spain), MA Company, V Maneu, JA Formigos 



Thu 408 Hippocampal neuroplasticity pathways in an animal model of depression: influence of chronic fluoxetine 

and δ-9-tetrahydrocannabinol administration 

Angel Pazos, (Spain), F Pilar-Cuillar, V Valdizin, R Madureira, A Diaz, A Rodriguez-Gaztelumendi, 

E Castro 

Thu 409 Adult neurogenesis and novelty-induced c-Fos expression in the hippocampus of GluA1 AMPA/glutamate 

receptor knockout mice 

Chiara Procaccini, (Finland), T Aitta-aho, K Jaako-Movits, A Zarkovski, A-M Linden, E Korpi 

Thu 410 Behavioral inhibition in rats: A model to examine mechanisms underlying the risk to develop anxiety and 

depression 

Chao Qi, (USA), P Roseboom, S Nanda, J Lane, J Speers, N Kalin 

Thu 411 CANCELLED 

Thu 412 The effects of URB597, fatty acid amide hydrolase (FAAH) inhibitor, in the basolateral amygdala of rats 

on anxiety-Like behaviors 

Ali Roohbakhsh, (Iran), A Hajizadeh Moghaddam, J Damchi Jelodar 

Thu 413 Effect of combined psychiatric and clinical pharmacological audit 

Eva Sædder, (Denmark), B Brock, B Klindt Poulsen, U Bartels 

Thu 414 The role of the histamine receptors on responses under restraint and psychological stress 

Eiko Sakurai, (Japan), A Oikawa, K Yanai 

Thu 415 Multitarget effects of anxiolytic afobazol 

S Seredenin, Mikhail Voronin, (Russian Federation), M Yarkova 

Thu 416 Effect of Yokukan-san, a kampo Chinese traditional medicine on mGlur5 knock-out mouse, a model 

mouse for schizophrenia 

Shigenobu Shibata, (Japan), A Fujimori, T Shimane, Y Nakano, K Horikawa 

Thu 417 Reversal of suppressive action of β-amyloid on long term potentiation in rat hippocampal slices by 

donepezil 

Elena Solntseva, (Russian Federation), N Kapai 

Thu 418 Effects of polymorphism of MDR1, SLCO1B1 and CYP3A4 on the pharmacokinetics of Simvastatin in 

healthy Koreans 

Hankil Son, (South Korea), SB Jang, YJ Lee, LA Lim, S Cho, J Chung, K Park 

Thu 419 Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with 

psychotic disorders 

Edoardo Spina, (Italy), C D'Arrigo, V Santoro, U Micograve, MR Muscatello, G Pandolfo 

Thu 420 Human cerebrospinal fluid contains exosomes that represent a novel reservoir for therapeutic 

biomarker discovery 

Jonathan M Street, (UK), RTA Chalmers, TS Walsh, DJ Webb, JW Dear 

Thu 421 Emotional behavior in pentylenetetrazol kindled mice 

Kenshi Takechi, (Japan), K Suemaru, H Araki 

Thu 422 Increase in hippocampal synaptosomal-associated protein 25 in mice adapted to chronic variable 

stress 

Hiroshi Takeda, (Japan), K Miyagawa, T Takeuchi, M Tsuji 



Thu 423 The 5-HT7 receptor mediates fear conditioning through the amygdaloid extracellular signal-regulated 

kinase signalling in mice 

Minoru Tsuji, (Japan), K Miyagawa, T Takeuchi, H Takeda 

Thu 424 Ethic and psychiatry clinical trials’ design 

E Valle Cabrera, Y Mendoza Rodríguez, Yinet Barrese-Pérez, (Cuba) 

Thu 425 The impact of psychiatry clinical trials over the clinical practice. The Cuban experience 

R Valle Cabrera, Y Mendoza Rodríguez, Yinet Barrese-Pérez, (Cuba) 

Thu 426 A “two-step” competition binding approach to determine unlabelled ligand-receptor complex dissociation 

rates 

Georges Vauquelin, (Belgium), M Wennerberg, A Balendran, A Packeu 

Thu 427 Peripheral blood mononuclear cell gene expression profiles identify subjects with major depressive 

disorder (MDD) among healthy controls 

J Vistisen, J Tamm, R Artymyshyn, I Antonijevic, M Das, A Abdourahman, Birgitte Søgaard, (Denmark) 

Thu 428 Stereotypy in the deer mouse, correlation with cortico-striatal oxidative status and dopamine turnover, 

and response to combined fluoxetine/risperidone treatment 

De Wet Wolmarans, (South Africa), M Guldenpfennig, B Harvey, D Stein, J du Preez 

Thu 429 Erythropoietin-induced sonic hedgehog expression contributes to brain-derived neurotrophic factormediated 

neuroprotection against mitochondrial dysfunction 

Ding I Yang, (Taiwan), CL Wu 

Thu 430 Gravity-changing stress increases serotonin-related gene expression in the mouse brain 

Mitsuhiro Yoshioka, (Japan), T Yamaguchi, H Ohta, J Gyotoku, T Ochiai 

Thu 431 Inhibition of acetylcholinesterase activity in a rat model of Wernicke’s encephalopathy: In vivo and in 

vitro effects of thiamine 

A Zarros, Hussam Al-Humadi, (Greece), C Liapi, M Almpani, V Stolakis, N Skandali, E Katsouni, 

S Tsakiris 

Thu 432 Discovery and validation of the combinational therapeutic targets for Alzheimer's disease: A preliminary 

study 

Wenxia Zhou, (PR China), X-R Cheng, N Jiang, Y Zhang 



Thu 433 In silico approach to develop new selective PPARγ modulators (SPPARMs) 

Francesca Mancini, (Italy), M Vitiello, G Mangano, G Pochetti, MA Alisi, R Ombrato, E Fioravanzo, 

N Cazzolla, L Polenzani 

Thu 434 Peroxisome proliferator-activated receptor (PPAR) agonists protect podocytes from human kidney 

against cell death induced by oxygen/glucose deprivation-reoxygenation 

Gianluca Miglio, (Italy), AC Rosa, L Rattazzi, R Fantozzi 

Thu 435 Analysis of glucocorticoid receptor gene haplotype structure and its influence on disease activity and 

steroid therapy outcome in inflammatory bowel disease patients 

Jessica Mwinyi, (Switzerland), C Wenger, JJ Eloranta, GA Kullak-Ublick 

Thu 436 Influence of LHRH on sex hormone receptors in the CA3 of hippocampi of the male rat 

Bojana Petrovic, (Republic of Serbia), Z Zoric, D Drekic 

Thu 437 Inhibition of leukocyte endothelial cells interactions by activation of retinoid X receptor 

Laura Piqueras, (Spain), E Morcillo, C Company, J Cortijo, MJ Sanz 

Thu 438 Comparative analysis of gene regulation by the transcription factor PPARá between mouse and human 

Maryam Rakhshandehroo, (The Netherlands), G Hooiveld, M Müller, S Kersten 

Thu 439 Interaction between peroxisome proliferator-activated receptor-α and NADPH oxidases plays an 

important role in the development of pressure-overload cardiac hypertrophy 

Emma Robinson, (UK), DJ Grieve 

Thu 440 The fat-induced satiety factor OEA suppresses feeding through central release of oxytocin 

Adele Romano, (Italy), S Gaetani, J Fu, T Cassano, P Dipasquale, L Righetti, S Cianci, L Laconca, 

E Giannini, S Scaccianoce, D Piomelli, V Cuomo 

Thu 441 Renal side effects of short-term dexamethasone treatment 

Ita Samarzija, (Croatia) 

Thu 442 Activation of liver X receptors (α and β) by HIV protease inhibitors atazanavir and ritonavir and inhibition 

by non-nucleoside reverse transcriptase inhibitor efavirenz 

Jenny Svard, (Ireland), JP Spiers, F Mulcahy, M Hennessy 

Thu 443 Expression of the receptor for advanced glycation end products (RAGE) and high mobility group box 1 

(HMGB1) is related to human dental pulpitis progression 

Salunya Tancharoen, (Thailand), T Tengrungsun, T Suddhasthira 

Thu 444 Bag1 regulates chaperone-mediated triage decisions on degradation of chronic myelogenous leukemia 

oncoprtein, BCR-ABL 

Fujiko Tsukahara, (Japan), Y Maru 

Thu 445 Neuroprotection of ginsenoside Rg1 against Aβ25-35-induced neurotoxicity in primary cultured rat 

cortical neurons via nuclear steroid receptors activation 

Jiang Wu, (PR China), Z Wang, X Zhang, W Zhu, Y Shen, R Cui, J Lin, Y Su, Y Lou 


Index 

The index shows the presentation reference 

for all authors and co-authors 

WorldPharma2010 provides a very large number of bursaries 

for young scientists from lesser developed countries 

Professor Zhi-Bin Lin (PR China) 

President of the 15th World Congress on Pharmacology (Beijing, 2006) 

Index 313

314 Index 

Name Paper ref. Name Paper ref. 

Aalkjær, C Tue 038, Wed 221, Wed 433 

Aalling, M Tue 161 

Ab Wahab, MS Mon 147, Mon 333 

Abacioglu, N Mon 366 

Abad, S Wed 177 

Abasnejad, M Tue 165 

Abass, K Thu 348 

Abbasi, S Thu 113 

Abdallah, DM Wed 382 

Abdel Aziz, H Tue 464 

Abdel Razek, H Tue 264 

Abdel-Aziz, H Wed 382 

Abdel-Maksoud, S FC06.2.6 

Abdel-Rahman, SM FC10.2.4 

Abdel-tawab, AM-D Mon 252 

Abdel-Tawab, M Thu 010 

Abdourahman, A Thu 427 

Abdul Hamid, R Wed 323 

Abdul Sattar, MZ FC05.1.5 

Abduljalil, K Mon 384 

Abdulla, MH FC05.1.5 

Abdullah, AD Tue 408 

Abdullah, N Mon 389 

Abdullah, NA YI.04, FC05.1.5 

Abdullah, NR Thu 328 

Abdullah, WZW Mon 361 

Abduzaimovic, D Wed 171, Wed 004 

Abe, K Thu 038 

Abe, M Tue 216 

Abe, N Mon 255 

Abedzadeh, M Thu 209 

Abel, U FC18.2.6 

Abernethy, D Mon 392, FC13.1.6 

Abid, M Tue 002 

Abi-Dargham, A FC17.1.3 

Abildstrøm, SZ FC04.2.4 

Able, S Mon 393, Wed 020 

Able, S Mon 420 

Abler, B Thu 112 

Abotaleb, N Mon 188 

Aboulafia, J Thu 351, Thu 352 

Abu Bakar, NH Mon 107 

Abu Bakar, R Mon 147, Mon 333 

Aburto-Cortes, L Tue 025 

Acheampong, P Mon 116, 

Acher, F FC11.3.6, Thu 083 

Achike, F Wed 370 

Achike, F I Wed 195, Wed 194 

Acimovic, J Tue 383 

Ackermann, S Thu 098 

Acosta, G Mon 040 

Acquaviva, AM Wed 307 

Adam de Beaumais, T FC10.1.5 

Adamicova, K Mon 293 

Adamu, I Tue 011 

Adamus, M Mon 081 

Adaramoye, O Wed 294 

Adcock, Ian M FC09.1.1 

Addolorato, G FC14.2.2 

Adeneye, A Tue 361 

Aderaye, G FC01.4.7, Mon 018 

Adeyemi, OO Wed 296, Tue 361, Wed 295 

Adham, N Wed 423 

Adler, A FC05.4.3 

Ado, S Tue 011 

Afshartous, D Wed 155 

Afzal, S FC13.3.6, Tue 482, Mon 119, 

Mon 118, Mon 406, Tue 480 

Agbani, EO Thu 272 

Agha Alaie, SY Mon 002, Mon 231 

Agirgol, M Mon 199 

Ago, Y Tue 360, Tue 060 

Agostini, S Tue 249 

Agouni, A Mon 148, Wed 196 

Ågren, G FC14.5.2 

Agresta, A Tue 487, Mon 448, Tue 488 

Agüero, J Tue 165, Thu 048 

Aguero, J Tue 163 

Aguiar, D FC17.5.5 

Aguila, JDF Mon 038 

Aguilera, R Mon 023, W04.1.3 

Aguiñiga, I Tue 420 

Ahluwalia, A Thu 278 

Ahmad, D Tue 137 

Ahmad, ED Tue 444 

Ahmad, F Tue 119 

Ahmad, M FC08.2.5 

Ahmadi, A Wed 012 

Ahmadzadehd, A Tue 251 

Ahnstedt, H Wed 021 

Ahokas, J Thu 348 

Ai, H Thu 370, Thu 378 

Aigbe, FR Wed 295 

Aihara, E Thu 072 

Ain-Shoka, A Tue 386 

Airaksinen, AJ Thu 170 

Aitta-aho, T Thu 409 

Aitta-aho, T Wed 393 

Ajami, A Wed 123 

Ajdary, S Wed 027, Wed 437 

Akagi, M Mon 253 

Akagi, R Mon 253 

Akahane, T Tue 311 

Akaike, A Mon 432, Mon 424, Mon 464 

Akaike, O Wed 371 

Akamine, EH FC06.1.5 

Akamine, T Mon 213 

Akarasereenont, P Mon 334 

Akarasereenont, P Thu 335 

Akbarali, H FC12.1.5 

Akdis, Cezmi A FC09.1.3 

Akhtar, S FC01.4.6, Mon 151 

Akiba, Y W02.1.5 

Akici, A Tue 027, Mon 117 

Akimoto, Y Tue 432 

Akindele, A Wed 296 

Akinyandenu, A Wed 144 

A, Shizuo PL14 

Akiyama, K Wed 414 

Aklillu, E FC01.4.7, Mon 018, Tue 005, 

Wed 136, Tue 489 

Akramiene, D Mon 403 

Akritopoulos, P Tue 246 

Akula, KK Wed 168 

Akuwoah, GA Thu 327 

Al, T Mon 264 

Alabi, T Tue 361 

Al-A, A Thu 338


Albarran-Juarez, J FC11.4.2, W01.2.1 

Albarran-Juarez, J Wed 022 

Albertioni, F Mon 055 

Albrechtsen, C Tue 482 

Alcántara-Vázquez 

del Mercado, O Thu 203 

Alcaraz, MJ W09.1 

Alderton, A FC03.2.6 

Alefishat, E Wed 023 

Alegret, M Tue 133 

Aviciene, C Mon 403 

Alemà, S Tue 249 

Aleshcheva, G Wed 252 

Alessandra, M Thu 400 

Alessi, F Tue 312 

Aleth, P Tue 190 

Alewijnse, A Thu 258, Thu 082 

Alexander, N FC11.3.2 

Alexander, S Mon 404, Wed 023 

Alexander, SPH Mon 282 

Alfonzo, M Wed 040 

Alfonzo, Marcelo J Wed 024 

Alfonzo, RG Wed 024 

Alfonzo-Gonzalez, M Wed 024 

Alhamoruni, A Tue 460 

Al-hosaini, K Wed 025 

Al-Humadi, H Thu 431, 

A Alsinde, H FC01.1.5 

A Arab, H Wed 301 

Alimahomed, R Thu 085 

Alisi, MA Thu 433 

Al-Kashi, A FC09.5.7 

Alkhawajah, AA Thu 338 

Al-khrasani, M Thu 062 

Al-Khrasani, M Thu 192, 

Allegaert, Karel FC10.4.3, Wed 001, Wed 002 

Allen, M Wed 096 

Allen, TJ Thu 228 

Allerheiligen, SRB FC07.3.4 

Alloza, JL Mon 138 

Al-magableh, M Wed 255 

Almaguer, D Mon 023, W04.1.3 

Almeida, OF FC18.3.1 

Almenar, L Tue 165, Thu 048, Tue 163 

Almpani, M Thu 431 

Alonso, M Wed 228, Thu 264 

Alp, FI Thu 269 

Alp, H Wed 312 

Alp, I Tue 461 

Al-Rasheed, NMI Mon 189 

Alstrup, AKO FC17.4.5 

Altaany, Z FC15.3.6 

Altcheh, J Mon 003, Wed 003 

Altcheh, J Mon 022 

Altinok, A FC07.1.3 

Alvarez de Mon, M Mon 254 

Álvarez de Sotomayor, M Tue 118 

Alvarez López, MC Mon 128 

Alvarez, J-C Tue 188, Tue 189 

Alvarez, M Tue 226 

Álvarez, M Thu 205 

Alvarez, S FC18.3.5 

Alvarez-Laviada, A FC03.2.4 

Alvarez-Leon, A Wed 344 

Alvarez-Sala, JL Mon 374 

Alves, FHF Wed 411 

Alves, G Thu 169, Mon 383, Tue 407 

Alves, JN Wed 342 

Alves, RS Thu 374 

Alves, RS Wed 297 

Alves-Filho, J Mon 275 

Alvey, C Mon 251 

Alving, Kjell FC09.3.2 

Amabeoku, G Wed 298 

Amada, K Tue 132 

Amadio, M Mon 152 

Amagase, K Tue 262, Tue 236, W02.2.3, 

Tue 467, Mon 335, Mon 255, 

Mon 405 

Amano, Y Mon 386 

Amaral, F W31.4 

Amberg, C Wed 071 

Ambrus, N Wed 197 

Amidzic, L Tue 237 

Amigo, G Thu 325 

Amini, M YI.07 

Aminlari, M Wed 299 

Ammendrup-Johnsen, I Mon 067, Mon 061 

Ammer, H FC16.1.5 

Amogne, W FC01.4.7, Mon 018 

Amrah, SS Thu 312 

Amrutka, DV Thu 106 

Amrutkar, D Mon 099 

Amrutkar, M Mon 336 

Amundsen, R Mon 041 

Amunjela, J-A Thu 315 

Amyrkulova, M Tue 079 

Anand, KJS Wed 006, Thu 003 

Ananthan, S FC14.3.5 

Anca, C Tue 190 

Ancrenaz, V Mon 337 

Andalib, S Mon 294 

Andersen, B FC05.3.5 

Andersen, CB Mon 050 

Andersen, CU Tue 161 

Andersen, D FC06.2.5 

Andersen, DC Wed 070 

Andersen, J FC13.3.6, Tue 065 

Andersen, JT Mon 118, Mon 119, Mon 406 

Andersen, M Wed 160 

Andersen, MP Tue 303 

Andersen, MV Tue 053 

Andersen, N Mon 118 

Andersen, NL Mon 119 

Andersen, SE Tue 053 

Anderson, C Tue 202 

Anderson, L Wed 254 

Anderson, ME FC06.4.4 

Andersson, J Mon 122 

Andersson, KE FC08.2.2 

Andersson, M Wed 136, Mon 371 

Andersson, S Wed 006 

Ando, H Mon 386, Thu 268 

Andó, R W19.2 

Ando, Y FC07.4.3 

Andrade, RJ Tue 123, Wed 109 

Andrade, T Mon 298 

Andrade-Lopes, AL Wed 054 

Index 315

316 Index 


Andre, JL FC10.5.5 

Atini, R Wed 394, Wed 395 

Andrés, V W09.4 

Andresen, B FC02.3.6 

Andresen, T W12.5 

Andressen, KW Wed 026 

As, PLR Tue 471 

As, W FC13.3.5 

Andriantsitohaina, R W08.2, Wed 216, Mon 148, 

Wed 196, Tue 118 

Androwiki, ACD Wed 233, Wed 237 

Andújar, Isabel Wed 300 

Andurkar, S Wed 184 

Angeles-Gamiño, M Tue 025 

Angelotti, T Wed 028 

Anggono, V YI.10 

Anguiano, L Tue 150 

Angulo, J FC08.1.4 

Anisina, EA Tue 165 

Anizon, F Tue 429 

Anjum, WA Tue 137 

Ansiau, D Mon 124 

Antipova, T Mon 225 

Antonijevic, I Thu 427 

Antsaklis, A Tue 381 

Antunes, M Wed 337 

Anuka, J Wed 145 

Anunobi, C Wed 296 

Anwar, EI Mon 364 

Anwer, T Tue 137 

Anzellotti, P Mon 281 

Anzenbacher, P Thu 118, Wed 118 

Anzenbacher, P Mon 081 

Anzenbacherova, E Thu 118, Mon 081, Wed 118 

Aoki, A Mon 307 

Aoki, D Tue 311 

Aoki, K Tue 443 

Aoki, Y FC03.2.5 

Aono, H Mon 402, Mon 112 

Aouichri, M Mon 020, Mon 021, Mon 338 

Aoyagi, H Mon 399 

Aparecida-S, E Wed 054 

Apicella, C Mon 296 

Araki, H Thu 421, Wed 413 

Arami, S Mon 002 

Aramphongphan, A Wed 338 

Arapovic, S Mon 342, Mon 343 

Araújo e Silva, AC Wed 302 

Araújo, A Mon 299, Wed 198 

Araújo, J Mon 042 

Araújo, JR Mon 057 

Araya, K Thu 187 

Araya, KA Wed 169 

Arce, MP Mon 079 

Archambault, NS Wed 156 

Arendt-Nielsen, L W12.2, W12.3, W12.5, 

W26.1 

Arici, A Mon 170 

Aricioglu, F Tue 145 

Arietti, P FC18.4.6 

Arima, H Tue 162 

Arima, J Tue 167 

Arimura, Y Thu 109 

Ariyama, Y Tue 153 

Arkan, S Wed 309 

Armor, D W03.7 

Arnal, JF Wed 216 

Aronowski, J FC18.3.2 

Aronson, J Tue 355 

Aronson, JK OL 

Arrang, J-M Wed 051 

Arrebola, MM Tue 116, Wed 250 

Arreto, C-D Mon 339 

Arriagada, L Tue 326 

Arribas, S Thu 054 

Arslan, F Mon 170 

Arslan, Rana Wed 303 

Artamonov, A Tue 167 

Artymyshyn, R Thu 427 

Arya, DS Mon 190, Mon 260, Wed 315 

Aryamanesh, S Mon 188 

Arýcý, MA Mon 043 

Asada, Y Thu 263 

Asadi, M Mon 044, Tue 164 

Asano, H Mon 399 

Asanuma, M Wed 424, Wed 413 

Åsberg, A Mon 041 

Asceric, M Wed 199 

Asghari, A Tue 165 

Asghari, M Thu 342 

Ashar, HD Wed 304 

Ashby, C Wed 182 

Ashcroft, FM FC12.4.2 

Ashida, Y Wed 305 

Ashna, A Mon 222 

Ashton, N Wed 269, Wed 238 

Asili, J Thu 313 

Ask, B Tue 318, Tue 138 

Asker-Hagelberg, C W35.4 

Aslan, S Wed 312 

Asmawi, MZ Tue 247, Mon 302 

Asmawi, Z FC16.3.4 

Assefa, A FC01.2.5 

Asslaber, M Mon 153 

Assreuy, J Wed 097 

Assunção, JPFC YI.08 

Assylbekova, D Thu 336, Tue 079 

Atabey, N Tue 200, Tue 411 

Ataee, R Wed 027, Wed 437 

Ataie, A Wed 396 

Ates, M Mon 043, Mon 170 

Atkinson, J Wed 244 

Attia, HA Mon 189 

Attia, TA Mon 340 

Atukeren, P Tue 461 

Au, CL FC15.4.7 

Auger, C Wed 306, Wed 273, Wed 385 

Aulaskari, PH Tue 247 

Aumiler, MR FC01.3.7 

Aurelio, L Thu 080 

Aursnes, I Tue 143 

Ausperger, KM FC01.3.7 

Autio, Anu Mon 256 

Aviello, G Wed 307 

Avila Albuerne, Y Wed 311 

Avissar, S Wed 410 

Avorn, J FC04.1.3 

Ayadi, T Thu 346


Ayajiki, K Wed 200 

Aydin, S Wed 309, Wed 308, Mon 348 

Aydin, Y Wed 309 

Ayugase, T Wed 414 

Azam, A Tue 002 

Azarpira, N Tue 485 

Azcutia, V Tue 134 

Aziba, P Wed 310 

Aznar, S FC11.2.6 

Azougagh, S FC10.1.5 

Azuma, E Thu 286 

Baandrup, J Wed 240 

Baba, A Wed 075, Mon 106, Mon 318 

Babaie, J Mon 455 

Babaoglu, M Wed 249, 

Babenko, A Wed 098 

Babosha, K FC01.2.5 

Bach, A YI.10, Tue 053, Thu 037 

Bach, KF Mon 345 

Bacha, S Thu 346, Wed 348, Mon 004 

Bach-Rojecky, L Mon 096 

Bachurin, SO Mon 422 

Bäck, S Mon 341 

Backman, JT FC05.2.4, Mon 380, Tue 316, 

Tue 330 

Badawy, A Tue 386 

Baditoiu, LM Tue 102 

Badyal, DK Mon 005 

Badzek, S Tue 328 

Bae, J-T Thu 385 

Bae, J-W Mon 358, Tue 350, Mon 359, 

Mon 049, Mon 069, 

Mon 066, Mon 065, Tue 043, 

Tue 044, Tue 073, 

Tue 160, Tue 161, Tue 323, 

Tue 162, Tue 324, 

Tue 331, Tue 332, Tue 333, 

Wed 142, Wed 143 

Baek, S FC18.4.2 

Baggott, MJ Wed 170 

Bagheri, A Tue 469 

Bagley, E FC03.3.1 

Bagoly, T Tue 250 

Baharuddin, KA Mon 107 

Bahgat, AK Tue 451 

Bahrke, S Wed 099 

Bai, J Mon 310 

Bai, X Mon 092 

Bai, X-Y Mon 172 

Baigent, C W18.4 

Bailey, LK Thu 241 

Bailey, M Tue 270 

Baillargeon, J Wed 443 

Bairy, LK FC04.3.7 

Bajagic, M Tue 081 

Bajcetic, M FC10.1.6 

Bajraktarevic, A Wed 171, Wed 004 

Baker, J FC11.1.5 

Baker, M Thu 278, W06.3 

Baktir, G Tue 142 

Bakuridze, K Wed 272 

Balaguer, P FC18.3.5 

Balazin, A Mon 342, Mon 343 

Bal-dit-Sollier, C Tue 188, Tue 189 

Balendran, A Thu 426 

Balenga, N Wed 073 

Balenga, NAB FC11.1.6 

Balfagón, Gloria Wed 201 

Balikuddembe, R FC01.4.5 

Balkau, B Mon 161 

Ballabeni, V Tue 258, Mon 381 

Ballagas Flores, CM Wed 311 

Balle, T Wed 066 

Ballesteros, MP Thu 115 

Balogh, A Mon 261 

Balster, RL Wed 172 

Banani, A Tue 223, 

Banaudi, E Wed 010 

Bandieramonte, G Tue 487 

Bang, O-Y Tue 335 

Banken, L Mon 259 

Baños, J-E Mon 137 

Banovac, M Mon 342, Mon 343 

Baoxue, Y Wed 363 

Barakat, W Mon 165 

Baranyi, M Mon 460, W19.2 

Barar, J Mon 044 

Barat, I Mon 142 

Barbeiro, DF Wed 202, Wed 204, Wed 

203, Mon 257 

Barbeiro, HV Wed 202, Wed 204, Wed 

203, Mon 257 

Barbosa, FJ Wed 395 

Bardou, M Tue 289, Tue 290 

Bareggi, S Thu 111 

Baretta, IP Wed 395 

Barettino, D Tue 165, Tue 163 

Barnard, EA Wed 047 

Barnes, KI FC10.1.3 

Barnes, N Tue 233 

Barnes, PJ PL19 

Barnett, JW W17.3 

Barocco, B Wed 320 

Barocelli, E Tue 258, Mon 381 

Baron, R W03.6 

Barranco-Garduño, M Mon 019 

Barreira, B Wed 226 

Barreiro, E Mon 398 

Barreiro, EJ Thu 212 

Barrero, P Mon 128 

Barrese Pérez, Y Thu 425, Thu 424, Wed 311, 

Thu 347, Mon 038 

Barrett, I Wed 173 

Barriga, C Wed 352 

Barrios, M Tue 394 

Barrondo, S Wed 046 

Barroso, I Mon 161 

Bartella, C Mon 296 

Bartels, U Thu 413 

Bartlett, S FC14.3.5 

Bartlett, SE FC14.2.3 

Bartolini, A Mon 113, Tue 446, Mon 391 

Basaran, NF Mon 156 

Basinoglu, F Mon 199 

Basir, R FC16.3.4 

Basit, A Tue 319 

Baskaran, P Thu 202 

Bass, CC Wed 029 

Index 317

318 Index 


Bass, R W10.3 

Bastholm, P Mon 371 

Bastien, O Mon 193 

Bastos, R Tue 123 

Bastrigin, D Tue 150 

Batacchi, P Mon 120 

Bate, A FC04.2.1 

Bateman, J W03.7 

Bathgate, R W14.2 

Batista, MT Mon 291 

Batista, V Thu 366 

Battaglia, G Wed 400 

Baudouin, V FC10.5.5 

Bauer, C FC03.2.4 

Bauer, HW Tue 214 

Bauer, J Thu 267, Wed 252 

Bauer, R FC16.2.2, Mon 153 

Baun, M Wed 220 

Baveewo, S FC01.4.5 

Baw, B Wed 013 

Bayat, M Thu 391 

Baydan, E Wed 312 

Baydemir, C Wed 421 

Baydemýr, C Wed 420 

Baydoun, A Thu 290 

Bayever, D Tue 110 

Bay-Jensen, A-C W26.2, W26.4 

Baykov, A Wed 205 

Bayliss, DA FC03.4.4 

Bazarbachi, A FC01.3.4 

Beart, P Mon 045 

Beauchamp, GK W02.1.1 

Beauchesne, M-F FC04.1.5 

Beausejour, CM Tue 396 

Beaussier, H Mon 191 

Becemberg, IL Wed 024 

Bech Thorsen, L Wed 240 

Becic, F Wed 199 

Beck, J Wed 094 

Beck, L Thu 259 

Becker, AJ Mon 247 

Becker, E-M Thu 091 

Beck-Nielsen, H FC05.4.4 

Becquemont, L FC13.5.5, W02.2.6, Tue 189, 

FC02.2.6 

Bedi, G FC14.3.4 

Beetens, J Tue 280 

Begg, E FC10.5.3 

Begg, EJ Tue 322, Mon 064 

Begovic, B Wed 171 

Beh, J Tue 196 

Beheshti, S Mon 455 

Behrends, S Wed 280, Thu 252, Wed 210 

Behr-Roussel, D FC08.1.1, Mon 233, Mon 232 

Beiraghdar, F Thu 311 

Beitnere, U Mon 429 

Bejarano, I Mon 407 

Bek, T Wed 229 

Bekarev, A Tue 167 

Bekhit, AA Tue 264 

Bekker, Z Mon 258 

Bektas, N Wed 303 

Bel, L Tue 171 

Belanger, F Tue 051 

Beleslin-Cokic, B Wed 103 

Beleznai, TZ Wed 206 

Belkhiria, M-N Mon 006 

Bellido, I Mon 471, Mon 149, Tue 394, 

Wed 005, Wed 007, Mon 123 

Bellido, MV Wed 005 

Bellien, J Thu 242 

Bellien, J Wed 207 

Belyakova, G Thu 114 

Benameur, T Mon 148 

Ben-Attia, M Mon 338 

Bendayan, R FC02.4.5, Mon 070 

Bender, B Mon 401 

Bendhack, L Wed 198, FC15.4.5 

Benedito, S Mon 239, Mon 411 

Benemei, S Mon 120 

Benetti, LR Mon 289 

Bengtsson, F W29.1 

Bengtsson, T Wed 063 

Benham, C Mon 086 

Benhamou, PY Tue 268 

Benhanifia, MEB Wed 313 

Bénichou, J FC04.2.6, Mon 145, Mon 132 

Benkõ, I Mon 150, Mon 167 

Benkõ, K Mon 150, Mon 167 

Bennett, BM Tue 385 

Bennett, L Thu 393 

Benoît, LG Tue 190 

Bensaid, D Mon 021 

Bensman, A FC10.5.5 

Benter, I Mon 151 

Bentley, D Mon 259 

Bentzen, BH FC06.1.4, Wed 099 

Benyhe, S Wed 050 

Ben-Zvi, Z Mon 054 

Beraud-Dufour, S FC17.2.5 

Berdnikova, N Mon 344, Wed 314, Thu 114 

Berendt, L Mon 345 

Berényi, A Tue 442 

Bérézovski, V Thu 237 

Berger, K Tue 313 

Berggren, P-O FC12.4.1 

Bergman, J Mon 234 

Bergman, P Mon 122 

Bergman, U W35.4, Mon 129, Tue 308, 

Wed 138 

Bergmann, JF FC01.4.4 

Bergmann, J-F Tue 188, Tue 189 

Bergmann, TK Tue 395, Wed 151 

Bergougnan, L Thu 215 

Bergquist, K FC14.3.3 

Bergqvist, L Wed 006, Thu 003 

Berisa, A Mon 254 

Berkman, K Mon 117 

Bernabé, J Mon 233 

Bernhard, D Wed 234 

Bernhard, F YI.02 

Berrue, F Wed 316 

Bertilsson, L Tue 489, Tue 308, Mon 018 

Wed 147 

Bertin, F Thu 273 

Bertoni, S Tue 258, Mon 381 

Bertran, F Mon 362 

Bertrand, H-O FC11.3.6


Bessac, A-M Tue 171 

Besson, M Mon 337 

Bethell, D Tue 090 

Bettler, B FC11.3.5, Thu 028 

Beubler, E Mon 369 

Beugels, IPE Mon 212 

Beukers, MW FC11.4.6 

Beuve, A Thu 202 

Bevan, S Mon 287 

Beyens, MN FC04.2.5 

Bhala, N W18.4 

Bhanot, S Tue 148 

Bharti, D Mon 336 

Bhat, SJS Wed 172 

Bhatia, J Mon 260, Wed 315, Wed 358 

Bhatia, VK Thu 026 

Bhosale, A Mon 336 

Bhosale, AV Thu 363 

Bhupathyraaj, M Tue 152 

Bi, K Tue 130 

Bi, Y-Q FC16.5.5 

Biazzotto, J Wed 198, FC15.4.5 

Bibby, BM Tue 359 

Biddie, SC FC18.4.2 

Bie, P FC06.2.5 

Bielen, L FC01.3.7, Mon 135, Mon 

373, Tue 328 

Biermann, J Wed 099 

Bieth, B Tue 196 

Bihari, P FC16.1.5 

Biliczki, P Mon 100 

Billesbølle, CC Mon 073 

Billing Jr., CB Wed 193 

Bilsen, M FC18.2.5 

Binder, A W03.6 

Binder, EB FC17.5.1 

Bindslev, N FC02.2.5, FC07.1.5, 

Mon 071 

Birk, B FC18.2.6 

Bischof, L Mon 045 

Bishnoi, M Mon 183 

Bisogno, A Tue 487, Mon 448, Tue 488, 

Mon 449 

Bissantz, C Wed 094 

Bissoli, F FC04.2.6, Mon 141 

Bistawros, AA Tue 264 

Bitay, M Wed 197 

Bitel, M Mon 181 

Bittner, RE Mon 218 

Bjarnason, NH Mon 346 

Bjerregaard, BK Mon 121 

Bjerrum, L FC13.1.5 

Bjerrum, OJ Mon 089 

Björk, Susann Wed 028 

Björkhem-Bergman, L Tue 383, Mon 122 

Blad, CC FC11.2.5 

Blagojevic, D Thu 329, Tue 122, Thu 318, 

Wed 387 

Blais, Lucie FC04.1.5 

Blaise, S Thu 244, Wed 208, Thu 245 

Blakely, R FC02.4.1 

Blakemore, D FC05.3.6 

Blalock, JE FC09.5.2, FC09.5.3 

Blanchard, SC FC02.1.2 

Blanco, E Mon 123, Mon 149, Mon 471, 

Wed 007, Thu 187 

Blanco-Rivero, J Wed 201 

Blank, MD Wed 172 

Blankesteijn, MW Wed 085 

Blasio, A FC18.4.6 

Blättermann, S FC11.1.6 

Blayden, C FC03.2.1 

Blazer, L YI.01 

Blazsó, G Mon 261 

Blin, P Mon 140 

Bloch, V Wed 191 

Block, W Tue 049 

Blockhuys, S Tue 280 

Blume, LC Wed 029 

Boari, G Thu 251 

Bobadilla, RA Wed 209 

Bobkiewicz-Kozlowska, T Mon 262, Thu 174, Thu 291 

Bocan, T Tue 372 

Bocca, M-L Mon 362 

Bochorishvili, T Mon 192, Tue 174 

Bock, E PL23 

Bock, H Tue 151 

Bock, P Tue 169 

Bocos, C Tue 387 

Bocsan, C Mon 438 

Bocsan, IC Mon 417, Tue 481 

Bode, C Wed 099 

Bodo, L P16.281 

Bodvarsdottir, T Tue 132 

Boehlen, F Tue 305 

Boekschoten, M FC18.2.5 

Boerngen-Lacerda, R Wed 395 

Boeuf-Cazou, O Mon 124 

Boeynaems, J-M W10.3 

Bogacz, A Thu 174 

Bogdanov, B Tue 167 

Bogdelis, A Thu 023 

Bøgebo, R Wed 036 

Bøgesø, K Mon 046 

Bogoslovscaya, S Tue 129 

Bohman, L Tue 489 

Bohotin, C Mon 108 

Boije af Gennäs, G Tue 433 

Boizel, R Tue 268 

Bölcskei, K Mon 110, Tue 078 

Bomba, A Tue 423 

Bonaccini, L Tue 446, Mon 391 

Bonaterra, G Mon 317, Tue 462 

Bonci, A FC14.3.1 

Bond, CM Tue 109 

Bonde, MM Thu 058 

Bondiolotti, G Thu 111 

Bondolfi, G Mon 160 

Bongue, B Mon 124 

Bonke, G Mon 064, Mon 047 

Bonnabry, P Tue 305 

Bonnefond, A Mon 161 

Bonta, P FC18.2.4 

Booranasubkajorn, S Thu 361 

Boos, J FC10.4.5 

Booth, L Wed 020, Mon 420 

Børgesen, M Wed 447 

Børglum, A FC13.3.6 

Index 319

320 Index 


Born, W Thu 197 

Borobia, AM Tue 348, Mon 451 

Borrelli, E FC17.4.6 

Borrelli, F Wed 307 

Börresen-Dale, A-L Wed 151 

Borsodi, A Wed 050 

Borsotto, M Thu 237 

Bosch, M FC10.4.6 

Bosco, P Wed 400 

Boskovic, A Wed 135 

Boskovic, J Mon 127 

Bosmans, G Wed 002 

Bosnjak, Z Mon 373 

Bossert, J FC14.3.2 

Bost, JGPJ Wed 287 

Bõsze, Z Mon 401 

Botros, S Mon 372 

Böttiger, Y Mon 371, Wed 008 

Botto, H Tue 204 

Botz, B Mon 110, Mon 106 

Botzenhart, E W03.7 

Boukraâ, L Wed 313 

Boulieu, R Mon 193, Mon 263 

Bounoure, F Thu 242 

Bouraoui, A Wed 316 

Bourinet, E FC03.2.3 

Bourrel, R Tue 104 

Boussaïd, M Mon 004 

Boutaud, O FC05.3.6 

Boutin, JA Wed 072 

Bouvier, M FC11.3.1 

Bouzinova, EV Wed 397, Wed 433 

Boxwalla, M Wed 184 

Boyd, B Thu 280 

Boyden, PA FC06.1.2 

Boyer, M FC04.2.5 

Boyle, EM Wed 006 

Bozec, E Mon 191 

Bozina, N Tue 304, Wed 398, Wed 112, 

Mon 048, Tue 121 

Božina, T Mon 048 

Bozkurt, A Wed 249, 

Bozkurt, TE Mon 366 

Bozo, T FC16.2.6 

Braber, S FC09.5.2 

Brabet, I FC11.3.6, Thu 083 

Bradamante, V Mon 347 

Bradley, SJ Wed 030 

Bradnock, D Thu 214 

Brain, S Thu 197 

Brain, SD Mon 287 

Brajovic, M FC10.1.6 

Bramanti, P FC18.1.5, Mon 277, 

FC18.3.6, Thu 364 

Brancaleone, V Thu 081, FC09.4.6 

Branco, T Wed 130 

Brand, L Wed 399 

Brandes, RP FC15.1.1 

Brasch-Andersen, C Mon 090, Tue 395, Wed 151 

Brauch, H Wed 133 

Bräuner-Osborne, H FC11.5.1, FC11.5.6, Wed 

084, Thu 027 

Breckenridge, A FC13.1.3 

Bregnedal, P Mon 046 

Breitkreutz, J FC10.3.2 

Bremner, JD FC17.5.3 

Brenneman, D Tue 389 

Brennum, LT FC17.4.2 

Breschi, MC Wed 442, Mon 382 

Breum-Leer, C Tue 358 

Briedis, V Tue 329 

Briggs, JP FC16.5.4 

Brink, CB W20.2, W15.3, Mon 412 

Brito, GAC Mon 298, Tue 255, Wed 318, 

Wed 319 

Brive, L Wed 092 

Briyal, S FC05.2.5 

Broadstock, M Wed 044 

Broccardo, M Tue 249, 

Brochard, K FC10.5.5 

Brock, B Tue 356, Tue 357, Tue 358, 

FC05.4.6, Thu 413 

Brock, C W12.6 

Brødbæk, K FC13.3.6, Mon 119, 

Mon 118, Mon 406 

Bröer, S FC02.3.4 

Brøgger, T Wed 433 

Broquères-You, D Mon 232 

Brørs, O Wed 139 

Broselid, S Thu 047 

Brøsen, K FC13.5.5, Mon 050, 

Mon 090, Wed 151 

Brouillette, D Wed 123 

Broux, F FC10.5.5 

Brown, DA Wed 047 

Brown, MJ PL17 

Brown, VJ FC17.3.4 

Brum, P Wed 042 

Brune, K Tue 310 

Brunet, A Mon 203, Mon 201, Mon 205, 

Mon 204, Mon 202 

Brunetti, L Mon 105, Wed 434, Wed 329 

Bruno, V Wed 400 

Brusco, A Thu 176 

Brussee, J FC11.2.5 

Brusselle, GG FC09.5.1 

Brusturean, E Mon 417, Mon 438 

Bruttmann, G Tue 268 

Bruun, J FC05.1.1 

Bryan, K Mon 443 

Bryson, P Tue 012 

Brzozowska, I Tue 463 

Brzozowski, T Tue 463 

Buadze, M YI.02 

Bubik, MF FC16.1.5 

Buble, T Tue 095 

Bucci, M Thu 081, Thu 202 

Bucolo, C Mon 152 

Bucsics, A Mon 153 

Buda, S Mon 120 

Budimir, A Mon 373 

Bühler, FR W10.3 

Bünemann, M Wed 026 

Buhl, CS Mon 154 

Buhl, ES Mon 154 

Bui, V Mon 285 

Bukarica, LG Thu 324 

Bukumiric, Z Wed 436


Bult, H Wed 246, Wed 245 

Bulut, G Tue 411 

Bungay, P Mon 236 

Buniatian, GH YI.02 

Bunton, D Wed 132, Tue 160 

Burande, DM FC01.1.6 

Burcher, E Mon 235, FC08.1.6 

Buresova, E Tue 222, Tue 421 

Burgess, C Tue 136 

Burggraaf, J Tue 148, Thu 214, Thu 215, 

Mon 316 

Burggraaf, JK FC10.4.6 

Burhenne, J Mon 018 

Buriani, A Wed 320 

Burk, O FC02.1.5 

Burkhardt, T Mon 153 

Burkin, DJ FC12.4.5 

Burnet, M FC18.2.6 

Burstein, S Mon 264 

Burul-Bozkurt, N Wed 438, Mon 155 

Busenlehner, LS FC11.3.2 

Busija, D FC05.1.6 

Busillo, V Mon 448 

Busker, M Wed 210, Wed 280, Thu 252 

Busserolles, J Thu 083 

Bustamante, S Mon 411 

Butler, A Tue 233 

Butler, N Tue 110 

Butterweck, V Wed 417 

Buus, NH Mon 200 

Buyukdeligoz, M Tue 366, Tue 449, Tue 450 

Buyukuysal, RL Wed 179 

Buzoianu, AD Mon 417, Mon 438, Tue 481 

Bylund, DB W15.1 

Byun, B-Y Wed 383 

Cabal, J Tue 343, Tue 448 

Cabral, A Mon 376 

Cabriol, N Tue 170 

Cabrita, A Tue 407, 

Cachimaille, Y Thu 394 

Cadete, V FC06.3.6 

Caduff, P W32.1 

Cahalan, MD FC12.5.1 

Cai, G Tue 384 

Cai, Y Mon 266, Thu 277 

Cailliez, M FC10.5.5 

Cairns, BE W12.3 

Cairrão, E Wed 211 

Caisey, A Mon 232 

Caixas, U Wed 130 

Cakir, B Wed 249 

Cakmak, A Mon 348 

Cakmakci, Y Wed 308 

Calapai, G Wed 317, Thu 316, Thu 364 

Calignano, A FC18.1.6 

Caliskan, F Mon 348 

Callado, LF Wed 031, Thu 399 

Callahan, M Tue 372 

Callegari, E Mon 236 

Calloe, K FC06.1.4 

Callreus, T Mon 345 

Calmettes, Y Tue 170 

Calou, I Mon 299, Mon 298, Wed 318, 

Wed 319 

Calvet, D Mon 191 

Calvo Duo, R Tue 197 

Calvo, A Mon 007, Tue 261 

Calvo, R Wed 111 

Camacho, E Wed 212 

Camarasa, J Wed 174, Wed 177, Wed 

181, Thu 179 

Camargo, LL Wed 237 

Camici, PG FC05.2.2 

Camins, A Mon 443 

Camm, AJ FC06.2.1 

Camparo, P Tue 204 

Campbell, A Wed 032 

Campbell, AP Wed 048 

Campbell, WB FC15.3.4 

Campos, A Mon 451 

Campos, M Wed 337 

Campos-Toimil, M Wed 359, Wed 227 

Can, C Thu 233 

Canals, M Thu 060 

Candeletti, S FC14.1.5 

Canet, E PL04 

Cantilena, L Tue 107 

Cao, D Thu 020 

Cao, G Mon 349 

Cao, L Wed 034 

Cao, Lei Wed 213, Wed 033 

Cao, N Thu 280 

Cao, Y Tue 418, Tue 173, Tue 325, 

Wed 327, Tue 035 

Cao, Y-B Mon 265 

Cao, Y-X Mon 266, Wed 034 

Cao, Y Mon 008 

Cao, Y-X Tue 298, Wed 213, Wed 033 

Cap, R Tue 421 

Capasso, A Tue 406, Tue 487, Mon 448, 

Tue 488, Mon 449 

Capasso, F Wed 307 

Capasso, R Wed 307 

Capdeville-Atkinson, C Wed 244 

Capellà, D FC14.4.5 

Caputi, A FC04.4.5, FC04.3.6 

Caputi, F FC14.1.5 

Cara, D Tue 229 

Caraci, F Wed 400 

Carageorgiou, H Tue 457 

Caramona, MM Mon 350, Mon 376, Thu 119, 

Wed 214 

Carbonell, N W02.2.6 

Carbonneau, C Tue 396 

Carcak, N Mon 418 

Carcas, AJ Mon 451 

Carcas-Sansuán, AJ Tue 348 

Cardell, LO Mon 266 

Cardell, L-O Tue 292 

Cardeso, ALC Mon 125 

Cardoso, J Tue 420 

Carle, F FC04.3.6 

Carleton, B FC10.5.2, Thu 019, Thu 020 

Carlier, P FC04.2.5 

Carling, R Thu 088 

Carlsson, L FC06.2.2 

Carmo, A Tue 397 

Carnero, M Thu 240, Wed 215, Mon 206 

Index 321

322 Index 


Caron, MG FC11.4.1, Wed 423 

Carpino, F Tue 249 

Carral, N Tue 197 

Carrara, M Wed 320 

Carraro, R Tue 134 

Carrasco, VH Tue 326 

Carrasco-Portugal, M Mon 009, Mon 019 

Carreño, P Thu 187 

Carroll, P Tue 309 

Cars, Otto PL12 

Cartwright, C Mon 351, Tue 353 

Carvajal, A Mon 129, Mon 130 

Carvalheiro, H Tue 397 

Carvalho, DM Mon 010 

Carvalho, L Wed 341 

Carvalho, LCRM Wed 340 

Carvalho, MH Wed 042 

Carvalho, MHC FC06.1.5, Wed 237 

Casadesus, G Mon 443 

Casanova, M Thu 358 

Casarin, E Wed 320 

Casarotto, P FC17.5.5 

Casas, M FC14.4.5 

Cascorbi, I FC02.4.3, Mon 059 

Casey-Green, K Mon 352, Mon 353 

Cash, C Thu 394 

Casolini, P Tue 249 

Cassali, GD Wed 302 

Cassano, T Thu 440 

Castañeda-Hernández, G Mon 011, Mon 019 

Castanheira, L Mon 126, Thu 218 

Castel-Branco, MM Mon 376 

Castells, X FC14.4.5 

Castelo-Branco, M Thu 218 

Castillo, I Tue 420 

Castillo, MD Tue 326 

Castillo, N Thu 225 

Castro, E Wed 401, Thu 408 

Castro, N Mon 398 

Cataneo, SC Wed 332 

Catanozi, S Wed 203, Mon 257 

Cathala, C Mon 084 

Catic-Djordjevic, A Tue 149 

Catterall, WA FC12.1.2, Tue 479 

Cavaleiro, C Tue 257 

Cavun, S Mon 156, Wed 179 

Cazzolla, N Mon 296, Thu 433 

Ccalleja, G Tue 302 

CCB Tue 281 

Ceccelli, R Thu 237 

Cekic, EG Mon 419, Wed 253 

Cekic, V Wed 321 

Celikyurt, IK Mon 387, Tue 145 

Cellier, C W02.2.6 

Ceman Saric, J Wed 171 

Centurión, D W13.3, Thu 022, Thu 203 

Ceravolo, GS FC06.1.5, Wed 042, 

Wed 233, Wed 237 

Cercas, E Tue 134 

Cerná, O Mon 267 

Cernecka, H Mon 219 

Cervantes-Nevárez, A Mon 019 

Cervenka, R Mon 217, Mon 218 

Ceverie, J Tue 370 

Cha, E-Y Tue 351 

Chadha, R Tue 344 

Chadwick, B Tue 139 

Chai, L Wed 322 

Chaisri, S Thu 335 

Chalian, M Thu 006 

Challiss, RAJ Wed 030, Wed 025 

Chalmers, RTA Thu 420 

Chalon, S Tue 012 

Chalopin, M Wed 216, Tue 118 

Chamorro, G Wed 217 

Champagne, M Wed 123 

Chan, A W10.3 

Chan, CKY Wed 218 

Chan, C-M Tue 374 

Chan, Elsa Mon 194, Wed 219 

Chan, HC Thu 341 

Chan, K Wed 292, Wed 220 

Chan, M-H FC17.1.5, Mon 354 

Chan, MLY Wed 290 

Chan, P Mon 465, Tue 155 

Chan, PF Wed 323 

Chandra, V FC18.4.1 

Chandranipapongse, W Mon 355 

Chang, C FC15.2.5 

Chang, C-Z Mon 319 

Chang, H-C Tue 398 

Chang, HH Mon 356 

Chang, H-H Wed 286 

Chang, J Mon 443 

Chang, L-Y Thu 199 

Chang, W-C Wed 368 

Changkija, B Wed 294 

Chanthap, L Tue 090 

Chantratita, W Tue 127 

Chao, PL Mon 325 

Chaouch, W Wed 316 

Chappell, M Mon 151 

Charbeneau, R Thu 044 

Charoin, J-E FC07.2.5 

Charpentier, G Mon 161 

Chartier-Kastler, E Mon 233, Mon 232 

Chataigneau, T Wed 306, Wed 273, Wed 385 

Chatsiricharoenkul, S Mon 334, Mon 357, Tue 007, 

Tue 341 

Chatterjee, P Mon 157 

Chatterjee, S FC14.2.3 

Chatterjee, SS Wed 324, Wed 325 

Chatzimichael, A Tue 224 

Chaudhary, J Tue 020 

Chauhan, NK Mon 195, Mon 237, Wed 425 

Chaves, M Wed 318, Wed 319 

Chávez, LB Tue 302 

Chavkin, C FC14.4.4 

Chefer, V FC03.3.1 

Chekina, K Wed 100 

Chelarescu, D Thu 175, FC14.2.6 

Chen, AF FC15.1.2, FC15.4.6, W04.2.2 

Chen, B Thu 384 

Chen, B-C Mon 326 

Chen, B-R Tue 146 

Chen, C FC05.3.6 

Chen, C-T Mon 012, Mon 158, Wed 262 

Chen, CX Wed 291


Chen, D W02.2.1 

Chen, FH Wed 291 

Chen, G Thu 276 

Chen, H Mon 185, 

Chen, H-H Mon 268, Mon 354 

Chen, H-Z Tue 399 

Chen, H Wed 221 

Chen, H-H FC17.1.5 

Chen, H-Z Thu 368 

Chen, I-J Mon 269, Thu 105 

Chen, I-S Thu 105 

Chen, J Wed 331, 

Chen, J-C Wed 326 

Chen, K Wed 366, Wed 365 

Chen, K-H FC12.3.5 

Chen, L Thu 390, Tue 400 

Chen, LH Thu 295 

Chen, L Tue 401 

Chen, M Mon 045 

Chen, M-F Thu 090, Thu 362, Wed 286 

Chen, M-S Mon 186, FC09.5.6 

Chen, N Wed 331, Wed 013, Wed 193 

Chen, P Wed 072 

Chen, PS Mon 356 

Chen, P-Y Wed 286, Thu 090 

Chen, S Wed 122, Wed 121, Wed 120 

Chen, S-F Thu 277 

Chen, S-H Mon 270 

Chen, S-J Wed 222, Thu 283 

Chen, S-S Mon 268 

Chen, T-Y Wed 439 

Chen, W-L FC16.4.5 

Chen, X Tue 412, Wed 327, Thu 104 

Chen, XH Tue 439 

Chen, Y Tue 069 

Chen, Y-H Wed 106 

Chen, Y-C Tue 402 

Chen, Y-F Wed 328 

Cheng, G Mon 310, Mon 032 

Cheng, J Mon 331, FC13.2.1 

Cheng, L Thu 297, 

Cheng, LS FC10.2.5 

Cheng, P-W Tue 146 

Cheng, R FC09.3.3 

Cheng, W-H Tue 146 

Cheng, X Tue 403 

Cheng, Wed 402 

Cheng, X-R Thu 432, Mon 470 

Cheng, Y Mon 467 

Cheng, Y-C FC16.5.3 

Cheong, SK Thu 379, Thu 380 

Cherny, SS Mon 271, Mon 159 

Chess-Williams, R Tue 199 

Chetan, P Mon 091 

Cheung, BMY Mon 271, Mon 159 

Cheung, CM Thu 389 

Cheung, N Mon 045 

Chevet, E FC17.2.5 

Chiavaroli, A Mon 105, Wed 329, Wed 434 

Chiavegatti, T Wed 054 

Chiavegatto, S FC03.1.5 

Chiba, Y Mon 303, Mon 304, Tue 234, 

Tue 259, Mon 272, 

Tue 265, Tue 287 

Chick, J W06.3 

Chidiac, P Tue 180 

Chien, C-H Mon 158 

Chien, W-L Wed 403 

Chignalia, AZ Wed 233 

Chik, Z Tue 444 

Chimienti, F FC05.1.4 

Chin, P Tue 322 

Chinen, K Thu 344 

Ching, P Wed 369 

Chiou, L-C Wed 035 

Chipashvili, M Wed 272 

Chisyaki, A Wed 223 

Chitaley, FC08.1.2 

Chiu, C-T Thu 283 

Chiu, P-H FC17.1.5 

Chiu, P-T Mon 423 

Chladek, J Wed 017, Tue 342, Tue 125, 

Thu 168 

Chladkova, J Wed 017 

Cho, CH W02.1.4, Tue 476, Tue 417 

Cho, CWC Wed 330 

Cho, G Tue 068 

Cho, IH Mon 427 

Cho, S Tue 349, Thu 418 

Cho, SK Mon 013 

Choe, BI Tue 334 

Choe, T-B Tue 427 

Choi, C-I Mon 049, Mon 065, Mon 066, 

Mon 069, Mon 358, Mon 359, 

Tue 044, Tue 043, Tue 073, 

Tue 350, Tue 161, Tue 162, 

Tue 323, Tue 324, Tue 332, 

Tue 333, Wed 143 

Choi, J-Y Tue 352 

Choonara, I Thu 007 

Choong, E Mon 160 

Chopard, P Tue 305 

Chopra, K Mon 183, Wed 168 

Chopra, SC FC01.3.6 

Chotewuttakorn, S Thu 335 

Chou, SH Tue 135 

Choudhary, S W03.2 

Choudhury, MR Thu 120 

Choudhury, WR Thu 120 

Chowdhury, A Tue 097 

Christ, G J FC08.3.1 

Christakidis, D Mon 187 

Christensen, GL Wed 036, Wed 070, Thu 058 

Christensen, H Mon 041 

Christensen, HR Wed 161, Mon 360 

Christensen, KL Mon 200 

Christensen, LP Wed 380 

Christensen, MMH Mon 050 

Christensen, T Mon 320 

Christians, U Mon 053 

Christiansen, B FC11.5.1 

Christiansen, C Mon 346, W26.4, W26.2 

Christiansen, S Wed 397 

Christie, MJ FC03.3.1 

Crsen, N Wed 241 

Christopoulos, A Wed 089, Wed 082, 

Wed 043, Thu 041, Thu 080 

FC11.2.2 

Index 323

324 Index 


Chu, S Wed 331 

Chu, TTW FC02.4.6, Tue 140 

Chua, CB Wed 194 

Chua, T Mon 238 

Chua, YA Mon 361 

Chuang, Y-F Mon 423 

Chumakov, D Tue 024 

Chung, HC Mon 029 

Chung, J Tue 349, Thu 418 

Chung, JY Mon 013, Mon 033 

Chung, YW Thu 341 

Chuppa, S Mon 280 

Churchill, GC Wed 268 

Churin, A Tue 167 

Ciaccioli, G FC18.4.5 

Cianci, S Thu 440 

Ciangherotti, C Thu 205 

Cichutek, K PL02 

Cifuentes, L Mon 014, Mon 015 

Cintra, A Wed 339 

Cipriano, M Tue 465 

Ciric, B Tue 321 

Cirillo, MC Thu 353, Wed 332, Wed 

333,Wed 334 

Cirino, G Thu 081, Thu 202 

Cirovic, S Wed 103 

Ciubotariu, D Thu 175 

Clairambault, J W07.4 

Clanachan, A Tue 183 

Clark, AR FC09.1.5, W21.5, Tue 239 

Clark, Nicolas C FC14.1.4 

Clark, R Wed 270 

Clarke, K FC06.3.4 

Clausen, BE Wed 056 

Clausen, RP FC11.5.6, Wed 084 

Clavreul, N Thu 273, Thu 274 

Clawson, G Mon 285 

Clement, N Thu 055, Mon 161 

Clemmensen, C FC11.2.6, FC11.5.1 

Climent, B Mon 239, Wed 224, Wed 225 

Coats, P Thu 272 

Cobos-Puc, LE W13.3 

Coccuzzo Sampaio, S Thu 353 

Coe, JW FC14.2.3 

Coelho, AL Mon 314 

Coelho, M Mon 095, Mon 097, Mon 094 

Cogolludo, A Mon 374, Tue 121, Wed 226, 

Thu 217 

Cohall, D Wed 335 

Cohen, A Thu 215 

Cohen, AF Tue 148, FC10.4.6 

Cole, W W03.7 

Cole, WC Wed 239 

Coll, T Wed 440 

Coller, J Tue 495 

Colli, E FC08.2.3 

Collis, M W15.2 

Coloma, P FC04.1.6 

Colucci d'Amato, C Tue 488, Mon 449 

Coman, O Mon 111 

Coman, OA Mon 274 

Combescure, C Tue 305 

Comerma-Steffensen, S Tue 362 

Compagnie, S Mon 232 

Company, C Thu 437 

Company, MA Thu 407 

Compeer, MG Wed 037, Thu 208 

Comps-Agrar, L FC11.2.1, FC11.3.5, Wed 

077, Thu 035 

Conde, MV Thu 054 

Conde, S Mon 079 

Conforti, A Mon 129 

Cong, W Wed 336 

Cong, W-H Thu 376 

Cong, Y Tue 360, 

Conigrave, AD Wed 043 

Conn, PJ FC11.5.2, FC17.2.3 

Conradie, KR Thu 016 

Cons, BL Wed 339 

Constable, T FC14.3.3 

Contreras, C Thu 249, Mon 239 

Cook, JM FC03.3.3 

Cooper, M FC03.3.5 

Cooper, ME Thu 228 

Copani, A Wed 400 

Coquerel, A Thu 173, Mon 362 

Corbin, JD FC08.1.5 

Corcostegui, R Mon 254 

Cordeddu, G Tue 133 

Cornell, C Thu 088 

Cornes, L W10.2 

Cornish, J Wed 190 

Corrao, G FC04.1.6, FC04.3.6, Tue 093 

Côrrea, FMA Wed 411 

Correa-Basurto, J Tue 195 

Correia-de-Sá, I Wed 114 

Correia-de-Sá, P FC08.2.6, Thu 064 

Cortes, L FC16.2.5 

Cortijo, J Thu 437 

Cosic-Cerovac, N Wed 009 

Cossey, V Wed 002 

Costa, CA Wed 341, Wed 340 

Costa, ECA Mon 010 

Costa, ES Mon 273 

Costa, TJ FC06.1.5 

Costa-Neto, C Thu 068 

Cöster, M Thu 087 

Costescu, M Mon 274 

Cotrim, M Wed 337 

Cots, JM FC13.1.5 

Coupar, I Thu 032 

Couture, R Tue 275, Thu 073 

Cowan, A Wed 038 

Cox, J Wed 152 

Coyle, JR Mon 388, Wed 170 

Cracowski, J-L Wed 208, Thu 244, Thu 245 

Cristante, E FC15.1.5 

Cromarty, D Mon 368 

Crowe, A Mon 051, Tue 063 

Crown, N Tue 301 

Crozier, A Thu 328 

Crupi, D Wed 317 

Cruz, J FC03.1.5 

Cruz, MDC Wed 217 

Cruz, MT Mon 291 

Cruz-Machado, S Thu 204 

Csajka, C FC10.5.3 

Cseharovszky, R Mon 318


Csikasz, R Wed 063 

Cuautle-Rodríguez, P Tue 431 

Cuciureanu, M FC14.2.6, 

Cui, P Wed 378 

Cui, R Thu 445 

Cui, S-Y Mon 082 

Cui, X-Y Thu 386 

Cui, Y FC13.4.3 

Cui, YG Thu 341 

Cui, Zong Jie Wed 039 

Cuíñas, A Wed 359 

Cuíñas, A Wed 227 

Culie, C Tue 172 

Culig, J Mon 127 

Cullen, W Mon 453 

Culter, M Wed 013 

Cumming, P FC17.1.2 

Cummins, TR FC12.2.2 

Cumps, J Tue 182 

Cunha, F Mon 275 

Cunha, FQ Tue 255 

Cunha, Thiago FC03.1.5 

Curnow, J Tue 233 

Cury, Y Mon 273 

Cury, Yara Mon 276 

Cusinato, F Thu 360 

Cussac, D Mon 084 

Cussonneau, X Mon 193 

Cuzzocrea, S FC18.1.5, FC18.3.6, 

Mon 277, Mon 286 

D´Ocon, P Tue 165 

Da Costa-Guevara, DJ Wed 040 

da Cruz e Silva, O Mon 146 

da Motta, NAV Wed 232 

da Silva Rodrigues, E Wed 041 

da Silva, AL FC16.2.3 

da Silva, LL Mon 279, Wed 232 

da Silva, R Wed 198, FC15.4.5 

da Silva, RF Thu 061 

Daali, Y Tue 166, Mon 337 

D'Acunto, CW Tue 406 

D'Addario, C FC14.1.5 

Dadgar, FN Mon 036 

Dadkhah, F FC01.3.5 

D'Agostino, G FC18.1.6 

Dahan, A W12.4 

Dahan-Farkas, N Tue 404 

Dai, H Tue 070 

Dai, JM Wed 228 

Dai, Y-W Wed 262 

Dai, Z-K Thu 105 

Daiber, A W30.3, W04.2.4 

Dalhoff, K Mon 345 

Dalla, C W33.4 

Dalli, J FC09.5.7, FC09.4.6 

Dalodom, T Wed 338 

Dalsgaard, T Wed 229, Wed 230, Wed 

281, Wed 282, Thu 259 

Dalton, GD Wed 029 

Daly, AK FC13.3.2 

Daly, C Thu 030 

Daly, CJ W01.2.2 

Dam, E W26.4 

Dambrova, M Tue 141 

Damchi Jelodar, J Thu 412 

Damkier, P FC04.4.2, Mon 050, Tue 395, 

Damsgaard, EM Mon 142 

Damsgaard, J Wed 160 

Danchin, N Mon 145, Mon 132 

Dandara, C Thu 016 

Daniel, H FC02.3.3 

Danielyan, L YI.02 

Danscher, G Mon 320 

Danser, J Wed 292, Wed 220 

Dantas, AP YI.03, Thu 225 

Dantas, R Wed 131 

Darabi, M Tue 164 

D'Arrigo, C Thu 419 

Darrouzain, F Mon 363 

Darsova, D Tue 445 

Darvas, F Tue 130 

Darwish, IE Mon 364, Tue 464 

Darwish, SA Mon 364 

Darýverenli, E Wed 357 

Das, A Mon 314 

Das, M Thu 427 

Daulat, A Thu 055, Wed 072 

Daulat, AM Thu 028 

Dautreaux, B Thu 242 

Davarian, A Mon 196 

Davel, AP Wed 042, Wed 231 

Davenport, AP W14.1, Tue 479 

Davey, AE Wed 043, Wed 089 

Davids, H Mon 308, Tue 404 

Davidson, C Wed 425, Mon 195, Mon 430 

Davidson, M SS01.1 

D'Avolio, A Tue 405 

Davy, J-M FC06.2.3 

Davydova, KS Thu 253 

Dawson, J FC15.1.6 

Dawson, N FC17.1.4 

Dayer, P Tue 166, Tue 305, Mon 337 

de Almeida, RB Wed 395 

de Andrade Cavalcante, 

F Thu 351 

de Andrade, GM Tue 282 

de Araujo, I W02.1.6 

de Basilio, V Tue 362 

de Bock, M Thu 237 

de Brito Gariépy, H Tue 275 

de Brito, FCF Wed 232 

de Bruin, ML FC04.3.3 

de Carvalho, AGG Tue 281 

de Carvalho, MHC Wed 233 

de Cock, J FC03.2.6 

de Cock, P Mon 365, Tue 306 

de Diego, AMG FC12.1.6, FC16.2.5 

de Esch, I Thu 060 

de Fátima, A Mon 097 

de Filippis, D FC18.4.6, Tue 465 

de Francia, S Tue 405, Wed 010 

de Franco, F FC18.4.5 

de Graaf, C Thu 082 

de Jesus Barreiro, E Mon 279 

de Jesús, ML Wed 046 

de Jesus, S Thu 254 

de Jong-van den Berg, 

LTW FC04.4.4 

Index 325

326 Index 


de Kam, ML FC17.3.5, FC10.4.6, Tue 148 

de Koning, C Tue 404 

de la Cortes, J P Mon 278 

de la Cruz, JP Mon 206, Tue 116, Wed 215, 

Wed 250, Thu 246 

de la Puerta, R Tue 409 

de la Villa, P Wed 225 

de Lemos Neto, M Wed 339, Wed 340, Wed 342 

de Leon, MW Mon 038 

de Lera, A FC18.3.5 

de Lima, CKF Mon 279 

de Luca, P Mon 223 

de Lucca Camargo, L Wed 233 

de Man, J Tue 465 

de Martin, S Wed 404 

de Martino, F Tue 405, Wed 010 

de Menorval, LC Thu 358 

de Mey, JGR W25.3, Wed 037, Thu 251 

Thu 208, Wed 287, Thu 221 

de Miranda, ALP Mon 279 

de Moura, RS Wed 341, Wed 340, Wed 342 

de Munnik, S Thu 060 

de Oliveira, AM Thu 236 

de Oliveira, D Tue 241 

de Sarro, A Wed 317 

de Vries, A Mon 442 

de Vries, C FC04.2.6, Mon 140 

de Vries, CJM FC18.2.4 

de Vries, C FC04.4.3 

de Vries, R Wed 292 

de Wit, H FC14.3.4 

Deak, BH Wed 050 

Dear, JW Thu 420, Tue 270 

Debeer, A Wed 002 

Debets, JJ Mon 212 

DeBold, J FC14.4.3 

Debruyne, F Wed 001 

Dechent, C Mon 136 

Deforges, L W02.2.6 

Degenhardt, T FC18.2.5 

Degenne, D Mon 363 

DeGorter, M FC02.1.6 

Dehpour, AR Wed 418 

Dehpour, AR. Thu 180 

Dejanovic, M Wed 436 

DeJesus, S Wed 265 

Dekanski, D FC16.3.6, Wed 343 

del Caño, GG Wed 046 

del Rosario Garrido, M Tue 226 

Delagrange, P Thu 028, Thu 055 

de-la-Hera, A Mon 254 

Delchier, JC W02.2.6 

Delgado-Buenrostro, NL Tue 149 

Delgado-Hernandez, R Tue 114, Wed 344, Thu 358 

Deli, J FC16.2.6 

Della-Casa, MC Wed 332 

Della-Casa, MS Wed 333, Wed 334 

Dellai, A Wed 316 

Delpón, E FC06.2.4 

Demare, P Tue 420 

Demir, O Mon 043, Tue 200 

Demir, T Tue 200 

Demircan, D Mon 117 

Demirci, C Tue 461 

Demiryurek, AT Thu 272 

Demotes, J W10.1 

Denadai-Souza, A Wed 233 

Dencker, L W10.2 

Deng, J Tue 178 

Deng, L Tue 184 

Deng, SY Wed 345 

Deng, X W02.2.7, Tue 466, Wed 366, 

Wed 365 

Denich, D Wed 148 

P, M Tue 190 

Denise, P Mon 362 

Denizalti, M Mon 366 

Denys, P Mon 233, Mon 232 

Dercho, RA Tue 414 

Dermentzopoulou, M Tue 246 

Desch, M Wed 234 

Deschenes, G Wed 011 

Descotes, J FC09.2.7 

Deshimaru, . M Thu 108 

Desloovere, C Wed 001 

Desmeules, J Mon 337 

Desmeules, JA Tue 166 

Desmoulins, F Wed 196 

Despars, G Tue 396 

Desta, Z Tue 045 

Desvergne, B FC18.1.2, FC18.2.5 

Deswal, R Mon 005 

Detilleux, P W10.2 

Deuschle, U FC18.2.6 

Deval, E FC17.2.5 

Devay, A FC16.2.6 

Devi, LA Wed 065 

Dewhurst, D W20.1 

Dey, A Mon 240, Mon 242, Mon 248 

Dézsi, L Tue 078 

Dhaunsi, G Mon 151 

di Bari, M Mon 120 

di C, F Tue 405, Wed 010 

di Cesare Mannelli, L Mon 113, Mon 391, Tue 446 

di Francesco, A Mon 281, Wed 235 

di Francesco, L Wed 235, Mon 281 

di Gion, P Thu 010 

di Lio, A FC03.3.3 

di Matteo, A Mon 296 

di Michele, P Mon 105, Wed 434, Wed 329 

di Nisio, C Mon 105, Wed 434, Wed 329 

di Paola, R FC18.1.5, Mon 277, 

FC18.3.6 

Dias, MF FC01.4.3 

Diaz Acedo, C FC04.4.6 

Díaz Casañas, E Wed 311 

Diaz, A Thu 408 

Díaz, A Wed 401, Wed 087 

Dib-Hajj, SD FC03.1.4 

Diddi, G Thu 302 

Didier, R Thu 082 

Diederichs, C Tue 313 

Diéguez, G Wed 224 

Dieleman, J FC04.4.5 

Dieplinger, H Tue 151 

Dietrich, D W10.2 

Diez, R Mon 128, Mon 280 

Diez-Alarcia, R Wed 031


Díez-Juan, A W09.4 

Dilley, R Mon 194, FC06.4.5 

Dimitri, W Mon 352, Mon 353 

Dimmeler, S PL05 

Dimosiari, G Mon 367 

Dinat, N Tue 001 

D'Incau, P Mon 129, Mon 130 

Diness, J FC06.3.5, FC06.1.4 

Ding, G Tue 299, 

Ding, J Tue 441 

Ding, Y Thu 372 

Dingemanse, J Tue 312 

Diniz, C Thu 054 

Dinter, D Tue 447 

Dionísio, T Mon 007, Tue 261 

Dipasquale, P Thu 440 

Dirach, J W10.2 

Direito, R Mon 383, Tue 407 

Disania, N Mon 131 

Dittz, D Tue 428 

Dixit, VK Mon 237 

Diz, D Mon 151 

Djordjevic, A Tue 122 

Djordjevic, V Tue 149 

Djulbegovic, B Tue 107 

Dlugokecka, J Mon 197 

Dmitriev, V Tue 129 

Doan, AE Mon 103 

Dobric, S Tue 321 

Docherty, JR Wed 236 

D’Ocon, P Thu 050, Wed 068, Thu 048, 

Tue 163 

Dodgen, T Mon 368 

Dodoo, A W32.4, W35.3, W27.4 

Doe, M Mon 404 

Dogan, BSU Tue 461 

Dohmoto, M Thu 286 

Doi, H Tue 244 

Doi, M Wed 424 

Doig, C Mon 116 

Dolezal, K Thu 118 

Dolidze, N Tue 174 

Dolphin, A FC03.2.4 

Dombi, G Mon 261 

Dominguez, H FC04.2.4 

Donadio, L FC18.4.5 

Donaldson, K W10.3 

Donati, M Mon 130 

Doncheva, N Mon 083 

Donertas, B Mon 117 

Dong, H-J Tue 083 

Dong, J Tue 152, Tue 419 

Donnelly, L Tue 269 

Donnerer, J Mon 369 

Donnini, S Wed 243 

Dora, KA FC15.2.2, Wed 268, 

Wed 206, Thu 289 

Dorchies, O Thu 013, W04.3.2 

Dorchies, OM Wed 102 

Doroshyenko, O Mon 315 

Doroszko, A FC06.3.6 

Doroumian, S Mon 204 

dos Santos Dias, AA Wed 237 

dos Santos Filho, A Wed 203, Mon 257 

dos Santos, ARS Wed 394 

Dosa, MD Mon 162 

Dosenko, V FC06.1.6 

Doshi, M Mon 116, 

Doudet, D Thu 405, Thu 404 

Doudet, DJ FC17.4.5 

Doustar, Y Mon 294, 

Dovizio, M Mon 281, Wed 235 

Draganic, P Mon 370 

Drago, F Thu 396, Mon 152, Wed 400 

Dragojevic-Simic, V Tue 091, Tue 321, Tue 151, 

W34.3, W34.5 

Drake, MJ FC08.4.4 

Drecun, M Tue 081 

Drekic, D Thu 436, Mon 446 

Dresser, G Tue 301 

Drevensek, G Thu 359, Thu 293 

Drewelow, B Wed 119, Tue 131, Tue 115 

Drewes, AM W12.1 

Dridi, M Wed 316 

Drimba, L Mon 163 

Drouet, L Tue 188, Tue 189 

Droz-Perroteau, C Mon 145, Mon 132 

Drummond, GR FC15.1.4, Mon 305 

Dsokey, N Mon 165 

D'Souza, Y Tue 385 

Du Plessis, JB Mon 258, Wed 389, 

Wed 390, Wed 391 

du Preez, J Thu 428 

du Souich, P W06.5 

Du, G Thu 314, Mon 034, Thu 384, 

Thu 372, Tue 307 

Du, GH Mon 433, Tue 297, Tue 365 

Du, G-H Mon 421, Wed 346 

Du, J Thu 367 

Du, L Mon 092 

Duan, DD FC12.4.5 

Duarte, C Mon 398 

Duarte, H FC03.1.5 

Duarte-Araújo, M FC08.2.6, Thu 064 

Duborija-Kovacevic, N Wed 135, Wed 134 

Duburs, G Wed 045 

Ducimetière, P Mon 145, Mon 132 

Duckles, S PL15, Wed 261 

Ducluzeau, PH Mon 148, Tue 118 

Ducourau, E Tue 198, Tue 190 

Ducret, T Wed 293 

Ducza, E Wed 101 

Duczynski, G Mon 251 

Dufournet, B Thu 244 

Dufton, N FC09.4.6 

Dugina, JL Mon 198, Mon 284, Thu 015 

Dukat, A Tue 113 

Dulak, J W24.5 

Dulger, GA Tue 027 

Dumas de la Roque, E Wed 293 

Dumas, M Tue 289, Tue 290 

Dumbrava, LP Mon 417, Mon 438 

Dunlop, A FC03.2.6 

Dunne, F Tue 364 

Dupuis, F Wed 244 

Duque-Bascuñana, B Tue 348 

Duran, JA Wed 109 

Durán, JJT Mon 288, Thu 115, Tue 302 

Index 327

328 Index 


Durán, ST Mon 288, Thu 115, Tue 302 

Dureau-Pournin, C Mon 145, Mon 132 

Duret, J-P Mon 202 

Durman, DK Mon 199 

Durnev, A Tue 276 

Durnev, AD Tue 165 

Durroux, T FC11.3.5 

Duruewuru, K Mon 017 

Dusting, G Mon 194, FC06.4.5, Wed 

219, FC15.2.5 

Dutta, S Tue 453 

Duty, S Wed 044 

Duvauchelle, T Mon 201 

Dygai, A Tue 167 

Dyhring, T YI.10 

Dykhal, YI Wed 175 

Dyr, W Thu 174 

Dyve, S FC17.4.5 

Dzirkale, Z Wed 045 

Eandi, M Wed 154 

Eandi, M Mon 223 

Eap, CB Tue 166, Mon 160 

Ebeid, F Tue 386 

Ebner, K W33.5 

Ebrahimi, R Mon 202 

Ebrahimi, SM Mon 188 

Echeazarrra, L Wed 046 

Echeverría, O Mon 176 

Echizen, H Tue 486 

Eden, T Tue 353 

Edington, A Mon 052 

Edlert, M Mon 371 

Edvinsson, L Mon 450, Tue 185, Tue 220, 

Thu 239, Tue 298, Wed 021, 

Wed 033, Wed 213, 

Wed 292, Thu 053, Thu 056, 

Thu 066 

Edwankar, RV FC03.3.3 

Edwards, B W32.3 

Edwards, G FC15.2.1, Wed 238 

Edwards, R FC02.2.4 

Eftekhari, A Mon 200, Thu 234 

Eftekhari, S Wed 292 

Egashira, N Mon 093, Thu 109 

Egea, J Tue 042 

Egutchi, S Thu 261 

Eichelbaum, M Wed 133 

Eidne, KA Wed 079 

Eiermann, B Mon 371 

Ejtemaei Mehr, S Thu 180 

Ekici, H Wed 312 

Ekokoski, E Tue 433 

Ekström, L Thu 256, Wed 183, FC14.1.6, 

Wed 176 

El Deeb, K Mon 282 

El jebari, H FC07.3.6 

El Saghir, N FC01.3.4 

El-Banna, H Mon 016 

El-Bassossy, H Mon 164, Mon 165 

El-denshary, ES Tue 451 

Elekes, K W19.3, Mon 283, Tue 271, 

Tue 250, 

Elgabarty, H FC06.2.6 

El-Gendy, AAM Mon 340 

Elgharbi, A Mon 290, Mon 377 

Elhwuegi, A Wed 405 

Eliasson, E FC13.4.5, Thu 256, Tue 318, 

Tue 138 

Elie, V FC10.5.5 

Elie, Valery Wed 011 

Elies, J Wed 227 

Elisabeth, S-G Tue 190 

Elisabetsky, E FC16.2.3 

Eliseeva, E Mon 133, Mon 134 

Elkarimi, H Mon 378 

El-Kiweri, I Mon 053 

El-Lakkany, N Tue 386, Mon 372 

Elliot, D Wed 124 

Ellis, EM Mon 413 

El-Maadawy, W Tue 386 

El-Mallah, A Tue 264 

Elmedal Laursen, B Wed 281, Wed 240 

El-Moselhy, M Mon 164, Wed 441 

Eloranta, JJ Thu 435 

El-Yacoubi, M FC17.2.5 

El-Yazbi, A Wed 239 

Elzinga, CRS Wed 095 

Elzorba, H Mon 016 

Emami, A Tue 389 

Emami, SA Thu 313 

Embil, K Tue 142 

Engelstoft, MS Thu 036 

Enggaard, TP FC13.5.5 

Engidawork, E FC01.2.5 

Engström Hellgren, K Tue 308 

Enwere, O Mon 017 

Enzaka, J Mon 304 

Epstein, D FC14.3.4 

Epstein, OI Mon 198, Mon 284, Thu 015 

Erb, C FC18.3.5 

Ercanlý, T Tue 029 

Erdeljic, V FC01.3.7, Mon 135, 

Mon 373, Tue 328 

Erden, F Thu 401 

Erdozain, AM Wed 031 

Erenmemisoglu, A Tue 018 

Ergüden, J Thu 091 

Eriksson, L Tue 383 

Eriksson, M Wed 006 

Erin, N Mon 285 

Erlendsson, S Tue 053 

Erlinge, D Thu 074, Wed 052, Wed 062 

Ermakov, S Tue 196 

Ernst, G Mon 245 

Eroglu, E Tue 031 

Erol, A Thu 233 

Erol, K Mon 103, Wed 406, 

Wed 420, Wed 421 

Eromon, A Wed 369 

Eromosele, S Mon 241 

Ertoy Baydar, D Wed 253 

Eruanga, V Mon 241 

Esaki, Y Tue 260, Tue 294 

Eschalier, A Thu 083 

Escobar, L Mon 136, Tue 164, Tue 326 

Escobar, T Mon 480 

Escolano, L Mon 374, Tue 121, Wed 226, 

Thu 217


Escubedo, E Wed 174, Wed 177, 

Wed 181, Thu 179 

Esen, AA Tue 200 

Eskildsen, T FC06.2.5 

Eskildsen-Helmond, Y Wed 240, Wed 241 

Esmaeili, J Mon 454 

Espino, J Mon 407 

Esposito, E FC18.1.5, FC18.3.6, 

Mon 277, Mon 286 

Esposito, G Tue 465, FC18.4.6 

Esposti, ED Mon 120 

Esposti, LD Mon 120 

Esteban, A Thu 235 

Esteves Pinto, C Wed 114, Thu 398 

Estrada, S Wed 068 

Estupiñan, J Mon 480 

Eto, B Tue 040 

Etter, M Mon 160 

Euikyung, K Tue 017 

Evangelista, JSAM Thu 374 

Evans, A Wed 124, Tue 495 

Evans, B Wed 063, Mon 395, Thu 059 

Evans, C FC14.1.3 

Evans, SJW FC04.2.3, FC04.3.2 

Evans, W E FC13.2.4 

Evcim, AS Tue 200 

Exintaris, B Mon 240, Mon 242, Mon 248, 

Tue 416 

Eyakem, AH Mon 018 

Eybl, V Mon 409 

Ezenwanebe, K Wed 296 

Ezeokoli, CD Thu 326 

Faal, M FC17.2.6 

Fabio, B Thu 400 

Fadda, E Tue 133 

Faddah, LM Mon 189 

Faghih Mirzaei, E Wed 376 

Fagni, L FC11.3.3 

Fago, A Wed 230 

Fagundes, C W31.4 

Fahmy, A Mon 165 

Faiad, OJ Mon 273 

Fakhoury, M FC10.1.5, Wed 011 

Fakhrjou, A Tue 223 

Falahi, G Thu 005 

Falahpour, M Thu 005 

Falcão, A Thu 169, Mon 383, Tue 407 

Falcão, S Thu 366 

Falk, E Wed 241 

Falkay, G Mon 208, Mon 261, Wed 050, 

Wed 101 

Falkbring, S Wed 092 

Fameli, N Thu 264 

Fan, D Tue 286 

Fan, GW Wed 242 

Fan, J FC15.2.5 

FAN, L Tue 419 

Fan, L Wed 257 

Fan, S-J Thu 277 

Fan, T-P FC16.4.1, Wed 330 

Fan, X Tue 117 

Fan, Y Tue 069 

Fang, C Tue 399 

Fang, C-K Wed 430 

Fang, H Tue 138, Mon 458 

Fang, L-H Wed 346 

Fang, S Mon 457, Mon 458 

Fang, SF Mon 325, Tue 317 

Fantozzi, R Tue 256, Thu 434 

Farar, V Thu 039 

Farker, K Wed 119, Tue 131 

Farooqi, S FC11.4.3 

Farre, M Thu 177, Thu 178, Mon 137, 

Mon 109, Mon 375 

Faruque, R Tue 097, Tue 120 

Fätkenheuer, G Mon 315 

Fauler, M FC12.2.3 

Faure García, R Thu 347 

Favaloro, JL Wed 288, Wed 289 

Fawcett, K Mon 161 

Fazekas, K Wed 423 

Fazni, R Thu 181 

Fazzi, G Thu 251 

Fedorenko, A Mon 431 

Fedotova, Y FC17.1.6, Wed 407, Wed 347 

Feinshtein, V Mon 054 

Feizi, I Thu 311 

Felder, CC Thu 041 

Feldkötter, M Thu 018 

Feldman, BJ Wed 079 

Feldman, M FC09.2.1 

Félétou, M Thu 273, Thu 274 

Félétou, Ml FC15.3.1 

Felino, A Tue 261 

Felix, AMR Mon 010 

Fellman, V Thu 008 

Feltner, D Wed 193 

Fendt, A Wed 185 

Feng, J Wed 267 

Feng, L Mon 457, Mon 458, Tue 138 

Feng, N Mon 466 

Fennell, T Thu 021 

Fenner, K Mon 236 

Fenwick, P Tue 269 

Feoktistova, Y Mon 133 

Ferchichi, H Thu 346, Wed 348, Mon 004 

Ferk, Polonca Wed 178 

Fernandes, AC Mon 276 

Fernandes, D Wed 097, Wed 251, Thu 064 

Fernandes, ES Mon 287 

Fernandes, K W01.2.4 

Fernandes, LGR Mon 289 

Fernandes, MA Wed 045 

Fernandes, MH Tue 261 

Fernandes, P Thu 204 

Fernández Lima, O Wed 311, Thu 347 

Fernández, H Thu 205 

Fernandez, MC Tue 123, Wed 109 

Fernández, N Wed 224 

Fernández-Arche, MA Tue 409, Wed 349 

Fernandez-Aviles, F W09.5 

Fernández-Llimós, F Mon 376 

Fernandez-Morales, JC FC16.2.5, FC12.1.6 

Fernández-Pérez, L Tue 387, Tue 391, Tue 392 

Fernandez-Vallin, E Wed 209 

Ferrand, N Thu 055 

Ferrante, C Mon 105, Wed 434, Wed 329 

Ferreira, EB Tue 101 

Index 329

330 Index 


Ferreira, HHA Mon 289 

Ferreira, S Mon 275 

Ferreira, W Mon 095, Mon 097, Mon 094 

Ferreirinha, F Thu 064 

Ferro, H Mon 280 

Feske, S FC12.5.3 

Festa, M Tue 406 

Fey, V Mon 410, Tue 436 

Fickl, H Mon 368 

Field, J Mon 102 

Figueiras, A Thu 119, Tue 086, Mon 146 

Figueiredo, C Wed 302, Tue 428 

Figueiredo, I Wed 214, Mon 299, Mon 298, 

Wed 319 

Figueiredo, IV Mon 376, Thu 119 

Figueirinha, A Mon 291 

Figueiró, M FC16.2.3 

Figura, P Thu 174 

Filali, H Mon 290, Mon 378, Mon 377 

Filaretova, L W02.2.5 

Filipcsei, G Tue 130 

Filipovic, B Mon 096 

Filippov, AK Wed 047 

Filiz Basaran, N Wed 179 

Filppula, A Mon 380 

Finch, AM Mon 394, Wed 032, Wed 048 

Finetti, F Wed 243 

Fingerhut, R Wed 016 

Fioravanzo, E Thu 433 

Firenzuoli, F Thu 302 

Firstova, J Wed 426 

Firuzi, O Thu 309 

Fischer, DF W14.4 

Fischer, J Thu 197 

Fischer, M Tue 169 

Fish, R Mon 393, Wed 020, Mon 420 

Flacco, N Wed 068 

Flammer, A FC16.1.2 

Flammini, L Tue 258, Mon 381 

Fleckenstein, L Tue 012 

Flioni, E Tue 141 

Flor, H W03.6 

Flordellis, C Wed 074 

Floreani, M Wed 404 

Flores, ML Wed 350 

Flores-Morales, A Tue 387, Tue 391, Tue 392 

Flores-Murrieta, F Mon 009, Mon 019 

Flores-Santana, W FC09.3.3 

Flower, K FC14.2.5, Mon 388, Wed 170 

Flower, RJ FC09.4.6 

Flynn, C Wed 158 

Fogli, S Wed 442, Mon 382 

Fois, C Tue 133 

Fok, BSP FC02.4.6, Tue 140 

Folarin, OA YI.09 

Folkerts, G FC09.5.2 

Folmes, CD FC05.2.6 

Foltin, V Mon 479 

Foltinova, J Thu 211, Thu 354 

Fonseca, D Wed 337 

Fontana, P Mon 337 

Fontes Ribeiro, C Wed 140, Wed 180 

Foo, Y-T FC01.3.1 

Ford, L Tue 284 

Forget, A FC04.1.5 

Forjasz, R Mon 262 

Formigos, JA Mon 138, Mon 472, Thu 407, 

Formigós-Bolea, J Mon 477, Mon 473, Mon 481 

Fors, M Thu 394 

Forsberg, M Mon 425 

Förstermann, U FC15.4.3 

Fortes, R Tue 008, Thu 322, Thu 321 

Fortes, ZB Wed 233, FC06.1.5 

Fortin, A Tue 396 

Fortuna, A Thu 169, Mon 383, Tue 407 

Fotoohi, A Mon 055 

Fotouhi, M Mon 036 

Fouad, M Mon 164 

Foulquier, S Wed 244 

Fourrier-Réglat, A FC04.4.6, W10.4 

Frade, M Mon 298 

Fraga, C Mon 398 

Fraga, CAM Mon 279 

Frame, F Tue 270 

Francetic, I FC01.3.7, Mon 135, Mon 

373, Tue 328 

Francisco, V Mon 291 

Franco, DW W31.3 

Franco, LAM Mon 292 

Frank, D Mon 384, Mon 315 

Frank, E Thu 308 

Frank, L Wed 092 

Frankic, T Wed 171, Wed 004 

Franks, N FC03.4.1 

Franova, S Mon 293 

Fransen, P Wed 246, Wed 245 

Frappier, M Wed 123, Tue 051 

Frau, A Tue 133 

Frazziano, G Thu 217 

Fredberg, U Tue 358 

Fredericia, PM Tue 248 

Free, R Thu 063 

Freeman, D Wed 013 

Freeman, DJ FC10.2.5 

Freilij, H Mon 003, Wed 003 

Freire, C Thu 366 

Freire-Garabal, M Thu 325 

Freissmuth, M FC11.4.5 

Freitas, A Mon 275 

Freitas, L Mon 298 

Fresco, P Mon 126, Thu 054 

Frey II, WH YI.02 

Frey, N FC07.2.2 

Freyer, J Tue 049 

Frias, J Mon 451 

Frías-Iniesta, J Tue 348 

Friberg, L W29.3 

Frigerio, C Wed 337 

Frigerio, F Wed 447 

Fröbert, O Thu 222 

Frølund, B FC11.5.6 

Fromm, MF FC02.2.6, FC02.3.2 

Frotscher, M Tue 442 

Fry, C H FC08.3.2 

Fu, J Tue 419, Thu 440 

Fu, S-Y Wed 035 

Fu, W-M Wed 403 

Fu, X Tue 384


Fuad, WEM Thu 312 

Füchtbauer, EM FC02.3.6 

Fürjes, G Tue 125 

Fürst, R Tue 227, FC16.1.5 

Fürst, S Wed 185, Thu 192 

Fuhr, U Mon 315, Mon 384, Thu 010 

Fujibayashi, M Wed 422, Wed 415 

Fujii, M Tue 154 

Fujii, A Tue 201, Tue 432 

Fujii, N FC05.2.6 

Fujimori, A Thu 416 

Fujimura, A Thu 268, Wed 189 

Fujimura, S Wed 189 

Fujisawa, S Tue 430 

Fujita, A Tue 234 

Fujita, K Wed 141 

Fujiwara, H Thu 261 

Fujiwara, Y Wed 189 

Fukami, K Mon 243 

Fukasawa, T Wed 136 

Fukazawa, I Tue 345 

Fukuda, K FC13.2.5, Tue 126, Tue 260 

Fukuhara, Y Wed 247 

Fukui, H Wed 061 

Fukuishi, N Mon 253 

Fukumoto, A FC16.4.6 

Fukunaga, K Thu 406 

Fukushima, T Mon 307 

Fulga, I Mon 111, Mon 274 

Fuller, PJ FC18.2.3 

Funaki, Y Tue 166 

Fung, KP Thu 297, Wed 345 

Funk, C Wed 235 

Furlan, G Mon 385 

Furlotti, G Mon 296 

Furman, C Thu 063 

Furuie, H Mon 386 

Furukawa, K-I Tue 430 

Furumoto, S FC17.5.6 

Furuno, T Wed 422 

Furuta, T W23.4, Tue 159, Mon 459, 

Tue 473 

Furuta, Y Thu 406 

Fusco, FB Wed 203, Mon 257 

Fuster, JJ W09.4 

Gaasemyr, J Tue 143 

Gabrielsen, M Mon 224 

Gacar, G Mon 387 

Gacar, N Wed 351, Mon 387, Tue 145 

Gad, M FC06.2.6 

Gaedigk, A Mon 384 

Gaetani, S Thu 440 

Gagiano, C FC14.5.5 

Gahrn-Hansen, B FC13.1.5 

Gaïes, E FC07.3.6, Mon 020, Mon 021 

Gailly, P Wed 102 

Gajski, G Tue 447 

Galán, J Tue 103 

Galasso, L Tue 487 

Galasso, R Tue 487 

Gales, C Mon 162 

Galindo, P Wed 268 

Galione, A Wed 268 

Gallardo, E Tue 144 

Gallardo-Ortiz, I Wed 049 

Galleyrand, J Mon 203, Mon 201, Mon 205, 

Mon 204 

Gallo, C W04.3.2, Wed 102 

Gallo, E Thu 302 

Galloway, GP FC14.2.5, Mon 388, Wed 170 

Gallwitz, B FC05.3.3 

Galuppo, M FC18.1.5, Mon 277, 

FC18.3.6 

Gambassi, G FC04.4.5 

Gammeltoft, S Wed 070, Thu 058, Wed 036 

Gan, SH Mon 361, Mon 389, Tue 153, 

Tue 164, Tue 408, Tue 434, 

Tue 455 

Ganafa, AA Tue 209 

Gandelman, K Mon 251 

Gandhi, T FC16.1.6 

Ganpathy, P Mon 166, Tue 131 

Ganshina, T Wed 248 

Gantumur, M Tue 095 

Gao, C Mon 056 

Gao, D-L Mon 470 

Gao, J Thu 377, Thu 242 

Gao, J-W Mon 031 

Gao, L Mon 434, Tue 181 

Gao, M Mon 421 

Gao, X Thu 371 

Gao, X Tue 419 

Gao, XM Wed 242 

Gao, Y Tue 178, Wed 291, Thu 089 

Gao, Y Tue 388 

Gao, Z Mon 331 

Gao, Z-Y Tue 082 

Garaj-Vrhovac, V Tue 447 

Garayt, C FC04.2.5 

Garcia Fuentes, JL Mon 390 

García -Gonzalez, D Wed 349 

García Mondragón, MJ Thu 330 

García Sacristán, A Wed 224 

García, A Tue 042 

Garcia, AG FC12.1.6 

García, AG FC16.2.5, Mon 079 

Garcia, MR Mon 038 

Garcia, R Mon 207 

Garcia, TSL Wed 204 

Garcia-Algar, O Mon 375 

Garcia-Arnes, JA Mon 471 

Garcia-Barreto, D Mon 207 

Garcia-Bournissen, F FC10.5.3, Mon 003, Mon 

022, Wed 003, 

García-Cabanes, MC Mon 472, Mon 473, Mon 477, 

Mon 481 

García-Carrascal, L Mon 149 

García-Gimenez, D Tue 409 

García-Iglesias, B Thu 265 

Garcia-M, E Wed 109 

Garcia-Ratés, S Thu 179 

Garcia-Rates, S Wed 181 

Garcia-Rivera, D Wed 344 

Garcia-Rodriguez, C Mon 291 

García-Sacristán, A Thu 249, Mon 239, Tue 213, 

Mon 411, Wed 225 

García-Villalón, AL Wed 224 

Gard, P Wed 409 

Index 331

332 Index 


Gardner, E Thu 195, Wed 182 

Garduño, L Wed 217 

Gårevik, N Wed 183 

Garg, V FC06.1.1 

Garibova, TL Mon 422 

Garjani, A Mon 294, Tue 164, Tue 223 

Garland, CJ FC15.2.2, Wed 268, Thu 289 

Garland, S Wed 053 

Garle, M FC14.1.6, Mon 404 

Garrido Suarez, B Wed 344 

Garrido, M Wed 352 

Garrido, MR Mon 295, Wed 212, Wed 

265, Thu 254 

Garrone, B Mon 296 

Gärtner, F Wed 148 

Garuoliene, K Mon 139 

Gashaw, HH Thu 241, Thu 238 

Gaspar, M Wed 337 

Gaspar, R Mon 208, Wed 101, Wed 050 

Gassmann, M FC11.3.5 

Gaszner, B Mon 110, Mon 106 

Gatti, S Wed 094 

Gaud, C Mon 203, Mon 201, Mon 205, 

Mon 204, Mon 202 

Gaudette, N Thu 021 

Gavanji, S Thu 392 

Gayi, E W04.3.2 

Gazerani, P W12.3 

Gbahou, F Wed 051 

Gbotosho, GO YI.09 

Ge, W Tue 163 

Gean, PW Mon 356 

Geerts, A Thu 091 

Geerts, BF Tue 148 

Gelal, A Mon 043, Mon 474 

Gellett, A Tue 410 

Genovese, T FC18.1.5, Mon 277, Mon 

286, FC18.3.6 

Gentgall, M Wed 113 

Gentry, C Mon 287 

George, AL FC12.3.2 

Georgiadi, A FC18.2.5 

Georgieva, A Tue 196 

Georgopoulou- 

Karanikola, T Mon 297, Tue 126 

Geppetti, P W11.2, FC04.3.6, Mon 120 

Gerardin, E Mon 191 

Géresi, K Mon 150, Mon 167 

Gergs, U Tue 169 

Germain, P FC18.3.5 

Germano, I Wed 130 

Germer, M FC09.2.6 

Gersting, SW Thu 014, Wed 016 

Geta, D Mon 108 

Gether, U FC02.1.1, FC02.3.5, 

FC02.3.6, Mon 058, 

Mon 061, Mon 067, Mon 073, 

Tue 053 

Getova, D Mon 083 

Gevoyan, S Tue 218 

Gezer, A Thu 266 

Gezerler, F Thu 269 

Ghahremani, MH Wed 418 

Ghasemi, M Wed 418 

Ghelardini, C Mon 113, Mon 391, Tue 446 

Ghersi, D FC01.3.3 

Gheyle, L Tue 280 

Ghita, I Mon 111 

Ghizzardi, P Tue 258 

Ghosh, R Tue 131, Mon 166 

Giachetti, A Wed 243 

Giannini, E Thu 440 

Giaquinto, C FC04.1.6 

Gibson, C Wed 425, Mon 430 

Gibson, CL Mon 195 

Giddings, A Tue 221 

Gidener, S Tue 200, Mon 474 

Gidlöf, O Wed 052, Wed 062 

Giessrigl, B Thu 308 

Giglio, F Mon 007 

Giglio, N Wed 003 

Gil, ML Tue 478, Tue 422 

Gilani, AH FC16.2.4 Wed 356, Wed 354, 

Wed 355, Wed 353 

Gilbert, A FC13.1.6 

Gill, C Wed 307 

Gill, D FC12.2.5 

Gill, JS FC01.2.6 

Gill, PK FC01.2.6 

Gille, A Wed 056 

Gilleron, V Tue 092 

Gilles, N Tue 203 

Gilles, P Mon 363 

Gillies, G FC15.1.5 

Gilligan, J FC09.5.7 

Gilså Hansen, D Wed 160 

Gilsbach, R FC11.4.2, W01.2.1, Wed 022 

Giltay, EJ Wed 432, Tue 096 

Gini, R FC04.1.6 

Ginnaga, A Wed 371 

Giommoni, F Thu 302 

Giorgio, C Mon 381 

Giorgio, R Thu 400 

Girgis, R FC17.1.3 

Gislason, GH FC04.2.4 

Giuffrida, ML Wed 400 

Giuli, C Tue 249 

Giuliano, F FC08.2.1, Mon 233, Mon 232 

Gjedde, A FC17.1.2, FC17.4.5, 

Tue 193, Thu 405, Thu 404 

Glass, C K FC18.2.1 

Glenthøj, B FC17.3.2 

Gloriam, D Wed 053, Wed 066 

Gloriam, DE FC11.5.1 

Glossmann, H Thu 014, Wed 016 

Glynn, RJ FC04.1.3 

Glynn, R J FC04.1.4 

Glynn, S FC09.3.3 

Gnjidic, D FC13.1.6, Mon 392, Tue 309 

Gobbetti, T Tue 258 

Gobburu, JVS FC07.4.1 

Gocmez, SS Wed 351, Mon 387, Tue 145 

Goda, M Tue 415 

Godfredsen, C Tue 132 

Godin, A Mon 094, Mon 095, Mon 097 

Godinho, R Wed 054 

Goel, PC FC09.5.5 

Goerlandt, N Mon 365, Tue 306


Goh, G FC02.2.4 

Goirand, F Tue 289, Tue 290 

Gojkovic-Bukarica, L Wed 103 

Gok, Sule Wed 357 

Goktas, MT Wed 249 

Golan, M Wed 410 

Goldbeter, A FC07.1.3 

Goldman, M W24.1 

Goldstein, DB FC13.4.1 

Golechha, M Mon 260 

Golechha, M Wed 358 

Golkar, M Mon 455 

Golocorbin-Kon, S W34.4 

Gomes, FV Wed 411 

Gomes, N Wed 337 

Gomes, P Tue 032 

Gomez, E Thu 242 

Gomez, JE Wed 359 

Gomeza, J FC02.3.6 

Gomez-Foix, AM Wed 440 

Gomez-Luque, A Mon 471, Mon 149, Wed 005 

Gómez-Pliego, R Mon 168 

Gómez-Zamudio, J Mon 168 

Gonçalves, D Mon 298, Mon 299, Wed 318, 

Wed 319 

Gonçalves, J Tue 257, Thu 054, Thu 193 

Gonçalves, LRC Wed 333, Wed 334 

Gonçalves, P Mon 007, Mon 042, Mon 057 

Gong, I Tue 301 

Gong, J Mon 251 

Gong, J-P Thu 176 

Gong, L-L Wed 346 

Gong, N Tue 082 

Gong, Q-H FC14.4.6, Tue 178, Tue 382, 

Thu 182, Thu 184, 

Thu 185, Thu 186 

Gong, Z-H Tue 083 

Gongadze, N Wed 272 

González Correa, JA Wed 215, Mon 206 

González, AVM Tue 302 

Gonzalez, C Thu 217 

González, D Mon 407 

Gonzalez, E Mon 280 

Gonzalez, FJ FC13.2.1 

Gonzalez, JC FC16.2.5 

González, MC Thu 054 

Gonzalez-Correa, JA Mon 278, Tue 116, Tue 144, 

Wed 007, Thu 246, Wed 250 

Gonzalez-Dalhaus, E Tue 150 

González-Flores, L Mon 011 

Gonzalez-Gomez, D Wed 352 

González-Hernández, A Thu 022, Thu 203 

González-Navarro, H W09.4 

Gonzalez-Rocafort, A Thu 240 

González-Serryn, C Wed 251 

Gonzalo, A Mon 080 

Goodacre, R FC13.4.2 

Goodyear, LJ FC05.2.6 

Goon Goh, F Tue 252 

Göransson, H Wed 014, Wed 015 

Gordillo-Moscoso, A Thu 240 

Gordon, J Tue 233 

Gorelik, J Thu 238 

Gorny, D Mon 233 

Gorovic, N Tue 482 

Gossard, D Wed 123 

Gossart, S Tue 012 

Gotfryd, K Mon 058, Mon 073 

Goto, M Tue 244 

Gottesman, MM FC02.1.3 

Gottwald, M W10.3 

Gotzsche, O Mon 200 

Gou, H-Y FC14.5.4 

Goudet, C FC11.3.6, Thu 083 

Goulas, A Mon 300 

Goulden, N Mon 351 

Goulding, NJ W17.2 

Goupille, P Tue 198 

Gouraud, A FC04.2.5, FC09.2.7 

Gourley, I Tue 012 

Gous, A Tue 110 

Gous, H Thu 016 

Gouveia, S Wed 130 

Govantes, GF Mon 288 

Govoni, S Mon 152 

Goyal, A Mon 169, Wed 358 

Goyal, S Mon 190 

Gozalbo, D Tue 478, Tue 422 

Gozukizil, A Tue 411 

Grabnar, I FC07.3.5 

Grace, AA FC17.1.1 

Graepel, R Mon 287 

Graff, C Tue 303 

Grafström, RC Mon 410 

Graham, B Thu 280 

Gramsbergen, JB Wed 380 

Granic, P Tue 304 

Grant, D Tue 389 

Gratzke, C FC08.2.4 

Graudal, N FC09.2.4 

Gray, A FC01.1.4 

Grbovic, L Tue 151, 

Greedy, B YI.01 

Gréen, H Tue 395 

Green, I Mon 157 

Green-Thompson, L Mon 478 

Greenwood, JR Wed 084 

Gregori, D FC04.3.6 

Gresshoff, I W03.7 

Gribble, Fiona M FC05.3.2 

Grieve, DJ Thu 439 

Griffith, R Wed 032, Mon 394 

Grigoriev, VV Mon 422 

Grimaldi, M FC18.3.5 

Grimm, D Thu 267, Wed 252 

Groen, G Thu 112 

Gronemeyer, H FC18.3.5 

Groning, JE Mon 207 

Grossberg, A Mon 280 

Grove, KL Wed 257 

Grube, M Tue 039 

Gruber, C FC11.4.5 

Grubiè, Z Tue 048 

Grubišin, J Wed 398 

Gruetzner, C FC17.2.2 

Grunnet, M Wed 099, FC06.3.5, 

FC06.1.4 

Grzywa-Celiñska, A Tue 022 

Index 333

334 Index 


Gschwind, L Tue 305 

Guan, X Tue 130 

Guan, Y-F Thu 210 

Guan, Y-Y Wed 104 

Guantai, A W27.3 

Guarner, C Tue 123 

Gudasheva, T Mon 225, Wed 188 

Guddattu, V FC04.3.7 

Gudi, G W03.2 

Guedes, PMM W31.3 

Guegan-Massardier, E Mon 191 

Güler, S Wed 253 

Gülhan, R Mon 418 

Gültekin, H Tue 030 

Güney, HZ W05.1, Tue 029 

Guénolé, E Mon 203 

Guentert, T W10.2 

Guerard, M Mon 244 

Guérard, M Tue 203 

Guerra-López, P Tue 348 

Guerrero, A Wed 250, Mon 278 

Guevara, M Tue 016 

Guevara-García, MM W04.1.3, Mon 023, Wed 344 

Guglielmotti, A Mon 296 

Guh, JH Mon 249 

Guh, J-H Tue 402 

Guillaume, J-L Mon 161, Wed 072, Thu 028 

Guillén, JE Mon 388 

Guilloteau, V Mon 244, Tue 203 

Guimaraes, FS FC17.5.5, Wed 411 

Guimaraes, M Mon 398 

Gujar, S Thu 333 

Gulati, A FC05.2.5, Wed 184 

Gulati, K FC16.4.2 

Gulati, V Wed 360 

Gulbinovic, J Mon 139 

Guldenpfennig, M Thu 428 

Gullapalli, S W03.2 

Gulmez, SE FC04.2.6, Mon 140, Mon 141 

Gultekin, H Tue 031 

Gumusel, B Tue 027 

Gumustas, K Tue 461 

Gumustekin, M Tue 411, Mon 170 

Gunduz, O Wed 050 

Guneli, E Mon 170 

Guneli, M Mon 474 

Gunnar, N Tue 387 

Gunnarsson, L Wed 092 

Guo, D FC11.4.6 

Guo, H Wed 322 

Guo, J Tue 441, Tue 076 

Guo, L Tue 295 

Guo, LC Thu 093 

Guo, N Mon 194 

Guo, Y-K Mon 031 

Gupta, A Tue 495 

Gupta, BM Mon 131 

Gupta, DD Mon 024 

Gupta, J Mon 171 

Gupta, M Mon 024 

Gupta, N Mon 169 

Gupta, S W13.2, Mon 099, Tue 436, 

Wed 220 

Gupta, SK Thu 354 

Gupta, YK Mon 169 Mon 452, 

Gurdal, H Tue 450 

Gurel, A Tue 461 

Gurianova, V FC06.1.6 

Gurney, A Thu 279, Wed 269, Wed 238 

Gustafsson, L Tue 005, Wed 136 

Gutierrez, V Mon 276 

Guven, H Mon 474 

Guyon, A FC17.2.5 

Gyarmati, S Wed 185, Thu 192 

Gyires, K W19.1, Thu 062, Thu 094 

Gylling, H Mon 215 

Gyotoku, J Thu 430 

Gysling, K Thu 187, Wed 169 

H. Nazmy, W Wed 441 

Haas, B Tue 129 

Haas, H W33.3 

Haase, G Tue 115 

Haase, T Wed 280 

Haazen, W Tue 280 

Habtewold, A FC01.4.7 

Hacker, J FC03.3.1 

Haddad, E FC05.3.6 

Haegeman, E Mon 365, Tue 306 

Haenisch, S Mon 059, W03.6 

Hafizoglu, E Mon 098 

Hagenbuch, B Wed 158 

Hager, GL FC18.4.2 

Haggholamali, M Tue 165 

Haghparast, A Wed 396 

Hagiwara, E Tue 154 

Hajagos-Tóth, J Mon 208, Wed 050 

Hajdu, D Tue 475 

Hajikhani, R Wed 012 

Hajizadeh Moghaddam, A Thu 412 

Hajj, A Wed 191, FC01.4.4 

Hajmohammadi, A Tue 015 

Hakala, Ae Wed 361 

Hakkola, J Wed 448, Wed 445 

Hakkou, F Mon 290, Mon 378, Mon 377 

Halayko, AJ Tue 242, Wed 095 

Halimi, S Tue 268 

Hall, D Wed 055 

Hall, Ian P FC13.5.2 

Halling, J Wed 151 

Halliwell, B PL09, W04.1.1 

Hallow, M Tue 196 

Halls, M W14.2 

Halonen, P Mon 410 

Hamaguchi, A Tue 177 

Hämäläinen, M Mon 302, Thu 223 

Hamase, K Wed 305 

Hamaue, N Mon 309 

Hambrock, A Thu 098 

Hambruch, E FC18.2.6 

Hamishehkar, H Tue 223 

Hammond, J Tue 047 

Hamoud, F Mon 140, Mon 141 

Hamza, I Mon 020, Mon 021 

Hamzeiy, H Mon 044, Tue 164 

Han, C Mon 331 

Han, X Wed 254 

Han, X Mon 209 

Han, Yantao Tue 412


Han, Z Mon 414, Tue 412, Tue 173, 

Tue 325, Wed 327 

Han, Zhiwu Mon 408 

Han, ZQ Wed 039 

Han, Z-W Mon 008 

Hanamitsu, M Wed 200 

Hanazaki, M Mon 303, Tue 259 

Hanig, JP Wed 150 

Hanly, L Wed 013 

Hänninen, P Wed 444 

Hannonen, P FC09.2.5 

Hanse, D Thu 315 

Hansen, BS Mon 227 

Hansen, BK FC11.5.1 

Hansen, H FC05.3.5 

Hansen, JL Wed 070, Thu 058, Wed 036 

Hansen, JT Thu 058 

Hansen, KB Wed 084 

Hansen, MB Mon 071 

Hansen, MP FC13.1.5 

Hansen, R Wed 125, FC06.3.5 

Hansen, RS FC06.1.4 

Hansen, S Thu 101 

Hanson, J Wed 056 

Hao, Q Tue 425, Tue 371 

Hao, X Tue 296 

Hao, Y Tue 181 

Haouari, M Mon 338 

Happi, CT YI.09 

Hara, H Thu 220 

Hara, T Mon 304 

Harakawa, T Wed 371 

Haramburu, F Tue 092 

Harbig, P Mon 142 

Harding, I Wed 360 

Hardman, M W10.3 

Hardman, M W10.1 

Hargreaves, R W10.3, Wed 292 

Harimoto, Y Wed 117 

Härlin, U Mon 245 

Härmä, H Wed 444 

Harmar, A Tue 479 

Harmatha, J Wed 386 

Harmer, C FC17.4.3 

Harmse, L Tue 003, Tue 404 

Haron, DEM Tue 444 

Haron, MH YI.04 

Haroun, F FC01.3.4 

Harrabi, I Mon 006 

Harrington, LS Thu 200, Thu 238 

Harris, CW FC14.2.5 

Harrison, C Mon 305 

Harrison, N L FC03.4.3 

Hart, J Wed 255 

Hartzema. AG. FC04.2.2 

Härter, M Thu 091 

Harthy, KAI Tue 152 

Hartmann, A W10.2, Thu 112 

Harvey, B FC16.3.7, Thu 428 

Harvey, BH Wed 399, Mon 412 

Hasford, J W35.2 

Hashemi, J Mon 055 

Hashiguchi, T Thu 331 

Hashii, M Tue 413 

Hashikawa, N Mon 174, Mon 306 

Hashimoto, H Mon 110, Mon 318 

Hashimoto, T Tue 201, Wed 256, Thu 117 

Hashimoto, Y Tue 147 

Hashtroodi, AA Mon 002 

Haslemo, T Wed 412 

Hasnan, J Thu 312 

Hassan, AI Tue 120 

Hassan, AM Mon 252 

Hassan, AN-E Mon 252 

Hassan, M W07.3 

Hassan, R Tue 434 

Hassan, SK Mon 389 

Hassanein, S FC06.2.6 

Hassanzadeh, K Tue 164 

Hasumi, K Thu 213, Thu 117 

Hasunuma, T Mon 307 

Hatazawa, R Mon 255 

Hatoum, H FC01.3.4 

Hatta, N Tue 001 

Hattori, Y FC09.1.6 

Hatzitolios, A Mon 143 

Hatzokos, H Tue 246 

Haubold, M FC11.4.2 

Hauptmann, S Tue 169 

Hausman, M Thu 255 

Hauta-aho, M Mon 144 

Havlik, I Mon 308, Tue 002 

Havt, A Wed 297 

Hay, D Wed 057 

Hayakawa, T Tue 318, Tue 138 

Hayashi, H Wed 424 

Hayashi, M Tue 336 

Hayashi, S Thu 072 

Hayashizaki, Y Tue 492 

Haynes, J Tue 202 

Hay-Schmidt, A Thu 106 

Haythornthwaite, A FC03.2.6 

Hazelwood, L Thu 063 

He, G FC12.2.5, Tue 307, Thu 314 

He, G-W Mon 172, Wed 257, Thu 287, 

Thu 288 

He, M FC06.4.6, Mon 210, Tue 036, 

Tue 158, Thu 298, 

Tue 317, Wed 258, Wed 362 

He, X Tue 138, Wed 259, Thu 292, 

Thu 372 

Hector, E Tue 232 

Hedlund, P FC08.3.5, Tue 212, Tue 210 

Heedaard, A-M Mon 089 

Heerdink, ER Mon 129 

Hegedus, Z Tue 250 

Hegele, R FC02.1.6 

Heidarsson, PO Tue 053 

Heijnen, BFJ Thu 221 

Heikkilä, T Thu 170 

Heikkinen, AT Mon 060 

Heilig, M FC14.4.2 

Hein, L FC11.4.2, W01.2.1, W01.2.4, 

Wed 022, Thu 062 

Hein, W Mon 315 

Heinemann, A FC11.1.6 

Heiniger, AI Tue 394 

Heinonen, I Thu 243 

Index 335

336 Index 


Heinrich, A W19.2 

Heishman, S FC14.3.4 

Heitman, L Wed 058 

Heliopoulos, I Mon 187 

Helldén, A W35.4, Tue 308, Wed 147 

Hellmann, M Wed 208 

Hellstrom-Westas, L FC10.4.4, Wed 006, Thu 008 

Helms, P Wed 137 

Helms, PJ Tue 109 

Heltovics, G Tue 130 

Helyes, Z W19.3, FC16.2.6, Mon 318, 

Tue 250, Tue 271 

Hempel, G FC10.4.5 

Hendrich, J FC03.2.4 

Heneka, M T FC18.3.3 

Hennessy, M Thu 442 

Henningsen, K Wed 433, Wed 397 

Henningsson, A FC07.4.4 

Henriksen, F Mon 061 

Henriksen, K W26.4, W26.2 

Henriksen, T Mon 406 

Henríquez-Hernández, L Tue 387 

Henthorn, T Mon 053 

Heo, DK Mon 062 

Hepburn, C Mon 211 

Heras, M YI.03 

Herber, O Tue 108 

Hercberg, S Mon 145, Mon 132 

Herdeiro, MT Thu 119, Tue 086, Mon 146 

Herings, R FC04.1.6 

Herman, Arnold G FC16.4.3 

Hermann, M Tue 490 

Hermans, JJR Mon 212 

Hermenegildo, C Thu 225 

Hernandes, MZ Thu 374 

Hernandez Casaña, P Wed 344 

Hernández, M Thu 249, Tue 213, Mon 411 

Hernández, MC Tue 394 

Hernandez, MT Wed 352 

Hernandez-Balmaseda, I Wed 344 

Hernandez-Cañero, A Mon 207 

Hernández-Guijo, J FC16.2.5 

Herrera Henriquez, MA Thu 330 

Herrera, MD Tue 118 

Herrera, E Tue 387 

Hervera, A Thu 042, Wed 059 

Hesse, B Wed 395 

Heurteaux, C FC17.2.5, Thu 237 

Heusler, P Mon 084 

Hewett, P Mon 102 

Heydari, A Tue 231, 

Heymes, C Wed 196 

Hibbins, A Tue 456 

Hibino, H Tue 147 

Hibino, Y Wed 266, Thu 227 

Hidaka, A Tue 266 

Hieke, B Wed 234 

Higa, T Mon 399 

Higgins, P FC15.1.6 

Higuchi, H Tue 140 

Higuchi, H Wed 060 

Higuchi, M Mon 213 

Higuchi, Y Tue 413 

Hikumwah, G Thu 315 

Hilber, K Mon 218, Mon 217 

Hildebrand, M FC03.2.1 

Hildebrandt, W Tue 462 

Hill, SR FC10.2.2, W36.1, W36.2 

Hiller, S Thu 098 

Hilmer, S FC13.2.6, FC13.1.6, Mon 

392, Tue 309, 

Wed 125, Wed 126 

Hintze, TH FC15.1.3 

Hinz, B Tue 310, Thu 337 

Hippisley-Cox, J FC04.1.6 

Hippius, M Wed 119, Tue 131 

Hirabara, Y Wed 223 

Hirabayashi, N Tue 459 

Hirafuji, M Mon 309, Thu 201 

Hirai, K Thu 261 

Hiramoto, T Tue 377 

Hirano, M Mon 309 

Hirao, A Mon 173, Tue 122 

Hirasawa, A Tue 311, Wed 064 

Hirata, M Thu 038 

Hirayama, Y Mon 313 

Hirayasu, Y Wed 422, Wed 415 

Hirokane, G Wed 414 

Hirose, S Thu 108 

Hiroshi, K Thu 375 

Hirota, Y Tue 168 

Hirshman, MF FC05.2.6 

Hirvonen, J Thu 170, Tue 032 

Hisa, H Thu 263 

Hisayuki, O Thu 213 

Hishinuma, S Mon 178, Wed 061 

Hjelvang, B FC13.3.6, Mon 118, Mon 406 

Hjelvang, BR Mon 119 

Hnasko, T FC02.2.4 

Ho, EYW Thu 255 

Ho, HP Thu 381 

Ho, HR Mon 327 

Ho, WSV Wed 260, Tue 471 

Ho, W-Y Tue 146 

Ho, Y-C Wed 035 

Hoang, T Tue 396 

Hobara, N Mon 174, Mon 306, Tue 154, 

Tue 415 

Hocaoglu, N Mon 474, Tue 366, Tue 449, 

Tue 450, 

Hoch, M Tue 312 

Hochi, H Wed 278 

Hochstrasser, D Tue 166 

Hodková, A Mon 409 

Hodler, C Wed 443 

Hoecherl, K Wed 234 

Hoeck, Hans C W26.5 

Hoedemaker, F Thu 315 

Hoehn, T Thu 272 

Hoever, P Tue 312 

Hoffmann, C W01.1.4 

Hofmann, F Wed 234 

Hofmann, KP FC11.1.3 

Hofstetter, A Mon 245 

Høg, S FC11.5.6 

Hogaboam, CM Mon 314 

Hogan, P FC12.5.4 

Högberg, C Wed 052


Högberg, Carl Wed 062 

Högestätt, E FC09.4.5 

Højgaard, L W24.4 

Hokkanen, J Thu 348 

Holanda, IR Tue 282 

Holcberg, G Mon 054 

Holgate, J FC14.3.5, FC14.2.3 

Holicka, M Tue 240 

Holler, M Mon 479, Tue 099 

Holloway, K FC01.1.4 

Holm, K Mon 328 

Holm, L W35.4 

Holst, B FC11.5.4, Thu 036 

Holt, S Tue 314, Tue 313, Tue 131 

Höltke, C Wed 037 

Høltzermann, M Thu 405, Thu 404 

Holý, A Tue 300 

Home, P FC05.4.2 

Homma, M Tue 315 

Homma, N Wed 105 

Hommers, L Wed 026 

Hompesch, M Mon 175 

Honda, K Tue 201, Wed 223, Wed 256, 

Thu 108, Thu 117, Thu 213, 

Thu 224 

Hong, E Mon 176 

Hong, T Wed 267 

Hong, Zhou Wed 363 

Hongprasong, N Thu 357 

Honkalammi, J Tue 316 

Honore, B Wed 240 

Hooiveld, G Thu 438 

Hopfgartner, G Tue 166 

Hoppu, K FC10.3.1 

Hoppu, Kalle FC10.2.1 

Horikawa, K Thu 416 

Horinouchi, T Mon 399 

Horinouchi, Y Wed 247 

Horiuchi, M Mon 439 

Horiuchi, S Tue 459 

Hornbak, M Thu 053 

Horne, J Wed 261 

Horner, B Thu 394 

Horrillo, I Thu 031 

Horsdal, HT FC04.2.7 

Horsmans, Y FC04.2.6, Mon 141 

Horvath, A Wed 185 

Horváth, C Tue 078 

Hosoda, M Tue 154 

Hosoda, T Mon 178 

Hosohata, K Tue 156 

Hossain, MA Wed 080 

Hosseini, R Tue 015 

Hosseinzadeh, H Wed 364 

Høst, C Mon 320 

Hosten, N Tue 041 

Hostettmann, K Wed 375 

Hotchkiss, C Wed 150 

Hotershall, J FC03.1.5 

Hothersall, J Mon 275 

Hou, H Mon 458 

Hou, L Tue 033 

Hou, N Mon 186 

Hou, Qi Mon 310 

Houze, P Wed 191 

Hovatta, O W21.3 

Howell, R Mon 265 

Howlett, A Tue 145, Wed 029 

Howng, S-L Mon 319 

Hrabinova, M Tue 448 

Hracsko, Z Mon 460 

Hracskó, Z W19.2 

Hristov, M Thu 240 

Hristovski, D Thu 293 

Hsiao, M-C Wed 430 

Hsiao, WLW Thu 296 

Hsieh, H-L Mon 311, Tue 293 

Hsieh, W-K Wed 192 

Hsu, C Wed 439 

Hsu, H-Y Wed 106 

Hsu, M-J Mon 423 

Hsu, S-P Wed 449 

Hsu, T Mon 158 

Hsu, Y-H Thu 362 

Hu, C-B Mon 158 

Hu, J Thu 372, Mon 323 

Hu, J-J Mon 421, Wed 346 

Hu, L Wed 242 

Hu, M FC02.4.6, Tue 139, Tue 140 

Hu, X Mon 349, Mon 032 

Hu, Y Mon 466, Mon 445, Thu 300 

Hu, Z Tue 076 

Hua, Y Tue 158 

Huabprasert, S Thu 361 

Huala, I Tue 326 

Huang, C Wed 365, Wed 366 

Huang, C-Y Mon 158 

Huang, F Tue 365 

Huang, HC Mon 356 

Huang, J-H Thu 287, Thu 288 

Huang, J-L Tue 082 

Huang, O Tue 317 

Huang, OP Tue 036 

Huang, P FC18.4.1 

Huang, P-T Tue 083 

Huang, Q Tue 158, Wed 258 

Huang, Q-R Wed 291 

Huang, S-C Wed 262 

Huang, T Wed 076 

Huang, W-T Mon 270 

Huang, X Thu 044 

Huang, X-N Tue 184, Tue 178 

Huang, Y FC07.2.5, FC15.3.2, 

FC15.4.7 

Huang, Y-W Mon 158 

Huang, Z-M Wed 367 

Huang, Z-N Tue 382 

Hüpkes, M Mon 463 

Hüting, D Mon 245 

Hütter, J Thu 091 

Hugar, S Thu 333 

Hughes, AD Thu 069, Thu 259 

Hughes, IE PL18 

Hughes, KH Thu 207 

Huh, W Tue 335 

Huhtinen, A Thu 084 

Huizer-Pajkos, A FC13.2.6 

Hum, M Tue 414 

Index 337

338 Index 


Hume, JR FC12.4.5 

Humphrey, SJ Wed 048 

Hung, C-F Tue 374 

Hung, J-J Wed 368 

Hunt, L Wed 190 

Hunter, A Wed 096 

Hurbin, F Mon 203 

Hurd, YL FC14.1.2 

Hurlé, MA Wed 087 

Hurst, RS FC14.2.3 

Hurt, C Wed 028 

Hurttila, H Wed 448 

Husbands, S YI.01 

Husmann, K Thu 197 

Hussain, M FC08.3.2 

Husson, J-M W10.3 

Hutchinson, D Thu 059, Wed 063, Mon 395 

Huttunen, R Wed 444 

Huynh, MB Mon 469 

Hwa, L FC14.4.3 

Hwang, L-L Wed 262 

Hwang, M-S Tue 351 

Iacob, M Wed 207 

Iacono, A FC18.1.6 

Iannazzo, S Wed 154, Mon 223 

Iaquinto, G W02.3.3 

Ibáñez, L Tue 087 

Ibañez, MR Wed 169 

Ibara, M A FC13.1.2 

Ibarra, M Wed 049 

Ibarra-Barajas, M Mon 168 

Ibrahim, M Mon 372, FC01.2.5 

Ichimura, A Wed 064 

Ichishima, K Tue 162 

Idriss Khodja, N Wed 273 

Igarashi, T Tue 380, Wed 263 

Igarashi, Y Mon 178 

Igbe, I Wed 369 

Ignatiev, I Tue 057 

Iguegbe, A Wed 370 

Iijima, H Tue 345, Mon 307 

Iino, M PL11 

Iizuka, K Thu 201, Mon 309 

Ijzerman, AP FC11.2.3, FC11.2.5, 

FC11.4.6, W25.1 

Ikarashi, N Mon 177, Mon 182 

Ikeda, A Tue 156 

Ikeda, R Tue 167 

Ikeda, Y Mon 180 

Ikeda-Matsuo, Y Mon 313 

Ikegami, Y Mon 093 

Ikehara, A Tue 060 

Ikesue, H Mon 093 

Ikuma, M Tue 473 

Ikuta, Y Wed 413 

Ilett, K FC10.5.3 

Ilic, K FC10.2.6, Tue 367 

Iljin, K Mon 410, Tue 436 

Iljuhhina, J FC04.3.4 

Imai, S Wed 065, Thu 188 

Imaizumi, Y Wed 107, Thu 102, Thu 107 

Imamoglu, S Mon 156 

Imamura, Y Wed 247 

Imanishi, M Wed 247 

Imashova, S Tue 079 

Immonen, E Mon 063 

Imprialos, K Mon 367 

Improta, G Tue 249 

Imreh, A Mon 110, Mon 106 

Inakuma, T FC16.4.6 

Inal, A Tue 018 

Inan, S Wed 038 

Incerti, M Mon 381 

Indarte, M Tue 059 

Infanger, M Wed 252 

Infante, F Tue 488, Mon 449 

Ingelman-Sundberg, M FC13.5.1, W23.5, Tue 489 

Ingham, TR Tue 136 

Inotsume, N Tue 138, Tue 318 

Inoue, H FC09.1.4, Mon 402 

Inoue, Y Tue 060, Wed 414 

Insel, P Thu 067 

Institoris, A FC05.1.6 

Inui, K Tue 225, Tue 156 

Inui, N Thu 262, W23.1 

Iordanidou, M Tue 224 

Iosifidou, E Tue 246 

Iqbal, MZ Thu 181 

Iqbal, Z Tue 319 

Irer, B Tue 200 

Irie, M FC16.4.6 

Irie, Y Wed 186, Tue 477 

Irs, Alar FC01.2.1, FC04.3.4 

Irving, H Thu 032 

Isabel, O Mon 376 

Isah, AO FC01.4.1, Tue 010 

Isajevs, S Mon 429, Tue 253 

Isaksson, A Wed 014, Wed 015 

Isberg, V Wed 066 

Ishibashi, N Tue 390 

Ishida, S Wed 413 

Ishiguro, H Thu 176 

Ishiguro, S Wed 414 

Ishihara, Y Tue 177, Tue 379 

Ishihata, A Mon 178 

Ishii, C Wed 422, Wed 415 

Ishii, K Wed 264 

Ishii, N Wed 422, Wed 415 

Ishii-Nozawa, R Mon 179 

Ishikawa, E Thu 268 

Ishikawa, M Mon 025 

Ishikawa, S FC16.4.6 

Ishikawa, T Thu 226, Tue 136 

Ishikawa, Y Tue 068, Thu 103 

Ishimaru, Y Wed 067, Wed 075 

Ishimura, M Tue 373 

Ishizawa, K Mon 180 

Ishizuka, T Tue 377 

Ishola, I Wed 144 

Isla, KKY Thu 355 

Islam, T Tue 097 

Ismail, M Tue 452 

Ismail, R Mon 107 

Ismail, Z Thu 328 

Ismailoglu, S Wed 421 

Ismailoglu, U Mon 314 

Isnard, S Wed 208 

Isotalo, T Thu 223


Israel, A Mon 295, Tue 127, Wed 212, 

Wed 265, Thu 205, Thu 254 

Isrona, L Mon 475 

Isuta, H Thu 220 

Ito, F Tue 379 

Ito, K Mon 177 

Ito, S FC10.5.3, Mon 022, Mon 101 

Ito, T Thu 331 

Ito, Y Thu 038, Tue 216, Tue 217, 

Wed 371 

Itoh, H Tue 132 

Itoh, Y Thu 109 

Itokawa, M Mon 173 

Iuvone, T Tue 465, FC18.4.6 

Ivankova-Susankova, K Thu 028 

Ivanova, I Mon 479 

Ivanova, S Thu 211 

Ivashev, M Tue 176 

Ivashev, MN Tue 179 

Ivorra, MD Wed 068 

Iwai, S Wed 372 

Iwamoto, K Tue 266 

Iwamoto, T Tue 071, Thu 286 

Iwamoto, Y Wed 415, Wed 422 

Iwanami, J Mon 439 

Iwase, H Tue 167 

Iwase, M Tue 320, Thu 319, Thu 343 

Iwashita, M Wed 373 

Iwata, F Thu 103 

Iwata, N Wed 266, Thu 227 

Iwata, R FC17.5.6 

Izuhara, C Mon 405, Tue 467 

Izumi, Y Mon 424, Mon 432, Mon 464 

Izushi, Y Mon 329 

Izzo, AA Wed 307 

Jaako-Movits, K Thu 409 

Jaba, I Mon 108, Tue 134 

Jaberi, E Mon 454 

Jackson, G FC08.1.3 

Jacky, P Thu 037 

Jacobs, GE FC17.3.5 

Jacobs, M FC14.1.2 

Jacobsen, S Thu 405 

Jacobson, K Wed 108 

Jacqz-Aigrain, E FC10.1.5, FC10.5.1, 

FC10.5.5, Wed 011 

Jadhav, A Tue 124 

Jaehde, U Mon 384 

Jafari, M Tue 165 

Jagtap, PN Thu 363 

Jähnichen, S Thu 085 

Jahnsen, JA Mon 397, Wed 069 

Jahromy, MH FC17.2.6 

Jaisin, Y Thu 305, Tue 277 

Jakab, L Mon 283 

Jäkälä, P W21.1, Wed 361 

Jakobsen, S FC17.4.5, Tue 193, Thu 404 

Jakobsson, P-J FC09.4.4 

Jakovljevic, E FC10.2.6 

Jakovljevic, M FC07.3.5 

Jakovljevic, V Tue 148, Tue 454, Wed 321 

Jalaei, J Tue 015 

Jalali, A Tue 251 

Jalil, ATMA Mon 001 

Jalkanen, Aaro Mon 425 

James, AE Tue 139 

Jamnik, P Thu 329, Thu 318 

Jamshidzadeh, A Mon 085, Mon 088 

Jan, IU Tue 319 

Janani, S Mon 131 

Janchawee, B Wed 124 

Jandric, D Tue 091, Tue 321, Tue 151 

Janes, D Thu 359 

Jang, C-G Mon 358, Tue 350, Mon 359, 

Mon 049, Mon 069, Tue 161, 

Tue 160, Mon 065, Tue 324, 

Tue 162, Wed 142, Tue 044, 

Tue 331, Tue 332, Tue 323, 

Tue 043, Tue 073, Tue 333, 

Mon 066, Wed 143 

Jang, S Mon 033 

Jang, SB Mon 013, Mon 226, Tue 349, 

Thu 418 

Jang, YJ Tue 351 

Jani, Nitya Mon 214 

Janiszewski, M Wed 237 

Janizewski, M Wed 233 

Jankova, L W06.3 

Jankovic, S FC07.3.5 Mon 039 

Jankovic, SM Wed 435 

Jankowski, J FC15.3.3 

Jansakul, C Wed 374, Wed 375 

Jansen, E Tue 242 

Jansen-Olesen, I Wed 220, Thu 106 Mon 099 

Jansone, B Mon 429, Tue 253 

Janssen, BJA Thu 208, Wed 287, Thu 221 

Janssen, G Thu 251 

Janssens, K Wed 002 

Jantaka, J Tue 007 

Jantschak, F W13.4 

Janzek, M Thu 359 

Japundzic-Zigon, N Wed 435 

Jara, P Tue 326 Mon 136 

Jardine, D Mon 064 

Jarrott, B FC03.1.6 

Järvenpää, S-M Wed 445 

Järvensivu, P Wed 446 

Jasna, L Mon 347 

Jauslin, P FC07.2.2 

Javed, I Tue 319 

Javid, FA Mon 246 

Javidnia, K Wed 376 

Javier, MCJ Wed 377 

Javitch, JA FC02.1.2, FC02.3.5, 

Mon 058, Mon 073 

Jayaprakash, V Tue 194 

Jebabli, N FC07.3.6, Mon 020, Mon 021 

Jebali, MA Mon 006 

Jebrouni, N Tue 116, Thu 246 

Jedlickova, B Tue 137 

Jedlitschky, G FC02.4.2 

Jennissen, K Tue 129 

Jensen, B FC06.2.5, Wed 113 

Jensen, BP Tue 322, Mon 064 

Jensen, BP Mon 047 

Jensen, GM FC02.2.5, Mon 071 

Jensen, H FC06.2.5 

Jensen, HB Wed 070 

Index 339

340 Index 


Jensen, KG FC07.4.5 

Jensen, SA Tue 480 

Jeon, K-J Mon 065, Tue 324, Tue 323, 

Mon 066 

Jeong, HY Wed 416 

Jeppesen, P FC06.2.5 

Jeppesen, P Wed 070 

Jespersen, T FC06.3.5 

Jessen, N FC05.2.6, Mon 154 

Jesus-Sandoval, R Tue 025 

Jetter, A Mon 315, Mon 384 

Jevtic, M Tue 091 

Jezova, D Tue 113 

Jha, S W01.2.4 

Jhaveri, D W01.2.4 

Ji, C Wed 429 

Ji, Y Mon 470 

Jiaang, W-T Mon 158 

Jian, Y Mon 433 

Jiang, F Mon 194, Wed 219, Tue 285 

Jiang, H-K Tue 187, Tue 186, Thu 277 

Jiang, L Wed 267 

Jiang, M Wed 378 

Jiang, N FC16.3.1, Wed 379, Thu 432 

Jiang, P-S Thu 199 

Jiang, T FC18.4.5 

Jiang, X-P Mon 470 

Jiang, Y Tue 441 

Jiang, Y-Y Mon 265 

Jievaltas, M Tue 329 

Jimenez-Altayo, F Wed 268 

Jimenez-Flores, JR Tue 150 

Jiménez-Serranía, M-I Tue 088, Tue 089 

Jin, F Thu 186 

Jin, H Tue 286, Thu 186 

Jin, H-O Tue 427 

Jin, M-W FC12.3.5 

Jin, X Thu 261 

Jin, Y Wed 322 

Jindal, R FC09.5.5 

Jing, F Tue 173, Tue 325 

Jing, W-B Mon 172 

Jingami, H FC11.1.4 

Jinsheng, G Wed 363 

Jiron, M Mon 390 

Jirón, M Tue 326 Mon 136, Tue 164 

Joannides, R Wed 207, Mon 191 

Jockers, R FC11.3.4, Thu 028, Thu 055, 

Thu 078 

Jõgi, K FC10.3.6 

Johansen, LD FC11.5.1 

Johansson, L Thu 051 

Johansson, S Thu 239 

Johns, EJ FC05.1.5 

Johns, S Tue 327 

Johnsen, SP FC04.2.7 

Johnson, I Wed 238 

Johnson, Ian Wed 269 

Johnson, MS Wed 088 

Johnson, O Wed 149 

Johnson, RP Wed 239 

Johnson, TA FC18.4.2 

Johnson, T FC10.3.5 

Jokela, H Mon 215 

Jones, B Tue 136 

Jones, R Wed 270 

Jönsson, Siv FC07.4.4 

Jorge, ARC Thu 374, Wed 297 

Jørgensen, FS Wed 066 

Jørgensen, H Mon 346, Tue 358 

Jørgensen, M Wed 241, Wed 380 

Joseph, J Mon 443 

Joshi, C FC16.1.6 

Joshi, S YI.05, Wed 315 

Joskova, M Mon 293 

Jost, N Mon 100 

Jouanjus, É FC04.3.5 

Jovanoviæ, N Wed 398 

Jovanovic, D Tue 321 

Jovanovic, I FC10.1.6 

Jové, J Mon 141 

Jovic, N Wed 009 

Judas, F Tue 257 

Jürgenliemk, G FC16.1.5 

Jürgens, G FC09.2.4 

Jugovic, VM Wed 435 

Juhl, K Mon 046 

Jun, D Tue 343, Tue 448 

Jun, R Tue 158 

Jung, I-S Tue 352 

Jung, J Mon 068 

Jungke, P Wed 417 

Juricic, D FC01.3.7, Mon 135, Tue 328 

Jurkat-Rott, K FC12.2.3 

Juslin, S Tue 283 

Juvonen, T Tue 166 

Käär, R FC10.3.6 

Kaboutari, J Wed 301 

Kacevska, M W06.3 

Kadam, V Tue 131, Mon 166 

Kadoi, H Mon 416 

Kadurin, I FC03.2.4 

Kadyrova, D Tue 079 

Käenmäki, M Wed 071 

Kagawa, Y Tue 484 

Kagota, S Tue 143, Tue 067, Wed 271, 

Thu 320 

Kahlon, N Tue 387 

Kaila, M Mon 328 

Kaipiainen-Seppänen, O FC09.2.5 

Kajioka, S Thu 038 

Kakefuda, K Thu 406 

Kalekou, H Mon 297 

Kalenic, S Mon 373 

Kales, A Thu 214 

Kales, AJ Mon 316 

Kalikstad, B Wed 014, Wed 015 

Kalin, N Thu 410 

Kalinina, TS Wed 187, Mon 422 

Kaliszan, R Mon 197 

Kalkan, S Tue 449, Tue 450, Tue 366, 

Mon 474 

Kalliokoski, A Tue 363 

Kallioniemi, O Mon 410, Tue 436 

Kalokasidis, K Mon 300 

Kalvinsh, I Mon 429 

Kamal, M Thu 078, Wed 072 

Kamataki, A Thu 248


Kamatani, N W23.2 

Kamath, S FC04.3.7 

Kamei, J Tue 234 

Kamerman, P Tue 001 

Kaminska, E Thu 174 

Kaminski, P FC08.2.5 

Kamisaki, Y Wed 186 

Kamiuchi, S Wed 266, Thu 227 

Kamiya, A Mon 309, Thu 402 

Kanai, A FC08.3.2 

Kanai, T Thu 263 

Kanaoka, D FC03.2.5 

Kandrotaite, K Tue 329 

Kane, K Mon 211 

Kane, S Wed 292 

Kaneko, S Tue 055, Thu 108 

Kaneko, T Tue 126, FC13.2.5 

Kaneko, Y Tue 136 

Kang, CY Mon 270 

Kang, F Thu 116 

Kang, M FC12.1.5 

Kang, Y Thu 350 

Kang, YJ Thu 116 

Kanjuh, V Thu 324, Wed 103 

Kanno, S-I Mon 025 

Kanters, JK Tue 303 

Kapai, N Thu 417 

Kapanadze, KT Mon 216 

Kapic, E Wed 199 

Kapitsa, I Mon 462 

Kaplan, T W02.2.7 

Kaplinskiy, S FC06.1.6 

Kapoor, A FC18.3.6 

Kapucu, A Tue 461 

Kapur, S FC17.3.1 

Karajeva, N Tue 253 

Karaman, M Mon 170 

Karasiewicz, M Thu 174 

Karasova, JZ Tue 074 

Karatassas, A Mon 102 

Karbwang-Laothavorn, J FC01.3.2 

Kargi, A Tue 411 

Kargl, J FC11.1.6, Wed 073 

Karhi, T Mon 256 

Karimi, G Mon 230 

Karimollah, A Wed 418 

Kariyazono, H Tue 167 

Karkoulias, G Wed 074 

Karlsson, MO FC07.2.2 

Karonen, T Tue 330 

Karsdal, MA W26.2, W26.4 

Kartal, M Wed 312 

Kasabova, L Tue 128 

Kasai, A Mon 416, Mon 435, Mon 440, 

Wed 067, Wed 075 

Kasamatsu, R Mon 243 

Kashaf, SS Mon 231 

Kashanian, M FC01.3.5 

Kashimoto, T Tue 477 

Kasiotis, K Tue 457 

Kassa, J Tue 343 

Kast, R Thu 091 

Kastratovic, DA Wed 435 

Katafuchi, T Wed 141 

Katakam, P FC05.1.6 

Katano, Y Mon 178 

Katayama, Y Wed 263 

Katende-Kyenda, NL Mon 026 

Katisart, T Mon 086 

Katiskalahti, T Mon 144 

Kato, M Tue 166 

Kato, S FC18.4.3, Mon 335 

Katoh, Y Tue 144 

Katramadou, M Tue 457 

Katryniok, C Mon 317 

Katsiki, N Mon 143 

Katsoulieris, E Mon 157 

Katsouni, E Thu 431 

Kattamuri, V Mon 264 

Kattige, V W03.2 

Katugampola, S Mon 393, Tue 372, Wed 020 

Kauffman, M Mon 280 

Kaulambaeva, I Thu 336 

Kaunitz, JD W02.1.5 

Kauppi, M FC09.2.5 

Kaur, H FC09.5.5 

Kaur, St FC01.3.6 

Kaushal, S FC01.3.6 

Kautiainen, H FC09.2.5 

Kawabata, A FC03.2.5, Tue 263, Tue 077, 

Mon 243, Mon 250 

Kawada, K Tue 376 

Kawahara, K Thu 331 

Kawahara, R Mon 335 

Kawakami, J Tue 484, Tue 491 

Kawamoto, E Mon 292 

Kawamoto, K Mon 101 

Kawamura, E Thu 109 

Kawanishi, C Wed 422, Wed 415 

Kawanishi, T Tue 168 

Kawasaki, H Mon 174, Tue 154, Thu 261, 

Tue 415, Wed 413, Wed 424 

Kawasaki, T Mon 093, Tue 060 

Kawazoe, K Wed 278 

Kaya, A FC11.3.2, Thu 049 

Kaya, AI FC11.3.2 

Kaygisiz, B Wed 420 

Kayiwa, J FC01.4.5 

Kaytanlioglu, L Tue 142 

Kazakova, FF Thu 096 

Kazakova, RR Thu 096 

Kazemi, M Tue 165 

Kearns, GL FC10.2.4, FC13.3.5 

Kedia, G Tue 211 

Keeble, J Mon 287 

Kegeles, L FC17.1.3 

Keiko, T Tue 244 

Kelber, O Mon 317, Tue 462, Thu 317, 

Wed 382, Wed 417 

Keldsen, N Tue 395 

Kelicen, P Wed 438, Mon 155 

Keller, M Wed 006 

Kelley, S Wed 173 

Kellomäki, M Thu 223 

Kelly, J Tue 364 

Kelstrup, CD Wed 036 

Kemeny, A Tue 271, Tue 250, FC16.2.6, 

Mon 318 

Index 341

342 Index 


Kemény, A W19.3 

Kemme, M Thu 215 

Kemter, K Thu 014 

Kendall, DA Mon 282 

Kennedy, P Wed 076 

Keown, O Mon 211 

Keres Kos, M FC07.3.5 

Kereskai, L Mon 283, W19.3 

Keri, G Tue 250 

Kerr, R Wed 316 

Kersten, S Thu 438, FC18.2.5 

Keshavarz, M Tue 058 

Ketelslegers, J Tue 182 

Ketola, K Mon 410, Tue 436 

Keum, S-K Mon 069, Tue 331, Tue 332, 

Tue 333 

Kezeli, T Wed 272 

Khadke, VV Wed 381 

Khairatkar Joshi, N W03.2 

Khakpour, SH FC17.2.6 

Khalaf, M Thu 247 

Khalifa, HM Mon 364 

Khalili-Mahani, N Mon 400 

Khalkhali, H Thu 391 

Khan, A Tue 119, Wed 356 

Khan, GM Tue 023 

Khan, MAH FC05.1.5 

Khan, S Wed 355 

Khan, UA Tue 319 

Khanam, R Wed 419 

Kharazmi, F Tue 058 

Khare, Ah Wed 381 

Kharel, Y Tue 410 

Khaylov, N Wed 248 

Khayyal, M T Wed 382 

Khazaee, P Tue 231, 

Khazali, S Mon 002 

Kheifets, IA Thu 015 

Khemawoot, P Tue 090 

Kheyfets, IA Mon 198 

Khodadadi, A Tue 251 

Khoddami, M Tue 052 

Kholova, D Tue 056, Tue 342 

Khorami, H Thu 004 

Khori, V Mon 196 

Khotimchenko, M Mon 426 

Khotimchenko, Y Mon 426 

Khoza, S Tue 004 

Kido, M Wed 141 

Kieffer, B L FC11.4.4 

Kihira, Y Mon 180 

Kilibarda, V Tue 321 

Kilic, FS Wed 420, Mon 103, Wed 421 

Kilinc, E Mon 043 

Kilpinen, S Tue 436 

Kilty, I Tue 269 

Kim, CM Tue 334 

Kim, E-J Wed 383 

Kim, H-G Tue 335 

Kim, H-S Tue 351 

Kim, IK Wed 274, Wed 384, Wed 275 

Kim, J-H Wed 306, Wed 385 Thu 385 

Kim, JY Wed 276 

Kim, J-W Tue 335 

Kim, JY Mon 062 

Kim, K-S Tue 334, Wed 383 

Kim, M-J Mon 049, Mon 065, Mon 066, 

Mon 069, Mon 358, Mon 359, 

Tue 043, Tue 044, Tue 073, 

Tue 162, Tue 323, Tue 324, 

Tue 333, Tue 350, Wed 142, 

Wed 143 

Kim, R FC02.1.6, 072, Tue 054, 

Tue 064, Mon Tue 301 

Kim, RB FC02.3.1 

Kim, SA Mon 428, Mon 427, Wed 277 

Kim, S-R Tue 335 

Kim, W-Y Tue 352 

Kimbacher, S Mon 218 

Kimland, E Wed 008 

Kimoto, Y Thu 320 

Kimura, J Tue 071 

Kimura, M Tue 390 

Kinjo, T Wed 075 

Kinoshita, Y Wed 117, Tue 273, Tue 336, 

Tue 337, Tue 483 

Kinscherf, R Mon 317, Tue 462 

Kinsey, S Tue 353 

Kinyua, CG Wed 298 

Kiraly, I Wed 284 

Kirchheiner, J Mon 384, Mon 315, Wed 148, 

Thu 112 

Kirchmayer, J Thu 014 

Kirkeby, B Wed 161 

Kirkpatrick, C Wed 125, Wed 126 

Kis, O Mon 070 

Kishida, I Wed 422 

Kishuku, M Wed 278 

Kisida, I Wed 415 

Kiss, B Wed 423 

Kis-Varga, Á Tue 078 

Kita, S Thu 286 

Kitagawa, T Wed 247 

Kitaichi, K Thu 406 

Kitamoto, T Mon 435 

Kitamura, T FC13.2.5, Tue 126 

Kitamura, Y Wed 413, Wed 424, Thu 261, 

Tue 415 

Kitano, H FC07.1.2 

Kitao, T Tue 060 

Kitazawa, T Tue 468 

Klaassen, T Mon 384, Mon 315 

Klaerke, D Thu 106 

Klapkova, E Tue 445 

Klayoncu, NI Tue 027 

Kleberg, K FC02.2.5, Mon 071 

Klein, AB FC11.2.6 

Klein, U Thu 069 

Kleinau, G Thu 087 

Kleinloog, HD FC17.3.5 

Kleinschnitz, C FC15.4.4 

Klemp, M Tue 143 

Kliewer, SA FC18.1.3 

Klimas, J FC05.4.5, Mon 219, Mon 221 

Klimas, Jan Thu 097 

Klindt Poulsen, B Thu 413 

Klitgaard, T Mon 227 

Kloppenburg, A Thu 101


Klouz, A W27.1, FC07.3.6, Mon 004, 

Mon 020, Mon 021, Mon 338, 

Wed 348, Thu 346 

Kluft, C Mon 316 

Klukovits, A Wed 050 

Klumpers, LE Mon 400 

Klungel, OH FC04.1.2 

Klusa, V Mon 429, Tue 253, Wed 045 

Kmecova, J Thu 097 

Kmonícková, E Tue 300, Wed 386 

Knani, J Mon 006 

Knapp, A Mon 229 

Knauer, M Mon 072 

Kneepkens, K Wed 001 

Kniazeff, J FC11.2.1, FC11.3.5, Mon 

058, Mon 073, Wed 077 

Knight, S Wed 425, Mon 430 

Knowles, RG FC09.3.4 

Knudsen, GM FC11.5.6, FC11.2.6 

Knudsen, LB FC05.3.4 

Knuhtsen, S Mon 071 

Knuistingh-Neven, A Tue 096 

Ko, J-W Tue 335 

Ko, SSW Tue 140 

Ko, YK Mon 104 

Kobayashi, D Wed 078 

Kobayashi, N Mon 307 

Kobayashi, S Tue 273, Tue 336, Tue 380, 

Tue 483, Tue 492 

Kobayashi, T Tue 315 

Kobayashi, Y Tue 177, Mon 178 

Kobayasi, S Tue 337 

Køber, L FC13.3.6, FC04.2.4 

Kobilka, B Wed 028 

Kobilka, BK PL10, W01.1.2 

Kobuchi, S Wed 200 

Kocan, M W14.2, Wed 079, Wed 080 

Kochar, S Tue 453 

Kocic, I Wed 279, Mon 181 

Koda, Ken Tue 360 

Kodaira, C W23.4, Tue 473 

Kodetova, D Tue 445 

Koenig, J FC02.2.6 

Koenig, S Tue 115 

Koenig, X Mon 217, Mon 218 

Koh, H-J FC05.2.6 

Kohda, K Thu 402 

Kohda, Y Tue 315 

Kohjitani, A Mon 303 

Kohler, R Thu 273 

Kohonen, P Mon 410, Tue 436 

Koike, Y Tue 084, Tue 338, Thu 285 

Koistinaho, J W21.3 

Koivula, K Wed 081 

Koiwa, G Tue 122 

Koizumi, N Tue 154 

Kojima, J Wed 263 

Kojima, S Tue 274 

Kojo, A Mon 255, Mon 405 

Kokkas, B Mon 300, Mon 297 

Kokki, H Tue 339 

Kokki, M Tue 339 

Kolb, C Wed 417 

Koley, M Mon 217 

Kolik, L Wed 188 

Kolkhof, P Thu 091 

Kollia, G Tue 495 

Kolliali, M Tue 102 

Kolyvanov, G Tue 150 

Komatsu, Y Tue 274 

Komazaki, H Wed 061 

Kombian, S Tue 340 

Komsuoglu Celikyurt, I Thu 401, Wed 351 

Komuro, I Thu 286 

Koncz, I Mon 100 

Kondo, Y Wed 186, Wed 263 

Kondo, Yukiko Tue 477 

Kondratenko, S Thu 114 

Kong, SK Thu 381 

Kong, S-S Tue 187, Tue 186 

Kong, WCB FC15.2.6 

Kongpatanakul, S Mon 334, Mon 355, Mon 357, 

Tue 007, Tue 341 

Kongsiang, A Tue 007 

Konhan, K Mon 357 

König, F FC07.4.2 

Konsman, J-P W11.1 

Konturek, PC Tue 463 

Konturek, SJ Tue 463 

Konwar, R Wed 294 

Koob, GF FC14.4.1 

Koole, C Wed 082 

Koolwijk, P Thu 216 

Koon, CM Thu 297 

Koon, JCM Wed 345 

Kopanchuk, S Tue 192 

Kopecky, J Tue 342, Thu 168 

Koponen, J W21.3 

Koren, G Wed 003, Wed 099, Wed 013 

Korhonen, R W21.5, Tue 278, FC09.5.4, 

FC09.1.5, Tue 239 

Koriyama, Y Tue 413 

Korjamo, T Mon 060 

Kormányos, Z Mon 208 

Kormos, V Mon 110, Mon 106 

Korpela, M FC09.2.5 

Korpela, R Wed 361 

Korpi, ER Wed 393, Thu 194, Thu 409 

Korstanje, C W01.3.2 

Korth-Bradley, J Tue 012 

Koshelev, V Wed 283 

Koshimizu, T Wed 189 

Koskimies, P Wed 446 

Koskinen, A Tue 283 

Koskinen, P Tue 429 

Kostantinidis, G FC10.2.6 

Kostenis, E FC11.1.6 

Kostkova, L Tue 113 

Kostowski, W Thu 174 

Kostrzewa, A Tue 092 

Kotani, T Tue 274 

Kotoula, M Tue 246 

Kotsar, A Thu 223 

Kotyzová, D Mon 409 

Kou, Y Mon 078 

Kouchi, K FC03.4.5 

Koutani, A Wed 083 

Koutsioumpa, M Thu 232 

Index 343

344 Index 


Kovacevic, A Tue 091, Tue 151 

Kovacevic, I Tue 367 

Kovacs, P Mon 027 

Kovalenko, L Tue 276, 

Kovalev, G Wed 426 

Koyama, M Thu 072 

Koyama, T Tue 154 

Kraahs, P Mon 229 

Kraehling, JR Wed 280, Thu 252, Wed 210 

Krahn, T Thu 057 

Krahtz, C Mon 247 

Kraneveld, AD FC09.5.2, W11.3 

Krassoi, I Wed 197 

Krause, D Wed 261 

Krause, G Thu 087 

Kraushaar, N Wed 190 

Krayneva, V Mon 431 

Krcmova, I Tue 222, Tue 421, Tue 240 

Kreft, S Thu 359 

Kreilgaard, M FC17.4.2 

Krejsek, J Tue 222, Tue 421, Tue 240 

Kremoser, C FC18.2.6 

Krenek, P FC05.4.5, Thu 097, Mon 221 

Krenek, P Mon 219 

Kreuchwig, A Thu 087 

Kringen, M Wed 139 

Krishnan, S Mon 102 

Krishnaswami, S FC07.3.3 

Kristensen, AK Tue 065 

Kristensen, AS Tue 080 

Kristensen, J FC10.5.3 

Kristensen, SD FC05.2.3 

Kristensen, VN Wed 151 

Kristhal, O Wed 325 

Kristiansen, K Mon 224 

Kristiansen, U Thu 101 

Kristof, A Mon 100 

Kristoffersen, T Wed 014, Wed 015 

Kristova, V Tue 113 

Krnic, D Mon 342, Mon 343 

Krobert, KA Wed 026 

Kroemer, H Tue 045 

Kroemer, HK FC02.4.2, Tue 039 

Kroetz, D W16.1 

Kroigaard, C Wed 229, Wed 230, Wed 

281, Wed 282 

Krøjgaard, C Thu 259 

Krombach, F Tue 227, FC16.1.5 

Krook, A FC05.1.2 

Kropotov, A Mon 426 

Krotov, GI Wed 175 

Krs, O Tue 125 

Krstic-Milosevic, D Wed 387 

Krüger, DB Mon 073 

Kruger, D Mon 058 

Kruger, HS Thu 016 

Krupitza, G Thu 308 

Krzan, M Tue 048 

Krzan, Mojca Mon 074 

Ksouda, K Wed 191 

Ku, DD FC16.1.3 

Ku, HC Mon 220 

Ku, Y-L Wed 326 

Kubes, P Tue 229 

Kublickiene, K Thu 256 

Kubo, K Thu 402 

Kuca, K Tue 074, Tue 448 

Kuca, K Tue 343, Mon 075 

Kucur, M Thu 266, Mon 199 

Kuczyk, M Tue 212, Tue 211, Tue 210 

Kuczyk, MA FC08.3.5, Mon 247 

Kudo, K Wed 186, Tue 477 

Kudo, T Mon 182 

Kudryavtseva, O Wed 283 

Kudumija-Slijepèevic, M Wed 398 

Küçük, N Tue 018 

Kühn, J-P Tue 041 

Kuei, C Wed 093 

Kuhad, A Mon 183, Tue 344 

Kukes, V Tue 129, Tue 057 

Kukes, VG Thu 253 

Kuki, A Tue 274 

Kukkonen, J Thu 051 

Kulakova, AV Tue 165 

Kulkarni, SK Wed 168 

Kullak-Ublick, GA FC02.4.4, Thu 435 

Kumagai, Y Tue 345 

Kumai, T Wed 117, Tue 492, Tue 273, 

Tue 337, Tue 336, Tue 483 

Kumakura, Y FC17.1.2 

Kumana, C Tue 346 

Kumano, K Thu 285 

Kumar, JK Thu 379 

Kumar, V Wed 324 

Kume, T Mon 424, Mon 432, Mon 464 

Kummu, M Mon 063, Mon 076 

Kun, A Wed 284 

Kunitomo, M Thu 320, Tue 143 

Kunze, G Tue 438 

Kuo, H-S Wed 286 

Kurahashi, C Wed 128, Wed 372 

Kuramoto, N Tue 375, Wed 083 

Kurata, N Thu 319, Tue 320, Thu 343, 

Thu 072 

Kurihara, T FC03.4.5 

Kuroda, Y Tue 236 

Kuroiwa, K Tue 294 

Kurokawa, S Tue 373 

Kurose, H Thu 109 

Kusljic, S Mon 240, Mon 242, Tue 416 

Kusturica, J Wed 199 

Kuszpit, K Tue 372 

Kutcher, S Thu 394 

Kuwabara, M Thu 263 

Kuwamata, M Mon 307 

Kuzelova, M Tue 113 

Kuzmenko, M FC06.1.6 

Kuzumaki, N Thu 188, Wed 065 

Kvell, K Mon 401 

Kvetina, J Tue 056, Tue 342, Thu 168 

Kvetnansky, R Thu 039 

Kvist, T Wed 084 

Kwak, HC Wed 285 

Kwan, A-L Mon 319, 

Kwan, CY Wed 194 

Kwan, YW Thu 255, Wed 345, Thu 381 

Kwan, Y-W Wed 244 

Kwanashie, H Wed 145


Kwiecien, S Tue 463 

Kwizera, EN Mon 037 

Kwok, HF Thu 297 

Kyselovic, J FC05.4.5, Mon 219, Thu 097, 

Mon 221 

Kýyýcý, S Mon 156 

la Cour Poulsen, L Wed 447 

La Rana, G FC18.1.6 

La Torre, M Thu 302 

Laavola, M FC16.3.4 

Labar, B Tue 304 

Labarrios, F Wed 217 

Lacadie, C FC14.3.3 

Lacerda, RB Mon 279 

Lachaux, A Mon 263 

Lächelt, S Mon 059 

Lackovic, Z Mon 096, W17.1 

Lacoin, L Tue 092 

Laconca, L Thu 440 

Ladwa, S Mon 353, Mon 352 

Laeremans, H Wed 085 

Lafuente-de-carvalho, J FC08.2.6 

Lagercrantz, H Wed 006 

Laget, M FC11.3.5 

Lagler, FB Thu 014, Wed 016 

Lagrue-Lak-Hal, A-H Wed 196 

Laguna, JC Tue 133 

Lahdenranta, M Wed 444 

Laher, I FC15.1.3 

Lahtinen, M Thu 052 

Lai, C-C Wed 192, Thu 198 

Lai, X Tue 075 

Laine, K Mon 144 

Laitila, J Mon 380, Tue 330 

Laitinen, J Mon 328 

Laius, O FC04.3.4 

Lakhal, M FC07.3.6, Mon 004, 

Mon 020, Mon 021, Mon 338, 

Wed 348, Thu 346 

Lalic, Z Tue 304 

Lalla, A Wed 129, Tue 347 

Lallemand, C FC09.2.3 

Lalosevic, D Wed 321 

Laloux, B Mon 191 

Lam, FFY Tue 417, Wed 345 

Lam, KSL Mon 271, Mon 159 

Lam, M Mon 242, Mon 248 

Lam, TH Mon 271, Mon 159 

Lamaida, E Tue 487, Mon 449 

Lamandé, S W03.7 

Lambert, JJ FC03.3.5 

Lamminen, T Mon 215 

Lampreia, F Wed 130 

Lämsä, V Wed 448 

Lan, X Mon 433 

Lan, Xi Tue 297 

Landau, A FC17.4.5, Thu 404, Thu 405 

Landreth, GE FC18.3.4 

Lane, G Thu 113 

Lane, J Thu 410 

Lane, JR FC11.2.5 

Lane, K Tue 364 

Lane, N Tue 124 

Lane, R FC03.2.6 

Lang, R Mon 242 

Lang, RJ Mon 240 

Lange, AJ Wed 156 

Langemeijer, E Wed 086 

Langer, SZ W01.3.1 

Langerová, P Tue 124 

Langlois, N Tue 301 

Lanius, R FC17.5.3 

Lantero, A Wed 087 

Lanvers-Kaminsky, C FC10.4.5 

Laohapand, T Thu 335 

Laorden, ML Wed 087 

Laosa, O Tue 348 

Lapa, AJ Thu 355 

LaPerle, J Mon 236 

Lapeyre-Mestre, M Tue 104, Mon 129, Mon 130, 

FC04.3.5, Mon 124 

Lapi, F Tue 093 FC04.3.6 

Lapidus, N FC13.4.6 

Laplanche, J-L FC01.4.4, Wed 191 

Larger, M Mon 193 

Laroche, A Wed 316 

Larrey, D FC04.2.6, Mon 141 

Larsen, A Tue 359, Tue 248, Mon 320 

Larsen, AM Mon 320 

Larsen, AP Wed 099 

Larsen, C Mon 450, Thu 239 

Larsen, F FC07.4.5 

Larsson, C Mon 055 

Lartaud, I Wed 244 

LaRue, S Tue 301 

Laruelle, M FC17.1.3 

Larvin, M Wed 285, Tue 460 

Lashkari, MH Mon 036 

Lass, J FC10.3.6, FC04.3.4 

Lassalle, R Mon 141 

Lasseter, K Mon 205 

Lathers, D Tue 495 

Lattanzio, F Thu 110 

Lau, BS Thu 297 

Lau, C Mon 045 

Lau, CBS Wed 345 

Lau, CP Tue 346, Thu 297 

Lau, CW FC15.4.7 

Lau, HYA Mon 321 

Lau, KM Thu 297 

Lau, S Thu 280 

Lau, YS Thu 219 

Lau, YT Wed 388 

Lau, YY Mon 228 

Laudet, V FC18.4.4 

Lauferon, F Tue 198 

Laurie, G Thu 110 

Laurikainen, T Mon 144 

Laurila, J Wed 092 

Laurila, Jonne M Wed 088 

Laurindo, FR Wed 202 

Laurindo, FRM Wed 237 

Lauris, JR Tue 261 

Lavhale, M FC05.2.5 

Law, IKM YI.06 

Law, PY Tue 135 

Lawal, B Thu 332 

Layegh, P Tue 052 

Index 345

346 Index 


Lazdunski, M FC03.4.2 

Lazo-Langner, A Tue 301 

Le Couteur, D FC13.2.6, Mon 392, 

FC13.1.6 

Le Gall, C Mon 263 

Le Grand, B Tue 183, Tue 170, Tue 171, 

Tue 172 

le Maire, A FC18.3.5 

Le, O Tue 396 

Leach, K Wed 043, Wed 089, Thu 041 

Leadbeater, PDM Thu 200 

Leal, LK Mon 299 

Leal, N Wed 111 

Leánez, S Thu 042, Wed 059 

Lebedeva, E Wed 148 

Lecomte, C Tue 092 

Ledent, C Thu 057 

Ledo, F Mon 254 

LeducC, N Thu 024 

Lee, A Tue 460 

Lee, AJ Tue 109 

Lee, DH Mon 013 

Lee, D Tue 349 

Lee, F Wed 122, Wed 121, Wed 120 

Lee, G-S Thu 385 

Lee, HC Thu 090 

Lee, H-J Wed 035 

Lee, H-K Wed 427 

Lee, MG Tue 046, Mon 068, Mon 062 

Lee, M-H Wed 383 

Lee, MYK Thu 270 

Lee, S Mon 034, 

Lee, S-C Tue 335 

Lee, S-Y Tue 350 

Lee, SH Tue 334 

Lee, S-J Thu 034 

Lee, SS Tue 157, Tue 352, Tue 351 

Lee, S-J Tue 352, Tue 351 

Lee, S-Y Mon 049, Mon 069, Mon 065, 

Mon 066, Mon 358, Mon 359, 

Tue 043, Tue 044, Tue 073, 

Tue 160, Tue 161, Tue 162, 

Tue 323, Tue 324, Tue 331, 

Tue 332, Tue 333, Tue 335, 

Wed 142, Wed 143 

Lee, TJF Wed 286, Thu 090, Thu 362 

Lee, VHL FC02.4.6, Tue 140 

Lee, W-H Mon 104 

Lee, W-S Wed 449 

Lee, W-Y Tue 229 

Lee, WYW Thu 389, Thu 381 

Lee, Y Mon 033 

Lee, Y-C Wed 286 

Lee, YJ Mon 029, Mon 226, Mon 013, 

Tue 349, Thu 418 

Leeb-Lundberg, F Thu 047 

Leeder, P Wed 285 

Leeder, SJ FC13.3.3 

Leeds, C Wed 432 

Lees, KR FC15.1.6 

Lees, P Tue 191 

Leeya, Y Wed 375 

Leftheriotis, G Mon 148 

Lehmann-Horn, F FC12.2.3 

Lehri, S Mon 469 

Lehtimäki, L Mon 328 

Lehto, V-P Thu 170 

Lei, Saobo Wed 090 

Lei, SH Tue 348 

Lei, SL Mon 451 

Lei, T Thu 377 

Lei, Y Tue 298 

Leirisalo-Repo, M FC09.2.5 

Leiro, J Wed 359 

Leitão, R Mon 298 

Lekhooa, Makhotso R Wed 389, Wed 390, Wed 391 

Lello, J Wed 392 

Lelong-Boulouard, V Thu 173, Mon 362 

Lemasson, I FC11.3.6 

Lemière, C FC04.1.5 

Lemkens, P Thu 251, Thu 221 

Lemkens, P Wed 287 

Lemmer, B W07.1 

Lemos, FO Wed 302 

Lemos, M Wed 231, Wed 341 

Lendak, D Mon 115 

Lennard, L Mon 351, Tue 353 

Leo, CH Wed 288, Wed 289 

León, O Thu 358 

Leone, S Mon 105, Wed 329, Wed 434 

Leong, CF Thu 380 

León-Molina, H Mon 019 

Leopardi, R FC17.5.4 

Lepikkö, V Mon 060 

Lepine, JP FC01.4.4 

Lepine, -J-P Wed 191 

Leppänen, T FC09.5.4, Tue 247 

Leppee, M Mon 127 

Leppiniemi, J Thu 223 

Leprán, A Thu 307 

Lepran, I Tue 157 

Lerner, F Mon 030 

Leskinen, H Tue 166 

Letienne, R Tue 170, Tue 171, Tue 172 

Letierce, A W02.2.6 

Lett, K Tue 063 

Lettfuss, NY Mon 463 

Leung, GPH Wed 091 Thu 255 

Leung, JYT Mon 184 

Leung, PC Wed 345 

Leung, RYH Mon 271, Mon 159 

Leung, SWS FC15.2.6, Tue 157, Wed 091, 

Wed 290, Wed 388 

Leurs, R Wed 086, Thu 085, Thu 060 

Leutenegger, D Wed 392 

Levälampi, T FC09.2.5 

Levanov, A Tue 129 

Lévesque, D FC17.4.6, Wed 443 

Lévi, F FC07.1.3, FC07.2.4, W07.2 

Levonen, A-L Wed 448 

Levy, FO FC06.3.3, Wed 026 

Levy-Cooperman, N Wed 193 

Levykh, A Tue 354 

Leweke, M FC17.2.2 

Lewis, RS FC12.5.2 

Leybaert, L Thu 237 

Leymarie, F FC04.3.5 

Li, BL Tue 299


Li, DJ Mon 322 

Li, D-L Tue 187, Tue 186, Tue 159 

Li, F FC14.4.6, Thu 182, Thu 185 

Li, G Mon 264, Thu 196 

Li, G-R FC12.3.5 

Li, H FC15.4.3, W04.3.3, W30.1, 

W30.4, Tue 163, Thu 340 

Li, J FC12.2.5, FC14.5.4, 

Mon 323, Mon 457, Mon 466, 

Tue 117, Tue 299, Wed 034, 

Wed 417, Thu 195, Thu 171, 

Thu 340 

Li, J-R Wed 403 

Li, K Tue 403 

Li, KX Mon 032 

Li, L Tue 158, Thu 370, Thu 370, 

Thu 378 

Li, M Wed 150 

Li, M-J Wed 403 

Li, N FC16.3.5, Tue 355, Thu 296 

Li, P Tue 412, Mon 408, Wed 327, 

Mon 469 

Li, Q Tue 138, Mon 458 Mon 330, 

FC16.4.5 

Li, QY Tue 036 

Li, R FC14.3.5 

Li, RWS Thu 255 

Li, S Tue 401, Thu 276, Tue 365 

Li, T Mon 056 

Li, TT Wed 039 

Li, W Thu 377 

Li, WD Thu 295 

Li, W-L Tue 393 

Li, X Mon 056, Mon 092, Mon 251, 

Tue 069, Tue 070, Tue 307, 

Wed 182, Thu 195, Thu 299, 

Thu 314, Thu 377 

Li, X-Y Mon 031 

Li, X-J Tue 426, Thu 076, Thu 103 

Li, X Tue 418 

Li, X-Z Mon 209 

Li, Y Tue 069, Tue 070, Tue 260, 

Tue 294, Mon 310 

Li, Y Mon 185 

Li, Y Mon 032 

Li, Y Thu 296, FC16.3.5 

Li, Y-F FC14.4.6 

Li, Y-H Wed 262 

Li, YJ Mon 469 

Li, Z Thu 372, Thu 020 

Li, ZX Wed 291 

Lia, S Thu 279 

Liam, CK Tue 254 

Lian, LH Wed 431 

Liang, A Wed 392 

Liang, CF YI.06, Mon 324 

Liang, HY Wed 039 

Liang, J-H Thu 172 

Liang, L Thu 197 

Liang, M Mon 228 

Liao, H-T Wed 035 

Liao, M-H Thu 283, Wed 222 

Liao, Y-Y Wed 035 

Liao, Z Mon 210, Wed 362, 

Wed 258, FC06.4.6, Wed 366 

Liapi, C Tue 381, Thu 431 

Lichtenstein, L FC18.2.5 

Liddle, C W06.3 

Liem-Moolenaar, M FC17.3.5 

Liepinsh, E Tue 141, Thu 189 

Lignot-Maleyran, S FC04.2.6, Mon 140, Mon 141 

Likic, R FC01.3.7, Mon 373 Tue 328, 

Mon 135 

Liley, H Thu 011 

Lilic, R Wed 435 

Lilleyman, J Tue 353 

Lim, AL Wed 428 

Lim, LA Mon 013, Mon 033, Mon 226, 

Tue 349, Thu 418 

Lim, SL Mon 184 

Lima, C Mon 398 

Lima, L Mon 292 

Lima, LM Thu 212 

Lima, TMA Thu 355 

Lima, TS Wed 332 

Lima-Júnior, RCP Tue 255 

Lima-Landman, MTR Thu 355 

Limas Nzouzi, N Tue 040 

Liminana, P Wed 244 

Lin, AHY Wed 091 

Lin, AM-Y Mon 325 

Lin, C Wed 336, Thu 340 

Lin, C-H Mon 326 

Lin, C-L Mon 319 

Lin, C-Y FC17.1.5, Wed 326 

Lin, G Tue 401, Thu 296, FC16.3.5 

Lin, H-H Tue 374 

Lin, H-H Thu 198 

Lin, J Thu 445 

Lin, K-M Wed 430 

Lin, L Tue 441, Tue 094 

Lin, M Mon 310 

Lin, W-W Mon 327 

Lin, Y-C Thu 373 

Lin, ZB FC16.2.1, Thu 295 

Lind, U Wed 092 

Lindemalm, S Wed 008 

Linden, AM Wed 393 

Linden, A-M Thu 409 

Linden, H W10.2 

Lindh, J Mon 122 

Lindholm, M Tue 247 

Lindhorst, T Tue 151 

Lindquist, L FC01.4.7, Mon 018 

Ling, B Tue 094, Thu 083 

Lingam, PRVS W03.2 

Lingueglia, E FC03.1.1 

Linkosalo, L Mon 328 

Linnet, J FC17.1.2 

Lionnais-Couvreur, S Tue 289, Tue 290 

Lipnik-Stangelj, M Wed 178 

Lirussi, F Tue 289, Tue 290 

Lisby, M Tue 356, Tue 357, Tue 358 

Little, C W03.7 

Litvin, A Tue 150 

Litvinov, D Tue 106 

Litvinova, SA Mon 422 

Index 347

348 Index 


Liu, A Thu 092 

Liu, Ailin Mon 034 

Liu, A-J PL22, Mon 330 

Liu, AL Tue 365 

Liu, C Thu 184, Wed 093 

Liu, C-F Mon 354 

Liu, C-H Wed 286 

Liu, C-Z Thu 199 

Liu, C-L Thu 297 

Liu, D Thu 298, Tue 158, Wed 362, 

Wed 258, Tue 036 

Liu, G Tue 094, 

Liu, G-L Mon 031 

Liu, H Thu 306, Thu 369 

Liu, J FC16.4.5, Mon 323, Tue 076, 

Tue 458, Wed 336, Thu 116, 

Thu 340 

Liu, JTC YI.06 

Liu, J Thu 299 

Liu, J-J Tue 159 

Liu, J-X Thu 376, Mon 209 

Liu, K Tue 272, Mon 077, Mon 078, 

Mon 329, Thu 275 

Liu, K Mon 035 

Liu, L FC12.4.5 FC08.1.6 

Liu, LL Wed 291 

Liu, M Thu 403 

Liu, P Mon 434 

Liu, P FC06.4.2 

Liu, P Thu 300 

Liu, Q Mon 434 

Liu, Q-C FC16.5.5 

Liu, Q-R Thu 176 

Liu, R Mon 329, Mon 433, Tue 297 

Liu, S Tue 139 

Liu, W Tue 269, Tue 035 

Liu, X Tue 299, Mon 468, Mon 469, 

Mon 330, Thu 378 

Liu, X-C Mon 172 

Liu, Y FC14.5.4, FC06.4.6, 

Mon 077, Mon 078, Tue 059, 

Wed 429, Thu 017, Thu 268, 

Liu, Y-L Tue 083 

Liu, Y Mon 331 

Liu, Y-L Wed 430 

Livesey, MR FC03.3.5 

Llerana, A W16.3 

Llor, C FC13.1.5 

Lloret Linares, C FC01.4.4 

Lluel, P Tue 205, Tue 206, Tue 204, 

Mon 244, Tue 203 

Lo, A Tue 196 

Lo, TWC Tue 139 

Lo, Y-C Thu 301 

Locht, LJ Tue 359 

Löf, Cr Thu 079 

Loftus, L Tue 107 

Loga-Zec, S Wed 199 

Logothetis, N W33.2 

Loh, HH Tue 135 

Lohse, MJ Wed 026 

Loilier, M Mon 362 

Loirat, C FC10.5.5 

Loke, AC Wed 431 

Loland, C Mon 058 

Loland, CJ FC02.3.5, Mon 073 

Lonka, L Mon 341 

Lönngren, T PL21 

Lopaschuk, GD FC05.2.6 

Lopes, C Tue 257, Wed 214 

Lopes, LR Wed 233, Wed 237 

Lopes, MC Tue 397, Mon 291 

Lopes, MTP Wed 302 

López, E Mon 128 

Lopez, EG Mon 038 

López, GJ Mon 125 

López, M Tue 420, Tue 042 

López, MG Mon 079 

Lopez, P Wed 209 

Lopez-Durán, JL Tue 348 

López-Guerrero, JJ Wed 049 

López-Islas, I Thu 265 

Lopez-Nevot, MA Tue 123 

López-Sánchez, P Wed 049 

Lopez-Villodres, JA Mon 278, Tue 116, Wed 250, 

Thu 246 

Lorente, JA Thu 235 

Lorigados, CB Wed 204, Wed 203, Mon 257 

Lorrio, S Mon 079 

Lösle, M Thu 098 

Lötsch, J FC13.5.3 

Lotufo, C FC03.1.5 

Lou, Y Thu 445, Thu 089 

Louback, L Thu 212 

Lovasz, N Wed 101 

Lovenberg, T Wed 093 

Lovinger, DM Thu 190 

Lovrek, M Tue 437 

Lovriæ, M Wed 398 

Lovric, M Tue 304 

Lowry, C A FC17.4.1 

Lozano, M Wed 352 

Lozinskaya, L Mon 133 

Lozoya-Moreno, G Mon 009 

Lu, H Mon 228 

Lu, L Mon 445 

Lu, M-L Wed 430 

Lu, P FC07.2.5 

Lu, PH Mon 249 

Lu, Q Tue 399 

Lu, RB Mon 356 

Lu, S-C Wed 430 

Lu, SM Mon 266 

Lu, XH Tue 365 

Lu, X-Q FC14.5.4 

Lu, Y Mon 092 

Lu, YF Thu 116 

Lu, Y-F Tue 458, Thu 186, Thu 184, 

Thu 182, Thu 185 

Luan, H Tue 419 

Lubbe, M Tue 110, Mon 026 

Ls, G FC17.2.5 

Ls, S Tue 080 

Lucena, MI Wed 109 

Lucenteforte, E Thu 302 

Lucero, ML Mon 080 

Lucero, ML Mon 254 

Luciani, S Thu 360


Lue, S-I Wed 439 

Luescher, TF FC16.1.2 

Lütjohann, D Tue 045 

Lugovkina, T Wed 110 

Lukacs, P Mon 218, Mon 217 

Lukas, J Tue 197 

Lukas, JC Mon 229, Wed 111 

Lukaskova, J Tue 137 

Lukasova, M Wed 056 

Luksha, L Thu 256 

Lumlerdkij, A Thu 335 

Lumlerdkj, A Thu 361 

Lund Nielsen, P Mon 142 

Lund, S Mon 154, Tue 132 

Lundberg, MH Thu 200, Thu 238 

Lunder, M Thu 359, Thu 293 

Lundmark, J FC14.1.6 

Lundström, L Wed 094 

Luo, Dali Thu 390 

Luo, G Wed 378 

Luo, G FC16.4.4 

Luo, J-D Mon 186, FC09.5.6 

Luo, Y FC06.4.6 

Luo, Y Mon 434 

Luoto, P Mon 256 

Lupi, P Thu 302 

Lupp, A Tue 219 

Lutsar, I FC10.3.6 

Luviano, A Tue 420 

Lv, Y Wed 346 

Ly, K Wed 057 

Lyhne, NM Tue 358 

Lynagh, S Wed 132, Tue 160 

Lynagh, T Tue 037 

Lynch, J Tue 037 

Lynch, K Tue 410, Wed 076 

Lyngsøe, C Wed 036 

Lyoussi, B W27.2 

M. Carnero, MC Tue 144 

M. I, H Wed 441 

Ma, B Tue 426 

Ma, HI Tue 135 

Ma, J Thu 295 

Ma, Lin Lin Thu 173 

Ma, Q Tue 004 

Ma, X FC13.2.1, Thu 340 

MA, Z Tue 419 

Maarsingh, H Wed 095 

Mabley, J Mon 157, Wed 096 

MacDonald, E Mon 476 

Macdonald, T Wed 076 

MacDougall, IJA Mon 394 

Macedo, A Thu 218, 

Macedo, AF Mon 126 

Macedo, T Wed 180, Wed 140 

Macek, K Tue 342, Thu 168 

Machado, MA Tue 243 

Machado, MM Wed 339 

Machida, T Mon 309, Thu 201 

Macias, D Mon 129 

Maciulaitis, R Tue 329 

Mackovicova, K Thu 097 

MacLeod, S W36.1 

Macolic-Sarinic, V Mon 342, Mon 343, Mon 370, 

Wed 112 

Macugova, A Tue 113 

Madazli, R Thu 266 

Maddahi, A Tue 220 

Maddison, J Tue 327, Tue 322, Wed 113 

Madjarevic, T Tue 095 

Madsen, J Mon 227 

Madsen, KL YI.10 

Madura, J Tue 059 

Madureira, R Thu 408 

Maechler, P Wed 447 

Maeda, A Thu 109, Mon 416 

Maeda, S Mon 435, Mon 440, Wed 067, 

Wed 075 

Maeda, Y Mon 250, Tue 263 

Maekawa, T Thu 268 

Maes, L Thu 366 

Magalhães, MH Mon 010 

Magalhães-Cardoso, T FC08.2.6 

Magina, S Wed 114 

Maglajlic, JA Wed 171 

Magour, S Mon 245 

Maguire, JJ W14.3 

Magyar, I Mon 436 

Mahé, I Tue 188 

Maher, J Wed 096 

Maheux, J FC17.4.6 

Mahmoudi, G Mon 437 

Mahmoudian, M Thu 100 

Mahmud, FH FC10.2.5 

Maier, C W03.6 

Maihöfner, C W03.6 

Mainz, J Tue 356, Tue 357 

Maitra, R Thu 021, Tue 221 

Maïzi, H Mon 132 

Majzoob Zanjani, S Mon 455 

Mak, JCW Wed 218 

Mak, JW Thu 379, Thu 380 

Mak, TW YI.06 

Mak, VWL Tue 139 

Makar-Ausperger, K Mon 373, Tue 328, Mon 135 

Makarenko, O Mon 087 

Mäkilä, E Thu 170, Tue 032 

Makonnen, E FC01.4.7, Mon 018 

Maksimovic-Ivanic, D FC16.3.6 

Makvandi, M Tue 251 

Mala, E Tue 222, Tue 421, Tue 240 

Malan, SF Mon 442 

Malashenko, EA Thu 253 

Maldonado Espinza, A Thu 330 

Maleki-Dizaji, N Mon 294 Tue 164 

Maleki-Dizaji, N Tue 223 

Malhotra, B Mon 236, Mon 251 

Mali, A Mon 256 

Malita, IM Tue 102 

Malkin, B Wed 013 

Mallal, S FC13.3.1 

Mallayasamy, SR FC04.3.7 

Malm, T W21.3 

Malone, D Thu 191 

Malone, DT Wed 428 

Malthery, Y Tue 118 

Mamadou, G Tue 040 

Index 349

350 Index 


Mamchur, V Tue 354 

Mammen, M Thu 069 

Man, GSK Wed 290 

Man, RYK FC15.2.6, YI.06, Thu 281, 

Wed 091, 

Mancini, F Thu 433 

Mandia, R Tue 020 

Mandoki Weitzner, JJ Thu 330 

Mandrup, S FC18.1.4, Wed 447 

Maneu, V Mon 472, Mon 473, Mon 477, 

Mon 481, Tue 478, Tue 422, 

Thu 407 

Mangano, G Thu 433 

Mangelsdorf, DJ FC18.1.3 

Manjunatha, N FC01.4.6 

Mann, D L FC06.4.1 

Mannani, R Thu 392 

Männistö, PT Wed 071, Mon 444, Mon 447, 

Mon 341 

Mannoury La Cour, C Wed 072 

Mannucci, C Thu 316 

Manolopoulos, VG Tue 224, Mon 187 

Manoury, B Tue 061 

Manrique-Maldonado, G Thu 022, Thu 203 

Mansell, S Tue 064 

Mansoori, SD Mon 002 

Mansour, D Tue 451 

Mantegazza, M FC12.1.3 

Manthey, L Wed 432, Tue 096 

Manukyan, A Wed 205 

Mao, H Wed 322 

Maponga, C Tue 004 

Marandykina, A Thu 023 

Marathe, S W01.2.4 

Marazioti, A FC15.3.6 

Marazioti, Antonia Thu 202 

Marbury, T Mon 205, 

Marchais-Oberwinkler, S Tue 442 

Marchei, E Mon 375 

Marchionni, N Mon 120 

Marçola, M Thu 204 

Mardirosian, Artin Mon 036 

Marek, J Tue 448 

Marichal-Cancino, BA Thu 022, Thu 203 

Marie, S Mon 362 

Marija, M Mon 347 

Marijan, K Mon 347 

Marimuthu, G Thu 327 

Marinda, E Tue 001 

Marjason, J Tue 312 

Markholt, S Tue 359 

Márki, A Mon 261 

Markovic-Lipkovski, J Wed 103 

Markovics, A W19.3, Mon 106, Mon 283 

Marks, AR FC12.3.3 

Markvardsen, LH Tue 161 

Marques, AR Thu 202 

Marques, E Wed 180, Tue 162 

Marques, EB Wed 232 

Marques, S Tue 162 

Marquez, E-I Mon 471, Mon 149 

Márquez, EI Wed 007, Mon 123 

Marquié, J-C Mon 124 

Marre, M Mon 161 

Marrero Faz, E Thu 347 

Marsch, R Thu 396 

Marsh, A Mon 353, Mon 352 

Marston, A Wed 375 

Martel, F Mon 042, Mon 057 

Martel, J-C Thu 024 

Mårtensson, U Thu 047 

Mårtensson-Lindblad, L Wed 092 

Marthan, R Wed 293 

Martikainen, JE Tue 363 

Martikkala, E Wed 444 

M, Roland FC09.2.2 

M-Aurioles, E Tue 116 

Martín-Campos, J Thu 042, Wed 059 

Martínez Sánchez, G Thu 347 

Martinez, C Mon 148, Wed 109 

Martinez, G Mon 136 

Martinez, GS Mon 038 

Martinez, K Thu 037 

Martinez, KL Thu 086 

Martinez, MC Wed 216, Wed 196 

Martínez, P Thu 249 

Martinez-Caro, L Thu 235 

Martínez-González, J W09.4 

Martínez-Saénz, A Mon 411 

Martini, L Wed 073 

Martinkova, J Tue 125, Wed 017 

Martinovic, M Thu 231, Wed 019, Wed 018, 

Thu 001 

Martins, A Wed 131 

Martins, AMC Thu 374, Wed 297 

Martins, F Wed 140 

Martins, VV Wed 339 

Martiny, L FC11.5.6 

Marton, Z Wed 197 

Martos, J Thu 088 

Maru, Y Thu 444 

Maruo, T Mon 035 

Marusic, S Wed 112 

Maruyama, A Mon 253 

Maruyama, I Thu 331 

Mashinchian, O Thu 303 

Mason, BJ FC14.2.4 

Masri, B Wed 423 

Massard, J W02.2.6 

Masson, E Tue 495 

Masson, I Mon 191 

Mastrantonio, G Wed 003 

Masubuchi, Y Wed 115 

Masuda, S Tue 156, Tue 225 

Masuda, T Wed 223 

Mataji, A Mon 099 

Matak, I Mon 096 

Matchkov, V Tue 038, Wed 433 

Mateos-Campos, R Tue 088, Tue 089 

Matesanz, N Tue 134 

Mathews, T Wed 076 

Mathiasen, S Thu 026 

Mathiassen, ON Mon 200 

Mathie, AA FC03.3.6 

Mathiesen, JM Thu 027 

Mathison, Y Thu 205 

Mathison, Y Mon 295, Wed 251, Thu 271 

Mathur, M Tue 453, Tue 020, Wed 116


Mato, ID Mon 125 

Matos, MG Mon 295, Tue 226, Wed 212, 

Thu 254 

Matreja, P Mon 005 

Matsabisa, G Wed 389 

Matsabisa, MG Wed 390, Wed 391 

Matschke, K Tue 012 

Matsuda, M Thu 038 

Matsuda, T Tue 360, Tue 060 

Matsui, N Mon 253 

Matsumoto, H Tue 432 

Matsumoto, K FC16.3.3, Mon 386 

Matsumoto, N Tue 273, Tue 337, Tue 483, 

Tue 492, Wed 117 

Matsumoto, Y Tue 263 

Matsumura, K Tue 162 

Matsunaga, H Wed 413 

Matsunami, M Tue 263, Tue 077 

Matsuo, Y Thu 263 

Matsuoka, T Tue 260, Tue 294 

Matsuomoto, N Tue 336 

Matsushima, S Mon 424 

Matsushita, A Thu 099, Mon 461 

Matsushita, K PL14 

Matsuzaki, T Thu 344 

Mattace Raso, G Thu 081 

Mattheij, NJA Thu 208 

Matthews, S Tue 309 

Matuskova, Z Wed 118 

Matwyshyn, G FC05.2.5, Wed 184 

Matz, J Tue 303 

Maulik, SK Thu 304 

Maurel, D Wed 077 

Maurice, P Thu 028 

Maurizio, R Thu 400 

Maussang, D Wed 086 

Mavrakanas, T Tue 126, Thu 206 

Mavri, J Mon 074 

Maxwell, S FC01.3.7, 

Maxwell, SRJ FC01.1.3, W20.4 

May, D W03.6 

May, K Tue 039, Tue 131, Wed 119 

Mayer, B PL24, Tue 227 

Mayer, ME Mon 247 

Mayer, P Tue 129 

Mazella, J FC17.2.5 

Mazzaglia, G FC04.1.6 

Mazzon, E FC18.1.5, Mon 277, 

Mon 286, FC18.3.6 

McArthur, K FC15.1.6 

McArthur, S FC15.1.5 

McCarthy, C FC08.3.2 

McClymont, D Thu 029 

McDougal, I Wed 032 

McFadzean, I Tue 230 

McField, R Tue 097, Tue 120 

McGarth, J C W01.2.2 

McGrath, J Thu 030 

McGuire, JJ Wed 271 

McGuire, J J Thu 207 

McIntyre, P W03.7 

McKown, R Thu 110 

McLachlan, A FC13.2.6 

McLaverty, M Tue 456, Tue 279 

McLay, J Wed 137 

McLay, JS Tue 109 

McNally, G FC03.3.1 

McNaughton, PA FC03.1.3 

McPhaden, A Thu 272 

McQuain, C Mon 264 

Meana, JJ Wed 031, Thu 031, Thu 399 

Mécs, Z Thu 307 

Medard, Y Wed 011, FC10.1.5 

Medina, A Wed 007 

Medina, I Wed 265 

Medina, P Thu 225 

Medved, V Wed 398 

Medvedeva, N Wed 283 

Meena, S Wed 294 

Meens, M Wed 037 

Meens, MJPMT Thu 208 

Meesarapee, B Tue 277, Thu 305 

Megersa, TN Thu 032 

Megson, I Mon 211 

Megyeri, A Mon 150, Mon 167 

Mehdipour, AR Thu 309 

Mehla, J Mon 452, 

Mehmood, MH Wed 354 

Mehnert, F FC04.2.7 

Mehta, N FC09.5.7 

Mei, Q Tue 286 

Meier, SM FC11.3.2 

Meiler, J FC11.3.2 

Meili, S Thu 309 

Meissner-Kirch, O Mon 037 

Mejyr, S W35.4 

Melcon de Dios, A Wed 109 

Meli, R FC18.1.6, Thu 081 

Mellor, I Thu 029 

Melo, PA Wed 339 

Melo, T Wed 318, Wed 319 

Mendell, J Tue 228, Wed 122, Wed 121, 

Wed 120 

Mendelson, J FC14.2.5, Mon 388, Wed 170 

Mendes, AF Tue 257 

Mendes, E Tue 086 

Mendez-Cruz, AR Tue 150 

Mendoza Hernandez, IC Mon 038 

Mendoza Patiño, N Thu 330 

Mendoza Rodríguez, Y Thu 425, Thu 424 

Mendoza, Y Thu 394, Thu 395 

Mendoza-Ramos, MI Tue 150 

Menendez, C Tue 121, Wed 226, Thu 217, 

Thu 235 

Menezes, G Tue 229 

Menezes, R Wed 131 

Meng, X Tue 117, Thu 306, Thu 369 

Meng, Y Tue 035 

Menghini, L Wed 329 

Menna, A FC04.3.6 

Menon, G Wed 006 

Menon, P Tue 230 

Menoyo, E Thu 177, Thu 178 

Menzen, MH Tue 242, Wed 095 

Mer, M Mon 308 

Meræep, I Mon 048 

Meraner, P FC12.5.4 

Merino -Garcia, N Wed 344 

Index 351

352 Index 


Merino, D Wed 087 

Merkord, J Thu 337 

Merlin, J Wed 063 

Mesarosova, L FC05.4.5, Mon 219 

Mesdaghinia, A Tue 231 

Mesdaghinia, Eh Thu 209 

Mesquita, C Mon 398 

Messing, DD Thu 014 

Messlinger, K Mon 099 

Messripour, M Thu 004 

Mester, G Thu 307 

Mester, M W19.3 

Methven, L W01.2.2, Thu 030 

Metsvaht, T FC10.3.6 

Metz, J Tue 462 

Meurs, H Tue 242, Wed 095 

Meyer zu 

Schwabedissen, H Tue 045, Tue 054 

Meyer, J FC02.2.5 

Meyer, JG Mon 071 

Meyer-Lindenberg, As FC17.3.3 

Meyers, T Thu 012 

Meyers, TM Thu 016 

Mezei, Zsofia Thu 307 

Mezhapuke, R Wed 045 

Mhadhebi, L Wed 316 

Miantezila Basilua, J Tue 040 

Miao, Chao-Yu Thu 210 

Micaelo, N Tue 146 

Micale, V Thu 396 

Micali, S Thu 316 

Miceli, N Thu 316 

MIchael, M Tue 238, Thu 317 

Michailov, MC Mon 479, Thu 211, Tue 214, 

Mon 245, Tue 099 

Michaud, V Wed 123 

Michel, Lisa Tue 232 

Michelon, H FC02.2.6 

Michiels, C Wed 245 

Micograve, U Thu 419 

Micon, S Mon 140, Mon 141 

Miczek, K FC14.4.3 

Miettinen, T Mon 215 

Mifsud, J Thu 002 

Miftah, A Mon 378 

Miglio, G Tue 256, Thu 434 

Mihovilovic, MD Mon 217 

Mijatovic, S FC16.3.6 

Mikelis, C Thu 232 

Miki, N Wed 186 

Mikkelsen, S FC13.5.5 

Mikkonen, J Thu 223 

Mikolajczak, PL Thu 174 

Mikov, I Tue 148 

Mikov, M Mon 115, Tue 148, Tue 149, 

Tue 454, Wed 321 

Mikov, MM W34.4, Wed 435 

Milan, Z Tue 151 

Milanese, M Thu 400 

Milani, L Wed 136 

Milbradt, J Tue 214, Thu 354 

Milijasevic, B Tue 148, 

Militaru, FC Mon 417, Mon 438, Tue 481 

Miljkovic, D FC16.3.6 

Millan, MJ Wed 072 

Millard, R FC08.1.6 

Mille, M Mon 217, Mon 218 

Millet, C Thu 244, Thu 245 

Millfors, P Thu 003 

Milliken, P Thu 272 

Millington, WR Wed 179 

Mills, A Thu 272 

Milne, RW Tue 066 

Milovan, D Wed 193 

Milovanovic, D Mon 039, 

Milovanovic, DR Wed 435 

Milovanovic, M Mon 114 

Milovanovic, S Thu 329, Tue 122 

Milton, S Tue 233 

Milusheva, E Mon 460 

Minakuchi, K Wed 278 

Miners, J Wed 124 

Mingorance Gutiérrez, C Tue 118 

Minnaar, EL Wed 399 

Minnaard-Huiban, M Mon 212 

Mino, Y Tue 491 

Minorics, R Thu 308 

Miokovic, M Wed 171 

Miralles, Diana V Tue 163 

Miranda, AL Thu 212 

Mirecki-Garrido, M Tue 392 

Miremont, G FC09.2.7 

Miremont-Salamé, G Tue 092 

Miri, M Tue 469 

Miri, R Wed 376 

Miri, Ramin Thu 309 

Mirkhani, H Wed 376 

Mirmohammad 

Sadeghi, H YI.07 

Mironidou-Tzouveleki, M Mon 367, Thu 206, Mon 297, 

Tue 126 

Miroševic, V Mon 048 

Mirosevic-Skvrce, N Wed 112 

Mirossay, A Thu 033 

Mirossay, L Thu 033, Thu 216 

Mirtsou, V Tue 246 

Mirtsou-Fidani, V Mon 143 

Mirza, M Tue 395 

Mirzadegan, T Wed 093 

Mirzaei, A Thu 313 

Mirziashvili, M Wed 272, Tue 174 

Mirzoyan, R Wed 248 

Misaka, S Tue 144 

Misawa, M Mon 303, Mon 304, Mon 272, 

Tue 259, Tue 234, Tue 265, 

Tue 287 

Misbahuddin, M Tue 119 

Misfeldt, M Wed 229 

Mishina, M Thu 034 

Misioreck, C Thu 237 

Misle, A Wed 024 

Mistchenko, AS Mon 128 

Mistiran, AF Tue 408 

Mita, M Mon 179, Wed 305 

Mitani, Y Tue 492 

Mitchell, C Tue 353, Mon 351 

Mitchell, JA FC09.4.1, Thu 200, Thu 238, 

Thu 241


Mitchell, S FC13.2.6, Wed 125, Wed 126 

Mitic, R Wed 436 

Mitjavila Cors, M Thu 347 

Mitrovic, D Wed 343 

Mittal, DK Thu 310 

Miura, Jun Wed 127 

Miura, M Tue 144 

Miwa, S Mon 399 

Miwa, T Tue 162 

Miyagawa, K Thu 397, Thu 423, Thu 422 

Miyahara, T Tue 459 

Miyakawa, M Wed 223 

Miyake, F Wed 117 

Miyashiro, C Tue 241 

Miyata, T Thu 387 

Miyauchi, S Wed 064 

Miyazaki, I Wed 424, Wed 413 

Miyazaki, T Wed 256, Thu 213 

Mizobuchi, S Mon 303 

Mizuguchi, H Tue 154 

Mizuma, K Wed 186, Tue 477 

Mizutani, H Wed 107 

Moachon, L FC09.2.7 

Moazen, F YI.07 

Mobasher, MA Mon 085, Mon 088 

Mobini, H FC14.5.2 

Moch, S Mon 478, Tue 001 

Mochizuki, Y Wed 128 

Modaresi, M Thu 004 

Modess, C Tue 041, Tue 045 

Moerland, M Mon 316, Thu 214, Thu 215 

Mogi, M Mon 439 

Mohajeri, SA Mon 230 

Mohamad, MA Tue 444 

Mohamad, N Mon 107, Thu 181 

Mohammadi, S Mon 044, Tue 164 

Moharamzad, Y Thu 005, Thu 311 

Mohr Drewes, A W12.5 

Mohsin, SSJ Thu 312 

Mohy El-Din, MM Tue 264 

Moibenko, A FC06.1.6 

Moilanan, E FC09.1.5, FC09.3.1, 

FC09.5.4, FC16.3.4, W21.5, 

Mon 302, Mon 328, Tue 278, 

Tue 235, Tue 239, Tue 247, 

Tue 283 

Moilanen, L Tue 235 

Moilanen, T W21.5, Tue 283, Tue 239 

Mojic, M FC16.3.6 

Mojzis, J Thu 033, Tue 423 

Mojzis, Jan Thu 216 

Mojzisova, G Tue 423, Thu 216 

Mokhtari, F FC01.3.5 

Mokoena, M Mon 412 

Mokrane, H Thu 035 

Mokrosinski, Thu 036 

Molana, H Mon 036 

Molden, E Tue 490, Wed 412 

Molero, E FC04.4.6 

Molina-Guarneros, JA Tue 431 

Mollentze, W FC14.5.5 

Møller, A Thu 405, Thu 404, FC17.1.2 

Møller, LB Mon 089 

Möller, M FC18.2.5 

Møller, MU Mon 090 

Møller, TC Thu 086 

Møller, T Thu 037 

Mollica, A Mon 105, Wed 434 

Mollik, AH Tue 097, Tue 120 

Molloy, M W06.3 

Molnar, P FC16.2.6 

Molnar, S Tue 099 

Molyva, D Mon 300 

Momma, T Tue 345 

Momo, K Tue 315 

Moncada, S PL01, FC09.3.5 

Monge, A Thu 212 

Monge, L Wed 224 

Mönkkönen, J Mon 060 

Monnier, C FC11.2.1 

Monopoli, A Mon 281 

Monsalvo, I Tue 420 

Montagnani, M W08.4 

Montaña, M Wed 046 

Montanaro, N FC04.3.6 

Montane Jaime, L Wed 129, Tue 347 

Montastruc, JL Tue 104 

Monteiro, EC Wed 130 

Monteiro, F Wed 131 

Monteiro, H Wed 131 

Monteiro, HSA Wed 297 

Monteiro, J Wed 131 

Montó Guillot, FJ Tue 165 

Monto, F Thu 048, Tue 163 

Monuki, Y Mon 307 

Moon, S-M, Mon 049, Mon 359 

Moore, N W32.2, Mon 140, Tue 092 

Moradi, N FC09.5.7 

Moraes, MEA Thu 374 

Morales, C Tue 016 

Morales, L Wed 152 

Moral-Sanz, J Tue 121, Wed 226, Thu 217, 

Thu 235 

Morbidelli, L Wed 243 

Morcillo, E Thu 437 

Moreau, P Tue 429 

Moreira, A-P Mon 314 

Moreira, F FC17.5.5 

Moreira, IS YI.10 

Moreno, E Thu 235, Thu 217 

Moreno, L Tue 121, Mon 374, Wed 226 

Moreno, L Thu 217 

Morgadinho, T Thu 193 

Morgado, M Thu 218 

Morgado, S Thu 218 

Morgan, ET W06.1 

Mori, A Wed 264 

Mori, H FC16.4.6 

Mori, M Tue 147 

Mori, S Tue 272, Mon 035, Mon 329, 

Thu 275 

Mori, T Thu 103 

Moriguchi, S Thu 406 

Morikawa, M Mon 307 

Morin, C Mon 469 

Morini, G Mon 381 

Morishima, S Thu 046 

Morishima, T Tue 122 

Index 353

354 Index 


Morisset, S Wed 051 

Morita, H Thu 038 

Morita, K Mon 303 

Morita, S Wed 414 

Moritani, T Wed 422, Wed 415 

Mørk, A FC17.4.2 

Moro, C Tue 199 

Moro, N Wed 263, Tue 214 

Moroni, S Mon 003, Wed 003 

Morris, B FC17.1.4 

Morris, R Mon 102, Tue 495 

Morrow, L Mon 175 

Morvay, N Tue 157 

Moscatelli, G Mon 003, Wed 003 

Mosekilde, E FC07.1.1 

Moseley, E Tue 002 

Moshfegh, A Mon 055 

Moshkov, AV Thu 238 

Mosquera, B Tue 348 

Moss, E Wed 132 

Mostefai, HA Wed 196 

Motamedi, R Thu 309, Tue 469 

Motau, Harold Tue 003 

Motavallian Naeini, A YI.07 

Motegi, T Mon 440 

Motevalian, M Thu 006 

Motomura, S Tue 430 

Motosugi, Y Thu 268 

Motsoaole, M Thu 315 

Möttönen, T FC09.2.5 

Mou, Y Tue 155 

Mouly, S Tue 188, Tue 189, Wed 191, 

FC01.4.4 

Moura, D Wed 114 

Moura, D Tue 123 

Moura, E Wed 114, Thu 398 

Mousavi, SH Thu 313, Thu 342, Tue 424 

Moustafin, IG Thu 096 

Moutin, E FC11.3.3 

Mozhaeva, T Tue 150 

Mpamhanga, CP Tue 479 

Mpindi, J-P Tue 436 

Mrhar, A FC07.3.5 

Mrsic Pelcic, J Tue 095 

Mu, X Tue 307, Thu 314 

Muceniece, R Thu 189, Wed 045 

Mudzviti, T Tue 004 

Mülders, V Tue 108 

Müller, C Thu 018 

Müller, CE Tue 238 

Müller, M Thu 438 

Müller, S Wed 119 

Mueller, SC Tue 115 

Mürdter, T Wed 133 

Mugabo, P Thu 315 

Mugelli, A Thu 302, Tue 093 

Mugosa, S Tue 098, Wed 135, Wed 134 

Muguruza, C Thu 399 

Muhamedzhanova, G Tue 079 

Mukonzo, JK Tue 005, Wed 136 

Muktar, H Wed 145 

Mulabegovic, N Wed 199 

Mulcahy, F Thu 442 

Mulder, P Wed 196 

Mulleman, D Tue 198 

Mulvany, M Wed 375, Wed 240 

Mulvany, M W17.1 

Mulvany, MJ Thu 234, Mon 200 

Munck, A Wed 160, FC13.1.5 

Mungiu, O Mon 108, Tue 134 

Munhoz, C Mon 292 

Munk, S Thu 058 

Muñoz, A Mon 123, Mon 254 

Muñoz, R Mon 451 

Muñoz-Marin, J Mon 206, Mon 278, Tue 144, 

Wed 215 

Muntau, AC Wed 016, Thu 014 

Muona, A W21.3 

Muraguchi, M Thu 103 

Murai, M Mon 402 

Murakami, M Tue 236 

Muramatsu, I W01.2.3, Thu 046 

Muramatsu, M Wed 107, Thu 286 

Murase, S-I Wed 060 

Murat, N Tue 200 

Murciano, C Tue 478, Tue 422 

Murguia-Romero, M Tue 150 

Murphy, SE FC17.4.3 

Murphy-Ullrich, J Thu 251 

Murugan, DD Thu 219 

Musabegovic, J Wed 004, Wed 171 

Musavi, P Mon 231 

Musazzi, L Thu 400 

Muscará, MN Wed 233 

Muscatello, MR Thu 419 

Musgrave, U FC16.3.7 

Musil, P Mon 219 

Musilek, K Tue 343, Mon 075, Tue 448 

Mustafa, J Thu 057 

Mustafa, MR Thu 219, Tue 254 

Mustafa, R Wed 370 

Mustata, C Thu 177, Thu 178, Mon 109 

Mustonen, E Tue 166 

Muthig, V W01.2.4 

Mutka, A-L Mon 215 

Mutlu, O Mon 387, Tue 145, Wed 351, 

Thu 401 

Mwandingi, P Thu 315 

Mwinyi, J Thu 435 

Myllynen, P Mon 063, Mon 076 

Myöhänen, TT Mon 444 

Myronidou-Tzouveleki, M Tue 141 

Myslivecek, J Thu 039 

Mzah, D Mon 378 

Nabeshima, T Thu 402 

Nabipoor, I Tue 014 

Nada, SA Tue 451 

Naeini, KS Tue 369 

Nafrialdi, Tue 009 

Nagahama, H Mon 173 

Nagai, H Tue 373 

Nagano, M Thu 108 

Nagano, M Thu 403 

Nagashima, R Mon 461, Tue 375, Thu 099 

Naggara, O Mon 191 

Nagy, S Tue 414, 

Nahimi, A Thu 405, Thu 404 

Naidoo, D Mon 478


Naidoo, M Tue 110 

Naidoo, P Tue 110 

Naidu, R Tue 254 

Naim Abu Nabah, Y W09.4 

Naina, MI Wed 137 

Naito, T Tue 484, Tue 491 

Najafi, E Thu 365 

Najafi, M Tue 164 

Najafian, B Mon 231 

Najafzadeh, H Mon 222 

Nakabeppu, Y Wed 141 

Nakada, Y Tue 151 

Nakae, Y Thu 013 

Nakagawa, M FC03.2.5, Wed 138 

Nakagawa, S Tue 225 

Nakagawa, T Tue 055 

Nakagiri, A Tue 236 

Nakahara, T Wed 264 

Nakahata, N Wed 373, Wed 078 

Nakajima, K Thu 402 

Nakamori, Y Tue 274 

Nakamura, E W02.1.3, Thu 263 

Nakamura, K Tue 067, Tue 143, Tue 167, 

Thu 040, Thu 263, Thu 320 

Nakamura, M Mon 112 

Nakamura, S Thu 220 

Nakamura, T Tue 373 

Nakamura, Y Mon 441 

Nakanishi-Ueda, T Tue 443 

Nakano, Y Tue 201, Thu 416 

Nakarandake, E Wed 203, Mon 257 

Nakashima, H Wed 127 

Nakasone, J Thu 344 

Nakatsu, K Tue 414 

Nakayama, J Wed 115 

Nakayama, K Thu 226, Thu 248, W09.4 

Nakayama, KI W09.4 

Nakazawa, M Tue 177 

Nam, JH Tue 046, Mon 068 

Nam, MH Thu 090 

Namekata, I Tue 168, Thu 260 

Namiki, N Tue 144 

Namkung, Y Thu 063 

Namour, F Tue 280 

Namvaran, F Tue 485 

Namvaran, MM Mon 088 

Nanba, D Thu 406 

Nancy, G Wed 219 

Nanda, S Thu 410 

Näpänkangas, J Tue 166 

Narita, M Thu 188, Thu 188, Wed 065 

Narum, S Wed 139 

Narumiya, S Mon 194, Tue 260, Tue 294 

Nasal, A Mon 197 

Nascimento, E Mon 094, Mon 095, Mon 097 

Nascimento, NRF Wed 297 

Nascimento, TL Thu 351, Thu 352 

Nashida, T Tue 060 

Nashun, B Wed 039 

Nasisi, A Thu 111 

Näsman, J Wed 081, Thu 051 

Nasser, A Mon 089 

Nassif, A Tue 045, Tue 041 

Nastos, S Tue 368 

Nasu, Y Wed 373 

Nasyrova, S Tue 079 

Natvig, B Tue 143 

Naulaers, G Wed 001 

Navarra, Michele Thu 316, Thu 364 

Navarrete-Vazquez, G Tue 149 

Navarro, JM Tue 123 

Navarro-Dorado, J Mon 206, Tue 144, Wed 215, 

Wed 228, Thu 264, Thu 240 

Nawaratne, V Thu 041 

Nayeri, K Tue 015 

Naylor, C Wed 409 

Nazer, D Tue 110 

Nazifi, S Tue 015 

Nazila, T Thu 181 

Ndisang, JF Tue 124 

Nechifor, M FC14.2.6, Mon 162, Thu 175 

Neef, CK W29.4 

Negoro, T Tue 201 

Negredo, P Mon 079 

Negrete, R Thu 042, Wed 059 

Negura, T Tue 459 

Nejime, N Tue 143, Tue 067 

Nelissen, J Wed 287 

Nelissen, Jelly Thu 221 

Nelson, M Thu 279, YI.05 

Nelson, MT FC08.3.3, FC15.2.4 

Németh, J Tue 125, Tue 142 

Nemethy, Z Wed 423 

Nepote, V Tue 305 

Nerobkova, L Mon 462 

Nesi, M Thu 043 

Nesi, RT Wed 342 

Nesic, Z Mon 114 

Neta, C Wed 140 

Neu, E Mon 245, Mon 479, Tue 099, 

Tue 214, Thu 211, Thu 354 

Neu, R Thu 354, Tue 099 

Neubig, R YI.01, Thu 044, Tue 479, 

Thu 065 

Neugebauer, W Wed 037 

Neumann, J Tue 169 

Neuvonen, PJ Mon 380, Tue 062, Thu 284, 

Tue 316, Tue 330 

Neverauskas, V Tue 329 

Neves, BM Mon 291 

Neville, K FC13.3.5 

Newall, DR W10.2 

Newman, A Wed 126 

Newman, AH FC02.3.5 

Newman-Tancredi, A Thu 024 

Nezic, D Thu 324 

Nezic, L Tue 237 

Neznamov, G Tue 024 

Ng, ESK Tue 417, Wed 345 

Ng, K-Y Thu 045 

Ng, KFJ Thu 281 

Ng, L Thu 393 

Ng, PY Tue 252 

Ng, WK Tue 452 

Ngokpol, S Mon 355, Tue 006, Tue 007 

Nguyen, CH Tue 180 

Nguyen, D-T Mon 242 

Nguyen, TMH Mon 263 

Index 355

356 Index 


Nichols, CG FC12.4.3 

Nichter, M Wed 172, Wed 172 

Nicolau, S Tue 042 

Nicoletti, F Wed 400 

Nicolucci, A W18.2 

Nicotra, F Tue 093 

Nie, L-Y Mon 470 

Nie, YL Mon 032 

Nieber, K Wed 417 

Nieber, K Thu 317, Tue 238 

Nielsen, C FC14.3.5 

Nielsen, E W29.3, Thu 222 

Nielsen, HB Mon 050 

Nielsen, J Tue 303 

Nielsen, LP Tue 356, Tue 357, Tue 358 

Nielsen, NM Tue 038, Wed 433 

Nielsen, S FC02.2.2 

Niemi, M Tue 062, Tue 330, Tue 316, 

Thu 284 

Nieminen, R FC09.1.5, FC09.2.5, 

FC16.3.4, W21.5, Mon 302, 

Tue 235, Tue 239, Tue 278, 

Tue 283, Thu 223, 

Niesters, M W12.4 

Nieto, MA Mon 374 

Niida, S Thu 286 

Niihara, H Wed 083 

Niikura, K Thu 188 

Nijkamp, F FC09.5.2 

Niki, T Tue 140 

Nikitina, T Wed 347 

Nikolic, D W34.3 

Nikolic, V Thu 070, 

Nikolic-Kokic, A Wed 387, Thu 318 

Nilsson Remahl, I Tue 308 

Nin, N Thu 235 

Nishibori, M Tue 272, Mon 035, Mon 329, 

Thu 275 

Nishida, M Thu 109 

Nishida, Y Mon 272 

Nishihara, K Tue 225 

Nishikawa, H Tue 263 

Nishimaki-Mogami, T Thu 250 

Nishimoto, A W01.2.3, Mon 399, Thu 046 

Nishimura, Y Tue 320, Thu 319, Thu 343 

Nishino, M W23.4, Tue 473 

Nishio, H Tue 467 

Nishioka, Y Wed 278 

Nishiuchi, A Thu 320 

Nishiwaki, M Mon 307 

Nishiya, T Mon 399 

Niu, J Tue 371, Tue 425 

Niwa, M Mon 112, Thu 402 

Nobakht, M Mon 188 

Nobe, H Thu 224 

Nobe, K Tue 201, Wed 256, Thu 117, 

Thu 224 

Nobuoka, Y Tue 486 

Noches, V Wed 169 

Noda, M Wed 141 

Noda, Y Thu 402 

Noe, CR W24.2 

Noedl, H Tue 090 

Noehr-Jensen, L FC13.5.5 

Noguchi, A Tue 136 

Noguchi, K Thu 344 

Noguchi, N Tue 153 

Noguera, M-A Thu 050 

Nolasco-Velazquez, XE Tue 025 

Noll, G FC16.1.2 

Nomura, F Tue 126, FC13.2.5 

Nonaka, K Wed 371 

Nor Aripin, KNB Thu 007 

Norel, X Thu 266 

Nørgaard, ML FC04.2.4 

Nørgaard-Strandfelt, K FC02.3.6 

Norman, E Thu 008 

Norstedt, G Tue 391, Tue 392 

Nosalova, G Mon 293 

Nosjean, O Wed 072 

Nossent, AY FC06.2.5 

Nossent, Y Wed 070 

Nouailhetas, VLA Thu 351, Thu 352 

Nour El-Din, NA Tue 264 

Novaes, LC Thu 321 

Novaes, MR Tue 008, Thu 323, Thu 322, 

Thu 321 

Novakova, E Mon 293 

Novakova, M Thu 039 

Novakovic, A Wed 103, Thu 324 

Noveck, R Tue 228, Wed 122, Wed 121, 

Wed 120 

Novella, S Thu 225 

Novensa, L YI.03 

Novensa, L Thu 225 

Novio, S Thu 325 

Novosad, J Tue 222, Tue 421, Tue 240 

Novosadova, M Tue 240 

Novotny, L Tue 343, Tue 074 

Nowaczyk, M Mon 262 

Ntaios, G Mon 143 

Ntale, M FC01.4.5 

Nürnberg, B Wed 022 

Nugroho, AW Tue 009 

Nukui, K Mon 405 

Nulman, I Thu 009 

Nunes, FPB Wed 333, Wed 334 

Nunes, S Wed 214 

Nuñez, MJ Wed 152 

Nuñez-Iglesias, MJ Thu 325 

Nunn, A J FC10.3.3 

Nurfadhlina, M Thu 181 

Nuriyev, M Tue 245 

Nurullina, DV Thu 096 

Nutt, D J FC17.4.4 

Nuutinen, S FC14.3.6 

Nyegaard, M FC13.3.6 

Nygaard Jørgensen, T Mon 067 

Nygaard, EB FC05.3.5 

Nygaard, R Thu 036 

Oates, J FC05.3.6 

Obando, EP Mon 480 

Obara, K Thu 226 

Obili, N Tue 133 

O'Brien, S Tue 364 

Obua, C FC01.4.5 

Ocampo-López, JO Tue 195 

Ochi, A Mon 335


Ochiai, T Thu 430 

Ochiai, W Mon 177, Mon 182 

Ochodnicky, P FC05.4.5, Mon 219, Thu 097, 

Mon 221 

Odar-Cederlöf, I Tue 308, W35.4 

Odenholt, I W29.2 

Odeon, MM Mon 040 

Odlind, V FC10.1.4 

O'Donnell, P Thu 402 

Odoriz, B Mon 280 

Oduola, MJ YI.09 

Offermanns, S FC11.5.3, Wed 056 

Offiah, NV Thu 326 

Offringa, M W36.1, W36.3 

Ofori-Adjei, D W36.1, W36.5 

Ogawa, R Tue 486 

Ogawa, Y Tue 470 

Oger, S Mon 233, Mon 232 

Ogihara, M Tue 390 

Ogita, K Thu 099, Tue 376, Mon 461, 

Wed 083, Tue 375 

Oguchi, K Wed 128, Wed 372, Tue 443 

Ogundele, SO Tue 100 

Ogunleye, OO Tue 100 

Ogwal-Okeng, J Tue 005, Wed 136 

Oh, D-H Wed 142, Tue 044, Tue 043, 

Wed 143 

Oh, J-Y Thu 385 

O'Halloran, A Tue 364 

O'Hara, G Wed 123 

Ohashi, K Tue 144 

Ohata, H Wed 256 

Ohhara, M Tue 168 

Ohi, K Mon 182 

Ohkubo, S Wed 078 

Ohkubo, T Tue 147 

Ohlstein, E Tue 479 

Ohmoto, Y Thu 103 

Ohnishi, K Tue 484, Tue 491 

Ohta, H Thu 430 

Ohta, R Tue 459 

Ohtake, S Tue 477 

Ohura, K Tue 266 

Ohya, S Wed 107, Thu 102, Thu 107 

Oida, Y Thu 406 

Oikawa, A Thu 414 

Oikonen, V Mon 256 

Oishi, K Tue 470 

Oishi, R Mon 093, Thu 109 

Oiso, S Tue 167 

Ojala, Y FC14.3.6 

Ojoo, A FC10.3.1 

Okada, M Thu 108 

Okamoto, H Tue 153 

Okamoto, S Mon 459 

Okamura, C Wed 305 

Okamura, M Mon 329 

Okamura, N FC17.5.6 

Okamura, T Wed 200 

Okaniwa, T Mon 177 

Okazaki, M Wed 266, Thu 227 

Okechukwu, P Thu 327 

Oki, K Mon 402 

Okubo, K Tue 077 

Okuda, A Wed 373 

Okuda, T Tue 373 

Okulicz-Kozaryn, I Thu 174 

Okuno, T Tue 443 

Okuno, Y Tue 468 

Okuyama, C Tue 241 

Okuyama, H Tue 147 

Okwara, V Mon 017 

Okyar, A Tue 245, Tue 142 

Ola, R Mon 215 

Olazabal, EV Mon 038 

Olde, B Thu 074, Thu 047, Wed 052, 

Wed 062 

Oldenburger, A Tue 242 

Olesen, J PL13, Thu 106, Mon 099 

Olesen, S-P FC06.1.4, Wed 282 

Olinda, T Wed 318, Mon 299, Wed 319 

Oliveira, A C Wed 144 

Oliveira, F Mon 097 

Oliveira, JL FC04.4.6 

Oliveira, L Thu 025 

Oliveira, MFSC YI.08 

Oliveira, PRB Wed 341, Wed 340 

Oliveira, R Mon 298 

Oliveira, SHP Tue 243 

Oliveiros, B Mon 350 

Oliver, DW Mon 442 

Oliver, DW Mon 412 

Oliver, E Tue 165, Thu 048, Tue 163 

Oliver, V Tue 202 

Oliveros, I Tue 362 

Olivier, E Thu 332 

Olivier, NB Wed 156 

Olli, A Tue 433 

Olmez, E Wed 357 

Oloro, J Tue 209 

Olowofela, A Tue 010 

Olsen, JV Wed 036 

Olukman, M Thu 228 

Olurishe, T Tue 011, Wed 145 

O'Mahony, B Thu 177 

Omar, MH Thu 328 

Omara, EA Tue 451 

Ombrato, R Thu 433 

Omic, S Tue 437 

Omidi, Y Mon 044, 

Onaivi, E Thu 176 

Onaran, O Thu 049 

Onat, F Mon 418 

Oneda, B Mon 160 

Ong, KL Mon 271, Mon 159 

Oniki, H Tue 162 

Onlamul, W Thu 361 

Ono, K Tue 430 

Onoe, H Tue 244 

Onoue, S Tue 216 

Ooga, K Thu 103 

Opie, L FC06.3.1 

Oppenheim, C Mon 191 

Or, PMY Thu 389 

Orallo, F FC16.2.5, Wed 359 

Oram, D FC05.3.6 

Oransay, K Tue 449, Tue 366 

Ordyan, N FC17.1.6 

Index 357

358 Index 


Oreagba, I Wed 144 

Orellana, S Tue 326 

Orensanz, LM Mon 411 

Orer, SH W17.4 

Orescanin-Dusic, Z Thu 329, Tue 122, Thu 318 

Oriá, RB Tue 255 

Orlandi, S FC18.4.5 

Orlando, G Mon 105, Wed 434, Wed 329 

Orlando, R Wed 404 

Orozco, FAJ Thu 330 

Orrenius, S FC13.2.3 

Orrico, M Mon 275 

Orrtiz, E Thu 178 

Ørskov, C FC05.3.5 

Orta, IA Mon 125 

Orta, ML Mon 040 

Ortega, JE Thu 031, Thu 399 

O'Shea, R Mon 045 

Ospina, DA Mon 480 

Østergaard, L Wed 240 

Østergaard, S Thu 404 

Östervall, J FC13.4.5 

Östman, J Thu 278 

Ostrow, G Wed 417 

O'Sullivan, S Wed 285, Tue 460 

Oswald, S Tue 049, Tue 041 

Oswald, S Tue 045 

Ota, M Wed 128 

Otake, S Wed 186 

Oteo, I Wed 111 

Otsu, K FC06.4.3 

Otsuguro, K Mon 101 

Otsuka, A Mon 035 

Ottenheijm, HCJ Wed 085 

Otto, M Mon 090 

Otto, S FC13.4.5 

O'Tuathaigh, C FC17.2.1 

Otukesh, H Thu 006 

Ouanes, I Thu 346 

Ouanes, L Wed 348, Mon 004 

Oueslati, N FC11.3.6 

Overvad, K Tue 482 

Ovesjö, M-L Mon 371 

Oyagi, A Thu 406 

Oyama, Y Thu 331 

Oyamada, H Wed 128 

Özatýk, Y Wed 420 

Ozawa, H Thu 403 

Özcan, G Thu 049 

Ozdemir, O Thu 266, Mon 199, Tue 461, 

Thu 269 

Özdemir, V W16.6 

Ozkan, MH Thu 229 

Özkutlu, U W05.2 

Ozokwere, JJC Thu 332 

Oztop, I Tue 411 

Öztürk, N Tue 245 

Ozturk, EI Thu 230 

Ozyogurtcu, H Tue 461 

Pacifici, R Mon 375 

Pacini, A Tue 446, Mon 391 

Packeu, A Thu 426 

Padin, F Tue 116 

Padrosa, A Tue 133 

Pageaux, GP FC04.2.6, Mon 141 

Pai, H-C Mon 326 

Paillard, F Mon 145, Mon 132 

Paintaud, G Tue 198, Tue 190 

Painter, A W06.3 

Pairoj, V Tue 127 

Pajdo, R Tue 463 

Pajeau, P Tue 171 

Pajor, L Wed 284 

Pajouhesh, H FC03.2.1 

Pakarinen, P Mon 215 

Pal, A FC16.2.6 

Pala Kara, Z Tue 245 

Palatini, P Wed 404 

Palea, S Tue 205, Tue 206, Tue 204, 

Mon 244, Tue 203 

Palivoda, M Tue 137 

Pallas, M Mon 443 

Palma, C Wed 152 

Palme, R Wed 397 

Palmero, M Mon 138 Mon 477, Mon 472, 

Mon 481, Thu 407 

Palmero, MM Mon 473 

Palmiere, PCR Tue 101 

Palombo, E Wed 360 

Pamplona, F Thu 396 

Pan, X Tue 299 

Pan, Y FC14.1.2, Thu 103, Tue 426 

Panagiotidis, G Wed 147 

Panagopoulos, P Tue 126 

Panahi, Y Thu 005, Thu 311 

Panayiotou, C Thu 278 

Panchaud, A Mon 022, FC10.5.3 

Panda, VS Wed 304 

Pandolfo, G Thu 419 

Panduriv, M Tue 167 

Pang, CCY Mon 184 

Panhelainen, AE Thu 194 

Pani, L SS01.4 

Panich, U Tue 007 

Pantovic, S Thu 231, Wed 019 

Pantsurkin, VI Tue 179 

Panula, P FC14.3.6 

Papadimitriou, E Thu 232 

Papadopoulos, C Mon 143 

Papadopoulou-Daifoti, Z W33.4 

Papaioannidou, P Tue 246 

Papakosta, M FC03.2.6 

Papantonakis, PB Tue 302 

Papapetropoulos, A Thu 202 

Papapetropoulos, As FC15.3.6 

Papaseit, E Thu 178, Mon 109 

Papathanasopoulos, P Wed 074 

Papouchado, M Mon 280 

Papp, GJ Wed 197 

Papp, J Mon 100 

Papp, JG Wed 284 

Paquet, B Wed 443 

Parada, C Mon 276 

Paraskakis, E Tue 224 

Pardo, L W01.1.3 

Pardo, R Mon 109, Mon 375, Thu 177, 

Thu 178 

Pardo-Andreu, GL Wed 344


Paredes, SD Wed 352, Mon 407 

Parente, L Tue 406 

Pariente, JA Mon 407 

Parini, P Tue 387, Tue 383 

Park, BK FC13.2.2 

Park, HW Tue 046 

Park, I-C Tue 427 

Park, J Tue 047 

Park, K Mon 226, Mon 013, Tue 349, 

Mon 029, Thu 418, Mon 033 

Park, M Mon 427 

Parkel, S Thu 077 

Parks, V Tue 012 

Parlar, A Thu 233 

Parmar, S Wed 148 

Parsaee, H Tue 424 

Parsons, M Mon 086 

Pascale, A Mon 152 

Pascual, MA Thu 394, Thu 395 

Pascual-Brazo, J Wed 401 

Pasko, K Mon 347 

Paskulin, R Thu 329, Thu 318 

Pasqualina, F Thu 400 

Passeri, D FC18.4.5 

Pastor, A Thu 178 

Pastor, M YI.03 

Pastor, MJ FC09.2.7 

Pastorello, M Tue 127, Thu 254 

Pastro, L Wed 231 

Pásztor, M Mon 261 

Patacchini, R W03.4 

Patapoutian, A FC03.1.2 

Pataricza, J Wed 197, Wed 284 

Patel, K FC16.1.6 

Patel, P Wed 149, Thu 113 

Paterniti, I FC18.1.5, FC18.3.6, 

Mon 286 

Patil, AW Wed 381 

Patil, RN Thu 333 

Patiño-Camacho, S Mon 009 

Patonay, T Mon 163 

Patras, X Mon 108 

Patrignani, P FC09.4.2, W18.3, Mon 281, 

Wed 235 

Patrikainen, S Mon 447 

Patrono, C W18.1, W18.4 

Patte-Reutenauer, J W04.3.2 

Patterson, TA Wed 150 

Paukkeri, E-L Tue 247 

Paul, F Thu 013 

Paul, R Thu 224 

Paul-Clark, M Thu 241 

Paule, MG Wed 150 

Paules, RS FC13.4.3 

Paulo, M FC15.4.5 

Paunescu, H Mon 274 

Paunovic, B W02.2.7 

Paunovic, G Tue 149 

Pavelkova, V Tue 137 

Pavlyuchenko, V FC06.1.6 

Pawar, V Thu 333 

Pawlik, M Tue 463 

Pawlik, WW Tue 463 

Pawlowska, I Wed 279, Mon 181 

Paz Lopes, MT Tue 428 

Pazos, A Wed 401, Thu 408 

Pechanova, O Mon 148, Mon 293 

Pedersen, A FC05.4.6 

Pedersen, AF Thu 066 

Pedersen, DS FC11.5.1, Tue 248 

Pedersen, L FC04.1.6 

Pedersen, MFH FC11.5.6 

Pedersen, MØ Tue 359, Tue 248 

Pedersen, ME Thu 234 

Pedersen, RS Wed 151 

Pedersen, S FC05.1.1, Thu 026 

Pedroso, A Wed 140 

Peeters, M FC11.4.6 

Peiro, C W08.1, Tue 134 

Peitl, B Tue 142, Mon 163, Tue 125 

Mon 150, Mon 167, Tue 128 

Peixoto, AVB Tue 281 

Pekiner, C Wed 438, Mon 155 

Pekson, R Thu 334 

Pelkonen, O PL16, Thu 348 

Pellaquini, EH Mon 289 

Pellegrini, M Mon 375 

Peltonen, I Mon 444 

Peltonen, T Tue 166 

Pena Dias, J Thu 073 

Peña, C Tue 114 

Pendek, R YI.04 

Peng, M Mon 331 

Peng, SR Wed 291 

Peng, X Wed 099 

Peng, X-Q Wed 182 

Peng, Y Mon 445, Mon 466 

Penkowa, M Tue 359 Tue 248 

Penninx, BWJH Wed 432, Tue 096 

Peoch, K Wed 191 

Peoc'h, K FC01.4.4 

Pepedil, F Wed 249 

Pepper, M Mon 368 

Perälä, M Mon 410, Tue 436 

Peränen, J Mon 341 

Percie du Sert, N Tue 471 

Perdan-Pirkmajer, K Mon 074, Tue 048 

Perdomo, L Tue 226 

Pereira do Vale, AC YI.08 

Pereira, F Wed 180 

Pereira, FC YI.08, Thu 193 

Pereira, J Wed 214 

Pereira, JCM W31.3 

Pereira, L Wed 394, Tue 123 

Pereira, M Wed 394 

Pereira, P Thu 187 

Pereira, R Tue 241 

Pereira, SA Wed 130 

Perez Vizcaino, F Thu 235 

Pérez, E Tue 087 

Pérez, JA Mon 125 

Perez, M Thu 177, Thu 178 

Pérez, R Wed 152, Wed 217 

Pérez, T Tue 016 

Perez-Aso, M Thu 050, Wed 068 

Perez-Gutthann, S FC04.2.6 

Perez-Maña, C FC14.4.5, Thu 178, Thu 177 

Index 359

360 Index 


Perez-Vizcaino, F Tue 121, Mon 374, Wed 226, 

Thu 217 

Pergolizzi, S Thu 316 

Perhariè, L Wed 153 

Peric, M Thu 324, Wed 103 

Perju-Dumbrava, L Tue 481 

Perkecz, A Tue 271 

Perna, A Thu 014 

Pernas, S Mon 146 

Pernomian, L Thu 236 

Perreau, V Mon 045 

Perretti, M FC09.5.7, FC09.4.6 

Perrin-Sarrado, C Wed 244 

Perroy, J FC11.3.3 

Perry, M FC06.1.1 

Pertz, HH W13.4 

Peshavariya, H Mon 194, FC06.4.5, 

Wed 219, FC15.2.5 

Pesic, S Thu 070 

Pesquero, JB Thu 061, Wed 041 

Petcu, LC Mon 162 

Petermann, O Wed 108 

Peters, D YI.10 

Peters, JA Tue 479, FC03.3.5 

Peters, J Tue 049 

Peters, S Thu 258, Thu 082 

Petersen, CN Mon 154 

Petersen, KB FC07.4.5 

Petersen, L J W26.3 

Petersen, LG Mon 345 

Petersen, M FC13.3.6, Mon 119, 

Mon 118, Mon 406 

Petersen, MS Wed 151 

Peterson, C Tue 395 

Peterson, S Wed 423 

Pethö, G Tue 078 

Pétrault, O Thu 237 

Petrella, C Tue 249, 

Petridis, I Mon 187 

Petroni, RC Wed 204 

Petronijevic, M Tue 367 

Petronijevic, N Wed 343 

Petrovic, B Thu 436, Mon 446 

Petrovic, V Tue 050 

Petrrault, O FC17.2.5 

Petrushun, V Wed 122, Wed 121, Wed 120 

Petsalo, A Mon 063 

Pexa, K Wed 022 

Peyronel, C Tue 289, Tue 290 

Peytavin, G Tue 040 

Pfeifer, A Tue 129 

Pfister, M FC07.3.2 

Pfleger, KDG Wed 079 

Phadungrakwittaya, R Thu 335 

Philippu, A W33.1 

Phillips, M Wed 123 

Phillips, O Tue 340 

Piacente, S Tue 406 

Picchianti, L Wed 442, Mon 382 

Piccione, F Tue 405, Wed 010 

Pichette, V W06.4 

Pichini, S Mon 375 

Pichkhadze, G Thu 336 Tue 079 

Piekorz, R Wed 022 

Pieles, U Tue 134 

Pieratti, A Wed 317 

Pierse, N Tue 136 

Pietro, B Thu 400 

Pietrobon, D FC12.1.4 

Pietsch, J Thu 267, Wed 252 

Pignier, C Tue 170, Tue 171, Tue 172 

Pihlaja, T Mon 063 

Pilar-Cuellar, F Wed 401 

Pilar-Cuillar, F Thu 408 

Pilatova, M Tue 423 

Pilegaard, H Wed 281 

Pillai, K Wed 419 

Pillai, KK Tue 137, 

Piltonen, M Mon 447 

Pimentel, F Tue 086 

Pin, J-P FC11.2.1, FC11.3.5, 

FC11.3.6, Wed 077, Thu 035, 

Thu 083 

Ping, J Tue 130 

Pinheiro, H Tue 123 

Pinheiro, R Mon 298 

Pinho, MJ Mon 057 

Pintér, E W19.3, Mon 318, Tue 271, 

Tue 250 

Pinto, R Tue 207 

Pipelzadeh, MH Tue 251 

Piperski, V Wed 343 

Piqueras, L Thu 437 

Piquette-Miller, M W06.2, Tue 050 

Piras, V Tue 133 

Pirkmajer, S Tue 048 

Pirmohamed, M FC13.3.4 

Pirovano, M Thu 111 

Pirro, E Tue 405, Wed 010 

Pistritto, G Mon 281 

Pitre, S Mon 166 

Pitre, Shweta Tue 131 

Pitterle, K Wed 148 

Pitychoutis, P W33.4 

Piwnica, D Thu 088 

Pizza, C Tue 406 

Pizza, V Tue 487, Mon 448, Tue 488, 

Mon 449 

Pizzolatti, MG Wed 394 

Plante, I Tue 051 

Plath, N FC17.4.2 

Platzer, W FC11.1.6 

Plenge, P FC02.3.5 

Plevin, R Tue 252 

Pliskova, M Tue 222 

Pochetti, G Thu 433 

Pochop, P Tue 445 

Podestá, MHMC Tue 101, Mon 010 

Podracka, L Thu 033 

Pogantsch, M Mon 153 

Pogge, T PL08 

Pohanka, M Tue 343, Mon 075, Tue 074, 

Tue 448 

Pohjanoksa, K Wed 092 

Pohjolainen, V Tue 166 

Poitou, C FC01.4.4 

Pokorná, P Wed 017, Mon 267 

Pol, O Thu 042, Wed 059


Polaskova, A Tue 342 

Pold, R Tue 132 

Polenzani, L Thu 433 

Polewicz, D FC06.3.6 

Polónia, J Thu 119 

Pols, T FC18.2.4 

Ponce, L Tue 394 

Ponciano, E Mon 350 

Pongnarin, P Tue 007, Mon 357, Mon 355, 

Mon 334 

Pons, G FC10.1.1 

Poopyruchpong, N Tue 277 

Pope, HG FC14.5.1 

Popova, O Mon 462 

Popovici, ED Tue 102 

Popovici, MG Tue 102 

Popp, R Mon 417, Mon 438, Tue 481 

Porreca, F FC03.2.1 

Pórszász, R Tue 125 

Porter, E Wed 269, Wed 238 

Porto, LC Wed 342 

Postnikov, PV Wed 175 

Poston, R Thu 197 

Potschka, H FC02.2.3 

Potter, CMF Thu 241, Thu 238 

Poulsen, A Thu 106 

Poulsen, FM Tue 053 

Poulsen, H Mon 118 

Poulsen, HE FC04.2.4, Mon 345, Tue 480, 

Tue 482, Mon 119 

Poulsen, M Tue 080 

Poulsen, P Mon 406 

Pourcel, L Mon 129 

Pourmotabbed, A Mon 437 

Poutanen, M Wed 446 

Pouton, C Thu 280 

Povarnina, P Mon 225 

Povlsen, GK Mon 450, Thu 239 

Powell, C Mon 393, Mon 420 

Poyner, D Wed 057 

Pozgai, G Thu 197 

Pozsgai, G Tue 271 

Pradelli, L Mon 223 

Pradelli, L Wed 154 

Praliev, K Tue 079 

Prasad, AN FC10.2.5 

Prasad, R Mon 028 

Prat, I Tue 394 

Pratt, J FC17.1.4 

Preininger, A FC11.3.2 

Preston, K FC14.3.4 

Preston, R Wed 155 

Prezeau, L FC11.2.1 

Pribula, J Wed 090 

Priestley, J Thu 278 

Prieto, D FC08.2.5, Thu 249, Mon 239, 

Tue 213, Mon 411 

Prieto, E Tue 103 

Prilutsky, A Tue 057 

Prinsen, J Wed 156 

Prinzis, S Tue 133 

Pritchard, D Mon 282 

Procaccini, C Wed 393, Thu 409 

Procházka, V Tue 475 

Proctor-Brown, C Tue 372 

Proksch, B YI.02 

Prosser, R Thu 019 

Prostran-Veselinovic, M Tue 013, Mon 114, Wed 009, 

Tue 026, W34.1, W34.2 

Prudhomme, M Tue 429 

Prunier, C Thu 055 

Prusa, R Tue 137 

Ptacek, LJ FC12.4.4 

Ptak-Belowska, A Tue 463 

Pubill, D Wed 177, Wed 174, Thu 179, 

Wed 181 

Puerta-Vazquez, R Wed 349 

Pugi, A Thu 302, 

Pugnet, G Tue 104 

Puppala, B Wed 184 

Pupure, J Mon 429, Tue 253, Wed 045 

Pursley, J Tue 495 

Putter, S Tue 110 

Puttonen, KA W21.3 

Putula, J Thu 051 

Pyo, H-B Thu 385 

Pyriochou, A FC15.3.6 

Qi, C Mon 032, Thu 410 

Qi, H Thu 368 

Qi, T Wed 057 

Qian, G Mon 031 

Qian, J Thu 089 

Qiang, G Thu 384 

Qiang, GF Mon 433 

Qin, H Thu 372 

Qin, H-L Wed 346 

Qin, Y Thu 295 

Qiu, H FC02.1.5 

Qu, H Tue 173, Tue 325 

Qu, HJ Mon 008 

Quadros, I FC14.4.3 

Que, A Tue 158 

Queckenberg, C Thu 010 

Queiroz, E Wed 375 

Queiroz, MGR Wed 297 

Quick, M FC02.1.2 

Quignard, J-F Wed 293 

Quinn, J Tue 271 

Quinn, JP W19.3 

Quinn, TJ FC15.1.6 

Quiroz, G Thu 187 

Ra, R Thu 051 

Raasmaja, A Mon 341 

Rabello, MM Thu 374 

Racca, S Tue 405 

Racek-Król, B Mon 181 

Radacic-Aumiler, M Tue 328, Mon 135 

Radhakrishnan, AK Tue 254 

Radojicic, R Tue 122 

Radonjic, N Wed 343 

Radovic, J FC16.3.6 

Radovic, V Wed 157 

Radwanska, A Mon 197 

Ragia, G Mon 187 

Rägo, L FC01.4.3 

Rahbar, A Tue 014 

Rahbari, S Wed 301 

Rahimi, A Wed 364 

Index 361

362 Index 


Rahimian, R Wed 254 

Rahimi-Moghaddam, P Tue 105, Tue 485 

Rahmoun, I Mon 290 

Rai, J FC01.2.6 

Raimundo, J Tue 162 

Rain, M Mon 136 

Raine, JM FC04.3.1 

Rainio, E Tue 429 

Raisman, R Mon 469 

Raj, VL YI.04, Tue 254 

Rajabi, O Tue 052 

Rajabnia, M Mon 230 

Rajaian, H Tue 015 

Rajakannan, T FC04.3.7 

Rajbanshi, S Mon 091 

Rakhshandehroo, M Thu 438 

Ralevic, V Wed 023 

Ram, Birendra Mon 028 

Ram, M Mon 028 

Rama, AC Mon 376 

Ramachandran, V Thu 380 

Ramadaniati, H Thu 011 

Ramajo, M Thu 264, Thu 240, Wed 215, 

Mon 206, Tue 144 

Ramanujan, S Tue 196 

Ramaswamy, M Mon 070 

Ramenckaya, G Tue 129 

Ramenskaya, GV Thu 253, 

Ramer, R Thu 337 

Ramirez, E Mon 451 

Ramírez, O Mon 023, W04.1.3 

Ramírez-Rosas, MB W13.3 

Ramsjö, M Tue 489, Tue 308 

Randhawa, MA Thu 338 

Rane, A Thu 256, Tue 318, Tue 138, 

FC14.1.6, Wed 183, Wed 176 

Rangachari, PK W20.3, Tue 368 

Rankin, L Wed 132 

Rantakari, P Mon 215 

Ranta-Panula, V Thu 052, Thu 071 

Rao, A FC12.5.4 

Rao, PGM FC04.3.7 

Rao, V Wed 318, Wed 319 

Raskovic, A Tue 454, 

Rasmussen, M Mon 450 

Rasmussen, MH Mon 227 

Rasmussen, MNP Thu 053 

Rasouli, A Wed 301 

Rassouli, A Tue 191 

Rastinejad, F FC18.4.1 

Rathbone, D Wed 057 

Rathje, MA YI.10, Tue 053 

Rattazzi, L Tue 256, Thu 434 

Rauch, A W33.2 

Raunsø, J FC04.2.4 

Rautio, A Mon 076 

Ravna, AW Mon 224 

Ray, A FC16.4.2 

Rayate, S Thu 333 

Raynaud, F FC11.3.3 

Rayyan, M Wed 001 

Razik, F Wed 149 

Rebola, N YI.10 

Rebollo, A Tue 133 

Rebsamen, M Tue 305 

Rebsamen, MC Tue 166 

Recinella, L Mon 105, Wed 329, Wed 434 

Recio, MC Wed 300 

Recio, P Mon 411 

Rédei, D Thu 307 

Redondo, S W09.3, Mon 206, Tue 144, 

Wed 228, Thu 240, Thu 264 

Reed, DM Thu 241 

Reed, G Wed 158 

Rees, K FC03.3.6 

Reeta, KH Mon 452, 

Reeves, J Mon 443 

Refsum, H Tue 490, Wed 412 

Regla, I Tue 420 

Reglodi, D Mon 110, Mon 106, Mon 318 

Reguillo, F Thu 240, Wed 215, Mon 206 

Reichel, C Tue 227 

Reiner, Z Mon 048 

Reis, DG Wed 411 

Reiter, RJ Mon 407 

Rekik, M Tue 205, Tue 206, Tue 204 

Rembold, CM W04.3.4 

Remirez-Figueredo, D Wed 159, Thu 339 

Ren, Junguo Thu 340 

Ren, S Thu 390 

Ren, X W02.1.6 

Resende, AC Wed 341, Wed 340, Wed 342 

Resstel, L Wed 411 

Reul, J FC17.5.2 

Reuther, L Wed 160, Wed 161 

Reyes-Vega, JJ Thu 246 

Reynolds, RF FC04.2.1 

Rezania, F Thu 180 

Rezapourian, P Thu 209 

Rezayat, M Wed 437 

Rezazadeh, H Mon 294 

Rheeders, M Thu 016, Thu 012 

Riba, P Thu 192 

Ribeiro, CF YI.08, Thu 193 

Ribeiro, RA Tue 255 

Ribel-Madsen, R Mon 406 

Ribuot, C Thu 245 

Ricciotti, E Mon 281 

Richards, B Wed 110 

Richards, J FC14.3.5 

Richards, S Tue 353 

Richelsen, B FC05.1.1 

Rickhag, M FC02.3.6 

Rieder, M Wed 013 

Rieder, MJ FC10.2.5 

Riegel, C Mon 463 

Riggi, C Wed 010 

Righetti, L Thu 440 

Rigoni, VLC Thu 351, Thu 352 

Rimando, A Mon 443 

Rimondini, R FC14.1.5 

Rinken, A Tue 192, Thu 077 

Rinne, P Thu 243 

Ríos, JL Wed 300 

Risso, A Tue 362 

Ristic, S Wed 343 

Ristimäki, A FC09.4.3 

Riva, MA SS01.3


Rivera, L Wed 225, Wed 224 

Rizzo, G FC18.4.5 

Robays, H Mon 365, Tue 306 

Roberts, RR Tue 322, Mon 064 

Robertson, G W06.3 

Robillard, K FC02.4.5, Mon 070 

Robinson, E Wed 392, Thu 439 

Robinson, K Thu 393 

Robson, R Mon 259 

Rocha, L Mon 095, Mon 097, Mon 094 

Rocha, M Mon 383 

Rocha-Pereira, C Thu 054 

Roche, M Thu 021 

Roda, JM Mon 079 

Rodchenkov, GM Wed 175 

Rodeiro-Guerra, I Wed 344 

Rodell, A Tue 193 

Roden, DM W23.3 

Roden, M FC05.4.1 

Rodrigo, M Tue 196 

Rodrigo, T Wed 174 

Rodrigues, E Thu 025 

Rodrigues, ES Thu 061 

Rodriguez, AB Mon 407, Wed 352 

Rodriguez, B FC07.2.3 

Rodríguez, C W09.4 

Rodriguez, E Thu 240, Thu 399 

Rodríguez, G Thu 358 

Rodríguez, JC Mon 023, W04.1.3 

Rodriguez, L Thu 358 

Rodriguez, M Mon 229, Mon 080 

Rodríguez, R Mon 023, W04.1.3 

Rodríguez-Franco, MI Mon 079 

Rodriguez- 

Gaztelumendi, A Thu 408 

Rodriguez-Mañas, L Tue 134 

Rodriguez-Salazar, M Tue 150 

Rodríguez-Soriano, NY Tue 150 

Rogava, MA Mon 192, Mon 216 

Rogava, M Tue 174 

Rogers, M Tue 284 

Roglans, N Tue 133 

Rognan, D Wed 216 

Roh, H-K Tue 489 

Roivainen, A Mon 256 

Rojas, J Tue 362 

Rolan, P Wed 113 

Rollason Gumprecht, V Tue 305 

Rollema, H FC14.2.3 

Romacho, T Tue 134 

Roman, A Mon 374 

Roman-Campos, D FC03.1.5 

Romano, Adele Thu 440 

Romao, C Thu 202 

Romashenko, O Tue 175 

Rombouts, SARB Mon 400 

Romero, E Thu 271 

Romero-Gomez, M Tue 123 

Romijn, JA Tue 148 

Rommelfanger, K W01.2.4 

Rompré, P-P FC17.4.6 

Romualdi, P FC14.1.5 

Rónai, A Thu 094 

Rondard, P FC11.2.1 

Rondinelli, S Wed 081 

Rong, Z-X Thu 368 

Rønn, JH Tue 161 

Roohbakhsh, A Thu 412 

Rosa, AC Thu 434 

Rosa, AC Tue 256 

Rosa, S Tue 257 

Roschin, V Wed 347 

Roscioni, SS Tue 242, Wed 095 

Roseboom, P Thu 410 

Rose'Meyer, R Tue 135 

Rosén, I Thu 008 

Rosenbaum, D S FC06.1.3 

Rosenblad, M Wed 092 

Rosenborg, S FC13.4.5 

Rosenkilde, MM FC11.2.4, FC11.5.5 

Röshammar, D Wed 136 

Roskos, L Mon 228 

Ross, G FC12.1.5 

Ross, R Tue 284 

Rossi, M Thu 062 

Rossier, BC FC12.3.4 

Rossier, MF Tue 166 

Rossini, M Tue 362 

Rosskopf, D Wed 119 

Rossoni, L Wed 231, Wed 042 

Rostami-Hodjegan, A FC07.2.1, FC10.3.5 

Rothman, KJ FC04.1.3 

Rouet, P Wed 196 

Rouget, C Tue 205, Tue 206, Tue 204 

Roughead, E FC13.1.6 

Rouholamin, M Thu 391, Thu 392 

Rouillard, C FC17.4.6, Wed 443 

Rouleau, A Wed 051 

Roulet, E Wed 108, Wed 102 

Rousseau, A Wed 011 

Roustit, M Wed 208, Thu 244, Thu 245 

Roux, T Thu 035 

Roviezzo, F Thu 081 

Rovira, EE Thu 048 

Rowan, M Mon 453 

Rowland, I Wed 307 

Rowlands, DK Tue 139, Thu 341 

Royer, C FC18.3.5 

Röyttä, M W21.4 

Rozas, I Thu 399 

Rozehnal, V Tue 039 

Ruan, J Mon 077, Mon 078 

Ruangnapa, T Mon 355 

Ruangrut, P Wed 124 

Rubets, I Tue 228, Wed 122 

Rubie, P Tue 309 

Rubino, A Tue 093 

Rubio, V Mon 254 

Rucman, R W02.3.1 

Rudberg, I Tue 490 

Rudd, JA Tue 471 

Rueda, E Wed 250, Mon 278 

Rueda, J Tue 165, Tue 163 

Rüegg, UT W04.3.2, Wed 102, Wed 108, 

Thu 013 

Ruengprasertkit, C Thu 357 

Rui, Y-C Thu 210 

Ruiz- Moreno, MI Thu 246 

Index 363

364 Index 


Ruiz, I Mon 390 

Ruiz, JD Wed 109 

Ruiz-Cabello, F Tue 123 

Rumaks, J Mon 429, Tue 253, Wed 045 

Rungby, J FC04.2.7, FC05.4.6, 

Tue 359, Tue 248 

Ruohonen, ST W21.4, Thu 243 

Ruohonen, S W21.4 

Ruponen, M W21.3 

Ruschitzka, FT FC16.1.2 

Rusiecka, I Mon 181 

Ruskoaho, H Tue 166 

Rusli, I Thu 181 

Russell, D Tue 145 

Russell, FA Mon 287 

Russell, R FC03.2.6 

Russo, R FC18.1.6 

Ruuskanen, JO Wed 088 

Ruzic Zecevic, D Mon 039 

Ryan, B Mon 453 

Ryan, M Mon 314 

Ryan, R Mon 052 

Rysä, J W21.2, Tue 166 

Saade, A Thu 055 

Saarelainen, T Tue 339 

Saarma, M Mon 341 

Saastamoinen, LK Tue 363 

Sabaté, M Tue 087 

Sabbatini, P FC11.5.6 

Sabetkasaei, M Wed 396 

Sabo, AJ W34.4, Wed 321, Wed 435 

Saboori, Mon 454 

Sabra, AN Mon 372 

Sabra, R Thu 247 

Saccani, F Tue 258 

Sadakata, Y Wed 115 

Sadananda, P Mon 235 

Saddichha, S FC01.4.6 

Sadee, W FC14.2.5 

Sadeghnia, HR Wed 364, Thu 342 

Sadeghpour, B FC18.4.5 

Sadikun, A FC16.3.4 

Sædder, E Thu 413 

Saegusa, H FC03.4.5 

Saeki, M Wed 186 

Saeki, Y Wed 414 

Saenz-Rodríguez, MT Tue 409 

Saenz-Rodriguez, R Wed 349 

Saferis, V Tue 329 

Safonts, L Tue 016 

Sagdieva, GZ Thu 096 

Sagot, P Tue 289, Tue 290 

Sahebgharani, M Mon 454 

Sahiner, M Mon 418 

Sahin-Erdemli, I Mon 366 

Sahnoun, R Mon 021 

Saiful Yazan, L Tue 452 

Saiko, P Thu 308 

Sailler, L Tue 104 

Saim, AH Mon 107 

Sain-Guven, G Wed 249 

Sainio, K Mon 215 

Saint Raymond, A W36.1, W36.4 

Sáinz, M Mon 130 

Saito, A Wed 414 

Saito, K Tue 201, Tue 311 

Saito, M Thu 248 

Saito, R Thu 108, Wed 223 

Saito, Y Thu 319, Tue 320, Tue 459 

Saito, Yusuke Thu 343 

Sajedianfard, J Mon 085, Mon 088 

Sakai, H Tue 234, Tue 259, Mon 304, 

Tue 287, Mon 303 

Sakai, Y Thu 224 

Sakai-Oshita, M Mon 304 

Sakallý, E Mon 418 

Sakamoto, K Tue 318, Tue 138, Wed 264 

Sakanashi, M Thu 344, Thu 344 

Sakata, D Tue 260, Tue 294 

Sakata, R Tue 167 

Sakata, S Tue 162 

Sakoda, N Mon 386 

Sakurada, T Wed 247 

Sakurai, E Tue 163, FC03.4.5 

Sakurai, E Thu 414 

Sakurai, T Mon 386 

Sakurai, Y Tue 163 

Salahuddin, M Thu 345 

Salari, A-A Wed 012 

Salari, R Tue 052 

Salas, CE Wed 302, Tue 428 

Salatino, A Mon 040 

Salazar, M Mon 123 

Salazar, N Tue 164 

Salcedo, MS Wed 352 

Saldaña, HKR Thu 115 

Saldiva, P Wed 231 

Saleh Moqadam, M Tue 165 

Salehi, A Thu 074 

Salehi, M Tue 165 

Salem, Z FC01.3.4 

Salenius, J-P Thu 223 

Salgueiro, L Tue 257 

Saliba, F W02.2.6 

Sallés, J Wed 046 

Sallinen, J W01.3.3 

Sallustio, B Tue 495 

Salmasi, H Mon 099 

Salmonsen, R Mon 264 

Salonen, J Thu 170, Tue 032 

Saloniemi, T Wed 446 

Salouage, I FC07.3.6, Mon 020, Thu 346, 

Wed 348, Mon 021, Mon 004 

Salter, M FC03.3.2 

Salvesen Blix, H Mon 234 

Salvicchi, A Mon 113 

Samai, M Mon 157 

Samarzija, I Thu 441 

Sambo, X Thu 315 

Samer, C Mon 337, Tue 166 

Sammons, HM Thu 007 

Samojlik, I Tue 167 

Sampaio, C SS01.2 

Sampaio, NG Wed 079 

Sampaio, SC Mon 273, Wed 332, 

Wed 333, Wed 334 

Sampayo, C Tue 207 

Samper, S W16.6


Samudre, S Thu 110 

SanAntonio, E Mon 254 

Sánchez Calero, J Thu 347 

Sánchez, A Thu 249, Mon 239 

Sánchez, G W04.1.3 

Sánchez-Ferrer, CF W08.3, Tue 134 

Sánchez-López, A W13.3, Thu 022, Thu 203 

Sanchez-Luque, JJ Mon 149 

Sandberg, K YI.03 

Sandberg, M FC06.2.5 

Sandén, C Thu 047 

Sander, T Wed 066 

Sandholm, J Tue 429 

Sandhu, H Thu 056 

Sandor, K Tue 271, Tue 250, Mon 283 

Sándor, K W19.3, Mon 106, Mon 110 

Sandor, Z W02.2.7, Tue 466 

Sándor, Z Mon 401 

Sandow, S Mon 235 

Sanguinetti, MC FC12.3.1, FC06.1.1 

Sanjani, MS Thu 057 

Sanjaya, KC Thu 181 

Sanni, SJ Thu 058 

Sano, S Tue 375 

Sansilvestri-Morel, P Thu 273, Thu 274 

Santana da Silva, J W31.3 

Santana-Farré, R Tue 387, Tue 391, Tue 392 

Santiago, E Tue 420 

Santibañez, M Mon 390 

Santio, N Tue 429 

Santoro, V Thu 419 

Santos Gomes, M Thu 236 

Santos Sierra, S Thu 014 

Santos-Silva, AJ Wed 211 

Sanvarinda, Y Thu 305 Tue 277 

Sanz, E FC10.1.2, Mon 254 

Sanz, F FC04.4.6 

Sanz, MJ W08.5, Thu 437 

Saragoni, S Mon 120 

Saraste, A Thu 243 

Sarc, L Wed 178 

Sári, R Tue 142, Tue 128, Tue 125 

Sarinic, VM Tue 121 

Sarkar, A Tue 196 

Sarkar, J Wed 294 

Sarkisyan, K Tue 176 

Sarparanta, M Thu 170 

Sartipy, P FC13.2.5, Tue 126 

Sarwar, M Mon 395 

Sarwar, U Wed 036 

Sasaguri, T Tue 162 

Sasaki, K Tue 154 

Sasaki, Y Mon 313 

Sasano, M Mon 402, Mon 112 

Sasay, J Tue 145 

Sasso, O FC18.1.6 

Satara, SS Tue 237 

Sathirakul, K Mon 357, Mon 355, Tue 341, 

Mon 334 

Sato, A Thu 320 

Sato, M Mon 395 

Sato, M Thu 059 

Sato, S Tue 265 

Sato, Y Tue 435, Thu 250, Tue 132 

Satoh, H W02.2.3, Tue 262, Tue 380 

Satoh, M Thu 250 

Satta, J Tue 166 

Satterfield, S Wed 126 

Saunders, D Tue 090 

Savarirayan, R W03.7 

Savchenko, A Tue 129 

Savci, V Mon 156 

Savenko, I Tue 472 

Savic Vujovic, K Mon 114 

Savineau, J-P Wed 293 

Savolainen, K W21.3, Mon 425 

Savontaus, E Thu 243, W21.4 

Savopoulos, C Mon 143 

Sawa, A Thu 402 

Sawada, H Mon 424, Mon 464 

Sawai, T Thu 248 

Sawicka, J FC06.3.6 

Sawicki, G FC06.3.6 

Sayama, Y Tue 136 

Sayyah, M Mon 455 

Scaccianoce, S Thu 440 

Scaglione, F W07.5, Thu 111 

Scammells, P Thu 080 

Scaramello, CBV Wed 232 

Scaramello, C Tue 162 

Scavone, C Mon 292 

Scekic, J Tue 081 

Schäfer, H-G FC07.3.1 

Schäfer, R YI.02 

Schaffer, C FC14.2.3 

Schätzle, R Tue 214 

Schautzer, A Mon 153 

Scheepers, R Wed 226 

Scheffer, I FC12.1.1 

Schegg, K FC12.4.5 

Scheinin, M W01.3.4, Wed 088, Thu 052, 

Wed 092, Thu 071, Thu 084, 

Schelstraete, P Mon 365, Tue 306 

Schetler, GFX FC11.1.1 

Scheuer, T FC12.2.4 

Schiavo, G Tue 488, Mon 449 

Schiesser, C Mon 214 

Schiffers, P Thu 251 

Schiffers, PMA Wed 287 

Schiffrin, E PL20, W04.2.1 

Schiltz, RL FC18.4.2 

Schinabek, R Tue 099 

Schini-Kerth, VB FC16.1.1, W04.2.3, W30.4, 

Wed 306, Wed 273, Wed 385 

Schjøtt, J Mon 234 

Schlossmann, J Wed 234 

Schlueter, T FC18.2.6 

Schmall, A Mon 059 

Schmidt, H FC15.4.4 

Schmidt, M Tue 242, Wed 095 

Schmidt, SF Wed 447 

Schmidt, WE FC05.3.1 

Schmiedl, S Tue 314, Tue 131 

Schmitz, O Mon 154 

Schneeweiss, S FC04.1.4 

Schneider, J FC11.4.2, W01.2.1 

Schneider, M Wed 070, FC06.2.5 

Schnuerch, M Mon 217 

Index 365

366 Index 


Schoeberl, B FC07.1.4 

Schoedel, K Wed 193 

Scholten, D Thu 060 

Schömig, E Mon 315 

Schöneberg, T Thu 087 

Schönfeld, D Tue 211 

Schramm, TK FC04.2.4 

Schratz, M Mon 479, Thu 354 

Schreiber, G Wed 410 

Schrey, D FC10.4.5 

Schrier, L Thu 214, FC10.4.6 

Schröder, R FC11.1.6 

Schroth, W Wed 133 

Schubert, B Mon 479 

Schuelein, R Thu 095 

Schuemie, M FC04.1.6 

Schul, W W31.2 

Schulpis, K Tue 381 

Schultz-Larsen, P Wed 160 

Schulz, A FC18.2.6 

Schulz, G Tue 099 

Schulz, R W22 

Schulz, S Tue 219 

Schuur, LJ Wed 095 

Schwab, M YI.02, FC02.1.5, Wed 133 

Schwab, M PL07 

Schwappach, D Tue 108 

Schwartz, A Wed 126 

Schwartz, T Thu 037 

Schwartz, TW FC11.1.2, Thu 036 

Schwarz, U Tue 301, FC02.1.6 

Schwarz, Ute Tue 054 

Sciulli, MG Mon 281 

Scotti, L Tue 093 

Scuderi, C Tue 465, FC18.4.6 

Se, Y Tue 090 

Sederino, R Tue 454 

Sediki, M Tue 289, Tue 290 

Sedivý, J Mon 267 

See, HB Wed 079 

Seeanner, M Wed 280, Wed 210, Thu 252 

Seeger-Armbruster, S Mon 463 

Seeman, P Wed 443 

Seeringer, A W16.5, Mon 315, Wed 148, 

Thu 112 

Segarceanu, A Mon 111 

Segarra, G Thu 225 

Segi-Nishida, E Tue 260 

Segura, V Thu 050 

Seidenbusch, W Mon 479, Thu 211, Thu 354, 

Mon 245 

Seif el-Din, S Mon 372 

Seiwerth, S W02.3.1 

Seki, A Tue 380 

Sekiguchi, F FC03.2.5, Mon 243, 

Mon 250, Tue 263 

Sekijima, M FC13.2.5 

Sekine, M Tue 379, Tue 177 

Selbach, O W33.3 

Selemidis, S Mon 305, FC15.1.4 

Selent, J YI.03 

Selimovic, A Wed 171 

Selke-Krulichova, I Wed 017 

Sellers, E Wed 193 

Selley, DE Wed 029 

Seltzman, H Thu 021 

Selvam, C FC11.3.6 

Sen, D Tue 120 

Senbel, A Tue 208, Tue 264 

Sendo, T Wed 413 

Sengupta, A Wed 149, Thu 113 

Seniuk, J Mon 095, Mon 097, Mon 094 

Senn, N Thu 211, Thu 354 

Senn, T Tue 099 

Seo, D FC14.3.3 

Seo, S-K Tue 427 

Seong, YH Wed 276, Wed 416, Wed 427 

Sepehr- Ara, L Thu 100 

Sepehri, H Mon 455 

Sepehrizadeh, Z Mon 454 

Serebrova, S Thu 114, Wed 314 

Seredenin, SB Mon 431, Thu 415, Wed 248, 

Mon 225, Wed 188, Tue 276 

Tue 150, Tue 165, Wed 187 

Serfontein, J Mon 026 

Sergeeva, O W33.3 

Sergeeva, SA Mon 198, Mon 284, Thu 015 

Sergienko, A Tue 472 

Serra, CSM Wed 144 

Serrano Lopez, DR Thu 115 

Serrão, MP Thu 398, Wed 114 

Sertiæ, J Mon 048 

Sertic, D Tue 304 

Sertic, J Tue 304 

Sestan, B Tue 095 

Sesti-Costa, R W31.3 

Seta, F Wed 235 

Seto, SW Wed 236 

Sevior, D Thu 348 

Sexton, P Thu 080 

Sexton, PM Wed 089, Wed 082, Wed 043 

Thu 041 

Seya, K Tue 430 

Seyedian, R Tue 017, 

Sezer, Zafer Tue 018 

Sfaxi, L Mon 338 

Shaban, G FC06.2.6 

Shabbi, H Thu 002 

Shafiee, A Thu 309 Tue 469 

Shah, A Thu 197 

Shah, T FC16.1.6 

Shaham, Y FC14.3.2, FC14.3.4 

Shaikh, NA Thu 338 

Shakib, S Tue 327 

Shalamai, A FC06.1.6 

Sham, PC Mon 271, Mon 159 

Shamsabadi, RH Thu 006 

Shamseddin, A FC01.3.4 

Shang, F FC08.1.6 

Shao, Z Thu 388 

Shapovalov, G Wed 102 

Sharifi, M Wed 376, Tue 469 

Sharma, K Tue 453, Tue 019, Tue 019 

Sharma, KK Tue 020, Wed 116 

Sharma, L Mon 131, Wed 116 

Sharma, LK Tue 453, Tue 020, Tue 019 

Sharma, M Tue 137 

Sharma, P FC09.5.5


Sharma, S FC09.5.5, FC05.2.5 

Sharman, JL Tue 479 

Sharp, T PL03 

Sharyari, S Wed 027 

Shaw, F-Z Mon 456 

Sheikh, S FC06.2.5 

Sheikh, SP Wed 070, Wed 036 

Shelihova, L Tue 106 

Shelton, J Wed 093 

Shen, F-M Mon 322 

Shen, WW Wed 430 

Shen, Y Tue 138, Mon 457, Thu 445, 

Thu 089 

Shen, Y Tue 138, Mon 457, Mon 458 

Shen, Z Tue 139 

Sheng, L Wed 336 

Sheppard, J Thu 110 

Sheu, J-R Mon 423 

Shevtsov, V Mon 134 

Sheykhzade, M Thu 066, Mon 099 

Shi, J-S FC14.4.6, Tue 182, Thu 184, 

Tue 382, Tue 178, Thu 185, 

Thu 186 

Shi, J-Z Thu 116, Tue 458 

Shi, L FC02.1.2 Thu 384, FC02.3.5, 

Mon 073 

Shi, M Tue 228, Wed 122, Wed 121, 

Wed 120 

Shiba, T Tue 376 

Shibasaki, H Tue 159 

Shibasaki-Hirano, H Mon 459 

Shibata, K Wed 256, Thu 117 

Shibata, M Tue 156 

Shibata, S Mon 173, Tue 122, Thu 416 

Shibayama, H Tue 077 

Shibuya, A Tue 265 

Shibuya, K Tue 166 

Shibuya, M Thu 286 

Shih, Y-T Thu 301 

Shiiya, T Wed 060 

Shiiya, T Tue 140 

Shikh, E Thu 349 

Shimada, S Wed 305 

Shimamoto, N Tue 379, Tue 177 

Shimane, T Thu 416 

Shimazawa, M Thu 220, Thu 406 

Shimizu, M Tue 474 

Shimizu, Y Mon 178 

Shimoda, M Mon 173 

Shimokawa, H FC16.1.4 

Shimuta, S Thu 025 

Shimuta, SI Wed 041, Thu 061 

Shin, Heung Thu 350 

Shin, J-G Tue 352, Tue 351 

Shin, MC Wed 371 

Shin, S Mon 029 

Shinohara, M Tue 266 

Shinozuka, K Thu 320, Tue 143, Tue 067 

Shintani, N Wed 075, Mon 110, Mon 318 

Shioda, N Thu 406 

Shipaeva, E Tue 276, 

Shipovskaya, N Tue 106 

Shippenberg, T FC03.3.1 

Shiraishi, F Tue 162 

Shirakawa, H Tue 055 

Shirinbeik Mohajer, O Mon 196 

Shohin, IE Thu 253 

Shohreh, R Mon 105, Wed 434, Wed 329 

Shoji, M Wed 061, Mon 179 

Shokrgozar, MA Wed 437 

Shono, M Tue 068 

Short, J Tue 215 

Shrivastava, AK Wed 315 

Shujaa, N W19.1, Thu 062, Thu 094 

Shukitt-Hale, B Mon 443 

Shukuri, M Tue 244 

Shumkova, O Thu 349 

Shweta, Wed 444 

Sia, I Thu 334 

Sibley, D Thu 063 

Siddika, MM Mon 001 

Siddiqi, HS Wed 355 

Siddique, MW Tue 137 

Siddiqui, S Tue 119 

Siderius, M Wed 086 

Siderius, N Thu 085 

Sidhu, P Tue 191 

Siegmund, W Tue 045, Tue 049, Tue 039, 

Wed 119, Tue 041 

Siegrist, J Wed 170 

Sierra, PP Mon 038 

Siest, J-P Mon 369 

Siew Hua, G Mon 147, Mon 333 

Sigrist-Flores, SC Tue 150 

Sikiric, P W02.3.1 

Silber, H FC07.2.2 

Siller, M Thu 118 

Silva, AP Wed 180, Thu 193 

Silva, BA Thu 351, Thu 352 

Silva, D Thu 119 

Silva, E Mon 350 

Silva, F Tue 123 

Silva, I FC08.2.6, Thu 064, Tue 207 

Silva, J Wed 212, Wed 265, Wed 140 

Silva, JA Mon 295 

Silva, JJN W31.3 

Silva, JLV Thu 351, Thu 352 

Silva, J Thu 254 

Silva, L Mon 398 

Silva, MAS Wed 342 

Silva, MS Thu 352 

Silva, TMS Thu 351 

Silva, WL Wed 144 

Silva-Lima, B Tue 207 

Silva-Ramos, M FC08.2.6 

Sim, HL Thu 181 

Sim, SC Wed 151 

Sim, TF Tue 063 

Simaan, J Mon 396 

Simard, G Tue 118 

Simatupang, A Tue 009, Tue 021 

Simic, D Tue 108 

Simmonds, M FC16.5.2 

Simms, J FC14.3.5, Wed 057, 

Wed 082, FC14.2.3 

Sa, Z Thu 400 

Seau, G Tue 188, Tue 189 

Set, S Thu 273, Thu 274 

Index 367

368 Index 


Ssen, C Thu 101 

Ssen, U Wed 229, Wed 230, Wed 

282, Wed 281, Thu 222, 

Wed 221, Wed 240, Wed 

284, Wed 225, Mon 403, 

Wed 241, Tue 161, Thu 259 

Ssick, A Wed 126 

Syi, M FC16.2.6 

Simpson, C Wed 137 

Simpson, J Mon 238, Tue 364 

Simpson, P Thu 030 

Sindrup, S FC13.5.5 

Sindrup, SH Mon 090 

Singer, D Mon 353, Mon 352 

Singer, W FC17.2.2 

Singewald, N W33.5 

Singh, G FC01.3.6 

Singh, KK Mon 028 

Singh, MF Wed 125 

Singh, N Wed 294 

Singh, PDA Wed 335 

Singh, S FC01.2.6, Mon 169 

Singh, TG FC09.5.5 

Singh, V Mon 028 

Sinha, BN Tue 194 

Sinha, RR FC14.3.3 

Sinha, S Wed 294 

Sinha, SK Thu 120 

Sinnayah, P Wed 257 

Siow, R Thu 197 

Sipetic, T W34.3 

Sirirugsa, P Wed 374 

Sissoeff, L Mon 469 

Sit, A SM Thu 255 

Siuni, L Tue 133 

Sizova, Z FC13.4.6 

Sjögren, B Thu 065 

Sjöqvist, F FC01.1.2 

Skaddan, M Tue 372 

Skandali, N Thu 431 

Skapare, Elina Tue 141 

Skeberdis, VA Thu 023 

Skene, K Tue 232 

Skiba, M Thu 242 

Skogastierna, C Wed 183, Wed 176, Thu 256 

Skomedal, T Tue 143 

Skorobogatova, TA Tue 179 

Skotnikov, A Tue 267 

Skougaard, K Tue 395 

Skov Paulsen, M Wed 160 

Skovsted, GF Thu 066 

Skrbic, R Tue 237 

Skvrce, NM Tue 121 

Sladic, H Wed 004 

Sladkova, M Mon 148 

Slavic, M Thu 329, Thu 318, Tue 122 

Slifstein, M FC17.1.3 

Slikker, W Wed 150 

Slinger, E Wed 086 

Slizova, D Tue 125 

Smajilovic, S FC11.5.1 

Smetana, J Tue 056 

Smetanova, L Tue 056 

Smid, S FC16.3.7 

Smidt, K FC05.4.6 

Smit, M Wed 086, Thu 085, Thu 060 

Smith, A Thu 019, Thu 020 

Smith, J FC05.3.6 

Smith, JAM Thu 069 

Smith, MA Mon 443 

Smits, JFM Mon 212, Wed 085 

Snape, W FC14.2.5 

Snead, A Thu 067 

Snopkova, M Mon 219 

Snutch, TP FC03.2.1 

Snyder, R Thu 021 

Snyman, J FC14.5.5 

So, SC Thu 341 

Soares de Lima, T Thu 353 

Soares-da-Silva, P Thu 169, Mon 383 

Sobey, CG Mon 305 

Sobey, C FC15.1.4 

Sobiesiak, AJ Tue 180 

Soboloff, J FC12.2.5 

Sobor, M Thu 192 

Sobotka, L Tue 222, Tue 421 

Soengas, I Mon 080 

Soeter, RP Mon 400 

Søgaard, B Thu 427 

Sokol, G Tue 107 

Sokova, E Tue 057 

Solati, J Wed 012 

Soler, D Thu 002 

Solís-Herruzo, JL Tue 123 

Solito, E FC15.1.5 

Solntseva, E Thu 417 

Soltani, N Tue 058 

Sommet, A Tue 104 

Somogyi, A Wed 113 

Somogyi, A W16.4 

Son, H Tue 349, Mon 033, Thu 418 

Son, HK Mon 013 

Søndergaard, J Wed 160 

Sonderskov, K Thu 101 

Sone, S Wed 278 

Soner, BC Tue 200 

Song, H Tue 419 

Song, J Mon 434 

Song, J-G Wed 367 

Song, J-S Mon 158 

Song, R FC14.5.4 

Sonmez, A Wed 357 

Sonnenberg, J Tue 210 

Sonnenberg, S Tue 115 

Sordi, R Wed 097 

Sørensen, G FC02.3.6 

Sørensen, JB Tue 480 

Sørensen, L Tue 065 

Sørensen, U FC06.3.5 

Soriano, FG Wed 202, Wed 204, 

Wed 203, Mon 257 

Soriano, G Tue 123 

Soriano-Ursúa, MA. Tue 195 

Sortino, MA Wed 400 

Sotomayor-Zarate, R Wed 169, Thu 187 

Soto-Núñez, M Tue 431 

Soubret, A Tue 196 

Souccar, C Thu 355


Soukasem, S Thu 361 

Souki, H Tue 457 

Soukup, O Tue 448 

Soultanov, V Wed 347 

Sousa, J Mon 383, Tue 407 

Sousa, PCP Thu 374 

Sousa, PJC Wed 341, Wed 340, Wed 342 

Soussi, F Wed 244 

Souto, F Mon 275 

Souza, CM Wed 302 

Souza, CR Wed 144 

Souza, D W31.4 

Souza, G FC03.1.5 

Souza, HP Wed 202 

Souza, L Thu 068 

Souza, MHLP Tue 255 

Souza, WA Tue 101, Mon 010 

Sowunmi, A YI.09 

Soydan, G Wed 253 

Soydan, Ö Tue 018 

Soylar, M Wed 357 

Spanagel, R FC14.2.1 

Spasic, M Thu 329, Tue 122, Thu 318, 

Wed 387 

Spasojevic, I Wed 387 

Spedding, M Tue 479, Wed 072 

Speers, J Thu 410 

Speerschneider, T Thu 058 

Spence, JD Thu 257 

Sperlagh, B Mon 460 

Sperlágh, B W19.2 

Spiers, JP Thu 442 

Spijkers, L Thu 258 

Spila, B Tue 022 

Spiliopoulos, A Mon 143 

Spiller, F Mon 275 

Spina, D Mon 287 

Spina, E Thu 419 

Sri Ranganathan, S FC10.2.3 

Srichunrasamia, C Tue 127 

Sritarab, P Tue 127 

Sriwichai, S Tue 090 

Staab, A FC07.3.1 

Staahl, C W12.5 

Staehler, G Mon 245 

Staels, B FC18.2.2 

Stamer, D Thu 088 

Stamou, D Thu 026 

Stancic, E Mon 395 

Stang, P FC04.2.2 

Stanimirovic, B W34.3 

Stanimirovic, V W34.3, W34.5 

Stanimirovic, VV Wed 435 

Stanke, F Tue 268 

Stankevicius, E Thu 222, Mon 403, Wed 241, 

Thu 259 

Stanojevic, Z Wed 436 

Stanovnik, L Wed 153 

Stappen, RK Tue 099 

Starodubtzev, A Thu 114 

Stasch, J-P FC15.4.1 

Stavreva, D FC18.4.2 

Steardo, L Tue 465, FC18.4.6 

Steensland, P FC14.2.3 

Selli, F Wed 442, Mon 382 

Sescu, C Tue 134 

Steffenhagen, V Tue 210 

Stein, D Thu 428 

Steinfeld, T Thu 069 

Stender, S FC13.3.6 

Steneker, I W10.1 

Stephens, C Tue 123, Wed 109 

Stephens, TD FC04.4.1 

Sterin-Prync, A Mon 280 

Stern, A Tue 226 

Stetinova, V Tue 056 

Stevens, L Tue 269 

Stevic, S Wed 436 

Stewart, D Tue 109 

Stewart, AG Thu 393 

Stichele, RV Mon 129 

Stief, CG FC08.3.5, Mon 247 

Stiglmayr, J Tue 214, Thu 354 

Stilinovic, N Mon 115 

Stilinovic, N Tue 454 

Stiller, C-O W05.4 

Stoddart, ES Mon 394 

Stodulka, P Mon 075, Tue 448 

Stoiljkovic, M Thu 070, 

Stojakovic, N Tue 237 

Stojanovic, R Tue 013, Wed 009 

Stojanovic, Z Wed 009 

Stojiljkovic, M W34.3, 

Stojiljkovic, MP W34.5 

Stojiljkovic, N Thu 070 

Stokland, O Wed 139 

Stolakis, V Thu 431 Tue 381 

Stoltenberg, M Tue 359, Tue 248, Mon 320 

Stoop, JE Tue 096 

Stosic-Grujicic, S FC16.3.6 

Stove, V Mon 365, Tue 306 

Strateny, K Tue 113 

Strauss, L Mon 215 

Street, JM Thu 420, Tue 270 

Streng, T Thu 052, Thu 071 

Strnad, M Thu 118 

Strojil, Jan Tue 124 

Strømgaard, K Tue 053, Thu 037, Tue 080, 

Thu 026, Tue 065 

Struijk, JJ Tue 303 

Struijker-Boudier, H AJ Mon 212, Thu 221 

Stubbs, S FC06.4.5 

Studena, S Tue 125 

Stürmer, Til FC04.1.3 

Stützer, H Thu 018 

Stuhr-Hansen, N YI.10 

Sturkenboom, M FC04.4.5, FC04.2.6, 

FC04.4.6, Mon 140, 

FC04.3.6 

Sturmer, T FC04.1.4 

Stys, PK Tue 085 

Su, D-F PL22, Mon 330, Thu 210, 

W04.1.2 

Su, F Tue 403 

Su, MJ Mon 220 

Su, M-W Tue 393 

Su, R-B Tue 083, Thu 171, FC14.5.4 

Su, X Tue 401 

Index 369

370 Index 


Su, Y Wed 322, Thu 445 

Suarez Gonzalez, ME Tue 197 

Suárez, C Thu 271 

Suarez, E Wed 111 

Suarez-Kurtz, G W16.2 

Subedi, GP Tue 023 

Subramaniam, SR Mon 413 

Suda, M Tue 373 

Sudano, I FC16.1.2 

Suddhasthira, T Thu 443 

Sudharmarajan, S Thu 393 

Sudo, G Tue 162 

Sudo, K Tue 380 

Sudo, R Tue 162 

Suemaru, K Thu 421 

Süverkrüp, R Mon 384 

Sugamori, K Tue 389 

Sugawara, A Tue 153 

Sugihara, M Thu 038 

Sugihara, T Mon 335 

Sugimoto, M W23.4, Tue 473 

Sugimoto, T Thu 260 

Sugimoto, Y Tue 294 

Sugiyama, A Tue 126, Tue 236, FC13.2.5 

Sugiyama, K Mon 177, Mon 182 

Sui, Z Tue 173, Tue 325 

Suilamo, S Mon 256 

Suissa, S FC04.1.1 

Sukasem, C Tue 127 

Sukoyan, GV Mon 216 

Sukumaran, P Thu 079 

Sulaiman, SA Tue 455 

Sulayman, D-HD FC12.2.1 

Suling, F Tue 021 

Suljagic, V Tue 091 

Sultan, E Mon 203, Mon 201, Mon 205, 

Mon 204, Mon 202 

Sumak, T Tue 030, Tue 031 

Summers, RJ W01.1.1, Wed 063, Mon 395, 

Thu 059, Wed 080, W14.2 

Sun, A Tue 138, Mon 457, Mon 458 

Sun, B Mon 031 

Sun, D Thu 298 

Sun, H FC16.3.2, Thu 092, Tue 181 

Sun, H-L Thu 172 

Sun, H-S W28.1 

Sun, JH Tue 297 

Sun, L Tue 187, Tue 186 Tue 159, 

Tue 297, Wed 259 

Sun, Y Tue 181 

Sung, M-H FC18.4.2 

Surber, C Tue 438 

Surratt, C Tue 059 

Susumu, N Tue 311 

Suziedelis, K Mon 403 

Suzuki, F Thu 046 

Suzuki, H Thu 403 

Suzuki, K Tue 435, Thu 250 

Suzuki, M Tue 244 

Suzuki, T Tue 435, Wed 065, Thu 188 

Suzuki, Y Thu 102 

Svalbe, B Tue 141, Thu 189 

Svard, J Thu 442 

Svensson, S Thu 074 

Svensson, TH FC17.2.4 

Svinarov, D Tue 128 

Svirina, D Mon 429 

Svirskis, S Mon 429, Wed 045, Tue 253 

Svoboda, Z Tue 056 

Switzer, C FC09.3.3 

Sy, GY W27.5 

Sychev, DA Tue 129, Tue 057, Thu 253 

Syed, S Tue 495 

Sylte, I Mon 224 

Syunyakov, S Tue 024 

Syyong, H Wed 228 

Szabó, B Mon 150, Mon 167 

Szabo, C FC15.3.6, FC15.4.2, Thu 202 

Szabó, G Thu 307 

Szabo, S W02.2.2, W02.2.7, Tue 466 

Szafir, D W10.4 

Szakacs, B Mon 283 

Szarek, WA Tue 414, 

Szczepazka, R Wed 279 

Szekeres, T Thu 308 

Szell, T Mon 100 

Szente, L FC16.2.6 

Szentirmay, É Tue 078 

Szilagyi, K Thu 033 

Szilvássy, Z Mon 163, Tue 128, Tue 125, 

Mon 150, Mon 167, Tue 142 

Szitter, I Tue 271, Mon 283 

Szõke, E FC16.2.6, W19.3, Tue 250, 

Mon 283, Mon 106, Mon 401 

Szolcsányi, J Tue 271, Mon 283Mon 110, 

Tue 078, Mon 401, Mon 318 

Sztojkov-Ivanov, A Tue 130 

Szulc, M Thu 174 

Szuts, T Tue 250 

Szymanski, J Tue 313, Tue 131, Wed 119 

Tabassum, F Mon 260, Wed 315 

Tabatabaei Naeini, A Tue 370 

Taché, Y W02.3.2 

Tachikawa, E Tue 477 

Tada, Y Tue 067, Tue 143 

Tadagaki, K Thu 078 

Taddio, A FC10.5.3 

Taegtmeyer, H FC05.2.1 

Tagliaferro, P Thu 176 

Tagwireyi, D Tue 004 

Taha, H Tue 444 

Tahara, Y Mon 173, Tue 122 

Taher, A FC01.3.4 

Tahmiscija, I Wed 171 

Tai, WCS Thu 296 

Taillon, I Wed 123 

Taimi, V FC09.1.5 

Taira, E Wed 186, Tue 477 

Tajti, J Mon 106 

Tajuba, J Thu 021, Tue 221 

Takada, M Tue 136 

Takahama, K Tue 167 

Takahara, A Tue 168 

Takahara, A Thu 260 

Takahashi, H Tue 272 

Takahashi, HK Mon 035, Mon 329, Thu 275 

Takahashi, K Tue 072, Thu 072 

Takahashi, R Tue 156


Takahashi, T Tue 077 

Takahashi, Y Thu 320 

Takahashi-Yanaga, F Tue 162 

Takahasi, Y Tue 373 

Takai, M Thu 103 

Takamura, E Thu 227 

Takano, K Thu 286, FC09.1.6 

Takano, Y Thu 108, Wed 223, Mon 309, 

FC09.1.6 

Takarada, T Mon 441 

Takashima, H Tue 459 

Takashima, T Tue 244 

Takashima-Hirano, M Tue 244 

Takashina, Y Tue 484, Tue 491 

Takatori, S Tue 154, Thu 261, Tue 415 

Takatsuki, M Mon 307 

Takayama, S Mon 335 

Takayanagi, S Tue 153 

Takeba, Y Wed 117, Tue 273, Tue 337, 

Tue 483 

Takechi, K Thu 421 

Takeda, H Thu 422, Thu 423, Thu 397 

Takeda, K Thu 260 

Takenoshita, S Wed 117 

Takenoshita-Nakaya, S Tue 337, Tue 483 

Takeuchi, K Tue 379, Mon 179, W23.1, 

Tue 262, Mon 335, Mon 255, 

Mon 405, Tue 236, 

W02.2.3, Tue 467, Thu 262 

Takeuchi, K Thu 072, Tue 274, W02.2.4 

Takeuchi, O PL14 

Takeuchi, Reiri Tue 432 

Takeuchi, S Tue 318, Tue 138 

Takeuchi, T Thu 423, Thu 422, Thu 397 

Takeya, K Wed 239 

Takeyama, M Tue 132 

Takir, S Thu 269 

Takuma, K Tue 060, Tue 360 

Talani, G Thu 190, Tue 133 

Talari, H Thu 209 

Talbot, S Thu 073 

Talbot, S Tue 275 

Talebi, M Mon 454 

Talja, M Thu 223 

Tallerova, A Tue 276 

Talman, V Tue 433 

Tam, C Thu 197 

Tam, CWY Tue 140 

Tamae, A Tue 243 

Tamaki, T Mon 180, Wed 247 

Tamargo, J FC06.3.2 

Tamariz, J Wed 217 

Tamashiro, WMSC Mon 289 

Tamba, B Mon 108 

Tamba, BI Tue 134 

Tambo, Ernest YI.09 

Tamm, J Thu 427 

Tammaro, P Tue 061 

Tamminen, T Mon 341 

Tampé, R FC02.2.1 

Tamuleviciute, A Tue 061 

Tamura, E Thu 204 

Tamura, H Tue 474 

Tamura, Y Tue 236 

Tan, C Thu 074 

Tan, H-M FC16.4.5 

Tan, KL Tue 434 

Tan, PCS Mon 389 

Tan, SC Tue 153, Thu 181 

Tanabe, M Mon 272 

Tanabe, S Tue 435 

Tanabe, T FC03.4.5 

Tanabe, Y Thu 248 

Tanae, M Thu 355 

Tanaka, A Mon 405 

Tanaka, H Wed 186, Tue 168, Thu 099, 

Thu 260, Tue 373, Mon 461 

Tanaka, M Tue 380, Tue 492, Wed 117 

Tanaka, N Thu 263, Tue 375 

Tanaka, S Wed 422, Wed 415 

Tanaka, Y Thu 108, 

Tanayen, JK Tue 209 

Tancharoen, S Thu 331, Thu 443 

Tandon, N Mon 169 

Tandon, S FC01.3.6 

Tang, H-S Wed 430 

Tang, L FC06.4.6, Mon 210, 

Wed 362, Wed 258, Tue 317, 

Thu 298 

Tang, SP Tue 455 

Tang, X FC12.2.5 

Tanigami, M Mon 255 

Tanigawara, Y Tue 311 

Tanii, H Tue 413 

Tanji, H Mon 313 

Tantisira, B Thu 356, Thu 357 

Tantisira, M Thu 356, Thu 357 

Tao, P-L Tue 135 

Tao, S Tue 152 

Tapaninen, T Tue 062 

Tapia-Pancardo, DC Tue 025 

Tarasov, SA Mon 284 

Taraz, M Tue 251 

Tardieu, J-L Thu 035 

Targonska, A Thu 291 

Tashiro, M Tue 166, Tue 484, FC17.5.6 

Taskinen, P Tue 166 

Tateishi, T Wed 127 

Taube, C FC09.1.2 

Tavares, F Mon 376 

Tavares, JJF Thu 352 

Tavares, PLF Tue 282 

Tavridou, A Tue 224, Mon 187 

Tay, Jolyn Tue 136 

Tayarani-Najaran, Z Thu 313, Tue 424, Thu 342 

Tayebi, H Mon 160 

Taylor, DA Wed 428 

Taylor, D Thu 191 

Taylor, M FC05.3.6 

Taylor, P Mon 353, Mon 352 

Taylor, R W06.3 

Techanaparukse, K Wed 374, 

Tedroff, J Wed 147 

Tee, LBG Tue 063 

Teft, W Tue 064 

Teixeira, M FC03.1.5, W31.4 

Teixeira, S Tue 232 

Teja-Isavadharm, P Tue 090 

Index 371

372 Index 


Tejerina, T Wed 228, Wed 215, Mon 206 

Tejerina, Teresa Thu 264, Tue 144 

Tekes, K Wed 050 

Tékus, V Tue 078 

Teleshova, E Tue 024 

Tenayuca, J Tue 378 

Teng, B Thu 057 

Teng, S-F Wed 035 

Tengrungsun, T Thu 443 

Teraoka, K Wed 278 

Teräs, M Mon 256 

Ternant, D Tue 198 

Ternant, T Mon 363 

Terrón, JA Thu 265 

Terry, D FC02.1.2 

Terzian, A FC17.5.5 

Tesfaye, H Tue 137, Tue 445 

Tesmer, J Thu 075 

Tesse, A Wed 216, Wed 196 

Teulon, I Mon 363 

Teyssier, C FC18.3.5 

Tezcan, K Mon 418 

Tfayli, A FC01.3.4 

Tfelt-Hansen, J FC15.2.3 

Thacker, T FC11.3.2 

Þahin, S Tue 030 

Thakore, P Wed 260 

Thakur, S Thu 290 

Thal, D Thu 075 

Thampithak, A Tue 277, Thu 305 

Thangboonjit, W Mon 357 

Thapa, KK Tue 097, Tue 120 

Theron, A Thu 012 

Thiblin, I FC14.5.2 

Thiele, Sie FC11.5.5 

Thiemermann, C FC18.3.6 

Thompson, J FC17.1.3 

Thompson, MA FC04.2.5 

Thomsen, A Tue 358 

Thomsen, H Wed 161, Mon 360 

Thomsen, M Tue 065 

Thomson, M Tue 093 

Thor, D Thu 087 

Thorneloe, KS W03.5 

Thörngren, J-O FC14.1.6 

Thorsen, TS YI.10 

Thürmann, PA W35.1, Tue 313, Wed 119, 

Tue 131, Tue 314, Tue 108 

Thuillez, C Wed 207, Thu 242 

Tian, W-W Thu 210 

Tian, Y-L Thu 277 

Tian, Y-P Mon 265 

Tibboel, D FC10.4.1 

Tiburcio, R Tue 420 

Tie, Lu Thu 076 

Tikka, S Thu 052, Thu 071 

Tikoo, K Mon 171 

Tilley, S Thu 057 

Tilton, R FC16.5.3 

Timar, J Wed 185 

Timar, J Thu 192 

Timotijevic, G FC16.3.6 

Tinel, H Thu 091 

Tirkkonen, T Mon 144 

Tirona, R Tue 054, Mon 072, Tue 301, 

FC02.1.6 

Tirotta, E FC17.4.6 

Tiwari, V Mon 183 

Tiziana, B Thu 400 

Tjønneland, A Tue 482 

Tkeba, Y Tue 336 

Tlala, V Tue 110 

Tlaskalova-Hogenova, H Wed 118 

Tobaiqy, M Tue 109 

Toda, N Wed 200 

Toda, T Mon 177, Mon 182, Tue 318, 

Tue 138 

Todoroki, M Mon 272 

Todorovic, S FC03.2.2 

Todorovic, Z Tue 098, Tue 013, Tue 026, 

Wed 135, Wed 134 

W34.1, W34.2 

Todt, H Mon 218, Mon 217 

Toft, E Tue 303 

Tognolini, M Tue 258, Mon 381 

Tohamy, MA Mon 340 

Toklu, HZ Tue 027 

Tokuoka, S Tue 373 

Tölle, TR W03.6 

Tolonen, A Thu 348 

Tolstanova, G W02.2.7 

Tomalik-Scharte, D Mon 384, Thu 010 

Tomic, S Mon 342, Mon 343, Mon 370, 

Wed 112, Tue 121 

Tomic, Z W34.4 

Tomita, K FC09.1.6 

Tomita, S Mon 180, Wed 247 

Tomlinson, B Tue 139, FC02.4.6, Tue 140 

Tomlinson, G FC10.5.3 

Tomono, Y Mon 035 

Tomos, C Tue 126, Thu 206 

Tomsig, J Wed 076 

Tong, J Mon 468, Mon 414, Tue 412, 

Mon 408 

Tong, X Tue 028 

Tonkin, J Mon 102 

Tontonoz, P FC18.1.1 

Tontson, L Thu 077 

Topal Tanyilmaz, G Thu 266 

Topcu, I Mon 117 

Torii, K W02.1.7 

Torndal, U-B Tue 383 

Törnquist, K Thu 079 

Torp-Pedersen, C FC13.3.6, FC04.2.4, 

Mon 119, Mon 118 

Torrens, M Thu 177 

Torres Domínguez, A Thu 358 

Torres, A Wed 131 

Torres, I Wed 177 

Toste, F Tue 162 

Tostes, R FC06.1.5 

Tóth, A Tue 125 

Toth, D Mon 283 

Tóth, DM Mon 401 

Toufiño, C Wed 209 

Toukola, L W21.4 

Tourette, A Mon 084 

Touw, DJ W28.5, W29.4


Touyz, R W04.3.1 

Tovey, MG FC09.2.3 

Toyama, MH Thu 374, Wed 297 

Toylu, A Tue 200 

Toyohira, Y Tue 072 

Tozawa, A Mon 435 

Trabelsi, S FC07.3.6, Mon 020, Mon 021 

Trajano, ETL Wed 342 

Tran, K Tue 309 

Trandafilovic, M Thu 359 

Trandafirescu, C Tue 102 

Tran-Van-Minh, A FC03.2.4 

Trapasso, E Thu 316, Thu 364 

Travassos, AS Thu 193 

Traynelis, SF Wed 084 

Treede, R-D W03.6 

Treinys, R Thu 023 

Trejo, E Wed 040 

Trenti, A Thu 360 

Trevisani, M W03.1 

Trevisi, L Thu 360 

Tributino, J Mon 398 

Tricoire, J Mon 145, Mon 132 

Trifa, A Mon 417, Mon 438, Tue 481 

Trifirò, G FC04.1.6, FC04.4.5, 

FC04.4.6 

Tringham, E FC03.2.1 

Trinh, S Wed 306 

Trinquet, E Thu 035, FC11.2.1, Wed 077, 

FC11.3.5 

Tripatara, P Thu 361 

Trujillo-Ferrara, JG Tue 195 

Truter, I Mon 026 

Truter, Ilse Tue 110, Tue 111, Tue 112 

Tsai, H-Y Wed 328 

Tsai, M-H Wed 430 

Tsakiris, S Thu 431 Tue 381 

Tsang, LL Thu 341 

Tsartsalis, S Tue 141, Mon 297, Tue 126 

Tschische, P Thu 078 

Tse, HF Tue 346, Thu 270 

Tseng, C-J Tue 146 

Tseng, T-L Thu 362 

Tsirlis, AT Mon 297 

Tsiwtsiwadze, ET Mon 192 

Tso, AWK Mon 271, Mon 159 

Tsoli, M W06.3 

Tsopanoglou, N Thu 095 

Tsuboi, A Wed 372 

Tsuchida, K Tue 236 

Tsuchiya, H Wed 189 

Tsuchiya, K Mon 180 

Tsuda, S Tue 132 

Tsuji, F Mon 402, Mon 112 

Tsuji, M Thu 422, Thu 397, Wed 128, 

Tue 443, Thu 423 

Tsujimoto, G Wed 064 

Tsukada, H Tue 217 

Tsukahara, F Thu 444 

Tsukahara, Y Mon 112 

Tsukuda, K Mon 439 

Tsuruhisa, M Wed 223 

Tsuruma, K Thu 220 

Tsuruta, H Tue 474 

Tsuruta, T Tue 311 

Tsushima, H Tue 147 

Tsutsui, M Tue 072, Thu 344 

Tsutsui, S Tue 085 

Tu, S Wed 366 

Tubéry, M FC04.3.5 

Tuleu, C FC10.3.4 

Tulunay, FC Tue 142 

Tumanovskaya, L FC06.1.6 

Tunaru, S Wed 056 

Tuncer, M Mon 419, Wed 253 

Tuncok, Y Tue 449, Tue 366, Mon 474 

Tunkova, A Mon 081, Wed 118 

Tunthong, R Tue 127 

Tuominen, RK Tue 433, FC09.5.4, Mon 341 

Turcekova, K Mon 219 

Turecek, R Thu 028 

Turgeon, J Tue 051 

Turkanovic, J Tue 066 

Turkoviæ, B W02.3.1 

Turpeinen, AM Wed 361 

Turpeinen, T FC09.1.5, Tue 278 

Tursas, L Thu 348 

Turunen, P Thu 051 

Tvete, IF Tue 143 

Tyner, S Tue 090 

Uchida, N Tue 320 

Uchida, S Tue 144 

Uchimura, T Thu 331 

Uchipichat, V Wed 124 

Uckert, S FC08.3.5 

Udoh, F Thu 332 

Ückert, S Tue 212, Tue 211, Tue 210 

Ueda, M Wed 414 

Ueda, Y Tue 163 

Uematsu, S Mon 313 

Uemura, T Thu 034 

Ueno, S Tue 072 

Uezono, Y Wed 065 

Ugur, Ö Thu 049 

Uhl, G Thu 176 

Uhlen, S Mon 397, Wed 069 

Uhlhaas, P FC17.2.2 

Uhlik, J Tue 445 

Ulak, G Thu 401, Wed 351 

Ulbrich, C Thu 267, Wed 252 

Ulsund, AH Wed 026 

Ulugol, A Mon 098 

Ulukus, C Tue 411 

Uluoglu, C Tue 029 

Ulupinar, E Wed 406 

Ulusoy, HB Tue 030, Tue 031 

Ulzurrun, E Wed 109 

Uma, S Thu 229, Thu 230 

Umegaki, K Tue 067 

Umemura, K W23.4, Tue 473 

Undale, V Mon 336 

Undale, VR Thu 363 

Ungvári, E Mon 150 

Uotani, T W23.4, Tue 473 

Upasani, CD Thu 363 

Uranga Piña, R Wed 311 

Uras, R Tue 133 

Urban, N FC17.1.3 

Index 373

374 Index 


Urbánek, K Tue 124, Tue 475 

Urbanova, I Tue 222 

Urbañska, A Tue 022 

Urigüen, L Thu 399 

Urquhart, B Tue 054 

Urrutia, P Wed 152 

Ursino, MR Thu 316, Thu 364 

Uruno, A Tue 153 

Ushijima, K Thu 268 

Ushiki, T Mon 182 

Usta, MP Mon 480 

Ustenova, G Thu 336 

Utkan, T Wed 351, Mon 387, Tue 145 

Uurto, I Thu 223 

Uyaiabasi, GN Wed 295 

Uyanik, O Tue 461 

Uydes Dogan, SB Thu 266 

Uydes-Dogan, BS Mon 199 

Uydes-Dogan, S Thu 269 

Vaag, A Mon 406 

Vaanhole, C Wed 002 

Vach, W Tue 395 

Vacher, B Tue 183, Tue 171, Tue 172 

Vadodaria, K W01.2.4 

Vahabi, S Thu 365 

Vàhàkangas, K Mon 063 

Vähäkangas, K Mon 076 

Vahakoski, R Tue 429 

Vaidya, VA W01.2.4 

Vaillant, E Mon 161 

Vainer, B Tue 480 

Vainio, J Mon 256 

Vainio, M Thu 079 

Vainio, P Mon 410 

Vainio, P Tue 436 

Vainio, PJ Mon 256 

Vaja, V Mon 221 

Vajner, L Tue 445 

Valadares, F Thu 323 

Valant, C Thu 080 

Valat, J-P Tue 198 

Valdés, MA Mon 011 

Valdivieso, A Wed 111 

Valdizán, EM Wed 401 

Valdizin, V Thu 408 

Valdman, E Mon 462 

Vale, N Thu 366, Tue 146, Tue 032 

Valença, SS Wed 342 

Valentin-Hansen, L Thu 036 

Valenza, M FC18.4.6 

Valera-Mota, MM Tue 025 

Valérie, D Tue 190 

Valinotto, ML Mon 128 

Valle Cabrera, R Thu 424, Thu 425, Thu 394, 

Thu 395 

van Breemen, C Wed 228, Thu 264 

van Buchem, MA Mon 400 

van den Anker, JN FC10.1.6, FC10.4.2 

van denBrink, AM W13.1, Wed 292, Wed 220 

van der Akker, R Thu 258 

van der Lee, M Thu 085 

van der Lei, J FC04.4.6 

van der Saag, P Wed 446 

van der Westhuizen, E W14.2 

van der Westhuizen, ET Wed 080 

van Dongen, Marloes GJ Tue 148 

van Eps, N FC11.3.2 

van Es, W FC10.4.6 

van Essen, H Mon 212, Thu 208, Thu 221 

van Eyk, A Tue 147 

van Gerven, JMA FC17.3.5, Mon 400, 

FC10.4.6 

van Grootheest, K FC13.1.1 

van Hove, CE Wed 246, Wed 245 

van Langen, J Wed 246, Wed 245 

van Lipzig, M Thu 085 

van Loenen, P Thu 082 

van Overmeire, B Wed 006 

van Patot, MT Mon 053 

van Ree, JM W25.2 

van Tiel, C FC18.2.4 

van Veen, HW FC02.1.4 

van Veen, T Wed 432, Tue 096 

van Veldhoven, JP FC11.2.5 

van Vuuren, SF Tue 279 

van Westen, GJP FC11.4.6 

van Wijhe, M Thu 216 

van Winsen, MR FC11.2.5 

van Zyl, J Wed 399 

van Zyl, RL FC14.5.5. Mon 012, Tue 002, 

Tue 003, Tue 456, Tue 279 

Vandeghinste, N Tue 280 

Vandenberg, R Mon 052 

Vandendriessche, K Wed 001 

Vang, K Thu 405 

Vanhaesebrouck, P Mon 365, Tue 306 

Vanhanen, J FC14.3.6 

Vanhaver, M Wed 002 

Vanhoutte, F Tue 280 

Vanhoutte, PMV IUL, FC15.2.6, YI.06, 

Thu 294, Thu 282, Thu 255, 

Tue 157, Thu 281, Wed 218, 

Thu 270, Mon 324 

Vanina, M Wed 045 

Vannacci, A Thu 302, Tue 093 

Vannasaeng, S Tue 341 

Vapaatalo, H Wed 361, FC16.3.4, Mon 302 

Varanou, K Tue 230 

Varela, M Wed 212, Tue 226 

Varendi, H FC10.3.6 

Varinska, L Thu 216, Tue 423 

Varro, A W19.4, Wed 197, Wed 284, 

Mon 100 

Varsamidis, K Mon 300 

Varsamidou, E Mon 300 

Vas, A Mon 027 

Vas, Adam W24.2 

Vasconcelos, V W31.4 

Vashchinkina, EV Thu 194 

Vasileiadis, M Tue 141 

Vasilenko, GF Thu 253 

Vasovic, V Mon 115, Tue 148, Wed 321 

Vassileiadis, M Mon 187 

Vathesatogkit, P Tue 127 

Vauquelin, G Thu 426 

Vaux, K FC08.1.6 

Vavers, E Thu 189 

Vavrinec, P Thu 097


Vaxillaire, M Mon 161 

Vayssettes-Courchay, C Thu 273, Thu 274 

Vaziri, B Mon 455 

Vázquez, J Thu 271 

Vazquez-Carrera, M Wed 440 

Veale, E FC03.3.6 

Vecera, R Wed 118 

Veg, A Mon 371 

Vegezzi, G Tue 258 

Veiksina, S Tue 192 

Veis, AA Mon 297 

Veitia, AM Mon 038 

Vekovischeva, OY Thu 194 

Velasco, IT Wed 202, Wed 204, Wed 

203, Mon 257 

Velasco-Bejarano, B Mon 168 

Velázquez, L Mon 023, W04.1.3 

Velickovic-Radovanovic, R Tue 149 

Vellecco, V Thu 081 

Velo, G W32.5 

Venner, M Tue 049 

Ventura, S Mon 238, Tue 215 

Vera, D Wed 152 

Verbeuren, TJ Thu 273, Thu 274 

Vercesi, J FC15.4.5, Wed 198 

Verde, I Wed 211 

Vereschagin, E Tue 167 

Verleysdonk, S YI.02 

Verli, J Wed 050 

Vermetten, E FC17.5.3 

Vermeulen, N W10.2 

Verri Jr, W FC03.1.5 

Verstraete, . A Tue 306 

Verstraete, A Mon 365 

Verstuyft, C W02.2.6, FC13.5.5, Tue 189 

Vertkin, A Tue 267 

Verzijl, D Thu 082 

Vestri, A FC04.3.6 

Vets, E Tue 280 

Vey, JL FC11.3.2 

Vial, T FC09.2.7, FC04.2.5 

Viana, CTR Wed 302, Tue 428 

Viana, G Mon 299 

Viana, GSB Tue 281, Tue 282 

Vidal, R Wed 401 

Vidal, X FC14.4.5, Tue 087 

Vie, B Tue 172 

Viegas, M Mon 128 

Vieira, C Thu 064 

Vieira, R Mon 095, Mon 097, Mon 094 

Vieira-Coelho, MA Wed 114, Thu 398 

Vienberg, S FC05.3.5 

Vieyra, A Tue 162 

Viglinskaya, A Tue 150 

Vilà, L Tue 133 

Vilakkthala, R FC04.3.7 

Vilar, B FC11.3.6, Thu 083 

Vilas-Boas, OMGC Tue 101, Mon 010 

Vilches-Flores, A Tue 149 

Viljoen, M Thu 012, Thu 016 

Villafaña-Godínez, L Mon 011 

Villalba, N Thu 249, Tue 213 

Villalobos-Molina, R Mon 168, Wed 049, Tue 025, 

Tue 150, Tue 149 

Villalón, CM PL06, W13.3, Thu 022, 

Thu 203 

Villamil-Hernández, MT Thu 203 

Villamor, E Wed 226, Thu 217 

Villarroya, M Mon 079 

Villas-Boas, M Thu 366 

Villier, C FC09.2.7 

Vilskersts, R Mon 429 

Vincent, F W03.3 

Vinklerová, I Tue 475 

Vinson, B Wed 382 

Vinué, A W09.4 

Viollet, B Thu 210 

Virag, L Mon 100 

Virtanen, S Tue 429 

Vischer, H Thu 085 

Visegrády, A Tue 078 

Vistisen, J Thu 427 

Vital, MABF Wed 394 

Vitezic, D Tue 095, Tue 437 

Vitezic, M Tue 095 

Vitiello, M Thu 433 

Vivoli, E Mon 113 

Vizi, S Mon 460 

Vlachos, G Tue 381 

Vlahakis, JZ Tue 414, 

Vlahovic-Palèevski, V FC01.2.3 

Vobruba, V Wed 017 

Vogel, U Tue 480, Tue 482 

Vohora, D Wed 419 

Vohra, K FC09.5.5 

Vokác, K Wed 386 

Volkova, AV Wed 187 

Vollmar, A Tue 227 

Vollmar, AM FC16.1.5 

Volpe, A Tue 487 

von Ameln-Mayerhofer, A YI.02, Mon 463 

von Moers, A Thu 013 

Vora, A Tue 353, Mon 351 

Voronin, M Thu 415 

Voronina, TA Mon 422, Mon 462, Wed 187 

Vorspan, F Wed 191 

Vorum, H Wed 240 

Vosmik, M Tue 421 

Vosper, H Tue 232 

Voss, TC FC18.4.2 

Voss, U Thu 317 

Voutilainen, MH Mon 341 

Vovk, T FC07.3.5 

Vrech, C Mon 280 

Vreeburg, SA Wed 432 

Vrioni, G Tue 457 

Vucinic, S Tue 321 

Vuckovic, S Mon 114 

Vukmirovic Papuga, M Mon 115 

Vukmirovic, S Mon 115, Tue 148, Tue 454 

Vukovic, J Tue 091, Tue 151 

Vukovic, MH Wed 435 

Vuolteenaho, K FC09.2.5, Tue 283 

Vuorela, P Mon 302 

Vuorenpää, Ae Thu 084 

Vural, K Wed 357 

Vyas, R Mon 064 

Vybiralova, Z Thu 168 

Index 375

376 Index 


Vyslouzil, L Tue 342 

Waako, P Tue 005, Wed 136, FC01.4.5 

Wachall, B Thu 010 

Wacheck, V W05.3 

Waddington, J L FC17.2.1 

Wade, JD Wed 080 

Wade, R Tue 353 

Wade, S Thu 044 

Wadi, N Tue 152 

Wadie, W Wed 382 

Wadsworth, R Thu 272 

Waeckel, L Thu 273, Thu 274 

Wagg, C FC05.2.6 

Wagner, M Tue 166 

Wainwright, C Tue 232, Mon 211 

Wake, H Tue 272, Mon 035, Mon 329, 

Thu 275 

Wakita, S Mon 464 

Wakuda, H Tue 067, Tue 143 

Waldhoer, M FC11.1.6, Wed 073, Thu 078 

Waldkirch, E FC08.3.5, Tue 212 

Wallace, E Thu 030 

Walsh, D Tue 090 

Walsh, MP Wed 239 

Walsh, S FC14.1.1 

Walsh, TS Thu 420, Tue 270 

Walter, M Thu 112 

Walter, Nicole Tue 438 

Walters, MR FC15.1.6 

Walubo, A FC01.1.1 

Walubo, A Mon 258, Wed 389, 

Wed 390, Wed 391 

Wan Aasim, WR Tue 153 

Wang, C Tue 325 

Wang, A-Y Tue 400 

Wang, B Mon 228 

Wang, B-S Thu 368 

Wang, C Tue 163, Mon 468, Tue 412, 

Tue 173, Mon 467, Mon 408, 

Wed 327, Wed 150, Tue 152 

Wang, C-B Mon 008 

Wang, C Mon 414 

Wang, C Tue 033 

Wang, C-Y Mon 423 

Wang, D Tue 135 

Wang, D Thu 103, Tue 068 

Wang, F Tue 138, Thu 367 

Wang, G FC12.4.5, Wed 378, Mon 092 

Wang, G-L FC16.4.5, 

Wang, H Wed 242, Tue 138, Mon 458 

Thu 089, Thu 368 

Wang, HC Mon 356 

Wang, J Tue 425, Wed 270, FC15.4.6, 

Thu 088, Tue 284, Tue 371 

Wang, J Tue 439 

Wang, K Thu 172, Tue 307 

Wang, L Thu 017, Mon 056, Tue 069, 

Tue 070, Mon 466, Mon 445, 

Tue 440, Tue 155, Tue 317, 

Tue 183 

Wang, LL Thu 276 

Wang, M Tue 070 Thu 340 

Wang, P Thu 370, Thu 306, Thu 210, 

Thu 369 

Wang, Q Mon 331, Thu 089 

Wang, Q-G Thu 375 

Wang, R FC15.3.6 

Wang, S Tue 389 

Wang, S Tue 034 

Wang, S-P Thu 277 

Wang, T FC12.2.5 

Wang, Tao Mon 465 

Wang, W Thu 378 

Wang, W Thu 370 

Wang, X Thu 371, Wed 378, Mon 445 

Thu 378 

Wang, X Mon 466 

Wang, X-J Wed 367 

Wang, XX FC18.4.5 

Wang, Y YI.06 , FC12.2.5, Wed 331, 

Mon 034, Thu 372, Thu 020, 

Thu 270, Tue 035, Wed 039, 

Thu 340 

Wang, Yn Tue 285 

Wang, Y-H Tue 187, Tue 186 Thu 277 

Wang, Y Thu 104 

Wang, Y-W Wed 328 

Wang, YX Tue 082 

Wang, Z Tue 286, Thu 445 

Wang, Z-J FC03.3.3 

Wannarat, K Thu 356 

Ward, M Tue 495 

Ward, MB Tue 066 

Ward, R FC03.2.6 

Warner, T FC09.4.1 

Warner, TD Thu 200 

Warren, S Tue 145 

Warstat, C Tue 238 

Wasilewski, R Mon 181 

Wasner, G W03.6 

Watanabe, A Tue 234 

Watanabe, H W23.1, W23.4, Mon 093, 

Tue 144, Tue 473, Thu 262 

Watanabe, M Mon 253, Wed 117, Tue 273, 

Tue 380, Tue 492 

Watanabe, T Tue 459, Wed 414 

Watanabe, Y Tue 071, Tue 244 

Watanabe, Y Tue 377 



Watanuki, S Tue 166 

Waterhouse, C Tue 229 

Waters, N Wed 147 

Waters, S Wed 147 

Watier, H Mon 363 

Watson, A Thu 228 

Watson, JM Wed 030 

Watt, S Mon 211 

Watts, A Thu 085 

Wawruch, M Tue 113 

Waxman, SG FC03.1.4, FC12.2.1 

Webb, DJ FC15.3.5, Thu 420, Tue 270 

Webb, T Tue 037 

Weber, C W09.2, Thu 240 

Weber, G Mon 479, Thu 354 

Weber, M-A FC12.2.3 

Webster, R Mon 236 

Weerasuriya, K FC01.2.2, W36.1, W36.6


Wegener, G Wed 399, Thu 405 

Wei, J Thu 262 

Wei, W Tue 288 

Weihe, P Wed 151 

Weikop, P FC02.3.6 

Weimann, A Mon 406 

Weinberg, PD Thu 238 

Weinshilboum, RM FC13.5.4 

Weinstein, H FC02.1.2, FC02.3.5, Mon 

073 

Weiser, D Wed 382, Mon 317, Thu 317, 

Wed 417, Tue 462 

Welch, S Tue 064 

Wellendorph, P FC11.5.1, FC11.5.6 

Welling, J FC16.3.4 

Wells, P Tue 301 

Wells, TNC W31.1 

Welscher, U Mon 479, Thu 211, Tue 214, 

Mon 245 

Welsh, D Thu 105 

Wen, H Thu 278 

Wen, M Mon 310 

Wenceslau, C Wed 042 

Wendling, D Tue 198 

Wendremaire, M Tue 289, Tue 290 

Wenger, C Thu 435 

Wennerberg, M Thu 426 

Wergin, K Wed 119 

Werner, B Tue 151 

Werner, M YI.05 

Werner, M Thu 279 

Westfall, T Tue 205, Tue 206, Tue 204, 

Mon 244 

Westley, I Tue 495 

Weston, AH FC15.2.1, Wed 269, Wed 238 

Weston, R FC03.1.6 

Wettstein, JG Wed 094 

Wheat, A Wed 392 

Whistler, J Wed 073 

White, C Tue 215 

White, P Thu 032 

White, P W20.1, Thu 280 

Whittard, J FC14.1.2 

Wiborg, O Mon 046, Wed 433, Wed 397 

Wibral, M FC17.2.2 

Wichmann, J Wed 094 

Wicklund, B FC13.3.5 

Widmann, C FC17.2.5, Thu 237 

Wiench, M FC18.4.2 

Wieninger, PR Mon 153 

Wiesen, M Thu 018 

Wietzorrek, G Tue 151 

Wigerinck, P Tue 280 

Wihl, J Tue 395 

Wijtmans, M Thu 060 

Wikström, S Thu 008 

Wilding, JPH FC05.1.3 

Wilkes, DK Mon 442 

Wilkowski, R Tue 214 

Willars, GB Wed 025 

Williams, D Tue 063, Tue 495 

Williams, JHG Tue 109 

Williams, P Thu 110 

Williams, R Thu 393 

Wilm, S Tue 108 

Wilson, C Mon 339 

Wilson, J X W04.1.4 

Wingler, K FC15.4.4 

Wink, D FC09.3.3 

Winkelmayer, WC Mon 153 

Wirth, A Wed 056, Tue 134 

Wirth, VF Thu 086 

Wise, H Mon 321, Thu 045 

Wissel, G Wed 088 

Witschi, R FC03.3.3 

Wittkopf, D Thu 087 

Wlash, EJ Wed 239 

Wojnowski, L FC02.1.5 

Wolber, G Thu 014 

Woldbye, D FC02.3.6 

Wölfling, J Thu 308 

Wolin, MS FC08.2.5 

Wolmarans, DW Thu 428 

Woltering, T Wed 094 

Wolzt, M W10.1 

Won, H-H Tue 335 

Wong, CCM W02.1.4, Tue 476 

Wong, DVT Tue 255 

Wong, ESW Thu 281 

Wong, M SK Thu 282 

Wong, SL FC15.4.7 

Wong, WT FC15.4.7 

Wong, Y-H Thu 045 

Wongkajornsilp, A Mon 334 

Wood, Ruth I FC14.5.3 

Woodman, OL Wed 288, Wed 289 

Woodward, D Wed 270 

Woodward, D Thu 088, Tue 284 

Woolf, CJ FC03.3.4 

Wootten, D Wed 082 

Worku, A FC01.4.7, Mon 018 

Wörtwein, G FC02.3.6 

Wotjak, C FC17.5.5 

Wotjak, CT Thu 396 

Wraber, B Wed 178 

Wright, C Mon 214 

Wright, J Tue 309 

Wright, K Tue 460 

Wright, WR Thu 241 

Wu, B-N Thu 105 

Wu, C Tue 299, Thu 367, Tue 440, 

Tue 155 

Wu, C-C Wed 222, Thu 283 

Wu, CL Thu 429 

Wu, C-S Wed 430 

Wu, J Thu 445 

Wu, J Thu 089 

Wu, JY Mon 032 

Wu, K Wed 099 

Wu, L Tue 130 

Wu, M Tue 382 

Wu, N Thu 171, FC14.5.4 

Wu, Q Tue 184, Tue 458, Thu 186, 

Tue 178, FC14.4.6, Tue 382, 

Tue 181, Thu 116, Thu 184, 

Thu 182, Thu 185 

Wu, W-B Thu 373 

Wu, Y Thu 388 

Index 377

378 Index 


Wu, Y-C Thu 090 

Wu, Z Mon 310 

Wudayagiri, R Mon 091 

Wulff, H Thu 273 

Wulf-Johansson, H Thu 106 

Wunder, F Thu 091 

Wung, B-S Tue 291 

Xavier, IPP Tue 282 

Xhaard, H Wed 088 

Xi, Z-X Wed 182, Thu 195 

Xia, X-D Mon 470 

Xia, Y W30.2 

Xia, Y-Q Tue 495 

Xia, Y Tue 152 

Xiang, J Thu 370 

Xiang, X Thu 284 

Xiao, Y FC12.2.2 

Xiao, Z Wed 090 

Xie, H Tue 441 

Xie, J Tue 399 

Xie, L-Y Wed 259 

Xie, Y Tue 094, 

Xie, Z-L Tue 382 

Ximenes, RM Thu 374, Wed 297 

Xin, H-W Tue 393 

Xiong, X Tue 466 

Xu, C-B Wed 213 

Xu, A FC15.4.7, YI.06, Mon 324 

Xu, C Thu 092, Tue 181 

Xu, C-B Tue 185 

Xu, CB Mon 266, Wed 034 

Xu, C-B Thu 056, Tue 298, Wed 033 

Xu, J Thu 104 

Xu, J Mon 467 

Xu, J-K Thu 375 

Xu, L Thu 299, 

Xu, Li Thu 376 

Xu, S Mon 466, Mon 445 

Xu, T-Y Thu 210 

Xu, X-H FC12.3.5 

Xu, X-L Wed 259 

Xu, Y Wed 327, Mon 077, Mon 078, 

Thu 104, Tue 028 

Xu, Y Tue 292 

Xue, H-M Thu 287, Thu 288 

Xue, M Mon 056, Mon 077, Tue 069, 

Tue 070, Mon 078 

Yabumae, N Tue 154 

Yadav, AV Thu 363 

Yagi, M Mon 386 

Yajima, T Mon 386 

Yakouben, K FC10.1.5 

Yam, MF FC16.3.4, Tue 247 

Yamada, A Mon 178 

Yamada, K Tue 147 

Yamada, S Tue 217, Tue 067, Tue 216, 

Tue 144 

Yamade, M W23.4, Tue 473 

Yamagishi, Y Tue 154 

Yamaguchi, T Tue 435, Thu 099, Mon 461, 

Thu 430 

Yamakawa, T Tue 071 

Yamamoto, K Tue 484 

Yamamoto, M Wed 448 

Yamamoto, N Mon 424, Thu 285 

Yamamoto, R Thu 263 

Yamamoto, S FC09.1.6, Thu 286 

Yamamura, H Wed 107, Thu 102, Thu 107 

Yamamuro, A Wed 075, Mon 416, Mon 435, 

Mon 440, Wed 067 

Yamanaka, R Mon 250 

Yamashita, K Tue 071 

Yamashita, S Thu 108 

Yamauchi, M Wed 117 

Yamazaki, H FC09.1.6 

Yamazaki, K Tue 467 

Yan, C Tue 181, Tue 403 

Yan, H-T Thu 171 

Yan, L Mon 408, Tue 238 

Yan, L-C FC16.5.5 

Yan, L-D Tue 083 

Yan, T-T FC16.4.5 

Yan, X-Z FC16.3.1, Wed 379 

Yan, Y Tue 155 

Yanagida, S Tue 390 

Yanagihara, N Tue 072 

Yanagino, S Thu 250 

Yanai, K FC17.1.6, Tue 163, Thu 414, 

Tue 166, Tue 153 

Yanaka, A FC16.4.6 

Yáñez, A Tue 478, Tue 422 

Yañez, M FC16.2.5 

Yang, B Thu 377 

Yang, C Wed 090 

Yang, C-M Mon 311, Tue 293 

Yang, DI Thu 429 

Yang, G FC15.3.6 

Yang, HG Mon 433 

Yang, J Thu 295, Thu 367, Tue 440, 

Tue 155, Thu 277 

Yang, L Mon 310 

Yang, N Wed 429 

Yang, N-S Mon 268 

Yang, Q Mon 172 

Yang, Qin Thu 287, Thu 288 

Yang, R-F FC14.5.4 

Yang, S Thu 185, Mon 092 

Yang, S Thu 196, Tue 378 

Yang, S-M Mon 265 

Yang, S-N FC12.4.1 

Yang, SY Mon 428, Wed 277 

Yang, X Tue 426 

Yang, X-B Wed 367 

Yang, YK Mon 356 

Yano, I Tue 156 

Yano, T Mon 093, Thu 109 

Yanpallewar, S W01.2.4 

Yao, C Mon 310, Tue 260, Tue 294 

Yao, Q Tue 299 

Yao, R Thu 378 

Yao, X FC15.4.7 

Yao, X-Q Thu 288 

Yao, X-S Thu 375 

Yaris, E Tue 027 

Yarkova, M Thu 415, Tue 276 

Yarova, P Thu 289 

Yasar, U Wed 249, 

Yasuda, K Tue 126, FC13.2.5


Yasuda, S Tue 156 

Yasuhara, H Thu 319, Tue 320, Thu 343, 

Tue 443 

Yasui, Y Mon 253 

Yasumura, M Thu 034 

Yazdanpanah, H Tue 231 

Ye, C Tue 295, Tue 296, Thu 378 

Ye, J Mon 468, Mon 414 

Ye, L FC12.4.5 

Yeadon, M Tue 269 

Yeh, J-C Wed 330 

Yeh, K-C Mon 158 

Yeh, K-H Mon 456 

Yeh, T-K Mon 158 

Yeo, JL Wed 195 

Yeoh, PN Thu 379, Thu 380 

Yeow, R Thu 075 

Yesilyurt, A Mon 043 

Yeung, JHK Wed 345, Thu 389, Thu 381 

Yeung, YT Tue 157 

Yi, B Tue 317, Tue 036 

Yi, D Tue 155 

Yi, J-H FC16.5.5 

Yildirim, E Wed 406 

Yilmaz, H Mon 117 

Yimer, G FC01.2.5, FC01.4.7, 

Mon 018 

Yin, D FC06.4.6, Mon 210, Tue 158, 

Wed 362, Wed 258, Tue 317, 

Tue 036, Thu 298 

Yin, L-J Mon 265 

Yin, L Tue 400 

Yin, M Thu 093 

Yin, OQP FC02.4.6, Tue 140 

Yin, S Mon 210 

Ying, J Mon 092 

Yinka-Ogunleye, AF Tue 100 

Yip, KH Mon 321 

Ylä-Herttuala, S W21.3, Wed 448 

Yli-Kauhaluoma, J Tue 433 

Ýnce, S Wed 312 

Yodu, N Tue 114 

Yokokawa, A Tue 159 

Yokomasu, A Tue 156 

Yokomi, I Tue 380 

Yokomizo, K Thu 387 

Yokoo, H FC09.1.6 

Yokota, S FC10.5.4 

Yokota, S Tue 459 

Yokotani, K Thu 040 

Yoneda, Y Mon 441 

Yonehara, N Tue 084, Tue 338, Thu 285 

Yoneko, M Wed 263 

Yoneyama, M Tue 376, Tue 375 

Yoo, HJ Mon 427 

Yoon, JS Mon 068 

Yoshida, A Tue 217 

Yoshida, S FC03.2.5, Mon 243 

Yoshida, T Thu 034 

Yoshida, Y Tue 459 

Yoshihara, T Tue 162 

Yoshikawa, N Thu 320 

Yoshikawa, T FC17.5.6, Tue 153 

Yoshiki, H Thu 046 

Yoshioka, M Thu 430 

Yoshioka, Y Wed 075, Mon 416, Mon 435, 

Mon 440, Wed 067 

You, H Tue 085 

Youn, S-J Tue 161, Tue 160, Tue 162, 

Tue 073 

Young, A Wed 425, Mon 430 

Young, AMJ Mon 195 

Yousif, M Mon 151 

Yshii, L Mon 292 

Yu, D-H Tue 399 

Yu, H Mon 185, Thu 089 

Yu, HJ Mon 325 

Yu, H-M Tue 426 

Yu, J Mon 468, Mon 414, Wed 093, 

Yu, X Tue 307 

Yu, X-J Tue 187, Tue 186 Tue 159, 

Thu 292, Wed 259 

Yu, Y FC12.2.5 

Yuan, S Mon 310, Tue 163 

Yuan, Y W03.7 

Yuan, ZY Wed 034 

Yubero, S Thu 177 

Yue, Q-Y FC13.4.5 

Yura, A Wed 372 

Yurdakok, B Wed 312 

Yusof, W Tue 164 

Yutani, C Mon 306, Mon 174 

Yýldýz Akar, F Thu 401 

Yýldýz, A Tue 245 

Zabihyan, B Mon 041 

Zablockaite, D Thu 023 

Zachow, A Tue 115 

Zadori, Z Thu 062 

Zadori, Z Thu 094 

Zádori, Z W19.1 

Zahaf, N Wed 405 

Zahir, H Wed 122 

Zahler, S Tue 227, FC16.1.5 

Zahora, J Tue 125 

Záhora, J Wed 017 

Zainal, NZ Wed 431 

Zaklyazminskaya, E Tue 106 

Zama, T Tue 311 

Zamami, Y Mon 174, Tue 154, Tue 415 

Zaman, G Thu 085 

Zamani, M Thu 290 

Zambelli, V Mon 276 

Zambon, A Tue 093 

Zampatis, D Thu 095 

Zamponi, F Thu 028 

Zamponi, G FC03.2.1 

Zamponi, GW Tue 085 

Zang, W-J Tue 187, Tue 186, Thu 292, 

Wed 259 

Zang, W-J Tue 159 

Zang, Z Wed 322 

Zanger, UM FC13.4.4 

Zangrossi, H FC17.5.5 

Zaniolo, O Wed 154 

Zannad, F Tue 182 

Zanou, N Wed 102 

Zaporowska-Stachowiak, IThu 291 

Zarate, V FC01.2.4 

Index 379

380 Index 


Zare, A Tue 017 

Zarkovski, A Thu 409 

Zarrindast, M Wed 027, Wed 437 

Zarrindast, M-R Mon 437 

Zarros, A Thu 431, Tue 381 

Zasadny, K Tue 372 

Zastre, J Mon 070 

Zaychenko, GV Tue 218, Thu 382 

Zdarova-Karasova, J Tue 343, Mon 075 

Zebedin-Brandl, E Mon 217 

Zebuhr, L Tue 214 

Zegarra, C Mon 451 

Zehender, M Wed 099 

Zeilhofer, HU FC03.3.3 

Zeng, Y Tue 094 

Zermani, R Mon 338 

Zerpa, H Tue 362 

Zezelic, S Mon 370 

Zgheib, N FC01.3.4 

Zhai, Q-W Thu 210 

Zhan, Q Tue 145 

Zhan, RX Wed 291 

Zhanataev, AK Tue 165 

Zhang, B Thu 276 

Zhang, B-R Mon 265 

Zhang, C Tue 285 

Zhang, D Tue 295, Tue 153, FC10.1.5 

Zhang, D Tue 296 

Zhang, D Tue 166 

Zhang, F Thu 186 

Zhang, G Mon 469, Wed 122 

Zhang, G-R Mon 470 

Zhang, G Tue 155 

Zhang, H Thu 371, Mon 467, Mon 092, 

Thu 384, Tue 440, Thu 372, 

Wed 322 

Zhang, H-L Thu 292, Wed 259 

Zhang, H-N FC09.5.6 

Zhang, J Wed 331, Wed 242, Thu 383, 

Mon 035, Mon 329, Mon 352, 

Tue 075, Thu 372, Thu 277, 

Thu 093 

Zhang, JQ Thu 295 

Zhang, K-Z Mon 265 

Zhang, L Thu 370, Mon 265, Tue 083, 

Thu 196, Tue 378, 

Thu 378, Thu 384 

Zhang, M FC12.4.5, Mon 265, Thu 172 

Zhang, P FC02.3.5 

Zhang, Q FC16.3.1, Tue 188, Tue 189, 

Thu 390, Wed 379 

Zhang, R Tue 299, Wed 254 

Zhang, SF Wed 039 

Zhang, S-Q FC14.5.4 

Zhang, T Tue 297 

Zhang, T Thu 019, Thu 020 

Zhang, W Tue 185, Tue 440 

Zhang, W-C Mon 421 

Zhang, W-K Thu 375 

Zhang, X Thu 445, Thu 089, W33.2, 

Tue 076 

Zhang, X-H W04.1.2 

Zhang, X-Q Mon 082, Thu 385 

Zhang, Y Wed 402, Thu 432, Tue 117, 

Thu 369, Thu 306, Tue 285, 

Thu 021, Tue 185, Tue 292, 

Thu 368, Wed 213, Wed 033, 

Tue 403, Tue 298 

Zhang, Y-H Mon 082, Thu 385 

Zhang, Y Tue 075 

Zhang, YL Mon 053 

Zhang, Y-H Thu 386 

Zhang, Y-X FC16.3.1, Wed 379, Mon 470 

Zhang, Z Tue 076 

Zhang, Z-Q FC14.5.4 

Zhao, J-N FC16.5.5 

Zhao, M Tue 159, Thu 277, Thu 292, 

Wed 259 

Zhao, P Tue 425, Tue 371 

Zhao, W FC10.5.5 

Zhao, X Mon 082 

Zhao, Y FC02.1.2, Wed 402, Tue 130, 

Tue 285 

Zhao, YB Mon 032 

Zhao, Z Wed 378, Tue 181, Tue 076 

Zhdanov, V Tue 167 

Zheng, J Tue 299, 

Zheng, J-P Tue 185 

Zheng, J-Q Thu 171 

Zheng, R Tue 296, Tue 295 

Zheng, S-Z Tue 400 

Zheng, X Thu 388, FC12.2.5 

Zheng, Y Thu 299 

Zherdev, V Tue 150 

Zhong, B Thu 298 

Zhong, H Mon 046 

Zhong, W Tue 152 

Zhorov, BS FC12.5.5 

Zhou, C Tue 155 

Zhou, F Tue 440 

Zhou, H Tue 229, Tue 299, Thu 377 

Zhou, J-C Mon 031 

Zhou, J Thu 387 

Zhou, L Thu 388 

Zhou, N Thu 372 

Zhou, PXL Thu 381, Thu 389 

Zhou, P-L Tue 083 

Zhou, S-P Mon 470 

Zhou, W Wed 402 

Zhou, W Thu 432 

Zhou, W-X FC16.3.1, Wed 379, Mon 470 

Zhou, Y FC12.5.4 

Zhu, A Tue 372 

Zhu, B Tue 156 

Zhu, C Tue 155 

Zhu, H Tue 163 

Zhu, J Wed 093 

Zhu, L Mon 414, Tue 173, Tue 325, 

Mon 408, Wed 267 

Zhu, Q Wed 362, Mon 323 

Zhu, R Wed 076 

Zhu, W Thu 445, Thu 089 

Zhu, X Tue 138, Tue 094 

Zhu, XX Mon 469 

Zhu, Y Wed 242 

Zhu, Z Tue 384, Thu 390, Tue 076 

Zhukov, V Wed 188


Zhuravlev, YN FC16.5.1 

Zia, M Thu 391, Thu 392 

Ziaurrahman, S Tue 119 

Zibar, L Tue 121 

Ziberna, L Thu 293, Thu 359 

Ziche, M Wed 243 

Zidariè, M Wed 153 

Zidek, Z Wed 118 

Zídek, Z Wed 386, Tue 300 

Ziganshin, AU Thu 096 

Ziganshina, LE Thu 096 

Ziogas, J Wed 288, Wed 289, 

Mon 214, Thu 393 

Zitman, FG Wed 432, Tue 096 

Zolfagharpour, A Thu 209 

Zolotarev, V W02.1.2 

Zolotov, N Mon 462 

Zong, S FC03.4.5 

Zoric, Z Thu 436, Mon 446 

Zorina, L Wed 314 

Zou, F Mon 210 

Zou, Q Thu 294 

Zou, X Wed 150 

Zoulova, J Tue 342, Thu 168 

Zsifkovits, C Wed 016 

Zubata, I Tue 342 

Zügel, S Tue 462 

Zúñiga, C Wed 217 

Zuo, P Mon 465, Wed 429 

Zupkó, I Tue 130, Tue 442, Thu 308 

Zusmanovich, M Mon 228 

Zvejniece, L Thu 189 

Zwane, N Tue 001 

Zwisler, ST FC13.5.5 

Zwykiel, S Wed 056 

Zychar, BC Wed 333, Wed 334 

Zygmunt, M Tue 039 

Zygmunt, P FC09.4.5 

Index 381

382 Notes 

Notes

Notes 383

Final Programme printed in Singapore by C.O.S. Printers Pte Ltd . 06.2010 . Layout: Christen Tofte . Photos: Wonderful Copenhagen, Bella Center, Øresundsbron

Impact 

factor for 

2008: 

2.073 

Basic & Clinical Pharmacology & Toxicology 

Official journal of 

WorldPharma 2010 

17–23 July 2010 

Copenhagen 

Denmark 

Preferred journal of 

The European Association for 

Clinical Pharmacology and Therapeutics

Final Programme - iuphar

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?